Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cellular potassium ion homeostasis (GO:0030007),-0.8907030885228346,-2.3675208436101793,0.0,0.0,0.0,6/13,5.29%,KCNMA1;SLC12A2;ATP1B1;ATP1A2;KCNJ2;ATP1B2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.6375068835311917,-2.2941134807120958,0.0,0.00044269886067910117,0.001,11/38,6.64%,BIN1;CACNB2;CTNNA3;ANK2;CACNA1C;SCN1B;JUP;KCNJ2;TRPM4;KCNJ3;AKAP9
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.4782375441656107,-2.211921831266481,0.0,0.0035415908854328102,0.009,39/159,8.98%,CADM1;TENM2;PTPRD;PTPRM;ADGRL3;LRRC4C;IL1RAPL1;PTPRT;SDK1;ITGAM;ACVR1;NTNG1;ROBO2;KIRREL3;ROBO1;TENM3;NLGN1;CNTN6;CDH23;TGFBR2;CNTN2;CDH11;GRID2;CNTN4;UNC5D;ATP2C1;CDH9;IGSF11;MAG;LRRC4B;ITGB2;CD164;CDH8;CDH2;CDH6;CDH12;BSG;CLDN11;TGFB2
prerank,regulation of NMDA receptor activity (GO:2000310),-0.619836168320644,-2.1174210615124673,0.0,0.012616917529354385,0.049,16/32,11.50%,DLG2;MEF2C;GRIN2A;NLGN1;GRIA4;GRIN2B;GRIA1;GRIA2;NEFL;OPRM1;RELN;GRIN1;GRIA3;ACTN2;CAMK2A;DLG1
prerank,triglyceride catabolic process (GO:0019433),0.8776032539537837,2.0779639214369925,0.0,0.0010337172838286906,0.001,3/19,1.44%,FABP4;LIPG;FABP5
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.7162097454816272,-2.0735571748737622,0.0,0.01770795442716405,0.089,11/18,14.95%,GRIK1;UNC13C;GRIA2;GRID2;GRIK2;SLC17A6;CDH8;GRIK5;GRID1;GRIK3;SLC1A4
prerank,regulation of T cell proliferation (GO:0042129),0.7262251979530423,2.069739919479192,0.0,0.0010337172838286906,0.002,15/61,4.35%,GPNMB;LGALS3;ARG1;LILRB1;ANXA1;NCK2;CEBPB;FOXP3;TFRC;IL6;CD28;CD46;CD274;PLA2G2D;TNFRSF1B
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.8112682972510294,-2.0526047438436947,0.002857142857142857,0.02213494303395506,0.128,7/12,11.50%,BIN1;CTNNA3;CACNA1C;RYR2;JUP;TRPM4;DLG1
prerank,cholesterol transport (GO:0030301),0.7421323900110905,2.0170327160147195,0.0,0.002756579423543175,0.006,13/45,9.57%,CD36;CEL;SOAT1;ABCA1;APOE;LIMA1;LIPG;NPC1;ABCG1;SERAC1;STARD5;RELCH;VPS4A
prerank,cholesterol efflux (GO:0033344),0.8345951235257126,2.003333019953456,0.0,0.0025842932095717264,0.008,5/20,1.95%,SOAT1;ABCA1;APOE;NPC1;ABCG1
prerank,positive regulation of synapse assembly (GO:0051965),-0.6016083354668432,-1.9995025449980635,0.0,0.04211963445889734,0.256,10/27,10.41%,PTPRD;IL1RAPL1;NRXN1;NLGN1;GRID2;LRRC4B;CUX2;SYNDIG1;AGRN;NLGN3
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5438875284174657,-1.9871133021137846,0.0,0.04604068151062653,0.308,23/46,17.28%,GRM5;MEF2C;OPHN1;NRXN1;SYT1;NLGN1;GRM1;GRM8;GRIK1;ATP1A2;RELN;TSHZ3;GRM3;CDH2;CACNG4;HOMER1;NLGN3;GRIK3;CACNG3;CCR2;GRM7;CACNG2;TNF
prerank,acylglycerol catabolic process (GO:0046464),0.7676614877567894,1.9711476860793793,0.0,0.006409047159737881,0.027,4/30,1.78%,FABP4;LIPG;FABP5;MGLL
prerank,secretory granule organization (GO:0033363),0.9179691210404061,1.948808227896871,0.0,0.01085403148020125,0.057,3/10,0.64%,LYST;ABCA1;DTNBP1
prerank,intestinal lipid absorption (GO:0098856),0.9201543396402878,1.9468904167322731,0.0,0.009746477247527655,0.058,3/11,0.71%,CD36;CEL;LIMA1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6203476089814371,-1.9411356778888011,0.0,0.07250423562677724,0.481,14/25,15.96%,ATP1B1;ANK2;ANK3;WNK3;ATP1B2;AKAP9;NDUFA4;TCAF1;GLRX;WNK2;ACTN2;WNK1;COX17;STAC
prerank,iron ion transport (GO:0006826),0.7008839020059137,1.9343675166552057,0.0,0.011500104782594183,0.077,23/47,17.14%,ATP6V0D2;STEAP3;ATP6V1A;ABCB7;TFRC;ATP6V1E1;SLC11A2;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;HEPH;ATP6V0A1;SLC39A14;ATP6V0E1;RAB11B;ATP6V0C;ATP6V0B;SLC11A1;ATP6V1H;MELTF;ATP6V1F;FTH1
prerank,fatty acid transport (GO:0015908),0.8443504528327554,1.9300029900505156,0.0,0.011370890122115597,0.086,8/17,8.01%,FABP4;CD36;PPARG;APOE;FABP5;SLC27A4;SLC27A3;SLC27A1
prerank,transferrin transport (GO:0033572),0.7246703627986711,1.9257581275707112,0.0,0.011681005307264205,0.096,15/33,13.86%,ATP6V0D2;STEAP3;ATP6V1A;TFRC;ATP6V1E1;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;RAB11B;ATP6V0C;ATP6V0B;ATP6V1H
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5378009833823406,-1.9237344936023053,0.0,0.08065973241573224,0.554,8/37,5.58%,CADM1;TENM2;PTPRD;IL1RAPL1;TENM3;NLGN1;GRID2;CD164
prerank,intracellular pH reduction (GO:0051452),0.7241717769302652,1.9234503387672341,0.0,0.011652813017705238,0.105,20/33,16.75%,ATP6V0D2;DMXL2;ATP6V1A;ATP6V1E1;RAB20;RAB7A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B;SLC11A1;ATP6V1H;DMXL1;GPR89A;GPR89B;ATP6V1F
prerank,regulation of neuron projection development (GO:0010975),-0.4026252823234562,-1.9228674191391335,0.0,0.0742124271902057,0.558,45/163,9.76%,TANC2;CSMD3;RTN4RL1;ARSB;CAMK1D;RIT2;LRRC4C;IL1RAPL1;CTNNA2;SPOCK1;NTNG1;TWF2;TENM3;DCC;DISC1;NTRK3;SETX;ITGA6;EPHA3;TOX;PTPRO;ABI2;MBOAT1;PLPPR5;KNDC1;MAGI2;SCN1B;FUT9;RELN;MAG;CDK5R1;ARHGAP44;NTRK2;SIPA1L1;ATP1B2;PRKD1;SRCIN1;PAK1;CDH2;MARK1;ULK4;MARK2;SEMA3A;DAB2IP;SERPINI1
prerank,vacuolar acidification (GO:0007035),0.7900496820963456,1.9176427338191695,0.0,0.01206003497800139,0.117,15/21,15.91%,ATP6V0D2;DMXL2;TCIRG1;ATP6V0D1;PPT1;TMEM199;CLN5;CLN3;ATP6V0A1;ATP6V0E1;SLC11A1;ATP6V1H;ATP6AP2;DMXL1;GRN
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.7594855707599977,1.9110459363408436,0.0,0.013358807975632311,0.138,6/27,2.82%,CD36;PPARG;ABCA1;PRKCH;ABCG1;NR1H3
prerank,phagosome maturation (GO:0090382),0.7152869092916898,1.907612464578094,0.0,0.013733672485152603,0.156,18/35,13.86%,ATP6V0D2;PIKFYVE;ATP6V1A;MREG;ATP6V1E1;RAB20;RAB7A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;RAB31;ATP6V0A1;ATP6V0E1;RAB43;ATP6V0C;ATP6V0B;ATP6V1H
prerank,long-chain fatty acid transport (GO:0015909),0.7473281789580285,1.9037352358554107,0.0,0.013989640574481614,0.167,11/30,9.83%,FABP4;CD36;PPARG;APOE;FABP5;PRKAG2;ABCD1;SLC27A4;SLC27A1;CPT1A;SLC25A20
prerank,response to glucocorticoid (GO:0051384),0.7373129353860091,1.9035590896997787,0.0,0.013373717359533683,0.171,8/26,7.20%,BCL2L11;ANXA1;ADAM9;IL6;UBE2L3;NR3C1;HNRNPU;ZFP36L2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.786596742037832,1.901800155704449,0.0,0.013863972983114203,0.184,7/18,7.20%,BCL2L11;ANXA1;AQP1;UBE2L3;NR3C1;HNRNPU;ZFP36L2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.7556086802305186,-1.9011825008956162,0.0029154518950437317,0.08846598899237372,0.656,5/11,8.98%,ACVR1;TGFBR2;TGFBR1;SMAD7;TGFB2
prerank,positive regulation of cholesterol transport (GO:0032376),0.7475375682601222,1.8994237088432948,0.001277139208173691,0.013955183331687323,0.192,12/27,12.31%,PPARG;EEPD1;APOE;LIPG;LRP1;NR1H3;RXRA;PLTP;ABCA3;SIRT1;LPCAT3;TREM2
prerank,reverse cholesterol transport (GO:0043691),0.8730388305667202,1.8971644775287158,0.0,0.013764761726771511,0.198,4/13,1.95%,ABCA1;APOE;LIPG;ABCG1
prerank,insulin receptor signaling pathway (GO:0008286),0.6496432252298406,1.8918953056358572,0.0,0.014161926788453062,0.213,30/69,14.61%,ATP6V0D2;NAMPT;GRB2;ATP6V1A;PDK4;BAIAP2;AP3S1;ATP6V1E1;SOS1;ATP6V1C1;TCIRG1;ATP6V0D1;FOXO4;IRS2;PIK3CA;APC;ATP6V1B2;ATP6V0A1;SLC39A14;SH2B2;GSK3B;FOXO1;APPL1;ATP6V0E1;GPLD1;ATP6V0C;ATP6V0B;ATP6V1H;PHIP;SHC1
prerank,regulation of cholesterol efflux (GO:0010874),0.7289571375833187,1.8840292169113662,0.001272264631043257,0.015948780950499796,0.247,12/30,12.31%,PPARG;EEPD1;APOE;LRP1;NR1H3;RXRA;PLTP;ABCA3;ABCA2;LAMTOR1;SIRT1;TREM2
prerank,cellular response to insulin stimulus (GO:0032869),0.6109124590920885,1.8746599460028608,0.0,0.01935870549715548,0.29,42/124,14.61%,ATP6V0D2;PPARG;MYO5A;DENND4C;NAMPT;GRB2;LPIN3;ATP6V1A;PDK4;RAB8B;BAIAP2;AP3S1;ATP6V1E1;SOS1;PDPK1;ATP6V1C1;TCIRG1;ATP6V0D1;ENPP1;FOXO4;SLC27A4;IRS2;APC;ATP6V1B2;RAB31;SLC27A1;ATP6V0A1;RAB12;SLC39A14;SH2B2;GSK3B;RAB10;FOXO1;EPRS1;APPL1;ATP6V0E1;GPLD1;ATP6V0C;ATP6V0B;ATP6V1H;PHIP;SHC1
prerank,regulation of cation channel activity (GO:2001257),-0.44277191828954954,-1.8676983650624097,0.0,0.11850707962794402,0.79,37/89,16.48%,FGF14;DLG2;CACNB2;MEF2C;GRIN2A;NLGN1;GRIA4;GRIN2B;GRIA1;GRIA2;ANK2;NEFL;ANK3;OPRM1;CACNB4;FGF12;KCNAB1;RELN;GRIN1;FGF13;GRIA3;CACNG4;JPH1;HOMER1;SHISA6;PRKACA;GSG1L;ACTN2;CAMK2A;DLG1;SELENON;DLG3;CACNG3;STAC;CACNG2;CACNB1;SHISA7
prerank,positive regulation of cholesterol efflux (GO:0010875),0.7715354536547379,1.8673786899866405,0.0013477088948787063,0.02206761679825596,0.334,10/21,12.31%,PPARG;EEPD1;APOE;LRP1;NR1H3;RXRA;PLTP;ABCA3;SIRT1;TREM2
prerank,negative regulation of T cell proliferation (GO:0042130),0.7384850497980564,1.8664826969840016,0.0,0.0217080629604025,0.341,7/28,4.18%,GPNMB;ARG1;LILRB1;CEBPB;FOXP3;CD274;PLA2G2D
prerank,phagosome acidification (GO:0090383),0.7335358556547584,1.8662020956041754,0.0,0.02104648389875214,0.343,14/26,13.86%,ATP6V0D2;ATP6V1A;ATP6V1E1;RAB20;RAB7A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B;ATP6V1H
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.723540858264418,-1.864752795868048,0.005934718100890208,0.1133309083338499,0.797,7/12,12.12%,ATP1B1;ANK3;WNK3;ATP1B2;GLRX;WNK2;WNK1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7211567112842356,-1.861890485761883,0.0029498525073746312,0.11008445002220317,0.806,6/12,7.98%,SYT1;RIMS1;UNC13C;RIMS2;SYT7;SYT2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.48095481064484047,-1.860789054400525,0.0,0.10525165412645632,0.812,26/57,16.48%,DLG2;MEF2C;GRIN2A;NLGN1;GRIA4;GRIN2B;GRIA1;GRIA2;DLGAP1;NEFL;DLGAP2;OPRM1;RELN;GRIN1;AKAP9;GRIA3;CACNG4;SHISA6;GSG1L;ACTN2;CAMK2A;DLG1;DLG3;CACNG3;CACNG2;SHISA7
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5229824869291496,-1.8551438484222351,0.0,0.10546649327943294,0.826,18/37,7.17%,GRM5;GRIN2A;GRM1;GRIA4;GRIN2B;GRM8;PLCB1;GRIK1;GRIA2;GRIN3A;GRID2;GRIK2;CDK5R1;GRIN1;FMR1;GRM3;GRIA3;HOMER1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.8586115493167938,1.8546684192188871,0.0014947683109118087,0.02624051566642061,0.419,4/12,2.82%,PPARG;ABCA1;ABCG1;NR1H3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7300394688252445,1.844476355627374,0.0012987012987012987,0.03131780511747662,0.486,9/26,12.73%,CCBE1;HPSE;IL6;ATF4;SULF2;BRCA1;RORA;SARS1;SULF1
prerank,negative regulation of lipid storage (GO:0010888),0.78711276554837,1.8436096994700233,0.0013736263736263737,0.030863844617170906,0.49,6/19,2.99%,PPARG;OSBPL8;ABCA1;ABCG1;NR1H3;IL6
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5835976527982553,-1.8427561639746368,0.0,0.11618385654711523,0.858,10/24,8.98%,ACVR1;ROBO2;ROBO1;BMPR1A;TGFBR2;FGFR2;ENG;ZFPM2;PARVA;TGFB2
prerank,sterol homeostasis (GO:0055092),0.6368128937390547,1.8403510234097322,0.0,0.03151055444498492,0.508,16/65,11.99%,SOAT1;ABCA1;GRAMD1B;APOE;LIMA1;LIPG;NPC1;ABCG1;NR1H3;ABCD1;FGFR4;ACSM3;ABCA2;LAMTOR1;SIRT1;RORA
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.49763186794456127,-1.840039074577343,0.0,0.1133775082139214,0.864,15/44,13.82%,KCNMA1;ATP1B1;ANK2;WNK3;KCNJ2;ATP1B2;KCNJ3;NOS1AP;GABBR1;AKAP9;KCNJ9;WNK2;ACTN2;WNK1;KCNN2
prerank,regulation of sequestering of triglyceride (GO:0010889),0.8237495514870814,1.839728894493529,0.0,0.03070140332971211,0.51,4/15,1.84%,PPARG;OSBPL8;PLIN2;PLIN3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.637459247827083,-1.8376369235869772,0.014545454545454545,0.11049763562550366,0.871,7/17,19.75%,SNTA1;ANK2;SCN1B;NOS1AP;AKAP9;CACNA2D1;SCN4B
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.7409891219862726,1.8372065249988285,0.0,0.031378321422025734,0.531,8/24,12.73%,CCBE1;HPSE;IL6;ATF4;SULF2;BRCA1;RORA;SULF1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.6087710662306508,-1.8335487211254313,0.010380622837370242,0.11092768594730623,0.888,7/19,6.96%,MEF2C;ERBB4;BMPR1A;FGFR2;TGFBR1;FGF2;ZFPM2
prerank,potassium ion transmembrane transport (GO:0071805),-0.4051423238120207,-1.8316628563660786,0.0,0.10777704989987574,0.891,33/135,13.96%,SLC24A3;SLC9A9;KCND2;SLC12A2;HCN1;ATP1B1;SLC12A6;KCNH7;SLC24A2;KCNC2;KCNB2;SLC1A3;ATP1A2;KCNH1;KCNAB1;KCNK2;KCNC1;KCNJ2;KCNK6;ATP1B2;KCNJ3;KCNC3;NALCN;KCNJ9;SLC24A4;KCNQ2;HCN2;HPN;KCNH8;PKD2;SLC12A4;KCNN2;PKD2L1
prerank,negative regulation of leukocyte activation (GO:0002695),0.794537739090491,1.830407969918423,0.002805049088359046,0.03517869131529513,0.577,4/15,2.82%,CD300LF;CD300A;CD84;NR1H3
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.7205050352450215,1.829495312118974,0.0,0.03477049045605596,0.582,9/26,7.99%,IQGAP1;PDPK1;EEF1A1;STAT5B;DUSP3;PTPN12;ZFP36L2;SOX9;SNAI2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.7105179210476272,1.828579845054755,0.0,0.034507915210163644,0.586,8/31,4.18%,GPNMB;CD300A;ARG1;LILRB1;CEBPB;FOXP3;CD274;PLA2G2D
prerank,positive regulation of nervous system development (GO:0051962),-0.5091312507138541,-1.8249196411095412,0.0,0.11021276853254493,0.905,13/42,10.41%,CX3CR1;PTPRD;IL1RAPL1;NUMB;NRXN1;NLGN1;OPRM1;GRID2;LRRC4B;CUX2;SYNDIG1;NAP1L1;NLGN3
prerank,regulation of synapse assembly (GO:0051963),-0.49851213602581224,-1.8235869738226698,0.0,0.10742825685812857,0.909,14/46,11.38%,PTPRD;MEF2C;IL1RAPL1;NRXN1;ROBO2;NLGN1;GRID2;LRRC4B;SLIT1;IL1RAPL2;CUX2;SYNDIG1;NLGN3;LRFN5
prerank,neutrophil activation involved in immune response (GO:0002283),0.573743344393332,1.8216876042537198,0.0,0.03809986560397174,0.623,147/428,16.15%,ANPEP;PSAP;LGALS3;CD36;IQGAP2;HPSE;IQGAP1;CTSB;ADGRE5;SDCBP;IDH1;CTSD;CLEC12A;CD300A;SYK;FTL;IGF2R;VAT1;ARG1;FRK;CPPED1;GALNS;ADGRG3;FABP5;LILRB3;DIAPH1;LAMP1;ATG7;GYG1;HK3;PLEKHO2;ANO6;CLEC4D;RAB7A;CD44;CYB5R3;GLA;PRKCD;CTSA;OSTF1;PYGL;DYNC1H1;PSMD1;SNAP29;GNS;CD63;ARHGAP9;PGRMC1;TCIRG1;CD93;APAF1;ATP8B4;TNFRSF1B;RNASE3;DNAJC5;IMPDH2;C3AR1;EEF1A1;AMPD3;CD53;ANXA2;ADAM8;NRAS;DDOST;RAB37;MANBA;PTAFR;DOK3;HSPA1B;CYBB;PTGES2;ARSA;CYBA;KCNAB2;RAB31;CAT;TIMP2;CTSS;LAMP2;CTSZ;SIRPA;TICAM2;CTSH;AGA;PAFAH1B2;HP;TYROBP;VAPA;HRNR;HUWE1;QSOX1;ATP6V0A1;LAMTOR1;PLAU;XRCC5;DERA;ROCK1;COTL1;RAP2B;FAF2;MOSPD2;LTA4H;RAB10;NHLRC3;DNASE1L1;RAB18;MAGT1;OLFM4;PSMD14;COMMD9;PGM1;BST2;GM2A;HMOX2;PSMD12;RAB24;STXBP3;FUCA1;VPS35L;DOCK2;BRI3;GLIPR1;MGST1;CRACR2A;LAMTOR3;CAP1;ATP6V0C;DEGS1;FGR;PPIE;SLC11A1;AGL;HSPA1A;ARL8A;SLPI;CREG1;PRDX6;GUSB;NCSTN;ATP6AP2;SLC44A2;DNAJC13;STK11IP;TOM1;GRN;RAB44;BST1
prerank,positive regulation of leukocyte migration (GO:0002687),0.7299749788943767,1.8216854080477494,0.001314060446780552,0.03704153600386141,0.623,7/27,10.29%,F7;LGALS3;VEGFA;IL6;ADAM8;IL6R;ADAM17
prerank,"wound healing, spreading of cells (GO:0044319)",0.7382770595076797,1.8205605735628927,0.0013175230566534915,0.0368506242532444,0.63,10/24,10.93%,ARHGAP24;MMP12;MRTFA;CD44;LCP1;ITGA5;CD151;ACVRL1;ADAM17;CCN1
prerank,acute inflammatory response (GO:0002526),0.7508791558191695,1.8172208449385563,0.0,0.03860117962507663,0.662,7/23,9.55%,SIGIRR;CEBPB;ANO6;IL6;HP;HPR;IL6R
prerank,Rac protein signal transduction (GO:0016601),-0.6133605418718671,-1.8163237423792313,0.003663003663003663,0.11053305153435798,0.925,12/18,24.93%,ELMO1;TIAM1;ABI2;AIF1;NCKAP1;DBNL;CYFIP1;HACD3;RHOG;HACE1;RHOH;RAC1
prerank,neutrophil mediated immunity (GO:0002446),0.5715045758050529,1.815694116509626,0.0,0.038751145357885784,0.672,149/432,16.15%,ANPEP;PSAP;LGALS3;CD36;IQGAP2;HPSE;IQGAP1;CTSB;ADGRE5;SDCBP;IDH1;CTSD;CLEC12A;CD300A;FTL;IGF2R;VAT1;ARG1;FRK;CPPED1;GALNS;ADGRG3;FABP5;LILRB3;DIAPH1;LAMP1;ATG7;GYG1;HK3;PLEKHO2;ANO6;CLEC4D;RAB7A;CD44;CYB5R3;GLA;IL6;PRKCD;CTSA;OSTF1;PYGL;DYNC1H1;PSMD1;SNAP29;GNS;CD63;ARHGAP9;PGRMC1;TCIRG1;CD93;APAF1;ATP8B4;TNFRSF1B;RNASE3;DNAJC5;IMPDH2;C3AR1;EEF1A1;AMPD3;CD53;ANXA2;ADAM8;NRAS;DDOST;RAB37;MANBA;PTAFR;DOK3;HSPA1B;CYBB;PTGES2;ARSA;CYBA;KCNAB2;RAB31;CAT;TIMP2;CTSS;LAMP2;CTSZ;SIRPA;TICAM2;CTSH;AGA;PAFAH1B2;HP;TYROBP;VAPA;HRNR;HUWE1;QSOX1;ATP6V0A1;LAMTOR1;PLAU;XRCC5;DERA;ROCK1;COTL1;RAP2B;FAF2;MOSPD2;ADAM17;LTA4H;RAB10;KMT2E;NHLRC3;DNASE1L1;RAB18;MAGT1;OLFM4;PSMD14;COMMD9;PGM1;BST2;GM2A;HMOX2;PSMD12;RAB24;STXBP3;FUCA1;VPS35L;DOCK2;BRI3;GLIPR1;MGST1;CRACR2A;LAMTOR3;CAP1;ATP6V0C;DEGS1;FGR;PPIE;SLC11A1;AGL;HSPA1A;ARL8A;SLPI;CREG1;PRDX6;GUSB;NCSTN;ATP6AP2;SLC44A2;DNAJC13;STK11IP;TOM1;GRN;RAB44;BST1
prerank,neutrophil degranulation (GO:0043312),0.5711948469675571,1.8138381414274256,0.0,0.03910035626082023,0.686,146/425,16.15%,ANPEP;PSAP;LGALS3;CD36;IQGAP2;HPSE;IQGAP1;CTSB;ADGRE5;SDCBP;IDH1;CTSD;CLEC12A;CD300A;FTL;IGF2R;VAT1;ARG1;FRK;CPPED1;GALNS;ADGRG3;FABP5;LILRB3;DIAPH1;LAMP1;ATG7;GYG1;HK3;PLEKHO2;ANO6;CLEC4D;RAB7A;CD44;CYB5R3;GLA;PRKCD;CTSA;OSTF1;PYGL;DYNC1H1;PSMD1;SNAP29;GNS;CD63;ARHGAP9;PGRMC1;TCIRG1;CD93;APAF1;ATP8B4;TNFRSF1B;RNASE3;DNAJC5;IMPDH2;C3AR1;EEF1A1;AMPD3;CD53;ANXA2;ADAM8;NRAS;DDOST;RAB37;MANBA;PTAFR;DOK3;HSPA1B;CYBB;PTGES2;ARSA;CYBA;KCNAB2;RAB31;CAT;TIMP2;CTSS;LAMP2;CTSZ;SIRPA;TICAM2;CTSH;AGA;PAFAH1B2;HP;TYROBP;VAPA;HRNR;HUWE1;QSOX1;ATP6V0A1;LAMTOR1;PLAU;XRCC5;DERA;ROCK1;COTL1;RAP2B;FAF2;MOSPD2;LTA4H;RAB10;NHLRC3;DNASE1L1;RAB18;MAGT1;OLFM4;PSMD14;COMMD9;PGM1;BST2;GM2A;HMOX2;PSMD12;RAB24;STXBP3;FUCA1;VPS35L;DOCK2;BRI3;GLIPR1;MGST1;CRACR2A;LAMTOR3;CAP1;ATP6V0C;DEGS1;FGR;PPIE;SLC11A1;AGL;HSPA1A;ARL8A;SLPI;CREG1;PRDX6;GUSB;NCSTN;ATP6AP2;SLC44A2;DNAJC13;STK11IP;TOM1;GRN;RAB44;BST1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6693291474988777,-1.8113961126513114,0.00946372239747634,0.11135579034005084,0.934,5/14,11.41%,ATP1B1;ANK2;ATP1B2;AKAP9;ACTN2
prerank,toll-like receptor signaling pathway (GO:0002224),0.624027328239722,1.8111059763888617,0.0,0.04031497406931893,0.7,31/84,16.65%,SFTPA1;SFTPA2;CD36;CTSB;RFTN1;TLR8;CTSL;MAP3K1;MAPKAPK3;IRAK2;TNIP1;RIPK1;LY96;NR1H4;IRAK3;RPS27A;UBC;CTSS;TICAM2;UNC93B1;EPG5;BIRC3;TAB2;S100A1;BTK;TRAF3;LBP;MYD88;HSPD1;TLR1;TRIL
prerank,cholesterol homeostasis (GO:0042632),0.6277455427549289,1.810606156763169,0.0,0.03977350311112295,0.703,15/64,11.99%,SOAT1;ABCA1;GRAMD1B;APOE;LIMA1;LIPG;NPC1;ABCG1;NR1H3;FGFR4;ACSM3;ABCA2;LAMTOR1;SIRT1;RORA
prerank,secondary alcohol metabolic process (GO:1902652),0.6697680615734417,1.8083323058056515,0.0,0.04057941337448442,0.723,7/42,3.64%,SOAT1;ABCA1;IDH1;APOE;ABCG1;OSBPL1A;RXRA
prerank,membrane repolarization (GO:0086009),-0.6559172701285647,-1.8059383514627176,0.01048951048951049,0.11310136077646075,0.944,4/15,5.29%,ATP1B1;ATP1A2;KCNJ2;ATP1B2
prerank,response to lipid (GO:0033993),0.6006593409905445,1.8056006859357552,0.0,0.04195952429359185,0.746,36/105,17.45%,CD36;PPARG;ANXA1;CTNNB1;ABCG1;MAPKAPK3;SPP1;FOXO3;RXRA;LY96;RARA;FGFR4;STAT5B;IRAK3;GPX3;SOX9;ABCA2;FOXP1;CTSH;HNRNPA0;ESR1;ADAM17;FOXO1;LIAS;PPARD;STRN3;TAB2;SLC11A1;ERBIN;SLPI;ASXL1;LBP;SCD;OTUD5;IFNAR1;ACER2
prerank,regulation of vasculature development (GO:1901342),0.7155764418510762,1.8055250053919745,0.0,0.04105006191559712,0.746,6/26,8.57%,GPNMB;PLXND1;CTNNB1;IL6;HMOX1;VASH2
prerank,cellular response to amino acid starvation (GO:0034198),0.6150771659764845,1.8024654655468058,0.0,0.0428093788194273,0.773,26/71,13.86%,ATP6V0D2;TFEB;ATP6V1A;CEBPB;ATP6V1E1;CDKN1A;ATP6V1C1;FAS;TCIRG1;ATP6V0D1;SESN2;SH3GLB1;FLCN;EIF2AK4;ATF4;ATP6V1B2;LAMTOR1;MIOS;ATP6V0E1;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;CASTOR1;NPRL3;ATP6V1H
prerank,triglyceride metabolic process (GO:0006641),0.6522784606238321,1.7938728854057777,0.0,0.04898060406567008,0.818,6/48,1.55%,FABP4;APOE;LIPG;LPIN3;FABP5;GPAT2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.576109871881498,-1.793074802412558,0.0,0.12360784617104331,0.964,9/25,12.16%,MEF2C;GRIN2A;GRIN2B;GRID2;GRIN1;ARRB2;GLRA1;NLGN3;GRIN2D
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.642086427634484,1.7921418296621443,0.0,0.04929539297258068,0.829,19/56,16.60%,SFTPA1;SFTPA2;CD36;CTSB;TLR8;CTSL;MAPKAPK3;IRAK2;LY96;RPS27A;UBC;CTSS;UNC93B1;TAB2;S100A1;TRAF3;LBP;MYD88;TLR1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.6597612990486571,-1.79140501214792,0.008695652173913044,0.12108577113471142,0.965,7/14,18.43%,ATP1B1;ANK3;WNK3;GLRX;WNK2;WNK1;SLC9A1
prerank,phospholipid homeostasis (GO:0055091),0.8447138001432213,1.7889836539762507,0.0014858841010401188,0.051010783516281105,0.843,3/11,1.95%,ABCA1;LIPG;ABCG1
prerank,water transport (GO:0006833),0.8181562430595035,1.7884062724083065,0.0,0.05056944952489954,0.847,1/12,1.90%,AQP1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.7721512954983255,1.7867432266029601,0.0013986013986013986,0.05099671933554874,0.853,6/15,7.20%,BCL2L11;ANXA1;UBE2L3;NR3C1;HNRNPU;ZFP36L2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.8166227658650927,1.7857668789891725,0.0,0.05079130115735201,0.858,4/13,0.68%,CD36;PPARG;ABCA1;SYK
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.7461287127795925,1.7838041052865206,0.0,0.05135429449662155,0.868,8/22,7.29%,SASH1;XDH;VEGFA;GADD45B;GADD45G;RELL1;GADD45A;MFHAS1
prerank,response to amino acid starvation (GO:1990928),0.608241740120202,1.7832813471186795,0.0,0.050786147296250306,0.87,26/72,13.86%,ATP6V0D2;TFEB;ATP6V1A;CEBPB;ATP6V1E1;CDKN1A;ATP6V1C1;FAS;TCIRG1;ATP6V0D1;SESN2;SH3GLB1;FLCN;EIF2AK4;ATF4;ATP6V1B2;LAMTOR1;MIOS;ATP6V0E1;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;CASTOR1;NPRL3;ATP6V1H
prerank,regulation of platelet activation (GO:0010543),0.7421882198338913,1.781456695454133,0.0,0.05146032587496282,0.875,4/21,3.73%,APOE;SYK;TEC;PDGFA
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7965029466561395,1.7769499506090356,0.002717391304347826,0.054657801382442014,0.889,4/15,5.21%,APOE;LIPG;ABCG1;PLTP
prerank,sensory perception of taste (GO:0050909),0.8552461384672426,1.772267928834465,0.0015128593040847202,0.058069521803850305,0.908,2/10,1.09%,CD36;TAS1R3
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.5683454110081231,-1.7721717971667845,0.004132231404958678,0.14322783805837855,0.984,9/25,6.64%,CTNNA3;ANK2;CACNA1C;RYR2;JUP;TRPM4;FGF13;NOS1AP;AKAP9
prerank,axonal fasciculation (GO:0007413),-0.6802258255433363,-1.7679326982196282,0.00949367088607595,0.14343443086002877,0.986,5/12,5.75%,SEMA5A;EPHA3;CNTN4;CDK5R1;MEGF8
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.44616436543904126,-1.7665085357879315,0.0,0.14111026184146352,0.986,18/59,13.62%,CADM1;PTPRM;PTPRT;SDK1;ROBO2;KIRREL3;ROBO1;TENM3;CNTN6;CNTN2;CNTN4;IGSF11;CDH2;BSG;IGSF9;NEXN;CELSR2;PKD1
prerank,negative regulation of defense response (GO:0031348),0.5976621289805777,1.7649103059168145,0.0,0.06458950752750302,0.93,24/77,14.46%,PPARG;APOE;NR1H3;RNF26;PRKCD;AOAH;MAPK7;NR1H4;IRAK3;PROC;METRNL;MFHAS1;RB1;SIRPA;MEFV;PTGER4;NLRC3;TRAFD1;PPARD;RORA;LPCAT3;TNFAIP8L2;TNFAIP3;ACOD1
prerank,synapse organization (GO:0050808),-0.3949398134618232,-1.7620246142877607,0.0,0.1423880517347873,0.99,29/125,8.61%,CX3CR1;GRM5;PTPRD;CACNB2;ADGRL3;LRRC4C;SDK1;GPM6A;NRXN1;ARHGAP39;NTNG1;KIRREL3;NLGN1;DNM3;RYK;UNC13C;CTNND2;MAPT;CNTN2;ANK3;CACNB4;LRRC4B;CDH2;FARP1;PPFIA4;SEMA3E;REST;DNER;AGRN
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.5125902445861528,-1.759383232811474,0.0,0.1417157176362158,0.99,13/34,13.79%,MEF2C;GRIN2A;GRIN2B;GRID2;GABRA2;GRIN1;ARRB2;GABRA3;GLRA1;GABRG3;NLGN3;GRIN2D;GABRA4
prerank,vasodilation (GO:0042311),-0.666518004271935,-1.7591854297618503,0.008928571428571428,0.13786907375434868,0.99,6/13,25.62%,KCNMA1;SOD2;ADRB1;KLF2;NOS1;ADRB2
prerank,lipid catabolic process (GO:0016042),0.7566430532484028,1.7572109203011235,0.0,0.07265806061080644,0.949,6/18,11.60%,CEL;LIPG;PPT1;ACADL;MT3;PLAAT3
prerank,response to hydrogen peroxide (GO:0042542),0.6329993363216594,1.752979795479251,0.001183431952662722,0.07635725003214595,0.96,18/45,13.66%,NFE2L2;ANXA1;AQP1;ADAM9;IL6;PRKCD;RIPK1;MAPK7;PPIF;STK24;HMOX1;CAT;SIRPA;HP;PLEKHA1;SIRT1;RELA;TNFAIP3
prerank,negative regulation of cell development (GO:0010721),0.7037456148196509,1.749735100532019,0.0013280212483399733,0.07885059871565406,0.963,9/25,11.96%,LILRB1;HOOK3;FBXW7;IL6;APPL2;SORL1;IGF1;GSK3B;NOTCH1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.35428422404739524,-1.7483287474435958,0.0,0.14825492956520123,0.996,57/224,11.50%,GRM5;DLG2;KCND2;CACNB2;RIT2;GRIN2A;GABRB3;NRXN1;SYT1;NLGN1;RPS6KA1;CACNA1E;GRM1;GRIA4;GRIN2B;SLC12A6;DTNA;CAMKK2;GRIA1;GRIK1;UNC13C;GRIA2;HTR2C;MBP;DLGAP1;NOVA1;AMPH;GLRB;SLC1A3;GLRA3;CACNB4;CHRM3;SYN2;GRIK2;CHRM2;GABRA2;GRIN1;SYNJ2BP;HCRTR2;GABRB1;SNAP25;GRM3;KIF5A;SLC1A2;AKAP9;GRIA3;HOMER1;GABRA3;GLRA1;GABRG3;SLC6A1;SLC1A1;NLGN3;HTR1F;KCNQ2;PRKACA;DLG1
prerank,central nervous system neuron differentiation (GO:0021953),-0.5089477564397739,-1.748091495463462,0.005128205128205128,0.1447744922761385,0.996,11/33,4.91%,OPHN1;MDGA2;SPOCK1;RYK;MAPT;TOX;GRID2;KNDC1;FAIM2;MAP2;NTRK2
prerank,positive regulation of proteolysis (GO:0045862),0.621906995979727,1.7478290322844872,0.0,0.08027981809088944,0.966,17/55,13.06%,CCBE1;APOE;ADAM9;TNIP1;TANK;SNX9;TNFRSF1B;FGFR4;ADAM8;TBC1D10A;NLRC4;CTSH;CYFIP2;SNX33;STUB1;RHBDD1;GPLD1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.5649576787872403,-1.7473815132241404,0.011811023622047244,0.14168693535734814,0.996,5/21,6.64%,SNTA1;ANK2;SCN1B;NOS1AP;AKAP9
prerank,cellular component disassembly (GO:0022411),0.6299797067177285,1.747367392895664,0.0,0.0796126390656636,0.966,15/53,8.05%,MMP12;TIMP1;TLL2;CTSL;FLOT1;CD44;LCP1;KIF9;WASHC1;MMP14;ADAM8;CAPG;CAPN2;TIMP2;CTSS
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7925217151358575,1.7472121467104458,0.00303951367781155,0.07856251357098049,0.966,2/12,0.46%,F7;CBLB
prerank,sodium ion export across plasma membrane (GO:0036376),-0.6484208699563245,-1.7469126411789961,0.009259259259259259,0.13846258211701737,0.996,3/13,5.29%,ATP1B1;ATP1A2;ATP1B2
prerank,negative regulation of T cell activation (GO:0050868),0.674002362973758,1.745929967712716,0.0,0.07915093725562143,0.969,9/35,5.43%,GPNMB;LGALS3;ARG1;LILRB1;CEBPB;FOXP3;CD274;PLA2G2D;DUSP3
prerank,organic acid transport (GO:0015849),0.5926525221301031,1.741652523487458,0.0,0.08357447615924081,0.974,30/94,13.51%,LRRC8D;SLC7A2;SLC6A6;SLC51A;SLC36A2;SLC43A2;SLC1A5;SLC7A4;SLC7A7;RXRA;SLC16A10;SLC16A1;SLC27A4;SLC26A1;SLC38A1;STARD5;SLC27A3;ABCC4;NR1H4;ABCC3;FOLR2;FOLR1;SLC27A1;SLC25A32;NCOA1;PPARD;SLC7A11;SLC23A2;SLC23A1;ATP8B1
prerank,chemical synaptic transmission (GO:0007268),-0.3309665010312107,-1.7398384617808058,0.0,0.14383285983463998,0.999,76/284,12.53%,GRM5;DLG2;KCND2;CACNB2;RIT2;GRIN2A;GABRB3;NRXN1;SYT1;NLGN1;RPS6KA1;CACNA1E;GRM1;RIMS1;GRIA4;GRIN2B;SLC12A6;FCHSD2;DTNA;CAMKK2;GRIA1;GRIK1;UNC13C;GRIA2;HTR2C;MBP;DLGAP1;NOVA1;DLGAP2;AMPH;GLRB;SLC1A3;GLRA3;CACNB4;GRID2;CHRM3;SYN2;GRIK2;CHRM2;GABRA2;PTPRN2;LIN7A;GRIN1;SYNJ2BP;SLC17A6;HCRTR2;GABRB1;SNAP25;GRM3;KIF5A;CDH8;SLC1A2;AKAP9;GRIK5;GRIA3;HOMER1;NSG1;SHISA6;GABRA3;GLRA1;GABRG3;PDLIM4;SLC6A1;GRID1;RIC3;SLC1A1;KIF1B;NLGN3;HTR1F;KCNQ2;PRKACA;DLG1;GRIK3;GRIN2D;HTR7;HRH2
prerank,extracellular matrix disassembly (GO:0022617),0.625322854060033,1.7383164098566053,0.0,0.08684768045778656,0.978,15/53,8.05%,MMP12;TIMP1;TLL2;CTSL;FLOT1;CD44;LCP1;KIF9;WASHC1;MMP14;ADAM8;CAPG;CAPN2;TIMP2;CTSS
prerank,amino acid transport (GO:0006865),0.631498825104381,1.73695542381576,0.0,0.08782036395115214,0.978,12/49,7.56%,SLC7A2;SLC6A6;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC7A4;SLC7A7;SLC16A10;SLC38A1;SLC38A7
prerank,natural killer cell mediated immunity (GO:0002228),0.7694001479476889,1.7347820627651773,0.0,0.08930418447685252,0.981,7/15,17.78%,LYST;PLEKHM2;SLAMF7;ARL8B;ULBP1;KLRD1;KIF5B
prerank,regulation of steroid metabolic process (GO:0019218),0.7027461962349004,1.7345029157774958,0.0,0.0884861994957359,0.983,12/23,15.47%,APOE;ABCG1;ACADL;NR1H4;ACADVL;ABCA2;NR5A1;LAMTOR1;STUB1;RORA;DGKQ;PANK2
prerank,regulation of mast cell activation (GO:0033003),0.8439277657971738,1.7328926993138662,0.0015527950310559005,0.0893510277585447,0.985,2/10,1.72%,CD300LF;CD84
prerank,cGMP-mediated signaling (GO:0019934),0.7964543188252429,1.7305536173071199,0.0,0.09135476495836053,0.99,4/13,1.90%,CD36;HTR2B;APOE;AQP1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4020384187125006,-1.728037821797661,0.0,0.15647785095028136,1.0,36/107,11.85%,CX3CR1;NRG3;GRM5;SLC12A2;MEF2C;OPHN1;LRRC4C;SYT1;NLGN1;GRM1;RIMS1;GRM8;GRIK1;DLGAP1;DLGAP2;RIMS2;ATP1A2;GRID2;GRIK2;SNCAIP;RELN;FMR1;GRM3;CDH2;AKAP9;GRIK5;HOMER1;CNTNAP4;BCR;LRP8;GRID1;SLC4A8;NLGN3;NMU;CAMK2A;GRIK3
prerank,response to alcohol (GO:0097305),-0.5491096819716083,-1.7277433465020897,0.00796812749003984,0.15315272489684148,1.0,9/27,12.28%,GRIN2A;GRIN2B;CCR5;TGFBR2;GRIN3A;TGFBR1;GRIN1;GLRA1;SMAD2
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.6665694580305624,-1.7269911656706063,0.015527950310559006,0.15049702198621165,1.0,4/13,5.78%,CACNB2;ANK2;CACNA1C;KCNJ3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.702286543281098,1.726572359126185,0.001310615989515072,0.09612154688533085,0.994,10/24,11.96%,NFE2L2;VEGFA;CEBPB;ATF3;SESN2;MAPK7;ATF4;DDIT3;MT3;NOTCH1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7222329546104329,1.725899326778227,0.004195804195804196,0.09580044773644811,0.995,9/21,11.72%,CD300A;ELF2;PRKCH;LPXN;STAP1;FOXP1;CD22;CBFB;PRKCB
prerank,ceramide transport (GO:0035627),0.8012216165810099,1.7247133474501313,0.001519756838905775,0.09620462188165682,0.995,4/12,8.23%,PSAP;CERT1;PLTP;ABCA2
prerank,membrane raft organization (GO:0031579),0.7625603804429867,1.7220158947908737,0.004366812227074236,0.0991824530747212,0.998,6/15,5.73%,RFTN1;FLOT1;NPC1;PPT1;CLN3;ANXA2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.5744797111342409,1.7210946372016587,0.0,0.09935768334566414,0.998,18/110,4.99%,LGALS3;CD36;FNIP2;ABCA1;FBLIM1;APOE;SYK;BCL2L11;VEGFA;FNIP1;TFRC;TFIP11;KIF9;SH3GLB1;RAF1;AIDA;SORL1;MTLN
prerank,smooth muscle contraction (GO:0006939),0.7687746573323869,1.720571617706544,0.001445086705202312,0.09886578124823117,0.998,6/14,12.21%,TPCN2;EDNRA;ADRA1A;SLC8A1;ROCK1;MYLK
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.7045992898712496,1.720261630111607,0.006830601092896175,0.0979283563566319,0.998,9/20,11.55%,FBXW7;ACADL;SIK1;ACADVL;BRCA1;SLC27A1;ABCA2;ERLIN1;WDTC1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5818704696633722,1.7177790160903537,0.0,0.10051608438629231,0.998,27/88,14.91%,LGALS3;FNIP2;SDCBP;SYK;SYNPO2L;BCL2L11;VEGFA;FLOT1;FNIP1;TFRC;RAB7A;SH3GLB1;MTLN;HAS3;STAM;CHMP2A;PDCD6IP;TPR;VPS4A;GSK3B;PFN1;SDC4;SYNPO;CX3CL1;BAX;PFN2;SNF8
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.5797195640371443,1.717710655006669,0.0,0.09939000254886225,0.998,18/90,10.43%,EPAS1;FABP4;CD36;CXCR4;SYK;FABP5;VEGFA;CEBPB;GADD45G;DYNC1H1;APPL2;SIRT6;ACADL;APC;KDM3A;KSR2;TRPV2;PTH2R
prerank,chloride transmembrane transport (GO:1902476),-0.4622487222105524,-1.7176989463073626,0.006060606060606061,0.15997527010903884,1.0,20/48,13.79%,SLC12A2;GABRB3;SLC12A6;ANO4;GLRB;SLC1A3;ANO3;GLRA3;GABRA2;GABRB1;GABRA3;GLRA1;GABRG3;SLC6A1;SLC4A8;SLC1A1;LRRC8A;CLCN3;SLC12A4;GABRA4
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.7969300768323369,1.7175720637761116,0.0015600624024961,0.0984048428971556,0.998,5/12,12.67%,CTSB;CTSL;CTSS;CTSH;GAS2L1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5974986555721422,-1.717554163156993,0.009966777408637873,0.15665637016564465,1.0,8/17,17.02%,NLGN1;RAB27A;SCAMP5;SYT4;SLC4A8;CACNA1G;STX1A;CACNA1I
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5823257468170617,-1.71709318683194,0.014705882352941176,0.15384747797426332,1.0,8/19,14.45%,DLG2;PARD3B;PARD3;SYNJ2BP;PATJ;MARK2;DLG1;DLG3
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6088236037644456,-1.7164048031032224,0.014336917562724014,0.1516290693449398,1.0,10/17,14.72%,CACNB2;ANK2;CACNA1C;ATP1A2;SCN1B;KCNJ2;TRPM4;CACNA1G;HCN2;CACNA2D1
prerank,positive chemotaxis (GO:0050918),0.743310222805116,1.7156843203633978,0.0014064697609001407,0.10014603228031929,1.0,3/17,1.73%,GPNMB;LGALS3;VEGFA
prerank,positive regulation of blood coagulation (GO:0030194),0.7443424054155693,1.7110933346259354,0.0,0.10602985854128569,1.0,4/17,7.36%,HPSE;ANO6;THBS1;ST3GAL4
prerank,phosphate ion homeostasis (GO:0055062),0.82612615300846,1.708798578979335,0.004746835443037975,0.10877138101839776,1.0,4/10,11.30%,TFAP2B;ENPP1;FGFR4;XPR1
prerank,regulation of vacuole organization (GO:0044088),0.7164377481268419,1.7084742329041231,0.0068212824010914054,0.10803547612851479,1.0,11/20,16.70%,MTM1;PIKFYVE;MTMR3;TBC1D12;ANXA2;SCARB2;RAB1B;ENO3;NPRL3;UBQLN2;NPRL2
prerank,myoblast differentiation (GO:0045445),0.7810179532870944,1.7066136976901507,0.0,0.10962155931728161,1.0,5/14,8.04%,EPAS1;MBNL1;IGF1;DDX5;RB1
prerank,regulation of immune response (GO:0050776),0.5555892194776134,1.7059746536209077,0.0,0.10939783027609769,1.0,36/135,13.55%,CD300LF;CD300A;SYK;ICAM2;CD200R1;SLAMF7;LILRB1;FOXP3;IFITM1;CLEC2D;FCRLB;ITGA4;CD3D;APPL2;COL1A1;ADCY7;RNF135;TKFC;GPR108;XIAP;DENND1B;FOXP1;CD22;TYROBP;ITGB1;TREML1;BIRC3;ULBP1;IL15;APPL1;TREM2;CD300LD;COL3A1;TRAF3;FGR;N4BP1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6927896973104803,-1.7035050967327927,0.006349206349206349,0.166159639041556,1.0,3/10,10.84%,ANK3;KCNAB1;KCNRG
prerank,cell-cell junction organization (GO:0045216),-0.41621686132948715,-1.700957299038108,0.0,0.16625600886156774,1.0,16/79,8.98%,CADM1;CADM2;SDK1;CSF1R;SMAD3;CTNND1;CTNND2;TLN2;CDH11;CDH9;JUP;CDH8;CDH2;CDH6;CDH12;TGFB2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.6716014081154992,1.698290056156802,0.0025575447570332483,0.12051517457310668,1.0,13/27,16.60%,CD36;MAP3K1;IRAK2;TNIP1;LY96;IRAK3;RPS27A;UBC;TAB2;BTK;MYD88;HSPD1;TLR1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6614383567273966,1.6982749356828817,0.0025031289111389237,0.1192335458158404,1.0,6/30,4.07%,SYK;PIBF1;IL6;CD28;CD46;CD274
prerank,positive regulation of protein maturation (GO:1903319),0.8013147117155285,1.6979300066870382,0.004511278195488722,0.1185367017225537,1.0,4/11,11.89%,CCBE1;ADAM8;NLRC4;RHBDD1
prerank,potassium ion transport (GO:0006813),-0.38958923839582865,-1.6968403305342088,0.0,0.16833181478462145,1.0,26/120,11.96%,KCNMA1;SLC24A3;SLC9A9;KCND2;HCN1;KCNH7;SLC24A2;KCNC2;KCNB2;SLC1A3;ATP1A2;KCNH1;KCNAB1;KCNK2;KCNC1;KCNJ2;KCNK6;KCNJ3;KCNC3;NALCN;SLC24A4;KCNQ2;HCN2;HPN;KCNH8;PKD2
prerank,lipid homeostasis (GO:0055088),0.5999920554255798,1.6961466716311049,0.0,0.12024828664711573,1.0,13/57,8.23%,PPARG;ABCA1;APOE;LIPG;ABCG1;FBXW7;RBP1;NR1H3;ABCD1;IRS2;ZBTB20;ABHD4;ABCA2
prerank,receptor metabolic process (GO:0043112),0.6077007868039709,1.6955168935716411,0.004651162790697674,0.12006681827868296,1.0,17/53,13.65%,CD36;SYK;GRB2;PHETA2;LILRB1;TFRC;LRP1;KIF16B;UVRAG;SH3GLB1;RAB31;PICALM;ITGB1;SNX25;ARFGEF2;RAB11B;PLEKHJ1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6374214251079005,-1.6953242148504457,0.014534883720930232,0.16694087232510735,1.0,6/13,17.02%,SYT1;SCAMP5;SYT4;CACNA1G;STX1A;CACNA1I
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6935541701342312,1.6952764375884986,0.0026666666666666666,0.11925138538125873,1.0,6/22,8.64%,LGALS3;CD300A;DGKZ;DUSP3;LPXN;CD22
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.5238816730596416,-1.6940845395992041,0.012048192771084338,0.16555234701472696,1.0,10/27,11.50%,CTNNA3;ANK2;CACNA1C;RYR2;JUP;TRPM4;FGF13;AKAP9;PDE4B;DLG1
prerank,intracellular sterol transport (GO:0032366),0.7735076603681045,1.6937392817217525,0.005641748942172073,0.12068377257835798,1.0,6/13,9.57%,ABCA1;NPC1;ABCG1;SERAC1;RELCH;VPS4A
prerank,positive regulation of exosomal secretion (GO:1903543),0.7414271300702355,1.6936016972903016,0.007320644216691069,0.11965277560317095,1.0,8/15,14.91%,SDCBP;RAB7A;STAM;CHMP2A;PDCD6IP;VPS4A;SDC4;SNF8
prerank,negative regulation of blood coagulation (GO:0030195),0.6389119937856493,1.6928360517663623,0.0012254901960784314,0.11961281230611569,1.0,7/38,9.79%,F7;APOE;F11;PDGFA;F10;PROC;PLAU
prerank,vasoconstriction (GO:0042310),0.8086566704669214,1.6924891152935921,0.004594180704441042,0.11906735408018633,1.0,3/11,5.00%,HTR2B;EDNRA;SLC8A1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6848965990045952,1.6914108927453846,0.0039011703511053317,0.11873276722056339,1.0,8/23,10.29%,SDCBP;ZEB2;CITED2;THBS1;CREBBP;FLCN;HIPK2;ADAM17
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6848965990045952,1.6914108927453846,0.0039011703511053317,0.11873276722056339,1.0,8/23,10.29%,SDCBP;ZEB2;CITED2;THBS1;CREBBP;FLCN;HIPK2;ADAM17
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7601167722583281,1.6903995795899762,0.005908419497784343,0.11943016816828703,1.0,6/14,8.69%,TLR8;LILRB1;PIBF1;THBS1;IRAK3;MEFV
prerank,cellular response to increased oxygen levels (GO:0036295),0.7983820272140134,1.6897225424566245,0.004724409448818898,0.11935380834951459,1.0,6/11,10.61%,ATP6V1A;ATG7;FAS;ATP6V0D1;TMEM199;FOXO1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.6972470170556783,1.686980442827922,0.007894736842105263,0.12275141843212345,1.0,4/22,3.73%,GPNMB;RAP2A;VEGFA;PDGFA
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5636876497459447,-1.6864194897424407,0.011904761904761904,0.17320384103852532,1.0,7/20,5.29%,KCNMA1;SLC12A2;ATP1B1;LACC1;ATP1A2;KCNJ2;ATP1B2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.649467532804406,1.685657093037413,0.0012468827930174563,0.12361867172093678,1.0,13/34,14.46%,CD300LF;CD300A;RAB7B;LY96;IRAK3;MFHAS1;GPR108;NFKBIL1;TICAM2;NLRP2B;TREM2;TNFAIP3;ACOD1
prerank,excitatory postsynaptic potential (GO:0060079),-0.5806097561451229,-1.685519710618398,0.022222222222222223,0.171094911525423,1.0,6/19,6.09%,MEF2C;GRIN2A;GRIN2B;GRID2;GRIN1;ARRB2
prerank,transition metal ion homeostasis (GO:0055076),0.6595204347254114,1.6823997193202516,0.009150326797385621,0.12780683598727677,1.0,11/28,13.77%,FTL;ABCB7;HMOX1;XIAP;HEPH;PICALM;SLC39A14;MT3;HMOX2;SLC11A1;PRKN
prerank,negative regulation of reproductive process (GO:2000242),0.7255628346786956,1.6815407974090162,0.008391608391608392,0.12816143909506275,1.0,5/17,12.73%,TIMP1;WEE2;IGF1;WDR77;SULF1
prerank,cytosolic transport (GO:0016482),0.5580588635626332,1.68057204901887,0.0,0.12875093683724262,1.0,44/108,19.07%,TMEM87B;PHETA2;PIKFYVE;LAMP1;HOOK3;RIC1;RAB7A;EEA1;WASHC1;KIF16B;SNX5;CLN5;WDR91;CLN3;STX8;VTI1B;GAK;TBC1D10A;TBC1D23;STX5;VPS54;KLHL20;SNX16;VTI1A;DENND2A;VPS52;VPS13C;VPS51;AP1G1;SPAG9;VAMP3;EPS15;PLEKHJ1;STX6;SNF8;TMEM87A;RAB29;ERC1;UBE2O;VPS29;AP4M1;BAIAP3;ANKRD27;VPS13A
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6938571725012513,1.6798526898094246,0.007874015748031496,0.12872651620566722,1.0,10/22,13.06%,APOE;TIMP1;ADAM9;SNX9;TNFRSF1B;ADAM8;TIMP2;SNX33;ROCK1;GPLD1
prerank,lipid transport (GO:0006869),0.5631535723760998,1.67932923087149,0.0,0.12828526328762108,1.0,29/97,14.01%,CD36;OSBPL8;ABCA1;APOE;SLC51A;FABP5;ABCG1;CERT1;ABCD1;RXRA;SLC27A4;CLN3;PLTP;STARD5;SLC27A3;ABCC4;NR1H4;ABCC3;ABCA3;SLC27A1;ABCA2;NCOA1;PITPNA;ABCA6;PPARD;GM2A;PITPNC1;ATP8B1;PRELID3A
prerank,cellular response to starvation (GO:0009267),0.5438867717945142,1.6771186998717682,0.0,0.13100956958050708,1.0,43/147,13.86%,ATP6V0D2;TFEB;MTMR3;ATP6V1A;ATG7;FNIP1;CEBPB;PDK4;CPEB4;PRKAG2;ATP6V1E1;CDKN1A;FOXO3;ATP6V1C1;FAS;TCIRG1;ATP6V0D1;SESN2;SH3GLB1;SIK1;STK24;FLCN;EIF2AK4;ATF4;ATP6V1B2;LAMP2;BMPR2;LAMTOR1;FOXO1;SIRT1;ATG5;XPR1;MIOS;WRN;GAS2L1;ATP6V0E1;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;CASTOR1;NPRL3;ATP6V1H
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.7307473746217802,1.6769811391081921,0.004424778761061947,0.13009937346925055,1.0,8/16,11.55%,NCOR1;APPL2;ACADL;ACADVL;BRCA1;SOX9;ERLIN1;WDTC1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.8153789694356389,1.6755306479209338,0.004484304932735426,0.13165127979046823,1.0,6/10,12.31%,CD300A;ANO6;APPL2;RAB31;STAP1;TREM2
prerank,regulation of exosomal secretion (GO:1903541),0.7024571346701469,1.675018031200069,0.008264462809917356,0.13143761003584625,1.0,10/19,14.91%,SDCBP;RAB7A;STAM;CHMP2A;PDCD6IP;VPS4A;CHMP6;SDC4;PRKN;SNF8
prerank,acute-phase response (GO:0006953),0.7837251014498616,1.674583718441487,0.0,0.130846845663579,1.0,5/12,15.61%,SIGIRR;CEBPB;IL6;IL6R;LBP
prerank,response to thyroid hormone (GO:0097066),0.753412322660928,1.6676739861942507,0.004524886877828055,0.1421316321034718,1.0,5/13,12.67%,CTSB;CTSL;CTSS;CTSH;GAS2L1
prerank,neutral amino acid transport (GO:0015804),0.6748446891349008,1.6673274477648319,0.0063532401524777635,0.14154797703737004,1.0,7/28,5.34%,SLC6A6;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC38A1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5710780538723184,1.666726131003101,0.002257336343115124,0.14144256407532912,1.0,40/71,25.18%,CTSB;CTSL;FBXL17;LONP1;SOCS6;CAPN2;RPS27A;UBC;CTSS;CTSZ;PDCD6IP;CTSH;RSPRY1;VPS4A;DDB1;ZER1;HM13;STUB1;CTSW;RHBDD1;OMA1;CHFR;TNFAIP3;PRKN;RNF123;ATE1;DDI2;ATXN3;PSMA6;CUL4B;LGMN;USP9X;CLPX;VCP;MALT1;ISG15;CASP8;PRPF19;CTSK;CTSO
prerank,sterol metabolic process (GO:0016125),0.5880743408514905,1.6656315863596605,0.0011614401858304297,0.1423025725297733,1.0,8/60,3.64%,LIPA;SOAT1;ABCA1;APOE;ABCG1;OSBPL1A;PRKAG2;RXRA
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.7625591481048846,1.6655397435091235,0.007936507936507936,0.14126311319010226,1.0,7/12,11.55%,PIBF1;ACADL;ACADVL;BRCA1;SIRT1;ERLIN1;WDTC1
prerank,lipoprotein transport (GO:0042953),0.7975939304747189,1.6651141994446998,0.005908419497784343,0.1409990375142334,1.0,5/10,11.72%,CD36;PPARG;LRP1;VMP1;PRKCB
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6750197635156084,1.6650895507827987,0.006711409395973154,0.1398850149207519,1.0,12/22,15.61%,RAB7B;FLOT1;NR1H3;APPL2;NINJ1;MFHAS1;TICAM2;APPL1;TREM2;TNFAIP3;ACOD1;LBP
prerank,peptidyl-arginine modification (GO:0018195),-0.6404601887752794,-1.663568437548926,0.02364864864864865,0.20061502551938032,1.0,7/15,22.59%,PADI2;PRMT1;ART3;PRMT7;PARK7;PRMT8;KRTCAP2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6227658868083457,1.6630167399505478,0.006242197253433208,0.14277160846322487,1.0,13/33,13.66%,NFE2L2;ANXA1;AQP1;IL6;PRKCD;RIPK1;MAPK7;PPIF;SIRPA;PLEKHA1;SIRT1;RELA;TNFAIP3
prerank,cellular iron ion homeostasis (GO:0006879),0.597110743244766,1.6627855896142518,0.002325581395348837,0.14203947816250975,1.0,17/55,14.75%,FLVCR1;FTL;ATP6V1A;ABCB7;TFRC;SLC11A2;ATP6V0D1;TMEM199;NUBP1;HMOX1;FRRS1;HEPH;GLRX3;SLC39A14;HMOX2;SLC11A1;CUL1
prerank,response to laminar fluid shear stress (GO:0034616),0.7927381440841874,1.662739467464158,0.011058451816745656,0.14097736279699183,1.0,4/10,5.25%,ABCA1;NFE2L2;MAP2K5;MAPK7
prerank,positive regulation of coagulation (GO:0050820),0.8091429292943165,1.6617464402005946,0.012558869701726845,0.14044608080843934,1.0,3/10,7.36%,HPSE;THBS1;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.8091429292943165,1.6617464402005946,0.012558869701726845,0.14044608080843934,1.0,3/10,7.36%,HPSE;THBS1;ST3GAL4
prerank,positive regulation of potassium ion transport (GO:0043268),-0.47639096837074174,-1.6605057835514727,0.005434782608695652,0.20198135518483992,1.0,25/38,37.94%,KCNMA1;ANK2;KCNJ2;KCNJ3;NOS1AP;GABBR1;KCNJ9;ACTN2;DLG1;KCNN2;KCNJ6;ADRA2A;KCNMB4;GNB1;KCNJ12;KCNJ16;KCNJ10;FHL1;KCNN1;AKAP6;GNG2;KCNQ1;KCNMB2;KCNN3;KCNJ15
prerank,negative regulation of viral release from host cell (GO:1902187),-0.6243015410794432,-1.6586441969166352,0.015337423312883436,0.2016532143626699,1.0,9/13,34.36%,TRIM11;TRIM13;TRIM8;PML;TRIM5;TRIM32;TRIM35;TRIM28;CHMP3
prerank,platelet degranulation (GO:0002576),0.5455985040304798,1.6566858003224887,0.0,0.14909947405648785,1.0,26/118,11.65%,PSAP;CD36;VWF;TIMP1;VEGFA;HGF;APLP2;CD63;PDGFA;LHFPL2;ANXA5;IGF1;ACTN1;THBS1;VTI1B;ABCC4;OLA1;TLN1;F13A1;LAMP2;QSOX1;ITIH3;WDR1;APP;CTSW;GTPBP2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.7969176850694862,1.6557132203907847,0.0029411764705882353,0.1497355637458418,1.0,2/11,1.95%,PLA2G7;ABCG1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6271377787229921,-1.6550374901535774,0.026865671641791045,0.20382466164783997,1.0,6/13,6.96%,MEF2C;ERBB4;BMPR1A;FGFR2;FGF2;ZFPM2
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.717641301951161,1.6550289725600416,0.005641748942172073,0.15005728571299273,1.0,4/18,2.60%,GPR137B;LILRB1;LILRB3;FBXW7
prerank,peptide metabolic process (GO:0006518),0.5737149121221444,1.654309606800485,0.0,0.1503104447401057,1.0,23/75,17.61%,ANPEP;CPQ;TPP1;NPEPPS;GSTM1;NAT8;NLN;RHD;CPXM1;CLN5;GSR;HPGDS;BACE1;DNPEP;LTA4H;HM13;SPCS2;GSTA4;CPM;LNPEP;PARL;ACE;OPLAH
prerank,regulation of glucose import (GO:0046324),0.6497103870578609,1.6542187235703043,0.007633587786259542,0.14939976591395876,1.0,7/30,5.76%,OSBPL8;PRKAG2;ENPP1;APPL2;PID1;IGF1;IRS2
prerank,regulation of blood coagulation (GO:0030193),0.6562146937226435,1.6537529468797436,0.010430247718383311,0.14898058793603797,1.0,5/27,7.36%,HPSE;APOE;THBS1;PROC;ST3GAL4
prerank,lysosome localization (GO:0032418),0.6156864175297099,1.6536056094488027,0.0025252525252525255,0.14821795941814384,1.0,11/37,12.53%,PLEKHM1;PLEKHM2;TFEB;FLCN;HPS6;BORCS5;VPS33A;LAMTOR1;ARL8B;MYH9;SPAG9
prerank,lipoprotein localization (GO:0044872),0.7863307484448021,1.6527797108220783,0.005979073243647235,0.14861614532059494,1.0,5/11,11.72%,CD36;PPARG;LRP1;VMP1;PRKCB
prerank,negative regulation of cellular metabolic process (GO:0031324),0.6158436687017199,1.6520270323680446,0.008684863523573201,0.1487098027350889,1.0,12/37,13.77%,SDCBP;APOE;OPTN;NCOR1;ATXN2;TRAT1;BRCA1;ABCA2;RIN3;MT3;ANKRD13D;PRKN
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5960897957935722,1.64990776748163,0.0034403669724770644,0.15123435879661365,1.0,12/47,8.76%,CD36;XDH;SYK;GRB2;PRKCD;CDKN1A;RIPK1;PID1;THBS1;GADD45A;CYBA;TYROBP
prerank,regulation of trophoblast cell migration (GO:1901163),0.7438022387523502,1.6494184082790408,0.00904977375565611,0.1511490848880024,1.0,5/14,11.94%,TIMP1;VEGFA;YTHDF3;AGO2;ACVR1B
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.5859041733592893,-1.649086976280901,0.020202020202020204,0.2107246576832522,1.0,6/17,8.22%,CTNNA2;FCHSD2;ABI2;NCKAP1;PICK1;ARFIP2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.7587789980589814,1.6465065396265663,0.009009009009009009,0.1555070348716204,1.0,8/12,15.91%,TMEM165;PPT1;TMEM199;CLN5;CLN3;VPS33A;ATP6AP2;GRN
prerank,carboxylic acid transport (GO:0046942),0.5885786082440401,1.646292028827066,0.0011325028312570782,0.15473037271467435,1.0,10/55,5.72%,PSAP;SLC6A6;SLC36A2;SLC36A4;SLC38A6;SLC1A5;SLC16A1;CLN3;SLC38A1;SLC17A5
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.657379882458634,1.646038389830855,0.003875968992248062,0.1542675372216631,1.0,6/26,7.28%,CD36;PIKFYVE;ABCB7;ABCD1;SPHK2;CYBA
prerank,neutrophil activation (GO:0042119),0.7647559154893171,1.6453394509548431,0.00894187779433681,0.15464703819207376,1.0,5/12,12.24%,SYK;PRKCD;TYROBP;KMT2E;IL15
prerank,amyloid precursor protein catabolic process (GO:0042987),0.7425102133592361,1.6448252167485258,0.009887005649717515,0.15443153844466087,1.0,11/14,23.00%,ABCG1;CLN3;DYRK1A;BACE1;ADAM17;ADAM19;NCSTN;ADAM10;APH1B;PSEN2;ABCA7
prerank,B cell receptor signaling pathway (GO:0050853),0.6291395077306523,1.642880297066974,0.009962640099626401,0.15708165438879332,1.0,12/32,14.53%,CD38;RFTN1;SYK;VAV3;TEC;MS4A1;BLNK;PLEKHA1;SH2B2;PRKCB;BTK;BAX
prerank,receptor internalization (GO:0031623),0.5997683282419608,1.6422917312595844,0.012121212121212121,0.1571968130644491,1.0,10/44,9.80%,CD36;SYK;GRB2;LILRB1;TFRC;LRP1;LMBRD1;RAB31;PICALM;ITGB1
prerank,negative regulation of cytokine production (GO:0001818),0.5217519703114676,1.6410758753513783,0.0,0.15856510225460507,1.0,44/163,15.19%,GPNMB;ANXA4;TLR8;CD200R1;LILRB1;ANXA1;CD84;SIGIRR;PIBF1;FOXP3;IKBKE;IL6;ATP2B1;ABCD1;CD274;APPL2;MAP2K5;HOMER3;RARA;TRIM25;THBS1;NPLOC4;ADCY7;NR1H4;IRAK3;RNF135;SIRPA;MEFV;TYROBP;DDIT3;PTGER4;MAVS;NLRC3;TAX1BP1;SARS1;TREM2;GAS6;N4BP1;TNFAIP3;SLC11A1;CX3CL1;ACOD1;JAK3;ARRB1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.502851256990829,-1.6406975488422517,0.01327433628318584,0.22028695307392077,1.0,14/29,13.82%,SNTA1;KCNIP4;DPP10;DPP6;FGF12;KCNAB1;WNK3;KCNIP3;HOMER1;DLG1;WNK1;ATP2B4;KCNIP1;KCNN2
prerank,positive regulation of protein processing (GO:0010954),0.6970245868905635,1.6394505922400489,0.008298755186721992,0.16055895099577547,1.0,6/19,12.31%,CCBE1;ADAM8;NLRC4;RHBDD1;LPCAT3;MYH9
prerank,iron ion homeostasis (GO:0055072),0.5826288384540427,1.6375372162178272,0.004592422502870264,0.1632640420316375,1.0,17/58,14.75%,FLVCR1;FTL;ATP6V1A;ABCB7;TFRC;SLC11A2;ATP6V0D1;TMEM199;NUBP1;HMOX1;FRRS1;HEPH;PICALM;GLRX3;HMOX2;SLC11A1;CUL1
prerank,cardiac cell development (GO:0055006),0.7757208282650996,1.6372500859297705,0.013432835820895522,0.16272665728811375,1.0,4/11,11.96%,ALPK3;VEGFA;SLC8A1;NOTCH1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.6870068043336858,1.637100713442875,0.016304347826086956,0.1619328531667481,1.0,10/20,12.07%,TXN;ANO6;P2RX4;PSTPIP1;C3AR1;ENTPD1;MEFV;NT5E;APP;SUGT1
prerank,response to fatty acid (GO:0070542),0.6887888731702879,1.6356611047626808,0.00846262341325811,0.16384418948684748,1.0,8/17,12.62%,CD36;PDK4;FOXO3;PID1;NR1H4;SOX9;FOXO1;KCNK4
prerank,regulation of fatty acid metabolic process (GO:0019217),0.7104058168954737,1.634238345063811,0.006954102920723227,0.16558644808773754,1.0,6/17,11.07%,PPARG;PDK4;PRKAG2;NCOR1;EIF6;PPARD
prerank,high-density lipoprotein particle assembly (GO:0034380),0.8057349147326729,1.6334962239824315,0.001557632398753894,0.16604083871498343,1.0,2/10,0.58%,ABCA1;APOE
prerank,response to chemokine (GO:1990868),-0.6114325209958016,-1.630366210501541,0.021739130434782608,0.23544322029756395,1.0,6/13,14.21%,DOCK8;SLC12A2;SH2B3;RIPOR2;WNK1;RHOA
prerank,cardiac muscle cell development (GO:0055013),0.6815828253002337,1.6298965709037796,0.005509641873278237,0.1722524323608658,1.0,5/20,6.79%,ALPK3;VEGFA;MYL2;SLC8A1;PDLIM5
prerank,mesonephric tubule development (GO:0072164),-0.6086174734283342,-1.6287331286503484,0.0196078431372549,0.23487316650287668,1.0,6/15,13.62%,SALL1;ROBO2;FGFR2;PKD2;NPNT;PKD1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6581885989344828,1.6281126138811604,0.014511873350923483,0.17485260731463353,1.0,8/24,9.84%,CDKN1A;NIBAN2;ZRANB3;ACVRL1;RTEL1;DACH1;BMPR2;XRCC5
prerank,neuropeptide signaling pathway (GO:0007218),-0.41982935467157384,-1.627687782259647,0.0,0.23278933105678198,1.0,15/58,14.94%,SORCS3;GLRB;OPRM1;GLRA3;SORCS1;HCRTR2;GPR37;PPY;GLRA1;CYSLTR1;ADCYAP1;NMU;GPR149;GPR84;RAPGEF2
prerank,cellular lipid catabolic process (GO:0044242),0.6381195903028236,1.62562409107267,0.006443298969072165,0.17883309010236345,1.0,9/27,11.23%,CEL;MGST2;LIPG;LPIN3;AOAH;ACADL;PLBD2;PPARD;MT3
prerank,positive regulation of lipid transport (GO:0032370),0.7545066644001356,1.624061476637385,0.013782542113323124,0.18119871234804832,1.0,4/12,7.85%,APOE;LRP1;SPP1;ABCA3
prerank,regulation of postsynapse organization (GO:0099175),-0.48876657565815523,-1.6235387854289602,0.00510204081632653,0.23656720367539472,1.0,8/28,7.17%,TANC2;IL1RAPL1;ABI2;CDK5R1;ARHGAP44;SIPA1L1;SRCIN1;HOMER1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5693415507271897,-1.6221065383496143,0.019083969465648856,0.23544768636425428,1.0,11/18,19.38%,PLCB1;RGS10;OPRM1;CHRM3;GNA15;CHRM2;CDK5R1;AGRN;GRK2;GNA11;RGS8
prerank,regulation of small molecule metabolic process (GO:0062012),0.6269730968196928,1.6190546301120916,0.00517464424320828,0.19090190399572649,1.0,11/28,15.47%,APOE;PDK4;ACADL;NR1H4;ACADVL;FOXK1;SIRT1;RORA;DGKQ;PRKN;PANK2
prerank,fluid transport (GO:0042044),0.7270295493973257,1.6187231562705098,0.021116138763197588,0.1903282879991167,1.0,1/12,1.90%,AQP1
prerank,energy reserve metabolic process (GO:0006112),0.6831716384121957,1.6182503165827438,0.01876675603217158,0.19009345699287475,1.0,8/19,12.58%,PRKAG2;PYGL;PID1;GBE1;GFPT1;GSK3B;MT3;UGP2
prerank,defense response to bacterium (GO:0042742),0.5323369646078275,1.617311308306927,0.0010515247108307045,0.19097280745432668,1.0,25/105,15.81%,LYST;SYK;OPTN;MPEG1;CEBPB;AQP1;IL6;STAB2;PRKCD;ANKRD17;LYZL4;RNASE3;GBP6;NLRC4;IL6R;MAVS;ADAM17;DROSHA;TREM2;FGR;SLC11A1;SLPI;SHC1;LBP;MYD88
prerank,glutathione derivative metabolic process (GO:1901685),0.6827894787773139,1.6154082750004435,0.01544943820224719,0.1929158928518074,1.0,8/20,15.32%,MGST2;GSTM1;AKR1A1;HPGDS;ESD;MGST1;GSTO2;GSTA4
prerank,glutathione derivative biosynthetic process (GO:1901687),0.6827894787773139,1.6154082750004435,0.01544943820224719,0.1929158928518074,1.0,8/20,15.32%,MGST2;GSTM1;AKR1A1;HPGDS;ESD;MGST1;GSTO2;GSTA4
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.675378099117353,1.6140028786787426,0.02074688796680498,0.19469399149411534,1.0,8/20,13.96%,EPAS1;ZMIZ1;WASHC1;HSPA1B;DCUN1D5;DCUN1D3;PRKN;HSPA1A
prerank,positive regulation of metabolic process (GO:0009893),0.5370560725511743,1.6135016307555443,0.0,0.19455945975573286,1.0,19/103,10.43%,EPAS1;FABP4;CD36;CXCR4;SYK;FABP5;VEGFA;CEBPB;GADD45G;DYNC1H1;FASN;APPL2;SIRT6;ACADL;APC;KDM3A;KSR2;TRPV2;PTH2R
prerank,cardiac muscle cell action potential (GO:0086001),-0.4886084216881541,-1.6133349748381072,0.00980392156862745,0.24775038057641338,1.0,9/30,11.00%,ATP1B1;ANK2;CACNA1C;ATP1A2;FGF12;SCN1B;KCNJ2;CACNA1G;HCN2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.6801035827847132,1.6131147665458718,0.009138381201044387,0.19433258440655848,1.0,9/20,12.98%,NFE2L2;VEGFA;RUNX2;SESN2;ATF4;CARF;MT3;NOTCH1;RELA
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.4419851409119988,-1.6119743231325365,0.0,0.2467484515403038,1.0,26/41,37.94%,KCNMA1;ANK2;ANK3;KCNJ2;KCNJ3;NOS1AP;GABBR1;KCNJ9;ACTN2;KCNN2;STAC;KCNJ6;NOS1;KCNMB4;GNB1;KCNJ12;KCNJ16;KCNJ10;KCNN1;AKAP6;GNG2;KCNQ1;PDZK1;KCNMB2;KCNN3;KCNJ15
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5828387158751577,1.6117046555505268,0.00842358604091456,0.19598283347383466,1.0,14/45,15.36%,IQGAP1;REPS2;GRB2;NCK2;SOS1;PDPK1;KIF16B;PIK3CA;SOX9;ADAM17;PTK2B;ERBIN;SHC1;CBL
prerank,potassium ion homeostasis (GO:0055075),-0.5055445317435323,-1.6116230891492518,0.00819672131147541,0.2438229077963779,1.0,7/23,5.29%,KCNMA1;SLC12A2;ATP1B1;SLC12A6;ATP1A2;KCNJ2;ATP1B2
prerank,snRNA metabolic process (GO:0016073),0.6970726851463419,1.6113150248692525,0.019471488178025034,0.19570682253180666,1.0,10/17,17.07%,INTS9;INTS6;INTS1;INTS8;MEPCE;INTS2;INTS5;INTS7;MTREX;RBM7
prerank,positive regulation of protein polymerization (GO:0032273),-0.4053460842501696,-1.6101827507694606,0.0,0.2427529578645576,1.0,17/65,7.81%,NAV3;BIN1;EVL;FCHSD2;PRKCE;VASP;MAPT;FER;HCK;CDK5R1;NCKAP1;NCK1;HSP90AA1;PAK1;TPPP;AKAP9;CARMIL1
prerank,blood vessel morphogenesis (GO:0048514),0.5732975174480165,1.6097715954010325,0.006818181818181818,0.19810453375088405,1.0,5/54,1.73%,CCBE1;APLNR;SYK;STRA6;VEGFA
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.5457966481780004,1.6092802710042386,0.0,0.19807001825408677,1.0,31/80,18.55%,TMEM87B;RAB7B;PHETA2;PIKFYVE;SNX8;RIC1;RAB7A;WASHC1;SNX5;CLN5;VTI1B;TBC1D10A;TBC1D23;STX5;VPS54;VTI1A;DENND2A;VPS52;VPS51;SPAG9;VAMP3;PLEKHJ1;TRAPPC10;STX6;TMEM87A;RAB29;ERC1;UBE2O;SNX3;VPS29;BAIAP3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.4819292050454548,-1.6085563794511881,0.010256410256410256,0.2420171428638264,1.0,10/31,9.04%,TANC2;NLGN1;ABI2;RELN;CDK5R1;ARHGAP44;SIPA1L1;CUX2;SRCIN1;LRP8
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.6299465584076729,1.6084637966976252,0.016795865633074936,0.19878991437016208,1.0,10/30,13.24%,CD300LF;IKBKE;TANK;RIPK1;LY96;RPS27A;UBC;TICAM2;BIRC3;TRAF3
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6862721865537827,1.6082899619662365,0.015277777777777777,0.19795383728803687,1.0,6/18,10.47%,F7;IL6;SLC8B1;IL6R;ADAM17;PTK2B
prerank,sulfur amino acid metabolic process (GO:0000096),0.6494869038635318,1.607451626545384,0.024804177545691905,0.1985578582740249,1.0,3/24,3.73%,CDO1;MSRA;TST
prerank,superoxide anion generation (GO:0042554),0.726306184378064,1.6070559165396938,0.02976190476190476,0.19825263445174637,1.0,6/13,16.90%,CYBB;CYBA;NCF2;NCF4;TAFA4;NCF1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.7489779124379378,1.606929151977278,0.01791044776119403,0.1974043557876996,1.0,3/12,2.75%,GCNT2;FLOT1;CD44
prerank,cellular protein catabolic process (GO:0044257),0.5688159325161546,1.6054799789728227,0.005720823798627002,0.1991884601599273,1.0,34/59,27.19%,CTSB;CTSL;RAB7A;TCIRG1;RIPK1;LONP1;HTRA2;CAPN2;AFG1L;CTSS;CTSZ;CTSH;RSPRY1;RAB12;CTSW;AP2B1;PRKN;RNF123;BNIP3;MYLIP;PSMA6;LGMN;CLPX;MALT1;SIAH2;AP2S1;CASP8;CLTC;CTSK;CTSO;UBE2G1;AP2A2;AP2A1;MAGEC2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.4200892441490064,-1.6054216302487883,0.0072992700729927005,0.24415777445735556,1.0,15/54,13.82%,BIN1;KCNMA1;KCNIP4;DPP10;DPP6;KCNAB1;KCNJ2;KCNIP3;KCNJ3;NOS1AP;GABBR1;KCNJ9;DLG1;KCNIP1;KCNN2
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.6594742303550284,1.6050326995138664,0.011188811188811189,0.19903756428628788,1.0,8/21,14.56%,CTNNB1;APC;DVL1;GSK3B;FZD5;FZD2;PPP1CA;LRP6
prerank,negative regulation of immune effector process (GO:0002698),0.723415192520072,1.6050007882786235,0.01649175412293853,0.1979889810117313,1.0,3/13,1.46%,LGALS3;CD300A;LILRB1
prerank,alcohol catabolic process (GO:0046164),0.763157363830925,1.6040610441265195,0.015337423312883436,0.19889765872948778,1.0,6/10,17.81%,CEL;APOE;MT3;CYP46A1;SNX17;CYP27A1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7051195127672225,1.603791850994889,0.011188811188811189,0.19835244440035776,1.0,4/16,7.11%,APLNR;VEGFA;THBS1;HMOX1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.5397713102605107,1.6017117313926823,0.001095290251916758,0.20188498553174328,1.0,27/86,19.68%,EPAS1;NFE2L2;VEGFA;ATF3;PSMD1;BACH1;MAPK7;CREBBP;ATF4;HMOX1;RPS27A;UBC;DDIT3;EGLN3;PSMF1;PSMD14;PSMD12;LIMD1;HSPA1A;PSME2;INO80;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11
prerank,regulation of cholesterol storage (GO:0010885),0.7204479985942103,1.6010527845466376,0.010432190760059613,0.20214027372283247,1.0,4/15,2.82%,PPARG;ABCA1;ABCG1;NR1H3
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.6301306433019321,1.6003613173233595,0.020942408376963352,0.20259722809983183,1.0,10/29,13.24%,CD300LF;IKBKE;TANK;RIPK1;LY96;RPS27A;UBC;TICAM2;BIRC3;TRAF3
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5235291054315888,1.600309377206141,0.0,0.20158616780324853,1.0,41/151,15.75%,CDO1;PLPP3;B4GALT5;APOE;SPTLC2;ARG1;MGST2;MOCOS;LPIN3;SAMD8;SGPL1;GSTM1;AKR1A1;CERT1;TNIP1;RHD;LCMT2;SGMS2;HACD4;CERS6;ARG2;SPHK2;ST3GAL4;SPTSSA;SLC27A1;HPGDS;VAPA;CSNK2A2;ESD;PCYT1A;ELOVL1;ALDH3A2;LPCAT3;MGST1;DEGS1;GOLPH3;GSTO2;SLC25A15;SLC44A2;GSTA4;PRKD3
prerank,regulation of organelle assembly (GO:1902115),0.5507867702589562,1.5996841755419424,0.004429678848283499,0.20179397346653663,1.0,27/72,16.70%,PIKFYVE;MTMR3;TBC1D22A;PLK2;TBC1D1;TBC1D2;KIF9;TBC1D12;ATXN2;STAM;TBC1D10A;TBC1D2B;MSN;RAB1B;PDCD6IP;TBC1D22B;ATG5;TBC1D24;TBC1D15;CEP76;NPRL3;IFT140;VPS11;ALMS1;UBQLN2;RABGAP1;NPRL2
prerank,lipoprotein biosynthetic process (GO:0042158),0.7641456021705444,1.5995554699817744,0.011940298507462687,0.20093787699331644,1.0,3/11,5.36%,APOE;ATG7;ATG10
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5876038304967763,1.5995160598412883,0.0035335689045936395,0.19994093012376865,1.0,12/44,7.92%,VEGFA;FNIP1;AQP1;DNAJB6;CD44;HGF;MAP2K5;RAF1;PCID2;THBS1;SH3RF1;XIAP
prerank,membrane depolarization during action potential (GO:0086010),-0.49901406925678266,-1.5980198069695744,0.013215859030837005,0.2544165757941646,1.0,13/26,21.22%,SCN2A;CACNA1C;ATP1A2;SCN1B;KCNJ2;SCN9A;CACNA1G;HCN2;YWHAH;SCN8A;CACNA1I;SCN4B;SCN1A
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6790560638665706,1.5974052435222899,0.013850415512465374,0.2035759701152898,1.0,3/19,3.65%,CCBE1;XDH;CD63
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.6133259033937173,1.5962860198218412,0.012919896640826873,0.20509390790856466,1.0,13/30,15.15%,MICALL2;NPEPPS;FBXW7;SH3GLB1;HTRA2;UBE2L3;HUWE1;CSNK2A2;ARIH2;FZD5;ATG13;VPS11;USP36
prerank,positive regulation of protein catabolic process (GO:0045732),0.5365262802980593,1.595330543386273,0.0021668472372697724,0.20617463878945144,1.0,30/84,17.43%,APOE;ATG7;WWP1;TIPARP;RAB7A;PLK2;ADAM9;SNX9;TNFRSF1B;SORL1;ADAM8;APC;STX5;MSN;NEDD4L;WWP2;HUWE1;SNX33;DDB1;GSK3B;FOXO1;OAZ2;GPLD1;TNFAIP3;PRKN;VPS11;SNF8;SH3D19;OAZ1;CSNK2A1
prerank,regulation of autophagy (GO:0010506),0.5074739178615756,1.5924139668017503,0.0,0.21146047195036694,1.0,74/216,19.59%,ATP6V0D2;PSAP;HTR2B;TPCN2;GPR137B;OPTN;TFEB;MTMR3;ERN1;ATP6V1A;PRKAG2;ATP6V1E1;FBXW7;PLK2;HGF;ABL2;FOXO3;CTSA;ATP6V1C1;WASHC1;ATP6V0D1;SNX5;DAPK1;SH3GLB1;HTRA2;EEF1A1;FLCN;ATP6V1B2;DCAF12;MEFV;CSNK2A2;ATP6V0A1;DDIT3;LAMTOR1;ROCK1;GSK3B;FOXK1;FOXO1;MT3;TAB2;FZD5;TREM2;ATP6V0E1;ATG13;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;VDAC1;PRKN;ZKSCAN3;ATP6V1H;MCL1;UBQLN2;EXOC4;USP36;BNIP3;RUBCN;PIP4K2A;NPRL2;KEAP1;ACER2;DRAM2;TRIM14;VPS29;EXOC7;EXOC1;CASP3;RHEB;EIF4G3;EIF4G2;PIK3CB;TLK2;ATP6V1G2
prerank,amino acid transmembrane transport (GO:0003333),0.5905087528214041,1.5921486226009387,0.010625737898465172,0.21099198068095026,1.0,9/45,7.56%,LRRC8D;SLC6A6;SLC36A2;SLC36A4;SLC38A6;SLC7A7;SLC38A1;MFSD12;SLC38A7
prerank,positive regulation of wound healing (GO:0090303),0.6020484943240495,1.5912694900480824,0.007444168734491315,0.2118635876872021,1.0,8/36,12.21%,HPSE;PLPP3;ANXA1;THBS1;ST3GAL4;RREB1;ITGB1;MYLK
prerank,regulation of fatty acid oxidation (GO:0046320),0.7021938564144515,1.5905492993671964,0.02005730659025788,0.21242086775464183,1.0,8/16,12.51%,PDK4;PRKAG2;ABCD1;APPL2;ACADL;ACADVL;SOX9;LONP2
prerank,serine family amino acid metabolic process (GO:0009069),0.6991042150302614,1.5904777755818875,0.022727272727272728,0.2114857680162924,1.0,5/16,12.19%,CDO1;BAAT;SEPHS2;GLYAT;SARS1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.452836168524547,-1.5897885129754477,0.014354066985645933,0.26608020837200336,1.0,8/35,7.65%,NLGN1;CDH23;CDH11;ATP2C1;CDH9;CDH8;CDH6;CDH12
prerank,alanine transport (GO:0032328),0.778639193099334,1.5895610503116804,0.02702702702702703,0.21267540364063198,1.0,3/10,1.64%,SLC6A6;SLC36A2;SLC36A4
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6161585740182203,1.58932007348182,0.013664596273291925,0.2121335540314163,1.0,8/31,12.04%,GPNMB;CDKN1A;PTEN;APC;RB1;BRD7;DCUN1D3;CDK2AP2
prerank,epithelial cell differentiation (GO:0030855),0.5466333677442317,1.5888658484102651,0.004310344827586207,0.21201174180616453,1.0,13/88,10.48%,LGALS3;PPARG;ANXA4;CTSB;ANXA1;VEGFA;TPP1;TST;ACADVL;CPT1A;FSTL1;FZD7;RAB10
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.6717344000919065,1.58811831998664,0.0174496644295302,0.2125072137422375,1.0,5/19,13.11%,SYK;ZMIZ1;MMP14;BTK;GAS6
prerank,regulation of interleukin-1 production (GO:0032652),0.6937302455488966,1.585278568717698,0.0213089802130898,0.21796370467061235,1.0,5/15,13.11%,ANXA1;SIRPA;FOXP1;MEFV;GAS6
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.564869113537231,1.5846433416347052,0.005917159763313609,0.21836243903597258,1.0,19/55,17.53%,XDH;GRB2;PIKFYVE;MPV17;CDKN1A;COQ7;RIPK1;PID1;THBS1;GADD45A;EIF6;SPHK2;BRCA1;MT3;PRKN;ACOD1;BST1;PARL;ARF4
prerank,positive regulation of positive chemotaxis (GO:0050927),0.6959752173051301,1.5843664461379563,0.016783216783216783,0.2179034891334409,1.0,2/15,1.73%,F7;VEGFA
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5903946819175532,1.5808337351520305,0.013836477987421384,0.2252019629180653,1.0,11/36,13.96%,CD300LF;CXCR4;RIPK1;UBE2K;HSPA1B;TICAM2;MAVS;ADAM17;GAS6;PRKN;HSPA1A
prerank,carbohydrate biosynthetic process (GO:0016051),-0.5239821785392617,-1.5781050530858562,0.026615969581749048,0.28518182011584803,1.0,6/21,5.93%,ST3GAL6;B3GALT1;ST8SIA6;FUT9;ST3GAL2;ST6GALNAC5
prerank,cholesterol metabolic process (GO:0008203),0.5464223483775751,1.5772270239260304,0.004540295119182747,0.23263731089514153,1.0,17/68,15.86%,CEL;SOAT1;ABCA1;APOE;ABCG1;OSBPL1A;RXRA;MVD;PLPP6;IDI1;PPARD;MT3;CYP46A1;INSIG2;PMVK;SNX17;ACAA2
prerank,negative regulation of chemokine production (GO:0032682),0.7009634413886368,1.5770228316937043,0.022388059701492536,0.23199352159573008,1.0,5/14,8.69%,SIGIRR;IL6;MAP2K5;SIRPA;MEFV
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.5859792658989924,1.5751664622732118,0.008641975308641974,0.23515807576268774,1.0,17/38,18.05%,MICALL2;NPEPPS;FBXW7;SH3GLB1;HTRA2;UBE2L3;HUWE1;CSNK2A2;ARIH2;BAG4;FZD5;ATG13;PRKN;VPS11;USP36;PARL;TOMM7
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6990540982891017,1.5748839916882207,0.024965325936199722,0.2346738956093813,1.0,8/15,16.16%,APOE;ADAM9;SNX9;TNFRSF1B;ADAM8;SNX33;GPLD1;SH3D19
prerank,receptor clustering (GO:0043113),-0.48621965468175804,-1.5748680132047768,0.02304147465437788,0.28796675489454177,1.0,11/27,14.45%,DLG2;NRXN1;NLGN1;MAGI2;SYNJ2BP;ITGB2;ITGB1BP1;PICK1;AGRN;DLG1;DLG3
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.7664865695944157,1.5747328603267807,0.018518518518518517,0.23397965998313755,1.0,3/10,4.64%,PPARG;RXRA;RARA
prerank,cellular response to oxygen levels (GO:0071453),0.7565624941841766,1.5731233597858902,0.027914614121510674,0.23675107676457294,1.0,4/10,4.29%,ATP6V1A;CPEB4;ATP6V0D1;TMEM199
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6911418032755101,1.5717451768199082,0.029455081001472753,0.23910523757000185,1.0,2/16,0.58%,CD36;APOE
prerank,regulation of protein autophosphorylation (GO:0031952),0.5972691635348191,1.571621902122303,0.007272727272727273,0.23828660131228216,1.0,5/36,4.26%,GPNMB;RAP2A;VEGFA;PDGFA;ENPP1
prerank,protein targeting to lysosome (GO:0006622),0.6522780691211194,1.5715855605796747,0.02642559109874826,0.23725526360784752,1.0,12/20,21.78%,RAB7A;SORL1;SCARB2;NCOA4;LAMP2;SNX16;VPS4A;M6PR;AP4M1;NAGPA;GGA3;ZFYVE16
prerank,regulation of mast cell degranulation (GO:0043304),0.7132761527487906,1.5701320862557435,0.028064992614475627,0.2399394344464255,1.0,7/14,13.54%,CD300A;SYK;GAB2;CD84;SPHK2;FES;FGR
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.7414067590108222,1.5700975375808077,0.02903225806451613,0.23890031461854985,1.0,5/10,13.77%,AOC3;ETFBKMT;HP;MT3;PRKN
prerank,positive regulation of endocytosis (GO:0045807),0.5695771516684439,1.5690830541596117,0.017482517482517484,0.24037308167235188,1.0,12/45,8.05%,APOE;FLOT1;ANO6;LRP1;CD151;PPT1;APPL2;CLN3;RAB21;RAB31;STAP1;NEDD4L
prerank,regulation of interleukin-10 production (GO:0032653),0.5751513414309875,1.5670905855032518,0.012910798122065728,0.24413036652877018,1.0,8/44,4.07%,SYK;LILRB1;PIBF1;FOXP3;IL6;CD28;CD46;CD274
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5408127088793737,-1.5662913360354358,0.03546099290780142,0.3021303224434687,1.0,9/18,16.33%,NRXN1;NLGN1;RELN;TSHZ3;CACNG4;NLGN3;CACNG3;CCR2;CACNG2
prerank,neuronal action potential (GO:0019228),-0.5153621608089386,-1.5647775127485586,0.04659498207885305,0.30131119338273166,1.0,9/22,25.76%,SCN2A;ANK3;SCN9A;CACNA1G;MYH14;SCN8A;CACNA1I;SCN1A;KCNMB4
prerank,long-chain fatty acid import into cell (GO:0044539),0.7560201370608876,1.5645776112081868,0.0273972602739726,0.24922636569419782,1.0,4/10,12.38%,CD36;SLC27A4;SLC27A1;SLC2A1
prerank,positive regulation of neuron projection development (GO:0010976),-0.38016823634764835,-1.564472665637157,0.0,0.29815200704095574,1.0,24/85,9.76%,ARSB;CAMK1D;RIT2;TWF2;TENM3;NTRK3;SETX;ITGA6;EPHA3;TOX;PLPPR5;MAGI2;SCN1B;FUT9;RELN;NTRK2;ATP1B2;CUX2;PRKD1;VLDLR;MARK2;LRP8;DAB2IP;SERPINI1
prerank,regulation of hemopoiesis (GO:1903706),0.7511082997568247,1.5642319924468382,0.02857142857142857,0.24883528128145385,1.0,5/10,11.72%,LGALS3;CREBBP;CBFB;MAFB;PRKCB
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6024001509203515,1.563705598882767,0.013597033374536464,0.24908793082349134,1.0,8/33,12.04%,GPNMB;CDKN1A;PTEN;APC;RB1;BRD7;DCUN1D3;CDK2AP2
prerank,peptide catabolic process (GO:0043171),0.6350035757894145,1.5620547096504964,0.0195822454308094,0.25170779852716324,1.0,6/23,10.37%,ANPEP;CPQ;TPP1;NPEPPS;CTSH;LTA4H
prerank,leukocyte cell-cell adhesion (GO:0007159),0.6385766311826697,1.561670194585481,0.019329896907216496,0.251470524151035,1.0,8/24,10.10%,SYK;TNIP1;ITGA4;CERCAM;MSN;NT5E;ITGB1;ROCK1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.6957658276713377,1.560570682112503,0.03203342618384401,0.2532139600002994,1.0,6/15,15.81%,CD36;MEFV;NLRP2B;NLRC3;TREM2;MYD88
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6268689905538303,-1.5603436134350348,0.05,0.30303017202636806,1.0,3/11,5.78%,ATP1B1;KCNJ2;KCNJ3
prerank,glycoprotein catabolic process (GO:0006516),0.688547384704302,1.560197599109052,0.026509572901325478,0.25284631634766547,1.0,6/17,12.95%,MMP12;CTSL;MANBA;EDEM2;OGA;FBXO6
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6665806597221273,1.5601589473491533,0.032624113475177303,0.2517773734132526,1.0,3/17,5.43%,LGALS3;DGKZ;DUSP3
prerank,glycogen metabolic process (GO:0005977),0.6238229779328329,1.5600751647704172,0.011688311688311689,0.2509117966029006,1.0,9/27,13.87%,GYG1;PRKAG2;PYGL;GBE1;NHLRC1;GSK3B;PGM1;UGP2;AGL
prerank,negative regulation of inflammatory response (GO:0050728),0.4991019438888896,1.5600645885003992,0.0010245901639344263,0.24980582166052176,1.0,43/182,14.46%,PPARG;APOE;SYK;CD200R1;GPR15;PTGDR;NR1H3;PLK2;IL6;HTR6;PRKCD;RHBDF2;TNFRSF1B;AOAH;IGF1;MAPK7;GPR83;ADCY7;NR1H4;PROC;PTGER2;METRNL;MFHAS1;GPR176;RB1;SIRPA;MEFV;PTGER4;VIPR1;NLRC3;ADAM17;PTH2R;PPARD;RORA;LPCAT3;MYH9;TREM2;TNFAIP8L2;FGR;TNFAIP3;ADCY8;ADCY3;ACOD1
prerank,synaptic membrane adhesion (GO:0099560),-0.5926038274795202,-1.5599972301262413,0.036544850498338874,0.2998288708664383,1.0,5/14,11.38%,PTPRD;LRRC4C;NTNG1;LRRC4B;LRFN5
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.7250795393556918,1.5597288005903902,0.019662921348314606,0.2495283747875681,1.0,3/12,9.91%,PPARG;NCOR1;ESR1
prerank,organonitrogen compound catabolic process (GO:1901565),0.5600231849780503,1.55959583510942,0.004540295119182747,0.24867959098062098,1.0,13/57,10.38%,ANPEP;PLA2G7;CPQ;SGPL1;TPP1;NPEPPS;TST;PPT1;CLN5;RENBP;NAGK;LTA4H;GGACT
prerank,protein localization to lysosome (GO:0061462),0.6082912146072162,1.559238546629985,0.02454780361757106,0.24851379595834217,1.0,18/28,26.14%,RAB7A;SORL1;GLMP;RNF128;LMBRD1;SCARB2;NCOA4;SNX16;VPS4A;M6PR;RTN4;AP4M1;NAGPA;GGA3;ZFYVE16;KPTN;ATP13A2;AP3M1
prerank,regulation of protein neddylation (GO:2000434),0.7490901586711718,1.558745481432481,0.029548989113530325,0.2485796654405168,1.0,6/10,16.74%,EPAS1;COPS9;DCUN1D5;DCUN1D3;DCUN1D4;DCUN1D1
prerank,protein-containing complex disassembly (GO:0032984),0.5549334087569648,1.557050552166548,0.013953488372093023,0.2518045414947227,1.0,19/54,14.80%,CTNNB1;SNAP29;TECPR1;UVRAG;CLN3;VTI1B;APC;RPL23;LAMP2;DVL1;VPS33A;VPS4A;GSK3B;EPG5;FZD5;FZD2;PPP1CA;LRP6;SNX14
prerank,vasculature development (GO:0001944),0.6828235470627009,1.556703726610284,0.027142857142857142,0.25167212139621453,1.0,6/16,9.45%,APLNR;STRA6;FBXW7;PIK3CA;ACVRL1;BMPR2
prerank,microglial cell activation (GO:0001774),-0.5177628879198815,-1.5565169726240538,0.03968253968253968,0.3026639198356453,1.0,7/21,7.99%,CX3CR1;ITGAM;MAPT;IFNGR1;AIF1;ITGB2;CLU
prerank,regulation of histone deacetylation (GO:0031063),0.7188481638224785,1.5565116608130496,0.03202328966521106,0.25096606039504743,1.0,4/13,7.02%,APLNR;FOXP3;SPHK2;NIPBL
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6684634214107655,1.5556484433467344,0.01741654571843251,0.2520451185046856,1.0,5/16,11.25%,LYST;PLEKHM2;SLAMF7;ARL8B;ULBP1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.5933142561046737,1.5553845843658918,0.015,0.2517145762075162,1.0,13/33,15.86%,VAT1;SLC35F6;TFRC;HGF;IGF1;PPIF;FLCN;HUWE1;OMA1;PRKN;HSPA1A;BNIP3;ACAA2
prerank,regulation of protein processing (GO:0070613),0.6486187051711092,1.554153981011983,0.01637107776261937,0.25389416129918385,1.0,4/21,7.32%,CCBE1;CLN3;ADAM8;NLRC4
prerank,Golgi localization (GO:0051645),0.7414973392564812,1.5536487572305047,0.03288490284005979,0.2541630470823881,1.0,3/11,4.22%,ARHGAP21;HOOK3;UVRAG
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.629563439105123,1.552281282763174,0.028534370946822308,0.25661050193879054,1.0,4/23,4.49%,PPARG;ARG1;NR1H3;IFNGR2
prerank,negative regulation of interferon-beta production (GO:0032688),0.7366544656634791,1.5520829827959608,0.03554868624420402,0.2560535085443395,1.0,5/10,12.28%,LILRB1;REL;SIRPA;NLRC3;RELB
prerank,pentose-phosphate shunt (GO:0006098),0.7395030099704577,1.551826302854687,0.03935860058309038,0.2556136307823924,1.0,6/11,20.05%,PGD;TALDO1;SHPK;DERA;RPIA;RBKS
prerank,peptide cross-linking (GO:0018149),0.6265859161403559,1.5515118523221971,0.023255813953488372,0.25537985496987803,1.0,6/25,15.34%,ANXA1;TGM2;THBS1;F13A1;COL3A1;CD247
prerank,regulation of macroautophagy (GO:0016241),0.5171224951817174,1.5510917683182186,0.0010672358591248667,0.2552724084223265,1.0,38/105,19.59%,ATP6V0D2;ERN1;ATP6V1A;TBC1D25;PRKAG2;ATP6V1E1;ATP6V1C1;WAC;ATP6V0D1;SNX5;SESN2;SH3GLB1;CLN3;PIK3CA;ATP6V1B2;EPM2A;PAFAH1B2;QSOX1;ATP6V0A1;LAMTOR1;SIRT1;ATP6V0E1;ATG13;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;ATP6V1H;UBQLN2;EXOC4;USP36;BNIP3;EXOC7;EXOC1;CASP3;RHEB;TBK1;ATP6V1G2
prerank,cell differentiation in hindbrain (GO:0021533),-0.6228230307407099,-1.5502016700160381,0.03058103975535168,0.31202711404645533,1.0,4/11,3.90%,OPHN1;GRID2;KNDC1;FAIM2
prerank,regulation of p38MAPK cascade (GO:1900744),0.5970302048127513,1.548986181978298,0.025031289111389236,0.25930926211613425,1.0,8/35,7.29%,SASH1;XDH;VEGFA;GADD45B;GADD45G;RELL1;GADD45A;MFHAS1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5538365295590519,1.5487506818727597,0.012746234067207415,0.2586930677538697,1.0,9/51,10.29%,F7;PLA2G7;VEGFA;ANO6;IL6;THBS1;IL6R;MOSPD2;ADAM17
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5668142650633727,1.5464011953090329,0.011862396204033215,0.2634792840814505,1.0,10/46,8.10%,DDHD1;GPAT2;AGPAT4;PLD2;PLA2G2D;DGKZ;DGKA;GPD1L;SLC27A1;ABHD4
prerank,amyloid precursor protein metabolic process (GO:0042982),0.655299453817387,1.545839021676521,0.03867403314917127,0.2638257471041804,1.0,11/18,22.94%,APOE;ABCG1;CLN3;BACE1;ADAM17;ADAM19;NCSTN;ADAM10;APH1B;LDLRAP1;PSEN2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5267320719617951,1.5454820005541499,0.006674082313681869,0.26362732209577466,1.0,23/74,20.63%,EPAS1;NFE2L2;VEGFA;PSMD1;CITED2;BACH1;CREBBP;RPS27A;UBC;EGLN3;PSMF1;PSMD14;NOTCH1;PSMD12;LIMD1;PSME2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6
prerank,chloride transport (GO:0006821),-0.3742042844788844,-1.545393007678639,0.009345794392523364,0.31780444475546465,1.0,24/74,14.62%,SLC12A2;GABRB3;SLC12A6;ANO4;GLRB;SLC1A3;ANO3;GLRA3;GABRA2;GABRB1;TTYH1;GABRA3;GLRA1;GABRG3;SLC4A10;SLC6A1;SLC4A8;SLC1A1;LRRC8A;CLCN3;CLCN6;SLC12A4;GABRA4;CLCN2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.5672546397303612,1.5436581923910109,0.020531400966183576,0.2675193369105164,1.0,12/42,18.02%,OPTN;MPEG1;AQP1;IL6;RNASE3;IL6R;DROSHA;TREM2;SLC11A1;LBP;TNFRSF14;DEFA6
prerank,positive regulation of interleukin-17 production (GO:0032740),0.6328297937228486,1.5425455517664979,0.025232403718459494,0.2695751274771642,1.0,8/22,19.66%,RFTN1;IL6;LY9;NR1H4;IL15;MYD88;ZBTB7B;OSM
prerank,positive regulation of cellular component organization (GO:0051130),0.5125997062630046,1.542312853039432,0.0020964360587002098,0.26909030884822516,1.0,19/107,8.05%,LGALS3;FNIP2;APOE;SYK;PLEKHM2;BCL2L11;VEGFA;FLOT1;ABCB7;FNIP1;TFRC;LRP1;CD151;SH3GLB1;MTLN;HAS3;ASAP1;RB1;NEDD4L
prerank,inhibitory synapse assembly (GO:1904862),-0.6086820612396687,-1.5420162411455647,0.05405405405405406,0.3213572110567724,1.0,4/11,5.27%,GABRB3;GABRA2;LGI2;FGF13
prerank,smooth muscle cell differentiation (GO:0051145),0.7220776412198033,1.5415010887400533,0.026509572901325478,0.2701103262644369,1.0,3/12,0.85%,APLNR;MRTFA;MRTFB
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5305090999330918,-1.5412892250800172,0.043478260869565216,0.3190973387774962,1.0,9/19,20.33%,GRM5;RYR2;TRPM2;PRKACA;PRNP;FIS1;PTPRJ;FKBP1B;ADGRL1
prerank,regulation of tissue remodeling (GO:0034103),0.652947079133023,1.5401271800773442,0.029453015427769985,0.2725718912865261,1.0,1/18,0.01%,GPNMB
prerank,regulation of response to biotic stimulus (GO:0002831),0.6063879035739941,1.5392467666188288,0.023653088042049936,0.273799712475054,1.0,13/28,14.32%,CD36;APPL2;RNF135;TKFC;XIAP;FOXP1;BIRC3;APPL1;TREM2;TRAF3;FGR;N4BP1;CX3CL1
prerank,positive regulation of cell communication (GO:0010647),-0.4796943398871518,-1.5388816161589602,0.01293103448275862,0.3204316125529383,1.0,10/28,17.40%,SYT1;RIMS1;RIMS2;ANK3;GRIK2;CD80;HOMER1;NMU;TNF;CDKN2AIP
prerank,intracellular cholesterol transport (GO:0032367),0.6903024840801244,1.53838936114712,0.030390738060781478,0.27490342407336743,1.0,6/15,9.57%,ABCA1;NPC1;ABCG1;SERAC1;RELCH;VPS4A
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6917420875829535,1.5381320408833457,0.04294478527607362,0.27443972959725954,1.0,4/13,4.60%,CBLB;IPO5;KPNA4;KPNA2
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.4851870009190587,-1.5379798625964085,0.02834008097165992,0.318722825718347,1.0,10/24,15.67%,HDGFL3;MAPT;STMN3;FGF13;TPPP;STMN4;STMN2;KIF18A;TPPP3;STMN1
prerank,negative regulation of type I interferon production (GO:0032480),0.5638853976650754,1.537848706083067,0.0275,0.27406074780597045,1.0,19/40,24.62%,LILRB1;IKBKE;TRIM25;NPLOC4;RNF135;REL;SIRPA;MAVS;NLRC3;TAX1BP1;RELB;TNFAIP3;ACOD1;OTUD5;TBK1;RNF125;ISG15;DHX58;GPATCH3
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6112969249479057,1.5377396123812186,0.020942408376963352,0.27335361424244936,1.0,9/26,14.89%,EYA1;MAP2K5;HTRA2;MAPK7;HSPA1B;SNAI2;HSPA1A;GDNF;MCL1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.7046556228768028,1.536887193666371,0.03392330383480826,0.2744418832409159,1.0,4/13,5.48%,PLXNA1;PLXNC1;PLXND1;NRP2
prerank,adherens junction organization (GO:0034332),-0.4105980403140635,-1.535951701168781,0.02112676056338028,0.31943741199319964,1.0,11/48,7.65%,CADM1;CADM2;CTNND1;CDH11;CDH9;JUP;CDH8;CDH2;CDH6;SMAD7;CDH12
prerank,triglyceride homeostasis (GO:0070328),0.6109884987365668,1.5357373632132747,0.035856573705179286,0.27642321367684186,1.0,6/26,11.99%,APOE;NR1H3;MTLN;NR1H4;SIRT1;RORA
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.604808877546307,1.5350345238402472,0.027848101265822784,0.2771519764723865,1.0,15/30,20.53%,ACD;CDKN1A;NIBAN2;TENT4B;HNRNPU;ACVRL1;DACH1;NAT10;TERF1;BMPR2;TEN1;STN1;EXOSC10;GNL3L;CERS1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.6410528794681162,1.5348193540207422,0.031207598371777476,0.2765710592883662,1.0,4/21,5.43%,GPNMB;LGALS3;PIBF1;DUSP3
prerank,protein neddylation (GO:0045116),0.6922785083569116,1.5337541978330171,0.041979010494752625,0.2784303641883408,1.0,8/13,17.33%,DCUN1D5;DCUN1D3;UBA3;DCUN1D4;UBE2F;RNF7;DCUN1D1;UBE2M
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.560386915509276,1.5333694813072283,0.013173652694610778,0.27847238890316406,1.0,21/46,24.11%,PPARG;CTNNB1;ID2;IL6;IGF1;THBS1;HMOX1;FOXP1;IL6R;XRCC5;RBPMS2;TNFAIP3;CX3CL1;APOD;TCF7L2;HES5;IGFBP3;PRKDC;MFN2;PDGFRB;OGN
prerank,endosome organization (GO:0007032),0.5680293057774867,1.5325501308042155,0.012077294685990338,0.27950457599857736,1.0,19/41,19.12%,PHETA2;HOOK3;SNX10;CORO1C;RNF26;EEA1;LAMTOR1;SNX33;PI4K2A;ARFGEF2;PLEKHJ1;SQSTM1;VPS11;DNAJC13;USP8;RAB22A;SNX3;ALS2CL;WASHC5
prerank,regulation of protein targeting to membrane (GO:0090313),-0.45707714447411113,-1.531516350179883,0.02631578947368421,0.3257666717257943,1.0,12/28,23.08%,ITGAM;ANK3;ITGB2;ITGB1BP1;TCAF1;PRNP;GDI1;FIS1;AKT2;MIEF2;CIB1;C2CD5
prerank,early endosome to late endosome transport (GO:0045022),0.6545565629123438,1.5314090075574542,0.027210884353741496,0.2814216993308169,1.0,7/20,9.47%,HOOK3;RAB7A;EEA1;KIF16B;WDR91;STX8;SNX16
prerank,receptor-mediated endocytosis (GO:0006898),0.5010095146110788,1.5308895324300489,0.0,0.2817211168127995,1.0,35/132,14.56%,CD36;TPCN2;APOE;SYK;IGF2R;GRB2;PIKFYVE;CTSL;LILRB1;TFRC;LRP1;STAB2;SNX9;PPT1;SORL1;CLN3;GAK;LMBRD1;SCARB2;RAB31;MICALL1;FOLR1;HP;HPR;PICALM;ITGB1;FCHO1;M6PR;AP1G2;AP1G1;EPS15;AP2B1;INPP5F;RABEPK;LRP6
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5976415325965148,1.5306456959436834,0.02594033722438392,0.28133431971990314,1.0,12/29,16.64%,GRB2;TGM2;NOTCH2;IGF1;IRS2;VAV1;NOTCH1;RAPGEF1;RASGEF1A;ERBIN;SHC1;LRRC59
prerank,phagosome-lysosome fusion (GO:0090385),0.7429705475748131,1.5305907559716951,0.03828483920367534,0.2804200107404946,1.0,6/10,9.74%,RAB7B;PIKFYVE;RAB20;RAB7A;CLN3;ARL8B
prerank,protein processing (GO:0016485),0.5139571446717986,1.530095857403059,0.0042643923240938165,0.280696671253975,1.0,47/102,25.35%,F7;CD5L;CTSL;PCSK4;KLK3;TMPRSS4;CPXM1;CLN5;MMP14;HTRA2;CLN3;FAM111A;PITRM1;CTSS;CTSH;HP;HPR;BACE1;ADAM17;HM13;MYRFL;LONP2;OMA1;SPCS2;ADAM19;NCSTN;CPM;PARL;CASP2;TYSND1;DDI2;AFG3L2;OGT;LGMN;ADAM10;APH1B;FURIN;XPNPEP3;PSEN2;PCSK7;SPRTN;SRGN;KLK1;ZMPSTE24;FXN;RCE1;SPPL3
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7275205400174136,1.5300368267140494,0.05247376311844078,0.27978000210569387,1.0,3/10,15.81%,CD36;TREM2;MYD88
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5572797653312019,-1.5299761151786828,0.032490974729241874,0.3250196657581366,1.0,7/16,35.27%,CLDN11;CLDN12;CLDN10;CLDN14;CLDN18;CLDN1;CLDN5
prerank,melanocyte differentiation (GO:0030318),0.7227757696944798,1.528843319693877,0.029940119760479042,0.28189087471755125,1.0,5/11,8.00%,LRMDA;MITF;MREG;ENPP1;HPS6
prerank,negative regulation of anoikis (GO:2000811),0.6874404311729005,1.528323812148032,0.039764359351988215,0.2822010040303107,1.0,7/14,14.89%,PDK4;ITGA5;PIK3CA;SNAI2;ITGB1;NOTCH1;MCL1
prerank,negative regulation of response to external stimulus (GO:0032102),0.5071869361141857,1.527343287231824,0.0032085561497326204,0.2836451819064497,1.0,29/105,14.46%,PPARG;APOE;SIGIRR;NR1H3;RNF26;PRKCD;AOAH;PTEN;MAPK7;DUSP3;NR1H4;IRAK3;PROC;METRNL;MFHAS1;RB1;SIRPA;NFKBIL1;MEFV;PTGER4;NLRC3;TRAFD1;PPARD;RORA;LPCAT3;TNFAIP8L2;TNFAIP3;INPP5F;ACOD1
prerank,response to copper ion (GO:0046688),0.6317408583820728,1.527316689539791,0.02699055330634278,0.28270085132106243,1.0,11/20,20.51%,AQP1;MT3;ATP5F1D;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,glycogen biosynthetic process (GO:0005978),0.7040912219602499,1.527198709448041,0.02857142857142857,0.28097563466046166,1.0,5/12,12.58%,GYG1;GBE1;NHLRC1;PGM1;UGP2
prerank,glucan biosynthetic process (GO:0009250),0.7040912219602499,1.527198709448041,0.02857142857142857,0.28097563466046166,1.0,5/12,12.58%,GYG1;GBE1;NHLRC1;PGM1;UGP2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.627806677917513,1.5264339465569148,0.0374331550802139,0.28199133339400706,1.0,5/23,8.19%,IRX3;HOPX;ID2;MYL2;MYBPC3
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.6749209319995925,1.5262486148832555,0.03183791606367583,0.28151442968556356,1.0,3/14,6.36%,AK8;ENPP1;ITPA
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.6253546476920417,-1.525873899563938,0.045584045584045586,0.3307106433952231,1.0,3/10,10.30%,WHRN;PLS1;ADGRV1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.54536436136368,1.525811452310936,0.0178359096313912,0.2816582125833519,1.0,13/47,12.33%,FBXW7;GLA;ACADL;SIK1;ACADVL;BRCA1;SNAI2;SLC27A1;ABCA2;SIRPA;ERLIN1;WDTC1;PGP
prerank,regulation of brown fat cell differentiation (GO:0090335),0.6652963678255049,1.5257556347103742,0.037463976945244955,0.2807931830546278,1.0,7/16,10.68%,PIM1;FLCN;HNRNPU;METRNL;RREB1;FTO;SIRT1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.5213118151138788,-1.525643727297447,0.04779411764705882,0.3276067807908105,1.0,10/19,21.55%,PTPRD;IL1RAPL1;RELN;CUX2;LRP8;CDKL3;DBNL;SS18L2;CUL7;DBN1
prerank,cellular glucan metabolic process (GO:0006073),0.7203637736046737,1.5252606344449804,0.03840472673559823,0.2810861887102322,1.0,5/11,12.58%,PRKAG2;PYGL;GBE1;GSK3B;UGP2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.4510643504171452,-1.5249118628911795,0.029411764705882353,0.3255312288860324,1.0,7/30,4.60%,SNTA1;ANK2;CACNA1C;RYR2;FGF12;SCN1B;KCNJ2
prerank,cellular response to fluid shear stress (GO:0071498),0.6970629528777642,1.5247716596618568,0.04833836858006042,0.28127778376806234,1.0,4/12,5.25%,MTSS1;NFE2L2;MAP2K5;MAPK7
prerank,carboxylic acid transmembrane transport (GO:1905039),0.5780993337824518,1.5241737027670437,0.015738498789346248,0.28188957137030607,1.0,16/40,19.77%,SLC36A2;SLC36A4;SLC38A6;SLC7A7;SLC16A1;SLC38A1;SLC38A7;SLC27A1;SLC7A11;SLC23A2;SLC23A1;SLC38A9;SLC36A1;ABCC1;SLC19A1;SLC7A8
prerank,organic hydroxy compound transport (GO:0015850),0.5794420578471572,1.5224533732957237,0.02696078431372549,0.2852840540692169,1.0,9/36,9.29%,STRA6;SLC51A;RXRA;SLC16A1;STARD5;ABCC4;NR1H4;ABCC3;NCOA1
prerank,positive regulation of bone resorption (GO:0045780),0.7319934619431044,1.52244525884805,0.035398230088495575,0.2843232109471632,1.0,4/11,5.77%,SYK;PLEKHM1;SPP1;ADAM8
prerank,regulation of keratinocyte migration (GO:0051547),0.7127006585522162,1.5219364230096983,0.03074670571010249,0.284526148526111,1.0,3/12,4.72%,IQSEC1;ADAM9;PTEN
prerank,regulation of cholesterol esterification (GO:0010872),0.7342937706374157,1.5216757509766528,0.0406885758998435,0.28421803711143034,1.0,4/10,9.61%,APOE;ABCG1;ABCA2;LAMTOR1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5256924537861373,1.520582046702883,0.009977827050997782,0.28607315424422913,1.0,24/74,16.07%,LGALS3;EYA1;FAS;BIRC6;RIPK1;MAP2K5;IGF1;MAPK7;THBS1;HSPA1B;HMOX1;BRCA1;SH3RF1;SNAI2;GSK3B;ARHGEF2;RNF34;RELA;TNFAIP3;HSPA1A;GDNF;PHIP;MCL1;TRAF2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5434432144093251,1.5181695379058666,0.02549246813441483,0.2912785590877288,1.0,15/50,13.11%,VEGFA;FNIP1;AQP1;DNAJB6;CD44;HGF;MAP2K5;RAF1;THBS1;SH3RF1;XIAP;PAK2;MT3;RNF34;GAS6
prerank,inflammatory response (GO:0006954),0.48630960890900954,1.5177064334630443,0.0,0.29146535152271513,1.0,43/195,14.72%,CDO1;ADGRE5;CXCR4;AOC3;HRH1;ANXA1;PTGDR;MGLL;CEBPB;IL36G;CD44;IL6;XCR1;IL10RB;PLA2G2D;PARP4;C3AR1;THBS1;ADAM8;PTGER2;CYBB;REL;CYBA;MFHAS1;NLRC4;FOLR2;BLNK;MEFV;HP;HPR;HNRNPA0;PTGER4;LIAS;NFATC3;SIGLEC1;RELB;AFAP1L2;RELA;SLC11A1;ADCY8;CX3CL1;TRAF3IP2;NRROS
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5830149033966426,-1.5173948433829336,0.05625,0.3380712235637085,1.0,2/13,3.60%,CYRIB;STX7
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5561569428320735,-1.5171959260653656,0.041666666666666664,0.3350531377139724,1.0,7/15,16.04%,GRM5;GRM1;GRM8;GRM3;HOMER1;GRIK3;GRM7
prerank,response to interleukin-6 (GO:0070741),-0.635972127502298,-1.5164371954324454,0.06830601092896176,0.3331032239822312,1.0,3/10,0.56%,SELPLG;ST3GAL6;PTPRT
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5182308771670937,-1.5154352496826857,0.04797047970479705,0.3319511230168427,1.0,8/18,10.41%,NRXN1;NLGN1;RIMS1;RIMS2;RELN;GRIN1;CUX2;NLGN3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.6669621594061533,1.5153944829385348,0.0329512893982808,0.2967338931365627,1.0,2/16,0.58%,HTR2B;APOE
prerank,proteolysis (GO:0006508),0.48293556904983914,1.5135063627112961,0.0,0.30065542869899964,1.0,76/252,22.64%,F7;ANPEP;MMP12;CTSB;ADAM33;CTSD;CAPN15;TINAGL1;CTSL;CPQ;PCSK4;TPP1;KLK3;NPEPPS;TMPRSS4;HGF;NLN;CTSA;CNDP2;CPXM1;MMP14;LONP1;HTRA2;CLN3;FAM111A;PITRM1;PROC;CAPN2;CTSS;CTSZ;CTSH;VASH2;RSPRY1;BACE1;PLAU;ADAM17;HM13;CTSW;PGPEP1;LONP2;ATG4B;FBXO6;UBA3;FBXW2;CAPN7;RNF123;TMPRSS5;ADAM19;NCSTN;CASP6;CPM;LNPEP;PARL;ACE;SENP1;CASP2;CASP3;APEH;PRCP;RNPEPL1;TYSND1;DDI2;LAP3;UFSP2;AFG3L2;PSMA6;OGT;LGMN;ADAM10;MMP19;CLPX;DPP3;APH1B;FURIN;XPNPEP3;MALT1
prerank,zymogen activation (GO:0031638),0.5678161489848595,1.5134505661903082,0.022167487684729065,0.29972845052273944,1.0,12/39,9.79%,CD5L;CTSL;KLK3;F11;MMP14;TBC1D10A;NLRC4;CTSH;HP;HPR;CYFIP2;PLAU
prerank,sterol transport (GO:0015918),0.6440047085165512,1.513435654347863,0.02401129943502825,0.298737238935817,1.0,2/19,1.88%,CD36;NPC1
prerank,nuclear migration (GO:0007097),0.6782064277027415,1.5132341789890424,0.04341534008683068,0.29823095242976033,1.0,3/13,5.01%,HOOK3;DYNC1H1;SYNE3
prerank,establishment of protein localization to membrane (GO:0090150),0.5258585528790508,1.5131296439037774,0.007891770011273957,0.29749682603312544,1.0,23/66,17.86%,RFTN1;SDCBP;PIKFYVE;ZDHHC14;ZDHHC19;NPC1;SYNE3;GRIN3B;RAB3GAP2;YIF1B;MICALL1;ZDHHC12;ZDHHC18;NACA;RAB10;RAB11B;RABGEF1;ZDHHC24;BID;NCF1;ZDHHC4;SEC63;ICMT
prerank,positive regulation of lyase activity (GO:0051349),-0.5752797388527351,-1.5110024268987303,0.05828220858895705,0.33768888399189323,1.0,6/14,25.16%,ORAI1;CACNA1C;AKAP5;PARK7;ISCU;NOS1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5687998526284054,1.5108061022399835,0.027980535279805353,0.3028267798399907,1.0,7/35,7.89%,CD36;HTR2B;APOE;AQP1;PDE7B;MAPK7;SOX9
prerank,positive regulation of vasoconstriction (GO:0045907),0.679637584045798,1.5100631039732666,0.03524229074889868,0.303738854966876,1.0,2/13,1.52%,ADRA1D;ADRA1A
prerank,fatty acid metabolic process (GO:0006631),0.49742903634340185,1.5098499191297938,0.003188097768331562,0.3033162392549688,1.0,18/115,9.13%,CD36;PPARG;CEL;BAAT;LIPG;LPIN3;GPAT2;SGPL1;FASN;AOAH;SLC27A4;PON3;ACSM3;SLC27A3;GPX4;CRAT;CPT1A;NDUFAB1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.5045726779914719,1.5088504369366997,0.0010775862068965517,0.30490856899661384,1.0,23/113,12.24%,LGALS3;CD36;FNIP2;ABCA1;SYK;BCL2L11;VEGFA;FNIP1;TFRC;LCP1;SH3GLB1;GTF2H5;MTLN;ASAP1;CAPG;IL5;TERF1;ESR1;DDB1;GSK3B;PIEZO1;STUB1;CUL4A
prerank,regulation of cellular metabolic process (GO:0031323),0.5494860701048297,1.5086805100675056,0.026159334126040427,0.30430224828921054,1.0,17/45,17.53%,FLOT1;ABCG1;PDK4;MPV17;COQ7;FASN;KIF16B;PID1;EIF6;ABCA2;LAMTOR1;STUB1;RNF34;PRKN;PANK2;PARL;ARF4
prerank,positive regulation of organelle organization (GO:0010638),0.5822234593358239,1.5083343269099807,0.03879849812265332,0.30420822924101465,1.0,10/32,12.31%,ANXA1;FYCO1;SORBS3;UVRAG;HTRA2;ANXA2;RAB3GAP2;GSK3B;SHCBP1L;TREM2
prerank,endocytic recycling (GO:0032456),0.5402517691374736,1.508312485972808,0.02564102564102564,0.3032591066071871,1.0,22/50,20.22%,MICALL2;SNX27;DENND1A;RAB7A;WASHC1;MICALL1;DENND1B;EIPR1;VPS52;VPS51;VPS35L;RAB11B;EPS15;ARL4C;STX6;SNF8;SNX17;SNX3;VPS29;ANKRD27;ANKRD50;RAB13
prerank,positive regulation of cell projection organization (GO:0031346),-0.34177410782753015,-1.5082624748195705,0.0,0.33968864901643686,1.0,27/115,6.11%,PTPRD;ARSB;CAMK1D;RIT2;PLXNA4;IL1RAPL1;ROBO2;TWF2;ROBO1;TENM3;NTRK3;SETX;ITGA6;EPHA3;TOX;TIAM1;ARHGDIA;PLPPR5;MAGI2;SCN1B;FUT9;RELN;NTRK2;ATP1B2;MAP3K13;CUX2;PRKD1
prerank,synapse assembly (GO:0007416),-0.3805283932846701,-1.5078280170158476,0.0,0.33716830627041705,1.0,16/67,6.54%,ADGRL3;GABRB3;SDK1;GPM6A;NRXN1;KIRREL3;NLGN1;DNM3;RYK;LRRTM3;GRID2;GABRA2;LGI2;FGF13;CDH2;FARP1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.6080547733672904,-1.5077889634573354,0.05846153846153846,0.33390013672091656,1.0,6/12,28.92%,RUBCNL;PPP1R3B;PPP1R3F;KHK;PPP1R3C;PPP1R3E
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.7087844364501868,1.506066811532182,0.050445103857566766,0.3081671568678607,1.0,7/11,21.00%,VCPIP1;LPCAT3;ATL2;ATL1;MOSPD3;RTN4;ARL6IP1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.49572859526586854,-1.5044447381342163,0.04263565891472868,0.3375101392338199,1.0,12/20,26.82%,PRKCE;MTDH;HCK;IL18;TNF;CD14;LYN;CCL3;IL1B;TGFB1;CCL5;TICAM1
prerank,positive regulation of transporter activity (GO:0032411),0.6858045528672805,1.5043800827102494,0.036418816388467376,0.3119921981113487,1.0,3/13,3.64%,SGK1;NR1H3;RXRA
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5059887950138878,1.5019945337854415,0.007675438596491228,0.317541003407193,1.0,32/91,20.51%,FLVCR1;FTL;ATP6V1A;ABCB7;TFRC;SLC11A2;ATP6V0D1;TMEM199;NUBP1;HMOX1;FRRS1;HEPH;GLRX3;SLC39A14;MT3;APP;HMOX2;SLC11A1;SLC39A12;CUL1;ATP7A;SLC31A2;FTH1;SLC30A1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,monocarboxylic acid metabolic process (GO:0032787),0.495157184400176,1.5016660749955497,0.008421052631578947,0.3174086348733985,1.0,27/117,15.47%,CD36;PPARG;BAAT;GPAT2;SGPL1;AMACR;NPC1;KYNU;MTHFS;PDZD11;FASN;SLC16A1;AOAH;SLC27A4;IGF1;GLYAT;CPT1A;GRHPR;MCCC1;PPARD;SLC6A8;MTHFD1L;HAGH;VDAC1;ME2;ALDH1A2;PANK2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5766661841251112,1.5007723281547363,0.031486146095717885,0.31881928670788134,1.0,5/33,5.84%,LGALS3;CD300A;DGKZ;DUSP3;TRAT1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.5412318578306904,-1.5007621828189655,0.04498269896193772,0.3418494813880873,1.0,9/16,13.93%,ST6GALNAC3;ST8SIA6;ST3GAL5;ST6GALNAC5;ST6GALNAC4;ST8SIA1;ST8SIA5;ST8SIA3;ST6GALNAC6
prerank,intermediate filament organization (GO:0045109),0.6479275614714204,1.5005478097777536,0.046153846153846156,0.3184017045439742,1.0,3/17,2.66%,MTM1;VIM;DNAJB6
prerank,positive regulation of integrin activation (GO:0033625),-0.6090732500153566,-1.500045924113771,0.07301587301587302,0.33991610404489375,1.0,3/11,11.87%,P2RY12;FERMT2;RAP1B
prerank,negative regulation of histone modification (GO:0031057),0.6716188818012867,1.4997276725337076,0.03784570596797671,0.31975986776763016,1.0,4/14,7.35%,FOXP3;TAF7;SPHK2;BRCA1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5294683394375387,-1.4996494110469314,0.045112781954887216,0.33756420553725297,1.0,6/17,11.17%,ATP1B1;CACNA1C;ATP1A2;RYR2;ATP1B2;PRKACA
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6268955594791731,1.499452537765379,0.03872752420470263,0.31854446820902377,1.0,8/21,14.89%,EYA1;MAP2K5;MAPK7;HSPA1B;SNAI2;HSPA1A;GDNF;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6268955594791731,1.499452537765379,0.03872752420470263,0.31854446820902377,1.0,8/21,14.89%,EYA1;MAP2K5;MAPK7;HSPA1B;SNAI2;HSPA1A;GDNF;MCL1
prerank,ureteric bud development (GO:0001657),-0.5438115384384499,-1.4992151493904682,0.0695970695970696,0.33531515213399693,1.0,12/17,35.69%,SALL1;ROBO2;FGFR2;PKD2;NPNT;FOXC1;FOXJ1;BMP2;BMP4;LHX1;SLIT2;BMP7
prerank,positive regulation of calcium ion import (GO:0090280),0.6921706199728236,1.4982059302169668,0.05660377358490566,0.3211050576821321,1.0,2/12,6.29%,LGALS3;SPHK2
prerank,T cell activation involved in immune response (GO:0002286),0.6883709044521071,1.4981357025696782,0.04852941176470588,0.3202971352637633,1.0,4/12,13.74%,LILRB1;LCP1;EIF2AK4;SLC11A1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.595465552004098,1.4978087738922243,0.037333333333333336,0.32022191145865203,1.0,8/26,19.26%,HTR2B;APOE;POR;S100A1;GDNF;ATP7A;GCH1;PIK3CB
prerank,protein transport (GO:0015031),0.4688076076098513,1.4971303045205488,0.0,0.3210036738716027,1.0,118/332,22.29%,ATP6V0D2;CD36;PPARG;ABCA1;APOE;TLK1;OPTN;STX3;STEAP3;SNX8;ATP6V1A;ACD;ABCG1;RAB8B;TBC1D22A;SNX27;RIC1;TBC1D25;TFRC;ATP6V1E1;RAB20;RAB7A;LRP1;TBC1D1;TBC1D2;CTSA;ATP6V1C1;ARRDC4;TCIRG1;SNX9;ATP6V0D1;TBC1D12;PPT1;RAB21;STX8;TBC1D10A;COG7;RAB3GAP2;STX5;CHMP2A;TANGO6;ATP6V1B2;VMP1;TBC1D2B;RAB31;KIF3A;RAB1B;LAMP2;TICAM2;RAB28;VPS33A;UNC93B1;STX11;ATP6V0A1;RAB12;SNX33;SIL1;TBC1D22B;RAB10;RAB18;ARHGEF2;TBC1D15;PRKCB;WLS;RAB24;STXBP3;MYH9;AP3D1;MACF1;ATP6V0E1;RAB43;RAB11B;ATP6V0C;ATP6V0B;ATP6V1H;ARL4C;NEURL1B;SLC10A7;STX6;GOLPH3;AP3B1;GOLPH3L;GOLGA4;TOM1;SNX17;TBC1D9;RABGAP1;ZDHHC17;RAB29;ATP6V1F;GGA2;RAB22A;ARF4;VPS29;AP4M1;ARF5;STXBP2;LRP2;ARL5B;SEC31A;ATP6V1G2;RAB1A;BBS1;VAMP2;RAB13;CALCRL;SGSM2;ARRDC3;GGA3;RPGR;CHMP2B;PREB;TBC1D4;NDC1;DNAJC27;VPS35;SNX13;VPS45
prerank,phagolysosome assembly (GO:0001845),0.6913049891718356,1.4962623624538625,0.07482014388489208,0.3223529584359589,1.0,6/12,9.74%,RAB7B;PIKFYVE;RAB20;RAB7A;CLN3;ARL8B
prerank,phosphatidic acid metabolic process (GO:0046473),0.5464918623234244,1.4962355694081553,0.02112676056338028,0.32142737839025304,1.0,10/48,8.10%,DDHD1;GPAT2;AGPAT4;PLD2;PLA2G2D;DGKZ;DGKA;GPD1L;SLC27A1;ABHD4
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.617690138818462,1.49477637342724,0.045020463847203276,0.32442144227480235,1.0,5/22,5.25%,GCNT2;FLOT1;CD44;MAP2K5;MAPK7
prerank,muscle cell development (GO:0055001),0.5821129805766607,1.4941445229298453,0.03117206982543641,0.32524504721191805,1.0,5/30,5.10%,MYOF;ALPK3;VEGFA;SLC8A1;IGF1
prerank,response to ethanol (GO:0045471),-0.5739261506950254,-1.494119534779147,0.05154639175257732,0.3420200375411082,1.0,5/14,8.50%,GRIN2A;GRIN2B;GRIN3A;GRIN1;GLRA1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.5024015691316517,1.4937920148049288,0.013993541442411194,0.3252720648227454,1.0,33/94,18.27%,FNIP2;BCL2L11;ERN1;CEBPB;IKBKE;PRKCD;CDKN1A;APAF1;TNFRSF1B;E2F1;HTRA2;CUL3;GSKIP;MLLT11;DDX5;STK24;ATF4;BRCA1;PRODH;TOPORS;HIPK2;DDIT3;CUL4A;BAX;CUL1;MCL1;QRICH1;BNIP3;TRAF2;RRP8;BBC3;C1QBP;CASP2
prerank,response to insulin (GO:0032868),0.5067044164670634,1.4937638070593522,0.00772626931567329,0.32433926378621253,1.0,30/80,22.71%,PPARG;MYO5A;DENND4C;LPIN3;RAB8B;PDPK1;ENPP1;IRS2;EIF6;RAB31;SLC27A1;RAB12;SLC39A14;RAB10;FOXO1;SIRT1;EPRS1;GPLD1;INSIG2;EPM2AIP1;ZBTB7B;CPEB2;VAMP2;RAB13;GCK;OGT;TBC1D4;PRKDC;PKM;SYAP1
prerank,positive regulation of protein deacetylation (GO:0090312),0.6718634829562788,1.4937506101363853,0.045845272206303724,0.3233801535237008,1.0,3/14,7.02%,APLNR;DYRK1A;NIPBL
prerank,oligosaccharide metabolic process (GO:0009311),-0.4113317034670073,-1.49351087298325,0.006329113924050633,0.33998452687450015,1.0,16/46,14.17%,ST3GAL6;B3GALT1;ST6GALNAC3;ST8SIA6;FUT9;MAN2B2;ST3GAL2;ST6GALNAC5;ST6GALNAC4;ST8SIA1;ST8SIA5;ST6GAL2;ST8SIA3;GAL3ST4;ST6GALNAC6;B4GALT1
prerank,neuron projection fasciculation (GO:0106030),-0.6034635638842805,-1.4934411627033786,0.08139534883720931,0.33706035273173035,1.0,3/10,4.35%,SEMA5A;CNTN4;CDK5R1
prerank,positive regulation of DNA binding (GO:0043388),0.5856214887654883,1.4927836181710643,0.03238341968911917,0.3251472906660789,1.0,5/31,8.04%,PPARG;TXN;NIBAN2;IGF1;RB1
prerank,regulation of interleukin-4 production (GO:0032673),0.6272567211271721,1.4927274450046821,0.04216073781291173,0.3243383692575834,1.0,6/21,9.57%,SYK;CEBPB;FOXP3;CD28;RARA;DDIT3
prerank,granulocyte chemotaxis (GO:0071621),0.5270331107919842,1.4926568935064126,0.023809523809523808,0.3235439678326833,1.0,4/55,1.56%,LGALS3;SYK;PIKFYVE;ANXA1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.499087647416677,1.492532211391579,0.008602150537634409,0.32292566927949035,1.0,25/98,16.95%,PPARG;XDH;APOE;GRB2;VEGFA;NR1H3;CDKN1A;FASN;CD63;IL10RB;RIPK1;PID1;THBS1;GADD45A;ANXA2;RAB1B;PAX8;PPARD;MT3;VAMP3;INPP5F;ACOD1;ARRB1;RAB29;IFNAR1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5528287615225884,1.4905481874171294,0.029197080291970802,0.3275682528061552,1.0,12/40,18.02%,MPEG1;IL6;STAB2;RNASE3;GBP6;ADAM17;DROSHA;FGR;LBP;MYD88;TNFRSF14;DEFA6
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.511119915145398,1.4902046691778654,0.009933774834437087,0.3274583138465013,1.0,20/80,13.33%,CTSD;SYK;VEGFA;FNIP1;AQP1;DNAJB6;CD44;HGF;DAPK1;MAP2K5;RAF1;HTRA2;THBS1;SH3RF1;XIAP;CYCS;SIRT1;MT3;GAS6;SOX2
prerank,regulation of cell communication (GO:0010646),0.5636647564492203,1.490029097423209,0.041044776119402986,0.32699713945259373,1.0,5/35,5.00%,MTCH1;ANXA1;MGLL;CDC42SE2;SLC8A1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5989406123295251,-1.4899976485833766,0.06432748538011696,0.3413288706537812,1.0,8/11,18.66%,PLCB1;GHR;GIGYF1;IRS1;IGF1R;GIGYF2;TSC2;EIF2AK3
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5906251778180756,1.4887435528927,0.04712041884816754,0.3294864205522333,1.0,12/24,15.91%,CTNNB1;FBXW7;FOXO3;TFAP2B;SRPK2;ATF4;TYROBP;BACE1;DDIT3;BAX;MCL1;GRN
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6528022914051357,1.4885551890776367,0.05627705627705628,0.3290156594740792,1.0,2/15,1.27%,CD36;PRKCH
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.5132959779981979,-1.4883201762684672,0.03745318352059925,0.341962934345473,1.0,10/18,11.97%,CAMK1D;RPS6KA5;EPHA5;RELN;PRKD1;CD200;LRP8;LPAR5;ADCY1;PRKD2
prerank,regulation of B cell differentiation (GO:0045577),0.6555215811678664,1.48723936366095,0.043055555555555555,0.33180145286507357,1.0,5/17,12.65%,SYK;ID2;MMP14;ZFP36L2;BTK
prerank,'de novo' posttranslational protein folding (GO:0051084),0.5802304096988283,1.4869205447092368,0.042416452442159386,0.3317456417063198,1.0,13/30,19.18%,DNAJB13;CHCHD4;GAK;HSPA1B;DNAJB5;DNAJB14;UGGT1;HSPA1A;DNAJC18;HSPA13;HSPE1;CCT2;BAG1
prerank,NAD biosynthetic process (GO:0009435),0.630662122627433,1.4868140024752363,0.043478260869565216,0.3310804572463783,1.0,3/20,6.99%,NAMPT;KYNU;NMNAT1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6218802558711402,1.4855938075758304,0.036671368124118475,0.3336098818622539,1.0,7/21,11.23%,HTR2B;IGF1;ZFP36L2;SOX9;CTSH;PTGER4;MT3
prerank,positive regulation of developmental growth (GO:0048639),-0.39227433558223374,-1.4854830925310871,0.026845637583892617,0.3448386964586263,1.0,13/49,8.61%,SYT1;TWF2;RIMS1;PLCB1;MAPT;GHR;RIMS2;SMURF1;LIMK1;MAP3K13;SYT2;SYT4;AGRN
prerank,regulation of fibroblast proliferation (GO:0048145),0.5357759993635107,1.4854609345687855,0.027315914489311165,0.3329615677370353,1.0,13/45,17.14%,CD300A;CTNNB1;AQP1;CDKN1A;PDGFA;B4GALT7;E2F1;IGF1;NLRC3;S100A6;GAS6;CDC73;FTH1
prerank,regulation of cytokine production (GO:0001817),0.47987200766918137,1.4851059600186682,0.005241090146750524,0.3330318077820913,1.0,24/126,13.74%,GPNMB;HTR2B;ANXA1;FLOT1;FOXP3;RNF26;IL6;CD28;ATP2B1;PLD3;TNFRSF1B;IGF2BP3;SNAI2;SIRPA;FOXP1;PTGER4;IL15;TREM2;AFAP1L2;TRAF3;POLA1;FGR;N4BP1;SLC11A1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.44738063636670417,-1.481693176497711,0.03619909502262444,0.34963024002164345,1.0,11/27,16.41%,IL1RAPL1;CTNNA2;NTNG1;DISC1;MBOAT1;MARK1;HOMER1;ULK4;NCS1;NDEL1;BRSK1
prerank,negative regulation of histone acetylation (GO:0035067),0.6907074681796856,1.4815951487365755,0.04776579352850539,0.34215124594181884,1.0,6/11,22.79%,TAF7;BRCA1;SIRT1;NOC2L;SIN3A;CTBP1
prerank,transport along microtubule (GO:0010970),0.6751674879706038,1.4808597304434046,0.052870090634441085,0.34317889166351717,1.0,4/13,11.57%,ARHGAP21;SPG11;BORCS5;APP
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.7024403100509109,1.4799027015156128,0.08536585365853659,0.34501530485763526,1.0,4/10,6.40%,SIGIRR;MAP2K5;MAPK7;IRAK3
prerank,negative regulation of immune response (GO:0050777),0.4785631967316172,1.4794765495627233,0.006230529595015576,0.3451857870741618,1.0,32/154,14.46%,LGALS3;CD300A;SYK;GPR15;LILRB1;PTGDR;FOXP3;PLK2;FCRLB;RNF26;IL6;HTR6;RHBDF2;GPR83;ADCY7;IRAK3;PTGER2;GPR176;PTGER4;VIPR1;NLRC3;ADAM17;PTH2R;TRAFD1;MYH9;TREM2;COL3A1;FGR;TNFAIP3;ADCY8;ADCY3;ACOD1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6715359797226483,1.4792559003485148,0.06891271056661562,0.34476889467812744,1.0,3/13,3.00%,NFE2L2;TXN;HGF
prerank,regulation of inflammatory response (GO:0050727),0.4696442361325885,1.4786997023200918,0.004056795131845842,0.3454152742025006,1.0,45/190,16.15%,PPARG;PLA2G7;APOE;MGST2;CD200R1;ANXA1;MGLL;NR1H3;IL6;PRKCD;TNIP1;RIPK1;TNFRSF1B;CELF1;SHPK;AOAH;NINJ1;MAPK7;NR1H4;PROC;METRNL;MFHAS1;XIAP;RB1;SIRPA;FOXP1;MEFV;PTGER4;NLRC3;BIRC3;PPARD;APP;RORA;LPCAT3;IL15;RELA;TNFAIP8L2;VAMP3;TNFAIP3;CASP12;CX3CL1;ACOD1;MYD88;GRN;BST1
prerank,O-glycan processing (GO:0016266),0.528086645315844,1.478179626282624,0.03125,0.34585956622750913,1.0,7/54,7.78%,B4GALT5;B3GNT8;GALNT3;GALNT6;GALNT9;ST3GAL4;GXYLT2
prerank,brain development (GO:0007420),-0.33032142923822067,-1.4773117791841195,0.0,0.3554871851253183,1.0,32/136,11.35%,ZFHX3;CX3CR1;CNTNAP2;ADGRL3;GRIN2A;CTNNA2;PHF8;ROBO2;PTCH1;GRIN2B;NFIB;TGFBR2;EML1;CNTN4;RELN;CDK5R1;GRIN1;PBX3;ARNT2;CDH2;POU6F1;ADGRG1;BBS2;MEIS3;PAX2;QARS1;UFM1;EPHA7;MEIS1;SOX6;IER3IP1;NDUFS4
prerank,cellular response to topologically incorrect protein (GO:0035967),0.565231753321263,1.4759855262134558,0.05717916137229987,0.3511282929197582,1.0,12/31,16.37%,OPTN;ERN1;HSPA1B;STUB1;RHBDD1;DNAJB14;PRKN;HSPA1A;BAX;DNAJC18;HSPA13;PTPN1
prerank,regulation of neuron differentiation (GO:0045664),-0.3651318390744122,-1.4758340720387335,0.00980392156862745,0.3554140435744234,1.0,10/76,4.37%,ZFHX3;BIN1;MEF2C;BRINP3;NLGN1;ZEB1;TIAM1;CNTN4;CDK5R1;VWC2
prerank,protein heterooligomerization (GO:0051291),-0.5207528624334323,-1.47505658051081,0.07857142857142857,0.3537240224215791,1.0,8/17,21.80%,GRIN2B;KCNC2;GRIN1;TMEM120A;PKD2;PKD1;MAT2A;NUDT21
prerank,fatty acid transmembrane transport (GO:1902001),0.6218937693966461,1.4742429831253492,0.059574468085106386,0.35520437950566675,1.0,7/19,12.38%,CD36;PRKAG2;ABCD1;SLC27A1;CPT1A;SLC25A20;SLC2A1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5886101649352921,1.4739271279070554,0.04221635883905013,0.3551250826741625,1.0,10/26,12.31%,CD36;FLOT1;APPL2;IRAK3;GPR108;NFKBIL1;NLRP2B;BIRC3;APPL1;TREM2
prerank,regulation of acrosome reaction (GO:0060046),-0.6235086871676275,-1.4737617755851273,0.08011869436201781,0.3534174733578698,1.0,2/10,8.50%,PLCB1;GLRA1
prerank,positive regulation of T cell proliferation (GO:0042102),0.5265159715263463,1.4736849461005006,0.025611175785797437,0.35487098490563845,1.0,9/55,5.10%,SYK;ANXA1;NCK2;TFRC;IL6;CD28;CD46;CD274;IGF1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5938697153020802,1.47332449578111,0.04491413474240423,0.35489380376442997,1.0,2/25,0.46%,PPARG;CBLB
prerank,acylglycerol homeostasis (GO:0055090),0.6113257169897024,1.4729157346755117,0.06521739130434782,0.3550671196053862,1.0,4/20,11.99%,APOE;NR1H3;MTLN;RORA
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5807159336676477,1.4717428447830077,0.05375,0.35741584980835817,1.0,9/27,9.45%,HGF;CDKN1A;NIBAN2;PDGFA;PARP4;FGFR4;ACVRL1;DACH1;BMPR2
prerank,cellular response to unfolded protein (GO:0034620),0.5836602148431961,1.4711834320428192,0.06860158311345646,0.3579950902495815,1.0,10/26,16.37%,OPTN;ERN1;HSPA1B;RHBDD1;PRKN;HSPA1A;BAX;HSPA13;HSPD1;PTPN1
prerank,nitrogen compound transport (GO:0071705),0.4853813480721824,1.470793570498896,0.00522466039707419,0.3581288638615115,1.0,43/141,21.68%,LRRC8D;SLC7A2;SLC6A6;FLVCR1;SLC18A1;SLC36A2;SLC43A2;AQP1;CERT1;RAB7A;SLC1A5;SLC7A4;SLC7A7;ARRDC4;SLC16A10;PPT1;SLC38A1;CHMP2A;SCARB2;KIF3A;SLC15A3;SLC7A11;SLC6A8;MYH9;SLC23A1;SLC52A1;SLC11A1;SLC44A2;TOM1;SLC7A1;SLC36A1;ABCC1;SLC6A4;LRP2;SLC19A2;SLC7A8;VAMP2;CALCRL;TMEM30A;ARRDC3;CHMP2B;NDC1;SLC22A5
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6486325144490797,1.4706298855396949,0.05352112676056338,0.35763697915151144,1.0,3/16,8.64%,LGALS3;TNFRSF1B;CD22
prerank,cardiac muscle cell differentiation (GO:0055007),0.6117747542488904,1.4702310068302418,0.05053191489361702,0.3577506247152369,1.0,6/21,7.96%,ALPK3;IRX3;VEGFA;SLC8A1;SIK1;AKAP13
prerank,negative regulation of platelet activation (GO:0010544),0.6393297040252937,1.4700237630777389,0.06125356125356125,0.35729741027482176,1.0,3/16,3.73%,APOE;PRKCD;PDGFA
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3831797248742882,-1.470021077723623,0.008547008547008548,0.3582334187356327,1.0,19/63,10.58%,SLC12A2;GABRB3;SLC12A6;ANO4;GLRB;SLC1A3;ANO3;GLRA3;GABRA2;GABRB1;SLC25A14;GABRA3;GLRA1;GABRG3;SLC6A1;SLC4A8;SLC1A1;LRRC8A;CLCN3
prerank,cilium-dependent cell motility (GO:0060285),-0.4741620466707909,-1.4684487317970782,0.04887218045112782,0.35831822573856864,1.0,16/22,41.53%,RFX3;CCDC39;CFAP44;CFAP54;DNAH8;EFHC2;EFHC1;DNAH2;RSPH9;DRC1;GAS8;DNAAF2;DNAH17;CCDC65;DNAH1;TEKT5
prerank,electron transport chain (GO:0022900),0.6413318710143983,1.4682545168670673,0.0625,0.3612711606483312,1.0,6/15,10.51%,ETFRF1;POR;UQCRFS1;ENOX2;SDHB;SDHA
prerank,sodium ion transmembrane transport (GO:0035725),-0.34712016215814756,-1.4680480427162084,0.0,0.35612909847330304,1.0,21/84,14.11%,SLC24A3;SLC9A9;SLC12A2;HCN1;ATP1B1;SLC24A2;SCN2A;ATP1A2;SCN1B;TRPM4;ATP1B2;SLC6A15;NALCN;SLC6A1;SLC4A8;SCN9A;SLC24A4;HCN2;PKD2;PKD2L1;SCN8A
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4858693474721173,1.4678944168289005,0.009513742071881607,0.3612437659998771,1.0,35/109,19.78%,SYK;GRB2;VAV3;MAP3K1;GAB2;TEC;SOS1;PDPK1;PSMD1;JUN;PIK3CA;VAV1;MAP2K4;PPP3CA;PPP3R1;PAK2;PSMF1;NFATC3;PSMD14;TAB2;PSMD12;BTK;RELA;PSME2;SHC1;CUL1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PSMA2;PIK3CB;PSMD11;LAT2
prerank,B cell differentiation (GO:0030183),0.5361355447156797,1.4678868357309347,0.035211267605633804,0.3602576720026262,1.0,12/46,17.42%,ADGRG3;FNIP1;TPD52;ITGA4;MS4A1;BLNK;ITGB1;ADAM17;DCAF1;JAK3;KLF6;ZBTB7A
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5299176278493247,1.4677021376297879,0.027090694935217905,0.35976232914137957,1.0,14/48,14.89%,FNIP2;BCL2L11;IKBKE;TNFRSF1B;E2F1;HTRA2;BRCA1;HIPK1;TOPORS;HIPK2;SIRT1;DYRK2;BAX;MCL1
prerank,positive regulation of lipid storage (GO:0010884),0.6132915147562998,1.4663802287563212,0.055873925501432664,0.3625827801391698,1.0,3/21,2.45%,PLIN2;PLIN3;IKBKE
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.5847700935756828,1.4662627380898683,0.059445178335535004,0.36194097239779754,1.0,14/25,26.85%,DNAJB13;GAK;HSPA1B;DNAJB5;DNAJB14;HSPA1A;DNAJC18;HSPA13;HSPE1;BAG1;HSPA9;ST13;ERO1A;DNAJB12
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.591153152608717,1.4662567703069327,0.04281767955801105,0.36096382377132097,1.0,9/26,11.55%,PDK4;PRKAG2;NR1H3;ACADL;EIF6;ACADVL;BRCA1;ERLIN1;WDTC1
prerank,purine-containing compound catabolic process (GO:0072523),0.6692242814497777,1.4661478109678117,0.05539358600583091,0.3603044311846084,1.0,4/13,9.12%,XDH;ITPA;NT5C2;NT5E
prerank,regulation of interleukin-17 production (GO:0032660),0.5664492458831302,1.4653858460471478,0.048162230671736375,0.3614923502059669,1.0,10/31,19.66%,RFTN1;FOXP3;IL6;LY9;NR1H4;DDIT3;IL15;MYD88;ZBTB7B;OSM
prerank,response to X-ray (GO:0010165),0.658802502528516,1.4646864081510003,0.06082036775106082,0.36240263890686003,1.0,5/14,9.84%,XRRA1;ANXA1;NIPBL;XRCC4;XRCC5
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5258617701881108,-1.4636401020151206,0.06802721088435375,0.36288135369914026,1.0,4/15,5.29%,SLC12A2;ATP1B1;ATP1A2;ATP1B2
prerank,cellular response to copper ion (GO:0071280),0.6332527641984965,1.4634657433351639,0.06051873198847262,0.3649782512369321,1.0,10/16,20.51%,AQP1;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,regulation of RNA splicing (GO:0043484),0.5169128274741094,1.462999740404002,0.021714285714285714,0.3653769246180687,1.0,25/69,18.38%,HNRNPLL;ERN1;AHNAK;POLR2A;HNRNPH2;MBNL1;SRPK2;CELF1;RBM39;AHNAK2;DYRK1A;SF1;GRSF1;PTBP3;LARP7;SRSF3;PTBP2;PQBP1;RPS26;HSPA1A;PRX;MBNL2;SRPK1;RBM22;CLK3
prerank,apoptotic cell clearance (GO:0043277),0.565513602630118,1.4629813246104262,0.04569190600522193,0.3644343670820443,1.0,9/30,13.11%,ANXA1;TGM2;LRP1;NR1H3;RARA;THBS1;TYROBP;TREM2;GAS6
prerank,neuron migration (GO:0001764),-0.4056949980591059,-1.4627060075285254,0.02666666666666667,0.36169948389156925,1.0,16/48,9.00%,ADGRL3;MEF2C;SPOCK1;GPM6A;DISC1;AUTS2;RELN;CDK5R1;NTRK2;FGF13;ASTN2;MARK1;TUBB2A;MARK2;DNER;SEMA3A
prerank,regulation of receptor recycling (GO:0001919),0.6451342261723172,1.4626032625580145,0.05832147937411095,0.364544590887933,1.0,8/16,16.69%,OPTN;KIF16B;ANXA2;TRAT1;LAMTOR1;VAMP3;INPP5F;RAB29
prerank,sphingolipid metabolic process (GO:0006665),0.4919693582387037,1.4622907512046222,0.009615384615384616,0.3644647520983712,1.0,39/108,20.66%,PSAP;PLPP3;SPTLC2;CERK;SAMD8;SGPL1;GALC;CERT1;GLA;CTSA;ESYT1;PPT1;SGMS2;HACD4;CERS6;HEXA;SPHK2;ARSA;SPTSSA;ABCA2;VAPA;ELOVL1;GM2A;ALDH3A2;DEGS1;PRKD3;SUMF1;ESYT2;NEU1;SGMS1;ACER2;CERKL;PPP2CA;NSMAF;ASAH1;SGPP2;PPP2R1A;CERS1;ARV1
prerank,Fc receptor signaling pathway (GO:0038093),0.4846736504845619,1.4619486175592549,0.007438894792773645,0.3644742644665019,1.0,35/110,19.78%,SYK;GRB2;VAV3;MAP3K1;GAB2;TEC;SOS1;PDPK1;PSMD1;JUN;PIK3CA;VAV1;MAP2K4;PPP3CA;PPP3R1;PAK2;PSMF1;NFATC3;PSMD14;TAB2;PSMD12;BTK;RELA;PSME2;SHC1;CUL1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PSMA2;PIK3CB;PSMD11;LAT2
prerank,regulation of mitochondrial fusion (GO:0010635),0.6880078616793526,1.4613871762877695,0.06769230769230769,0.3650989677522566,1.0,7/11,15.61%,VAT1;TFRC;PID1;HUWE1;OMA1;PRKN;BNIP3
prerank,RNA metabolic process (GO:0016070),0.48815730023538456,1.4611039610815666,0.0062827225130890054,0.36489114539170076,1.0,44/127,16.19%,APOBEC1;RBMS1;DHX8;POLR2A;ATXN1;WTAP;TFIP11;HNRNPH2;MPHOSPH10;RBM39;ATXN2;RNASE3;AGO2;NUFIP1;RNASEL;HNRNPUL1;THOC1;HNRNPU;RBPMS;POLR2L;TENT2;HNRNPA0;WDR74;POLR2G;FTO;DKC1;AGO3;POLR2I;NCBP2;DROSHA;HNRNPM;GTF2F2;SND1;DEDD2;DDX20;SIDT2;RNASEH2A;MRPL44;HNRNPD;RNASEH1;MTREX;ADARB1;PCBP1;SYNCRIP
prerank,DNA modification (GO:0006304),0.6079853647651963,1.460677166290736,0.06377204884667571,0.36514753676022316,1.0,8/22,11.12%,ACD;MUTYH;PARP2;PARP3;NEIL1;EXOSC3;TERF1;MBD4
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6448594395271746,1.4595538231710488,0.06102635228848821,0.36762395680586396,1.0,4/17,4.64%,SYK;CEBPB;CD28;RARA
prerank,plasma membrane organization (GO:0007009),0.5158566890224494,1.4592072468573816,0.02502844141069397,0.36770173792041133,1.0,18/61,14.30%,MYOF;CXCR4;PLSCR4;ANO6;ABCD1;BIN3;SNX9;AHNAK2;CLN3;FER1L6;MICALL1;A4GALT;EPB41L3;ARL8B;SNX33;MYH9;DEGS1;WHAMM
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5304863632739425,-1.4589685029596786,0.06060606060606061,0.3664538796658811,1.0,4/15,13.82%,ATP1B1;KCNJ2;KCNJ3;KCNN2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6732956368019953,1.458759401058324,0.07582938388625593,0.368011557148441,1.0,5/11,14.71%,LILRB1;MERTK;HCLS1;GAS6;CXCL12
prerank,T cell activation (GO:0042110),0.5072918272973047,1.4584897641228345,0.027563395810363836,0.367847886327504,1.0,18/69,16.91%,KIF13B;NCK2;FOXP3;CD44;LCP1;CD28;DDOST;EIF2AK4;LFNG;MSN;PPP3CA;NLRC3;CTPS1;GPR89A;GPR89B;HSPD1;RAB29;CHD7
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.45930734498187226,-1.4583058441068475,0.06,0.36486240454582886,1.0,11/24,23.08%,ITGAM;ANK3;ITGB2;ITGB1BP1;TCAF1;PRNP;FIS1;AKT2;MIEF2;CIB1;C2CD5
prerank,positive regulation of programmed cell death (GO:0043068),0.46366044754179103,1.4576354786081291,0.0010050251256281408,0.36945327754901575,1.0,80/272,18.65%,MTCH1;ABR;CTSD;MAP3K20;SYK;VAV3;LILRB1;RPS6KA2;BCL2L11;CTNNB1;ATG7;TGM2;GADD45B;ANO6;GADD45G;SOS1;IL6;FOXO3;FAS;JUN;APAF1;DAPK1;RIPK1;GNA13;SLC27A4;E2F1;HTRA2;GADD45A;AIFM2;MELK;MLLT11;SPHK2;STK3;APC;CTNNBL1;FLCN;ATF4;RPS27A;UBC;NLRC4;TNFAIP8;AKAP13;ING3;VAV1;NLRP2B;ITGB1;FOXO1;SIRT1;ARHGEF2;ING4;STPG1;DCUN1D3;DDX20;OMA1;GPLD1;BCLAF1;MCF2;SOS2;SQSTM1;FGD3;BAX;LATS1;NCSTN;QRICH1;BNIP3;HSPD1;BID;IFIT2;ADAMTSL4;CCAR1;UTP11;PRR7;SHQ1;ITSN1;C1QBP;CASP2;STK4;CASP3;CRADD;HTT
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5185000833776658,1.4575347059920751,0.03299203640500569,0.3688010246478581,1.0,32/59,26.41%,TLR8;IRAK2;TANK;RIPK1;LY96;REL;RPS27A;UBC;NFKBIL1;TICAM2;ROCK1;NLRC3;BIRC3;TAB2;RELB;RELA;TRAF2;ERC1;BIRC2;CARD11;TBK1;AZI2;BCL3;BCL10;TRAF6;PRDX4;TAB1;FAIM;TLR9;MAP3K7;TAB3;RNF31
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5907530675474286,1.456802647630904,0.05452127659574468,0.3699544267645858,1.0,7/23,13.11%,LILRB1;FOXP3;CD274;RARA;NR1H4;DDIT3;GAS6
prerank,amyloid fibril formation (GO:1990000),0.5184570533837831,1.4563582824803902,0.03686635944700461,0.37027861066773343,1.0,22/51,22.91%,CD36;MFGE8;NAT8;RIPK1;SORL1;RPS27A;UBC;CALB1;BACE1;APP;TSPAN15;PRKN;NCSTN;GGA2;CALCA;ADAM10;GGA3;USP9X;APH1B;FURIN;FKBP1A;SIAH2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.612261595533536,-1.4563408828676039,0.07225433526011561,0.36607300028187695,1.0,6/10,31.20%,GLI3;LAG3;IRF1;FOXJ1;BMP4;ZC3H8
prerank,regulation of dendritic spine development (GO:0060998),-0.4861965631091998,-1.4553690495868963,0.06274509803921569,0.3651492634337908,1.0,5/19,5.43%,TANC2;MEF2C;NLGN1;GRIN3A;FMR1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5631312010871468,1.455364331240734,0.05263157894736842,0.3723481960016063,1.0,13/31,21.16%,FBXW7;ARRDC4;PTEN;UBE2L3;TOPORS;DCUN1D5;DCUN1D3;DCUN1D4;DCUN1D1;UBE2S;RAB1A;CDC14B;ARRDC3
prerank,regulation of synapse maturation (GO:0090128),-0.5806036344779053,-1.454386126890269,0.06748466257668712,0.364177328902271,1.0,5/10,24.11%,NRXN1;RELN;DAB2IP;ADGRL1;YWHAZ
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3450712295162467,-1.4543432715616218,0.009708737864077669,0.36138753087780695,1.0,26/75,19.05%,MEF2C;OPHN1;CTNNA2;NTNG1;DCC;MEF2A;RYK;BTBD3;ANK3;CNTN4;FGFR2;PARD3;MAP2;FARP1;SPTBN4;PAX2;RAB8A;KLF7;CELSR2;BRSK1;SLITRK5;SLITRK3;ADGRB1;ABITRAM;S100B;LMTK2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6072712357210744,1.4543275581987583,0.04935064935064935,0.37449294960149165,1.0,6/22,10.31%,LGALS3;MGAT5;STYXL1;BOD1;ROCK1;GSK3B
prerank,AMP metabolic process (GO:0046033),0.6679577131719815,1.454070014765851,0.07088989441930618,0.3743315238764004,1.0,4/13,9.12%,XDH;ADSL;AMPD3;NT5E
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.5789578808659648,1.4539988481833233,0.0611183355006502,0.37354055182693346,1.0,8/26,19.08%,SPTLC2;CYB5R3;ARG2;SPHK2;ABCA2;ACER2;GCH1;ASAH1
prerank,regulation of DNA metabolic process (GO:0051052),0.5382780443929609,1.4539738520692216,0.04642857142857143,0.37266573769945766,1.0,20/44,19.37%,MPV17;ALYREF;PDGFA;KPNA2;HELB;THOC1;WDR18;POLH;XRCC5;WDR70;NBN;SIRT7;IL7R;KDM1B;HNRNPD;MPHOSPH8;CDT1;RADX;UBE2V1;HDAC8
prerank,ceramide metabolic process (GO:0006672),0.5283507734251662,1.4535282616148848,0.040236686390532544,0.3730257840621301,1.0,18/49,20.53%,PLPP3;SPTLC2;CERK;SAMD8;SGPL1;SGMS2;CERS6;SPTSSA;ABCA2;DEGS1;TLCD3B;SGMS1;ACER2;PPP2CA;NSMAF;ASAH1;PPP2R1A;CERS1
prerank,positive regulation of viral process (GO:0048524),0.5104761178159513,1.452914406864241,0.028506271379703536,0.3738319281895248,1.0,22/60,17.66%,MDFIC;POLR2A;RAB7A;CD28;SRPK2;KPNA2;POLR2L;RAD23A;VPS4A;PPIH;DDB1;POLR2G;CNOT7;PKN2;POLR2I;GTF2F2;CTDP1;PPIE;ADARB1;TMEM39A;NELFE;SRPK1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6037866230476081,1.4520390433745431,0.04155495978552279,0.3754429449527171,1.0,4/22,11.07%,PPARG;APOE;ZBTB20;PPARD
prerank,DNA dealkylation (GO:0035510),0.7018208317980564,1.4519117284898106,0.0668693009118541,0.3739110604717143,1.0,6/10,21.87%,ASCC2;ASCC1;FTO;ALKBH1;ALKBH5;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7018208317980564,1.4519117284898106,0.0668693009118541,0.3739110604717143,1.0,6/10,21.87%,ASCC2;ASCC1;FTO;ALKBH1;ALKBH5;MGMT
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.5797619328214736,-1.4518810473013024,0.060240963855421686,0.36361019445266274,1.0,5/11,31.68%,MEF2C;TGFB2;TGFB1;GREM1;EFNB2
prerank,cellular response to interleukin-2 (GO:0071352),0.6958499875580161,1.4518556825653233,0.07646176911544228,0.37219056229396547,1.0,5/11,14.72%,SYK;STAT5B;PTK2B;SHC1;JAK3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6958499875580161,1.4518556825653233,0.07646176911544228,0.37219056229396547,1.0,5/11,14.72%,SYK;STAT5B;PTK2B;SHC1;JAK3
prerank,angiogenesis involved in wound healing (GO:0060055),0.6967214495545937,1.451793956667405,0.07048458149779736,0.3714151421590848,1.0,2/11,1.73%,HPSE;VEGFA
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.484531697109312,-1.4512490592243497,0.06498194945848375,0.362120857283802,1.0,7/20,14.17%,ST3GAL6;B3GALT1;FUT9;ST3GAL2;ST6GALNAC5;ST6GALNAC6;B4GALT1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.699307245850828,1.4511585689358577,0.0641025641025641,0.3721929024376747,1.0,3/10,4.15%,NFE2L2;TXN;RIPK1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6864711500246288,1.4510038082604948,0.05956112852664577,0.3716992819246426,1.0,3/11,10.68%,TMEM106A;TAF7;SIRT1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.52108999940059,-1.4497108942256225,0.07741935483870968,0.3625129174257141,1.0,6/16,6.96%,MEF2C;ERBB4;BMPR1A;FGFR2;FGF2;ZFPM2
prerank,superoxide metabolic process (GO:0006801),0.5629085088774274,1.4485519437862364,0.06751592356687898,0.3777861010724303,1.0,12/29,16.90%,PRDX1;CYBB;CYBA;NCF2;MT3;CYB5R4;NCF4;SH3PXD2B;NRROS;ATP7A;TAFA4;NCF1
prerank,myelin maintenance (GO:0043217),0.687363199268702,1.44755862656122,0.0755813953488372,0.3796972798163259,1.0,6/10,14.96%,CXCR4;ABCD1;PTEN;EPB41L3;DEGS1;PRX
prerank,positive regulation of multicellular organismal process (GO:0051240),0.45834678473488205,1.4474832275651137,0.0,0.37897209878538557,1.0,57/308,14.22%,EPAS1;FABP4;CD36;HTR2B;B4GALT5;ABCA1;SDCBP;APOE;CXCR4;SYK;PRKCH;FABP5;GCNT2;ADRA1D;ADRA1A;CTNNB1;VEGFA;FLOT1;CEBPB;TFRC;GADD45G;LRP1;IL6;CD28;NIBAN2;DYNC1H1;APPL2;SORL1;COL1A1;AGO2;SIRT6;ACADL;APC;KDM3A;RREB1;SOX9;SLC27A1;KSR2;NCOA3;TRPV2;BMPR2;PTGER4;PAX8;ROCK1;CFL1;PTH2R;SIRT1;ACVR1B;IL15;TREM2;KMT5B;OMA1;GAS6;FGR;SLC11A1;GDNF;IL4R
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6369530502382669,1.4470691063534664,0.0718475073313783,0.37921481413130514,1.0,9/16,18.31%,ABCD1;APPL2;ADCY7;SIRPA;MEFV;NLRC3;TREM2;APOD;CUEDC2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.6833071254288443,1.4470601653272215,0.0629800307219662,0.37830718016246756,1.0,2/11,2.08%,ANXA1;FOXP3
prerank,cell junction assembly (GO:0034329),-0.3307647094601567,-1.4467226449194683,0.0,0.36597109905321884,1.0,25/100,10.41%,ADGRL3;OPHN1;SDK1;GPM6A;NRXN1;KIRREL3;NLGN1;DNM3;CTNND1;RYK;ITGA6;CTNND2;VASP;TLN2;CDH11;CDH9;CDH8;CDH2;FARP1;CDH6;CDH12;SH3BP1;DNER;FERMT2;NLGN3
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6367706042536244,1.4466715672658466,0.06866952789699571,0.37847101989485343,1.0,3/15,5.09%,GRB2;SOS1;ZFYVE27
prerank,cellular response to decreased oxygen levels (GO:0036294),0.5012056171717505,1.4466236134598178,0.027303754266211604,0.3776718001322561,1.0,17/65,15.86%,EPAS1;VEGFA;AQP1;NPEPPS;CPEB4;LMNA;ADAM8;HMOX1;HIPK2;EGLN3;SIRT1;MT3;STUB1;RORA;SUV39H2;BNIP3;ACAA2
prerank,positive regulation of cell killing (GO:0031343),0.6625158305395091,1.4460328080880442,0.07368421052631578,0.3784678309655161,1.0,3/13,9.80%,SYK;CYBA;FZD7
prerank,epithelium development (GO:0060429),0.48723151974063794,1.4455439411273527,0.014941302027748132,0.37892469043972976,1.0,15/107,9.89%,LGALS3;PPARG;ANXA4;CTSB;VEGFA;TPP1;TST;DAG1;ACADVL;SOX9;SNAI2;CPT1A;DVL1;RIPK4;PAX8
prerank,positive regulation of dendrite development (GO:1900006),-0.6016214685459674,-1.4454707616775435,0.07575757575757576,0.3661552290988259,1.0,9/10,36.02%,VLDLR;LRP8;DAB2IP;PACSIN1;BMP5;PTN;ZDHHC15;BMP7;COBL
prerank,pinocytosis (GO:0006907),0.7023178922833286,1.4441385848038688,0.07623318385650224,0.3821662932797844,1.0,5/10,12.41%,MAPKAPK3;SNX5;PPT1;SNX33;DOCK2
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4453594078567213,-1.4438593261764545,0.056451612903225805,0.3665876938707047,1.0,8/27,8.84%,SYT1;RIMS1;RIMS2;VAMP7;SYT7;SYT2;SYT4;SYT6
prerank,proteoglycan metabolic process (GO:0006029),0.566850730813518,1.4431113079343927,0.07503234152652005,0.38423953844965325,1.0,7/26,12.73%,HPSE;XYLT1;B4GALT7;IGF1;SULF2;BMPR2;SULF1
prerank,positive regulation of transport (GO:0051050),0.4917610523531138,1.4429849979991496,0.0175054704595186,0.3836654305238525,1.0,22/85,14.53%,APOE;SGK1;ANXA1;FLOT1;LRP1;NR1H3;DYNC1H1;RXRA;CD151;MERTK;ANXA2;CYBA;NEDD4L;SIRPA;GSK3B;IL15;TREM2;DOCK2;GPLD1;GAS6;SLC11A1;BAX
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6008619523237023,-1.442166121676541,0.09064327485380116,0.3671842727997061,1.0,5/11,16.35%,BIN1;CACNB2;NOS1AP;CACNA2D1;CACNB1
prerank,somite development (GO:0061053),-0.5802469983216881,-1.441747381990277,0.0744336569579288,0.36526562172443605,1.0,7/11,37.42%,PTCH1;SMO;SOX11;MTHFD1;MEOX2;SHH;SFRP2
prerank,regulation of biosynthetic process (GO:0009889),0.6732623280891076,1.440848452535752,0.08095952023988005,0.3891329367448261,1.0,2/11,6.29%,PIKFYVE;SPHK2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5166114751095346,1.440570738190275,0.04449648711943794,0.38911175961789435,1.0,12/48,13.11%,PPARG;ARG1;SIGIRR;NR1H3;IL6;YTHDF3;IRAK3;STAP1;NLRP2B;CNOT7;TREM2;GAS6
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5020377661361733,1.44029868376742,0.03650442477876106,0.38895802883045644,1.0,19/66,15.74%,GPNMB;ANXA1;ID2;CDKN1A;ANKRD17;APPL2;PTEN;E2F1;APC;RB1;BRD7;ADAM17;KMT2E;DCUN1D3;CDK2AP2;APPL1;PSME2;INO80;CDC73
prerank,regulation of autophagosome assembly (GO:2000785),0.5614864994383766,1.4400573580094753,0.05236907730673317,0.3887800716873098,1.0,13/33,17.79%,MTM1;PIKFYVE;MTMR3;TBC1D12;SH3GLB1;RAB3GAP2;RAB1B;NPRL3;UBQLN2;PIP4K2A;NPRL2;TMEM39A;PHF23
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.5440568158282305,1.440011154523718,0.057356608478802994,0.38797526914358843,1.0,7/33,9.38%,HTR2B;PIK3R5;PTEN;IGF1;PIK3CA;PIK3C2G;PLEKHA1
prerank,regulation of protein localization to cell surface (GO:2000008),0.5445105920149448,1.4399250937006558,0.05897114178168131,0.3872737317355415,1.0,11/33,13.02%,CTNNB1;STX3;RANGRF;GPD1L;KCNAB2;NEDD4L;ABCA2;TYROBP;PICALM;SNX33;RAB11B
prerank,regulation of anoikis (GO:2000209),0.615553066763956,1.439486277975545,0.05485232067510549,0.38768364444904735,1.0,8/19,14.89%,PDK4;ITGA5;SIK1;PIK3CA;SNAI2;ITGB1;NOTCH1;MCL1
prerank,purine nucleotide catabolic process (GO:0006195),0.6554271534971776,1.4391838660060459,0.062409288824383166,0.38760194030220607,1.0,4/13,9.12%,XDH;ITPA;NT5C2;NT5E
prerank,placenta development (GO:0001890),0.6737565064950374,1.4391453693821108,0.07496251874062969,0.3867854286558726,1.0,1/12,0.13%,PPARG
prerank,regulation of viral genome replication (GO:0045069),0.516346005153426,1.4389480704085233,0.03135498320268757,0.38647981887563765,1.0,21/56,17.66%,IFITM1;CD28;TNIP1;SRPK2;FAM111A;RNASEL;RAD23A;ZC3HAV1;IFITM2;PPIH;MAVS;DDB1;CNOT7;PKN2;BST2;N4BP1;PPIE;SLPI;ADARB1;TMEM39A;SRPK1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.6044607223795345,1.4387028782832179,0.06586021505376344,0.38623213478919965,1.0,9/20,20.22%,SLC8B1;MICU2;MICU1;PMPCA;LETM1;SMDT1;PMPCB;PARL;AFG3L2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4497363171225892,-1.4379955850557506,0.06692913385826772,0.37029659299752504,1.0,8/26,14.99%,NAV3;MAPT;CDK5R1;PAK1;AKAP9;NUMA1;STMN2;MAPRE1
prerank,lipoprotein catabolic process (GO:0042159),0.685367221583721,1.4376251957345132,0.08494783904619971,0.3885209264300971,1.0,4/11,9.89%,CTSD;APOE;PPT1;ABHD10
prerank,connective tissue development (GO:0061448),0.5519072157138084,1.4374921877020157,0.055345911949685536,0.38799832896804065,1.0,14/35,20.97%,NAMPT;SPTLC2;CD44;SULF2;SOX9;ARID5B;TRIP11;SULF1;SH3PXD2B;ATP7A;COL11A2;SOX8;HES5;ZBTB16
prerank,regulation of metal ion transport (GO:0010959),-0.5118322091911675,-1.437209933566818,0.07236842105263158,0.36919801795533624,1.0,7/16,14.72%,ANK2;ORAI1;EPB41;BCL2;DLG1;IL16;CACNA2D1
prerank,sodium-independent organic anion transport (GO:0043252),-0.5948644330035059,-1.4368398858663582,0.08383233532934131,0.3673062892402833,1.0,6/10,23.32%,SLCO2B1;SLCO1B1;SLC16A2;SLCO5A1;SLCO4A1;MFSD10
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.6872895327147844,1.4360003844271003,0.07078313253012049,0.39142290075164216,1.0,4/11,9.57%,CEBPB;ATF3;ATF4;DDIT3
prerank,negative regulation of phagocytosis (GO:0050765),0.61380494783627,1.4352534770063177,0.07943262411347518,0.39275662550777757,1.0,7/17,20.69%,CD300LF;CD300A;SIRPA;APPL1;SNX3;FCGR2B;CD47
prerank,wound healing (GO:0042060),0.5055599251065557,1.4346379517758148,0.029714285714285714,0.3936327472960623,1.0,15/62,13.74%,MYOF;HPSE;MMP12;PDGFA;RAF1;AHNAK2;IGF1;HMOX1;PPP3CA;ARL8B;FZD7;MYH9;MACF1;COL3A1;SLC11A1
prerank,actomyosin structure organization (GO:0031032),-0.3400993213521883,-1.4325319539991976,0.022727272727272728,0.3734038404439453,1.0,13/75,5.81%,EPB41L2;FRMD5;SORBS1;F11R;CAPN3;MYO18A;PHACTR1;CIT;CDC42BPA;EPB41;EPB41L4B;TMOD2;FRMD3
prerank,negative regulation of autophagy (GO:0010507),0.5198028034059872,1.4324804279865264,0.05011655011655012,0.39911170690062203,1.0,18/54,19.45%,HTR2B;ATG7;HGF;CTSA;WASHC1;PIK3CA;QSOX1;FOXK1;MT3;TAB2;TREM2;ZKSCAN3;MCL1;USP36;RUBCN;EIF4G3;EIF4G2;TLK2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.6145172627934461,1.432463644595689,0.06582633053221289,0.39728478062596545,1.0,6/19,10.93%,POLR2A;ACD;POLR2L;TERF1;POLR2G;POLR2I
prerank,regulation of DNA recombination at telomere (GO:0072695),0.6145172627934461,1.432463644595689,0.06582633053221289,0.39728478062596545,1.0,6/19,10.93%,POLR2A;ACD;POLR2L;TERF1;POLR2G;POLR2I
prerank,regulation of autophagosome maturation (GO:1901096),0.6529480281242276,1.432354795962023,0.08595988538681948,0.3966517457671685,1.0,7/13,17.79%,FYCO1;TBC1D25;UVRAG;CLN3;RUBCN;TMEM39A;PHF23
prerank,negative regulation of receptor binding (GO:1900121),-0.5925489184527167,-1.4318159757547286,0.1043956043956044,0.37213077846191345,1.0,4/10,25.33%,ADAM15;HFE;ATP2A2;ATP2A3
prerank,sulfur compound transport (GO:0072348),0.5690516641760928,1.4311528272377079,0.06274509803921569,0.39919235433978484,1.0,5/27,8.01%,SLC26A11;LRRC8D;SLC6A6;SLC26A1;SLC27A1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6105775734513057,1.4309773036191935,0.07703281027104136,0.39879233519816143,1.0,3/17,4.59%,ANXA4;ANXA1;MAP2K5
prerank,regulation of cholesterol transport (GO:0032374),0.5940773760118973,1.4305424935559765,0.07596685082872928,0.3992106332605858,1.0,5/20,9.61%,LIPG;LRP1;NR1H3;ABCA2;LAMTOR1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5203305214230936,1.4297493451022234,0.04242424242424243,0.4007059758701289,1.0,8/45,11.77%,CD36;TLR8;IL6;TMEM106A;NLRC4;TYROBP;APP;FZD5
prerank,cellular response to chemical stress (GO:0062197),0.47862126539225375,1.4288407943439598,0.024891774891774892,0.40246059583730354,1.0,23/96,11.23%,LRRC8D;MSRA;PRDX1;NFE2L2;ATG7;TXNRD1;FOXO3;FAS;SESN2;LONP1;HTRA2;PIK3CA;HSPA1B;CYBB;GPX3;ATF4;CYBA;NCF2;CAT;GSR;CYCS;FOXO1;MT3
prerank,myoblast fusion (GO:0007520),-0.5560261783230855,-1.4287812839668428,0.08895705521472393,0.3758887438878819,1.0,4/12,10.09%,ADGRB3;KCNH1;JAM2;ADAMTS5
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.650677652218289,1.4285474440892867,0.07971014492753623,0.40249299829038987,1.0,1/13,0.53%,NAMPT
prerank,negative regulation of programmed cell death (GO:0043069),0.44814139711578027,1.4273386076126946,0.0010030090270812437,0.40527867789100586,1.0,99/355,19.43%,HTR2B;ARHGAP10;ANXA4;CD38;ANXA1;CTNNB1;VEGFA;AQP1;TFRC;RAB7A;CD44;PLK2;NAT8;IL6;HGF;CD28;NIBAN2;FAS;TFAP2B;BIRC6;RIPK1;PPT1;ANXA5;NOTCH2;RAF1;CITED2;PIM1;IGF1;CLN3;PCID2;PPIF;THBS1;BABAM2;AIFM2;NR1H4;PROC;GPX4;HSPA1B;RPS27A;UBC;TNFAIP8;BFAR;CAT;SH3RF1;SOX9;XIAP;KLHL20;CTSH;TOPORS;COPS5;FSTL1;PIM3;CFL1;GSK3B;PTK2B;BIRC3;POU3F3;FOXO1;PAK2;SIRT1;BAG4;MT3;TAX1BP1;RHBDD1;ZFAND6;TREM2;RELA;GAS6;ATAD3A;VDAC1;HSPA1A;GDNF;CX3CL1;SQSTM1;PHIP;GOLPH3;SHC1;MCL1;RPL10;CBL;BNIP3;MYD88;HSPD1;TMBIM4;MIEN1;BID;ERC1;UBE2O;ARF4;TEK;HMGN5;BIRC2;CASP2;CASP3;SOX8;LRP2;BAG1;WFS1;DNAJA1
prerank,adipose tissue development (GO:0060612),0.6729269554383215,1.4268215305095453,0.08244274809160305,0.4059157604572241,1.0,4/11,13.44%,NAMPT;SPTLC2;ARID5B;SH3PXD2B
prerank,myotube differentiation (GO:0014902),-0.4958212711799609,-1.4268145201097349,0.09446254071661238,0.3771175133740237,1.0,5/17,4.13%,MEF2C;ADGRB3;MYEF2;KCNH1;JAM2
prerank,melanosome organization (GO:0032438),0.5604131477252794,1.4265044042260746,0.06746031746031746,0.4059306521105053,1.0,9/26,18.22%,LYST;DTNBP1;PIKFYVE;AP1G1;AP3D1;AP3B1;TRAPPC6A;RAB29;AP1M1
prerank,negative regulation of endocytosis (GO:0045806),0.5798955534729711,1.4259760695223853,0.04935064935064935,0.4066244403813317,1.0,7/24,13.04%,LGALS3;CD300A;LILRB1;NR1H3;PICALM;SNX33;MCTP1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5970303065964903,1.4259103481064068,0.08232118758434548,0.40592741638783103,1.0,8/18,17.48%,MDFIC;FLCN;MFHAS1;POLR1A;GSK3B;LATS1;CTNNA1;APOD
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.457480930616526,1.42583004858923,0.013457556935817806,0.40525225616414406,1.0,26/150,9.91%,F7;OSBPL8;HPSE;GDF15;PIK3R5;GRB2;GCNT2;GAB2;TXN;HGF;CD28;PDPK1;PDGFA;P2RX4;F10;FGFR4;THBS1;IRS2;ADAM8;TRAT1;PIK3CA;MFHAS1;VAV1;STRN;ITGB1;ESR1
prerank,metanephric mesenchyme development (GO:0072075),-0.589664401337641,-1.425389708466466,0.08888888888888889,0.3774684132770931,1.0,5/10,21.58%,PAX2;BASP1;STAT1;PKD2;WNT4
prerank,liver development (GO:0001889),0.542634197778924,1.425040694491434,0.07237635705669482,0.40681792030984554,1.0,6/32,9.02%,ANXA1;CEBPB;IL6;CCDC40;CITED2;ARID5B
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6086967554381532,1.4247672241691431,0.06533333333333333,0.40667695169544266,1.0,5/20,7.75%,ANO6;IL6;ITGA4;THBS1;PIAS4
prerank,lysosome organization (GO:0007040),0.5441950612143477,1.4243784845551144,0.05528255528255528,0.40691525915855187,1.0,12/36,13.81%,ABCA1;TPCN2;TFEB;TPP1;HOOK3;TMEM165;CLN5;CLN3;VPS33A;LAMTOR1;CLVS2;ZKSCAN3
prerank,positive regulation of secretion (GO:0051047),0.6966738059607052,1.424290808054703,0.05918057663125948,0.40626248130346276,1.0,3/11,13.06%,AQP1;TRH;GPLD1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4970760541630889,1.4227655357191444,0.03471444568868981,0.40998106251965455,1.0,24/68,20.02%,MMAB;MTHFS;CYB5R3;PDZD11;ENPP1;LMBRD1;ACP5;FOLR2;SLC25A32;CYB5A;MCCC1;SLC2A1;MTHFD1L;SLC23A2;SLC23A1;SLC52A1;GSTO2;PANK2;MTRR;ABCC1;SLC19A1;SLC19A2;GSTO1;BTD
prerank,protein maturation (GO:0051604),0.48055188400269366,1.42243620606095,0.031149301825993556,0.40997504365204035,1.0,43/95,26.01%,F7;PCSK4;TMPRSS4;CPXM1;MMP14;SORL1;CLN3;TSPAN17;PITRM1;CTSS;NDUFAB1;BACE1;GLRX3;ADAM17;STUB1;LONP2;NAA10;TSPAN15;CIAO2B;ADAM19;NCSTN;CPM;HSPD1;CIAO2A;CASP2;TYSND1;DDI2;AFG3L2;OGT;ADAM10;NAA15;APH1B;FURIN;XPNPEP3;PSEN2;GCSH;PCSK7;SRGN;TSPAN5;TSPAN33;CIAO1;TSPAN14;CPE
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6562099969815446,1.42240766069819,0.08087091757387248,0.40913332915793493,1.0,3/12,8.81%,CD300A;ELF2;CBFB
prerank,integrated stress response signaling (GO:0140467),0.6454803268750454,1.4222423138018039,0.07782672540381791,0.408727219726825,1.0,8/14,22.77%,NFE2L2;EIF2AK4;ATF4;DDIT3;OMA1;QRICH1;EIF2S1;HERPUD1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6501975222784082,1.421957851120454,0.09465648854961832,0.40864379907309484,1.0,3/12,5.71%,B4GALT5;PTEN;B4GALT6
prerank,positive regulation of apoptotic process (GO:0043065),0.4510350753288348,1.4215881692641312,0.0010050251256281408,0.4089609699370139,1.0,86/293,18.65%,MTCH1;ABR;CTSD;MAP3K20;VAV3;LILRB1;RPS6KA2;BCL2L11;CTNNB1;ATG7;TGM2;GADD45B;ANO6;GADD45G;SOS1;IL6;FOXO3;FAS;TFAP2B;JUN;APAF1;DAPK1;SRPK2;RIPK1;GNA13;SLC27A4;E2F1;HTRA2;GADD45A;AIFM2;MELK;MLLT11;SIK1;SPHK2;STK3;APC;CTNNBL1;FLCN;ATF4;RPS27A;UBC;NLRC4;TNFAIP8;AKAP13;ING3;VAV1;DLC1;BACE1;NLRP2B;DDIT3;ITGB1;FOXO1;SIRT1;ARHGEF2;ING4;STPG1;DCUN1D3;DDX20;OMA1;GPLD1;BCLAF1;MCF2;SOS2;SQSTM1;FGD3;BAX;LATS1;NCSTN;QRICH1;BNIP3;GRN;HSPD1;BID;IFIT2;ADAMTSL4;CCAR1;UTP11;PRR7;SHQ1;ITSN1;C1QBP;CASP2;STK4;CASP3;CRADD;HTT
prerank,sphingosine metabolic process (GO:0006670),0.623269144643774,1.4215542392224185,0.08356545961002786,0.4081357721836213,1.0,4/17,8.23%,PLPP3;SPTLC2;SPHK2;ABCA2
prerank,ERBB signaling pathway (GO:0038127),0.4899667745689729,1.4209323388002113,0.04017857142857143,0.4091084149922635,1.0,17/64,15.36%,IQGAP1;REPS2;GRB2;NCK2;SOS1;PDPK1;KIF16B;PIK3CA;PTPN12;SOX9;ADAM17;PTK2B;NRG4;STUB1;ERBIN;SHC1;CBL
prerank,positive regulation of exocytosis (GO:0045921),0.5418514404962695,1.4208093744612458,0.052434456928838954,0.408647753499487,1.0,10/35,14.91%,SDCBP;RAB7A;STAM;CHMP2A;STXBP5;PDCD6IP;VPS4A;SDC4;CLASP1;SNF8
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5590936063984102,1.4196379331644555,0.06153846153846154,0.4111882527292782,1.0,8/29,18.09%,LGALS3;PLA2G7;ANO6;MOSPD2;GAS6;CXCL12;CREB3;C1QBP
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4475494038072149,-1.4186495585741001,0.060085836909871244,0.3895017231034277,1.0,9/26,10.41%,NRXN1;NLGN1;RIMS1;RIMS2;RELN;GRIN1;CUX2;MTMR2;NLGN3
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.6577269110627589,1.4182346570548328,0.07303370786516854,0.4143668173026127,1.0,6/13,13.54%,SYK;LAMP1;GAB2;SPHK2;AP1G1;FGR
prerank,regulation of MAP kinase activity (GO:0043405),0.4717167164453599,1.4168390764122698,0.03017241379310345,0.4176488669624372,1.0,11/92,6.40%,HTR2B;PIK3R5;APOE;CD300A;VEGFA;PRKCD;PDGFA;SORL1;ADAM8;PPEF2;IRAK3
prerank,nucleotide catabolic process (GO:0009166),0.610808360600962,1.4163598674271574,0.08203677510608204,0.41818030529509054,1.0,5/16,9.85%,XDH;ITPA;NT5C2;NT5E;DERA
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4712502116036618,1.4163282222196392,0.024442082890541977,0.41736560055732036,1.0,20/102,14.12%,PPARG;MYO5A;DENND4C;LPIN3;RAB8B;PDPK1;PRKCD;ENPP1;ADCY7;IRS2;RAB31;RAB12;SLC39A14;RAB10;FOXO1;EPRS1;RELA;GPLD1;ADCY8;ADCY3
prerank,negative regulation of biosynthetic process (GO:0009890),0.6164850814024527,1.4162956777572668,0.09714285714285714,0.41654321864613675,1.0,3/16,3.44%,ABCB7;IL6;ABCD1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6006725782631406,1.4162620167131446,0.08,0.4157355842462984,1.0,6/16,13.77%,PDK4;SCARB2;FOXK1;SIRT1;RORA;PRKN
prerank,negative regulation of leukocyte migration (GO:0002686),0.6767763518522485,1.4156476220080723,0.09049079754601227,0.4166550449045927,1.0,3/10,7.11%,CD300A;CD200R1;HMOX1
prerank,regulation of interleukin-8 production (GO:0032677),0.48952577364271527,1.4154182619040556,0.03754266211604096,0.4163853320363494,1.0,17/69,16.60%,ANXA4;SYK;TLR8;ANXA1;IL6;RIPK1;MAP2K5;HSPA1B;DDIT3;MAVS;AFAP1L2;RELA;HSPA1A;ARRB1;LBP;MYD88;TLR1
prerank,regulation of interleukin-12 production (GO:0032655),0.5143238937099972,1.4153928053682745,0.04875148632580262,0.41555879419497804,1.0,16/47,22.24%,SYK;TLR8;LILRB1;PIBF1;THBS1;IRAK3;FOXP1;MEFV;JAK3;HSPD1;LTB;C1QBP;SCIMP;CD47;SLAMF1;TIRAP
prerank,lytic vacuole organization (GO:0080171),0.5513474753227601,1.415392616481843,0.05422446406052964,0.4146670371258901,1.0,7/32,5.19%,ABCA1;TPCN2;TFEB;TPP1;HOOK3;CLN5;CLN3
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6370319243373675,1.414971018265289,0.08522727272727272,0.4149854715639217,1.0,9/15,22.32%,IQGAP2;ARPC2;WASHC1;ACTR3;WHAMM;ARPC1A;ARPC4;ARPC5L;ARPC5
prerank,retrograde axonal transport (GO:0008090),-0.49847418119662934,-1.4148947931145464,0.07665505226480836,0.39499047798098497,1.0,4/16,5.90%,DLG2;DST;NEFL;KIF5A
prerank,negative regulation of cell death (GO:0060548),0.4753873628802305,1.4148649556974564,0.03938730853391685,0.41441239973216903,1.0,21/88,16.07%,GPNMB;HTR2B;CD200R1;SPEF1;CCN5;TNFRSF1B;SORL1;HTRA2;CHMP2A;HSPA1B;GSK3B;ATG5;NENF;CCN1;MT3;DUS2;PRKN;HSPA1A;BNIP3;INPP5A;TRAF2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5688089385693894,1.4135095836332447,0.06762028608582575,0.4177738647405313,1.0,8/25,15.10%,SDCBP;ATXN2;ABCA2;PICALM;RIN3;ANKRD13D;APP;UBQLN2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.6276557996298707,1.4129807136360448,0.07647907647907648,0.4185939167932852,1.0,10/15,21.00%,REEP4;ZFYVE27;RTN3;RAB10;RAB18;ATL2;ATL1;RTN4;TMEM170A;ARL6IP1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.5603716897081027,1.4126961463891503,0.07681940700808626,0.41853259513555724,1.0,9/26,18.09%,SIGIRR;RNF26;IRAK3;NFKBIL1;NLRC3;TRAFD1;TNFAIP3;ACOD1;C1QBP
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5508762594628613,1.4121039733873084,0.07661822985468957,0.41940012680761496,1.0,10/28,10.68%,MITF;PDK4;PRKAG2;TNFRSF1B;FGFR4;MFSD12;NR1H4;EIF6;SIRPA;SIRT1
prerank,monocyte chemotaxis (GO:0002548),0.5489661474628523,1.4118389416568333,0.06633291614518148,0.41937014170920733,1.0,9/32,19.25%,LGALS3;ANXA1;IL6;FOLR2;IL6R;CX3CL1;CCL7;CALCA;CCL25
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3954289649840285,-1.411044363699112,0.03409090909090909,0.4004768332864414,1.0,21/41,32.67%,SLC12A2;ATP1B1;SLC12A6;ATP1A2;KCNJ2;ATP1B2;KCNJ3;KCNJ9;HCN2;SLC12A4;KCNK9;ABCC9;KCNJ6;SLC12A9;KCNJ13;SLC12A1;FXYD2;KCNJ12;HCN4;KCNJ16;KCNJ10
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.42940412576822784,-1.410458481494772,0.059907834101382486,0.3990152514807391,1.0,13/31,20.58%,SYT1;SCAMP5;SYT7;REST;SYT2;SYT4;SYT6;CACNA1G;STX1A;CACNA1I;SYT3;SYT12;SYT11
prerank,neuron maturation (GO:0042551),0.6041507471086368,1.4102250046546887,0.08356940509915015,0.4233268552712126,1.0,4/18,5.71%,MTCH1;B4GALT5;CLN5;B4GALT6
prerank,regulation of T cell activation (GO:0050863),0.5208873148540318,1.4101051499950616,0.056626506024096385,0.42281430780198104,1.0,5/42,8.26%,GPNMB;LGALS3;TNFRSF1B;DUSP3;SIRPA
prerank,prostanoid biosynthetic process (GO:0046457),-0.5096541645258167,-1.4097971939286447,0.12576687116564417,0.39756140368959175,1.0,7/15,27.71%,PTGS1;PLA2G4A;CD74;PNPLA8;PTGDS;PTGIS;PRXL2B
prerank,regulation of protein localization to cell periphery (GO:1904375),0.6079563379906128,1.4096280711722624,0.08567415730337079,0.42338106467669373,1.0,7/18,12.30%,MMP14;CLN3;STX8;VTI1B;ABCA2;VPS4A;APPL1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5358244475448575,1.4089579579991909,0.05783132530120482,0.42451106410346057,1.0,11/38,16.07%,LGALS3;FAS;RIPK1;THBS1;HMOX1;BRCA1;GSK3B;ARHGEF2;RNF34;TNFAIP3;TRAF2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.609960910655592,1.4085811014371186,0.09078212290502793,0.4248469907112924,1.0,5/17,8.46%,CD36;SASH1;SIGIRR;LY96;NFKBIL1
prerank,regulation of lymphocyte activation (GO:0051249),-0.5431980146644897,-1.4083310560305724,0.10404624277456648,0.39811023143150215,1.0,1/12,0.04%,PAG1
prerank,carbohydrate homeostasis (GO:0033500),0.490731214051852,1.408254385121048,0.03222222222222222,0.4249635492630022,1.0,9/67,5.33%,PPARG;PDK4;IL6;PYGL;TFAP2B;SLC8B1;APPL2;TENT4B;FGFR4
prerank,activin receptor signaling pathway (GO:0032924),-0.5138653044413772,-1.4081126546226235,0.09621993127147767,0.39586659842421407,1.0,4/15,4.33%,ACVR1;SMAD3;ACVR2B;TGFBR1
prerank,vesicle organization (GO:0016050),0.5140666081467067,1.4061673431716482,0.05092592592592592,0.4302762050829939,1.0,23/46,24.04%,PHETA2;HOOK3;SNX10;RNF26;LAMTOR1;SNX33;PI4K2A;ARFGEF2;EPS15;PLEKHJ1;SQSTM1;VPS11;WASL;DNAJC13;USP8;RAB22A;ALS2CL;WASHC5;CHMP2B;ZFYVE16;PI4K2B;SRGN;HOOK1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6511363778708286,1.4059415888153164,0.10997067448680352,0.43008871398381854,1.0,5/13,12.98%,PPARG;SOX9;NFATC3;PPARD;RELA
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5164097632401872,1.4051526749971899,0.055288461538461536,0.4316134249068291,1.0,14/43,15.61%,LILRB1;CD274;RARA;IGF1;ARG2;NR1H4;IRAK3;SIRPA;NFKBIL1;NLRC3;GAS6;TNFAIP3;CX3CL1;LBP
prerank,phospholipid biosynthetic process (GO:0008654),0.5313376610753335,1.4050288478448605,0.07503075030750307,0.4310857897735535,1.0,8/36,8.59%,GPAT2;SAMD8;AGPAT4;SGMS2;CLN3;MVD;SPHK2;IDI1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6339610644220686,1.4040178243023977,0.10549132947976879,0.43313394926275745,1.0,4/12,8.89%,ADSL;IMPDH2;PPAT;LHPP
prerank,regulation of macrophage migration (GO:1905521),-0.5823469375388055,-1.4038379850934999,0.10270270270270271,0.4022851146871064,1.0,5/10,6.60%,CX3CR1;P2RY12;CSF1;MTUS1;CD200
prerank,regulation of organelle organization (GO:0033043),0.4784548475690634,1.4035021877757357,0.034178610804851156,0.4338415528316082,1.0,20/80,14.57%,MYO5A;MTM1;DIAPH1;ZEB2;SPEF1;TBC1D25;RAB33B;CLN3;STX5;CAPN2;SCARB2;MSN;MAVS;PAK2;SIRT7;CPLANE2;PRKN;SQSTM1;GOLPH3;VPS11
prerank,negative regulation of mRNA processing (GO:0050686),-0.4926730826132781,-1.403202800421087,0.07017543859649122,0.4008710519864405,1.0,8/15,30.76%,SRSF6;RBMX;PCBP4;SRSF12;SRSF9;SRSF4;SRSF7;SAP18
prerank,plasma membrane repair (GO:0001778),0.6474359601592956,1.4018963948125374,0.09748892171344166,0.4379068891192071,1.0,4/13,12.31%,MYOF;AHNAK2;ARL8B;MYH9
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4773463753820474,1.4017832148134028,0.048314606741573035,0.4373664195747468,1.0,19/76,15.19%,ANXA4;FOXP3;IRAK2;MAP2K5;RWDD3;NFKBIB;IRAK3;NWD1;NFKBIL1;NLRP2B;DDIT3;NLRC3;SIRT1;TAX1BP1;TRAF3;TNFAIP3;ERBIN;ACOD1;ARRB1
prerank,regulation of B cell apoptotic process (GO:0002902),0.6573044192359209,1.401736333213249,0.09803921568627451,0.4365760905678138,1.0,5/12,18.42%,FNIP1;IRS2;FOXP1;BTK;NOC2L
prerank,entry into host (GO:0044409),0.6405975250515277,1.4017148855708381,0.08263305322128851,0.4357319175759124,1.0,3/13,1.59%,CXCR4;GRB2;CTNNB1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.666265011343715,1.4011527507090686,0.0904836193447738,0.4365514667235152,1.0,4/10,11.72%,ENPP1;APPL2;PID1;PRKCB
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.5867140507580351,1.4010496173909532,0.08876560332871013,0.43602237138504507,1.0,9/19,19.93%,UGDH;RENBP;GFPT1;NAGK;SLC35D1;UGP2;GNPDA1;NANS;PMM2
prerank,regulation of embryonic development (GO:0045995),0.5377076176291747,1.4007134540613724,0.08034610630407911,0.43619087485068936,1.0,7/34,10.21%,B4GALT5;TRIP12;NIBAN2;DAG1;WDPCP;NIPBL;CFL1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6605279786268641,1.4004862770215951,0.0998439937597504,0.4359854661795125,1.0,4/11,7.65%,PRKCD;GSKIP;STK24;PRODH
prerank,regulation of neuroinflammatory response (GO:0150077),0.58678713265922,1.4003191125584087,0.08355795148247978,0.4356385960549793,1.0,4/19,5.10%,CD200R1;IL6;TNFRSF1B;IGF1
prerank,epiboly involved in wound healing (GO:0090505),0.6130951328847208,1.3995442925136812,0.1048158640226629,0.43715173021904535,1.0,4/16,3.79%,MRTFA;CD44;LCP1;CD151
prerank,Golgi to lysosome transport (GO:0090160),0.6498962777717097,1.399521969423844,0.10785824345146379,0.43633289914706114,1.0,5/11,18.34%,LAMP1;CLN3;GAK;AP1G1;AP4M1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.48849424301453576,1.3986855093558137,0.06178489702517163,0.4380361390868687,1.0,20/59,15.29%,CTNNB1;MITF;CEBPB;RUNX2;IL6;CDKN1A;JUN;MED12;PTEN;MED15;SOX9;CBFB;TNRC6B;MED16;AGO3;MED26;RELA;BCLAF1;BAX;CDK8
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.48628097095875267,-1.3984849392275207,0.09608540925266904,0.40809360818004264,1.0,4/17,10.84%,ANK3;KCNAB1;NOS1AP;KCNRG
prerank,membrane fusion (GO:0061025),0.5274996434379955,1.3983846851713777,0.0620253164556962,0.4380491155787552,1.0,12/33,20.56%,MYOF;SNAP29;VTI1B;RABEP1;VAPA;HUWE1;STX11;VAMP3;RABIF;GCA;VAMP2;SNAP23
prerank,carnitine metabolic process (GO:0009437),0.6397504769235223,1.397854255203735,0.09691629955947137,0.4386710839112466,1.0,4/12,8.43%,TMLHE;ACADL;CRAT;CPT1A
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5577769271692488,1.39769628519807,0.09461235216819974,0.4382713191285529,1.0,9/26,16.90%,CBLB;NCK2;FBXW7;ADAM17;CHMP6;APP;SHC1;CBL;NCF1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.49703304000916704,-1.3971025342507046,0.06333333333333334,0.40847109844440216,1.0,8/14,30.76%,SRSF6;RBMX;PCBP4;SRSF12;SRSF9;SRSF4;SRSF7;SAP18
prerank,protein import into nucleus (GO:0006606),0.47310567287624555,1.396877044187269,0.06418918918918919,0.43992201500934686,1.0,13/66,12.30%,MMP12;CBLB;SYK;IPO5;KPNA4;E2F3;APPL2;KPNA2;RPL23;TPR;NUP50;TNPO1;APPL1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4553153613076155,1.396568780173024,0.017580144777662874,0.4399681969379244,1.0,34/132,16.70%,APOE;OPTN;TFEB;PLK2;ADAM9;PRKCD;FOXO3;ABCD1;SNX9;DAPK1;TNFRSF1B;SH3GLB1;MTLN;IGF1;IRS2;ADAM8;FLCN;ZBTB20;MSN;MEFV;ZC3HAV1;SNX33;ROCK1;GRSF1;CNOT7;GSK3B;FOXO1;APP;GPLD1;VPS11;BNIP3;SH3D19;PTPN1;NPRL2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.5866737198732677,1.3964588252361543,0.08539944903581267,0.4394264355125612,1.0,10/20,22.37%,APOE;ACADL;NR1H4;ACADVL;ABCA2;LPCAT3;DGKQ;SREBF1;ARV1;LDLRAP1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5800504534702062,1.396215366149719,0.09416445623342175,0.4393380497326207,1.0,11/21,25.59%,PRKCH;TRAT1;STAP1;FOXP1;PRKCB;RELA;RAB29;CARD11;PTPRC;BCL10;SLC39A10
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5181845351285532,1.3959803892238647,0.07389749702026222,0.4392111216619221,1.0,8/41,14.67%,PLPP3;GCNT2;FLOT1;CD44;CITED2;PIEZO1;CX3CL1;ADAM19
prerank,cardiac muscle cell contraction (GO:0086003),-0.4854630298383326,-1.3955628463767251,0.06854838709677419,0.4089232078598534,1.0,9/19,21.22%,CACNA1C;FGF12;SCN1B;KCNJ2;CACNA1G;CACNA2D1;GSN;SCN4B;SCN1A
prerank,neutrophil chemotaxis (GO:0030593),0.49226339329929647,1.3955032690177578,0.06235827664399093,0.4399386356481044,1.0,3/53,1.15%,LGALS3;SYK;PIKFYVE
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6827151327379173,1.3951069744862257,0.09523809523809523,0.4403411351198543,1.0,2/10,2.89%,IQSEC1;ADAM9
prerank,regulation of interleukin-6 production (GO:0032675),0.4629107623870341,1.3950837589954368,0.03961456102783726,0.43953943791111943,1.0,26/96,16.60%,SYK;RAB7B;TLR8;CD200R1;IL6;TMEM106A;SPHK2;IRAK3;CYBA;SIRPA;TYROBP;IL6R;MAVS;NLRC3;ARHGEF2;APP;TREM2;AFAP1L2;GAS6;TNFAIP3;CX3CL1;ARRB1;LBP;MYD88;HSPD1;TLR1
prerank,protein catabolic process (GO:0030163),0.4932822539730936,1.3948170175205685,0.048642533936651584,0.43947809977595476,1.0,15/59,13.77%,CTSD;APOE;TPP1;RIPK1;PPT1;CLN5;HTRA2;SOCS6;MANBA;LAMP2;RAB12;DDB1;OGA;FBXO6;PRKN
prerank,regulation of apoptotic process (GO:0042981),0.43513134465778075,1.3946070155694101,0.0,0.4392771463146846,1.0,180/676,18.76%,MTCH1;HTR2B;ARHGAP10;ANXA4;ABR;CD38;CTSB;CTSD;SGK1;MAP3K20;VAV3;LILRB1;RPS6KA2;BCL2L11;ANXA1;CTNNB1;STEAP3;ATG7;VEGFA;AQP1;TGM2;GADD45B;ANO6;TFRC;GADD45G;CD44;PLK2;NAT8;SOS1;IL6;HGF;CD28;FOXO3;NIBAN2;FAS;TFAP2B;BIRC6;JUN;APAF1;DAPK1;RIPK1;PPT1;ANXA5;NOTCH2;GNA13;RAF1;CITED2;SLC27A4;OSGIN1;E2F1;PIM1;IGF1;HTRA2;CLN3;PCID2;ACTN1;PPIF;THBS1;GADD45A;BABAM2;AIFM2;MELK;MLLT11;NR1H4;SPHK2;HS1BP3;STK3;CREBBP;PROC;APC;CTNNBL1;FLCN;HSPA1B;ATF4;RPS27A;UBC;ANP32B;NLRC4;TNFAIP8;BFAR;CAT;USP42;NF2;SH3RF1;SOX9;XIAP;AKAP13;ING3;VAV1;KLHL20;FBXO11;CTSH;TOPORS;COPS5;FSTL1;NLRP2B;EGLN3;ITGB1;PAX8;PIM3;CFL1;GSK3B;PTK2B;BIRC3;POU3F3;FOXO1;PAK2;SIRT1;ARHGEF2;BAG4;ING4;MT3;OLFM4;STPG1;DCUN1D3;TAX1BP1;RHBDD1;ZFAND6;DDX20;WRN;OMA1;RELA;GPLD1;GAS6;BCLAF1;ATAD3A;VDAC1;PRKN;MCF2;HSPA1A;SOS2;GDNF;CX3CL1;SQSTM1;FGD3;PHIP;BAX;GOLPH3;SHC1;JAK3;MCL1;RPL10;LATS1;NCSTN;USP36;RTN4;CBL;CASP6;QRICH1;BNIP3;MYD88;HSPD1;TMBIM4;MIEN1;TRAF2;BID;GAS1;IFIT2;ADAMTSL4;CCAR1;UTP11;ERC1;UBE2O;ZBTB7A;PRR7;ACER2;ARF4;TEK;SHQ1;HMGN5;ITSN1;BIRC2;C1QBP;CASP2;STK4;CASP3;CRADD;HTT;SOX8;LRP2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.574643538615576,1.3937576677870267,0.10682110682110682,0.4410715884478912,1.0,8/21,20.31%,TGM2;SLC8B1;MICU2;MICU1;LETM1;SMDT1;AFG3L2;BCAP31
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6020527003741498,1.393290389129301,0.0930888575458392,0.44179501907163654,1.0,2/15,2.82%,PPARG;NR1H3
prerank,amide biosynthetic process (GO:0043604),0.507349384811896,1.3931475580317598,0.06801909307875895,0.4413106333270056,1.0,17/47,23.06%,SPTLC2;ARG1;SAMD8;RHD;SGMS2;CERS6;ARG2;SPTSSA;DEGS1;SLC25A15;TLCD3B;SGMS1;PAM;ASAH1;CERS1;FURIN;CERS2
prerank,positive regulation of TOR signaling (GO:0032008),0.5202713169933568,1.3922902150651768,0.08088235294117647,0.4431047237239765,1.0,13/40,14.55%,GPR137B;FNIP1;HTR6;SIK3;PIK3CA;FLCN;LAMTOR1;TREM2;MIOS;SLC38A9;GAS6;LAMTOR3;GOLPH3
prerank,regulation of phosphate metabolic process (GO:0019220),-0.49978103696100074,-1.3921195829140485,0.09797297297297297,0.4134525384946194,1.0,6/16,22.85%,SMG6;SIRT2;TIGAR;SMG7;IGBP1;SMG5
prerank,T cell migration (GO:0072678),-0.5237710509092603,-1.3920822798998735,0.09841269841269841,0.4109310145880908,1.0,4/13,7.30%,SLC12A2;GPR183;S1PR1;CXCL16
prerank,cellular senescence (GO:0090398),0.5549925066146911,1.3918603239235692,0.08238276299112801,0.44354500348358233,1.0,4/27,3.14%,NSMCE2;ID2;PRKCD;CDKN1A
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4720768810433522,1.391833409231068,0.05088495575221239,0.4427575399539976,1.0,33/76,24.05%,FBXW7;TNIP1;TANK;UBE2L3;RWDD3;CUL3;BRCA1;PIAS4;XIAP;HUWE1;DCUN1D5;BIRC3;STUB1;DCUN1D3;NSMCE3;DCUN1D4;CENPX;DCUN1D1;CRY1;PHF23;BIRC2;MYCBP2;WFS1;PAXIP1;PIAS1;HSPBP1;FKBP1A;MALT1;SPRTN;BCL10;TRAF6;FBXO4;NDFIP1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.45639519220173125,-1.38998987957624,0.09777777777777778,0.41272341455286726,1.0,10/23,19.21%,HACD2;ELOVL7;ACOT7;FAR2;ACSL6;ACSL4;ELOVL6;TECR;DGAT1;ACSBG1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6342279268465961,1.3897918691241289,0.10473457675753228,0.4481474340637207,1.0,5/13,9.95%,STX3;RANGRF;GPD1L;TYROBP;SNX33
prerank,positive regulation of interleukin-1 production (GO:0032732),0.4947496884248774,1.3895914400808944,0.06729634002361275,0.44785701542217415,1.0,8/51,11.77%,CD36;TLR8;IL6;TMEM106A;NLRC4;TYROBP;APP;FZD5
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5641932261572569,-1.3887658387763855,0.07580174927113703,0.41277241769719397,1.0,6/11,18.69%,CSNK1E;CSNK1D;RSPO3;WNT5B;NKD1;DAB2
prerank,regulation of protein metabolic process (GO:0051246),0.5101056857968779,1.3887502359777013,0.059186189889025895,0.44959531553249804,1.0,20/44,23.00%,APOE;MAP2K5;MAPK7;NEDD4L;MTPN;CHMP6;APP;TRAF3;SNF8;PARL;ACE;WFS1;SPOP;GSAP;VPS35;FURIN;FKBP1A;FAF1;PLAUR;ABCA7
prerank,regulated exocytosis (GO:0045055),0.44695369521044676,1.388613503856179,0.013333333333333334,0.4491899181806364,1.0,34/173,13.11%,PSAP;CD36;VWF;TIMP1;VEGFA;HGF;APLP2;CD63;PDGFA;LHFPL2;ANXA5;DNAJC5;IGF1;ACTN1;THBS1;VTI1B;ABCC4;OLA1;RAB31;TLN1;F13A1;LAMP2;QSOX1;ITIH3;ARHGAP17;SYT17;RAB10;WDR1;APP;CTSW;GTPBP2;MYH9;RAB11B;GAS6
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.5498430880319377,1.3880384348763737,0.07953063885267275,0.45006582302219744,1.0,3/26,3.87%,CD36;TMEM106A;P2RX4
prerank,ganglioside metabolic process (GO:0001573),-0.4637450749851175,-1.38737061948272,0.1,0.4132992568382257,1.0,8/20,13.93%,HEXB;ST6GALNAC3;ST8SIA6;ST3GAL5;ST6GALNAC5;ST6GALNAC4;ST8SIA3;ST6GALNAC6
prerank,snRNA 3'-end processing (GO:0034472),0.581346327503326,1.387240703922895,0.11095505617977527,0.451522560792966,1.0,10/19,13.35%,TOE1;INTS6;EXOSC3;EXOSC9;INTS1;INTS8;EXOSC8;INTS2;INTS5;INTS7
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.6012316035088731,1.3871947040032833,0.10058309037900874,0.4508035145232271,1.0,5/17,12.18%,APOE;ABCG1;ABCA2;ERLIN1;LPCAT3
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5985228118853867,1.3865684715013065,0.08823529411764706,0.4518567630934381,1.0,2/18,5.43%,GPNMB;DUSP3
prerank,regulation of dendrite development (GO:0050773),-0.40091641003725204,-1.3860113726786145,0.04522613065326633,0.41355725172674357,1.0,9/37,9.33%,CSMD3;CAMK1D;ADGRB3;DCC;KNDC1;VLDLR;MARK1;LRP8;DAB2IP
prerank,negative regulation of apoptotic process (GO:0043066),0.4325403208814381,1.385174913622718,0.001002004008016032,0.4553455720779793,1.0,105/444,16.22%,HTR2B;ARHGAP10;ANXA4;CD38;APOE;PRKCH;ANXA1;CTNNB1;VEGFA;FNIP1;AQP1;PDK4;CPEB4;TFRC;DNAJB6;CD44;PLK2;NAT8;IL6;HGF;CD28;ITGA5;PRKCD;NIBAN2;FAS;TFAP2B;BIRC6;RIPK1;PPT1;ANXA5;NOTCH2;MAP2K5;RAF1;CITED2;PIM1;IGF1;CLN3;PCID2;PPIF;THBS1;MERTK;BABAM2;ADAM8;NR1H4;PIK3CA;PROC;HSPA1B;RPS27A;UBC;TNFAIP8;BFAR;CAT;SH3RF1;SOX9;XIAP;SNAI2;RB1;KLHL20;CTSH;TOPORS;COPS5;CSNK2A2;FSTL1;ITGB1;PIM3;CFL1;GSK3B;PTK2B;BIRC3;POU3F3;FOXO1;PAK2;SIRT1;BAG4;MT3;TAX1BP1;RHBDD1;NOTCH1;ZFAND6;TREM2;MAZ;HCLS1;RELA;GAS6;ATAD3A;VDAC1;PRKN;HSPA1A;GDNF;CX3CL1;SQSTM1;PHIP;GOLPH3;SHC1;MCL1;RPL10;CBL;PRKCG;BNIP3;MYD88;GRN;HSPD1;TMBIM4;MIEN1;BID
prerank,regulation of store-operated calcium entry (GO:2001256),0.6574229178084797,1.3851620770056086,0.11128284389489954,0.45450347898924925,1.0,3/10,4.61%,CD84;SLC8B1;HOMER3
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5905241521390348,1.3843861401904534,0.1087866108786611,0.4560929346359221,1.0,3/17,4.72%,PPARG;CDKN1A;PTEN
prerank,monocarboxylic acid transport (GO:0015718),0.49948405261032186,1.3840531158671385,0.055944055944055944,0.4562804597245208,1.0,13/51,13.51%,CD36;SLC51A;RXRA;SLC16A1;SLC27A4;STARD5;ABCC4;NR1H4;ABCC3;SLC27A1;NCOA1;SLC6A8;ATP8B1
prerank,intestinal absorption (GO:0050892),0.635715571672204,1.3831065355356351,0.09037900874635568,0.45828263189534946,1.0,1/13,0.12%,CD36
prerank,regulation of potassium ion transport (GO:0043266),-0.40660737665713564,-1.3828904907520734,0.060085836909871244,0.41766328952732235,1.0,11/31,13.82%,KCNIP4;ANK2;DPP10;ANK3;DPP6;KCNAB1;KCNIP3;ACTN2;DLG1;KCNIP1;KCNN2
prerank,positive regulation of phagocytosis (GO:0050766),0.5046276334963534,1.3824768934324714,0.06190476190476191,0.4593722584736531,1.0,13/47,13.74%,CD300LF;ANO6;APPL2;MERTK;CYBA;RAB31;STAP1;SIRPA;IL15;TREM2;DOCK2;GAS6;SLC11A1
prerank,cellular amide metabolic process (GO:0043603),0.462316961040538,1.3818470690331235,0.03229278794402583,0.4604499940495239,1.0,31/102,20.71%,PLPP3;BAAT;CERK;SGPL1;MTHFS;NLN;PDZD11;CPXM1;ACSM3;ATF4;GLYAT;FOLR2;ABHD4;ABCA2;PLAAT1;SLC25A32;DNPEP;MCCC1;PLAAT3;MTHFD1L;ACOT9;PANK2;CPM;MTRR;SLC19A1;PPP2CA;NSMAF;ACOT2;BTD;PPP2R1A;ACOT6
prerank,positive regulation of catabolic process (GO:0009896),0.4784661857572552,1.3817363009153172,0.049773755656108594,0.45991092357891056,1.0,20/65,17.43%,ATG7;WWP1;TIPARP;RAB7A;PLK2;SORL1;APC;STX5;NEDD4L;WWP2;HUWE1;DDB1;GSK3B;FOXO1;OAZ2;TNFAIP3;PRKN;SNF8;OAZ1;CSNK2A1
prerank,neurotrophin signaling pathway (GO:0038179),0.5741379304432147,1.3809588926272354,0.08484005563282336,0.46151694830449225,1.0,7/21,18.39%,GRB2;SOS1;KIDINS220;ZFYVE27;RAPGEF1;FRS2;CASP3
prerank,negative regulation of neuron death (GO:1901215),0.45815471857117007,1.380586916055185,0.03925845147219193,0.4617018880414411,1.0,21/93,16.07%,GPNMB;APOE;CD200R1;CPEB4;PPT1;TNFRSF1B;SORL1;HTRA2;CLN3;ADAM8;ATF4;GSK3B;PTK2B;NENF;MT3;PRKN;GDNF;PRKCG;INPP5A;GRN;TRAF2
prerank,microtubule polymerization (GO:0046785),-0.4125375027404248,-1.3805164186167795,0.06048387096774194,0.41993766072028305,1.0,7/28,6.64%,TUBGCP5;HDGFL3;MAPT;FGF13;TPPP;CSNK1D;AKAP9
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4889127587011929,1.380503903427219,0.055304740406320545,0.461122924588509,1.0,21/63,19.45%,HTR2B;TIMP1;RIC1;HGF;WASHC1;SORL1;TIMP2;HP;ROCK1;FOXK1;MT3;TAB2;TREM2;GPLD1;ZKSCAN3;MCL1;NELL1;RUBCN;EIF4G3;EIF4G2;TLK2
prerank,cellular response to reactive oxygen species (GO:0034614),0.4822318438756409,1.3804632516358188,0.064,0.46038990670818103,1.0,16/59,13.66%,NFE2L2;ANXA1;AQP1;MPV17;IL6;PRKCD;JUN;RIPK1;MAPK7;PPIF;SIRPA;PLEKHA1;SIRT1;RELA;ERCC6L2;TNFAIP3
prerank,macrophage chemotaxis (GO:0048246),0.6680526516983313,1.380373067983965,0.10810810810810811,0.459796292855623,1.0,2/10,6.91%,LGALS3;CKLF
prerank,membrane depolarization (GO:0051899),-0.42476014565929343,-1.3803210430549333,0.07471264367816093,0.41776284121757656,1.0,11/32,17.02%,CACNA1E;SCN2A;CACNB4;SCN1B;CACNG4;SCN9A;CACNA1G;YWHAH;SCN8A;CACNG2;CACNA1I
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.663598775415732,1.380091291173447,0.11023622047244094,0.4598082077295098,1.0,2/10,4.07%,FOXP3;CD274
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5181317209304533,1.3794464504437134,0.09386733416770963,0.4609669484029918,1.0,13/37,18.31%,IL6;ABCD1;PLD3;APPL2;ADCY7;SIRPA;MEFV;NLRC3;APPL1;TREM2;MYD88;APOD;CUEDC2
prerank,activation of protein kinase B activity (GO:0032148),0.5342976905817983,1.379356991536434,0.09580052493438321,0.4603736495181727,1.0,7/29,15.40%,OSBPL8;TXN;PDPK1;IGF1;MT3;GAS6;MAPKAP1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.602726997643877,1.3792883477937838,0.10960960960960961,0.4597156676256562,1.0,5/15,10.25%,TENT4B;AGO2;TNRC6B;POLR2G;CNOT7
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.6370609003620691,1.3791657438394604,0.11360239162929746,0.45924130031939187,1.0,5/12,10.47%,IL6;NOTCH2;DOCK10;LFNG;PTK2B
prerank,natural killer cell activation (GO:0030101),0.559404348958103,1.379078593647086,0.08783783783783784,0.4586163830166382,1.0,3/23,2.23%,PRDX1;SLAMF7;SNX27
prerank,purine nucleotide metabolic process (GO:0006163),0.5614104119827923,1.3787942840469105,0.09126466753585398,0.4586132334880273,1.0,6/24,9.12%,XDH;ADSL;PPAT;ITPA;NT5C2;NT5E
prerank,sulfation (GO:0051923),-0.5612662182473875,-1.37840794979934,0.134375,0.4192411547843219,1.0,6/11,35.35%,UST;HS3ST5;SULT1A1;SULT4A1;SULT6B1;SULT2B1
prerank,positive regulation of lipid localization (GO:1905954),0.6613880656672672,1.377924651310292,0.09891808346213292,0.4605201015812011,1.0,2/11,2.64%,IKBKE;LRP1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4661888293098126,-1.3779107319720385,0.09386281588447654,0.4178971209155463,1.0,5/20,3.65%,ATP1B1;ANK2;CACNA1C;ATP1A2;RYR2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5215620439958047,1.377100210024078,0.07274969173859433,0.4621473560753682,1.0,6/37,5.10%,PPARG;ERN1;CDKN1A;JUN;PTEN;IGF1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6535894471057665,1.3767993959949498,0.1288888888888889,0.462222809386427,1.0,3/11,7.55%,CORO1C;CD44;RREB1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4730409772318187,1.3765332819245117,0.05245901639344262,0.4621848065959314,1.0,13/75,10.68%,HTR2B;APLNR;VEGFA;PDPK1;ITGA4;NRP2;NRAS;SIRT6;HMOX1;VASH2;BMPR2;ADAM17;SIRT1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.5460560131597724,1.3757065754670714,0.0901749663526245,0.4638528582038508,1.0,9/25,22.26%,LYST;CHMP2A;CHMP6;CHMP5;TMEM50A;CHMP7;LEPROTL1;CHMP2B;VCP
prerank,ovarian follicle development (GO:0001541),0.6254086208916145,1.375463116205981,0.12035661218424963,0.4638063914222863,1.0,2/13,1.89%,VEGFA;CEBPB
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.45765009562734993,1.3752715788932666,0.03481012658227848,0.46354059253791813,1.0,29/108,18.61%,MTCH1;PPARG;CTSD;XDH;SYK;ST18;FAS;APAF1;DAPK1;RIPK1;HTRA2;ANP32B;NLRC4;DLC1;EGLN3;CYCS;SIRT1;CASP12;BAX;HSPD1;TRAF2;BID;HSPE1;PRR7;ACER2;BBC3;SENP1;CASP2;CRADD
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5735799471024848,1.3751465338111546,0.10066225165562914,0.46312781527011926,1.0,5/21,12.18%,OSBPL8;PLA2G2D;PLA2G4F;PLAAT3;LPCAT3
prerank,cellular response to mechanical stimulus (GO:0071260),0.4997499425689656,1.3747263596882506,0.07381776239907728,0.463593227804583,1.0,17/46,18.61%,TLR8;MAP3K1;AQP1;FAS;GADD45A;SOX9;MAP2K4;PTGER4;PIEZO1;PIEZO2;KCNK4;MAP3K2;BNIP3;MYD88;LTBR;CASP2;CRADD
prerank,regulation of gluconeogenesis (GO:0006111),0.534261792231456,1.3747100109634547,0.10539845758354756,0.46280493073161366,1.0,12/27,20.71%,ZNF692;GNMT;SDHAF3;SIK1;DDB1;SIRT1;PGP;SIRT7;DGKQ;CRY1;GCK;OGT
prerank,digestive tract morphogenesis (GO:0048546),0.6264117702524337,1.3743560343046204,0.10662824207492795,0.4630476039916521,1.0,4/14,10.82%,STRA6;ID2;NIPBL;RBPMS2
prerank,positive regulation of immune effector process (GO:0002699),0.5407619819389144,1.3743333409859861,0.10756972111553785,0.46227056067244926,1.0,4/27,4.50%,LILRB1;CD46;ANKRD17;APPL2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.6153731944769294,1.373778537482432,0.12917271407837447,0.46319256885065724,1.0,4/13,12.96%,ATG7;ATG10;UBA5;UBA3
prerank,second-messenger-mediated signaling (GO:0019932),0.46812177543101446,1.373653413819843,0.05054945054945055,0.46273483516821806,1.0,9/82,3.95%,CD36;HTR2B;TPCN2;APOE;CXCR4;HRH1;PDPK1;P2RX4;XCR1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.6271073254986563,1.3726406047681485,0.11063218390804598,0.4649749105505142,1.0,4/13,15.61%,BCL2L11;VDAC2;BAX;BNIP3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5855286764196482,1.3724424517655223,0.128,0.46478144189403275,1.0,5/18,9.91%,IL6;RIPK1;NCOR1;DDX5;ESR1
prerank,cellular defense response (GO:0006968),0.5096003091604239,1.3715691202510698,0.07920792079207921,0.46665794016634377,1.0,14/40,16.90%,CD5L;VEZF1;TCIRG1;LY96;TRAT1;LSP1;NCF2;ZNF148;TYROBP;ITGB1;PTK2B;RELA;LBP;NCF1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.563329935459015,1.3711996180776633,0.10690121786197564,0.46695143361875124,1.0,4/20,8.04%,NIBAN2;GTF2B;IGF1;RB1
prerank,sensory perception of chemical stimulus (GO:0007606),0.6132496074235588,1.3710509891058198,0.09913793103448276,0.46658289295200567,1.0,1/15,0.12%,CD36
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5669378081948155,1.3710413351149358,0.1039136302294197,0.46577577947181087,1.0,6/20,8.89%,ADSL;IMPDH2;PPAT;AMPD3;NT5C2;LHPP
prerank,negative regulation of inclusion body assembly (GO:0090084),0.6595831371981739,1.370872292668541,0.1266025641025641,0.4654270904706137,1.0,4/10,13.96%,DNAJB6;SORL1;HSPA1B;HSPA1A
prerank,positive regulation of histone deacetylation (GO:0031065),0.6357519047494062,1.370743152895492,0.12336719883889695,0.46500840571664825,1.0,3/12,7.02%,APLNR;VEGFA;NIPBL
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3766179156458928,-1.369957397979199,0.06896551724137931,0.43255894867973704,1.0,16/41,14.72%,GRIN2A;RYR3;GRIN2B;SLC24A2;HTR2C;ITPR2;RYR2;GRIN1;FGF2;TRPM2;PKD2;GRIN2D;ATP2B4;HTR2A;CHERP;CACNA2D1
prerank,response to nitric oxide (GO:0071731),0.6196899390056938,1.3698008868333402,0.115625,0.46701961301130307,1.0,4/13,11.23%,TXN;AQP1;FOXO1;MT3
prerank,protein localization to chromosome (GO:0034502),0.5208637258727871,1.369646159044374,0.10049019607843138,0.4666614762056077,1.0,13/34,18.70%,ACD;TPP1;MCM9;PARP3;RB1;BOD1;XRCC4;XRCC5;ESR1;TNKS;CHMP7;TNKS2;RAD21
prerank,cellular response to hormone stimulus (GO:0032870),0.47762301843876276,1.3693784221563117,0.05736782902137233,0.4666279755161388,1.0,15/69,12.67%,CTSB;CTSL;RARA;UBE2L3;STAT5B;NR3C1;SLC5A5;NCOA4;CTSS;CTSH;NCOA3;NCOA1;PAX8;BCAS3;GAS2L1
prerank,central nervous system development (GO:0007417),-0.28107072791946797,-1.3681618493584566,0.0,0.43392346906208945,1.0,55/250,12.16%,ZFHX3;CX3CR1;CNTNAP2;ADGRL3;GRIN2A;ITGAM;SPOCK1;ADAM23;DCLK1;PHF8;ROBO2;CNTN6;PTCH1;MARCKS;GRIN2B;NFIB;GRIK1;TGFBR2;MBP;SMO;EML1;CNTN4;ANKLE2;RELN;CDK5R1;NCKAP1;GRIN1;PBX3;ARNT2;IL1RAPL2;TPPP;CDH2;POU6F1;MYRF;ADGRG1;MEIS3;ATN1;MAL;QARS1;UFM1;DNER;SZT2;EPHA7;SERPINI1;MEIS1;SOX6;ADAM22;SH3GL3;IER3IP1;HAPLN2;NDUFS4;SNTG2;RPS6KA6;PKD2;GRIN2D
prerank,mononuclear cell differentiation (GO:1903131),0.5375053173193345,1.3677158758323966,0.11140583554376658,0.4709271372695572,1.0,7/24,13.11%,PPARG;LILRB1;VEGFA;RELB;MYH9;TREM2;GAS6
prerank,phasic smooth muscle contraction (GO:0014821),0.6603821138591817,1.3673968432751873,0.11729323308270677,0.47110714769907613,1.0,1/10,0.15%,HTR2B
prerank,regulation of multicellular organismal development (GO:2000026),0.5502891553626765,1.3671260205694435,0.1167979002624672,0.47106424336151487,1.0,3/25,7.02%,HPSE;TRIP12;NIPBL
prerank,retinol metabolic process (GO:0042572),0.6196858135188004,1.3669058272629717,0.10324483775811209,0.4708699490707834,1.0,2/14,5.06%,DHRS3;RDH12
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5878186809374472,1.3664431581615974,0.11001410437235543,0.47150294541046794,1.0,5/18,10.29%,PPARG;PDPK1;ITGA4;SIRT6;ADAM17
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5836331506973113,1.3660799176528162,0.12309820193637622,0.4718047482621178,1.0,5/17,12.31%,NFE2L2;HTRA2;MAPK7;SIRT1;TREM2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4415864463119695,1.3656297577802494,0.03333333333333333,0.4723531646197834,1.0,31/136,15.19%,ANXA4;ADGRG3;SIGIRR;FOXP3;IRAK2;ID2;MAP2K5;PIM1;RWDD3;SIK1;IRAK3;BHLHE40;PEX14;NWD1;EIF2AK4;RB1;WWP2;NFKBIL1;NLRP2B;DDIT3;ESR1;NLRC3;SIRT1;TAX1BP1;TBX6;GAS6;TRAF3;TNFAIP3;ERBIN;ACOD1;ARRB1
prerank,activation of phospholipase C activity (GO:0007202),0.5262804308123719,1.3653106278271057,0.09499358151476252,0.4724750856065949,1.0,5/29,5.03%,HTR2B;EDNRA;ADRA1A;GNAQ;LPAR2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4694779952429373,1.3650796203563,0.05511811023622047,0.47230864617010193,1.0,19/67,12.81%,VAV3;NCK2;VEGFA;MAPKAPK3;BAIAP2;ABI1;NRP2;PIK3CA;CYBB;CYBA;NCF2;VAV1;CYFIP2;ROCK1;PTK2B;PAK2;DOCK1;SULF1;NCF4
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5932305791956193,1.3650692572345036,0.1156558533145275,0.4715357628689651,1.0,5/16,8.89%,ADSL;IMPDH2;PPAT;AMPD3;LHPP
prerank,organelle transport along microtubule (GO:0072384),0.5269876355164783,1.3648838047070442,0.10154241645244216,0.4713251778328705,1.0,10/31,19.70%,ARHGAP21;CLN3;PEX14;UXT;BORCS5;NDE1;KIF5B;PAFAH1B1;HTT;RAB1A
prerank,sulfur compound biosynthetic process (GO:0044272),0.4549920309087331,1.3647938785697744,0.04153354632587859,0.47080395707457656,1.0,26/104,15.32%,CDO1;B4GALT5;MGST2;PAPSS2;GSTM1;AKR1A1;DSE;CNDP2;UGDH;SLC26A1;B4GALT6;ST3GAL4;LUM;HPGDS;SLC35B3;PAPSS1;ESD;B4GALT3;LIAS;GGTA1;MGST1;HAGH;B4GALT2;SLC10A7;GSTO2;GSTA4
prerank,long-term memory (GO:0007616),0.5783619650261239,1.3637542148708488,0.125,0.4732808866587836,1.0,4/19,8.41%,APOE;SGK1;EIF2AK4;CALB1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.650104284704955,1.3637341765769007,0.12264150943396226,0.4725329157077699,1.0,6/11,14.57%,SORL1;RAB21;MSN;EIPR1;PRKN;VPS11
prerank,snRNA transcription (GO:0009301),0.4724102942344501,1.3635576241639535,0.05298759864712514,0.47222294200628345,1.0,23/70,14.28%,POLR2A;GTF2B;INTS9;TAF5;POLR2L;RPAP2;INTS6;SNAPC1;INTS1;POLR2G;INTS13;INTS8;CDK7;POLR2I;NCBP2;GTF2F2;INTS2;INTS5;INTS7;ICE2;POU2F1;USPL1;GTF2A1
prerank,axonal transport of mitochondrion (GO:0019896),-0.556239132881479,-1.3629261673502175,0.11014492753623188,0.4432561404213679,1.0,3/11,9.74%,MAPT;NEFL;SPAST
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6350312735384895,1.3628554587418855,0.14055636896046853,0.47365986167885815,1.0,4/12,17.61%,MGST2;CNDP2;HAGH;OPLAH
prerank,T cell homeostasis (GO:0043029),0.6538966469054871,1.3627907547957365,0.13444108761329304,0.4730332627344136,1.0,3/10,14.72%,FOXP3;FAS;JAK3
prerank,negative regulation of cellular component organization (GO:0051129),0.46582070215758165,1.3618760202848075,0.06659267480577137,0.47500277751563946,1.0,19/74,16.11%,LGALS3;LILRB1;VEGFA;DNAJB6;TFIP11;RAF1;AIDA;SORL1;NR1H4;IRAK3;HSPA1B;RTEL1;XRCC5;SNX33;GSK3B;MCTP1;HSPA1A;WASL;RUBCN
prerank,neutrophil migration (GO:1990266),0.47589556310513215,1.3617900009252941,0.0707070707070707,0.47443931480294654,1.0,3/58,1.15%,LGALS3;SYK;PIKFYVE
prerank,response to interferon-alpha (GO:0035455),0.5946941055128737,1.36167417031442,0.08940852819807428,0.4739321715490381,1.0,8/16,16.95%,IFITM1;IFNAR2;KLHL20;IFITM2;TPR;BST2;GAS6;IFNAR1
prerank,regulation of glucose metabolic process (GO:0010906),0.5153430384105846,1.3611387531578532,0.0925,0.4747828443361317,1.0,12/34,13.77%,PDK4;ZNF692;GNMT;SDHAF3;IRS2;FOXK1;SIRT1;RORA;SIRT7;GPLD1;DGKQ;PRKN
prerank,bile acid metabolic process (GO:0008206),0.5396356240822069,1.36086133125277,0.10154241645244216,0.47488202415697683,1.0,4/27,2.16%,BAAT;AMACR;NPC1;OSBPL1A
prerank,regulation of mitotic spindle assembly (GO:1901673),0.570983394877437,1.360732329905482,0.13381294964028778,0.4744867101417321,1.0,8/19,16.59%,CHMP2A;HSPA1B;HNRNPU;EML3;PDCD6IP;TPR;HSPA1A;CHMP5
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4847159250514278,1.360597855499325,0.06944444444444445,0.47411016138933526,1.0,6/53,5.98%,HTR2B;HRH1;ANXA1;HTR6;XCR1;CNR2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4985474215509126,-1.3602576938852855,0.1180327868852459,0.4466805615429869,1.0,4/16,10.13%,MEF2C;PLCB1;RIPOR2;LRRC8A
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.55891383884268,-1.3594914257690498,0.11528150134048257,0.4458801152825859,1.0,5/10,14.72%,CACNB2;NOS1AP;PDE4B;NIPSNAP2;CACNA2D1
prerank,regulation of innate immune response (GO:0045088),0.4828045747783417,1.3592906200737636,0.07441860465116279,0.4772536958783633,1.0,22/57,20.36%,TLR8;APPL2;ADAM8;IFNAR2;RNASEL;IRAK3;RNF135;TKFC;XIAP;NLRC3;BIRC3;TRAFD1;APPL1;TREM2;FGR;N4BP1;TNFAIP3;ACOD1;PTPN1;BIRC2;FCGR2B;POLR3C
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.6401526226942715,1.3591869385930468,0.12643678160919541,0.4767504113017921,1.0,4/12,16.37%,BCL2L11;ERN1;BAX;PTPN1
prerank,membrane lipid catabolic process (GO:0046466),0.6480283258188139,1.358903064237169,0.11624203821656051,0.4767899561911735,1.0,4/10,12.21%,MGST2;SGPL1;PPT1;FUCA1
prerank,regulation of biomineral tissue development (GO:0070167),0.5459113666718178,1.3588182011582763,0.11703511053315994,0.4762579670881893,1.0,7/26,13.11%,CEBPB;ENPP1;SGMS2;SOX9;ROCK1;NOTCH1;GAS6
prerank,regulation of DNA binding (GO:0051101),0.5042414453672955,1.358523315180957,0.10132689987937274,0.47636561955032014,1.0,6/44,6.71%,PPARG;TXN;JUN;E2F1;IGF1;DOT1L
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5297439277980825,1.358462956558551,0.10602094240837696,0.4757619083632661,1.0,7/27,13.11%,AQP1;CDKN1A;PDGFA;E2F1;IGF1;S100A6;GAS6
prerank,PERK-mediated unfolded protein response (GO:0036499),0.655292051768158,1.358436167259164,0.14176829268292682,0.4750706207155705,1.0,6/10,22.77%,NFE2L2;ATF4;DDIT3;QRICH1;EIF2S1;HERPUD1
prerank,regulation of protein kinase B signaling (GO:0051896),0.43122579031210906,1.3580031134710038,0.014344262295081968,0.4755047905747559,1.0,32/193,9.91%,F7;OSBPL8;HPSE;GDF15;PIK3R5;XDH;GRB2;GCNT2;GAB2;TXN;HGF;CD28;PDPK1;PDGFA;P2RX4;PTEN;F10;FGFR4;THBS1;DAG1;IRS2;ADAM8;TRAT1;PIK3CA;FLCN;MFHAS1;VAV1;STRN;PLEKHA1;DDIT3;ITGB1;ESR1
prerank,positive regulation of glucose import (GO:0046326),0.5662220695304703,1.3577796931899073,0.11140583554376658,0.47532278248156756,1.0,3/21,5.76%,OSBPL8;IGF1;IRS2
prerank,regulation of Golgi organization (GO:1903358),0.5841421706587199,1.3574070655468622,0.10086455331412104,0.4757019511180614,1.0,3/17,6.57%,MYO5A;RAB33B;STX5
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4746471333198438,1.3573614832162995,0.0684931506849315,0.4750307438733301,1.0,7/66,5.77%,HTR2B;PIK3R5;SASH1;VEGFA;TAOK3;PDGFA;ADAM8
prerank,eosinophil migration (GO:0072677),0.6156967402670852,1.3572873624226467,0.11748251748251748,0.47367279954686853,1.0,1/14,0.11%,LGALS3
prerank,eosinophil chemotaxis (GO:0048245),0.6156967402670852,1.3572873624226467,0.11748251748251748,0.47367279954686853,1.0,1/14,0.11%,LGALS3
prerank,membrane repolarization during action potential (GO:0086011),-0.5231084735764862,-1.3572847316800392,0.12542372881355932,0.44824667067882545,1.0,2/13,4.60%,ATP1B1;KCNJ2
prerank,regulation of cell death (GO:0010941),0.4542698524045897,1.3566668125305026,0.05177993527508091,0.47472827637128434,1.0,27/94,18.30%,CD36;HTR2B;SPEF1;CCN5;LRP1;TNFRSF1B;CELF1;APC;CHMP2A;HSPA1B;PRODH;CTSZ;HP;HPR;SNCG;ATG5;CCN1;MT3;OLFM4;DUS2;PRKN;HSPA1A;BNIP3;RAB29;PRR7;ACER2;CCN2
prerank,diterpenoid metabolic process (GO:0016101),0.487544425149691,1.3560737345130671,0.07916181606519208,0.4757309756383321,1.0,6/55,5.06%,APOE;STRA6;DHRS3;LRP1;RBP1;RDH12
prerank,regulation of cell junction assembly (GO:1901888),0.5408310449624923,1.3560510926933416,0.0992462311557789,0.47502109903781076,1.0,8/27,12.57%,APLNR;PRKCH;FLOT1;PDLIM5;SNAI2;CBFB;ROCK1;RAPGEF1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6397152107349187,1.356050735588298,0.13221884498480244,0.47424237592463403,1.0,5/11,11.96%,P2RX4;LMNA;GLRX3;FOXO1;NOTCH1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.46920155712921646,1.3558918506943152,0.0639470782800441,0.47390269782856714,1.0,22/73,18.61%,MTCH1;PPARG;XDH;FAS;APAF1;RIPK1;ANP32B;NLRC4;DLC1;EGLN3;CYCS;CASP12;BAX;HSPD1;TRAF2;BID;HSPE1;ACER2;BBC3;SENP1;CASP2;CRADD
prerank,sphingoid biosynthetic process (GO:0046520),0.6440381959234996,1.3553295208754403,0.12985074626865672,0.4740006896003059,1.0,5/11,19.08%,SPTLC2;SPHK2;ABCA2;ACER2;ASAH1
prerank,sphingosine biosynthetic process (GO:0046512),0.6440381959234996,1.3553295208754403,0.12985074626865672,0.4740006896003059,1.0,5/11,19.08%,SPTLC2;SPHK2;ABCA2;ACER2;ASAH1
prerank,muscle contraction (GO:0006936),0.4446898653605394,1.3544574694245974,0.03433922996878252,0.47576753809283573,1.0,16/126,12.21%,MYOF;TPCN2;EDNRA;ADRA1A;VIM;SORBS3;MYL2;SLC8A1;KLHL41;TLN1;MYBPC3;TPM3;ROCK1;TPM4;SLC6A8;MYLK
prerank,glycolipid metabolic process (GO:0006664),0.4970148580521198,1.353656874178041,0.07821901323706378,0.47739249260654426,1.0,12/47,8.23%,PSAP;CERK;PGAP3;GALC;GLA;CTSA;ESYT1;HEXA;PGAP1;ARSA;ST3GAL4;ABCA2
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.37074246319585924,-1.3535795887077382,0.062146892655367235,0.4539851373800926,1.0,10/44,4.86%,BIN1;EVL;FCHSD2;SPIRE1;PRKCE;VASP;FER;HCK;NCKAP1;NCK1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.45254764799409214,1.3533237528082005,0.054429028815368194,0.47766464697748995,1.0,22/93,16.90%,SDCBP;SASH1;XDH;VEGFA;GADD45B;GADD45G;RELL1;TAOK3;RIPK1;GADD45A;MFHAS1;SH3RF1;HIPK2;FZD7;PTK2B;APP;TRAF1;TRAF3;TRAF5;TRAF2;LTBR;NCF1
prerank,thyroid hormone generation (GO:0006590),0.6507605774450465,1.3525979538183768,0.1293759512937595,0.47906680922176226,1.0,2/10,5.97%,CPQ;SLC5A5
prerank,regulation of kinase activity (GO:0043549),-0.32252902134994865,-1.3525268630689264,0.011363636363636364,0.453809337228259,1.0,28/89,19.05%,ERBB4;EPHA5;CSF1R;NTRK3;CAMKK2;EPHA6;RYK;MAPT;EPHA3;FGFR2;NTRK2;FLT3;TSPYL2;EGFR;VAC14;IGF1R;RAD50;EPHA7;LDB1;LDB2;ERBB3;RBL1;CD74;ANKRD54;TYRO3;FGFR3;ECT2;LMTK2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.4656050311711858,1.3524978853280003,0.06927374301675977,0.4785910302324152,1.0,24/67,22.96%,CD36;PSMD1;CYBB;CYBA;NCF2;PSMF1;PSMD14;PSMD12;NCF4;VAMP3;PSME2;NCF1;PSMB10;PSMD5;PSMD8;PSMA3;TAPBP;PSMA2;PSMD11;ITGAV;SNAP23;PSMA6;PSMB3;PSME3
prerank,integrin-mediated signaling pathway (GO:0007229),0.46391029439884135,1.3522524484255585,0.06762749445676275,0.4786161123510545,1.0,19/73,15.95%,PLPP3;SYK;NEDD9;TEC;PRAM1;ADAM9;ITGA5;CUL3;ITGB1;PTK2B;ITGA10;FBLN1;MYH9;DOCK1;COL3A1;FGR;ERBIN;LAMA3;NRP1
prerank,regulation of cellular catabolic process (GO:0031329),0.47579945511356386,1.3520294922138574,0.0651685393258427,0.47860776784080045,1.0,21/62,19.98%,PSAP;TPCN2;GPR137B;MTMR3;ABL2;ABCD1;DAPK1;WDR91;SCARB2;DCAF12;DDIT3;ROCK1;LONP2;PRKN;PIP4K2A;KEAP1;ACER2;DRAM2;VPS29;TYSND1;WDR41
prerank,glycosphingolipid metabolic process (GO:0006687),0.510845648350268,1.3519201762736457,0.08856088560885608,0.47816498931756923,1.0,15/42,16.79%,PSAP;CERK;GALC;GLA;CTSA;ESYT1;B4GALT6;HEXA;ARSA;ABCA2;A4GALT;GM2A;SUMF1;ESYT2;NEU1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5934108660059073,1.351367437077449,0.12517580872011252,0.4790515125094918,1.0,8/16,20.86%,STAM;CHMP6;SNF8;CHMP5;TMEM50A;CHMP7;LEPROTL1;VPS36
prerank,glucose homeostasis (GO:0042593),0.45693789829435627,1.3510741899554715,0.06311207834602829,0.4791868646879463,1.0,14/83,11.93%,PPARG;LRRC8D;PDK4;HK3;IL6;PYGL;TFAP2B;SLC8B1;APPL2;FGFR4;FOXK1;FOXO1;SIRT1;CYB5R4
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.624985638971508,1.351058413512083,0.11436950146627566,0.4784603519754587,1.0,2/12,2.39%,IQGAP1;MYO1E
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5516718678313475,1.3509453447985635,0.11580381471389646,0.4780520681055892,1.0,15/24,26.87%,IRAK2;RPS27A;UBC;TAB2;RNF34;TNFAIP3;UBE2V1;AAMP;IRAK1;TRAF6;CASP8;TAB1;MAP3K7;TAB3;CYLD
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.4997462721614011,1.3507102889132734,0.0856453558504222,0.47796709324224734,1.0,13/41,15.61%,LILRB1;RARA;IGF1;ARG2;NR1H4;IRAK3;SIRPA;NFKBIL1;NLRC3;GAS6;TNFAIP3;CX3CL1;LBP
prerank,central nervous system myelination (GO:0022010),0.6281422387496735,1.3506704590349214,0.1382488479262673,0.4773119489523057,1.0,4/11,8.23%,B4GALT5;PTEN;B4GALT6;ABCA2
prerank,axon development (GO:0061564),-0.32268232442678846,-1.350485859998439,0.021505376344086023,0.45602510251931644,1.0,26/78,19.05%,RTN4RL1;SEMA5A;CTNNA2;NTNG1;DCC;RYK;MAPT;ANK3;CNTN4;FGFR2;PARD3;CDK5R1;SPTBN4;PAX2;MARK2;RAB8A;KLF7;SVBP;GRM7;BRSK1;SLITRK5;SLITRK3;DHFR;ADGRB1;S100B;LMTK2
prerank,RNA polyadenylation (GO:0043631),0.5392167514581311,1.35036092311801,0.11772486772486772,0.4767425228392128,1.0,9/26,15.74%,CPSF1;TENT4B;CSTF3;WDR33;TENT2;GRSF1;APP;SSU72;CDC73
prerank,mRNA polyadenylation (GO:0006378),0.5392167514581311,1.35036092311801,0.11772486772486772,0.4767425228392128,1.0,9/26,15.74%,CPSF1;TENT4B;CSTF3;WDR33;TENT2;GRSF1;APP;SSU72;CDC73
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.46983094831039396,1.3503372378047853,0.0665163472378805,0.47604649905613733,1.0,10/63,5.76%,CD38;VAV3;ANXA1;NCK2;TFRC;IL6;CD28;CD46;CD274;IRS2
prerank,cellular response to ketone (GO:1901655),0.5125164947735668,1.349312336771937,0.0962962962962963,0.4783424342121324,1.0,12/35,14.55%,AQP1;SPP1;NR3C1;SPHK2;PTGER2;NCOA4;MSN;PTGER4;ADCY8;ADCY3;ACOD1;GOLPH3
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6071613001894879,1.349309058333581,0.12125748502994012,0.4775970126722189,1.0,4/13,13.11%,LAMP1;TYROBP;AP1G1;GAS6
prerank,negative regulation of response to wounding (GO:1903035),-0.4572523686388975,-1.349223157880587,0.11702127659574468,0.45647504895379326,1.0,5/19,16.89%,RTN4RL1;CASK;FGF2;GIT1;CRK
prerank,urogenital system development (GO:0001655),0.6376383971807066,1.3485489178198697,0.13650306748466257,0.47907815319179115,1.0,3/11,9.89%,ANXA1;SOX9;PAX8
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5137759754565239,1.3482654045096918,0.10596833130328867,0.47915241808812714,1.0,10/32,11.57%,SAMD8;PRKCD;FOXO3;ATXN2;NR1H4;PUM3;PICALM;ROCK1;MTPN;APP
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5547746440690203,1.347726569059669,0.12757201646090535,0.4799769115483251,1.0,9/20,18.52%,CELF1;AGO2;EIF6;TNRC6B;CNOT7;AGO3;LIMD1;CNOT6;AGO4
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5871948521501092,1.3469832210876016,0.12917271407837447,0.48149283314260244,1.0,6/18,12.95%,AOAH;MANBA;DERA;OGA;FUCA1;FBXO6
prerank,RNA catabolic process (GO:0006401),0.48982186442994724,1.3465355404904122,0.08731082654249127,0.4820643997125071,1.0,23/46,25.95%,ERN1;RNASE3;HSPA1B;ZFP36L2;AGO3;SND1;HSPA1A;SIDT2;RNASEH2A;HNRNPD;RNASEH1;RNH1;MTREX;AGO4;EXOSC7;RNASEH2B;PABPC4;LSM5;ZC3H12D;XRN2;LSM6;ZFP36;RIDA
prerank,membrane lipid biosynthetic process (GO:0046467),0.47493946727178726,1.3464924156243903,0.08239277652370203,0.48145139457342306,1.0,18/58,17.45%,PLPP3;SPTLC2;SAMD8;SGPL1;CERT1;SGMS2;HACD4;CERS6;SPHK2;ST3GAL4;SPTSSA;VAPA;ELOVL1;ALDH3A2;DEGS1;PRKD3;SGMS1;ACER2
prerank,positive regulation of catalytic activity (GO:0043085),0.5047814342962696,1.3464622654158047,0.08784596871239471,0.4807869236126049,1.0,12/37,15.22%,ABL2;CHTOP;FGFR4;XRCC4;XRCC5;MT3;BCAS3;WRN;SSBP1;PHACTR4;NCSTN;ATP7A
prerank,dopaminergic neuron differentiation (GO:0071542),0.5674922977153448,1.3464533429159378,0.14657534246575343,0.480053461060276,1.0,2/19,1.73%,CTNNB1;VEGFA
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6242353602202316,1.3463672357354433,0.12682215743440234,0.4780725405307512,1.0,3/12,8.04%,NSMCE2;CUL3;RB1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6242353602202316,1.3463672357354433,0.12682215743440234,0.4780725405307512,1.0,3/12,8.04%,NSMCE2;CUL3;RB1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6242353602202316,1.3463672357354433,0.12682215743440234,0.4780725405307512,1.0,3/12,8.04%,NSMCE2;CUL3;RB1
prerank,neurotransmitter transport (GO:0006836),-0.3352710134499413,-1.3462753226392463,0.050505050505050504,0.4601481595921606,1.0,15/73,6.68%,NRXN1;SYT1;CASK;RIMS1;SLC1A3;ATP1A2;SYN2;GABRA2;PTPRN2;LIN7A;SLC17A6;SNAP25;SLC6A15;SLC1A2;PPFIA4
prerank,lipid modification (GO:0030258),0.49850325793404543,1.3462548941819843,0.08982035928143713,0.47760948815009197,1.0,8/37,13.29%,PLPP3;PLA2G7;DGKZ;DGKA;PLPP6;PLPP5;LPCAT3;DGKQ
prerank,amide transport (GO:0042886),0.5351109626933899,1.3461776273485815,0.11719745222929936,0.4770981890546461,1.0,6/26,8.86%,CERT1;PLTP;FOLR2;FOLR1;SLC27A1;SLC25A32
prerank,cellular macromolecule catabolic process (GO:0044265),0.49192995219457614,1.3459982020105292,0.08032596041909197,0.4769165101470884,1.0,16/49,14.95%,RIPK1;RNASE3;HTRA2;MANBA;DFFB;RAB12;DNASE1L1;OGA;SND1;FBXO6;PRKN;SIDT2;RNASEH2A;HNRNPD;RNASEH1;MTREX
prerank,myeloid leukocyte differentiation (GO:0002573),0.4602377650106742,1.3458936565399071,0.07967667436489607,0.4764430122207896,1.0,14/65,12.31%,PPARG;GAB2;VEGFA;SNX10;CDKN1A;RXRA;RARA;E2F1;FOXP1;TYROBP;SIRT1;IL15;MYH9;TREM2
prerank,negative regulation of receptor internalization (GO:0002091),0.6310381626257099,1.345837330066343,0.11944869831546708,0.4758912135717456,1.0,5/12,15.10%,SDCBP;ATXN2;RIN3;ANKRD13D;UBQLN2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5719585499924893,1.3456166050686906,0.11020408163265306,0.475825321935925,1.0,4/19,5.76%,PRKCD;ABCD1;MTLN;IRS2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.4303923348667867,1.345467430145878,0.022357723577235773,0.4755783349353586,1.0,37/182,11.96%,SDCBP;APLNR;APOBEC1;XDH;APOE;OPTN;VEGFA;TIPARP;FBXW7;ID2;CD28;CD46;NOTCH2;CELF1;ATXN2;CITED2;IGF1;AGO2;TRAT1;FLCN;REL;RB1;WWP2;ZNF148;FOXP1;ACVRL1;PICALM;TNRC6B;ESR1;CNPY2;RIN3;CNOT7;AGO3;SIRT1;ANKRD13D;APP;NOTCH1
prerank,cellular response to acid chemical (GO:0071229),0.5392749976100836,1.3450734212914615,0.11139896373056994,0.4759672632766242,1.0,8/27,13.19%,VEGFA;IPO5;CPEB4;SESN2;CAPN2;LAMTOR1;SLC38A9;LAMTOR3
prerank,regulation of primary metabolic process (GO:0080090),0.44110104465069244,1.3450067137191726,0.035751840168243953,0.47541640865974694,1.0,44/126,23.06%,PSAP;PPARG;APOE;ID2;FASN;PSMD1;RXRA;NCOR1;FGFR4;MVD;IRS2;CREBBP;IDI1;TBL1XR1;NCOA1;OAZ2;PSMF1;PPARD;PSMD14;PSMD12;PSME2;AZIN1;PMVK;SCD;SC5D;OAZ1;PSMB10;PSMD5;NFYC;PSMD8;NCOA6;PSMA3;NCOA2;HMGCR;PSMA2;PSMD11;SREBF1;SIN3A;PSMA6;PSMB3;ADIPOR1;PSME3;ABCA7;CERS2
prerank,regulation of calcium ion import (GO:0090279),0.5609295659110272,1.344846561995659,0.12947658402203857,0.475152186233257,1.0,3/21,6.29%,LGALS3;CTNNB1;SPHK2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.47783939846991913,1.3441507424037182,0.09132947976878612,0.4765120556956738,1.0,16/54,14.97%,HPSE;GCNT2;XYLT1;NDST1;GNS;EXT1;UGDH;B4GALT7;HEXA;HS2ST1;IDUA;FUCA1;SGSH;SDC4;HS3ST2;GUSB
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5940062726312878,1.3430442706840007,0.1379800853485064,0.47915557945531106,1.0,4/14,8.89%,ADSL;IMPDH2;PPAT;LHPP
prerank,protein import (GO:0017038),0.4498126144234149,1.3429444956902186,0.05758582502768549,0.4787261349762805,1.0,18/84,12.83%,MMP12;APOE;SYK;IPO5;RAB8B;E2F3;ABCD1;APPL2;PEX14;LAMP2;TPR;SNX33;NUP50;ALDH3A2;TNPO1;PXMP2;APPL1;GDAP1
prerank,glutathione biosynthetic process (GO:0006750),0.6350423224423805,1.3425017138415598,0.14499252615844543,0.4793033940487334,1.0,4/11,17.61%,MGST2;CNDP2;HAGH;OPLAH
prerank,endomembrane system organization (GO:0010256),0.43256000459767735,1.3423039870173443,0.026449643947100712,0.4791232480578633,1.0,53/178,19.70%,MYOF;ARHGAP21;OPTN;PLEKHM2;PHETA2;HOOK3;SNX10;REEP4;RNF26;ATP8B4;NPLOC4;GAK;COG7;VMP1;FER1L6;TICAM2;VAPA;HUWE1;A4GALT;VPS4A;LAMTOR1;SNX33;BCAS3;TRIP11;PI4K2A;VPS51;AP3D1;ARFGEF2;LEMD3;RAB43;ATL2;DYM;ATP8B1;PLEKHJ1;CLASP1;ATL1;SQSTM1;GOLPH3;VPS11;GOLPH3L;DNAJC13;USP8;RAB2A;RAB29;RAB22A;COG2;TMEM170A;ALS2CL;HTT;ARFGEF1;WASHC5;SEC31A;RAB1A
prerank,regulation of leukocyte migration (GO:0002685),0.5918140779882708,1.3419784119223948,0.1301859799713877,0.4793765865318164,1.0,3/16,7.11%,ANXA1;VEGFA;HMOX1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.5591116710725617,1.341318197166727,0.11588541666666667,0.4806033575415172,1.0,8/21,20.25%,HK3;PGD;TALDO1;SHPK;DERA;RPIA;RBKS;GCK
prerank,positive regulation of cell death (GO:0010942),0.4750189578070336,1.3410789577179294,0.08256880733944955,0.48050338367355017,1.0,13/59,11.23%,CD36;SLC6A6;LRP1;RIPK1;CELF1;APC;PRODH;HP;HPR;TYROBP;PICALM;GSK3B;MT3
prerank,2-oxoglutarate metabolic process (GO:0006103),0.613139992512876,1.3405783126588529,0.12667660208643816,0.4812500483487419,1.0,2/13,4.10%,IDH1;D2HGDH
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.4475481216178303,-1.3402031518319004,0.11740890688259109,0.4716894531086008,1.0,8/22,14.94%,NTRK3;ACAP2;MAPT;MAGI2;NTRK2;EHD1;STMN2;RAPGEF2
prerank,regulation of RNA metabolic process (GO:0051252),0.4701091653191979,1.3392903773779756,0.08870967741935484,0.4842645848729595,1.0,17/59,15.76%,HNRNPLL;MITF;AHNAK;HNRNPH2;MBNL1;TNFRSF1B;CELF1;IGF2BP3;AHNAK2;GRSF1;PTBP3;PTBP2;PQBP1;PRX;USP36;PCBP1;MBNL2
prerank,P-body assembly (GO:0033962),0.6230597527848913,1.339234611228453,0.1441717791411043,0.48368472384039113,1.0,6/12,16.18%,DYNC1H1;DDX6;ATXN2;PATL1;LIMD1;EDC3
prerank,macroautophagy (GO:0016236),0.4405253674579924,1.3392021731217092,0.04535864978902954,0.4830661907366733,1.0,45/118,23.49%,PLEKHM1;MTMR3;ATG7;PRKAG2;SNAP29;TCIRG1;TECPR1;UVRAG;CLN3;ATG10;STAM;VTI1B;CHMP2A;TOMM20;AMBRA1;LAMP2;VPS33A;CSNK2A2;VPS4A;ARL8B;EPG5;ATG5;FUNDC1;CHMP6;ATG4B;ATG13;VDAC1;PRKN;SQSTM1;SNX14;SNF8;STAM2;PIP4K2A;CSNK2A1;TOMM7;TOMM22;ACBD5;PLAA;VPS36;CHMP2B;VPS37B;VCP;MFN2;MTERF3;KLHL3
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.46487043759694696,1.338651375074185,0.07231638418079096,0.4839969867593587,1.0,22/69,14.28%,POLR2A;GTF2B;INTS9;TAF5;POLR2L;RPAP2;INTS6;SNAPC1;INTS1;POLR2G;INTS13;INTS8;CDK7;POLR2I;NCBP2;GTF2F2;INTS2;INTS5;INTS7;ICE2;POU2F1;GTF2A1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5500566592977948,1.337962861433164,0.12771739130434784,0.48525045000477085,1.0,2/21,1.42%,CEL;LPIN3
prerank,glycoprotein biosynthetic process (GO:0009101),0.4549068151859528,1.3371379739901659,0.06541019955654102,0.48704177870355003,1.0,14/79,7.36%,B4GALT5;B3GNT8;GCNT2;NPC1;XYLT1;TMEM106A;TNIP1;B4GALT7;IGF1;DDOST;COG7;DAD1;B3GALNT2;ST3GAL4
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4688403449866503,-1.336811304692122,0.12367491166077739,0.47704245451533994,1.0,6/18,8.98%,ACVR1;BMPR1A;TGFBR2;ENG;MDM4;TGFB2
prerank,regulation of lipid metabolic process (GO:0019216),0.45131794607130893,1.3367893617757534,0.06907894736842106,0.4874231945945597,1.0,32/88,23.85%,PSAP;PPARG;PRKAG2;ID2;FASN;RXRA;NCOR1;FGFR4;MVD;IRS2;CREBBP;IDI1;TBL1XR1;NCOA1;PPARD;RORA;PANK2;PMVK;SCD;SC5D;NFYC;NCOA6;NCOA2;HMGCR;SREBF1;SIN3A;DISP3;ADIPOR1;ABCA7;CERS2;EDF1;MBOAT7
prerank,regulation of pseudopodium assembly (GO:0031272),0.6481845755852977,1.3357967877273285,0.14992272024729522,0.4887402993443882,1.0,2/10,6.49%,WASHC1;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6481845755852977,1.3357967877273285,0.14992272024729522,0.4887402993443882,1.0,2/10,6.49%,WASHC1;APC
prerank,dendrite morphogenesis (GO:0048813),-0.38126845650763663,-1.3357076637689775,0.07614213197969544,0.476838035802631,1.0,23/35,33.33%,CTNNA2;MEF2A;PHACTR1;CTNND2;BTBD3;MAP2;FARP1;KLF7;CELSR2;ABITRAM;TAOK2;DIP2A;MAPK8IP2;PAK3;DCDC2;MAP6;SHANK1;CHRNA7;WNT7A;PTN;EPHB3;SHANK3;SDC2
prerank,actin nucleation (GO:0045010),0.5625465142722887,1.3352063234819944,0.11994609164420485,0.48974202245105336,1.0,9/21,22.32%,IQGAP2;ARPC2;WASHC1;ACTR3;WHAMM;ARPC1A;ARPC4;ARPC5L;ARPC5
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5446837360467545,-1.334650992766443,0.13622291021671826,0.476451000188899,1.0,3/11,8.98%,BMPR1A;ZFPM2;TGFB2
prerank,positive regulation of organelle assembly (GO:1902117),0.4892617775327752,1.3341486549299366,0.1050767414403778,0.492224529287236,1.0,14/44,16.67%,SDCBP;LCP1;DYNC1H1;SH3GLB1;ASAP1;CAPG;RAB3GAP2;PDCD6IP;IL5;CNOT6L;SDC4;CNOT6;CCP110;PIP4K2A
prerank,regulation of necroptotic process (GO:0060544),0.5538616156847525,1.3334648245061054,0.11788079470198676,0.49357086262999095,1.0,7/23,11.54%,SDCBP;FLOT1;RIPK1;PDCD6IP;BIRC3;ARHGEF2;STUB1
prerank,protein acylation (GO:0043543),0.5012671875867847,1.3332231308205513,0.10319410319410319,0.4935732029504709,1.0,15/38,21.79%,ZDHHC14;ZDHHC16;GTF2B;CREBBP;ZDHHC12;ZDHHC18;NAT10;FOXO1;ING4;NAA10;ZDHHC17;NAT9;CLOCK;NAA80;KAT2A
prerank,hydrogen peroxide catabolic process (GO:0042744),0.629750282864135,1.3326991858796393,0.1634182908545727,0.494413520180562,1.0,3/11,7.52%,PRDX1;GPX3;CAT
prerank,activation of GTPase activity (GO:0090630),0.4486759142973936,1.332632216198305,0.06479481641468683,0.4939076751592064,1.0,16/89,11.43%,ARHGAP24;ABR;TBC1D22A;CORO1C;TBC1D25;TBC1D1;TBC1D2;TBC1D12;RALGAPA2;SLC27A4;TBC1D10A;TBC1D2B;TBC1D22B;CCDC125;TBC1D15;BCAS3
prerank,regulation of microtubule polymerization (GO:0031113),-0.3713174230575653,-1.3323904977912968,0.08333333333333333,0.4791985350502831,1.0,11/40,15.67%,NAV3;MAPT;CDK5R1;MAP2;TUBB4A;PAK1;AKAP9;NUMA1;STMN2;MAPRE1;STMN1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.637392287963074,1.3319146234818346,0.166412213740458,0.4940697363233513,1.0,3/10,12.63%,TERF1;NBN;WRN
prerank,t-circle formation (GO:0090656),0.637392287963074,1.3319146234818346,0.166412213740458,0.4940697363233513,1.0,3/10,12.63%,TERF1;NBN;WRN
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.637392287963074,1.3319146234818346,0.166412213740458,0.4940697363233513,1.0,3/10,12.63%,TERF1;NBN;WRN
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5858810353074155,1.3317837321944237,0.12349397590361445,0.49298917008775556,1.0,4/15,10.25%,AGO2;ZFP36L2;TNRC6B;CNOT7
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5858810353074155,1.3317837321944237,0.12349397590361445,0.49298917008775556,1.0,4/15,10.25%,AGO2;ZFP36L2;TNRC6B;CNOT7
prerank,response to estradiol (GO:0032355),0.5197387557155934,1.3315557451084266,0.1119496855345912,0.4929726592300343,1.0,8/31,12.74%,ANXA1;CTNNB1;STAT5B;LCOR;NCOA3;ESR1;STRN3;FAM210B
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.468307195650439,1.3315495328743476,0.10080183276059565,0.4922610066634743,1.0,23/61,22.96%,PDK4;PRKAG2;PSMD1;FGFR4;NR1H4;OAZ2;SIRT1;PSMF1;PSMD14;PSMD12;PSME2;AZIN1;PANK2;OAZ1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3
prerank,monocyte differentiation (GO:0030224),0.6297124065703985,1.331154775068854,0.1621212121212121,0.49259571273274283,1.0,2/10,1.73%,PPARG;VEGFA
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.6290828534783528,1.3308377103058817,0.13875598086124402,0.49289327794639853,1.0,4/11,12.64%,SOAT1;AGO2;ABCA2;ITM2C
prerank,postsynaptic membrane organization (GO:0001941),0.5831367640389545,1.3302040129043449,0.13389121338912133,0.4941123476208398,1.0,2/17,0.58%,CEL;APOE
prerank,response to steroid hormone (GO:0048545),0.5092726174135342,1.3297865679013914,0.11518987341772152,0.4946908151620074,1.0,7/31,8.23%,NR1H3;CATSPERB;UBE2L3;THBS1;NR3C1;CATSPER2;ABCA2
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4206144171309708,-1.329737491914695,0.12757201646090535,0.482681304520217,1.0,7/24,8.61%,TENM2;GPM6A;NLGN1;PLPPR5;RIPOR2;FMR1;AGRN
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5245072076430043,1.3292238996838648,0.11082138200782268,0.49570419532220517,1.0,10/28,17.42%,FBXW7;NIBAN2;MMP14;RITA1;LFNG;WWP2;TSPAN15;ARRB1;EGFL7;ZBTB7A
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4721986207996658,1.3290713921442234,0.1011764705882353,0.4954052629224223,1.0,18/52,18.05%,MICALL2;NPEPPS;FBXW7;SH3GLB1;E2F1;HTRA2;UBE2L3;HUWE1;CSNK2A2;ARIH2;PPP3R1;FZD5;ATG13;VPS11;USP36;BID;BBC3;TOMM7
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5136877086109704,1.3288971656406583,0.12747524752475248,0.4952074259246888,1.0,6/32,9.43%,APOE;PDK4;PRKAG2;EIF6;ZBTB20;NR5A1
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.5573688174742657,-1.3283478044471622,0.15469613259668508,0.48326443411819375,1.0,6/10,44.28%,SAG;GNB1;PDE6G;PDE6B;PDE6A;CNGB1
prerank,neuron projection extension (GO:1990138),0.5074382380237915,1.3279148047751836,0.10134310134310134,0.4974764428425574,1.0,7/32,7.01%,IQGAP1;CTNNB1;ALCAM;SPG11;NRP2;TNN;EIF2AK4
prerank,regulation of lipid storage (GO:0010883),0.5465889584203549,1.327508068986829,0.1375166889185581,0.4979653329432426,1.0,5/22,10.68%,IKBKE;FBXW7;IL6;FTO;SIRT1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5504192339658895,1.32714795933657,0.135752688172043,0.4983247166078894,1.0,6/21,9.53%,NCK2;PTEN;GADD45A;GPD1L;CNKSR3;NLRP2B
prerank,protein targeting to membrane (GO:0006612),0.4473464971878897,1.3265724787341244,0.07399347116430903,0.49928991017825247,1.0,29/83,22.04%,SDCBP;PIKFYVE;ZDHHC14;ZDHHC19;RAB8B;ABCD1;YIF1B;PEX14;MICALL1;ZDHHC12;GET3;ZDHHC18;NACA;SIL1;ALDH3A2;PXMP2;GDAP1;RABGEF1;ZDHHC24;NCF1;ZDHHC4;SGTA;SEC63;ICMT;ACBD5;SLC25A17;ARL6IP1;VPS37B;PXMP4
prerank,regulation of programmed cell death (GO:0043067),0.42946503762615096,1.3262118125423097,0.03790983606557377,0.49963299096916547,1.0,47/161,20.17%,CTSB;SGK1;BCL2L11;STEAP3;TGM2;FAS;APAF1;DAPK1;RIPK1;RAF1;OSGIN1;ACTN1;AIFM2;HS1BP3;CREBBP;ANP32B;NLRC4;USP42;NF2;SOX9;FBXO11;PAX8;BIRC3;SIRT1;OLFM4;WRN;OMA1;PRKN;BAX;JAK3;USP36;RTN4;CASP6;BNIP3;TRAF2;BID;GAS1;ZBTB7A;ACER2;BIRC2;CASP2;CRADD;ASAH1;WFS1;BCL3;AKT1S1;AMIGO2
prerank,positive regulation of cell motility (GO:2000147),0.4214429342408117,1.3260613289404957,0.02131979695431472,0.4994100280775526,1.0,36/205,12.60%,GPNMB;F7;SDCBP;NEDD9;GCNT2;VEGFA;RUFY3;ARHGEF39;ADAM9;MGAT5;HGF;WASHC1;PDGFA;CD151;SEMA4B;MMP14;IGF1;F10;THBS1;COL1A1;APC;CFAP20;GTSE1;SNAI2;CTSH;PPP3CA;PLAU;ITGB1;ADAM17;RHOD;PTK2B;CCN1;NOTCH1;MYLK;SPAG9;MAZ
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4537544592775439,1.325347156390926,0.07760532150776053,0.5008774911839794,1.0,23/70,20.63%,CD36;PSMD1;CYBB;CYBA;NCF2;PSMF1;PSMD14;PSMD12;NCF4;VAMP3;PSME2;LNPEP;NCF1;PSMB10;PSMD5;PSMD8;PSMA3;TAPBP;PSMA2;PSMD11;ITGAV;SNAP23;PSMA6
prerank,negative regulation of secretion by cell (GO:1903531),0.4956286683491279,1.3250062224056092,0.1166464155528554,0.5011783781655104,1.0,13/38,19.66%,APOE;LILRB1;ANXA1;SERGEF;RHBDF2;TNFRSF1B;TRH;NOTCH1;VAMP3;HTR1B;HMGCR;SLC30A1;OSM
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.4737257408056637,1.3249986211882265,0.10677382319173363,0.5004845601384988,1.0,11/54,10.68%,PPARG;APOE;VEGFA;PDPK1;P2RX4;THBS1;GADD45A;ACVRL1;ADAM17;ATP5F1A;SIRT1
prerank,amyloid-beta metabolic process (GO:0050435),0.5796557088716263,1.3249501259196312,0.16596931659693165,0.49990774294485774,1.0,9/16,23.00%,NAT8;DYRK1A;BACE1;NCSTN;ACE;APEH;APH1B;PSEN2;ABCA7
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5831292629276648,1.3246743957133942,0.13603473227206947,0.5000688349767175,1.0,7/16,19.84%,LILRB1;FOXP3;CD274;TYROBP;JAK3;TNFRSF21;FCGR2B
prerank,positive regulation of protein ubiquitination (GO:0031398),0.4485847023595545,1.3245704320421774,0.08879023307436182,0.4996868774185395,1.0,34/80,24.05%,FBXW7;ARRDC4;UBE2L3;SPSB4;CUL3;BRCA1;XIAP;TOPORS;HUWE1;DCUN1D5;BIRC3;STUB1;DCUN1D3;NSMCE3;DCUN1D4;CENPX;DCUN1D1;CRY1;PHF23;BIRC2;MYCBP2;WFS1;PAXIP1;ARRDC3;PEF1;FANCM;HSPBP1;FKBP1A;MALT1;SPRTN;BCL10;TRAF6;FBXO4;NDFIP1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.48412135637604714,1.323901318728364,0.10463733650416171,0.5010019473858425,1.0,8/47,7.55%,PPARG;CEBPB;ID2;ASXL2;PIM1;HNRNPU;METRNL;RREB1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5676279678531736,1.3236733257734394,0.1360544217687075,0.5010009789007179,1.0,9/20,20.71%,SDCBP;FLOT1;RIPK1;PDCD6IP;BIRC3;STUB1;BIRC2;ASAH1;OGT
prerank,sensory perception (GO:0007600),-0.36221205446555227,-1.3235678995911253,0.06060606060606061,0.49193839847334453,1.0,9/45,10.30%,WHRN;PCDH15;CDH23;OPRM1;MYO7A;TMEM150C;GNAL;SCN9A;ADGRV1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.626152069216003,1.3231646832339785,0.14733542319749215,0.5017892109155282,1.0,1/11,1.09%,TAS1R3
prerank,positive regulation of immune system process (GO:0002684),0.5625158808361121,1.322742406812397,0.1593172119487909,0.5023208046397927,1.0,2/16,1.73%,ANXA1;VEGFA
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6230415368569157,1.3224901776418108,0.1640378548895899,0.5023939002040475,1.0,5/10,22.79%,TAF7;BRCA1;SIRT1;NOC2L;CTBP1
prerank,regulation of integrin activation (GO:0033623),0.5898567489984392,1.3223081868077873,0.1564245810055866,0.50224080060593,1.0,3/15,10.72%,FBLIM1;PTGER4;PIEZO1
prerank,nucleic acid metabolic process (GO:0090304),0.4542587687188007,1.3209226996905605,0.09634551495016612,0.5056712002116134,1.0,21/69,15.96%,POLR2A;WTAP;HNRNPH2;ENPP1;KPNA2;ATXN2;HNRNPU;POLR2L;NT5E;HNRNPA0;WDR74;POLR2G;DNASE1L1;POLR2I;NCBP2;HNRNPM;GTF2F2;WRN;HNRNPD;PCBP1;DNASE2
prerank,cellular protein metabolic process (GO:0044267),0.4195504046426645,1.3207622379803359,0.007021063189568706,0.5053961565898651,1.0,95/396,17.47%,SFTPA1;SFTPA2;MFGE8;APOE;MSRA;TIMP1;RPL3L;KLK3;ITIH2;SPP1;IL6;MSRB1;ABL2;TNIP1;APLP2;FAM20C;D2HGDH;RIPK1;PARP4;CLN5;B4GALT7;IGF2BP3;GNMT;IGF1;HTRA2;UBE2L3;EEF1A1;AGO2;RPL18A;MRPL11;RPS14;MANBA;PROC;PIGH;RPS11;CSF2RB;RPS27A;MRPL23;RPL17;RPL23;DARS1;PPP4R2;ABCA3;WWP2;FBXO11;CTSH;RPL36A;EIF4EBP2;COPS5;QSOX1;MRPS7;FSTL1;RAB12;RPL22;RPS21;RRBP1;ADAM17;LTA4H;MRPL32;CCN1;MRPL36;HM13;IGFALS;APP;SARS1;STK38;RPL10A;CSF2RA;MRPL28;DHPS;OMA1;UBA3;FBXW2;GAS6;RPS26;PRKN;MRPS21;SPCS2;SERPINC1;SRBD1;MCRS1;NUCB1;MRPL35;RPL15;RPL10;NCSTN;RPSA;CDC34;PARL;MELTF;MRPL43;RPL7;UBE2M;RPL26;TTF1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.6018853123683267,1.3204878084511928,0.16224188790560473,0.5055153369444667,1.0,4/13,7.55%,PIM1;HNRNPU;METRNL;RREB1
prerank,positive regulation of cell migration (GO:0030335),0.41646486441899816,1.3202033291912767,0.01812688821752266,0.5056820268497796,1.0,56/253,16.02%,GPNMB;F7;SDCBP;NEDD9;GCNT2;VEGFA;KIF20B;RUFY3;ARHGEF39;ADAM9;MGAT5;HGF;WASHC1;PDGFA;CD151;SEMA4B;DOCK5;MMP14;IGF1;F10;THBS1;COL1A1;AGO2;APC;NIPBL;GTSE1;RREB1;SOX9;SNAI2;CTSH;PPP3CA;BMPR2;PLAU;ITGB1;ADAM17;RHOD;PTK2B;ARHGEF2;CCN1;ACVR1B;NOTCH1;PFN1;MYLK;DOCK1;SPAG9;MAZ;FGR;CAPN7;CLASP1;CXCL12;RTN4;CCL7;GRN;NRP1;MIEN1;SEMA3B
prerank,positive regulation of cytokine production (GO:0001819),0.4168668150195323,1.3200759435053184,0.00802407221664995,0.5053545557276468,1.0,53/292,13.96%,CCBE1;HTR2B;HPSE;RFTN1;SYK;RAB7B;TLR8;LILRB1;ANXA1;CTNNB1;FLOT1;CEBPB;PIBF1;IL6;CD28;CD46;TMEM106A;LY9;CD274;RIPK1;RARA;SORL1;NR1H4;SPHK2;CREBBP;HSPA1B;ATF4;HMOX1;SULF2;CYBA;BRCA1;POLR2L;FOXP1;TYROBP;IL6R;DDIT3;XRCC5;PTGER4;MAVS;ADAM17;ARHGEF2;APP;FZD5;RORA;PQBP1;IL15;APPL1;AFAP1L2;SULF1;RELA;FGR;SLC11A1;HSPA1A
prerank,negative regulation of axon extension (GO:0030517),-0.4036433030959223,-1.3199046008343147,0.10572687224669604,0.4978160525204426,1.0,10/30,12.08%,SEMA5A;MAG;RNF6;MAP2;SEMA4G;SEMA3E;DIP2B;SEMA3A;CDKL3;SEMA6A
prerank,regulation of receptor internalization (GO:0002090),0.5009215736409435,1.319746567935233,0.1073170731707317,0.5056308818776829,1.0,7/35,11.34%,SDCBP;VEGFA;FLOT1;CD63;ATXN2;RIN3;ANKRD13D
prerank,positive regulation of interleukin-8 production (GO:0032757),0.47878905235445135,1.3194109385252764,0.10688836104513064,0.5059569670397777,1.0,13/49,16.60%,SYK;TLR8;IL6;RIPK1;HSPA1B;DDIT3;MAVS;AFAP1L2;RELA;HSPA1A;LBP;MYD88;TLR1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5811614919190355,1.3191829200781766,0.14893617021276595,0.5058972018739694,1.0,3/16,6.73%,GPR137B;SIK3;FLCN
prerank,blood vessel diameter maintenance (GO:0097746),0.5098191449941735,1.3181932580908389,0.12280701754385964,0.508105158508108,1.0,2/34,1.12%,HTR2B;EDNRA
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.632901078304172,1.318113090035933,0.1476407914764079,0.5076486378528619,1.0,4/10,12.11%,ACD;TFIP11;RTEL1;DCLRE1B
prerank,regulation of dendrite extension (GO:1903859),-0.4640583738842854,-1.3180871214328596,0.15658362989323843,0.499218318413249,1.0,6/18,8.19%,SYT1;RIMS1;RIMS2;SMURF1;SYT2;SYT4
prerank,RNA stabilization (GO:0043489),0.5057386813756843,1.317574936129663,0.12356687898089172,0.508557317837821,1.0,11/33,17.11%,TRDMT1;E2F1;TENT5A;HNRNPU;TENT2;DKC1;SLC11A1;TENT5D;GDNF;THRAP3;TAF15
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.48968477518310777,1.3172239406885458,0.10731132075471699,0.5089028898922019,1.0,13/43,15.93%,ERN1;ID2;IL6;JUN;IGF1;THBS1;HMOX1;FOXP1;IL6R;RBPMS2;HTR1B;CX3CL1;DNMT1
prerank,glucose metabolic process (GO:0006006),0.4685624140680635,1.3170978288484605,0.10356731875719218,0.5085631322986895,1.0,19/58,22.83%,SORD;TPI1;AKR1A1;TFAP2B;SLC25A1;IRS2;ATF4;ENO3;SLC39A14;PPARD;PGM1;OMA1;CRY1;APOD;GAPDHS;MDH1;GALM;SLC37A4;SLC25A13
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.43358654667337615,-1.3169459294451213,0.1198501872659176,0.4992799912535159,1.0,6/22,6.49%,PPM1E;DUSP6;PPP5C;PPM1F;PPP2CB;DUSP7
prerank,leukocyte tethering or rolling (GO:0050901),-0.4648128402632475,-1.3169035034146879,0.13513513513513514,0.4967733615140516,1.0,4/17,5.39%,CX3CR1;SELPLG;JAM2;ADD2
prerank,lipid oxidation (GO:0034440),0.5995423859406345,1.316246191296171,0.17142857142857143,0.5103689562279021,1.0,1/12,0.36%,PLA2G7
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5696744843845586,1.3161056440629744,0.13994565217391305,0.5101294850653334,1.0,9/19,18.86%,ACD;TENT4B;HNRNPU;NAT10;TERF1;TEN1;STN1;EXOSC10;GNL3L
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5547717896728195,1.315796007240131,0.13908205841446453,0.510406820246311,1.0,6/19,11.57%,TMEM106A;MAP2K5;MAPK7;PAX8;MTPN;APP
prerank,regulation of extracellular matrix organization (GO:1903053),0.5901312540105599,1.3153890829696318,0.16235632183908047,0.5109354134009467,1.0,5/15,11.96%,RIC1;LRP1;FGFR4;RB1;NOTCH1
prerank,regulation of osteoclast differentiation (GO:0045670),0.5089861356886004,1.3150103105121995,0.13171355498721227,0.511304722092289,1.0,4/33,5.28%,GPR137B;LILRB3;CEBPB;PRXL2A
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.50440471634574,1.3143294944513577,0.12862547288776796,0.5126158572384111,1.0,7/33,11.96%,PPARG;APOE;MAP2K5;THBS1;GADD45A;ACVRL1;NOTCH1
prerank,regulation of angiogenesis (GO:0045765),0.4195297207650327,1.3138145862015715,0.03850050658561297,0.5133831397707732,1.0,30/192,12.73%,GPNMB;PPARG;APLNR;SASH1;PLXND1;CTNNB1;VEGFA;AQP1;KLK3;IL6;PDPK1;NIBAN2;RHOJ;CEMIP2;NINJ1;FOXO4;THBS1;AGO2;HMOX1;BRCA1;HIPK1;CTSH;VASH2;HIPK2;ITGB1;ROCK1;SIRT1;PRKCB;SARS1;SULF1
prerank,calcium ion transport (GO:0006816),-0.3002146112175298,-1.3137893925549993,0.03333333333333333,0.5015893981248322,1.0,35/113,15.93%,SLC24A3;TRPM3;CACNB2;CACNA1E;RYR3;CCR5;CDH23;SLC24A2;ANK2;ORAI1;TRPC1;CACNA1C;GRIN3A;RYR2;ATP2C1;TRPM4;CRACR2B;RAMP1;NALCN;TRPC7;TRPM2;TRPC4;MCOLN1;SLC24A4;CACNA1G;CAMK2A;PKD2;ATP2B2;ATP2B4;PKD1;CACNA2D1;CACNG3;TRPM6;ORAI2;CCR1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4574805381496423,1.313401158236048,0.11123853211009174,0.5139401606513715,1.0,17/60,15.29%,CTNNB1;CEBPB;RUNX2;IL6;CDKN1A;MED12;PTEN;MED15;SOX9;CBFB;TNRC6B;MED16;AGO3;MED26;RELA;BAX;CDK8
prerank,modified amino acid transport (GO:0072337),0.5871986682874225,1.3131458825555415,0.14788732394366197,0.5140106164565738,1.0,6/15,18.81%,FOLR2;FOLR1;SLC25A32;SLC6A8;MGST1;SLC19A1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4770779417423556,1.3130442927393116,0.13267813267813267,0.5136205084009311,1.0,6/40,5.03%,HTR2B;EDNRA;ADRA1A;GNAQ;ABL2;LPAR2
prerank,protein modification by small protein conjugation (GO:0032446),0.40951384713767325,1.3129625774796174,0.006012024048096192,0.5131976186280981,1.0,125/361,23.74%,EPAS1;EYA1;FBXO32;NSMCE2;NFE2L2;ATG7;WWP1;FBXW7;RNF26;WAC;ARRDC4;BIRC6;UBE2Q2;TRIM17;FBXL17;BRAP;UHRF2;ZNRF3;TSPAN17;UBE2L3;ATG10;SPSB4;CUL3;UBE2K;FBXL3;KLHL41;RNF135;SUMO2;DET1;PEX14;NUB1;CNOT4;RPS27A;UBC;BRCA1;PIAS4;NEDD4L;KLHL20;WWP2;FBXO11;EIPR1;MEFV;VCPIP1;SPSB2;TOPORS;HUWE1;TRIM7;PCNP;TPR;ARIH2;RLIM;DDB1;DCUN1D5;FBXO9;NUP50;SIRT1;MIB2;LZTR1;CAND2;KLHL24;STUB1;DCUN1D3;TRIM41;CUL4A;UBA5;RNF34;UBA3;CHFR;DCUN1D4;PRKN;UBE2F;VPS11;CUL1;ARRB1;CBL;NUP98;CDC73;CDC34;RNF7;DCUN1D1;TMEM129;KEAP1;UBE2M;GAN;TRIM14;MYLIP;AMFR;MYCBP2;TRPC4AP;TNFAIP1;NFX1;RNF43;UBE2S;CBLL1;FBXO7;NUP88;PIAS2;UBE2R2;BCL11A;DTX1;CUL4B;MKRN1;FBXO45;PIAS1;DTX2;NUP188;NDC1;NUP43;USP9X;PRKDC;UBE2H;UBR3;VCP;KCTD10;NUP54;RNF168;RNF138;RANBP2;UBE2D3;ARIH1;KLHL3;BCL10;EGR2;MIB1;ISG15
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.43178630282734654,1.3124026985542923,0.07939914163090128,0.5141799903151053,1.0,39/105,26.36%,SYK;ICAM2;CLEC4D;PDPK1;PRKCD;PSMD1;RAF1;NRAS;CREBBP;TYROBP;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELB;RELA;PSME2;CUL1;KLRD1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;MALT1;PSME3;BCL10;HRAS;TRAF6;PSMC5;TAB1;MAP3K7;TAB3;PSMC1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5130511911665946,1.3121221337544358,0.15579227696404793,0.5143299022186665,1.0,8/27,15.19%,CD200R1;IRAK3;SIRPA;NLRC3;GAS6;TNFAIP3;CX3CL1;ARRB1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5440900740149225,1.312077743983442,0.1509433962264151,0.5137518720341429,1.0,9/22,21.94%,STAM;MVB12B;RNF115;VPS4A;UBAP1;SNF8;PLAA;VPS36;VPS37B
prerank,generation of neurons (GO:0048699),-0.2893301586177589,-1.3115694011663188,0.043478260869565216,0.5044876318690937,1.0,32/190,9.00%,CX3CR1;PTPRD;ADGRL3;MEF2C;OPHN1;IL1RAPL1;SPOCK1;GPM6A;TAFA1;DISC1;AUTS2;RYK;MAPT;FZD3;MYEF2;EML1;CIT;FUT9;RELN;MYT1L;CDK5R1;NTRK2;FGF13;ASTN2;ACSL4;MARK1;MAP2K1;TUBB2A;MARK2;DNER;TGFB2;SEMA3A
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4565208836920622,1.311533747723649,0.09163802978235967,0.5147168694687464,1.0,16/66,15.81%,CD36;TLR8;IL6;TMEM106A;IGF1;NLRC4;SIRPA;FOXP1;MEFV;TYROBP;NLRP2B;APP;FZD5;TNFAIP3;CX3CL1;MYD88
prerank,positive regulation of mitochondrial fission (GO:0090141),0.5543735768586485,1.3114471285995963,0.14166666666666666,0.5142799515084799,1.0,1/18,0.05%,DDHD1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5488062308485101,1.311372545693918,0.13760217983651227,0.5137980554231177,1.0,8/21,15.14%,ADAM9;DAG1;BACE1;ADAM17;HM13;MYH9;ADAM19;NCSTN
prerank,regulation of acute inflammatory response (GO:0002673),0.5599329804251681,1.3112223681439474,0.14726507713884993,0.5135591280975841,1.0,3/18,5.77%,IL6;PLA2G2D;ADAM8
prerank,receptor recycling (GO:0001881),0.6341881265230891,1.3111327903465266,0.18597560975609756,0.5131241464098792,1.0,5/10,13.65%,PHETA2;SORL1;ARFGEF2;RAB11B;PLEKHJ1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.43180290395027615,1.3102010567374056,0.079484425349087,0.5145978201293901,1.0,39/104,26.36%,SYK;ICAM2;CLEC4D;PDPK1;PRKCD;PSMD1;RAF1;NRAS;CREBBP;TYROBP;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELB;RELA;PSME2;CUL1;KLRD1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;MALT1;PSME3;BCL10;HRAS;TRAF6;PSMC5;TAB1;MAP3K7;TAB3;PSMC1
prerank,cellular response to lectin (GO:1990858),0.43180290395027615,1.3102010567374056,0.079484425349087,0.5145978201293901,1.0,39/104,26.36%,SYK;ICAM2;CLEC4D;PDPK1;PRKCD;PSMD1;RAF1;NRAS;CREBBP;TYROBP;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELB;RELA;PSME2;CUL1;KLRD1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;MALT1;PSME3;BCL10;HRAS;TRAF6;PSMC5;TAB1;MAP3K7;TAB3;PSMC1
prerank,primary miRNA processing (GO:0031053),-0.540468578701886,-1.3100960308606875,0.16374269005847952,0.5051721568938992,1.0,5/10,12.28%,SMAD3;DGCR8;METTL3;SMAD1;SMAD2
prerank,regulation of cardiac conduction (GO:1903779),-0.3513010583959032,-1.3095265313921978,0.12056737588652482,0.5038734537568607,1.0,14/54,12.35%,ATP1B1;RYR3;ANK2;ITPR2;TRPC1;ATP1A2;ASPH;RYR2;ATP1B2;ATP2B3;PRKACA;ATP2B2;ATP2B4;AGT
prerank,response to cytokine (GO:0034097),0.4284838269499018,1.3094132946252612,0.051041666666666666,0.5162584189753481,1.0,36/141,14.89%,CXCR4;TIMP1;ANXA1;SIGIRR;MAPKAPK3;IRAK2;IKBKE;KYNU;IFITM1;ADAM9;CD274;RIPK1;PID1;IFNAR2;DDOST;IRAK3;PTPN12;NUB1;REL;TIMP2;KLHL20;MEFV;MAP4K3;IFITM2;IL6R;APP;BST2;RELB;HCLS1;RELA;COL3A1;SLC11A1;ALDH1A2;JAK3;YTHDC2;MCL1
prerank,bile acid and bile salt transport (GO:0015721),0.5255397367875712,1.309237085067401,0.13333333333333333,0.516101045086197,1.0,8/24,13.51%,SLC51A;RXRA;STARD5;ABCC4;NR1H4;ABCC3;NCOA1;ATP8B1
prerank,actin crosslink formation (GO:0051764),0.5994518168755709,1.3085461222726849,0.17267267267267267,0.5174849692766652,1.0,3/12,3.01%,GAS2L3;BAIAP2;LCP1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5194327272928572,-1.3076927276608146,0.16332378223495703,0.5054758293739654,1.0,3/11,11.55%,P3H2;P4HTM;CRTAP
prerank,snRNA processing (GO:0016180),0.5728010315863741,1.307451321243841,0.15648286140089418,0.5201729028176515,1.0,8/16,13.35%,TOE1;INTS9;INTS6;INTS1;INTS8;INTS2;INTS5;INTS7
prerank,protein autoprocessing (GO:0016540),0.5666646456237857,1.3067339148953732,0.14804469273743018,0.5215186615414447,1.0,5/17,12.84%,CTSL;HTRA2;FAM111A;MYRFL;OMA1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5290425421595761,1.3066083573319422,0.14647137150466044,0.5211963901427479,1.0,7/25,15.26%,ARHGAP24;PRKCD;ODF2L;STAP1;CAPZB;PFN2;CCP110
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5724558692013196,1.3065577482253938,0.15027322404371585,0.5199515350391962,1.0,6/16,11.43%,CORO1C;PTEN;THBS1;DLC1;ACVRL1;BCAS3
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5724558692013196,1.3065577482253938,0.15027322404371585,0.5199515350391962,1.0,6/16,11.43%,CORO1C;PTEN;THBS1;DLC1;ACVRL1;BCAS3
prerank,response to interferon-beta (GO:0035456),0.5462507373218178,1.3064813986185646,0.1392235609103079,0.5195061678301086,1.0,9/22,16.20%,IKBKE;IFITM1;HTRA2;IFNAR2;UBE2K;IFITM2;BST2;ACOD1;CDC34
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.45011132025734996,1.3063140938861053,0.09309967141292443,0.5193379160373129,1.0,18/78,12.77%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;MMP14;PID1;CLN3;STAC2;STX8;VTI1B;PICALM;VPS4A;ITGB1;APPL1;TREM2;ITGA3
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.44576602299593815,-1.3049626950516255,0.13970588235294118,0.5093385912172451,1.0,15/20,33.26%,PLCB1;RGS10;CHRM3;CHRM2;CDK5R1;AGRN;GRK2;GNA11;RGS8;LYPD1;CHRNA7;GNB1;LY6G6D;CHRNB2;LY6H
prerank,calcium import into the mitochondrion (GO:0036444),0.6296672723022022,1.3044454649234214,0.17397881996974282,0.5242153089501871,1.0,6/10,28.16%,MICU2;MICU1;SMDT1;AFG3L2;SLC25A23;MICU3
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4412132079983349,1.3031137530386567,0.09415584415584416,0.5275011378709021,1.0,27/87,22.96%,GPNMB;CDKN1A;PSMD1;PTEN;APC;ZFP36L2;RB1;BRD7;PSMF1;PSMD14;DCUN1D3;CDK2AP2;PSMD12;PSME2;CUL1;CDC73;PSMB10;PSMD5;PSMD8;PSMA3;FBXO5;PSMA2;PSMD11;PSMA6;PSMB3;CDK6;PSME3
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5959469045908606,1.3030841426690647,0.16,0.5268895281500163,1.0,3/13,8.23%,SOAT1;IGF1;ABCA2
prerank,positive regulation of cell junction assembly (GO:1901890),-0.3373659973516844,-1.3030079842870317,0.04411764705882353,0.5114003305708854,1.0,15/56,12.97%,CNTNAP2;PTPRD;IL1RAPL1;NRXN1;NLGN1;GRID2;LRRC4B;CUX2;PPM1F;SYNDIG1;FERMT2;NLGN3;NPHP1;AGT;LIMS1
prerank,response to estrogen (GO:0043627),0.5065594456769345,1.302846994560547,0.11491442542787286,0.5268885672112036,1.0,7/31,11.43%,RARA;CITED2;TRIM25;BRCA1;NCOA4;ESR1;BCAS3
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.5658184719597945,1.302617864364669,0.1715076071922545,0.5269353398169974,1.0,5/17,16.67%,PLA2G7;ANO6;MOSPD2;CXCL12;CREB3
prerank,cellular response to hypoxia (GO:0071456),0.4255114420906497,1.3020937769797793,0.07329842931937172,0.5277542127583894,1.0,33/126,19.68%,EPAS1;VEGFA;AQP1;NPEPPS;PSMD1;LMNA;BACH1;ADAM8;CREBBP;HMOX1;RPS27A;UBC;HIPK2;EGLN3;SIRT1;PSMF1;MT3;PSMD14;STUB1;RORA;PSMD12;LIMD1;SUV39H2;PSME2;BNIP3;ACAA2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;CPEB2;PSMD11
prerank,cellular response to fatty acid (GO:0071398),0.6015511986573377,1.3020471945313785,0.16883116883116883,0.5271917342896697,1.0,4/12,12.62%,PDK4;PID1;NR1H4;KCNK4
prerank,positive regulation of protein metabolic process (GO:0051247),0.4293277364504019,1.3019916201597308,0.06788793103448276,0.5266728434592367,1.0,25/110,13.77%,APOE;ATG7;WWP1;TIPARP;RAB7A;NR1H3;PLK2;MAP2K5;SORL1;MAPK7;APC;STX5;RAB1B;NEDD4L;WWP2;ABCA2;HUWE1;DDB1;GSK3B;MTPN;FOXO1;OAZ2;APP;TNFAIP3;PRKN
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.42844611874331784,-1.3011742783127325,0.11153846153846154,0.5133339233385668,1.0,13/21,40.23%,SMO;ARMC9;TTC23;ULK3;PDCL;TEDC2;DCDC2;GAS8;KIF7;SFRP1;SHH;STK36;TEDC1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5534439746159246,1.3011427701114375,0.16393442622950818,0.5284574382092736,1.0,8/18,22.90%,APOE;RNF128;MSN;ABCA2;VPS11;VPS35;FAF1;EZR
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.41404223188874706,-1.3010576439968815,0.12601626016260162,0.5110168607366651,1.0,5/22,7.50%,SSH2;TWF2;CYRIB;TMSB4X;SSH3
prerank,cellular zinc ion homeostasis (GO:0006882),0.5145090874285715,1.3008917032911806,0.16294349540078842,0.5285330086702456,1.0,17/26,29.24%,SLC39A14;MT3;SLC39A12;SLC30A1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;ATP13A2;SLC39A10;SLC30A9;SLC39A13;SLC30A5
prerank,cellular respiration (GO:0045333),0.48129896774290554,1.3007856498414867,0.13691931540342298,0.5281659394810421,1.0,14/41,16.76%,ETFRF1;LYRM7;UQCRFS1;MTLN;MTFR1L;NDUFS8;SDHAF4;CYCS;SDHB;SDHA;ATP5F1D;NDUFS1;SIRT3;COX15
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.5675144592537147,1.3007407975505636,0.16879432624113475,0.527579573848851,1.0,3/15,3.03%,VEGFA;ITGA5;PDPK1
prerank,membrane organization (GO:0061024),0.41310896713562195,1.300576544241506,0.034623217922606926,0.5274427733204399,1.0,73/227,20.79%,MYOF;MTCH1;REPS2;IGF2R;GRB2;ARPC2;NPC1;CORO1C;TFRC;CERT1;REEP4;SNAP29;SNX9;CD3D;PPT1;SH3GLB1;GRIN3B;CLN3;STAM;VTI1B;GAK;CHMP2A;SCARB2;RABEP1;SH3KBP1;RPS27A;UBC;FER1L6;ACTR3;PDCD6IP;TRIP10;VAPA;HUWE1;STX11;PICALM;A4GALT;VPS4A;FCHO1;CHMP6;M6PR;LPCAT3;AP3D1;IL7R;LEMD3;VAMP3;EPS15;AP2B1;OCRL;WASL;STAM2;ARRB1;MOSPD3;CBL;GAPVD1;CHMP5;ARPC1A;RABIF;NEMP1;CHMP7;SNX3;ITSN1;TMEM170A;FCHO2;LRP2;SYNJ2;AZIN2;ARPC4;AGFG1;GCA;VAMP2;ACTG1;SNAP23;TOR1A
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4479686676421013,-1.2998185943531675,0.12890625,0.51125077925526,1.0,4/18,5.39%,CX3CR1;SELPLG;JAM2;ADD2
prerank,cellular response to chemokine (GO:1990869),-0.3467956165501117,-1.2995219600376564,0.05442176870748299,0.5094208471736917,1.0,9/46,15.93%,DOCK8;SLC12A2;SH2B3;RIPOR2;CCL4;WNK1;RHOA;CCR2;CCR1
prerank,mesenchymal cell differentiation (GO:0048762),0.47123525224058693,1.299509093062709,0.13466042154566746,0.5299977681204026,1.0,11/51,11.96%,HTR2B;CTNNB1;HGF;HNRNPAB;FBXL17;DDX5;SOX9;SNAI2;ROCK1;GSK3B;NOTCH1
prerank,regulation of presynapse assembly (GO:1905606),-0.45106188774910205,-1.2993006462513106,0.13804713804713806,0.5050256263845628,1.0,4/18,5.54%,PTPRD;IL1RAPL1;LRRC4B;IL1RAPL2
prerank,regulation of presynapse organization (GO:0099174),-0.45106188774910205,-1.2993006462513106,0.13804713804713806,0.5050256263845628,1.0,4/18,5.54%,PTPRD;IL1RAPL1;LRRC4B;IL1RAPL2
prerank,negative regulation of viral genome replication (GO:0045071),0.48609771095588605,1.29927426460114,0.10714285714285714,0.5299672000226886,1.0,13/40,17.66%,IFITM1;TNIP1;SRPK2;FAM111A;RNASEL;ZC3HAV1;IFITM2;MAVS;BST2;N4BP1;SLPI;MPHOSPH8;SRPK1
prerank,hexose metabolic process (GO:0019318),0.48770475505132804,1.2989731734413754,0.14927184466019416,0.5301746411518056,1.0,18/39,26.19%,SORD;AKR1A1;TFAP2B;IRS2;GALK2;PPARD;PGM1;FUCA1;OMA1;APOD;SLC35A2;PMM2;GALM;SLC37A4;HK1;GALT;CHST15;BRAT1
prerank,membrane protein proteolysis (GO:0033619),0.48919677383822513,1.2986001266014624,0.12698412698412698,0.530573519539792,1.0,18/37,25.35%,ADAM9;DAG1;CTSH;BACE1;ADAM17;HM13;RHBDD1;MYH9;RELA;ADAM19;NCSTN;PARL;AFG3L2;ADAM10;APH1B;PSEN2;TRAF6;SPPL3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4061283896762085,1.2985086258682659,0.008008008008008008,0.5301628917294323,1.0,87/390,15.95%,ATP6V0D2;MTSS1;GDF15;SDCBP;NAMPT;SYK;GALNT3;GRB2;FRK;NEDD9;VAV3;NCK2;ARPC2;ATP6V1A;VEGFA;POLR2A;PDK4;MAPKAPK3;BAIAP2;AP3S1;ATP6V1E1;SOS1;HGF;ATP6V1C1;KIF16B;PDGFA;TCIRG1;COL4A6;ATP6V0D1;ABI1;ANKS1B;FOXO4;ZFYVE27;IGF1;FGFR4;NRP2;COL1A1;MERTK;IRS2;PIK3CA;APC;CYBB;ATP6V1B2;SULF2;CYBA;NCF2;POLR2L;STAP1;ACTR3;VAV1;BLNK;CYFIP2;ATP6V0A1;SLC39A14;SH2B2;ROCK1;POLR2G;GSK3B;PTK2B;FOXO1;PAK2;FES;POLR2I;NCBP2;HNRNPM;GTF2F2;ROR1;APPL1;DOCK1;RAPGEF1;SULF1;NCF4;ATP6V0E1;GPLD1;ATP6V0C;ATP6V0B;FGR;AP2B1;ATP6V1H;PHIP;SHC1;WASL;NCSTN;CBL;FRS2;FLRT1;NRP1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4182721361700094,1.2970590392536039,0.07327141382868937,0.5337663467626677,1.0,26/140,10.90%,ARHGAP24;ARHGAP10;ARHGAP21;ABR;ARHGAP19;ARHGAP15;VAV3;TGM2;SOS1;RHOJ;ARAP2;ARHGAP9;ARHGAP31;MYO9B;GNA13;FLCN;ARAP1;AKAP13;VAV1;TRIP10;DLC1;ARHGAP18;ARHGAP17;RHOD;FAM13B;ARHGEF2
prerank,regulation of mitochondrion organization (GO:0010821),0.47079187794846067,1.2969926695473746,0.12252042007001167,0.5332724141545954,1.0,18/47,16.38%,FBXW7;PID1;HTRA2;MYO19;FLCN;CSNK2A2;INF2;GSK3B;FZD5;TREM2;SIRT7;OMA1;VDAC1;PRKN;SQSTM1;GOLPH3;USP36;PARL
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5797968187831158,1.2959894134553154,0.17588652482269504,0.5356765702465757,1.0,8/15,19.95%,ANP32B;GTSE1;TPR;GSK3B;GAS6;CAMK1;RBM22;TCF7L2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.541930048238562,1.2954236616037471,0.16666666666666666,0.5366473252987097,1.0,5/19,15.73%,HRH1;PPP3CA;PPP3R1;NFATC3;INPP5A
prerank,response to unfolded protein (GO:0006986),0.46981409240730215,1.2949183960764596,0.14957780458383596,0.5374370756779865,1.0,16/48,19.43%,OPTN;ERN1;HSPA1B;DNAJB5;DDIT3;RHBDD1;PRKN;HSPA1A;BAX;HSPA13;HSPD1;PTPN1;HSPE1;HSPA4;HSPA4L;DNAJA1
prerank,regulation of endocytosis (GO:0030100),0.45673572945268054,1.2944081111763786,0.13258426966292136,0.5382234628422796,1.0,17/61,16.37%,LGALS3;APOE;LILRB1;FLOT1;LRP1;ABL2;CD151;NEDD4L;CD22;PICALM;SNX33;ROCK1;MCTP1;STON1;SNX17;RUBCN;PTPN1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5676856283607671,1.2940581128832889,0.15502793296089384,0.5385853064711148,1.0,4/15,13.06%,PPARG;IRS2;PPARD;GPLD1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.47864381331060146,1.2936726490631025,0.1316425120772947,0.5390497255311197,1.0,10/38,13.66%,TNIP1;TANK;RIPK1;NR1H4;ESR1;NLRC3;SIRT1;RORA;TREM2;TNFAIP3
prerank,negative regulation of protein transport (GO:0051224),0.5284044505754888,1.2934630877228777,0.15591397849462366,0.5389656137240202,1.0,5/25,8.29%,APOE;SERGEF;RHBDF2;WWP2;PKDCC
prerank,neuromuscular process (GO:0050905),0.5690250435482165,1.2924995668267383,0.16929698708751795,0.5411979852335844,1.0,7/16,18.98%,STRA6;TPP1;CLN3;UBA5;MYCBP2;PAFAH1B1;GCH1
prerank,protein localization to Golgi apparatus (GO:0034067),0.5071269108829703,1.292234511123106,0.16710526315789473,0.5413492814507829,1.0,10/27,19.44%,OPTN;RAB33B;SORL1;GAK;COG7;VPS13D;VPS13C;GOLPH3;VPS13A;ARL5B
prerank,positive regulation of actin nucleation (GO:0051127),-0.5298734800048288,-1.2921790987718067,0.17897727272727273,0.5191642383991444,1.0,5/11,17.56%,FCHSD2;ABI2;NCKAP1;CYFIP1;GSN
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.48156390687914175,1.2908706771729865,0.1423312883435583,0.544823136813527,1.0,3/36,2.95%,HTR2B;APOE;GLA
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5214380283257577,1.2905393127790812,0.16382699868938402,0.5451381933219445,1.0,10/24,16.76%,LYRM7;PID1;MTLN;ACADVL;SDHAF4;GFPT1;CYCS;MT3;NDUFS1;COX15
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.49540401923526206,1.2902702413242357,0.14432989690721648,0.5452536047056804,1.0,10/33,15.74%,FBXW7;ID2;CDKN1A;APPL2;PTEN;E2F1;APPL1;PSME2;INO80;CDC73
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.5286642084107138,1.29013179393539,0.1477124183006536,0.5449781193259754,1.0,8/22,22.76%,ERCC6;ALYREF;TCERG1;THOC1;CDC73;CDK13;CCNT1;SUPT4H1
prerank,ethanol metabolic process (GO:0006067),-0.495064077882184,-1.2891978787407858,0.15047021943573669,0.5241252179511315,1.0,5/12,24.51%,ACSS1;ACSS2;SULT1A1;ALDH1A1;ADH5
prerank,regulation of cellular component size (GO:0032535),0.49993105253649694,1.2891884164895353,0.1592920353982301,0.5471687563255663,1.0,11/30,16.96%,VAV3;PTEN;PEX11A;MSN;VAV1;PICALM;RIN3;MTPN;RAP1GAP2;PPP1CA;RAB22A
prerank,vesicle transport along actin filament (GO:0030050),0.5440156182956865,1.2891805564295882,0.16968011126564672,0.5464914334427796,1.0,4/19,9.64%,MYO5A;MYO1E;MYO19;MYO1F
prerank,icosanoid biosynthetic process (GO:0046456),0.6156262068166781,1.2890909904109267,0.2085987261146497,0.5460555869968832,1.0,2/10,10.37%,MGST2;LTA4H
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5165052454087927,1.2888189552355638,0.14967741935483872,0.5461992022374981,1.0,3/26,5.76%,OSBPL8;IGF1;IRS2
prerank,heart morphogenesis (GO:0003007),0.4720618235723586,1.2887022595009112,0.11592505854800937,0.5458680682941548,1.0,8/50,8.88%,HTR2B;SYNPO2L;VEGFA;NIPBL;SOX9;MYBPC3;DLC1;ACVRL1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.580663544795184,1.28857962420056,0.17410071942446043,0.5455456017391822,1.0,3/14,11.45%,ERN1;CPSF1;NCBP2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.4984888928636048,1.2884920661704686,0.14625,0.5451496459634425,1.0,5/32,9.34%,APLNR;PDPK1;P2RX4;P2RX3;TRPC3
prerank,regulation of protein kinase C signaling (GO:0090036),0.5896233947539996,1.2882076880422122,0.18795888399412627,0.545280659575887,1.0,4/14,6.29%,ADRA1A;VEGFA;GPD1L;SPHK2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6120736427685197,1.2881903854347474,0.18484848484848485,0.5446428820663597,1.0,3/11,6.35%,IL6;RIPK1;DDX5
prerank,zinc ion homeostasis (GO:0055069),0.503147475123517,1.287928526898333,0.1640625,0.5447625153787009,1.0,18/28,29.24%,SLC39A14;MT3;PRKN;SLC39A12;SLC30A1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;ATP13A2;SLC39A10;SLC30A9;SLC39A13;SLC30A5
prerank,sphingoid metabolic process (GO:0046519),0.6010015483990228,1.2879096141256279,0.19203413940256045,0.5441373645159576,1.0,2/12,6.29%,PLPP3;SPHK2
prerank,protein tetramerization (GO:0051262),-0.3171495283471101,-1.2877697900991099,0.08620689655172414,0.5251010214260888,1.0,20/67,16.79%,HCN1;RYR3;GRIN2B;ACACA;KCNC1;KCNJ2;GRIN1;TRPM4;HOMER1;KCNC3;TRPM2;SOD2;MCOLN1;APIP;PKD2;PKD1;PKD2L1;ALDOA;GBP5;OSBPL2
prerank,regulation of JNK cascade (GO:0046328),0.43062309800165577,1.2876875781673218,0.09041980624327234,0.5441433375901394,1.0,26/101,16.90%,SDCBP;RAP2A;GADD45B;GADD45G;TAOK3;RIPK1;NCOR1;AIDA;DUSP3;GADD45A;MFHAS1;SH3RF1;SIRPA;COPS5;HIPK2;FZD7;PTK2B;APP;TRAF1;TRAF3;PRKN;FKTN;TRAF5;TRAF2;LTBR;NCF1
prerank,positive regulation of dendrite extension (GO:1903861),-0.4640634963320819,-1.2875621458991233,0.16725978647686832,0.5230946846918972,1.0,6/17,8.19%,SYT1;RIMS1;RIMS2;SMURF1;SYT2;SYT4
prerank,hydrogen peroxide metabolic process (GO:0042743),0.5376718836762066,1.2873600370809228,0.15061058344640435,0.5443964046005701,1.0,4/19,7.52%,PRDX1;GPX3;CYBA;CAT
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5183981561555346,1.2869334279618974,0.14747736093143596,0.5449783363276952,1.0,5/24,10.10%,PRKCH;CTSL;NCOA3;CBFB;ROCK1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4188269139311525,1.2866023995114444,0.06742738589211618,0.5453110326216751,1.0,18/140,9.91%,CD36;CXCR4;EDNRA;ADRA1D;ADRA1A;PTGDR;ABL2;P2RX4;XCR1;GPR157;C3AR1;SLC8A1;LPAR2;PTGER2;P2RX3;TRPC3;PTGER4;ESR1
prerank,phospholipid transport (GO:0015914),0.46808299717698343,1.28640606054181,0.12937062937062938,0.5452098206862852,1.0,12/52,14.01%,OSBPL8;ABCA1;APOE;ABCG1;ATP8B4;PLTP;SCARB2;ABCA3;PITPNA;PITPNC1;ATP8B1;PRELID3A
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.5691026879205149,1.2863750740452158,0.18181818181818182,0.5446145302787668,1.0,6/15,16.59%,FLOT1;ADAM9;CD53;TYROBP;TREM2;CAMK1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.5107752812904178,1.2854435174901584,0.17345597897503284,0.5466847284196413,1.0,7/27,17.65%,AK8;TXNRD1;GSR;CTPS1;AK2;CTPS2;RRM1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.46457355914961607,1.28532859141723,0.14634146341463414,0.5463163742013393,1.0,14/48,17.56%,PAPSS2;ADSL;IMPDH2;COASY;SLC26A1;AMPD3;ADCY7;SLC35B3;PAPSS1;ADCY8;ADCY3;PANK2;NPR2;ADSS1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5711622703329609,1.2852491867951732,0.1689291101055807,0.545896350379811,1.0,9/15,25.57%,FBXW7;NR1H3;SIK1;SLC27A1;GPLD1;SREBF1;NR1H2;CTDNEP1;C3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4785762592121168,1.2851864851049852,0.1394517282479142,0.5453877018219445,1.0,10/43,12.98%,PPARG;FOXO3;JUN;NR3C1;DDX5;KLF5;SOX9;NFATC3;PPARD;RELA
prerank,negative regulation by host of viral process (GO:0044793),0.6242019723678074,1.2851127821438788,0.20344287949921752,0.544939162536568,1.0,3/10,13.77%,EIF2AK4;VAPA;PRKN
prerank,protein palmitoylation (GO:0018345),0.5027584691759637,1.2850252371168032,0.15802781289506954,0.5445568984799256,1.0,8/30,17.17%,ZDHHC14;ZDHHC19;ZDHHC16;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC17;ZDHHC4
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.5695706612259812,1.284992764256659,0.16244411326378538,0.5439969111002925,1.0,2/15,5.35%,PAOX;SAT1
prerank,import into cell (GO:0098657),0.48341270144304915,1.284677773684811,0.1467780429594272,0.5443037720689684,1.0,15/41,19.77%,LRRC8D;SLC6A6;SLC11A2;SLC38A1;SLC27A1;LRRC8C;SLC39A14;TREM2;SLC12A7;NEURL1B;SLC7A1;SLC36A1;LRP2;SLC19A1;SLC7A8
prerank,protein localization to microtubule organizing center (GO:1905508),0.5646949548727913,1.2840066963324164,0.20784883720930233,0.5455939455234354,1.0,3/15,2.20%,HOOK3;PIBF1;SNX10
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5804387203383488,1.2837810665560372,0.18962962962962962,0.5456221749952466,1.0,4/13,10.68%,CD44;DYRK1A;SNAI2;SIRT1
prerank,iron ion transmembrane transport (GO:0034755),0.6299219909948188,1.283403866474656,0.17488789237668162,0.5461621140572778,1.0,3/10,9.99%,ABCB7;SLC11A2;SLC39A14
prerank,actin filament-based transport (GO:0099515),0.5300450321223509,1.2833654857126557,0.16847826086956522,0.5456112027819682,1.0,4/21,9.64%,MYO5A;MYO1E;MYO19;MYO1F
prerank,negative regulation of catalytic activity (GO:0043086),0.5155569898103026,1.2831754386315626,0.1646586345381526,0.5454948909351143,1.0,7/24,11.96%,TIMP1;CLN3;HP;NOSIP;SIRT1;MT3;NOTCH1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.37741338597168395,-1.282922644236617,0.12875536480686695,0.5316728182359721,1.0,7/31,7.03%,MEF2C;CTNNA2;MEF2A;FGFR2;CDH2;CDON;HDAC9
prerank,protein targeting (GO:0006605),0.4202052239041057,1.2826915089785529,0.08333333333333333,0.5462202616065467,1.0,35/118,19.28%,SDCBP;KIF13B;PIKFYVE;ZDHHC14;ZDHHC19;TIMM22;ZFAND2A;HOMER3;SORL1;PITRM1;YIF1B;TIMM17A;TOMM20;MICALL1;LAMP2;ZDHHC12;ZDHHC18;NACA;TIMM17B;ZFAND6;LONP2;GDAP1;SPCS2;ZFAND2B;RABGEF1;ZDHHC24;TOMM34;NCF1;ZDHHC4;SEC63;ICMT;TOMM7;AP4M1;TOMM22;FBXO7
prerank,regulation of cell migration (GO:0030334),0.4025164816737696,1.2824309107964438,0.009045226130653266,0.5463726604520214,1.0,75/382,13.12%,GPNMB;F7;PLXNA1;SDCBP;SASH1;SGK1;PLXNC1;PLXND1;NEDD9;ADGRG3;GCNT2;ANXA1;MITF;RAP2A;VEGFA;RUFY3;CORO1C;ARHGEF39;IFITM1;ADAM9;MGAT5;HGF;FOXO3;WASHC1;PDGFA;CD151;SEMA4B;LMNA;APPL2;MMP14;PTEN;CITED2;YTHDF3;OSGIN1;SORL1;IGF1;CLN3;F10;DUSP3;ZMYND8;THBS1;COL1A1;DAG1;GNA12;STK24;APC;FLCN;DOCK10;GTSE1;NF2;SNAI2;CTSH;DLC1;ACVRL1;DACH1;PPP3CA;PLAU;ITGB1;ROCK1;RAP2B;ADAM17;RHOD;PTK2B;CCN1;BST2;NOTCH1;MYLK;APPL1;SPAG9;MAZ;SULF1;ARID2;MACF1;MCTP1;PODN
prerank,regulation of spindle assembly (GO:0090169),0.5154485833703546,1.281965696958108,0.16960651289009498,0.5470648959272736,1.0,9/25,16.59%,DYNC1H1;CHMP2A;HSPA1B;HNRNPU;EML3;PDCD6IP;TPR;HSPA1A;CHMP5
prerank,modification-dependent protein catabolic process (GO:0019941),0.405888447226452,1.2816656963122288,0.04405737704918033,0.5473671687264651,1.0,78/193,24.85%,RNF149;TRIP12;BIRC6;RNF19A;RNF130;TRIM25;WDR91;LONP1;ZNRF3;UBE2L3;ANAPC1;SPSB4;CUL3;NPLOC4;UBE2K;RNF128;NUB1;CNOT4;RPS27A;UBC;BFAR;KCTD21;NEDD4L;FBXO11;RNF146;SPSB2;TOPORS;ARIH2;RLIM;DDB1;PSMF1;PSMD14;STUB1;RNF34;CHFR;PRKN;SQSTM1;UBQLN2;ANAPC10;ARRB1;CBL;PCYOX1;CDC34;RNF7;KEAP1;MYLIP;AMFR;TRPC4AP;RNF43;UBE2S;ATXN3;FBXO7;ANAPC15;PSMD11;UBE2R2;RNF19B;FBXO45;FBXL4;TAF1;UBE2H;UBR3;KCTD10;RNF125;HERPUD1;UBE4A;RNF168;SIAH2;ARIH1;KLHL3;UBE4B;MIB1;ISG15;NDFIP1;PTTG1;RNF150;TTC3;UBE2E1;ANAPC7
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5345577973885765,1.2811933111894551,0.15768725361366623,0.5481459023112505,1.0,11/24,18.86%,ACD;TENT4B;HNRNPU;NAT10;TERF1;TEN1;STN1;TNKS;EXOSC10;TNKS2;GNL3L
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5082523687275129,1.2810452831610124,0.17063492063492064,0.5478613574839665,1.0,7/26,13.77%,NFE2L2;TXN;HTRA2;MAPK7;ATF4;SIRT1;PRKN
prerank,response to exogenous dsRNA (GO:0043330),0.553783739316976,1.2810143534070817,0.1768033946251768,0.5472760555990105,1.0,5/18,12.13%,RFTN1;FLOT1;IRAK3;MAVS;PQBP1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4954390831024173,1.2808325055304184,0.14912280701754385,0.5471463074282725,1.0,5/33,6.91%,PPARG;FOXO3;JUN;NR3C1;KLF5
prerank,autophagosome maturation (GO:0097352),0.49617851411505226,1.280747132240371,0.1571072319201995,0.546752492772024,1.0,9/32,10.42%,SNAP29;TECPR1;UVRAG;CLN3;VTI1B;VMP1;LAMP2;VPS33A;EPG5
prerank,positive regulation of neuron differentiation (GO:0045666),-0.35743118627972537,-1.280636034426992,0.09740259740259741,0.5345895878273346,1.0,13/40,23.71%,MEF2C;BRINP3;ZEB1;VWC2;REST;RHOA;BRINP1;HOXD3;ECT2;NBL1;SOX11;TRIM32;MMD
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4920780199130722,1.2804334681567513,0.16149068322981366,0.5470604569393306,1.0,6/32,7.11%,ANXA1;VEGFA;RHOJ;MAP2K5;THBS1;HMOX1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.4075179401968782,-1.279056774950714,0.13257575757575757,0.5357625935530993,1.0,17/25,29.70%,MEF2C;NLGN1;RELN;CACNG4;SHISA6;NLGN3;GSG1L;CACNG3;CACNG2;SHISA7;MAPK8IP2;CACNG7;ADRB2;CNIH3;CACNG5;SHANK1;SHISA8
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6201100609063577,1.278673888407934,0.1848184818481848,0.5515425442017439,1.0,4/10,15.22%,ZEB2;MFSD12;APPL1;ATP7A
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.586377618037288,1.278518112038459,0.1850282485875706,0.5513383568235007,1.0,3/14,5.50%,ANO6;ITGA4;THBS1
prerank,sulfate transport (GO:0008272),0.57301748363578,1.277988356704105,0.191044776119403,0.5521771079543499,1.0,2/14,5.34%,SLC26A11;SLC26A1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5436847827389838,1.2779577120172425,0.16402877697841728,0.551620187828734,1.0,6/17,13.77%,CD44;DYRK1A;SNAI2;SIRT1;RNF34;PRKN
prerank,mitotic sister chromatid cohesion (GO:0007064),0.5664252930560552,1.2777697648540847,0.1843191196698762,0.5515634295214893,1.0,7/16,19.77%,NIPBL;RB1;SMC1A;BOD1;RAD21;SGO1;PDS5A
prerank,glutathione metabolic process (GO:0006749),0.484590701972704,1.2777115793767415,0.16209476309226933,0.5510533138921497,1.0,9/38,17.61%,MGST2;GSTM1;NAT8;CNDP2;GSR;HPGDS;HAGH;GSTA4;OPLAH
prerank,cellular response to oxidative stress (GO:0034599),0.41916445001159,1.2774367789553966,0.08691099476439791,0.5511971664771589,1.0,27/118,13.96%,MSRA;PRDX1;NFE2L2;TXNRD1;MPV17;PRKCD;FOXO3;JUN;DAPK1;SESN2;LONP1;HTRA2;HSPA1B;CYBB;GPX3;ATF4;HMOX1;CYBA;NCF2;CAT;GSR;CYCS;FOXO1;MT3;NCF4;ERCC6L2;HSPA1A
prerank,positive regulation of cyclase activity (GO:0031281),-0.48208863017101644,-1.2772816339903506,0.19076923076923077,0.5373734738984556,1.0,2/14,2.47%,ORAI1;CACNA1C
prerank,embryonic hemopoiesis (GO:0035162),-0.4988823994669256,-1.2768378456228908,0.17717717717717718,0.5358285011912076,1.0,5/12,9.32%,TGFBR2;KITLG;SH2B3;TAL1;THOC5
prerank,multivesicular body assembly (GO:0036258),0.49305227775178995,1.275783246609223,0.16688227684346701,0.5555536297846665,1.0,12/30,21.94%,STAM;CHMP2A;PDCD6IP;VPS4A;CHMP6;SNF8;STAM2;CHMP5;CHMP7;VPS36;CHMP2B;VPS37B
prerank,response to histamine (GO:0034776),0.6167482679529628,1.275479650509259,0.19969512195121952,0.5558118327355067,1.0,2/10,1.52%,HRH1;DIAPH1
prerank,negative regulation of cell population proliferation (GO:0008285),0.40269709109478147,1.2748623164125699,0.012048192771084338,0.5569918499062445,1.0,67/351,15.94%,GPNMB;PPARG;MTSS1;CD300A;ADAMTS8;FRK;RPS6KA2;ADRA1A;CTNNB1;NCK2;FOXP3;ST18;IFITM1;E2F3;IL6;CDKN1A;NIBAN2;TFAP2B;RUNX3;LMNA;APPL2;CELF1;B4GALT7;ABI1;PTEN;RAF1;FOXO4;E2F1;TNN;APC;NUDT6;FLCN;HSPA1B;HMOX1;NF2;MCC;SOX9;TES;BNIPL;P3H3;DLC1;STRN;ACVRL1;BRD7;BMPR2;NLRC3;CNOT7;PTK2B;ING4;FBLN1;APP;NOTCH1;TREM2;ARID2;GPLD1;PODN;SOX2;TNFAIP3;TENM1;HSPA1A;SPEG;FKTN;ALDH1A2;ADARB1;SMYD2;CDC73;NELL1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.47897362625988493,1.27476845670358,0.1806775407779172,0.5565808032044076,1.0,6/33,5.50%,VEGFA;ITGA5;PDPK1;RHOJ;CEMIP2;THBS1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.5279015711306986,-1.2747160868965024,0.209366391184573,0.5383550689602982,1.0,8/10,32.30%,SLC1A3;SLC1A2;SLC1A1;ARL6IP5;PRAF2;SLC1A6;SLC25A18;SLC25A12
prerank,primary alcohol metabolic process (GO:0034308),0.5196902627097313,1.2745457885857407,0.16120576671035386,0.5565987803580507,1.0,5/25,14.58%,DHRS3;RDH12;IGF1;ALDH3A2;GDE1
prerank,negative regulation of protein polymerization (GO:0032272),-0.3881348124143789,-1.2739649789431395,0.13366336633663367,0.5375770875304391,1.0,10/27,15.67%,SSH2;TWF2;CYRIB;MAP2;TUBB4A;SSH3;HIP1R;STMN2;MAPRE1;STMN1
prerank,actin polymerization or depolymerization (GO:0008154),0.45693643763553826,1.2735861326582467,0.13396004700352526,0.5588011970705983,1.0,19/50,19.69%,VILL;DIAPH1;MICALL2;MSRB1;ABI1;PSTPIP1;CAPG;SVIL;CFL1;WDR1;PSTPIP2;MICAL2;WASL;DSTN;WASHC3;FLII;WASHC5;CFL2;MICAL1
prerank,membrane assembly (GO:0071709),0.4815923557905467,1.2733277821414122,0.16604708798017348,0.55891493736059,1.0,9/34,9.57%,CEL;RFTN1;FLOT1;PTEN;ANXA2;GAK;CHMP2A;PICALM;VPS4A
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.42058800733627016,1.2730756979757851,0.10828025477707007,0.5589829285184987,1.0,12/110,6.50%,ADGRE5;ABCA1;ADGRG3;ADRA1D;ADRA1A;GNAQ;GNA13;LPAR2;ADCY7;CNR2;ADGRE1;PTGER2
prerank,glycine metabolic process (GO:0006544),0.5988083203957635,1.272997127589128,0.17872968980797638,0.558579324166543,1.0,6/12,25.95%,BAAT;GLYAT;GCSH;SHMT2;AMT;RIDA
prerank,regulation of tumor necrosis factor production (GO:0032680),0.41574842017734637,1.2721984051376487,0.09745762711864407,0.5602723153623536,1.0,27/112,14.32%,SYK;LILRB1;IL6;TMEM106A;RIPK1;LY96;RARA;IGF1;THBS1;ARG2;NR1H4;SPHK2;IRAK3;CYBA;SIRPA;FOXP1;NFKBIL1;TYROBP;MAVS;NLRC3;ARHGEF2;APP;FZD5;ARFGEF2;GAS6;TNFAIP3;CX3CL1
prerank,mRNA splice site selection (GO:0006376),-0.3677834144864474,-1.2719959232687,0.1262135922330097,0.5396560883612292,1.0,14/30,19.42%,LUC7L2;SETX;SF3A1;SLU7;SRSF6;SRSF5;CELF2;SNRPC;CELF5;SF3A2;CELF4;SRSF12;SRSF1;SRSF9
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.5530994171649527,1.2719141006248595,0.16500711237553342,0.5604119435884547,1.0,3/17,7.96%,ADRA1D;ADRA1A;AKAP13
prerank,muscle cell differentiation (GO:0042692),0.4869608251741023,1.2714634039687185,0.17418546365914786,0.5610858383193851,1.0,4/32,4.99%,MRTFA;MRTFB;NINJ1;MTLN
prerank,myeloid cell differentiation (GO:0030099),0.46287051949642843,1.2713733365207505,0.15901060070671377,0.5607183131945236,1.0,19/47,23.11%,FLVCR1;RPS14;MFHAS1;HIPK2;TET2;KMT2E;UBA5;HCLS1;JAK3;ACIN1;CASP3;NCOA6;ZBTB16;CEBPA;SNRK;TIRAP;HSPA9;JAK2;SLC25A38
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6113826023299582,1.2712799425424355,0.18788819875776397,0.5603565376793257,1.0,1/10,0.55%,XDH
prerank,Rap protein signal transduction (GO:0032486),0.6099068419410935,1.2710726982354335,0.2006125574272588,0.5603040239846926,1.0,4/10,12.57%,RAP2A;PLK2;RAP2B;RAPGEF1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4139304979496177,1.2709561452478924,0.07716049382716049,0.5599862036463783,1.0,19/142,9.91%,CD36;CXCR4;EDNRA;ADRA1D;ADRA1A;PTGDR;ABL2;ATP2B1;XCR1;SLC8B1;C3AR1;SLC8A1;LPAR2;CLN3;PTGER2;CALB1;TRPC3;PTGER4;ESR1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.45627338165687664,1.2708975286493243,0.14434180138568128,0.5595098170451172,1.0,16/54,18.01%,SYK;RIPK1;UBE2K;HSPA1B;HIPK1;NLRP2B;ADAM17;BIRC3;TRAF1;TAX1BP1;GAS6;TNFAIP3;PRKN;HSPA1A;TRAF2;BIRC2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.41939185630265635,1.2708504846029252,0.10020876826722339,0.5589932499333417,1.0,27/118,14.62%,GPNMB;KIF13B;PLXND1;CTNNB1;RAP2A;RUFY3;ZMYM6;IL6;PID1;DAG1;MYO19;PDLIM5;HMOX1;LFNG;NEDD4L;VASH2;CAPZB;INF2;TNIK;CFL1;GSK3B;PAK2;TNFAIP3;CLASP1;GDNF;PHIP;RNH1
prerank,protein ubiquitination (GO:0016567),0.3956826279590112,1.270742464670564,0.007,0.5586877934134978,1.0,158/471,23.74%,EPAS1;FBXO32;SASH1;TRIP12;NFE2L2;CTNNB1;ZNRF1;WWP1;NPEPPS;FBXW7;RNF26;WAC;PSMD1;ARRDC4;BIRC6;UBE2Q2;RNF19A;TRIM17;FBXL17;BRAP;TRIM25;UHRF2;ZNRF3;TSPAN17;UBE2L3;SPSB4;CUL3;FBXW10;RNF10;UBE2K;FBXL3;KLHL41;RNF135;DET1;PEX14;NUB1;CNOT4;RPS27A;UBC;NHLRC1;BRCA1;BFAR;SH3RF1;LONRF1;NEDD4L;KLHL20;WWP2;RNF115;FBXO11;EIPR1;RNF146;MEFV;CBFB;VCPIP1;SPSB2;TOPORS;HUWE1;TRIM7;PCNP;ARIH2;RLIM;DDB1;FBXO9;SIRT1;MIB2;NHLRC3;PSMF1;ASB4;UNKL;LZTR1;CAND2;PSMD14;KLHL24;STUB1;RUSC1;TRIM41;PSMD12;CUL4A;RNF34;FBXO6;CHFR;FBXW2;PRKN;VPS11;PSME2;CUL1;FBXO28;TNKS;ARRB1;CBL;LNPEP;CDC73;TRAF2;CDC34;RNF7;BLMH;TMEM129;KEAP1;UBE2O;PSMB10;GAN;PSMD5;TRIM14;TNKS2;MYLIP;UBE2V1;BIRC2;PSMD8;AMFR;MYCBP2;TRPC4AP;PSMA3;TNFAIP1;NFX1;FBXO31;RNF43;PSMA2;UBE2S;CBLL1;FBXO7;PSMD11;PELI2;UBE2R2;DTX1;DDA1;RNF19B;PSMA6;SPOP;CUL4B;MKRN1;FBXO45;FBXL4;DTX2;TAF1;USP9X;PRKDC;UBE2H;PSMB3;UBR3;VCP;KCTD10;RNF141;RNF125;IRF2BP1;KLHL12;UBE4A;RNF168;SIAH2;OBI1;PSME3;RNF138;UBE2D3;ARIH1;KLHL3;BCL10;UBE4B;MIB1;ISG15
prerank,response to organic cyclic compound (GO:0014070),0.46509809901353194,1.2703055628558086,0.14450867052023122,0.5593246689482549,1.0,10/52,11.13%,ANXA1;CTNNB1;TIPARP;KYNU;SPP1;FGFR4;STAT5B;ABCA2;ESR1;STRN3
prerank,positive regulation of biosynthetic process (GO:0009891),0.4780273617307262,1.27020684251555,0.14916467780429593,0.5589892786601783,1.0,6/40,10.49%,CD36;APOE;VIM;CYBA;ZBTB20;MTPN
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.4227190404187965,-1.270009388304294,0.14184397163120568,0.5418019195183479,1.0,7/20,18.64%,CCND3;EGFR;PKD2;PKD1;TTBK1;PSMD10;RGCC
prerank,secondary palate development (GO:0062009),-0.48025960477288654,-1.2699887542034058,0.20634920634920634,0.5393622589127287,1.0,7/14,29.92%,TGFBR2;TGFB2;SMAD2;SMAD4;WNT5A;LEF1;WNT7A
prerank,negative regulation of centrosome duplication (GO:0010826),-0.5055702168756105,-1.2697365039627122,0.18658892128279883,0.5374201710346792,1.0,7/11,17.96%,TRIM37;MDM1;CENATAC;RBM14;TMEM67;CCNF;NPM1
prerank,DNA geometric change (GO:0032392),0.5187568936808166,1.2696812655539818,0.17146596858638743,0.5598866704689409,1.0,6/24,12.63%,ANXA1;MCM9;ZRANB3;RTEL1;NBN;WRN
prerank,regulation of hydrolase activity (GO:0051336),0.4438535885443764,1.2692728816076677,0.1273532668881506,0.5603955292000836,1.0,17/71,14.42%,PLXNA1;GPR137B;PLXNC1;PLXND1;ARHGAP15;FGD6;VAV3;ARHGAP9;ADAP1;RAB3GAP2;SCARB2;VAV1;TBC1D15;FGD5;WRN;OCRL;FGD3
prerank,regulation of cell cycle (GO:0051726),0.404130132145254,1.2691557370794766,0.04116465863453815,0.5600950433598989,1.0,62/271,14.56%,IQGAP1;SDCBP;MAP3K20;LILRB1;RPS6KA2;ERN1;KIF20B;GADD45B;GADD45G;ID2;CDKN1A;LIN37;ANKRD17;RUNX3;JUN;SRPK2;NOTCH2;FBXL17;RARA;CITED2;FOXO4;UHRF2;HTRA2;THBS1;GADD45A;APBB2;FBXL3;SIK1;APC;NUDT6;HNRNPU;BRCA1;RPL23;NF2;SOX9;XIAP;RB1;PPP1R9B;RAD23A;HIPK2;CSNK2A2;NLRP2B;PIM3;INTS13;BIRC3;SIRT1;CDK7;ING4;NBN;DCUN1D3;CDC123;NOTCH1;SND1;AFAP1L2;GAS2L1;SOX2;HBP1;PHACTR4;JUNB;WHAMM;UHMK1;LRP6
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.41265991644253114,1.2687274413414973,0.08515057113187954,0.5606868089902428,1.0,32/138,13.00%,PPARG;POLR2A;NR1H3;E2F3;RXRA;NCOR1;NOTCH2;RARA;GTF2B;GTF2H5;TAF7;MAML1;NR3C1;MAML2;NR1H4;CREBBP;TAF5;POLR2L;TBL1XR1;NR5A1;ESR1;NR2C1;POLR2G;CDK7;MED26;POLR2I;PPARD;NOTCH1;GTF2F2;RORA;MAZ;NRBF2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5398688895208339,1.2686300382607918,0.18604651162790697,0.5602988357579403,1.0,5/19,8.90%,PAPSS2;ENPP1;SLC26A1;SLC35B3;PAPSS1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5585911186471919,1.2684422235012043,0.19940915805022155,0.560187022065709,1.0,6/14,15.91%,CD200R1;TNFRSF1B;IGF1;TREM2;CX3CL1;GRN
prerank,regulation of DNA recombination (GO:0000018),0.4878902372939883,1.2681983689581782,0.15586034912718205,0.5602351480089409,1.0,8/32,12.76%,ALYREF;ZRANB3;KPNA2;SIRT6;THOC1;PPP4R2;RTEL1;IL7R
prerank,fat cell differentiation (GO:0045444),0.4427151829331627,1.2679720253386733,0.15098722415795587,0.5602100106039127,1.0,8/57,10.69%,PPARG;OSBPL8;TFAP2B;PID1;METRNL;FOXO1;SIRT1;MAFB
prerank,response to progesterone (GO:0032570),0.5349458907878167,1.2678207848093475,0.1843191196698762,0.5600423910645098,1.0,6/18,17.70%,NR1H3;CATSPERB;THBS1;CATSPER2;ACOD1;CATSPER3
prerank,protein localization to nucleus (GO:0034504),0.4209206315827312,1.2676419233235208,0.09904153354632587,0.5599325882712903,1.0,19/102,12.63%,MMP12;SYK;PIKFYVE;IPO5;E2F3;LMNA;APPL2;COL1A1;HNRNPU;DVL1;TOPORS;TPR;INTS13;NUP50;SUPT7L;TNPO1;NOL8;APPL1;WRN
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4401149737789435,1.267164352068013,0.14609286523216308,0.5607444220461846,1.0,22/62,23.07%,LGALS3;THBS1;EIF6;CREBBP;CNOT4;CBFB;TNRC6B;PTK2B;AGO3;KMT2E;MAFB;FES;PRKCB;CDC73;AGO4;KMT2A;PURB;RBM15;SIN3A;ZBTB16;CDK6;HSPA9
prerank,positive regulation of macroautophagy (GO:0016239),0.4671424597628874,1.2667813407406794,0.1396713615023474,0.56122612196357,1.0,12/48,10.68%,OPTN;SPTLC2;FYCO1;WAC;UVRAG;SESN2;SH3GLB1;RAB3GAP2;EPM2A;VPS13D;PAFAH1B2;SIRT1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5269319993178302,1.2666110169671874,0.19187675070028012,0.5610640652306458,1.0,7/20,16.72%,LRP1;PDGFA;SORL1;IGF1;PLAU;NRP1;ACE
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.512568333268797,1.2658875266691278,0.17408376963350786,0.5625934862125864,1.0,5/23,10.72%,NIBAN2;MMP14;IGF1;MAML1;PIEZO1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5537513668012223,1.2657873411476186,0.1903409090909091,0.5615805785189752,1.0,4/15,14.86%,DTNBP1;AP3S1;AP3D1;AP3B1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5537513668012223,1.2657873411476186,0.1903409090909091,0.5615805785189752,1.0,4/15,14.86%,DTNBP1;AP3S1;AP3D1;AP3B1
prerank,gliogenesis (GO:0042063),-0.4588151682201207,-1.2655863063664372,0.17701863354037267,0.5451745503743813,1.0,6/15,8.98%,NFIB;RELN;METTL3;CDH2;PAX2;TGFB2
prerank,positive regulation of MAPK cascade (GO:0043410),0.39990904276045924,1.2653273230631592,0.045408678102926335,0.5623065979039388,1.0,21/245,5.77%,GPNMB;CD36;HTR2B;IQGAP1;GDF15;PIK3R5;APOE;GCNT2;ADRA1D;ADRA1A;VEGFA;FBXW7;CD44;TAOK3;IL6;TMEM106A;PDGFA;NOTCH2;IGF1;FGFR4;ADAM8
prerank,cellular response to glucose starvation (GO:0042149),0.46971169125558143,1.2652990662867147,0.15311004784688995,0.5617352491352385,1.0,8/41,7.01%,MTMR3;CPEB4;PRKAG2;FOXO3;SESN2;SH3GLB1;SIK1;ATF4
prerank,post-translational protein modification (GO:0043687),0.4000712892154158,1.2651824821321789,0.030120481927710843,0.5614541291349137,1.0,89/332,21.26%,EPAS1;MFGE8;FBXO32;APOE;TIMP1;CCDC8;GPS1;ITIH2;FBXW7;SPP1;IL6;APLP2;PSMD1;FAM20C;SPSB4;CUL3;FBXW10;SOCS6;FBXL3;DCAF13;PROC;KLHL41;NUB1;BTBD1;RAB1B;WSB2;KLHL20;FBXO11;SPSB2;COPS5;QSOX1;FSTL1;DDB1;FBXO9;ATG5;CCN1;PSMF1;ASB4;ASB8;PSMD14;DCUN1D3;WDTC1;APP;RHBDD1;PSMD12;CUL4A;COPS7A;FBXO6;UBA3;RAB11B;FBXW2;GAS6;RBBP7;UBE2F;SERPINC1;PSME2;CUL1;NUCB1;SUMF1;RNF7;RAB2A;MELTF;LRRC41;DCUN1D1;KEAP1;UBE2M;PSMB10;GAN;PSMD5;DCAF10;ICMT;PSMD8;PSMA3;FBXO31;PSMA2;FBXO7;WFS1;PSMD11;RAB1A;DCAF7;SHISA5;RAB13;DDA1;ANO8;PSMA6;CUL4B;ZBTB16;FBXL4;ADAM10
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5374215613757247,1.2649314645849503,0.17166212534059946,0.5614965412381195,1.0,1/19,0.58%,APOE
prerank,replicative senescence (GO:0090399),-0.5020474758473075,-1.2647281698628634,0.18674698795180722,0.544885831329129,1.0,8/12,40.69%,ATM;ATR;CHEK2;ROMO1;CDKN2A;CHEK1;TERT;PLA2R1
prerank,embryonic heart tube development (GO:0035050),-0.4780604887054345,-1.2646269789046514,0.1891025641025641,0.5427207589208609,1.0,3/14,5.75%,ACVR1;RYR2;MEGF8
prerank,positive regulation of viral genome replication (GO:0045070),0.49708956544296223,1.2644932491947622,0.17358490566037735,0.5621248264254083,1.0,11/29,17.66%,CD28;SRPK2;RAD23A;PPIH;DDB1;CNOT7;PKN2;PPIE;ADARB1;TMEM39A;SRPK1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5283111929229045,1.2643797894095432,0.18356164383561643,0.56179820278198,1.0,4/20,10.39%,ADRA1D;ADRA1A;AKAP13;LMBRD2
prerank,regulation of blood circulation (GO:1903522),-0.3623208078566014,-1.264296106477932,0.13875598086124402,0.5411455154268754,1.0,22/34,37.44%,CELF2;ECE1;AGT;KCNG2;ADORA3;TPM1;FXYD1;KCNMB4;PER2;TMIGD3;DMPK;KCNJ12;AGER;CACNA1H;BDKRB2;KCNQ1;PLN;KCNIP2;CAMK2D;TBX2;KCNMB2;DES
prerank,retinoid metabolic process (GO:0001523),0.43810348796466864,1.2640158040437082,0.12597547380156077,0.5622007587607786,1.0,6/71,5.06%,APOE;STRA6;DHRS3;LRP1;RBP1;RDH12
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4616560928446423,1.263871473280279,0.14608076009501186,0.5619878186870532,1.0,10/48,10.68%,ANXA1;VEGFA;PDPK1;RHOJ;P2RX4;THBS1;HMOX1;ADAM17;ATP5F1A;SIRT1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.508446695396899,1.2638420770095378,0.16623376623376623,0.5614401988115715,1.0,4/26,10.69%,GPR137B;LILRB3;RARA;MAFB
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5887663110109351,1.2638154333843623,0.2027231467473525,0.5608703299520835,1.0,4/12,22.58%,IRX3;SRI;CALM2;PDE4D
prerank,regulation of response to external stimulus (GO:0032101),0.41428255023204036,1.2637873393056294,0.08937960042060988,0.5603123148874574,1.0,28/121,16.77%,CD36;CXCR4;ANXA1;MGLL;P2RX4;PPEF1;APPL2;CELF1;SHPK;STK24;RNF135;TKFC;CAMKMT;XIAP;FOXP1;BIRC3;APPL1;TREM2;RELA;TRAF3;FGR;N4BP1;CASP12;CX3CL1;MYD88;GRN;BST1;NLRP6
prerank,cellular response to ionizing radiation (GO:0071479),0.457540229901247,1.2635480618907597,0.1404561824729892,0.5603661850099106,1.0,16/47,20.72%,MAP3K20;GRB2;CDKN1A;TANK;GADD45A;NIPBL;XRCC5;SIRT1;WRN;INTS7;INO80;RPL26;CLOCK;TLK2;EEF1D;TNKS1BP1
prerank,rRNA 3'-end processing (GO:0031125),0.6040584073565598,1.2633294558729635,0.2115085536547434,0.5603719349184547,1.0,7/10,20.78%,EXOSC3;EXOSC9;RPS21;ERI1;EXOSC8;EXOSC10;EXOSC7
prerank,regulation of defense response (GO:0031347),0.4301885563184833,1.263120440123684,0.11817168338907469,0.5603004938309016,1.0,22/76,16.77%,APOE;ANXA1;MGLL;APPL2;CELF1;SHPK;RNF135;TKFC;XIAP;FOXP1;BIRC3;APPL1;TREM2;RELA;TRAF3;FGR;N4BP1;CASP12;MYD88;GRN;BST1;NLRP6
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.3179064026227926,-1.2629566186232264,0.0898876404494382,0.5420460435662087,1.0,24/75,22.24%,SLC9A9;SLC12A2;ATP1B1;SLC12A6;SLC24A2;ATP1A2;KCNJ2;TRPM4;ATP1B2;KCNJ3;TRPM2;KCNJ9;SLC6A1;HCN2;ATP2B4;SLC12A4;CACNA2D1;KCNK9;SLC39A8;SLC9A1;ABCC9;KCNJ6;SLC8A2;SLC12A9
prerank,macromolecule catabolic process (GO:0009057),0.5101207237535889,1.2627792046470643,0.18471337579617833,0.5607034392963539,1.0,6/26,4.46%,TPP1;KIF16B;UVRAG;PPT1;CLN5;SH3GLB1
prerank,protein targeting to peroxisome (GO:0006625),0.49024470662599384,1.2626582360506584,0.18610747051114024,0.5604206083097312,1.0,9/29,12.83%,RAB8B;ABCD1;PEX7;PEX14;ALDH3A2;PXMP2;ZFAND6;LONP2;GDAP1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4628898960121596,1.262635797089687,0.14066193853427897,0.5598575516146197,1.0,11/43,15.36%,CBLB;GRB2;RAB7A;DUSP3;STAM;SH3KBP1;RNF115;CHMP6;EPS15;STAM2;CBL
prerank,positive regulation of chemotaxis (GO:0050921),0.4632471214373959,1.26249961355696,0.15558194774346792,0.5596112330921522,1.0,10/43,12.31%,F7;STX3;VEGFA;IL6;P2RX4;THBS1;DSCAM;IL6R;ADAM17;TREM2
prerank,protein lipidation (GO:0006497),0.44413430433311796,1.262079462027129,0.13963963963963963,0.5602387214506749,1.0,14/59,16.35%,ZDHHC14;ATG7;PGAP3;DPM2;ZDHHC16;ATG10;PIGH;ZDHHC12;ZDHHC18;ATG5;PIGC;GPLD1;PIGQ;ZDHHC17
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.42581747337170417,1.2620550278494207,0.1222707423580786,0.5596858974273963,1.0,21/86,13.29%,VEGFA;TEC;CD44;IL6;HGF;ITGA5;PRKCD;PDGFA;IGF1;IL5;IL6R;RAP2B;CNOT7;PTK2B;PAK2;ARHGEF2;APP;IL15;TREM2;HCLS1;DGKQ
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5441144675308867,1.2616814550940731,0.20385674931129477,0.5601622307122194,1.0,4/18,7.11%,ANXA1;VEGFA;RHOJ;HMOX1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.5210257429086895,1.2615460721477028,0.18252933507170796,0.5599421704579544,1.0,4/22,6.49%,IPO5;CDKN1A;PTEN;APC
prerank,protein polyubiquitination (GO:0000209),0.3958197593479549,1.26124933690228,0.03733602421796166,0.5602273071311896,1.0,116/297,25.54%,FBXO32;SASH1;TRIP12;CTNNB1;ZNRF1;WWP1;NPEPPS;FBXW7;RNF26;PSMD1;UBE2Q2;RNF19A;FBXL17;UBE2L3;ANAPC1;CUL3;FBXW10;UBE2K;FBXL3;RNF135;RPS27A;UBC;NHLRC1;BRCA1;BFAR;LONRF1;NEDD4L;KLHL20;WWP2;RNF115;FBXO11;RNF146;CBFB;TOPORS;HUWE1;ARIH2;RLIM;FBXO9;MIB2;NHLRC3;PSMF1;UNKL;PSMD14;STUB1;RUSC1;TRAF1;PSMD12;RNF34;FBXO6;CHFR;FBXW2;TRAF3;TNFAIP3;PRKN;HECTD1;TRAF3IP2;PSME2;CUL1;FBXO28;TNKS;ANAPC10;TRAF5;LNPEP;TRAF2;CDC34;BLMH;TMEM129;UBE2O;PSMB10;PSMD5;TRIM14;TNKS2;MYLIP;UBE2V1;BIRC2;PSMD8;AMFR;PSMA3;FBXO31;PSMA2;UBE2S;FBXO7;PSMD11;PELI2;UBE2R2;DDA1;RNF19B;PSMA6;SPOP;MKRN1;FBXL4;TAF1;UBE2H;PSMB3;RNF125;IRF2BP1;UBE4A;RNF168;SIAH2;PSME3;UBE2D3;ARIH1;KLHL3;UBE4B;TRAF6;FBXO4;UBE2J2;TTC3;PRPF19;UBE2E1;PSMC5;ANAPC7;UBR5;FBXO30;FBXW8;FZR1
prerank,regulation of mRNA stability (GO:0043488),0.4090437394793542,1.261159271321239,0.08722741433021806,0.5598654435415538,1.0,43/145,20.78%,SAMD4A;VIM;PRKCD;PSMD1;CELF1;IGF2BP3;YTHDF3;E2F1;PCID2;TENT5A;HNRNPU;RPS27A;UBC;ZFP36L2;EXOSC3;EXOSC9;SERBP1;ROCK1;FTO;PSMF1;PSMD14;PUM2;TNPO1;EXOSC8;PSMD12;SLC11A1;HSPA1A;TENT5D;GDNF;HNRNPD;PSME2;THRAP3;EXOSC1;TAF15;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;XPO1;PSMA6;EXOSC7
prerank,sphingolipid biosynthetic process (GO:0030148),0.4385050919651644,1.260993672293926,0.13919821826280623,0.5597042020941321,1.0,20/71,17.45%,PLPP3;SPTLC2;SAMD8;SGPL1;CERT1;SGMS2;HACD4;B4GALT6;CERS6;SPHK2;SPTSSA;VAPA;A4GALT;ELOVL1;ALDH3A2;DEGS1;PRKD3;TLCD3B;SGMS1;ACER2
prerank,positive regulation of angiogenesis (GO:0045766),0.41643908931190826,1.2605009517793035,0.09957627118644068,0.5605874211654155,1.0,20/108,12.10%,APLNR;SASH1;VEGFA;AQP1;ITGA5;PDPK1;NINJ1;THBS1;AGO2;SIRT6;HMOX1;BRCA1;HIPK1;CTSH;VASH2;HIPK2;ITGB1;SIRT1;PRKCB;S100A1
prerank,respiratory electron transport chain (GO:0022904),0.5509749776013769,1.2604265281619793,0.19914651493598862,0.5601687455496295,1.0,9/14,25.88%,ETFRF1;UQCRFS1;SDHB;SDHA;ETFA;SLC25A13;GPD2;SLC25A22;NDUFA5
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.615308318015442,1.2601721199699212,0.21351766513056836,0.5603035461559696,1.0,5/10,13.29%,ZNF692;GNMT;SDHAF3;SIRT7;DGKQ
prerank,glycoprotein metabolic process (GO:0009100),0.445007314454294,1.2601639716069257,0.16342857142857142,0.5597009915007448,1.0,13/53,14.55%,HPSE;B4GALT5;MAN1C1;TNIP1;B4GALT7;MAN2A1;MANBA;ST3GAL4;AGA;OGA;MAN2A2;FBXO6;GOLPH3
prerank,cellular response to UV-A (GO:0071492),0.6052537562342254,1.2599583201985902,0.20948012232415902,0.5597004804552455,1.0,1/11,0.97%,TIMP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5889081150160402,1.259604712305064,0.218562874251497,0.560180689236622,1.0,5/11,17.43%,ST18;FAS;HTRA2;CAAP1;PRR7
prerank,oogenesis (GO:0048477),-0.46545773323413137,-1.259475357610747,0.1715210355987055,0.5479781834843499,1.0,8/15,38.37%,FMN2;METTL3;IHO1;TRIP13;PIWIL2;PTN;HORMAD1;NANOS1
prerank,stress granule assembly (GO:0034063),0.5230721646929842,1.2591619067561712,0.20272108843537415,0.5608684103551318,1.0,5/20,4.88%,DYNC1H1;UBAP2L;DDX6;ATXN2;YTHDF3
prerank,positive regulation of transmembrane transport (GO:0034764),0.583836984173687,1.259009517959273,0.18059701492537314,0.5606926048324896,1.0,7/13,25.57%,ANO6;ACSL5;AZIN1;CA2;AZIN2;BRAF;C3
prerank,defense response to protozoan (GO:0042832),0.5739669382748126,1.2588153356703449,0.2043343653250774,0.5606681292794391,1.0,4/12,15.81%,LYST;GBP6;SLC11A1;MYD88
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6092813957258414,1.2588097869225343,0.2123076923076923,0.5600634554622129,1.0,6/10,25.38%,SOX9;PKDCC;ACVRL1;ZBTB16;BMPR1B;SOX5
prerank,innate immune response (GO:0045087),0.39711426841903197,1.2585366625058474,0.04554655870445344,0.5602188603882324,1.0,52/217,18.02%,PPARG;SYK;TLR8;FRK;CLEC4D;KYNU;IFITM1;MSRB1;ANKRD17;SRPK2;TRIM17;RNASE3;TRIM25;ANKHD1;RNF135;CYBB;NUB1;REL;CYBA;MFHAS1;NCF2;TKFC;AKAP1;MEFV;TYROBP;IFITM2;MAVS;TREML1;PTK2B;FES;APP;BST2;RELB;TREM2;BTK;MFAP4;CYBC1;RELA;ATAD3A;FGR;SLC11A1;SLPI;NRROS;KLRD1;LBP;MYD88;CAPZA1;NCF1;MASP1;SRPK1;TRIM14;DEFA6
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5905425967147521,1.25775269609627,0.2,0.5618464284022945,1.0,2/12,7.28%,CD36;CYBA
prerank,positive regulation of RNA splicing (GO:0033120),0.4918822234989398,1.2567855299136492,0.1927860696517413,0.5640669619677862,1.0,10/29,19.65%,HNRNPLL;ERN1;POLR2A;DYRK1A;HSPA1A;PRDX6;NUP98;THRAP3;RBM22;NCL
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.44250958308692445,-1.256755424115793,0.17406143344709898,0.5524488271176801,1.0,6/17,18.64%,CCND3;EGFR;PKD2;PKD1;PSMD10;RGCC
prerank,positive regulation of RNA metabolic process (GO:0051254),0.46262923636889736,1.2565898772415314,0.17341040462427745,0.5640696133534522,1.0,11/45,13.96%,HNRNPLL;ERN1;POLR2A;IL6;RIPK1;DDX5;DYRK1A;GRSF1;SIRT7;RELA;HSPA1A
prerank,regulation of protein kinase activity (GO:0045859),0.41647623303235715,1.256294745525421,0.11419423692636073,0.5643505674113891,1.0,24/106,14.56%,IQGAP1;DTNBP1;GNAQ;PRKAG2;PDPK1;CDKN1A;SNX9;UVRAG;TAF7;GSKIP;CACUL1;RB1;DVL1;CEP85;XRCC5;RAP2B;PTK2B;PAK2;SIRT1;CCN1;TAB2;GAS6;FGR;LRP6
prerank,negative regulation of axonogenesis (GO:0050771),-0.39130351878333197,-1.2562226645583252,0.17766497461928935,0.5513089537287182,1.0,13/27,14.21%,DCC;ARHGDIA;MAG;RNF6;MAP2;FGF13;DIP2B;EFNB3;CDKL3;LINGO1;ULK2;GDI1;RHOA
prerank,positive regulation of B cell activation (GO:0050871),0.4552621864214544,1.2561534815020141,0.16896551724137931,0.5641021316094139,1.0,8/50,7.14%,CD38;SYK;VAV3;TFRC;IL6;MMP14;IRS2;SH3KBP1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5371209018187177,1.2556678789457973,0.19241573033707865,0.5648800236730844,1.0,3/17,10.54%,CEBPB;SOX9;MAFG
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.4030624014422806,-1.2549967046902053,0.13358778625954199,0.5518134036526506,1.0,5/24,6.87%,MEF2C;CTNNA2;MEF2A;CDH2;CDON
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5785069508943055,1.254942317571512,0.20029895366218237,0.566301577366169,1.0,8/12,23.37%,APOE;ABCA2;PICALM;ROCK1;RANBP9;FKBP1A;ABCA7;TMED10
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5532865349631917,1.2548258071759386,0.19094766619519093,0.5660314647439995,1.0,5/17,11.12%,ACD;MUTYH;NEIL1;TERF1;MBD4
prerank,regulation of actin filament polymerization (GO:0030833),-0.3174182523730898,-1.2547276291385672,0.06837606837606838,0.5500921676271762,1.0,14/69,7.81%,SSH2;BIN1;TWF2;EVL;FCHSD2;PRKCE;VASP;CYRIB;FER;HCK;NCKAP1;NCK1;SSH3;CARMIL1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5080534994112434,1.254704395514371,0.20485175202156333,0.5657924456648982,1.0,15/26,26.87%,IRAK2;RPS27A;UBC;TAB2;TNFAIP3;UBE2V1;AAMP;ALPK1;IRAK1;TRAF6;CASP8;TAB1;MAP3K7;TAB3;CYLD
prerank,negative regulation of immune system process (GO:0002683),0.5575842238344346,1.254215175710263,0.21030042918454936,0.5666960029279291,1.0,5/16,13.02%,FOXP3;FCRLB;HMOX1;SOX9;COL3A1
prerank,regulation of protein catabolic process (GO:0042176),0.41371002227382264,1.2538699681692302,0.11302475780409042,0.5671106038320284,1.0,28/99,17.72%,ATG7;WWP1;TIPARP;RAB7A;PLK2;CTSA;WDR91;SORL1;EEF1A1;IRAK3;APC;STX5;NEDD4L;WWP2;HUWE1;DDB1;GSK3B;FOXO1;OAZ2;CHMP6;TNFAIP3;PRKN;SNF8;AZIN1;PRKCG;OAZ1;CSNK2A1;SNX3
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.6072115348012174,1.253868395916902,0.2020033388981636,0.5665007186655302,1.0,7/10,26.73%,NPLOC4;TKFC;C1QBP;RNF125;DHX58;GPATCH3;RIOK3
prerank,regulation of protein sumoylation (GO:0033233),0.5387343383169685,1.2532685912603605,0.20985915492957746,0.5676502675414232,1.0,4/17,7.75%,ZMIZ1;CTNNB1;RWDD3;PIAS4
prerank,lamellipodium assembly (GO:0030032),-0.39400108829318403,-1.2531175633967788,0.16818181818181818,0.5515950476749693,1.0,9/26,9.91%,P2RY12;ABLIM1;SPATA13;PTPRO;SRGAP2;S1PR1;CARMIL1;ARFIP2;ARHGEF6
prerank,fatty acid catabolic process (GO:0009062),0.43179507595383504,1.253081157768802,0.14479638009049775,0.5675939356469547,1.0,19/67,19.89%,CEL;LPIN3;ABCD1;HADHA;SLC27A4;MTLN;ACADL;ACADVL;AIG1;PPARD;ALDH3A2;MCEE;ECHDC1;EHHADH;ACAA2;ACAD10;NUDT7;ACBD5;SLC25A17
prerank,negative regulation of cell activation (GO:0050866),0.5621896748554971,1.2530005643284057,0.20784883720930233,0.5672066222813241,1.0,3/14,12.31%,APOE;PDGFA;TREM2
prerank,positive regulation of viral transcription (GO:0050434),0.5030760556266451,1.2528562089700872,0.20509383378016086,0.5670331710747591,1.0,7/25,13.41%,MDFIC;POLR2A;POLR2L;POLR2G;POLR2I;GTF2F2;CTDP1
prerank,extracellular transport (GO:0006858),0.5783082668736397,1.2519005268167027,0.2075187969924812,0.5692635163942067,1.0,3/12,12.58%,CCDC40;WWP2;SPAG17
prerank,signal peptide processing (GO:0006465),0.5999234756561002,1.2518870744718114,0.2026431718061674,0.5686821113286272,1.0,6/11,25.35%,CLN5;HM13;SPCS2;PARL;FURIN;SPPL3
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5384177542635316,1.2513859559175886,0.21587743732590528,0.569525699376268,1.0,6/16,21.80%,PYGL;AOAH;AGL;PHKG2;MGAM;PYGB
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.5430665493857225,1.2507639953636496,0.20140845070422536,0.5706956650754752,1.0,7/16,23.38%,MUS81;MSH4;EME1;CENPX;RMI1;FANCM;ERCC4
prerank,protein localization to vacuole (GO:0072665),0.5725746440738574,1.2505830468061157,0.19448476052249636,0.570606365067807,1.0,4/13,6.72%,SH3GLB1;GLMP;RNF128;LMBRD1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5314119540547162,1.2497250293057003,0.211484593837535,0.5724710722970472,1.0,5/18,13.77%,NFE2L2;HTRA2;MAPK7;SIRT1;PRKN
prerank,blood circulation (GO:0008015),0.45428388266321096,1.2495536307141442,0.16355140186915887,0.5723377700676442,1.0,6/49,10.10%,MYOF;CYB5R3;MYL2;C3AR1;ACVRL1;ROCK1
prerank,regulation of fibrinolysis (GO:0051917),0.5798593913157817,1.2494304043396351,0.21783625730994152,0.5721336169761915,1.0,2/13,5.50%,F11;THBS1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3859519401365825,-1.2487515192864367,0.18018018018018017,0.5597022447789325,1.0,6/27,7.50%,P2RY12;IRS1;FGF2;FLT3;PRKD1;ATG14
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.426045582434433,-1.2484670501371913,0.14338235294117646,0.5579462142972762,1.0,5/19,8.98%,ACVR1;BMPR1A;TGFBR2;MDM4;TGFB2
prerank,protein oxidation (GO:0018158),0.5943418352474218,1.2481662338468618,0.21898928024502298,0.5752220310734981,1.0,2/11,15.82%,CHCHD4;SUMF1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.554412783297619,1.2477925399695113,0.19472913616398244,0.5757295067116192,1.0,2/14,6.99%,AK8;NMNAT1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6092421151037873,1.2476388079348468,0.219435736677116,0.5755600450566943,1.0,1/10,0.53%,NAMPT
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5065801018165899,1.2475170329128427,0.18972332015810275,0.5753057254707793,1.0,5/24,8.88%,TRPS1;SOX9;SNAI2;PKDCC;ACVRL1
prerank,response to muscle stretch (GO:0035994),0.5491671752813548,1.247140825670933,0.21337126600284495,0.5757451485331341,1.0,3/15,6.43%,CTNNB1;SLC8A1;PIK3CA
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.39743740821721996,1.2466725611042289,0.06707317073170732,0.576527100686457,1.0,63/234,18.80%,CD36;PPARG;PLPP3;RAB7B;PRKCH;CTNNB1;VEGFA;FLOT1;IRAK2;TFRC;IKBKE;IL6;RIPK1;PTEN;TRIM25;ADAM8;NFKBIB;CRTC1;STK3;IRAK3;HSPA1B;RPS27A;UBC;NLRC4;ARID5B;COPS5;HIPK2;RIPK4;DDIT3;MAVS;ESR1;MTPN;ARHGEF2;APP;TAB2;PRKCB;TRAF1;TRIM41;ROR1;BTK;HCLS1;FZD2;PPRC1;RELA;BUD31;HSPA1A;ADCY8;CX3CL1;LRP6;TRAF5;PPARGC1B;MYD88;NHLH2;TRAF2;SLCO3A1;ERC1;ZBTB7A;SMARCB1;TRIM14;UBE2V1;CARD11;CLOCK;CRTC3
prerank,lamellipodium organization (GO:0097581),-0.3756937202229335,-1.2457490146349028,0.1461187214611872,0.5623229622996738,1.0,9/29,9.91%,P2RY12;ABLIM1;SPATA13;PTPRO;SNX2;S1PR1;CARMIL1;ARFIP2;ARHGEF6
prerank,androgen receptor signaling pathway (GO:0030521),0.5940378770094359,1.2457482775568818,0.2125748502994012,0.5786985443985858,1.0,3/11,7.18%,ZMIZ1;DDX5;KDM3A
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.42701164241937983,1.2454795883204208,0.15138121546961325,0.5788563319317767,1.0,34/77,25.34%,LGALS3;SLC35F6;HGF;BIRC6;RIPK1;IGF1;PPIF;THBS1;SH3RF1;RB1;CSNK2A2;MAZ;RELA;PRKN;HSPA1A;CX3CL1;PHIP;MCL1;ACAA2;CAAP1;NDUFS3;CSNK2A1;NOC2L;HTT;TCF7L2;ITGAV;PLAUR;HERPUD1;SIAH2;PSME3;NDUFA13;BCL2L1;GPX1;FXN
prerank,negative regulation of catabolic process (GO:0009895),-0.34026286324874744,-1.2451167083247865,0.0896551724137931,0.5614789549890356,1.0,18/47,23.82%,PDE3B;FMN2;CST3;BANP;CBFA2T3;EGFR;MDM4;APOC1;SIRT2;GIT1;CYP51A1;TNF;ADGRB1;TIGAR;AGAP2;PFKFB1;IL1B;ADRA2A
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.398172222245316,1.2450978967326352,0.06350806451612903,0.5793275314466766,1.0,54/208,18.37%,HTR2B;LITAF;OPTN;TFRC;IKBKE;PLK2;PDPK1;TMEM106A;TNIP1;ANKRD17;TANK;RIPK1;TRIM25;NR1H4;SPHK2;REL;HMOX1;AKAP13;TICAM2;VAPA;MAVS;ESR1;NLRC3;BIRC3;SIRT1;MIB2;TAB2;BST2;PRKCB;WLS;TRAF1;RORA;ROR1;ZFAND6;TREM2;RELA;TRAF3;GOLT1B;TNFAIP3;PRKN;CX3CL1;SQSTM1;TRAF3IP2;TRAF5;SLC44A2;MYD88;GPR89A;TRAF2;ZDHHC17;LTBR;TRIM14;UBE2V1;BIRC2;CARD11
prerank,regulation of protein kinase A signaling (GO:0010738),-0.41893141859020117,-1.244637886823215,0.15671641791044777,0.5602675700724434,1.0,6/20,19.70%,PJA2;AKAP12;ADGRV1;AKAP5;PRKAR2B;TCIM
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.452419887788486,1.2446204287729863,0.17661388550548113,0.5801540309625666,1.0,10/44,10.44%,CELF1;YTHDF3;AGO2;ZFP36L2;ZC3HAV1;TNRC6B;ROCK1;POLR2G;CNOT7;FTO
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5692838497713363,1.2444143806424384,0.22575757575757577,0.5801175258561893,1.0,4/13,10.29%,PDPK1;ITGA4;SIRT6;ADAM17
prerank,response to muramyl dipeptide (GO:0032495),0.5853668343276969,1.244060354870848,0.2290748898678414,0.5805134598369046,1.0,5/12,16.59%,VIM;ARHGEF2;TRIM41;ERBIN;CHMP5
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.4838228662907721,1.243998824805701,0.20595533498759305,0.5800798263366699,1.0,9/30,16.07%,FAS;RIPK1;HMOX1;BRCA1;GSK3B;ARHGEF2;RNF34;TNFAIP3;TRAF2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.43165110745220253,1.2436565900782504,0.1514476614699332,0.58048919692358,1.0,16/68,16.60%,SYK;RAB7B;TLR8;IL6;TMEM106A;SPHK2;CYBA;TYROBP;IL6R;MAVS;ARHGEF2;APP;LBP;MYD88;HSPD1;TLR1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4962111321418173,1.2434612698245535,0.20584498094027953,0.5804820264427348,1.0,9/28,14.35%,APOE;EIF2AK4;CALB1;TYROBP;GSK3B;APP;CYP46A1;ADCY8;SQSTM1
prerank,proton transmembrane transport (GO:1902600),0.4788595007784492,1.2432418183395828,0.17037037037037037,0.5804967256094989,1.0,10/36,17.31%,SLC36A2;ATP6V1A;ATP6V0D1;NNT;ATP6V0E1;ATP6V0C;ATP6V1H;ATP6V1F;COX15;SLC36A1
prerank,inositol phosphate metabolic process (GO:0043647),-0.33715217154738575,-1.243161356585786,0.09554140127388536,0.561673708530375,1.0,13/46,11.22%,INPP4B;INPP5D;PLCB1;IP6K2;IMPA1;PPIP5K1;PLCH1;FGF2;ITPK1;PLD4;ITPKC;NUDT3;MINPP1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.49610262732700916,1.2427763877255433,0.18758256274768825,0.5811892590264467,1.0,2/25,3.87%,CD36;P2RX4
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.4774774557971389,1.2421646585636217,0.17791411042944785,0.582368839148375,1.0,8/30,13.96%,DPM2;MGAT5;MCFD2;NUDT14;DDOST;DAD1;MAGT1;UGGT1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4195712505676654,1.2421217794125403,0.1345093715545755,0.5818793501401642,1.0,22/85,15.40%,DENND4C;GRB2;DENND1A;MYO9B;NOTCH2;RAF1;IGF1;IRS2;FLCN;AKAP13;VAV1;DLC1;ARHGAP17;ARHGEF2;LZTR1;NOTCH1;RAPGEF1;RASGEF1A;ERBIN;SQSTM1;SHC1;MAPKAP1
prerank,action potential (GO:0001508),-0.34017922057153444,-1.2419914079697418,0.13836477987421383,0.5620549755404989,1.0,12/44,17.99%,KCND2;SCN2A;ANK3;GNA15;KCNJ2;SCN9A;CACNA1G;MYH14;YWHAH;SCN8A;CACNA1I;GNA11
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4099450320810578,1.2419889708967864,0.12632696390658174,0.581660746252381,1.0,21/117,14.12%,SYK;GPR15;PTGDR;PLK2;IL6;HTR6;RHBDF2;PLA2G2D;GPR83;ADCY7;PTGER2;GPR176;PTGER4;VIPR1;ADAM17;PTH2R;MYH9;TREM2;FGR;ADCY8;ADCY3
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4206607728477854,1.2417521679180625,0.13577586206896552,0.5817230427505107,1.0,17/86,12.73%,GDF15;SDCBP;ZEB2;CITED2;THBS1;CREBBP;FLCN;RBPMS;ACVR2A;ACVRL1;HIPK2;BMPR2;ADAM17;CCN1;ACVR1B;NOTCH1;SULF1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5351839009648286,1.2406198688384553,0.21662125340599456,0.5843695015832162,1.0,6/18,19.84%,BCL2L11;ERN1;DDIT3;BAX;ATXN3;FCGR2B
prerank,small GTPase mediated signal transduction (GO:0007264),0.41125433161568625,1.2405070479646712,0.12134344528710726,0.5840437571746446,1.0,29/103,16.26%,ABR;GRB2;PLK2;SOS1;CDKN1A;PLD2;RGL1;JUN;RGL2;ARHGAP31;BRAP;IGF1;NRAS;RREB1;RB1;KSR2;RGS19;ARHGAP18;RRAD;RAB18;CCNA2;RIT1;ARL3;RRAS;SHC1;NUCB1;DNMT1;USP8;CCDC88C
prerank,ether lipid metabolic process (GO:0046485),0.5560472184326904,1.240199344351908,0.22910662824207492,0.5842973172926786,1.0,5/14,11.60%,PLA2G7;NCEH1;PEX7;PEDS1;PLAAT3
prerank,carboxylic acid metabolic process (GO:0019752),0.47482524914231483,1.2399027586285707,0.17423312883435582,0.5846196216891724,1.0,11/33,14.65%,CYB5R3;GNMT;PON3;GLYAT;GRHPR;CYB5A;LIAS;SLC2A1;SLC23A2;SLC23A1;GSTO2
prerank,female gonad development (GO:0008585),0.5185089337544363,1.239808375107086,0.2181571815718157,0.584295719153408,1.0,3/19,9.43%,VEGFA;CEBPB;NR5A1
prerank,negative regulation of DNA recombination (GO:0045910),0.4618723980734983,1.2397318430994186,0.18579881656804734,0.5839055233401872,1.0,10/43,10.93%,POLR2A;ACD;ZRANB3;HELB;PARP3;POLR2L;RTEL1;TERF1;POLR2G;POLR2I
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3796249139192909,-1.2390598688958006,0.17972350230414746,0.5669683535198575,1.0,4/29,3.60%,CADM1;ITGAM;CYRIB;STX7
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5245198951223754,1.2386809397344225,0.21562952243125905,0.5864824143796505,1.0,9/18,24.62%,ANKRD17;NPLOC4;BIRC3;PUM2;BIRC2;C1QBP;RNF125;DHX58;GPATCH3
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.42552414635654917,1.238210916060572,0.17640449438202246,0.5873163376989775,1.0,22/73,21.52%,FNIP2;VEGFA;TXN;FNIP1;TFRC;CD44;IL6;RAF1;APP;HCLS1;GAS6;TENM1;PFN2;LATS1;CAMK1;SH2D3C;STK4;BCAR3;TBK1;OSM;TNKS1BP1;BRAF
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3881219384190884,-1.2376825831265763,0.1680327868852459,0.5679826382512869,1.0,7/26,11.50%,ATP1B1;ANK2;KCNAB1;ATP1B2;AKAP9;ACTN2;DLG1
prerank,positive regulation of vasculature development (GO:1904018),0.4132326208233563,1.2374426140873809,0.12837108953613807,0.5889830350269802,1.0,17/94,11.72%,APLNR;SASH1;VEGFA;AQP1;PDPK1;NINJ1;THBS1;AGO2;HMOX1;BRCA1;HIPK1;CTSH;VASH2;HIPK2;ITGB1;SIRT1;PRKCB
prerank,organophosphate ester transport (GO:0015748),0.5028295927889195,1.2366742375697917,0.22795115332428764,0.5906107666265517,1.0,7/24,14.01%,OSBPL8;PLTP;ABCA3;PITPNA;EPG5;PITPNC1;PRELID3A
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5835403537711219,1.2364725381926618,0.2196969696969697,0.5906093197296243,1.0,2/11,3.44%,ABCB7;ABCD1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5565028524926601,1.236115777127825,0.22741433021806853,0.5910512042262742,1.0,4/13,10.25%,AGO2;TNRC6B;POLR2G;CNOT7
prerank,detection of calcium ion (GO:0005513),-0.4676493416517682,-1.2357262013328099,0.21021021021021022,0.5703480208667145,1.0,2/13,3.65%,SYT1;RYR2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5541181147985254,1.2356841975378885,0.22423398328690808,0.5916465861501836,1.0,8/14,26.89%,ACD;TPP1;XRCC5;TNKS;TNKS2;TERF2IP;BRCA2;TINF2
prerank,cellular response to nutrient levels (GO:0031669),0.4369937730393377,1.2356175648867722,0.15754189944134078,0.5912359394978454,1.0,12/62,12.67%,TFEB;ATG7;FNIP1;PDK4;STK24;FLCN;LAMP2;BMPR2;FOXO1;SIRT1;WRN;GAS2L1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.5696386093134315,1.235433867570731,0.2303120356612184,0.5911867669841766,1.0,6/11,19.08%,FGFR4;NR1H4;NR5A1;SIRT1;DGKQ;ASAH1
prerank,carboxylic acid catabolic process (GO:0046395),0.5785522338748246,1.2353149353164108,0.23273273273273273,0.5909484842179636,1.0,4/12,14.64%,RENBP;PON3;NAGK;GNPDA1
prerank,regulation of developmental growth (GO:0048638),0.48830381775219506,1.23528185435338,0.20310478654592498,0.5904394497734861,1.0,7/29,15.05%,APOE;IGF1;STAT5B;NIPBL;GSK3B;APP;LATS1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4137578510796684,1.2342126567131475,0.13867822318526543,0.5929334065628403,1.0,25/93,19.66%,FNIP2;NCK2;VEGFA;TXN;FNIP1;TFRC;CD44;IL6;PTEN;RAF1;GPD1L;CNKSR3;NLRP2B;APP;HCLS1;GAS6;TENM1;PFN2;LATS1;CAMK1;SH2D3C;STK4;BCAR3;TBK1;OSM
prerank,positive regulation of T cell activation (GO:0050870),0.4298539231599344,1.2341246409395468,0.1712018140589569,0.5925597834161711,1.0,8/62,4.07%,ZMIZ1;ANXA1;NCK2;TFRC;IL6;CD28;CD46;CD274
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.568688141966347,1.2337360635271268,0.22976878612716764,0.5924635754788159,1.0,5/13,14.72%,GRB2;STAT5B;IL15;SHC1;JAK3
prerank,cellular response to interleukin-15 (GO:0071350),0.568688141966347,1.2337360635271268,0.22976878612716764,0.5924635754788159,1.0,5/13,14.72%,GRB2;STAT5B;IL15;SHC1;JAK3
prerank,regulation of translational initiation (GO:0006446),0.4316329408112268,1.233466576179554,0.15754189944134078,0.5926780331555769,1.0,21/63,19.01%,NCK2;CEBPB;EIF1;ATF3;YTHDF3;AGO2;EIF2AK4;ATF4;EIF4EBP2;TPR;EIF3B;EIF5;POLR2G;NCBP2;CDC123;UHMK1;ALKBH1;EIF3H;EIF2B2;EIF4G3;EIF4G2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4148746139111002,1.2328872996361238,0.1512513601741023,0.5938228205474962,1.0,31/88,20.56%,MYO5A;DTNBP1;FTL;KIF16B;CLINT1;SORL1;CHMP2A;RABEP1;KLHL20;RAB10;VPS13C;APP;AP1G2;VPS35L;AP1G1;ARFGEF2;CLVS2;EPS15;ARL3;EXOC4;ARRB1;SH3D19;RABIF;FTH1;EXOC1;AP1M1;AP4M1;VPS13A;GOPC;VAMP2;SNAP23
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.47518997008593084,1.2328618914951979,0.19506172839506172,0.5932943484377766,1.0,8/32,11.43%,MMP12;CORO1C;PTEN;THBS1;NF2;DLC1;ACVRL1;BCAS3
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3852460283175144,1.2324855050217036,0.0473313192346425,0.5937816120884335,1.0,124/341,24.85%,RNF149;TRIP12;NFE2L2;CTNNB1;ZNRF1;WWP1;FBXW7;PSMD1;BIRC6;RNF19A;RNF130;ZFAND2A;FBXL17;TRIM25;WDR91;ZNRF3;UBE2L3;ANAPC1;SPSB4;CUL3;NPLOC4;UBE2K;MVB12B;RNF128;NUB1;CNOT4;NHLRC1;BFAR;KCTD21;NEDD4L;KLHL20;WWP2;RNF115;FBXO11;RNF146;RAD23A;SPSB2;TOPORS;TBL1XR1;HUWE1;PCNP;VPS4A;DDIT3;ARIH2;RLIM;DDB1;SIRT1;NHLRC3;PSMF1;PSMD14;STUB1;UBAP1;PSMD12;CUL4A;RNF34;CHFR;TNFAIP3;PRKN;ZFAND2B;SQSTM1;PSME2;UBQLN2;ANAPC10;ARRB1;CBL;ATE1;CDC34;RNF7;KCTD5;KEAP1;PSMB10;PSMD5;MYLIP;BIRC2;PSMD8;AMFR;TRPC4AP;PPP2R5C;CLOCK;PSMA3;TNFAIP1;AGAP3;RNF43;PSMA2;UBE2S;ATXN3;FBXO7;ANAPC15;PSMD11;UBE2R2;PLAA;RNF19B;PSMA6;SPOP;FBXO45;FBXL4;TAF1;USP9X;VPS37B;UBE2H;KCTD2;PSMB3;UBR3;VCP;KCTD10;FAF1;RNF125;HERPUD1;UBE4A;RNF168;SIAH2;PSME3;UBE2D3;ARIH1;KLHL3;UBE4B;MIB1;NDFIP1;PTTG1;RNF150;TTC3;UBE2E1;PSMC5;ANAPC7
prerank,phospholipid dephosphorylation (GO:0046839),0.4681133441811919,1.2322517150581351,0.1715686274509804,0.5938404250635857,1.0,8/37,13.73%,PLPP3;MTM1;MTMR3;PTEN;PLPP6;PLPP5;OCRL;INPP5F
prerank,regulation of nuclear division (GO:0051783),0.5218305393411965,1.2321406686683842,0.24509803921568626,0.5935418616912078,1.0,2/20,2.01%,CCDC8;KIF20B
prerank,signal transduction in response to DNA damage (GO:0042770),0.4454273176760125,1.2318511777004777,0.19186046511627908,0.5938109217183812,1.0,16/49,20.60%,MAP3K20;GRB2;ERCC6;SESN2;BRIP1;E2F1;GADD45A;DOT1L;NBN;FBXO6;INTS7;BID;ACER2;CLOCK;BCL3;PAXIP1
prerank,response to lipopolysaccharide (GO:0032496),0.39837365314817624,1.2318284977223357,0.10559006211180125,0.5932672262061643,1.0,35/138,16.95%,LILRB1;MAPKAPK3;VIM;IL36G;NR1H3;ADAM9;IL6;CD274;TNFRSF1B;LY96;SHPK;NFKBIB;IRAK3;STAP1;SIRPA;FOXP1;NFKBIL1;TICAM2;HNRNPA0;ADAM17;LIAS;TAB2;TRIM41;RELA;TNFAIP3;SLC11A1;ERBIN;SLPI;ACOD1;LBP;CDC73;MYD88;CHMP5;OTUD5;IFNAR1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.3659353317434117,-1.2315629714037701,0.16071428571428573,0.5780761722747705,1.0,11/31,21.65%,TGFBR2;FGFR2;TGFBR1;MEGF8;HOXD4;HOXD3;HOXC9;HOXA9;SOX11;HOXB9;DSCAML1
prerank,skeletal system development (GO:0001501),0.4010753544520336,1.2311554391949857,0.1059190031152648,0.5947551928722985,1.0,30/148,17.17%,PRDX1;TRPS1;HAPLN4;XYLT1;TGM2;PAPSS2;CD44;EXT1;RAB33B;MMP14;IGF1;COL1A1;SULF2;SOX9;AKAP13;PKDCC;PAPSS1;PTGER4;PLS3;TRIP11;SULF1;SH3PXD2B;DYM;GDF10;SLC10A7;ATP7A;WWOX;CHD7;COL11A2;BPNT2
prerank,DNA damage checkpoint signaling (GO:0000077),0.48617131882869413,1.2306629733087093,0.20451527224435592,0.5955948452529752,1.0,8/28,13.35%,MAP3K20;ERCC6;BRIP1;E2F1;DOT1L;NBN;FBXO6;INTS7
prerank,cellular response to lipid (GO:0071396),0.39338033328030686,1.2306374692829218,0.07040816326530612,0.5950520458549861,1.0,48/191,15.81%,LILRB1;AQP1;PDK4;VIM;SPP1;IL36G;NR1H3;ADAM9;IL6;ABL2;CD274;TNFRSF1B;LY96;SHPK;PID1;HTRA2;UBE2L3;NR3C1;NFKBIB;NR1H4;SPHK2;NCOA4;MSN;STAP1;SOX9;LCOR;SIRPA;NFKBIL1;TICAM2;NCOA3;FZD7;ESR1;PTK2B;FES;TRIM41;RORA;KCNK4;FAM210B;MGST1;RELA;GPLD1;TNFAIP3;ADCY8;ADCY3;ACOD1;LBP;CDC73;MYD88
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.5857320363114423,1.2305732799012414,0.23738872403560832,0.594631160162725,1.0,4/11,12.31%,P2RX4;TRAT1;P2RX3;TREM2
prerank,keratan sulfate catabolic process (GO:0042340),0.5787243564853416,1.2304736682896453,0.2225609756097561,0.5943349652429271,1.0,4/11,7.94%,GALNS;GNS;HEXA;LUM
prerank,peptidyl-asparagine modification (GO:0018196),0.47202564946249653,1.2304217655755005,0.19235511713933415,0.5938873538765618,1.0,8/31,13.96%,DPM2;MGAT5;MCFD2;NUDT14;DDOST;DAD1;MAGT1;UGGT1
prerank,positive regulation of autophagy (GO:0010508),0.42081607919953545,1.2299143992759647,0.1479028697571744,0.59473201062944,1.0,25/81,19.57%,OPTN;TFEB;PLK2;FOXO3;WAC;DAPK1;SESN2;SH3GLB1;FLCN;EIF2AK4;EPM2A;MEFV;PAFAH1B2;ROCK1;GSK3B;FOXO1;SIRT1;PRKN;BNIP3;NPRL2;TRIM14;HTT;PIK3CB;FBXO7;TBK1
prerank,carbohydrate derivative transport (GO:1901264),0.5304723528527607,1.2296845404972216,0.21428571428571427,0.5948049009507356,1.0,6/18,15.61%,ABCG1;CLN3;PLTP;SLC15A3;SLC10A7;LBP
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.4824159731070934,-1.2296422155148792,0.2188449848024316,0.5806041480924741,1.0,2/12,1.96%,MEF2C;DOCK4
prerank,nervous system development (GO:0007399),-0.2465961835714734,-1.2291154352525602,0.0,0.5795001259654836,1.0,88/429,12.31%,NAV3;NAV2;RAPGEF5;RBFOX1;ADGRL3;MEF2C;OPHN1;ERBB4;SEMA5A;LSAMP;SDK1;SPOCK1;GPM6A;NRXN1;ADAM23;DCLK1;ROBO2;KIRREL3;ROBO1;NLGN1;CNTN6;MARCKS;RBFOX2;EVL;GRIK1;DNM3;SIAH1;RYK;MBP;SCN2A;SMO;BTBD3;GLRB;CHRM3;CNTN4;CHRM2;FUT10;ANKLE2;FGF12;RBFOX3;LIMK1;RELN;SRRM4;MYT1L;TGFBR1;NCKAP1;STMN3;TRIM3;ARNT2;FGF2;FGF13;TMOD2;IL1RAPL2;MOBP;INTU;ARHGAP26;CDH2;FARP1;VLDLR;EDNRB;ADORA1;GSS;MBD5;ATN1;MAL;DNER;SZT2;PPP2R5D;IRF2BPL;EFNB3;SERPINI1;ADGRV1;NLGN3;SOX6;ADAM22;SH3GL3;KCNQ2;MARK4;SREBF2;HAPLN2;SNTG2;RPS6KA6;PKD2;SEMA6A;LDB1;LDB2;ERBB3;GFRA2
prerank,Notch signaling involved in heart development (GO:0061314),0.5751050383486354,1.2289181825787592,0.24816446402349487,0.5964109737540677,1.0,3/11,11.96%,NOTCH2;SNAI2;NOTCH1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.49287634699633404,1.2288033346737002,0.20833333333333334,0.5961499783783686,1.0,9/26,20.25%,B4GALT5;TPI1;TNIP1;ST3GAL4;GOLPH3;GK5;RRM1;ALG6;GK
prerank,regulation of fibroblast migration (GO:0010762),0.5097997909965996,1.2286775338453404,0.23497267759562843,0.5959020269967739,1.0,7/20,12.30%,CORO1C;APPL2;CLN3;THBS1;GNA12;ITGB1;APPL1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.49211860997920737,1.2281596472242433,0.20526315789473684,0.5967831196889186,1.0,9/26,14.88%,SYNPO2L;PTGER4;ROCK1;PFN1;SYNPO;PRKN;CX3CL1;PFN2;ALMS1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.44445802031583326,1.2280297428275238,0.1885245901639344,0.5965641782221274,1.0,8/52,5.51%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;CLN3;STAC2
prerank,proteasomal protein catabolic process (GO:0010498),0.38980050596074184,1.227240782207892,0.08979591836734693,0.5982945567481213,1.0,69/201,23.57%,NFE2L2;CTNNB1;ZNRF1;WWP1;FBXW7;PSMD1;ZFAND2A;FBXL17;SPSB4;CUL3;SOCS6;UBE2K;NHLRC1;BFAR;NEDD4L;KLHL20;WWP2;RAD23A;SPSB2;TOPORS;TBL1XR1;HUWE1;PCNP;DDIT3;DDB1;SIRT1;NHLRC3;PSMF1;PSMD14;STUB1;RHBDD1;PSMD12;CUL4A;RNF34;PRKN;ZFAND2B;PSME2;ARRB1;ATE1;CDC34;KCTD5;PSMB10;PSMD5;BIRC2;PSMD8;PPP2R5C;CLOCK;PSMA3;TNFAIP1;AGAP3;PSMA2;DDI2;ATXN3;PSMD11;PLAA;BRSK2;PSMA6;SPOP;CUL4B;FBXO45;KCTD2;PSMB3;VCP;KCTD10;FAF1;SIAH2;PSME3;UBE2D3;UBE4B
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.4721382931917357,1.2271190422282074,0.20024570024570024,0.5980464857126977,1.0,4/35,5.50%,PPARG;XDH;APOE;THBS1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.512126882571148,1.227034591756794,0.21732954545454544,0.5977138075736568,1.0,4/18,13.06%,SPG21;C3AR1;SH2B2;GPLD1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.44689382708535924,1.2269501215458243,0.18171296296296297,0.5973558760987905,1.0,10/52,8.64%,TATDN2;ERN1;TPP1;CXXC1;ATP6V0D1;LMNA;YIF1A;ACADVL;TLN1;GFPT1
prerank,neuron differentiation (GO:0030182),-0.2738550335885944,-1.2266721626974215,0.03225806451612903,0.5831163807848724,1.0,20/165,4.91%,ATP8A2;TENM2;PTPRD;MEF2C;OPHN1;IL1RAPL1;EPHA5;SPOCK1;TENM3;RYK;RORB;FZD3;MYEF2;MYO7A;FUT9;MYT1L;TGFBR1;CDK5R1;PBX3;NTRK2
prerank,mitotic chromosome condensation (GO:0007076),0.4838455542209018,1.2261393336617499,0.2152230971128609,0.5991883195747897,1.0,10/26,20.74%,NCAPG2;NCAPG;RB1;CSNK2A2;SMC2;CSNK2A1;PHF13;MCPH1;NCAPD2;NCAPH
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5203448473321388,1.2253362357754007,0.22998544395924309,0.6009084455315155,1.0,6/18,16.44%,POR;ABL2;PDP1;GDNF;ATP7A;SIRT3
prerank,purine-containing compound salvage (GO:0043101),-0.4804344139637221,-1.225313837860195,0.20063694267515925,0.5842246062873496,1.0,5/12,11.93%,GMPR2;PNP;AMPD2;DCK;GMPR
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5177964316004796,1.2248114056090718,0.22752043596730245,0.6018539781425917,1.0,10/20,24.01%,ADAM9;ADAM17;HM13;RHBDD1;RELA;NCSTN;ADAM10;APH1B;PSEN2;TRAF6
prerank,acidic amino acid transport (GO:0015800),0.5351892233653521,1.224534577878616,0.22411347517730495,0.6020912653117488,1.0,2/17,0.70%,LRRC8D;SLC6A6
prerank,microtubule anchoring (GO:0034453),0.568835480421619,1.2242492090683577,0.24143302180685358,0.6023043508123767,1.0,4/12,13.70%,SAXO2;DAG1;PEX14;CLASP1
prerank,axonogenesis (GO:0007409),-0.2583539996586043,-1.2241375685114986,0.1111111111111111,0.5847853186817152,1.0,57/237,12.38%,UNC5C;OPHN1;SEMA5A;RPS6KA5;EPHA5;CTNNA2;NRXN1;NTNG1;ROBO2;ROBO1;NRXN3;DCC;CNTN6;NCAM1;EVL;AUTS2;EPHA6;SIAH1;RYK;DAB1;VASP;CNTN2;EPHA3;ENAH;PTPRO;ANK3;CNTN4;UNC5D;FGFR2;PARD3;DOK6;SCN1B;RELN;CDK5R1;HSP90AA1;SLIT1;TUBB3;SEMA4G;KIF5A;VLDLR;SEMA3E;SPTBN4;BSG;PAX2;RAP1GAP;SEMA3A;EPHA7;EFNB3;RAB8A;NLGN3;KLF7;IGSF9;PRKCA;NEXN;SEMA6A;GFRA2;ULK2
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.47977528141148995,-1.2240845839924595,0.21839080459770116,0.5825377129877607,1.0,5/12,14.21%,DOCK8;JAM2;AIF1;PYCARD;RHOA
prerank,macrophage migration (GO:1905517),0.5521057244504377,1.2240214214765135,0.24316546762589927,0.602402611996448,1.0,3/13,6.91%,LGALS3;P2RX4;CKLF
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.34488282028288275,-1.2239105123695688,0.10309278350515463,0.5806129980537388,1.0,12/39,13.64%,FGF14;PRKCE;ANK3;FGF12;SCN1B;WNK3;FGF13;PTPN3;GLRX;WNK2;WNK1;YWHAH
prerank,regulation of intracellular protein transport (GO:0033157),0.47757865511589764,1.2234569196111305,0.2206060606060606,0.6035004179616243,1.0,12/32,16.82%,KIF20B;RUFY3;LCP1;TPR;OAZ2;BCAS3;SIRT7;TENM1;UHMK1;PTPN1;RAB29;OAZ1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5259104522456133,1.223059852910928,0.21389645776566757,0.6040334090350747,1.0,6/18,16.22%,SLC35F6;GSK3B;HSPA1A;BAX;ACAA2;BID
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5006287523417554,1.2229521372494028,0.21635883905013192,0.6037474091144152,1.0,6/24,13.52%,PLA2G2D;SERAC1;ABCA3;SLC27A1;PLA2G4F;CDS2
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5437169227030748,1.222914515207523,0.22478386167146974,0.6032453790576616,1.0,7/15,22.26%,ATF3;PPIF;GSTO2;CPEB2;MKNK2;GSTO1;VCP
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.46075796358912696,1.221930815965876,0.20689655172413793,0.6054404192383083,1.0,17/36,27.85%,TAOK3;NCOR1;AIDA;DUSP3;SIRPA;FOXO1;TREM2;PRKN;FKTN;DUSP10;EZR;MEN1;FOXM1;PPIA;CYLD;PER1;PTPN22
prerank,heart trabecula morphogenesis (GO:0061384),-0.4286774046409645,-1.2219196889245205,0.16901408450704225,0.5831450742295461,1.0,5/18,8.98%,BMPR1A;TGFBR1;ENG;S1PR1;TGFB2
prerank,negative regulation of gene expression (GO:0010629),0.3854747132574908,1.2218136210329973,0.055055055055055056,0.605234810452417,1.0,56/302,13.96%,GPNMB;APLNR;XDH;APOE;SAMD4A;ERN1;VEGFA;TIPARP;FOXP3;DNMT3A;FBXW7;ID2;CD28;CD46;ATP2B1;DAPK1;DDX6;NCOR1;NOTCH2;CELF1;IGF2BP3;CITED2;IGF1;AGO2;SMYD5;EED;FLCN;HSPA1B;REL;ZFP36L2;RB1;EPC1;WWP2;ZNF148;FOXP1;ACVRL1;PICALM;TNRC6B;PTGER4;ESR1;CNPY2;CNOT7;AGO3;SIRT1;PTBP3;APP;NOTCH1;EPRS1;PTBP2;DGKQ;N4BP1;RPS26;RBBP7;SLC11A1;PRKN;HSPA1A
prerank,amino acid import across plasma membrane (GO:0089718),0.4942575819654479,1.2216311294429716,0.22849807445442877,0.6051923425236551,1.0,3/24,3.08%,SLC7A2;SLC6A6;SLC1A5
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.47574384417921617,-1.2214950732424028,0.21301775147928995,0.5818840936394389,1.0,5/12,23.31%,CD80;IL18;CARD9;RASGRP1;IL1B
prerank,cellular response to alcohol (GO:0097306),0.44882560155246054,1.2210614425121826,0.21096543504171633,0.6062971700729477,1.0,14/42,15.58%,GRAMD1B;CTNNB1;ADCY7;SPHK2;PTGER2;BRCA1;GRAMD1C;PTGER4;GPLD1;ADCY8;ADCY3;GOLPH3;LRP6;CTNNA1
prerank,icosanoid secretion (GO:0032309),0.5614919687075688,1.2210196650956855,0.2272069464544139,0.6058053154728776,1.0,4/12,22.10%,ANXA1;ABCC4;ACE;DRD2
prerank,sympathetic nervous system development (GO:0048485),0.5413031648265283,1.2208041182769434,0.21518987341772153,0.605847107596755,1.0,5/15,15.95%,CTNNB1;TFAP2B;NRP2;GDNF;NRP1
prerank,regulation of multicellular organism growth (GO:0040014),0.541476245920037,1.2207616369216296,0.24300441826215022,0.605368900313334,1.0,4/15,11.57%,GDF15;IGF1;STAT5B;APP
prerank,bone development (GO:0060348),0.4504968968339732,1.220668917293597,0.1997563946406821,0.605037272326617,1.0,10/39,14.56%,TGM2;SULF2;AKAP13;PTGER4;PLS3;SULF1;SH3PXD2B;DYM;SLC10A7;LRP6
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5884570309155497,1.220496865622416,0.23882896764252695,0.6049514997743252,1.0,2/10,8.76%,LILRB1;TYROBP
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5700010781072061,1.2200548179402173,0.24539877300613497,0.605649569474675,1.0,4/11,14.64%,RENBP;GFPT1;NAGK;GNPDA1
prerank,phosphatidylserine metabolic process (GO:0006658),0.47497764235993356,1.2193529109954737,0.2194513715710723,0.6071190170862163,1.0,6/32,12.18%,OSBPL8;PLA2G2D;SLC27A1;PLA2G4F;PLAAT3;LPCAT3
prerank,regulation of filopodium assembly (GO:0051489),-0.3439952780377783,-1.2192096200380318,0.14925373134328357,0.5850176904102187,1.0,9/38,8.61%,TENM2;GPM6A;NLGN1;PLPPR5;RIPOR2;ARHGAP44;FMR1;TRPM2;AGRN
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.47234386677749124,1.2191336799580323,0.21611253196930946,0.6071927505408194,1.0,9/29,17.11%,DHX34;E2F1;TENT5A;HNRNPU;SLC11A1;TENT5D;GDNF;THRAP3;TAF15
prerank,hexose biosynthetic process (GO:0019319),0.45086953594343837,1.2184599008011956,0.22019464720194648,0.6085686205079823,1.0,15/42,26.04%,SORD;TPI1;SLC25A1;ATF4;ENO3;SLC39A14;PGM1;CRY1;GAPDHS;MDH1;SLC37A4;SLC25A13;GOT1;PGK1;CHST15
prerank,negative regulation of cell communication (GO:0010648),-0.404855302525723,-1.2184037906392173,0.18382352941176472,0.5846023648018015,1.0,5/21,12.17%,ACVR1;UBASH3B;OPRM1;GLRA1;ERBB3
prerank,negative regulation of MAP kinase activity (GO:0043407),0.44108458570832726,1.2183782552005173,0.1941747572815534,0.6082003715053901,1.0,6/44,6.40%,APOE;CD300A;PRKCD;AIDA;SORL1;IRAK3
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.295944099489231,-1.2183286982946542,0.10843373493975904,0.5824792691970169,1.0,18/86,7.99%,NAV3;BIN1;SEMA5A;EVL;FCHSD2;PRKCE;VASP;MAPT;FER;HCK;LIMK1;CDK5R1;NCKAP1;NCK1;PAK1;AKAP9;CARMIL1;CLU
prerank,chemical homeostasis (GO:0048878),0.4242103961623286,1.2177788614874316,0.16666666666666666,0.6093621783062758,1.0,9/61,8.10%,PPARG;FBXW7;RBP1;NR1H3;TENT4B;IRS2;ZBTB20;NEDD4L;ABHD4
prerank,regulation of mRNA catabolic process (GO:0061013),0.39916421844242234,1.217203865182558,0.1521511017838405,0.6104125822916625,1.0,34/121,20.78%,SAMD4A;VIM;PRKCD;PSMD1;IGF2BP3;YTHDF3;PCID2;RPS27A;UBC;ZFP36L2;ZC3HAV1;EXOSC3;EXOSC9;SERBP1;CNOT7;PSMF1;PSMD14;PUM2;TNPO1;EXOSC8;PSMD12;HSPA1A;HNRNPD;PSME2;EXOSC1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;XPO1;PSMA6;EXOSC7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4995037739683105,1.2170742782508244,0.21941489361702127,0.6096259437221327,1.0,6/22,17.17%,ZDHHC14;ZDHHC19;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC4
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4995037739683105,1.2170742782508244,0.21941489361702127,0.6096259437221327,1.0,6/22,17.17%,ZDHHC14;ZDHHC19;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC4
prerank,chromosome condensation (GO:0030261),0.4658285970779503,1.2169377056130943,0.19720101781170485,0.609429737468127,1.0,13/36,20.74%,NCAPG2;NCAPG;INCENP;RB1;DFFB;CSNK2A2;SMC2;ACIN1;CSNK2A1;PHF13;MCPH1;NCAPD2;NCAPH
prerank,regulation of cellular component biogenesis (GO:0044087),0.45692218505538307,1.2162294596426073,0.2039072039072039,0.6108343129997064,1.0,9/39,16.07%,CD36;APOE;MSN;ROCK1;NOTCH1;RAPGEF1;VPS11;LATS1;TRAF2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.5667681451843021,1.2155754887330978,0.23374613003095976,0.6122090057319406,1.0,5/12,19.85%,NCOR1;FOXP1;SIRT1;ZBTB7A;PIAS2
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3301439555854001,-1.2155733429231208,0.14772727272727273,0.5870396868349078,1.0,7/41,8.98%,MEF2C;BMPR1A;TGFBR2;FGFR2;ENG;SMAD7;TGFB2
prerank,transport across blood-brain barrier (GO:0150104),0.41487918882561126,1.2151759296401181,0.16612729234088458,0.6127502353162732,1.0,15/83,8.23%,CD36;SLC7A2;SLC6A6;FABP5;TFRC;LRP1;SLC1A5;SLC16A1;SLC27A4;SLC38A1;SLC5A5;ABCC4;ABCC3;SLC27A1;ABCA2
prerank,exit from mitosis (GO:0010458),0.5547184205117072,1.2149122287764254,0.24096385542168675,0.6128889703640038,1.0,7/12,23.42%,CHMP2A;SIRT7;CTDP1;CLASP1;CHMP7;UBE2S;EPS8
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.31761561699414415,-1.2144528810605377,0.15503875968992248,0.5873916717651548,1.0,14/52,9.85%,RBFOX1;RBFOX2;NOVA1;KHDRBS2;SRSF6;RBFOX3;SRRM4;KHDRBS3;FMR1;KHDRBS1;RBM8A;REST;RBMX;CELF2
prerank,aorta development (GO:0035904),0.5477278611285438,1.2144024760454744,0.24216524216524216,0.6137242680132527,1.0,3/14,3.48%,APLNR;LRP1;TFAP2B
prerank,regulation of protein localization (GO:0032880),0.4371731379637651,1.2142788110125853,0.19085714285714286,0.6135162162725014,1.0,11/58,9.57%,CTSD;PLEKHM2;FBXW7;DNAJB6;TRIM17;TRIM25;WDPCP;DVL1;PICALM;TPR;VPS4A
prerank,regulation of epidermal cell differentiation (GO:0045604),0.50088229393082,1.2139724933665743,0.2213225371120108,0.6138529450795568,1.0,4/21,10.54%,CTSL;CBFB;ROCK1;MAFG
prerank,negative regulation of JNK cascade (GO:0046329),0.4661081431202886,1.2131838001187576,0.21510883482714468,0.6156406255679518,1.0,9/31,19.92%,TAOK3;NCOR1;AIDA;DUSP3;SIRPA;PRKN;FKTN;DNAJA1;DUSP10
prerank,cellular response to zinc ion (GO:0071294),0.5315598116941536,1.213092106558585,0.2320675105485232,0.6153384405810859,1.0,10/15,20.51%,P2RX4;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.42819704518074464,1.213062090346445,0.1732283464566929,0.6148332884552941,1.0,14/66,13.33%,MTSS1;XDH;APOE;FBXW7;RUNX3;THBS1;MCC;SOX9;SNAI2;WDR77;NLRC3;ATP5F1A;SULF1;SOX2
prerank,response to amyloid-beta (GO:1904645),0.4525714801813211,1.2129634533847895,0.21580188679245282,0.6145254869651492,1.0,8/44,12.31%,CD36;MMP12;LRP1;ITGA4;IGF1;GSK3B;APP;TREM2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4089767589700341,1.2125382025219713,0.1587473002159827,0.615172325899752,1.0,25/92,17.97%,SASH1;IQSEC1;VEGFA;ADAM9;DOCK5;NRP2;THBS1;RREB1;SOX9;FOXP1;CTSH;BMPR2;PTK2B;BCAS3;PFN1;DOCK1;GPLD1;CAPN7;CLASP1;RRAS;RTN4;GRN;NRP1;TEK;AAMP
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.49247086603180684,-1.2119912744030032,0.22647058823529412,0.5913415134294724,1.0,3/10,11.41%,SEMA5A;CARMIL1;ACTN2
prerank,organophosphate biosynthetic process (GO:0090407),0.46046003742134617,1.2119495538280163,0.23875,0.616363133451938,1.0,6/37,7.30%,MOCOS;GPAT2;TPI1;AGPAT4;ITPKB;IPPK
prerank,telomere maintenance via recombination (GO:0000722),0.5769475586896963,1.2117720765697508,0.2867756315007429,0.6163191419204203,1.0,2/11,4.73%,NSMCE2;TEP1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4210563855436168,1.2117712526376259,0.2057471264367816,0.6157290826434242,1.0,16/61,16.64%,GRB2;SYNPO2L;NOTCH2;IGF1;IRS2;AKAP13;VAV1;NOTCH1;RAPGEF1;RASGEF1A;COL3A1;LPAR6;ERBIN;SHC1;ARRB1;LRRC59
prerank,positive regulation of JNK cascade (GO:0046330),0.41645170890765093,1.2113566757484873,0.19668508287292819,0.6163087921561636,1.0,18/70,16.90%,SDCBP;GADD45B;GADD45G;TAOK3;RIPK1;GADD45A;MFHAS1;SH3RF1;HIPK2;FZD7;PTK2B;APP;TRAF1;TRAF3;TRAF5;TRAF2;LTBR;NCF1
prerank,ketone body metabolic process (GO:1902224),0.5856042814322333,1.210236452018087,0.2553191489361702,0.6190578990155563,1.0,3/10,12.14%,ACSS3;AACS;HMGCL
prerank,regulation of macrophage activation (GO:0043030),0.4631927732269515,1.210226483068361,0.21954314720812182,0.6184966165002949,1.0,6/30,7.29%,GPR137B;NR1H3;IL6;SHPK;THBS1;MFHAS1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4153342475632979,1.2101861312294913,0.1760797342192691,0.6180214796801909,1.0,16/75,16.37%,APOE;CD300A;IPO5;PRKCD;PTEN;SORL1;SLC8A1;GADD45A;IRAK3;APC;RB1;SIRT1;STK38;LRP6;LATS1;PTPN1
prerank,negative regulation of phosphorylation (GO:0042326),0.4115760269013455,1.2101321537221628,0.17903930131004367,0.6176095115623065,1.0,14/85,11.35%,PLPP3;XDH;CORO1C;CDKN1A;NCOR1;PID1;PTEN;IRS2;HNRNPU;STAP1;SIRPA;ROCK1;SIRT1;FBLN1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.49077149208974286,1.2100614653977169,0.2430647291941876,0.6172664550287772,1.0,6/24,15.05%,APOE;NUB1;PTK2B;PSMD14;PSME2;LATS1
prerank,steroid metabolic process (GO:0008202),0.4199328905044122,1.209737231692634,0.18924972004479285,0.6176184586869297,1.0,4/72,1.88%,LIPA;BAAT;AMACR;NPC1
prerank,establishment of protein localization to organelle (GO:0072594),0.4113739733573595,1.2094999293770403,0.1850613154960981,0.6177185062776916,1.0,12/72,12.30%,MMP12;SYK;LAMP1;IPO5;E2F3;APPL2;TSPAN17;LAMP2;TPR;NUP50;TNPO1;APPL1
prerank,receptor catabolic process (GO:0032801),0.4895661013488079,1.2093254309283508,0.24666666666666667,0.6176283562199198,1.0,13/24,26.75%,KIF16B;UVRAG;SH3GLB1;ZNRF3;SNX25;AP2B1;MYLIP;RNF43;LGMN;AP2S1;CLTC;AP2A2;AP2A1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5798971613839516,1.2092401495453298,0.2488822652757079,0.6172826531710159,1.0,3/10,8.81%,RUNX3;SH3RF1;CBFB
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.3663348295803601,-1.2089910076784427,0.1729957805907173,0.5964294986347681,1.0,8/28,14.99%,NAV3;MAPT;CDK5R1;PAK1;AKAP9;NUMA1;GIT1;MAPRE1
prerank,aggrephagy (GO:0035973),0.48343522494775665,1.208833458512424,0.2304635761589404,0.6179408633853124,1.0,12/27,20.14%,VIM;DYNC1H1;RPS27A;UBC;ATG5;WDFY3;PRKN;SQSTM1;UBE2V1;ARL13B;ACBD5;IFT88
prerank,response to ionizing radiation (GO:0010212),0.4145215620717586,1.2088253970745644,0.16777777777777778,0.6173756220907815,1.0,16/70,15.49%,EYA1;GRB2;XRRA1;ANXA1;CDKN1A;TANK;GADD45A;BABAM2;BRCA1;XRCC4;SIRT1;INIP;DCUN1D3;INTS7;INO80;BRCC3
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5686332473570723,1.208365916109434,0.2526475037821483,0.6181560704345032,1.0,3/11,9.11%,RFTN1;RIPK1;UNC93B1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.47339689776877225,1.2082092906707544,0.21645569620253163,0.6179904862111173,1.0,6/28,4.96%,PRKCD;ENPP1;APPL2;PID1;SLC27A4;PTPRE
prerank,regulation of B cell proliferation (GO:0030888),0.4453706172067528,1.207806998410723,0.1942098914354644,0.6185740732856252,1.0,7/44,8.76%,CD38;CD300A;VAV3;TFRC;IRS2;CD22;TYROBP
prerank,phosphorylation (GO:0016310),0.3810960080532806,1.2074329194542839,0.04704704704704705,0.6190470231700311,1.0,73/384,13.64%,HTR2B;FNIP2;SGK1;MAP3K20;MAK;SYK;TLK1;FRK;PRKCH;MAP3K1;CERK;ERN1;TEC;PDK4;PRKAG2;IKBKE;PLK2;TAOK3;PDPK1;PRKCD;PPP4R1;RUNX3;BIRC6;SIK3;FAM20C;DAPK1;SRPK2;SHPK;RARA;DGKZ;MAPK6;PIM1;MAML1;PKN3;DGKA;MERTK;MELK;RNASEL;SIK1;SPHK2;STK24;STK3;IRAK3;PIK3CA;DYRK1A;EIF2AK4;TKFC;TOP1;BRD2;ACVR2A;HIPK1;MAP4K3;ACVRL1;HIPK2;BMPR2;TNIK;ROCK1;PIM3;GSK3B;PTK2B;PKN2;PAK2;CDK7;APP;PRKCB;ACVR1B;STK38;BTK;DYRK2;GAS6;DGKQ;FGR;LIMD1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5323721657173156,1.2066334060317032,0.23931623931623933,0.6208517731256785,1.0,4/16,12.31%,APOE;LRP1;ROCK1;TREM2
prerank,protein import into peroxisome membrane (GO:0045046),0.4930997901268527,1.2064103589912656,0.25034387895460797,0.6209546556839952,1.0,12/22,27.07%,RAB8B;ABCD1;PEX14;ALDH3A2;PXMP2;GDAP1;ACBD5;SLC25A17;PXMP4;ABCD2;PEX3;ABCD3
prerank,positive regulation of phospholipid transport (GO:2001140),0.579313817088212,1.2063347605731978,0.25577812018489987,0.6205921713465544,1.0,2/10,7.85%,APOE;ABCA3
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5392841341962582,1.2061706454616505,0.23952095808383234,0.6205314246239845,1.0,5/15,18.31%,LILRB1;FOXP3;IRAK3;JAK3;CUEDC2
prerank,Golgi organization (GO:0007030),0.3982402633312168,1.2060639012038992,0.16613756613756614,0.6202615180873109,1.0,30/112,17.02%,ARHGAP21;OPTN;PLEKHM2;ATP8B4;VTI1B;NPLOC4;GAK;COG7;STX5;VMP1;TICAM2;VCPIP1;HUWE1;VTI1A;BET1;BCAS3;TRIP11;PI4K2A;VPS51;RAB43;ATL2;DYM;ATP8B1;CLASP1;STX6;GOLPH3;GOLPH3L;RAB2A;RAB29;COG2
prerank,protein localization to centrosome (GO:0071539),0.520389676839057,1.2059628377468392,0.2633863965267728,0.6199512763551083,1.0,3/17,2.20%,HOOK3;PIBF1;SNX10
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.41386754832453443,1.2058041495005738,0.17480136208853575,0.6197941493757491,1.0,14/69,12.63%,SYK;IL6;TMEM106A;RIPK1;LY96;THBS1;SPHK2;CYBA;TYROBP;MAVS;ARHGEF2;APP;FZD5;ARFGEF2
prerank,intracellular protein transport (GO:0006886),0.37798111205842816,1.205439008777255,0.07622868605817452,0.620261430347057,1.0,90/304,22.29%,MMP12;KIF13B;SYK;TLK1;STX3;SNX8;ACD;IPO5;TBC1D22A;SNX27;RIC1;TBC1D25;RAB20;RAB7A;TBC1D1;E2F3;TBC1D2;CTSA;RANGRF;SNX9;TBC1D12;APPL2;HOMER3;SORL1;RAB21;STX8;STAM;TBC1D10A;COG7;RAB3GAP2;STX5;TBC1D2B;RAB31;RAB1B;LAMP2;TECPR2;TICAM2;RAB28;VPS33A;UNC93B1;STX11;TPR;SIL1;TBC1D22B;NUP50;RAB18;ARHGEF2;TBC1D15;WLS;TNPO1;RAB24;STXBP3;APPL1;AP3D1;RAB43;ARL4C;STX6;AP3B1;SNF8;SNX17;TBC1D9;RABGAP1;RAB29;GGA2;RAB22A;ARF4;VPS29;AP4M1;ARF5;STXBP2;NUP88;ARL5B;SEC31A;RAB1A;XPO1;CSE1L;SGSM2;VPS36;NUP188;GGA3;RPGR;PREB;TBC1D4;PPP1R10;GIPC1;DNAJC27;RPAIN;VPS35;SNX13;VPS45
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5506201443507792,1.2052232040142505,0.2646638054363376,0.6203292813318771,1.0,5/14,16.37%,BCL2L11;BFAR;COPS5;BAX;PTPN1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.36596257707942237,-1.204881303316196,0.18981481481481483,0.6044648140112973,1.0,8/31,8.98%,BMPR1A;FGFR2;RYR2;TGFBR1;ENG;ZFPM2;SMAD7;TGFB2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3774375318188657,1.2043459574067013,0.037037037037037035,0.6223036177080797,1.0,102/509,16.53%,F7;OSBPL8;HTR2B;HPSE;IQGAP1;GDF15;PIK3R5;SASH1;VWF;LITAF;GRB2;GCNT2;ADRA1D;ADRA1A;BCL2L11;GAB2;VEGFA;TXN;FNIP1;TGM2;TFRC;IKBKE;PLK2;IL6;HGF;CD28;PDPK1;HTR6;TMEM106A;ANKRD17;PDGFA;P2RX4;RIPK1;TRIM25;IGF1;F10;FGFR4;THBS1;IRS2;ADAM8;TRAT1;SPHK2;PIK3CA;FLCN;REL;HMOX1;P2RX3;MFHAS1;RPL23;SOX9;AKAP13;VAV1;TICAM2;STRN;VAPA;STYXL1;DDIT3;LAMTOR1;ITGB1;MAVS;ESR1;ROCK1;BIRC3;SIRT1;MIB2;NRG4;APP;TAB2;BST2;PRKCB;WLS;PUM2;ROR1;TREM2;MIOS;MAZ;HCLS1;RELA;SLC38A9;GAS6;BCLAF1;LAMTOR3;SOX2;FGR;GOLT1B;PRKN;CX3CL1;TRAF3IP2;BAX;GOLPH3;SHC1;TRAF5;SLC44A2;RTN4;CBL;FRS2;MYD88;GPR89A;TRAF2;BID;ZDHHC17;LTBR
prerank,cell projection assembly (GO:0030031),0.49838966668008244,1.204073889798857,0.2452316076294278,0.6224971922810411,1.0,4/22,6.20%,RHOJ;PDGFA;CAPG;PARVB
prerank,glucose import (GO:0046323),0.5468692656594536,1.2040219759711073,0.2525697503671072,0.6220821650573004,1.0,3/13,12.38%,SLC27A4;SLC27A1;SLC2A1
prerank,establishment of melanosome localization (GO:0032401),0.5017225035446542,1.202943246731067,0.24549237170596394,0.6246318805263018,1.0,2/19,2.09%,MYO5A;MREG
prerank,protein K48-linked ubiquitination (GO:0070936),0.4264276994041011,1.202634719741722,0.20725995316159251,0.6249781343673856,1.0,23/54,25.91%,ZNRF1;UBE2Q2;CUL3;UBE2K;BFAR;NEDD4L;RNF115;RNF146;TOPORS;ARIH2;RNF34;TNFAIP3;PRKN;CDC34;AMFR;UBE2R2;UBE2H;UBE2D3;KLHL3;TTC3;UBE2E1;UBR5;UBE2G1
prerank,regulation of urine volume (GO:0035809),0.5843014196291966,1.202602112379262,0.2638888888888889,0.6244954183815187,1.0,1/10,3.48%,TFAP2B
prerank,ventricular septum morphogenesis (GO:0060412),-0.37046185153633315,-1.2021100191216545,0.2,0.6091364734238743,1.0,9/27,8.98%,ACVR1;ROBO2;ROBO1;BMPR1A;TGFBR2;TGFBR1;ZFPM2;SMAD7;TGFB2
prerank,negative regulation of nervous system development (GO:0051961),0.5195192463765972,1.2019121849885626,0.2637517630465444,0.6259028095956145,1.0,4/17,4.99%,HOOK3;IL6;APPL2;SORL1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4998492381447007,1.2013205826330442,0.2542134831460674,0.6271035314925781,1.0,12/19,24.71%,FBXW7;HTRA2;CSNK2A2;FZD5;VDAC1;PRKN;USP36;HTT;FBXO7;SREBF1;HAX1;ATP13A2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.48731692823085826,1.2006184135944722,0.23521320495185694,0.6286626185408365,1.0,10/26,19.85%,NCOR1;BRCA1;FOXP1;SIRT1;STRN3;VPS11;CRY1;ZBTB7A;CLOCK;PIAS2
prerank,mRNA catabolic process (GO:0006402),0.438597144134187,1.200586977521791,0.21212121212121213,0.6281696264622333,1.0,22/44,27.05%,DHX34;ERN1;DDX5;HSPA1B;ZFP36L2;EXOSC9;AGO3;NBDY;HSPA1A;RNH1;EXOSC10;THRAP3;AGO4;LSM5;ZC3H12D;XRN2;LSM6;ZFP36;RIDA;RC3H1;EXOSC4;TUT7
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.43312073466061357,-1.200209761371326,0.24271844660194175,0.6116867585937732,1.0,4/16,3.65%,ANK2;CACNA1C;ATP1A2;RYR2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4738490178449964,1.1999221361472927,0.2222222222222222,0.6294983128159235,1.0,9/28,20.28%,ERN1;CEBPB;ATF4;DDIT3;BAX;QRICH1;TRAF2;BBC3;BRSK2
prerank,retinal metabolic process (GO:0042574),-0.4763301459517115,-1.1997717885537134,0.2411764705882353,0.6105157826349943,1.0,8/12,42.49%,BCO2;RDH11;DHRS13;ABCA4;CYP1B1;RDH10;ALDH1A3;ALDH8A1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.47064132463310887,1.1995776494914376,0.25161290322580643,0.6299193122599278,1.0,8/27,13.64%,IL6;RIPK1;DDX6;AGO2;DDX5;TNRC6B;PUM2;LIMD1
prerank,response to organophosphorus (GO:0046683),0.5246237306678146,1.1993931850954302,0.27015558698727016,0.629884465820052,1.0,4/16,13.29%,P2RX4;RFC3;TRPC3;DGKQ
prerank,protein-containing complex subunit organization (GO:0043933),0.3964768801487629,1.199275908185149,0.16167023554603854,0.6296448547451209,1.0,39/109,21.66%,REPS2;MITF;SKAP2;FAS;SNX9;CAPG;LPXN;CREBBP;APC;DET1;PEX14;DARS1;SOX9;PICALM;TPR;PPIH;PTK2B;TUBGCP4;TRAF1;EPRS1;SLC2A1;VAMP3;MNAT1;WASL;CD247;NUP98;FANCA;TRAF2;CAPZA1;KPNA3;RANBP9;TAPBP;KMT2A;VAMP2;AFG3L2;PPP2R1A;HES5;WIPF1;NDC1
prerank,error-free translesion synthesis (GO:0070987),0.49460418645843246,1.1991394507266109,0.21762349799732977,0.6294668876371786,1.0,5/22,9.37%,RFC3;NPLOC4;RPS27A;UBC;POLH
prerank,RNA interference (GO:0016246),0.5195851940951042,1.1990306946416935,0.24860335195530725,0.6292175962574514,1.0,7/17,22.47%,CELF1;AGO2;AGO3;DROSHA;MRPL44;AGO4;TSNAX
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3866309850984461,1.19866934265096,0.14537902388369678,0.6297485870602243,1.0,25/150,11.35%,PLPP3;XDH;DTNBP1;NCK2;CORO1C;GNAQ;PRKAG2;PDPK1;PRKCD;ENPP1;PID1;PTEN;TAF7;GPD1L;GSKIP;PPEF2;CNKSR3;RB1;SIRPA;DVL1;CEP85;NLRP2B;SNX25;PAK2;FBLN1
prerank,mesenchyme morphogenesis (GO:0072132),-0.4249747393895137,-1.1986449343615264,0.21951219512195122,0.6111856370266026,1.0,6/17,12.28%,ACVR1;BMPR1A;ENG;MDM4;TGFB2;SMAD2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.44777323617494097,-1.1976179467910086,0.21904761904761905,0.6114380935907721,1.0,6/13,32.44%,GTPBP1;RAB23;MFN1;ENTPD7;EFL1;AK4
prerank,granulocyte differentiation (GO:0030851),0.5141982653790562,1.197278435523576,0.23789764868603042,0.6332491049455808,1.0,4/18,4.97%,CDKN1A;RXRA;RARA;E2F1
prerank,organelle organization (GO:0006996),0.37564277174607885,1.197155235245381,0.059,0.6329865368531428,1.0,94/388,17.02%,ARHGAP10;ARHGAP21;APOE;OPTN;PLEKHM2;PIKFYVE;PALLD;FGD6;NEDD9;DIAPH1;MREG;RAB7A;ZMYM6;ABCD1;KIF9;PLD2;ATP8B4;PEX11A;YTHDF3;SYNE3;LONP1;NPLOC4;GAK;PEX7;WDPCP;COG7;CHMP2A;POLG2;PEX14;SH3KBP1;VMP1;VPS13D;RAB31;KIF3A;ABCA3;AFG1L;HPS6;KLHL20;GABPB1;PDCD6IP;TICAM2;VAPA;HUWE1;CAPZB;VPS4A;TNIK;CYCS;CFL1;FAF2;RAB18;VPS13C;CHMP6;BCAS3;TRIP11;PLAAT3;SPRYD3;PI4K2A;CFAP410;VPS51;MICAL2;LONP2;FGD5;POLRMT;PPRC1;RAB43;ATL2;SSBP1;ATAD3A;EPS15;DYM;ATP8B1;LIMD1;TNFAIP3;CLASP1;PRKN;MAST4;ATL1;FGD3;PHIP;GOLPH3;VPS11;WASL;ATP7A;GOLPH3L;TWNK;CCL7;SH3D19;RAB2A;SIRT3;CHMP5;RAB29;BRWD1;TFB2M;COG2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5811560484737579,1.1969945385683431,0.2656716417910448,0.6328919792378122,1.0,1/10,0.36%,PLA2G7
prerank,response to ketone (GO:1901654),0.4863127364589497,1.1969857696109312,0.23160762942779292,0.6323335164529529,1.0,4/24,6.90%,NR1H3;CATSPERB;THBS1;CATSPER2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.37345165901076044,1.1962690713272248,0.031,0.6339043217208012,1.0,128/532,19.90%,CD300LF;CD36;SYK;GRB2;TIMP1;BCL2L11;ANXA1;STX3;GAB2;VEGFA;TEC;ST18;IRAK2;VIM;IL17RE;IFITM1;IL36G;CD44;TALDO1;SOS1;IL6;HGF;LCP1;ABL2;PRKCD;CDKN1A;FOXO3;PSMD1;IL10RB;RIPK1;TNFRSF1B;IFNGR2;APPL2;TRIM25;PIM1;STAT5B;SOCS6;ANXA2;IRS2;IFNAR2;RNASEL;MAOA;IRAK3;PIK3CA;PTAFR;CSF2RB;HMOX1;RPS27A;UBC;MSN;F13A1;SLC27A1;VAV1;MAP3K8;IRF2;IL20RB;IFITM2;IL5;IL6R;ITGB1;IL3RA;CFL1;ADAM17;PITPNA;PTK2B;BIRC3;FOXO1;PAK2;SIRT1;PSMF1;BAG4;NUMBL;MT3;PSMD14;TAB2;BST2;TRAF1;RORA;PSMD12;IL15;APPL1;CSF2RA;RAPGEF1;IL7R;RELA;TRAF3;SOX2;POU2F1;JUNB;IL4R;CX3CL1;SQSTM1;TRAF3IP2;PSME2;SHC1;CXCL12;JAK3;CUL1;MCL1;TRAF5;CBL;LBP;MYD88;CCL7;TRAF2;LTB;LTBR;IFIT2;CAPZA1;BRWD1;IFNAR1;HNRNPDL;TNFRSF14;PSMB10;PSMD5;UBE2V1;BIRC2;PSMD8;CASP3;PSMA3;PSMA2;CCL25;PIK3CB;STAT6;OSM;PSMD11;PELI2;GSTO1
prerank,bile acid biosynthetic process (GO:0006699),0.48538009641131835,1.1961279727047107,0.26,0.6337560246381464,1.0,3/24,2.16%,BAAT;AMACR;OSBPL1A
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.4084433150317543,1.1961128066242537,0.19052987598647125,0.6332087382139077,1.0,15/73,12.63%,SYK;IL6;TMEM106A;RIPK1;LY96;THBS1;ADAM8;SPHK2;CYBA;TYROBP;MAVS;ARHGEF2;APP;FZD5;ARFGEF2
prerank,erythrocyte differentiation (GO:0030218),0.44149663030805475,1.195873791083533,0.21980676328502416,0.6333825514308771,1.0,12/44,18.39%,FLVCR1;VEGFA;ID2;RPS14;MFHAS1;HIPK2;KMT2E;UBA5;HCLS1;JAK3;ACIN1;CASP3
prerank,maintenance of blood-brain barrier (GO:0035633),-0.3551139059694886,-1.1958543699484445,0.2100456621004566,0.6136075531513137,1.0,5/30,4.32%,SLC12A2;F11R;MBP;JAM2;WNK3
prerank,neurogenesis (GO:0022008),0.44253729231644096,1.1954991495377378,0.23728813559322035,0.6339223911701981,1.0,8/43,11.67%,CXCR4;ANXA1;ERCC6;CLN5;RITA1;BTBD1;WDR62;THOC2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5119049746958751,1.195395880098271,0.2695417789757412,0.6336280272438908,1.0,6/18,17.69%,NCOR1;ESR1;PTBP3;PTBP2;RPS26;SHQ1
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.38982936742225,-1.1951551340244544,0.2159090909090909,0.6131010304688319,1.0,5/22,6.11%,CASK;FGFR2;SRSF6;EPB41L4B;PRKD1
prerank,regulation of ruffle assembly (GO:1900027),0.4930635900997106,1.1951540052956793,0.24476439790575916,0.6337792479323328,1.0,4/23,7.72%,ARHGAP24;PLEKHM1;P2RX4;STAP1
prerank,pigment granule transport (GO:0051904),0.502389797265387,1.1947990499952048,0.2537931034482759,0.6336602064326493,1.0,2/18,2.09%,MYO5A;MREG
prerank,melanosome transport (GO:0032402),0.502389797265387,1.1947990499952048,0.2537931034482759,0.6336602064326493,1.0,2/18,2.09%,MYO5A;MREG
prerank,positive regulation of nervous system process (GO:0031646),-0.4095111480099611,-1.1946295099148347,0.19924812030075187,0.612130573312293,1.0,9/18,14.57%,RIMS1;RIMS2;PARD3;TPPP;MYRF;CST7;TENM4;ATPSCKMT;DICER1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.38491243333929687,1.1937747928721079,0.13677811550151975,0.6360141118688922,1.0,40/172,17.99%,DDHD1;PIK3R5;MTM1;PIKFYVE;MTMR3;LPIN3;GPAT2;AGPAT4;PLD2;PLA2G2D;INPP4A;DGKZ;PTEN;CLN3;DGKA;GPD1L;FIG4;PIK3CA;PIK3C2G;SLC27A1;ABHD4;CSNK2A2;PLEKHA1;TAMM41;PCYT1A;PI4K2A;LPCAT3;DGKQ;CDS2;OCRL;INPP5F;GPD1;SLC44A2;GPAT3;PIP4K2A;DGKG;PTDSS1;CSNK2A1;PITPNM1;ETNPPL
prerank,intracellular lipid transport (GO:0032365),0.4870279482906552,1.1935305153223508,0.24694708276797828,0.6361089456242223,1.0,5/21,9.83%,PRKAG2;CERT1;ABCD1;CPT1A;SLC25A20
prerank,negative regulation of transport (GO:0051051),0.42743488493281573,1.1935195974595878,0.22427745664739884,0.6355621189108701,1.0,12/51,13.77%,LGALS3;LILRB1;RAB7A;NR1H3;PTEN;TRAT1;WWP2;SIRPA;SNX33;BST2;MCTP1;PRKN
prerank,dicarboxylic acid metabolic process (GO:0043648),0.42576821352893085,1.1931783654430501,0.23059360730593606,0.6360086550203814,1.0,18/52,24.43%,IDH1;MTHFS;D2HGDH;SDHAF3;FOLR2;SLC25A32;SDHA;MTHFD1L;ME2;ALDH18A1;OGDH;MTRR;SLC19A1;MDH1;IDH2;ACOT8;GOT1;SHMT2
prerank,diol biosynthetic process (GO:0034312),0.5283785768441213,1.1931231398477664,0.26685393258426965,0.6355887239110833,1.0,6/15,19.08%,SPTLC2;SPHK2;ABCA2;ACER2;GCH1;ASAH1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4924976222159958,1.1919061010942642,0.24423337856173677,0.6385568082048017,1.0,9/22,18.48%,MAN1C1;RPS27A;UBC;EDEM3;EDEM2;DERL2;UGGT1;AMFR;MAN1B1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.41657946822253505,1.1916815906120197,0.21787709497206703,0.6386967033530263,1.0,14/70,13.06%,PLA2G7;LPIN3;NR1H3;PLA2G2D;ABCA3;SLC27A1;ABHD4;PLAAT1;PLA2G4F;CSNK2A2;PCYT1A;PLAAT3;LPCAT3;GPLD1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5430270149576003,1.1914609002719667,0.2796992481203007,0.6387483292847869,1.0,5/13,22.58%,IRX3;SLC8A1;SRI;CALM2;PDE4D
prerank,regulation of protein localization to nucleus (GO:1900180),0.4408165744756691,1.1913865645309283,0.23130841121495327,0.6384004072237344,1.0,10/43,15.58%,TFRC;BYSL;SESN2;FLCN;MFHAS1;GTSE1;TPR;GSK3B;LATS1;CTNNA1
prerank,transepithelial transport (GO:0070633),-0.42390549429930263,-1.190939517296321,0.2226148409893993,0.6192425063299196,1.0,5/15,12.01%,SLC12A2;SLC1A3;SLC1A2;SLC1A1;ABCG2
prerank,protein targeting to mitochondrion (GO:0006626),0.4261264251798318,1.1905920752205115,0.22041763341067286,0.6401607386158066,1.0,21/52,23.59%,CHCHD4;TIMM22;IMMP2L;PITRM1;TIMM17A;TOMM20;PMPCA;TIMM17B;GDAP1;HSPD1;PMPCB;TOMM34;HSPA4;TOMM7;TOMM22;FBXO7;BCAP31;MFN2;AIFM1;AIP;NDUFA13
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.38591897392179,1.1904292729346122,0.1558974358974359,0.6400260095925029,1.0,54/158,24.56%,HTR2B;LITAF;TFRC;IKBKE;PLK2;TMEM106A;ANKRD17;RIPK1;TRIM25;REL;HMOX1;AKAP13;TICAM2;VAPA;MAVS;BIRC3;MIB2;TAB2;BST2;PRKCB;WLS;ROR1;RELA;GOLT1B;PRKN;CX3CL1;TRAF3IP2;TRAF5;SLC44A2;MYD88;GPR89A;TRAF2;ZDHHC17;LTBR;TRIM14;UBE2V1;BIRC2;CARD11;TBK1;PELI2;SHISA5;EEF1D;TIRAP;FKBP1A;MALT1;ALPK1;FLNA;IRAK1;BCL10;TFG;TRAF6;NDFIP1;TERF2IP;CASP8
prerank,synaptic vesicle cycle (GO:0099504),-0.3636349760021326,-1.1903439909184377,0.20642201834862386,0.6184420181278677,1.0,10/30,16.74%,NLGN1;RIMS1;SLC17A6;SNAP25;SYT7;SYNDIG1;STX1A;CPLX1;BRSK1;CPLX2
prerank,innate immune response in mucosa (GO:0002227),0.5766447954647955,1.1903330130715435,0.27149321266968324,0.6397403845927248,1.0,2/10,18.02%,RNASE3;DEFA6
prerank,purine ribonucleotide transport (GO:0015868),0.5209797012986329,1.1902620712814875,0.2841225626740947,0.6393788411373341,1.0,8/16,22.74%,LRRC8D;ABCC4;LRRC8C;SLC25A42;SLC17A9;SLC19A1;SLC25A17;SLC25A24
prerank,positive regulation of endothelial cell migration (GO:0010595),0.402249339660193,1.1902189678739592,0.2074235807860262,0.6389210963210358,1.0,20/84,17.97%,PLPP3;SASH1;VEGFA;PDPK1;P2RX4;NRP2;THBS1;FOXP1;BMPR2;ADAM17;PTK2B;ATP5F1A;SIRT1;BCAS3;GPLD1;RRAS;GRN;NRP1;TEK;AAMP
prerank,regulation of fat cell differentiation (GO:0045598),0.4076485507257577,1.1900849362940746,0.1864594894561598,0.6387628463181864,1.0,13/74,11.99%,PPARG;CEBPB;ID2;IL6;ASXL2;ENPP1;E2F1;ZFP36L2;FTO;FOXO1;SIRT1;PPARD;RORA
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3423776867331101,-1.1900057952460168,0.16847826086956522,0.6170197963785995,1.0,13/37,15.67%,MAPT;EPHA3;PRKAA2;STMN3;TRIM36;TPPP;MARK2;STMN4;BICD1;MAP6D1;STMN2;MAPRE1;STMN1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.4068051129640512,1.1895245482357264,0.1943502824858757,0.6397984897437916,1.0,29/69,24.39%,TRIM25;UBXN8;NPLOC4;FAM8A1;EDEM2;TMUB2;UBXN4;FAF2;ERLIN1;STUB1;DNAJB14;FBXO6;DERL2;UBQLN2;TMUB1;DNAJC18;TMEM129;SGTA;AMFR;MAN1B1;WFS1;FOXRED2;JKAMP;ECPAS;VCP;HERPUD1;UBE4A;UBE4B;UBE2J2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4875594696161219,1.1894117033719749,0.2660427807486631,0.6395607906281456,1.0,7/23,12.72%,GPS1;RPS27A;UBC;COPS5;DDB1;CUL4A;COPS7A
prerank,positive regulation of ERAD pathway (GO:1904294),0.5417356762027118,1.1893631846396358,0.2893175074183976,0.6391351478766056,1.0,8/13,28.10%,NFE2L2;UBQLN2;SGTA;ATXN3;BCAP31;HERPUD1;RNFT1;RNF185
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.4166883565884126,-1.1892836391698969,0.20689655172413793,0.6166087469371062,1.0,5/18,8.67%,HACD2;ELOVL7;ACSL6;ACSL4;ELOVL6
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.39190715636119855,1.1892122802997287,0.18663838812301167,0.639008795036183,1.0,20/116,14.12%,SYK;GPR15;PTGDR;PLK2;IL6;HTR6;RHBDF2;GPR83;ADCY7;PTGER2;GPR176;PTGER4;VIPR1;ADAM17;PTH2R;MYH9;TREM2;FGR;ADCY8;ADCY3
prerank,cellular component assembly (GO:0022607),0.3762801123848134,1.188947775566773,0.11088709677419355,0.6391049734267639,1.0,72/253,21.20%,FBLIM1;LIMA1;REPS2;NEDD9;MITF;ACD;DNAJB13;SPEF1;BAIAP2;SKAP2;LCP1;FAS;RHOJ;PDGFA;CCDC40;SNX9;YTHDF3;ZFYVE27;HAS3;CAPG;LPXN;PARVB;CREBBP;APC;DET1;PEX14;VMP1;DARS1;RTN3;ABCA3;SOX9;DVL1;VCPIP1;QSOX1;PICALM;PPIH;RHOD;PTK2B;PLS3;TOGARAM1;TUBGCP4;TRAF1;EPRS1;SLC2A1;SPAG17;GAS6;VAMP3;MNAT1;WASL;CD247;RTN4;NLGN2;FANCA;TRAF2;MYO9A;CAPZA1;KPNA3;RANBP9;NOC2L;RAD21;TAPBP;CORO1B;KMT2A;MICAL1;VAMP2;AFG3L2;ACTG1;PPP2R1A;PAWR;HES5;ARL6IP1;WIPF1
prerank,actin-myosin filament sliding (GO:0033275),0.45292538284051925,1.1889293707549287,0.22832722832722832,0.6380032805206088,1.0,5/38,10.95%,VIM;MYL2;MYBPC3;TPM3;TPM4
prerank,muscle filament sliding (GO:0030049),0.45292538284051925,1.1889293707549287,0.22832722832722832,0.6380032805206088,1.0,5/38,10.95%,VIM;MYL2;MYBPC3;TPM3;TPM4
prerank,L-amino acid transport (GO:0015807),0.4812674716700246,1.1887661547472717,0.25063291139240507,0.6378977903626512,1.0,3/28,1.64%,SLC7A2;SLC36A2;SLC36A4
prerank,amino sugar biosynthetic process (GO:0046349),0.5415874769390705,1.1883839648925545,0.2852852852852853,0.638434870034926,1.0,4/12,14.64%,RENBP;GFPT1;NAGK;GNPDA1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4826749739406886,-1.1882487835652347,0.23142857142857143,0.6169320152391161,1.0,4/11,17.08%,GTF2H2;ARRB2;GRK2;SAG
prerank,regulation of macromolecule metabolic process (GO:0060255),0.383683740320857,1.1877671620855605,0.15682281059063136,0.6396791938772598,1.0,32/170,15.94%,APLNR;APOE;AFF1;TFEB;MTMR3;FLOT1;TMPRSS4;C1D;AFF4;COQ7;KIF16B;HNRNPAB;TRIM17;IGF2BP3;SLC8A1;IGF1;SCARB2;SIRPA;FOXP1;MEFV;LAMTOR1;APP;TREM2;SOX2;GDNF;PRDM2;HNRNPD;ZNF513;ZFP64;TOB2;PCBP1;NELL1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.415385723026926,-1.1874588591836444,0.22866894197952217,0.6166027348948002,1.0,5/17,11.00%,SLC9A9;SLC12A2;TRPM4;SLC6A1;HCN2
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5688822225686962,1.187456075513666,0.29721362229102166,0.639988927221448,1.0,2/11,2.08%,LILRB1;FOXP3
prerank,regulation of membrane depolarization (GO:0003254),0.5190014601172768,1.187331790637109,0.273876404494382,0.6397817105541346,1.0,4/18,8.05%,ABCD1;RANGRF;GPD1L;NEDD4L
prerank,regulation of cellular component movement (GO:0051270),0.42308188435566296,1.1872990625692,0.2234891676168757,0.6392989594101184,1.0,13/49,13.73%,DIAPH1;VEGFA;ABL2;RAF1;ACTN1;ARAP1;ARHGAP18;ROCK1;ADAM17;PKN2;FES;NRG4;INPP5F
prerank,mitotic sister chromatid segregation (GO:0000070),0.39619654430625734,1.187176127588432,0.20257234726688103,0.6390844546944419,1.0,28/98,21.48%,NCAPG2;SPDL1;PIBF1;CUL3;NCAPG;CHMP2A;NIPBL;EML3;RB1;PDCD6IP;SMC1A;CSNK2A2;BOD1;VPS4A;SMC2;CHMP6;INO80;CHMP5;CSNK2A1;CHMP7;RAD21;PHF13;MCPH1;SGO1;PDS5A;NCAPD2;NCAPH;CHMP2B
prerank,respiratory tube development (GO:0030323),0.47281972731010036,1.1871053384948136,0.2603092783505155,0.6387353785477783,1.0,5/28,12.77%,STRA6;VEGFA;CCDC40;ABCA3;ITGA3
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.38339476089170976,1.1867055747940827,0.15360824742268042,0.6393124061204372,1.0,24/151,15.95%,GPNMB;CD36;HTR2B;APOE;GCNT2;ADRA1A;FBXW7;CD44;PDGFA;NOTCH2;FGFR4;MFHAS1;PTK2B;MT3;APP;NOTCH1;ROR1;TREM2;GAS6;CX3CL1;SHC1;ARRB1;CCL7;NRP1
prerank,positive regulation of cell population proliferation (GO:0008284),0.3710164664506745,1.1862954851781966,0.066,0.6399589746290087,1.0,74/423,14.61%,HTR2B;HPSE;CDCA7L;SDCBP;NAMPT;TIMP1;SLC35F6;PRKCH;GCNT2;ADRA1D;STX3;GAB2;VEGFA;AQP1;KIF20B;KDM4C;ID2;IL6;CDKN1A;TFAP2B;PDGFA;TCIRG1;SRPK2;RARA;PID1;PTEN;E2F1;CHTOP;PIM1;IGF1;FGFR4;THBS1;MVD;CUL3;IRS2;COPS9;SIRT6;DOT1L;HNRNPU;CACUL1;HMOX1;RPL23;FOLR2;SOX9;FOXP1;CTSH;CNOT6L;IL6R;VIPR1;WDR77;CNOT7;ADAM17;PTK2B;POU3F3;SIRT1;RBPMS2;CCN1;BST2;CDC123;NOTCH1;TBX6;IL15;S100A6;MAZ;HCLS1;IL7R;DHPS;RELA;GAS6;DERL2;GDNF;CX3CL1;PHIP;SHC1
prerank,acylglycerol metabolic process (GO:0006639),0.4464344926746739,1.1861441166495899,0.22263681592039802,0.6398389525385565,1.0,10/37,20.25%,APOE;MGLL;DGKZ;DGKA;PLAAT3;DGKQ;DGKG;GK5;LYPLA2;GK
prerank,regulation of cytoskeleton organization (GO:0051493),0.3917330072305138,1.1859347041582804,0.19012605042016806,0.6398874649829762,1.0,20/108,12.04%,IQGAP2;IQGAP1;DIAPH1;SPEF1;BAIAP2;LRP1;SORBS3;PRKCD;PDGFA;CLN3;CAPN2;DLC1;ARHGAP18;ARHGAP17;ROCK1;RHOD;GSK3B;PAK2;BST2;CDK2AP2
prerank,sphingolipid catabolic process (GO:0030149),0.5228891345718444,1.1859252745333762,0.28236914600550966,0.639339973277135,1.0,3/15,4.25%,SGPL1;GLA;PPT1
prerank,negative regulation of heart contraction (GO:0045822),-0.47781957135869313,-1.185242102930313,0.24722222222222223,0.6198109563375563,1.0,5/11,18.32%,ATP1A2;SPTBN4;GRK2;PIK3CG;FKBP1B
prerank,regulation of cell differentiation (GO:0045595),0.3831734517520651,1.1852140278259091,0.16424116424116425,0.6408234431484695,1.0,25/148,11.72%,LGALS3;SLC6A6;HOPX;TRPS1;CEBPB;RUNX2;ID2;TFAP2B;RUNX3;RAF1;DAG1;SMYD5;SIK1;DDX5;CREBBP;APC;KLHL41;ATF4;ANP32B;SNAI2;CBFB;ROCK1;MAFB;FES;PRKCB
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3705894039461877,1.1851021261647066,0.09227683049147442,0.6405808239740007,1.0,113/314,24.85%,NFE2L2;CTNNB1;ZNRF1;WWP1;FBXW7;PSMD1;ZFAND2A;FBXL17;TRIM25;UBXN8;ANAPC1;SPSB4;CUL3;NPLOC4;FAM8A1;UBE2K;FBXL3;RPS27A;UBC;NHLRC1;BFAR;RB1;NEDD4L;KLHL20;WWP2;RAD23A;DCAF12;TMUB2;SPSB2;TOPORS;TBL1XR1;HUWE1;PCNP;DDIT3;DDB1;UBXN4;FAF2;FBXO9;SIRT1;NHLRC3;PSMF1;ERLIN1;PSMD14;STUB1;PSMD12;CUL4A;DNAJB14;RNF34;FBXO6;PRKN;DERL2;ZFAND2B;PSME2;CUL1;AMN1;UBQLN2;ANAPC10;ARRB1;TMUB1;DNAJC18;CDC34;TMEM129;KCTD5;PSMB10;PSMD5;SGTA;BIRC2;PSMD8;AMFR;PPP2R5C;MAN1B1;CLOCK;PSMA3;TNFAIP1;AGAP3;FBXO5;FBXO31;PSMA2;UBE2S;ATXN3;ANAPC15;WFS1;PSMD11;PLAA;PSMA6;SPOP;FOXRED2;CUL4B;FBXO45;FBXL4;JKAMP;TAF1;ECPAS;KCTD2;PSMB3;UBR3;VCP;KCTD10;FAF1;HERPUD1;UBE4A;SIAH2;PSME3;UBE2D3;CDK2;UBE4B;FBXO4;PTTG1;UBE2J2;DMAC2;UBE2E1;PSMC5;ANAPC7
prerank,glycerolipid metabolic process (GO:0046486),0.5466577084062197,1.1851009517551252,0.25877192982456143,0.640019584154919,1.0,5/11,17.23%,DGKZ;DGKA;PGP;DGKQ;DGKG
prerank,positive regulation of intracellular transport (GO:0032388),0.4458482796968221,1.1844795452864563,0.25326991676575505,0.6412508063419423,1.0,12/38,16.82%,KIF20B;RUFY3;DYNC1H1;SORL1;PGAP1;EIPR1;TPR;OAZ2;BCAS3;TENM1;RAB29;OAZ1
prerank,regulation of protein modification process (GO:0031399),0.42901156319970046,1.1841421046661023,0.245593419506463,0.6416381456663638,1.0,12/50,14.48%,FNIP2;ATG7;FNIP1;CORO1C;SESN2;ATG10;FLCN;ABCA2;PUM3;MT3;FKTN;PHIP
prerank,cobalamin metabolic process (GO:0009235),0.5100813878160434,1.1840263437117613,0.26536312849162014,0.6413920268481349,1.0,4/17,18.34%,MMAB;LMBRD1;MTRR;ABCC1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3929897549668725,1.1837117738554412,0.19348054679284962,0.6416386734125699,1.0,30/108,19.10%,MDFIC;CTNNB1;FOXP3;GNAQ;LRP1;GSKIP;SULF2;FOLR1;CBFB;FZD7;ESR1;APP;WLS;APCDD1;SULF1;ITGA3;MACF1;ATP6V0C;TNFAIP3;PRKN;PPP1CA;KREMEN1;ATP6AP2;DEPDC1B;CDC73;WWOX;CSNK2A1;SNX3;PPP2CA;RNF43
prerank,genitalia development (GO:0048806),0.5503591014897503,1.182877950535266,0.2857142857142857,0.643474034350012,1.0,1/12,1.11%,STRA6
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.5025265091852492,1.1821589149040543,0.27012278308321963,0.6449353066111729,1.0,7/20,17.61%,MGST2;MTHFS;CNDP2;SLC27A1;HAGH;PTDSS1;OPLAH
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.4105873758803418,1.1821027598483194,0.21373200442967885,0.6445240854294373,1.0,18/72,14.94%,POLR2A;ERCC6;GPS1;RFC3;GTF2H5;RPS27A;UBC;POLR2L;ISY1;COPS5;DDB1;POLR2G;CDK7;POLR2I;CUL4A;COPS7A;PPIE;MNAT1
prerank,response to molecule of bacterial origin (GO:0002237),0.4090806906842033,1.1820168651300609,0.22982062780269058,0.6442222062060404,1.0,23/69,23.19%,MAPKAPK3;IL6;LY96;IRAK3;FOXP1;HNRNPA0;ADAM17;LIAS;TAB2;FZD5;TNFAIP3;SLC11A1;ERBIN;SLPI;ACOD1;LBP;OTUD5;IFNAR1;GCH1;FCGR2B;TIRAP;JAK2;IRAK1
prerank,cellular response to cytokine stimulus (GO:0071345),0.37005809558059544,1.1817410951574134,0.07807807807807808,0.6444490187168543,1.0,90/416,16.20%,CD36;CXCR4;SYK;GRB2;TIMP1;NFE2L2;BCL2L11;ANXA1;STX3;GAB2;VEGFA;TEC;SIGIRR;IRAK2;VIM;IL36G;SOS1;IL6;HGF;ABL2;CDKN1A;FOXO3;TANK;DAPK1;IL10RB;RIPK1;TNFRSF1B;IFNGR2;SHPK;PID1;PIM1;HTRA2;STAT5B;SOCS6;IFNAR2;UBE2K;MAOA;IRAK3;PIK3CA;PTAFR;CSF2RB;PTPN12;GBP6;HNRNPU;HMOX1;RPS27A;UBC;ZFP36L2;BRCA1;SOX9;F13A1;VAV1;SIRPA;IL20RB;IFITM2;IL5;TPR;IL6R;ITGB1;IL3RA;GSK3B;FOXO1;SIRT1;ARHGEF2;BAG4;NUMBL;EPRS1;RORA;ZFAND6;CSF2RA;RAPGEF1;HCLS1;RELA;GAS6;SOX2;POU2F1;JUNB;IL4R;ERBIN;CX3CL1;ACOD1;SHC1;CXCL12;JAK3;MCL1;CBL;LBP;CCL7;SYNCRIP;CDC34
prerank,response to zinc ion (GO:0010043),0.471140499764313,1.181664385433251,0.2688311688311688,0.644107974515023,1.0,12/25,20.51%,P2RX4;D2HGDH;MT3;PAM;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,lymphocyte differentiation (GO:0030098),0.41127355853581105,1.181005066691717,0.2181208053691275,0.6454521692127796,1.0,16/68,17.42%,ADGRG3;TPD52;ITGA4;MS4A1;LFNG;BLNK;ITGB1;ADAM17;RELB;DCAF1;JAK3;GPR89A;GPR89B;KLF6;CHD7;ZBTB7A
prerank,regulation of Rho protein signal transduction (GO:0035023),0.40718334093211894,1.1806573479443188,0.23883928571428573,0.645910036399587,1.0,17/72,15.95%,ABCA1;APOE;SYNPO2L;ABL2;MYO9B;RAF1;CUL3;FLCN;AKAP13;DLC1;CCDC125;ARHGEF2;ITGA3;COL3A1;LPAR6;ARRB1;NRP1
prerank,cellular response to growth factor stimulus (GO:0071363),0.38284438093174883,1.180422772081282,0.1689119170984456,0.6460192282542833,1.0,30/151,12.98%,IQGAP1;ANXA1;CTNNB1;ERN1;VEGFA;CD44;RUNX2;HGF;PDPK1;KIDINS220;APPL2;MAP2K5;HTRA2;MAPK7;EEF1A1;STAT5B;DUSP3;NR3C1;PTPN12;ZFP36L2;SOX9;ACVR2A;SNAI2;ACVRL1;BMPR2;ACVR1B;NOTCH1;APPL1;RAPGEF1;RELA
prerank,epidermal cell differentiation (GO:0009913),0.4373062964817418,1.1801498863866928,0.23261390887290168,0.6462236776424085,1.0,3/41,2.89%,ANXA1;CTNNB1;ADAM9
prerank,nucleotide-excision repair (GO:0006289),0.39274088401053947,1.1793025563164985,0.19128586609989373,0.6481596299657765,1.0,23/101,14.94%,POLR2A;ERCC6;GPS1;RFC3;GTF2H5;BRIP1;RPS27A;UBC;POLR2L;RAD23A;ISY1;COPS5;DDB1;POLR2G;POLL;SIRT1;CDK7;POLR2I;CUL4A;COPS7A;POLA1;PPIE;MNAT1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5543613515557834,1.1792553654640463,0.2898773006134969,0.6477362388930039,1.0,5/11,19.20%,NEDD4L;PICALM;SNX33;LEPROTL1;GOPC
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5236632489264864,1.1791762544623834,0.2815126050420168,0.6473809412854203,1.0,7/14,28.83%,VEGFA;PIK3CA;NRP1;GAB1;MYO1C;KDR;NUS1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.37334588022727744,1.1789612559868965,0.10220440881763528,0.6474722305574186,1.0,66/306,15.09%,B4GALT5;APOE;RBMS1;RPL3L;POLR2A;TNIP1;MCM9;EXT1;RFC3;IGF2BP3;BRIP1;E2F1;FAM111A;EEF1A1;AGO2;NFKBIB;RPL18A;MRPL11;RPS14;RPS11;HELB;RPS27A;BRCA1;ST3GAL4;MRPL23;RPL17;RPL23;DARS1;POLR2L;TOP1;EPC1;TAF1B;RPL36A;EIF4EBP2;TOPORS;COPS5;MRPS7;PAX8;RPL22;RPS21;RRBP1;POLR2G;POLL;MRPL32;POLR2I;MRPL36;DBF4;ING4;NBN;GTPBP2;SARS1;RPL10A;MRPL28;WRN;DHPS;POLA1;RPS26;MRPS21;RNASEH2A;SRBD1;GOLPH3;MRPL35;RPL15;RPL10;PWP1;ORC1
prerank,cellular response to ATP (GO:0071318),-0.4321989270963223,-1.1789060796055788,0.2620481927710843,0.6336172037677213,1.0,3/14,6.67%,P2RY12;RYR3;HSP90B1
prerank,tetrapyrrole metabolic process (GO:0033013),0.5005019804178517,1.178795734264622,0.265474552957359,0.6473670179528317,1.0,4/18,18.34%,MMAB;LMBRD1;MTRR;ABCC1
prerank,cellular response to superoxide (GO:0071451),0.5740723113176481,1.1787003766018032,0.2863849765258216,0.6470487946997682,1.0,3/10,15.22%,PRDX1;MT3;ATP7A
prerank,epithelial cell migration (GO:0010631),0.44206993620441076,1.1774531961717403,0.25090470446320867,0.6499880031716907,1.0,8/37,10.63%,PLXND1;ZEB2;PKN3;LPXN;PIK3CA;FSTL1;ROCK1;PKN2
prerank,negative regulation of growth (GO:0045926),0.38818231710505186,1.177121696866395,0.19327731092436976,0.6504147361411915,1.0,38/121,20.51%,TMPRSS4;CDKN1A;PPT1;ENPP1;MYL2;SESN2;NOTCH2;OSGIN1;APBB2;SPHK2;FLCN;HSPA1B;RB1;PPP1R9B;ACVRL1;BMPR2;NAIF1;SIRT1;ING4;MT3;DCUN1D3;BST2;ACVR1B;NOTCH1;RBBP7;HSPA1A;RTN4;NDUFS3;PPP2CA;PPP2R1A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.4097860362446616,1.1770471349163956,0.24804469273743016,0.6500955973037327,1.0,17/72,16.37%,SYK;SIGIRR;IRAK2;RIPK1;IFNGR2;IFNAR2;RNASEL;IRAK3;HIPK1;CBFB;BIRC3;TRAF1;TAX1BP1;GAS6;TNFAIP3;TRAF2;PTPN1
prerank,polyol metabolic process (GO:0019751),-0.3185959733862417,-1.1769632168607627,0.16071428571428573,0.6363262944802138,1.0,12/46,11.22%,INPP4B;INPP5D;PLCB1;IP6K2;IMPA1;PPIP5K1;PLCH1;ITPK1;PLD4;ITPKC;NUDT3;MINPP1
prerank,negative regulation of B cell activation (GO:0050869),0.4838320968821268,1.1761965548115334,0.2779291553133515,0.6519417457641663,1.0,7/21,19.84%,CD300A;ID2;PARP3;TYROBP;TNFAIP3;TNFRSF21;FCGR2B
prerank,organelle fission (GO:0048285),0.47468743124521723,1.1761889309762847,0.289544235924933,0.6513988639992657,1.0,6/24,13.77%,CORO1C;PEX11A;MTFR1L;MTFP1;GDAP1;PRKN
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.5075003911080134,1.1756046403194214,0.27323943661971833,0.6524627445697003,1.0,5/18,17.14%,CD300A;B4GALT7;NLRC3;CDC73;FTH1
prerank,GPI anchor metabolic process (GO:0006505),0.46239261179395436,1.1755393786665196,0.2585301837270341,0.6521002035938243,1.0,7/26,15.19%,PGAP3;DPM2;PGAP1;PIGH;PIGC;GPLD1;PIGQ
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.45472697318079663,1.1755078457765813,0.2563451776649746,0.6516502160352055,1.0,10/33,16.30%,RAB7B;FOXO3;STAT5B;HSPA1B;ACVR2A;FES;ACVR1B;FAM210B;HSPA1A;BRD1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.541963095213257,1.1754503750313443,0.28072837632776937,0.6512658874076583,1.0,3/12,5.76%,ABCD1;MTLN;IRS2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.4116130059257683,-1.1752938559001826,0.25951557093425603,0.638362098215031,1.0,5/16,12.55%,SALL1;FGF2;PAX2;PKD2;NPNT
prerank,regulation of response to oxidative stress (GO:1902882),0.5585504861219382,1.1750389474177427,0.2852760736196319,0.6518875180778341,1.0,4/11,13.77%,ABCD1;AIFM2;MCTP1;PRKN
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.5631456218503337,1.1750175367171847,0.28289473684210525,0.6513900697446068,1.0,3/10,17.48%,LRP1;PTPN12;APOD
prerank,protein O-linked glycosylation (GO:0006493),0.3924123779093215,1.1748387865676106,0.2053191489361702,0.6513544806603137,1.0,15/96,14.45%,B4GALT5;B3GNT8;GALNT3;DPM2;GALNT6;GALNT9;TET3;B3GALNT2;ST3GAL4;GXYLT2;TET2;OGA;TMTC4;POFUT2;FKTN
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4342528613163343,1.1748189059773966,0.24818401937046006,0.6508583416107917,1.0,13/36,21.42%,OPTN;RILPL2;RAB7A;RAB31;RAB10;MACF1;GOLPH3;GOLPH3L;GOLGA4;GGA2;BBS1;VAMP2;GGA3
prerank,mitochondrion morphogenesis (GO:0070584),0.5638775558259213,1.1746038435239268,0.27856025039123633,0.6509392078950637,1.0,2/11,4.72%,MTM1;PID1
prerank,response to prostaglandin E (GO:0034695),0.5651508162451053,1.1743082878426447,0.2711598746081505,0.6512463101862574,1.0,2/10,9.85%,PTGER2;PTGER4
prerank,regulation of isotype switching (GO:0045191),0.5341545615912201,1.1742749668522314,0.2935251798561151,0.6507957116938413,1.0,6/14,20.60%,TFRC;PARP3;KMT5B;SHLD1;SHLD2;PAXIP1
prerank,tyrosine metabolic process (GO:0006570),0.5530688090626779,1.173967337616624,0.28892215568862273,0.6510935843682807,1.0,2/11,16.04%,DCT;FAH
prerank,nitric oxide metabolic process (GO:0046209),0.5240545318616825,1.173851478983414,0.2658788774002954,0.6508908483010137,1.0,2/14,6.13%,CYB5R3;ARG2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.44993281658727025,1.173735544355842,0.2554002541296061,0.6506787640513193,1.0,11/35,19.31%,ARHGAP24;ABL2;CUL3;FLCN;DLC1;CCDC125;LZTR1;ITGA3;MAPKAP1;TNFAIP1;STAMBP
prerank,cellular response to cadmium ion (GO:0071276),0.47630532587781294,1.173395129779469,0.2657718120805369,0.6510816362178188,1.0,11/24,20.51%,JUN;MT3;NCF1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4454997940987222,1.1732035632225726,0.24623115577889448,0.6510976082720342,1.0,5/34,8.04%,NSMCE2;CD28;IGF1;CUL3;RB1
prerank,regulation of protein export from nucleus (GO:0046825),0.4844215246349835,1.1730732999128128,0.28165374677002586,0.6509210496891181,1.0,10/23,19.95%,ANP32B;GTSE1;TPR;GSK3B;SIRT7;GAS6;UHMK1;CAMK1;RBM22;TCF7L2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5211637476450988,1.172676637989852,0.29619181946403383,0.6515431335260541,1.0,2/15,5.80%,AK8;ENTPD1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3763280735940102,1.1726600090123527,0.19116135662898254,0.651036549385576,1.0,40/163,19.78%,CD38;RFTN1;SYK;VAV3;TEC;PRAM1;CD28;PDPK1;PSMD1;SPG21;CD3D;MS4A1;TRAT1;PIK3CA;DENND1B;BLNK;PLEKHA1;SH2B2;PAK2;PSMF1;PSMD14;TAB2;PRKCB;PSMD12;BTK;RELA;PSME2;CUL1;CD247;PSMB10;PSMD5;EIF2B2;PSMD8;CARD11;PSMA3;PSMA2;TNFRSF21;PIK3CB;PSMD11;LAT2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5349626865121927,1.172407666452539,0.3048048048048048,0.6512366281643203,1.0,1/13,0.53%,NAMPT
prerank,protein localization to chromatin (GO:0071168),0.4989530698963106,1.1719802170560392,0.28711484593837533,0.651870879498337,1.0,8/18,22.74%,MCM9;NIPBL;ESR1;CHMP7;RAD21;SGF29;RUVBL2;WAPL
prerank,immunoglobulin mediated immune response (GO:0016064),0.577199117321145,1.1716694050826617,0.3008982035928144,0.6522055829098697,1.0,1/10,0.92%,TLR8
prerank,negative regulation of neurogenesis (GO:0050768),0.44800253825833086,1.1713679582926786,0.24327784891165172,0.6524986161698262,1.0,6/34,4.99%,HOOK3;RUFY3;IL6;APPL2;PTEN;SORL1
prerank,adenine nucleotide transport (GO:0051503),0.5091944412507509,1.1711667304196502,0.28454172366621067,0.6524888157470062,1.0,8/17,22.74%,LRRC8D;ABCC4;LRRC8C;SLC25A42;SLC17A9;SLC19A1;SLC25A17;SLC25A24
prerank,gene expression (GO:0010467),0.3721568190056175,1.1709021020963233,0.10821643286573146,0.6526885691662171,1.0,89/348,17.41%,APOBEC1;RBMS1;RPL3L;DHX8;POLR2A;ATXN1;ALYREF;TNIP1;TFIP11;CPSF1;MPHOSPH10;RBM39;IGF2BP3;E2F1;SORL1;CHTOP;TSPAN17;EEF1A1;AGO2;NUFIP1;NFKBIB;RNASEL;RPL18A;HNRNPUL1;MRPL11;RPS14;RPS11;THOC1;HNRNPU;RPS27A;MRPL23;RPL17;RPL23;DARS1;RBPMS;POLR2L;WDR33;EPC1;TAF1B;RPL36A;EIF4EBP2;TOPORS;COPS5;MRPS7;TPR;PAX8;RPL22;RPS21;RRBP1;POLR2G;DKC1;NUP50;MRPL32;POLR2I;MRPL36;NCBP2;DROSHA;STUB1;SRSF3;THOC2;SARS1;DEDD2;RPL10A;DDX20;MRPL28;DHPS;TSPAN15;RPS26;MRPS21;UPF2;MRPL44;HNRNPD;SRBD1;GOLPH3;MRPL35;RPL15;RPL10;PWP1;ADARB1;EIF4A3;RPSA;DDX39A;NUP98;HSPD1;SYNCRIP;DHX38;MRPL43;RPL7;RPL26
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.48044583250089856,1.1707929517641726,0.27371273712737126,0.6524596688358935,1.0,5/20,20.25%,NCOR1;SIK1;PGP;CRY1;GCK
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.40723390766735634,1.1707630585803082,0.22850678733031674,0.6520001805801451,1.0,20/67,23.18%,CD36;NEDD9;DOCK5;TRIOBP;RREB1;GSK3B;PTK2B;OLFM4;VIT;DOCK1;CX3CL1;UTRN;NRP1;RSU1;C1QBP;CCL25;ILK;CDK6;JAK2;FLNA
prerank,tRNA export from nucleus (GO:0006409),-0.3463146845280255,-1.1702585570064414,0.22624434389140272,0.6464554063314477,1.0,12/32,14.68%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3463146845280255,-1.1702585570064414,0.22624434389140272,0.6464554063314477,1.0,12/32,14.68%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,regulation of protein ubiquitination (GO:0031396),0.38717189867430285,1.1701588031047512,0.2017075773745998,0.6531961108718153,1.0,43/108,24.05%,SASH1;FBXW7;WASHC1;UBE2L3;CUL3;HSPA1B;BRCA1;XIAP;HUWE1;BIRC3;STUB1;SIRT7;NSMCE3;N4BP1;TNFAIP3;PRKN;HSPA1A;SQSTM1;ARRB1;PRKCG;CENPX;DCUN1D1;CRY1;PRR7;PHF23;BIRC2;MYCBP2;GNL3L;HDAC8;WFS1;DNAJA1;PAXIP1;OGT;GTPBP4;HSPBP1;FKBP1A;MALT1;SPRTN;BCL10;ISG15;TRAF6;FBXO4;NDFIP1
prerank,regulation of receptor binding (GO:1900120),-0.4811319341650182,-1.1701290402899986,0.27945205479452057,0.6444931039354167,1.0,4/10,25.33%,ADAM15;HFE;ATP2A2;ATP2A3
prerank,cellular glucose homeostasis (GO:0001678),0.4261409303765544,1.1700853362468702,0.265281173594132,0.6528638155941094,1.0,10/41,14.11%,LRRC8D;ERN1;HK3;ZBTB20;SLC39A14;FOXK1;FOXO1;SIRT1;GAS6;ADCY8
prerank,melanosome localization (GO:0032400),0.4753877277518219,1.1699121928732281,0.27717391304347827,0.6528415858703129,1.0,4/21,13.02%,MYO5A;MREG;VPS33A;RAB11B
prerank,negative regulation of macroautophagy (GO:0016242),0.4695587581517461,1.16893803520718,0.26108998732572875,0.6550840161619693,1.0,7/26,17.79%,MTM1;PIK3CA;QSOX1;USP36;RUBCN;TMEM39A;PHF23
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3795869623193451,-1.1688029765155719,0.244,0.6456326531081082,1.0,7/22,15.74%,ORAI1;CACNA1C;GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,protein N-linked glycosylation (GO:0006487),0.40554706349375386,1.1686261488482477,0.23025583982202447,0.6554270985036132,1.0,21/66,19.93%,MAN1C1;DPM2;MGAT5;MCFD2;NUDT14;TMEM165;B4GALT7;DDOST;DAD1;GFPT1;ALG13;ALG12;MAGT1;MPDU1;MOGS;UGGT1;FUT8;ALG6;DPAGT1;ALG5;PMM2
prerank,negative regulation of cell cycle process (GO:0010948),0.41383197083761275,1.1683803139497182,0.2413793103448276,0.6555649430569459,1.0,26/61,24.59%,TOM1L2;APAF1;FOXO4;E2F1;EED;CHMP2A;BRCA1;UXT;EPC1;ZFYVE19;TERF1;VPS4A;CBX3;RBBP7;CCP110;AURKAIP1;FBXO5;MGA;EHMT2;PPP1R10;CBX5;WAPL;TFDP1;PHC3;RNF2;PCGF6
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5496076384477602,1.1677937268330802,0.29411764705882354,0.6567042138391129,1.0,6/11,16.60%,CYBA;MFHAS1;TREM2;TNFAIP3;ACOD1;TLR1
prerank,neuromuscular junction development (GO:0007528),-0.37086961470755103,-1.1676322504232803,0.22672064777327935,0.6465395510787934,1.0,4/24,3.20%,CACNB2;UNC13C;ANK3;CACNB4
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.540211454104874,1.1672702787961462,0.289193302891933,0.6576580352027405,1.0,6/12,25.32%,RAB10;CELSR1;LAMA3;VANGL2;ACTG1;ACTB
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4994978252723333,1.1669816598836176,0.2804878048780488,0.6579190969408396,1.0,7/20,24.01%,IPO5;PTEN;APC;LATS1;CEBPA;MEN1;NR2F2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5100396039183834,1.1669241201386753,0.29429429429429427,0.6575626032741481,1.0,3/14,10.68%,LILRB1;MAVS;SIRT1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.37463165075939087,1.1667786550109391,0.1699078812691914,0.6574208755838331,1.0,38/166,14.94%,PPARG;POLR2A;NR1H3;E2F3;RXRA;NCOR1;NOTCH2;RARA;GTF2B;GTF2H5;TAF7;MAML1;NR3C1;MAML2;NR1H4;CREBBP;TAF5;POLR2L;TAF1B;TBL1XR1;NR5A1;POLR1A;ESR1;NR2C1;POLR2G;CDK7;MED26;POLR2I;PPARD;NOTCH1;GTF2F2;RORA;POLRMT;MAZ;NRBF2;GTF2A1;NAT14;MNAT1
prerank,glycerophospholipid metabolic process (GO:0006650),0.3959391089004308,1.1667706146185162,0.2308522114347357,0.6569005849283928,1.0,16/75,15.19%,PLA2G7;DPM2;PLA2G2D;GPCPD1;CLN3;PIGH;PIGX;ABCA3;PLAAT1;PLA2G4F;PGP;PIGC;GPLD1;GDE1;PRDX6;PIGQ
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.5475410134921449,1.1663157555011934,0.2824302134646962,0.6576838700837748,1.0,3/10,14.71%,LILRB1;GAS6;CXCL12
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4686956203910914,-1.1661136995099541,0.270516717325228,0.6481678479024763,1.0,6/12,38.26%,FUT9;WNK1;LCK;PPARA;FUT4;ADTRP
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.38290513269140847,-1.1653513035042455,0.2217741935483871,0.6478473965427358,1.0,5/20,15.77%,RPGRIP1L;BICD1;GRK2;STMN1;RGS2
prerank,mitochondrial protein processing (GO:0034982),0.5565953312792469,1.1653456291248496,0.30349013657056145,0.6599233911340965,1.0,5/11,20.22%,IMMP2L;PMPCA;OMA1;PMPCB;AFG3L2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.48524043165767133,1.1653254365294008,0.28783783783783784,0.6594203914190195,1.0,8/21,12.80%,HPSE;XYLT1;EXT1;UGDH;SULF2;HS2ST1;SULF1;SGSH
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5330345684012913,1.1650023999083337,0.2895125553914328,0.659806606307624,1.0,2/13,7.65%,ARG1;PRODH
prerank,positive regulation of cellular process (GO:0048522),0.3637571061620517,1.1645991547247332,0.069,0.6604439489887347,1.0,105/565,15.06%,CD36;HTR2B;CDCA7L;SDCBP;NAMPT;SLC6A6;TIMP1;SLC35F6;GCNT2;ADRA1D;STX3;GAB2;VEGFA;FLOT1;KIF20B;TGM2;IER5;KDM4C;LRP1;IL6;PRKCD;ANKRD17;DYNC1H1;FASN;TFAP2B;PDGFA;P2RX4;TCIRG1;SRPK2;TNFRSF1B;LMNA;CELF1;RARA;MMP14;PTEN;CITED2;MTLN;CHTOP;IGF1;FGFR4;THBS1;MVD;CUL3;MERTK;RNF10;IRS2;ADAM8;COPS9;APC;DOT1L;FLCN;CACUL1;P2RX3;CYBA;RPL23;N6AMT1;PRODH;FOLR2;SOX9;SIRPA;RAD23A;CTSH;HP;HPR;PPP3CA;TRPC3;CNOT6L;IL6R;EXOSC9;FZD7;VIPR1;WDR77;CNOT7;ADAM17;RHOD;PTK2B;MTPN;POU3F3;SIRT1;MT3;CDC123;NOTCH1;TBX6;IL15;TREM2;DOCK2;MAZ;HCLS1;IL7R;DHPS;RELA;GAS6;BCLAF1;POFUT2;SLC11A1;DERL2;GDNF;CX3CL1;PHIP;LRP6;SHC1;CXCL12;INO80;CNOT6;NSMCE4A
prerank,cellular response to calcium ion (GO:0071277),-0.2925919284981835,-1.1642771177877744,0.18604651162790697,0.6482237621330342,1.0,20/67,12.04%,MEF2C;SYT1;NLGN1;MEF2A;RYR3;CAPN3;ADD1;PRKAA2;KCNH1;SYT7;SYT2;TRPM2;SYT4;SYT6;CPNE8;MCOLN1;ADGRV1;ADCY1;PKD2;CPNE4
prerank,neuromuscular process controlling balance (GO:0050885),-0.4566529364674462,-1.1642468890459767,0.2573099415204678,0.6460441648184982,1.0,4/12,3.59%,PCDH15;NRXN1;CDH23;MYO7A
prerank,vesicle transport along microtubule (GO:0047496),0.477432197079547,1.1641303296175716,0.2804718217562254,0.6612261897204171,1.0,9/23,19.70%,FYCO1;DYNC1H1;CLN3;KIF3A;NDE1;KIF5B;PAFAH1B1;HTT;RAB1A
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.4490710009616933,-1.1641021348232552,0.2631578947368421,0.6441377155934422,1.0,5/12,23.04%,CSF1R;CSF1;PTK2;IL34;LYN
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4703686003479977,1.163782800026998,0.2740076824583867,0.6616536951803977,1.0,9/26,16.60%,FLOT1;NR1H3;NINJ1;CYBA;MFHAS1;TICAM2;RTN4;LBP;TLR1
prerank,regulation of response to stress (GO:0080134),-0.48203934777723684,-1.163737250646155,0.27246376811594203,0.6428978111853678,1.0,8/10,32.48%,OPRM1;EIF4G1;MLC1;STOX1;SLC38A2;DYRK3;CORO2B;CRHBP
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3450801025473696,-1.1634072985879864,0.20103092783505155,0.6415369768278826,1.0,12/31,14.75%,DLG2;OPHN1;PARD3B;PARD3;LIN7A;SYNJ2BP;SH3BP1;MARK2;DLG1;RHOA;DLG3;ANK1
prerank,ESCRT complex disassembly (GO:1904896),0.5568682068643032,1.1630528124019577,0.3048211508553655,0.6626316205085439,1.0,5/10,21.48%,CHMP2A;VPS4A;CHMP5;CHMP7;CHMP2B
prerank,ESCRT III complex disassembly (GO:1904903),0.5568682068643032,1.1630528124019577,0.3048211508553655,0.6626316205085439,1.0,5/10,21.48%,CHMP2A;VPS4A;CHMP5;CHMP7;CHMP2B
prerank,vitamin transport (GO:0051180),0.4636297681631747,1.162682906645641,0.27918781725888325,0.6631476078269,1.0,8/29,19.52%,FOLR2;FOLR1;SLC27A1;SLC25A32;SLC23A1;SLC52A1;SLC19A1;SLC19A2
prerank,carbohydrate transport (GO:0008643),0.5521680448063264,1.1624873881879152,0.3120243531202435,0.6631292100668892,1.0,4/11,19.51%,AQP1;SLC23A2;SLC23A1;SLC50A1
prerank,cytosolic calcium ion transport (GO:0060401),0.454905000242861,1.1624122973082367,0.2827496757457847,0.662803290466665,1.0,5/28,5.00%,ADRA1A;ATP2B1;MICU2;MICU1;SLC8A1
prerank,protein autoubiquitination (GO:0051865),0.4086859586278628,1.1622365400802515,0.24324324324324326,0.6627211869400093,1.0,23/61,24.01%,TRIM17;UHRF2;CUL3;RNF10;CNOT4;BRCA1;BFAR;SH3RF1;WWP2;RNF115;RNF146;ASB4;KLHL24;STUB1;PRKN;TRAF2;AMFR;NFX1;RNF19B;RNF141;OBI1;UBE2D3;TRAF6
prerank,regulation of cytoplasmic transport (GO:1903649),-0.4632824274945825,-1.1622187896282477,0.2716417910447761,0.642432904286466,1.0,3/11,7.34%,USP7;ATP9A;MAP2K1
prerank,aminoglycan biosynthetic process (GO:0006023),0.42042497835377374,1.1620040214567418,0.26823529411764707,0.662826857348581,1.0,9/49,8.84%,B3GNT8;GCNT2;XYLT1;NDST1;EXT1;UGDH;B4GALT7;HEXA;HS2ST1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4350068019055525,-1.1618508764100495,0.24193548387096775,0.6411443693408875,1.0,5/13,13.66%,SPRED1;ATM;ATR;SPRED2;SPRED3
prerank,protein heterotetramerization (GO:0051290),-0.44140047778305264,-1.1616937629705317,0.26366559485530544,0.639342641497167,1.0,4/13,13.62%,GRIN2B;GRIN1;PKD2;PKD1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5412931023130518,1.161678531605181,0.2978723404255319,0.6632161357659719,1.0,4/11,15.93%,SIRT6;TPR;MPHOSPH8;DNMT1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5000515662590992,1.1616199097886617,0.29745042492917845,0.6628469405923891,1.0,5/16,15.19%,DPM2;PIGH;PIGX;PIGC;PIGQ
prerank,cellular response to radiation (GO:0071478),0.42828626342217113,1.1612566325313673,0.2817073170731707,0.6633657334989548,1.0,11/40,20.72%,GRB2;CDKN1A;TANK;GADD45A;SIRT1;NSMCE3;INTS7;INO80;CLOCK;EEF1D;TNKS1BP1
prerank,negative regulation of cellular process (GO:0048523),0.3638470708196263,1.1609922574891136,0.065,0.6635597863800666,1.0,99/521,15.74%,GPNMB;HTR2B;PLXNA1;PLXNC1;ADAMTS8;FRK;PLXND1;HOPX;LILRB1;RPS6KA2;ADRA1A;CTNNB1;NCK2;FOXP3;SPEF1;ST18;CCN5;IFITM1;NR1H3;IL6;CDKN1A;NIBAN2;TFAP2B;RUNX3;PPT1;ENPP1;TNFRSF1B;LMNA;MYL2;SESN2;APPL2;CELF1;ABI1;PTEN;RAF1;FOXO4;OSGIN1;HTRA2;ACTN1;APBB2;SMYD5;LPXN;SPHK2;APC;CHMP2A;NUDT6;FLCN;HSPA1B;ANP32B;NF2;TES;RB1;PPP1R9B;BNIPL;SIRPA;P3H3;DLC1;STRN;ACVRL1;BRD7;DSCAM;BMPR2;NLRP2B;CNOT7;NAIF1;PTK2B;SIRT1;ATG5;CCN1;ING4;VPS13C;MT3;FBLN1;DCUN1D3;APP;BST2;ACVR1B;NOTCH1;LPCAT3;MYH9;TREM2;SIRT7;DUS2;ARID2;GPLD1;PODN;VAMP3;RBBP7;PRKN;TENM1;HSPA1A;SPEG;FKTN;ALDH1A2;RTN4;ADARB1;SMYD2;BNIP3;CDC73
prerank,response to peptide hormone (GO:0043434),0.43321632775535945,1.1605869124237778,0.2608173076923077,0.6642206892203762,1.0,13/43,20.71%,ANXA1;STAT5B;EIF6;SLC27A1;ROCK1;SIRT1;CRY1;EIF2B2;CREB1;EPM2AIP1;ZBTB7B;STAT6;OGT
prerank,cellular response to peptide (GO:1901653),0.42125182721853865,1.1605358934278915,0.26914414414414417,0.6638136902286222,1.0,11/56,12.31%,CD36;VIM;LRP1;ITGA4;IGF1;RPL23;GSK3B;ARHGEF2;APP;TRIM41;TREM2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.49759970397219244,1.1601465032478564,0.27461858529819694,0.6644105481234579,1.0,6/18,12.77%,ABL2;CUL3;FLCN;DLC1;CCDC125;ITGA3
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5134818802178636,1.1599027727111564,0.3048780487804878,0.6645488805682469,1.0,4/17,6.73%,NCOR1;PID1;PPIF;FLCN
prerank,cellular response to DNA damage stimulus (GO:0006974),0.36590488811092037,1.159837228017237,0.1091091091091091,0.6641951029337613,1.0,104/336,23.45%,FNIP2;GRB2;TRIP12;VAV3;BCL2L11;IKBKE;TAOK3;CDKN1A;WAC;MUS81;MCM9;TANK;ZDHHC16;RFC3;MUTYH;UVRAG;TNFRSF1B;PARP4;ZRANB3;BACH1;E2F1;PARP2;HTRA2;FAM111A;GADD45A;BABAM2;APC;HELB;PARP3;DOT1L;NIPBL;BRCA1;ENDOV;XIAP;FOXP1;SMC1A;VCPIP1;TOPORS;RTEL1;SETD7;POLH;DDIT3;XRCC5;DDB1;XRCC2;DCUN1D5;FOXO1;SIRT1;MBD4;INIP;NBN;CBX1;CBX3;CUL4A;SIRT7;KMT5B;WRN;NSMCE3;FBXO6;DYRK2;USP16;POLA1;BAX;INO80;MCL1;MNAT1;MTREX;NSMCE4A;ALKBH8;FANCA;RNF169;BID;BAZ1B;ALKBH1;CRY1;POLI;ACER2;CASP2;NCOA6;FBXO31;ZBTB40;TLK2;PDS5A;BCL3;PHF1;MRE11;USP3;CUL4B;FBXO45;RAD51B;EPHA2;XPC;TAF1;MGMT;RPAIN;PRKDC;CBX5;VCP;RNF168;SPIDR;SLF1;POLD1;ERCC4;SPRTN
prerank,positive regulation of response to external stimulus (GO:0032103),0.3796218264704786,1.1597206716887947,0.21347150259067357,0.6639806356019083,1.0,19/128,12.31%,PLA2G7;SASH1;OPTN;TLR8;MGST2;STX3;TNIP1;ANKRD17;RIPK1;LY96;NINJ1;THBS1;ADAM8;CYBA;PTGER4;APP;PUM2;IL15;TREM2
prerank,regulation of interferon-beta production (GO:0032648),0.4224433931103177,1.1597124557991318,0.26417370325693607,0.6634571645159936,1.0,10/46,13.24%,TLR8;LILRB1;FLOT1;RNF135;REL;SIRPA;MAVS;NLRC3;RELB;TRAF3
prerank,programmed necrotic cell death (GO:0097300),0.503954235797176,1.1594668673608282,0.29088471849865954,0.6636321390335218,1.0,5/18,13.49%,RIPK1;LY96;PPIF;TICAM2;TRPM7
prerank,positive regulation of calcium ion transport (GO:0051928),0.4388396882745564,1.1586535525446233,0.2723926380368098,0.6654835595052807,1.0,9/36,14.71%,LGALS3;ATP2B1;P2RX4;SPHK2;P2RX3;TRPC3;MYLK;CRACR2A;CXCL12
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.5372164087456197,1.1586047571206077,0.2993730407523511,0.6650807157121406,1.0,1/12,0.35%,SOAT1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.36872208586878,1.1586032849210364,0.17593528816986856,0.664546259917391,1.0,37/214,16.37%,GPNMB;CD36;HTR2B;APOE;SYK;GCNT2;ADRA1A;FBXW7;CD44;TNIP1;PDGFA;NOTCH2;PTEN;FGFR4;DUSP3;FLCN;MFHAS1;CNKSR3;SIRPA;PTK2B;CCN1;MT3;FBLN1;STYX;APP;NOTCH1;ROR1;TREM2;GAS6;RRAS;CX3CL1;SHC1;ARRB1;CCL7;NRP1;ZDHHC17;PTPN1
prerank,B cell mediated immunity (GO:0019724),0.5708201391564877,1.158502622815205,0.315541601255887,0.6643039336762199,1.0,1/10,0.92%,TLR8
prerank,calcium ion transport into cytosol (GO:0060402),-0.38550065544701256,-1.1578753594567621,0.2318840579710145,0.6470157946469569,1.0,10/21,14.72%,GRIN2A;GRIN2B;CACNA1C;RYR2;GRIN1;JPH1;TRPM2;GRIN2D;ATP2B4;CACNA2D1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.41057717633913027,1.1578344172196648,0.24913892078071181,0.6656062694249526,1.0,24/63,24.56%,LGALS3;FAS;BIRC6;RIPK1;IGF1;THBS1;SH3RF1;PAK2;TRAF1;DEDD2;RELA;PHIP;WWOX;TRAF2;BID;LTBR;HTT;TCF7L2;ITGAV;SIAH2;PSME3;BCL10;BCL2L12;CASP8
prerank,heart development (GO:0007507),0.376246532842299,1.1575319388621852,0.21644120707596254,0.6659366422330056,1.0,26/150,13.66%,HTR2B;APLNR;ALPK3;SYNPO2L;STRA6;VEGFA;ID2;CDKN1A;ZDHHC16;MYL2;PTEN;CITED2;PDLIM5;NIPBL;SOX9;AKAP13;MYBPC3;DLC1;ACVRL1;BMPR2;TAB2;NOTCH1;MICAL2;COL3A1;SH3PXD2B;SMYD4
prerank,regulation of glucose transmembrane transport (GO:0010827),0.4965937859762299,1.157431559236854,0.2955801104972376,0.6656920976017777,1.0,4/18,12.38%,PRKAG2;PRKCB;APPL1;SLC2A1
prerank,regulation of myotube differentiation (GO:0010830),0.46786775068202496,1.1573499473445112,0.28897849462365593,0.6653783082909271,1.0,5/24,11.96%,MMP14;MAML1;SIK1;PIEZO1;NOTCH1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.44251021688746994,-1.1573189623622475,0.2739273927392739,0.6462251136003521,1.0,7/13,22.45%,ARSB;HEXB;HYAL1;IDS;BCAN;CSPG4;NCAN
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4383741301917973,1.1566329897833902,0.28743961352657005,0.6668474147822189,1.0,6/39,5.50%,NFE2L2;ANO6;PDPK1;ITGA4;MAPK7;THBS1
prerank,regulation of vasoconstriction (GO:0019229),0.45724206126608374,1.1566181311008588,0.28888888888888886,0.6663489046115618,1.0,4/27,9.45%,ADRA1D;ADRA1A;ATP2B1;BMPR2
prerank,neurotransmitter uptake (GO:0001504),-0.4473382522274117,-1.1564725492860808,0.273972602739726,0.6460683714211047,1.0,3/12,5.18%,SLC1A3;ATP1A2;SNAP25
prerank,regulation of type I interferon production (GO:0032479),0.38681288140039427,1.1563746226375384,0.26077348066298345,0.6665024017827347,1.0,32/84,24.62%,CTNNB1;IKBKE;RNF26;TRIM25;NPLOC4;CREBBP;RNF135;POLR2L;XRCC5;MAVS;TAX1BP1;PQBP1;RELA;TRAF3;POLA1;TNFAIP3;ACOD1;MYD88;OTUD5;STAT6;TBK1;MRE11;POLR3C;PRKDC;TIRAP;RNF125;POLR3K;IRAK1;ISG15;LRRFIP1;DHX58;GPATCH3
prerank,nitric oxide biosynthetic process (GO:0006809),0.5240583786656773,1.1563565490590761,0.2922374429223744,0.6660233768981497,1.0,2/13,6.13%,CYB5R3;ARG2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.4626667548447056,-1.1560520703090515,0.2861356932153392,0.6448646737225575,1.0,1/11,0.13%,BIN1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.36369450650258783,1.1560116442782618,0.13013013013013014,0.6664468087629748,1.0,60/348,15.25%,GPNMB;FNIP2;IQGAP1;GDF15;SDCBP;APLNR;RAP2A;VEGFA;TEC;FLOT1;TXN;FNIP1;TFRC;PRKAG2;CD44;IL6;HGF;ITGA5;CDKN1A;FAS;PDGFA;SNX9;RIPK1;RAF1;IGF1;UBE2K;FLCN;CACUL1;RBPMS;SOX9;ACVR2A;ACVRL1;IL5;BMPR2;IL6R;TNIK;XRCC5;MAVS;ADAM17;PTK2B;PAK2;SIRT1;ARHGEF2;CCN1;NBN;MT3;APP;TAB2;IL15;TREM2;HCLS1;GAS6;DGKQ;TENM1;CX3CL1;GDF10;PFN2;LATS1;ARRB1;CDK2AP1
prerank,aminoglycan catabolic process (GO:0006026),0.45382100756677735,1.1556951471278394,0.2847854356306892,0.6667977474532129,1.0,8/28,14.97%,HPSE;GNS;IDUA;FUCA1;SGSH;SDC4;CTBS;GUSB
prerank,protein secretion (GO:0009306),0.40828125195926834,1.1553864543696133,0.24382022471910111,0.66712225586647,1.0,9/56,11.93%,ABCA1;ANXA1;STEAP3;RAB8B;TANGO6;RAB12;RAB10;WLS;CYB5R4
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5534800312679014,1.1551607109960795,0.2981651376146789,0.667253669352799,1.0,5/11,15.92%,TENT4B;EXOSC3;DKC1;LARP7;EXOSC10
prerank,regulation of myoblast fusion (GO:1901739),0.5452706915717169,1.1550084579394488,0.3192771084337349,0.6671399775140529,1.0,2/11,5.61%,FLOT1;CD53
prerank,regulation of cell motility (GO:2000145),0.3754924353105172,1.154947696323158,0.22502628811777076,0.6667717847854724,1.0,19/121,11.51%,PLXNA1;SGK1;PLXNC1;PLXND1;ADGRG3;DIAPH1;ABL2;LMNA;RAF1;OSGIN1;DOCK10;CFAP20;ARHGAP18;ROCK1;CCDC125;PKN2;FES;FBLN1;NRG4
prerank,phospholipid translocation (GO:0045332),0.4672810795291003,1.1548048187944076,0.3076923076923077,0.6666278932112019,1.0,4/28,4.25%,ABCA1;PLSCR4;ANO6;ATP8B4
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.43273030557824466,1.154425458386978,0.27625,0.6672188037768454,1.0,9/35,12.69%,IQGAP2;BAIAP2;ABL2;NOTCH2;STAP1;PTK2B;FES;BCAS3;HCLS1
prerank,endochondral bone morphogenesis (GO:0060350),-0.4543353580957026,-1.1543559305480942,0.27380952380952384,0.6472287356610541,1.0,8/11,30.95%,MEF2C;TMEM119;FGFR3;FOXC1;INPPL1;COL13A1;SCX;BMP4
prerank,nucleic acid-templated transcription (GO:0097659),0.4280185593347964,1.1542204736595598,0.27864897466827504,0.6672723945139871,1.0,10/42,10.93%,POLR2A;E2F1;NFKBIB;POLR2L;EPC1;TAF1B;TOPORS;PAX8;POLR2G;POLR2I
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5541654225288349,1.1540159105107144,0.3191489361702128,0.6667609114829307,1.0,2/10,5.25%,MAP2K5;MAPK7
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5541654225288349,1.1540159105107144,0.3191489361702128,0.6667609114829307,1.0,2/10,5.25%,MAP2K5;MAPK7
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.2563496128620814,-1.1538296177426823,0.07894736842105263,0.6464719497662842,1.0,20/138,5.63%,PTPRD;ERBB4;PTPRT;LIFR;EPHA5;PTPRG;YES1;CSF1R;NTRK3;EPHA6;RYK;ACVR2B;EPHA3;FER;CSF1;HCK;FGFR2;NTRK2;IL6ST;FLT3
prerank,cytoskeleton organization (GO:0007010),0.38322377767311516,1.1535121233285375,0.22163865546218486,0.6676571204874893,1.0,30/114,16.87%,ARHGAP10;APOE;PALLD;FGD6;NEDD9;DIAPH1;ZMYM6;PLD2;SYNE3;WDPCP;SH3KBP1;KLHL20;CAPZB;EPB41L3;TNIK;CFL1;RHOD;SPRYD3;CFAP410;MICAL2;FGD5;LIMD1;TNFAIP3;MAST4;FGD3;PHIP;RND2;CCL7;SH3D19;BRWD1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5181033047074335,1.1527000651491852,0.29651162790697677,0.6694697426623898,1.0,3/13,6.36%,ENPP1;ENTPD1;ITPA
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.520781883397448,1.1525679666752235,0.31857142857142856,0.6693187096978441,1.0,4/14,12.51%,ABCD1;MTLN;IRS2;LONP2
prerank,embryonic limb morphogenesis (GO:0030326),0.44256427077880556,1.151915320382182,0.2779126213592233,0.6706296654951067,1.0,6/34,7.02%,MAP3K20;CTNNB1;MBNL1;CREBBP;WDPCP;NIPBL
prerank,RNA processing (GO:0006396),0.37400246278938176,1.1517339692843092,0.19120654396728015,0.6706042722170803,1.0,42/176,15.47%,APOBEC1;RBMS1;DHX8;ATXN1;TFIP11;MBNL1;SRPK2;MPHOSPH10;SCAF11;CELF1;RBM39;TENT4B;RNPC3;NUFIP1;TCERG1;RNASEL;HNRNPUL1;CSTF3;THOC1;HNRNPU;PRPF8;RBPMS;PPP1R9B;SNRNP25;TENT2;HNRNPA0;DKC1;PRPF6;DDX23;NCBP2;DROSHA;ZMAT5;SF3A3;DEDD2;SNRNP35;DDX20;RSRC1;SNRPF;MRPL44;HNRNPD;ADARB1;ZRSR2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4163931453181471,1.151610891039354,0.27164887307236063,0.6704353705425415,1.0,6/45,9.45%,GDF15;SDCBP;RBPMS;ACVR2A;ACVRL1;BMPR2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3826740601881032,1.1514207904007632,0.22943722943722944,0.6704612815333398,1.0,24/95,16.59%,LILRB1;VIM;IL36G;NR1H3;ADAM9;IL6;CD274;TNFRSF1B;LY96;SHPK;NFKBIB;STAP1;SIRPA;NFKBIL1;TICAM2;FZD5;TRIM41;RELA;TNFAIP3;ACOD1;LBP;CDC73;MYD88;CHMP5
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5212649480976005,1.151224503799826,0.2949852507374631,0.6704731486868418,1.0,4/13,14.64%,RENBP;GFPT1;NAGK;GNPDA1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.521228523944018,1.1512024347658805,0.3035190615835777,0.6700035283042398,1.0,3/12,15.93%,APOBEC1;MPHOSPH8;DNMT1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.4192579986825902,1.1508060177421042,0.26322115384615385,0.6705963329448581,1.0,20/46,26.13%,IPO5;PRKCD;ANP32B;GTSE1;TPR;MAVS;GSK3B;NCBP2;HCLS1;GAS6;CAMK1;RBM22;EFCAB7;TCF7L2;DMAP1;FLNA;CPSF6;BAG3;UBR5;ZIC1
prerank,regulation of phospholipase activity (GO:0010517),0.5558236753077709,1.1506118912846857,0.3360258481421648,0.670608886159101,1.0,2/10,3.03%,LRP1;PDPK1
prerank,positive regulation of binding (GO:0051099),0.3970195818625599,1.150475929659117,0.24511930585683298,0.6704637754933407,1.0,12/84,11.57%,PPARG;APOE;FLOT1;TXN;LRP1;CLN5;RARA;IGF1;STK3;HIPK2;GSK3B;APP
prerank,glial cell differentiation (GO:0010001),-0.346464184972644,-1.1502680062722488,0.2358490566037736,0.6535994054517815,1.0,14/28,22.46%,NFIB;RELN;TPPP;CDH2;MYRF;PAX2;PICK1;ERBB3;EIF2B5;SOX10;FGF10;SOX11;GPC1;METRN
prerank,regulation of cell population proliferation (GO:0042127),0.3585093766760955,1.149878949719726,0.057,0.6716528827044354,1.0,114/691,14.68%,GPNMB;HTR2B;CDCA7L;SDCBP;NAMPT;SGK1;TIMP1;ADAMTS8;FRK;SLC35F6;GCNT2;RPS6KA2;ADRA1D;ADRA1A;CTNNB1;STX3;NCK2;GAB2;VEGFA;KIF20B;FOXP3;IER5;ST18;KDM4C;TFRC;IFITM1;ID2;IL6;CDKN1A;NIBAN2;TFAP2B;BIRC6;PDGFA;RAB33B;TCIRG1;JUN;SRPK2;LMNA;CELF1;ABI1;RARA;PTEN;RAF1;FOXO4;OSGIN1;CHTOP;IGF1;FGFR4;STAT5B;THBS1;MVD;CUL3;IRS2;COPS9;APC;KLHL41;DOT1L;NUDT6;HSPA1B;CACUL1;RPL23;NF2;FOLR2;SOX9;TES;XIAP;PPP1R9B;BNIPL;P3H3;CTSH;DLC1;STRN;ACVRL1;BRD7;CNOT6L;BMPR2;IL6R;EGLN3;XRCC5;VIPR1;WDR77;CNOT7;ADAM17;PTK2B;POU3F3;AGO3;SIRT1;FES;ARHGEF2;ING4;APP;CDC123;NOTCH1;TBX6;IL15;MAZ;HCLS1;IL7R;DHPS;ARID2;RELA;GPLD1;PODN;TENM1;DERL2;HSPA1A;JUNB;GDNF;SPEG;CX3CL1;FKTN;PHIP;SHC1;ALDH1A2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5187428363562512,1.1498405624332806,0.32408759124087594,0.6712341942189063,1.0,1/13,0.14%,MDFIC
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5428225113013494,1.1497863594879292,0.3039647577092511,0.6708604012248968,1.0,5/11,19.65%,IPPK;SIRT7;PWP1;SMARCB1;NCL
prerank,actin filament bundle organization (GO:0061572),0.44351783480909823,1.1497856914382576,0.3096129837702871,0.6703308739353819,1.0,6/33,11.39%,LIMA1;NEDD9;BAIAP2;LCP1;RHOD;PLS3
prerank,positive regulation of heart rate (GO:0010460),0.49399898300214173,1.148988097628012,0.2923076923076923,0.6721198702510487,1.0,2/17,1.52%,ADRA1D;ADRA1A
prerank,mRNA stabilization (GO:0048255),0.4255587437471906,1.1488285137265826,0.2688564476885645,0.6720347238215779,1.0,11/40,17.11%,E2F1;TENT5A;HNRNPU;HNRNPA0;SLC11A1;TENT5D;GDNF;MYD88;SYNCRIP;THRAP3;TAF15
prerank,sensory perception of light stimulus (GO:0050953),-0.2755991898663541,-1.1487206634766522,0.13043478260869565,0.6554736003346258,1.0,12/87,10.30%,WHRN;PCDH15;RP2;ABLIM1;GRM8;CDH23;MYO7A;BBS2;PAX2;CABP1;SLC4A10;ADGRV1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4301545986184751,1.1482081203101657,0.27228327228327226,0.6732063397875819,1.0,6/39,10.48%,ABCA1;STEAP3;RAB8B;TANGO6;RAB12;RAB10
prerank,regulation of cell adhesion (GO:0030155),0.374550558782565,1.1481402927021163,0.23430962343096234,0.6728806021520155,1.0,21/129,11.35%,PLXNA1;CXCR4;PLXNC1;PLXND1;STX3;VEGFA;CYTH1;TGM2;ABL2;ADAM8;LPXN;FLCN;ACVRL1;DSCAM;PPP3CA;PLAU;ROCK1;RHOD;PTK2B;FES;FBLN1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.534899057270348,1.1476243457044315,0.3125,0.6738051327115441,1.0,3/12,9.91%,IL6;NCOR1;ESR1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5238039695343468,1.1474494249987894,0.3177710843373494,0.673808531770236,1.0,6/13,22.80%,ALG13;ALG12;MPDU1;ALG6;DPAGT1;SRD5A3
prerank,pore complex assembly (GO:0046931),0.4982450688538148,1.1474414254437295,0.30551816958277256,0.6733032063403372,1.0,11/19,24.87%,ANO6;PDZD11;TPR;RTN4;NUP98;TMEM170A;ADAM10;NDC1;GSDMD;AFDN;TSPAN33
prerank,keratan sulfate metabolic process (GO:0042339),0.44269655068593916,1.1472613781509122,0.289002557544757,0.673232983727452,1.0,8/31,10.52%,B4GALT5;GALNS;GNS;B4GALT6;HEXA;ST3GAL4;LUM;B4GALT3
prerank,regulation of epithelial cell migration (GO:0010632),0.41028067063217355,1.1469026151520858,0.2843488649940263,0.6737406804809409,1.0,16/51,15.35%,SASH1;CORO1C;RHOJ;DOCK5;RREB1;MCC;SOX9;CTSH;BMPR2;PFN1;DOCK1;MACF1;CAPN7;CLASP1;PFN2;RTN4
prerank,renal absorption (GO:0070293),0.5441001583206537,1.1468449272953518,0.3097744360902256,0.6733819530254209,1.0,1/10,0.58%,SGK1
prerank,central nervous system neuron development (GO:0021954),0.5135287129609722,1.1466357723749723,0.31432748538011696,0.6734270520573216,1.0,3/15,5.71%,B4GALT5;PTEN;B4GALT6
prerank,epithelial to mesenchymal transition (GO:0001837),0.4208821829704063,1.1466099928806543,0.273696682464455,0.6729653561869033,1.0,9/47,11.96%,CTNNB1;HGF;HNRNPAB;DDX5;SOX9;SNAI2;ROCK1;GSK3B;NOTCH1
prerank,thymus development (GO:0048538),-0.44108044497045223,-1.1463641682086023,0.3114754098360656,0.6594850873778056,1.0,9/13,45.44%,TGFBR1;FGF10;FOXE1;EPHB3;HES1;SHH;FADD;RIPK3;TBX1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3603684235081299,1.145981450677916,0.08708708708708708,0.6742105035699991,1.0,106/572,14.90%,PPARG;FNIP2;SDCBP;TFEC;IRX3;FRK;TRPS1;ZNF3;MITF;VEGFA;FNIP1;CEBPB;ZEB2;ATXN1;FOXP3;DNMT3A;ATF3;WWC2;NR1H3;GATAD2A;ID2;FOXO3;LIN37;CBX8;ZNF692;TFAP2B;RUNX3;RXRA;JUN;NCOR1;MAP2K5;RARA;MZF1;CITED2;BACH1;E2F1;TAF7;SAP30;GADD45A;NR3C1;SIRT6;TCERG1;EED;NR1H4;DDX5;CREBBP;BHLHE40;RPS14;FLCN;HNRNPU;TGIF1;ATF4;NIPBL;RPS27A;UBC;RITA1;ZNF177;RPL23;ETV6;RREB1;UXT;SOX9;SNAI2;RB1;NEDD4L;LCOR;EPC1;WWP2;ZNF148;FOXP1;IRF2;CHD3;CBFB;ARID5B;TBL1XR1;DACH1;TPR;DDIT3;ESR1;NR2C1;HCFC2;VPS72;SIRT1;NFATC3;LARP7;PPARD;CUX1;NOTCH1;TBX6;SARS1;SIRT7;DDX20;MAZ;RELA;KDM1B;SOX2;PRKN;ZKSCAN3;DCAF1;HSPA1A;SUV39H2;PRDM2;ID4;EID1;PER3;RPL10
prerank,translational termination (GO:0006415),0.3892014534844557,1.1459128083496124,0.2589382448537378,0.6738792449923957,1.0,30/95,19.56%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;N6AMT1;ETF1;MRPS23;MRPS7;MRPL1;MRPL14;MRPL32;MRPL36;MRPS35;MRPS28;MRPL30;MRPL28;MRPS21;MRPL19;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;APEH;AURKAIP1;MRPS10;MRPL17;MRPS31
prerank,cellular protein modification process (GO:0006464),0.35733452831912715,1.145739663810607,0.047,0.6738332219398805,1.0,244/982,20.64%,EPAS1;CEL;MFGE8;FNIP2;FBXO32;B4GALT5;APOE;SGK1;MAP3K20;MAK;B3GNT8;SYK;MSRA;TLK1;MTM1;TIMP1;CCDC8;FRK;PRKCH;MTMR3;GCNT2;MAP3K1;ANXA1;ERN1;ATG7;TEC;NPC1;TIPARP;PDK4;GPS1;TGM2;PRKAG2;IKBKE;ITIH2;FBXW7;SPP1;PPM1H;PLK2;TAOK3;IL6;PDPK1;ABL2;PRKCD;APLP2;PPP4R1;RUNX3;PSMD1;BIRC6;SIK3;FAM20C;DAPK1;SRPK2;PPEF1;PARP4;B4GALT7;RARA;PTEN;MAPK6;GNMT;PTPRE;PIM1;PARP2;UBE2L3;ATG10;MAML1;PKN3;SPSB4;THBS1;CUL3;FBXW10;MERTK;SOCS6;SIRT6;MELK;RNASEL;FBXL3;DDOST;SIK1;MAN2A1;PPEF2;STK24;STK3;TRIOBP;IRAK3;DCAF13;MANBA;PROC;COG7;PGAP1;PIGH;KLHL41;PARP3;PTPN12;DYRK1A;NUB1;EIF2AK4;DAD1;B3GALNT2;PDP1;ST3GAL4;BTBD1;PPP4R2;RAB1B;WSB2;BRD2;ACVR2A;F13A1;KLHL20;WWP2;FBXO11;HIPK1;AGA;MAP4K3;ZC3HAV1;ACVRL1;LHPP;SPSB2;COPS5;QSOX1;HIPK2;PPP3CA;BMPR2;FSTL1;EGLN3;TNIK;DDB1;ROCK1;PIM3;GSK3B;PTK2B;FBXO9;PPP2R2A;PKN2;PAK2;SIRT1;CDK7;ILKAP;ATG5;OGA;CCN1;PSMF1;ASB4;MAN2A2;MT3;ASB8;PSMD14;DCUN1D3;WDTC1;APP;PRKCB;RHBDD1;ACVR1B;METAP1D;PSMD12;CUL4A;STK38;SIRT7;BTK;COPS7A;ATG4B;FBXO6;UBA3;RAB11B;COL3A1;DYRK2;FBXW2;GAS6;CTDP1;FGR;RBBP7;PPP6C;UBE2F;PPP1CA;SERPINC1;MCRS1;PSME2;JAK3;CUL1;NUCB1;TNKS;LATS1;CDK8;CD247;PRKCG;ATE1;SUMF1;CDC34;RNF7;RAB2A;CDKL4;PTPN1;MELTF;SIRT3;PGGT1B;CAMK1;LRRC41;DCUN1D1;KEAP1;UBE2M;CSNK2A1;PSMB10;GAN;PSMD5;ARF4;PTPRU;SRPK1;DCAF10;ICMT;TNKS2;CREB1;PSMD8;STK4;CLK3;PPP2R5C;PSMA3;PPP2CA;FBXO31;CDK13;PSMA2;UBE2S;FBXO7;WFS1;TLK2;PIGU;TBK1;ALG5;GMFB;PSMD11;RAB1A;MKNK2;CDC14B;DUSP10;PMM2;DCAF7;JMJD4;SHISA5;RAB13;BRSK2;NAGPA;DDA1;PPP2R1A;ANO8;PSMA6;COQ8B
prerank,regulation of oxidoreductase activity (GO:0051341),0.5237903001619821,1.1453573069706853,0.2976,0.6743764654597001,1.0,5/13,15.22%,ABL2;HP;ECSIT;MT3;ATP7A
prerank,DNA biosynthetic process (GO:0071897),0.5138965573228838,1.145091260179647,0.3194842406876791,0.6746006690600916,1.0,6/16,13.40%,RFC3;POLH;POLL;SIRT1;WRN;POLA1
prerank,mitochondrial translational elongation (GO:0070125),0.39079312825267687,1.1447637609366725,0.26717557251908397,0.6750141584953767,1.0,27/88,19.56%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL1;MRPL14;MRPL32;MRPL36;MRPS35;MRPS28;MRPL30;MRPL28;MRPS21;MRPL19;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4359278102060132,1.1443443488973104,0.3117206982543641,0.6756761593673488,1.0,10/34,20.49%,ANXA1;ERN1;VEGFA;PIK3CA;NOTCH1;RELA;NRP1;GAS1;GAB1;MT1G
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.4831196401922139,1.1439222526439856,0.308411214953271,0.6763403510946531,1.0,5/19,17.61%,VEGFA;FLOT1;NOTCH1;ADAM19;PTPRU
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4062044340617982,-1.1438222278285535,0.25333333333333335,0.6638239902625744,1.0,3/17,3.65%,SNTA1;ANK2;RYR2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.37275243191541696,1.143362639733008,0.24661810613943808,0.6774471050025921,1.0,58/144,26.41%,MICALL2;IPO5;KIF20B;NPEPPS;RUFY3;FBXW7;PRKCD;SH3GLB1;E2F1;SORL1;HTRA2;UBE2L3;ANP32B;GTSE1;HUWE1;CSNK2A2;TPR;ARIH2;MAVS;MTCL1;PPP3R1;GSK3B;OAZ2;BCAS3;FZD5;HCLS1;ATG13;GAS6;TENM1;VPS11;USP36;BID;CAMK1;RAB29;OAZ1;BBC3;RBM22;TOMM7;EFCAB7;TCF7L2;VAMP2;TMEM30A;DMAP1;FLNA;UBE2D3;MYO1C;TM9SF4;HRAS;TFDP1;UBE2J2;CASP8;BAG3;UBR5;YWHAB;ABLIM3;ZIC1;CEMIP;RNF31
prerank,anterior/posterior axis specification (GO:0009948),0.5063973079426112,1.1430648459668369,0.29829545454545453,0.6777645805224501,1.0,4/15,18.46%,DDIT3;WLS;FZD5;HOXD8
prerank,regulation of signal transduction (GO:0009966),0.36683767534283584,1.1430610506471865,0.2191919191919192,0.6772512124145984,1.0,33/190,14.32%,MTCH1;CD36;MDFIC;DTNBP1;TIMP1;NCK2;MGLL;DHRS3;FOXP3;IRAK2;CD46;CD63;FBXL17;BRAP;CDC42SE2;GSKIP;CREBBP;LFNG;CBFB;ESR1;SIRT1;APP;RORA;TREM2;SULF1;ITGA3;TSPAN15;DGKQ;CASTOR1;RGS11;GDNF;ZFAND2B;CX3CL1
prerank,transcription preinitiation complex assembly (GO:0070897),0.52423900605473,1.14273054466516,0.30627871362940273,0.6776840074608119,1.0,3/12,8.35%,GTF2B;TAF7;TAF1B
prerank,protein deneddylation (GO:0000338),0.5570494028918547,1.142641354591511,0.330804248861912,0.6774291258105583,1.0,3/10,12.72%,GPS1;COPS5;COPS7A
prerank,regulation of actin filament-based process (GO:0032970),0.39285354583087184,1.1423981926383147,0.270509977827051,0.6775451418704903,1.0,12/70,11.70%,IQGAP2;IQGAP1;BAIAP2;LRP1;PRKCD;PDGFA;DLC1;ARHGAP18;ARHGAP17;ROCK1;RHOD;BST2
prerank,telomere capping (GO:0016233),0.5008356583225908,1.1422833128663323,0.31187410586552217,0.6773540682003245,1.0,7/16,14.85%,ACD;TFIP11;TERF1;NBN;DCLRE1B;TEN1;STN1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.440620338021715,-1.141989047158584,0.29283489096573206,0.6665779987939611,1.0,6/13,15.10%,SESN3;ATM;STK11;SZT2;DEPDC5;SESN1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.45901979393655135,1.141841674722662,0.3183023872679045,0.678062488455085,1.0,8/24,24.10%,PLA2G7;ANO6;MOSPD2;CXCL12;CREB3;LGMN;SLAMF8;CCN3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.44751413677872076,1.1413666199885284,0.3159235668789809,0.6788386198908825,1.0,9/30,21.13%,CD300A;PIBF1;PRKCD;NF2;INPP5F;SH3BP5;PPP2CA;PPP2R1A;PTPRC
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.3761261063275825,-1.141365118140597,0.273972602739726,0.6658777220720542,1.0,4/21,3.65%,ANK2;CACNA1C;ATP1A2;RYR2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5154459143496395,1.141244035890973,0.31366906474820144,0.6786733717530882,1.0,8/13,23.08%,MGAT5;IL6;DOT1L;IL7R;JAK3;PIGU;PTPRC;JAK2
prerank,midbody abscission (GO:0061952),0.4894004070336211,1.1410165472485674,0.30447330447330445,0.6787871791240512,1.0,7/17,21.48%,CHMP2A;PDCD6IP;VPS4A;CHMP6;CHMP5;CHMP7;CHMP2B
prerank,glycosaminoglycan catabolic process (GO:0006027),0.40714491500397554,1.1409690505936476,0.289198606271777,0.6784218683598487,1.0,12/55,12.91%,HPSE;GALNS;CD44;STAB2;GNS;CEMIP2;HEXA;LUM;IDUA;FUCA1;SGSH;SDC4
prerank,negative regulation of B cell proliferation (GO:0030889),0.5312751447300534,1.1406068909184317,0.33900928792569657,0.6789010047467413,1.0,4/11,19.84%,CD300A;TYROBP;TNFRSF21;FCGR2B
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.38433761185519494,1.1404501850627051,0.2554347826086957,0.6788278738759753,1.0,16/87,11.70%,IQGAP2;IQGAP1;BAIAP2;LRP1;ABL2;PRKCD;PDGFA;NOTCH2;PIK3CA;DLC1;ARHGAP18;ARHGAP17;ROCK1;RHOD;PTK2B;BST2
prerank,regulation of mitotic spindle organization (GO:0060236),0.4331848383253668,1.1404303419747437,0.30214917825537296,0.6783662162157126,1.0,8/35,9.50%,DYNC1H1;CHMP2A;PARP3;HSPA1B;HNRNPU;EML3;PDCD6IP;TPR
prerank,oligodendrocyte development (GO:0014003),0.501775387037735,1.1404270445534188,0.3227665706051873,0.6778535436916096,1.0,3/15,8.09%,B4GALT5;B4GALT6;PRDM8
prerank,histone H2A ubiquitination (GO:0033522),-0.39439846328768713,-1.1401600554471287,0.2857142857142857,0.6668535115219649,1.0,6/17,13.74%,RNF8;DDB2;TRIM37;RYBP;BCOR;UBE2B
prerank,DNA integrity checkpoint signaling (GO:0031570),0.4266382530143175,1.1397331859116893,0.30943396226415093,0.6792834580537819,1.0,8/36,13.35%,MAP3K20;ERCC6;BRIP1;E2F1;DOT1L;NBN;FBXO6;INTS7
prerank,peroxisomal membrane transport (GO:0015919),0.44790658236288905,1.1396360127456593,0.30364372469635625,0.6790537305383284,1.0,11/27,23.64%,RAB8B;ABCD1;PEX7;PEX14;ALDH3A2;PXMP2;GDAP1;ACBD5;SLC25A17;PXMP4;ABCD2
prerank,photoperiodism (GO:0009648),0.4494808980707004,1.1393935323466118,0.3002577319587629,0.6792348258268461,1.0,10/28,18.56%,ID2;FBXL17;FBXL3;CRTC1;SIK1;BHLHE40;PPP1CA;PER3;CRY1;CLOCK
prerank,multivesicular body organization (GO:0036257),0.43640298277342093,1.139087930648342,0.3057324840764331,0.679556063685326,1.0,12/31,21.94%,STAM;CHMP2A;PDCD6IP;VPS4A;CHMP6;SNF8;STAM2;CHMP5;CHMP7;VPS36;CHMP2B;VPS37B
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4340408234339098,1.1382327434762476,0.2969151670951157,0.6813623810792184,1.0,4/33,7.11%,PPARG;CDKN1A;PTEN;HMOX1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4180234426240005,1.1375707328225062,0.29484029484029484,0.6827334323644838,1.0,14/40,21.58%,FBXW7;PTEN;GNA12;NUB1;RPL23;RAD23A;HIPK2;CSNK2A2;PTK2B;LATS1;CSNK2A1;SGTA;XPO1;TAF1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.46212838659288585,1.1374764999237277,0.32432432432432434,0.6824789888168984,1.0,6/24,17.60%,IQSEC1;VEGFA;DUSP3;ROCK1;NRP1;TEK
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3551247760715204,1.1373889192150015,0.053,0.6821964619218588,1.0,167/834,16.67%,EPAS1;PPARG;MMP12;NAMPT;TFEC;MRTFA;LITAF;MRTFB;ZMIZ1;ATP1B4;IRX3;PLXND1;TFEB;LPIN3;LILRB1;NFE2L2;CTNNB1;MITF;NCK2;VEGFA;CEBPB;ZEB2;GRHL1;FOXP3;IER5;ST18;ATF3;VEZF1;RUNX2;NR1H3;E2F3;LMO1;IL6;HGF;FOXO3;TNIP1;TFAP2B;RXRA;JUN;MED12;RIPK1;ASXL2;MAP2K5;RARA;MZF1;PID1;CITED2;FOXO4;E2F1;TAF7;IGF1;MAPK7;MAML1;STAT5B;AGO2;RNF10;NUFIP1;GLMP;NR3C1;TCERG1;RNASEL;CRTC1;MAML2;NR1H4;CREBBP;MLLT10;DOT1L;FLCN;TET3;HNRNPU;KLF5;ATF4;REL;RPS27A;UBC;BRCA1;RREB1;TCF20;SOX9;ACVR2A;ACTR3;EPC1;GABPB1;GABPB2;IRF2;DVL1;NCOA3;ACVRL1;COPS5;TBL1XR1;HIPK2;NCOA1;PPP3CA;TET2;NR5A1;BMPR2;PAXBP1;DDIT3;MAVS;PAX8;ESR1;PPP3R1;FOXO1;MED16;SIRT1;CDK7;PRPF6;SALL2;ARHGEF2;CCN1;NFATC3;LARP7;PPARD;BCAS3;APP;FZD5;SP3;NOTCH1;RORA;MEPCE;CAMTA2;MICAL2;SIRT7;HCLS1;RFX5;PPRC1;RELA;KDM1B;BCLAF1;USP16;SOX2;BCL11B;POU2F1;SLC11A1;PRKN;FOXJ3;SMARCD1;JUNB;GDNF;ATF1;CX3CL1;SQSTM1;PRDM2;PHIP;ZNF513;LRP6;MCRS1;INO80;ZFP64;TNKS;WASL;ARRB1;CDK8;ASXL1;PCBP1;PPARGC1B;CDC73;NHLH2;KLF6;WWOX;MTF1;THRAP3;TCF12;NFATC2IP;CAMK1;CREB3L4;CREB3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.45259502331421814,1.1369162642606383,0.30749682337992373,0.683080855336239,1.0,9/25,22.63%,BCL2L11;PPIF;MLLT11;BAX;BNIP3;BID;BBC3;PDCD5;PLAUR
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.45149639156531807,1.1368416050958914,0.30709677419354836,0.6827769784187451,1.0,9/27,17.22%,ID2;FBXL17;FBXL3;CRTC1;SIK1;BHLHE40;PPP1CA;PER3;CRY1
prerank,regulation of protein import into nucleus (GO:0042306),0.4242586605850384,1.1364893126042772,0.30884184308841844,0.6832666080845206,1.0,14/36,26.13%,MDFIC;IPO5;PRKCD;TPR;MAVS;HCLS1;APOD;RBM22;EFCAB7;DMAP1;FLNA;BAG3;UBR5;ZIC1
prerank,cellular response to sterol (GO:0036315),0.5177894227138462,1.136218758807818,0.3438914027149321,0.6835284041598504,1.0,6/13,15.34%,GRAMD1B;GRAMD1C;RORA;GPLD1;LRP6;INSIG2
prerank,phospholipid metabolic process (GO:0006644),0.3923843020145836,1.136216427349847,0.27845303867403315,0.6830129374043831,1.0,11/71,12.33%,PLPP3;LIPG;GPAT2;AGPAT4;PLA2G2D;GPX4;ABCA2;PLA2G4F;PLBD2;PLAAT3;PGP
prerank,ventricular septum development (GO:0003281),-0.3301595935279319,-1.1353260773368505,0.23076923076923078,0.677268094496431,1.0,11/37,8.98%,ACVR1;SALL1;ROBO2;ROBO1;BMPR1A;TGFBR2;TGFBR1;ZFPM2;MDM4;SMAD7;TGFB2
prerank,regulation of cell size (GO:0008361),0.46416039472826875,1.1348386611063885,0.2984084880636605,0.6863441879870834,1.0,6/23,13.56%,VAV3;PTEN;MSN;VAV1;MTPN;RAP1GAP2
prerank,regulation of chemokine production (GO:0032642),0.4284348828811244,1.1344117248780208,0.3135802469135803,0.6870656208925219,1.0,9/36,12.31%,SIGIRR;IL6;HMOX1;SNAI2;FOXP1;IL6R;ADAM17;APP;TREM2
prerank,renal filtration (GO:0097205),0.546683088567343,1.1343941783012172,0.3323397913561848,0.6865934477254287,1.0,4/10,12.77%,MYO1E;SULF2;SULF1;ITGA3
prerank,negative regulation of hemostasis (GO:1900047),0.5354757907029701,1.1341942401295737,0.3397626112759644,0.6866317812935475,1.0,2/12,6.48%,APOE;PROC
prerank,protein K63-linked ubiquitination (GO:0070534),0.41786214135236155,1.1338264598662469,0.3226205191594561,0.6871551267176041,1.0,16/41,19.15%,RNF135;BFAR;WWP2;RNF115;ARIH2;STUB1;TRAF1;TRAF3;PRKN;HECTD1;TRAF3IP2;TRAF5;TRAF2;UBE2O;UBE2V1;UBE2S
prerank,epidermis development (GO:0008544),0.40434456531675383,1.1337707499529517,0.27367205542725176,0.6868008222067831,1.0,9/56,18.30%,FABP5;GRHL1;EMP1;DCT;SVEP1;ALDH3A2;LAMA3;PLOD1;CCN2
prerank,regulation of cell cycle process (GO:0010564),0.37959702389618094,1.1336940038822005,0.2572347266881029,0.6864878079975396,1.0,17/104,12.02%,CCDC8;CTNNB1;KIF20B;PLK2;DYNC1H1;BIRC6;UVRAG;SH3GLB1;APC;MYO19;FLCN;SOX9;CEP85;CSNK2A2;DBF4;DCUN1D3;SND1
prerank,neurotransmitter secretion (GO:0007269),-0.3132164848905728,-1.1335220295380315,0.20833333333333334,0.6798025645721304,1.0,8/44,5.18%,NRXN1;SYT1;RIMS1;RIMS2;SYN2;PTPRN2;LIN7A;SNAP25
prerank,cellular response to amino acid stimulus (GO:0071230),0.43670226823980623,1.133458082889042,0.30759651307596514,0.6866161641361854,1.0,8/33,13.43%,IPO5;CPEB4;SESN2;CAPN2;LAMTOR1;SLC38A9;LAMTOR3;CASTOR1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.38671410359694713,1.133289908662295,0.27467811158798283,0.6865815604661156,1.0,12/88,10.68%,HTR2B;XDH;APOE;VEGFA;NRP2;THBS1;NRAS;VASH2;ACVRL1;BMPR2;ATP5F1A;SIRT1
prerank,metal ion transport (GO:0030001),-0.28047975765332983,-1.132780187698093,0.12162162162162163,0.6793951848555274,1.0,20/86,15.93%,CACNA1E;RYR3;CCR5;CDH23;TRPC1;CACNA1C;GRIN3A;RYR2;ATP2C1;NDFIP2;RAMP1;TRPM2;NIPAL2;TRPC4;CAMK2A;PKD2;ATP2B2;CACNA2D1;CACNG3;CCR1
prerank,telomere maintenance (GO:0000723),0.40868833749820277,1.132727287042845,0.3087557603686636,0.6877206926889101,1.0,12/50,14.85%,NSMCE2;ACD;TEP1;PARP3;RTEL1;TERF1;XRCC5;NBN;DCLRE1B;WRN;TEN1;STN1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4701126328512031,1.1324126238398964,0.3085250338294993,0.6880876983007445,1.0,5/22,20.84%,RBP1;PIAS4;ALDH1A2;LRP2;LGMN
prerank,negative regulation of gluconeogenesis (GO:0045721),0.5308281991350834,1.1319772126027894,0.35023041474654376,0.6887297554155755,1.0,4/11,20.25%,SIK1;PGP;CRY1;GCK
prerank,protein glycosylation (GO:0006486),0.3714876243251656,1.131809509300575,0.24245577523413112,0.6886921007182099,1.0,21/125,11.06%,B4GALT5;B3GNT8;GCNT2;MAN1C1;NPC1;GALNT6;MGAT5;GALNT9;TMEM165;B4GALT7;DDOST;COG7;TET3;DAD1;B3GALNT2;ST3GAL4;GFPT1;TET2;ALG12;OGA;MAGT1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.449095386679875,1.131706986299816,0.32275132275132273,0.6884525927273926,1.0,5/25,9.80%,CD200R1;ITGA5;ITGA4;NINJ1;ITGB1
prerank,histone H4-K8 acetylation (GO:0043982),0.5088049460458912,1.1316532112569706,0.320863309352518,0.6875667764379408,1.0,6/15,22.46%,KANSL1;PHF20;ING4;MCRS1;OGT;KANSL3
prerank,histone H4-K5 acetylation (GO:0043981),0.5088049460458912,1.1316532112569706,0.320863309352518,0.6875667764379408,1.0,6/15,22.46%,KANSL1;PHF20;ING4;MCRS1;OGT;KANSL3
prerank,mesenchyme development (GO:0060485),-0.41168561339431586,-1.131649058522536,0.28825622775800713,0.6801325356180481,1.0,4/15,12.48%,FGFR2;TGFBR1;PKD2;CRELD1
prerank,base conversion or substitution editing (GO:0016553),0.5312525690527697,1.1310509735858087,0.34330708661417325,0.6887193906079501,1.0,1/11,0.51%,APOBEC1
prerank,regulation of actin filament depolymerization (GO:0030834),0.5271751574311075,1.1310048357670714,0.33136094674556216,0.6883158094426229,1.0,4/12,10.91%,LIMA1;PIK3CA;MTPN;WDR1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4544208759762959,1.1309910012507731,0.31586021505376344,0.6878374999420585,1.0,4/25,8.04%,NIBAN2;IGF1;DOT1L;RB1
prerank,cellular response to UV (GO:0034644),0.38657273677572795,1.130954887446278,0.2606741573033708,0.6874150091698371,1.0,26/76,23.38%,TIMP1;AQP1;PRKCD;CDKN1A;COPS9;CREBBP;EIF2AK4;ATF4;DDB1;SIRT1;RHBDD1;MFAP4;NSMCE3;N4BP1;INO80;RPL26;CDC25A;NOC2L;CERS1;CUL4B;EIF2S1;XPC;TAF1;RUVBL2;POLD1;ERCC4
prerank,peptide biosynthetic process (GO:0043043),0.3705327605254553,1.1308465976088937,0.23824130879345604,0.6872281232877467,1.0,40/153,18.10%,RPL3L;TNIP1;RHD;IGF2BP3;EEF1A1;AGO2;RPL18A;MRPL11;RPS14;RPS11;RPS27A;MRPL23;RPL17;RPL23;DARS1;RPL36A;EIF4EBP2;COPS5;MRPS7;RPL22;RPS21;RRBP1;MRPL32;MRPL36;GGTA1;SARS1;RPL10A;MRPL28;DHPS;RPS26;MRPS21;SRBD1;MRPL35;RPL15;RPL10;RPSA;MRPL43;RPL7;RPL26;MRPS18A
prerank,negative regulation of bone remodeling (GO:0046851),0.5344626197331259,1.1306925231576237,0.3313253012048193,0.6871267566507728,1.0,2/11,2.99%,GPR137B;IL6
prerank,extracellular matrix organization (GO:0030198),0.3609696795087687,1.1304145805710961,0.19095477386934673,0.6873499819802396,1.0,49/276,15.22%,MMP12;VWF;TIMP1;ICAM2;ADAMTS8;TLL2;CTSL;FLOT1;MMP27;SPP1;CD44;LCP1;ITGA5;ITGA4;KIF9;WASHC1;PDGFA;CD151;COL4A6;MMP14;HAS3;THBS1;COL1A1;DAG1;ADAM8;CAPG;CAPN2;TIMP2;LUM;COL4A1;CTSS;QSOX1;COL5A2;ITGB1;ITGA10;COL11A1;APP;VIT;COL5A3;ITGA3;COL3A1;GAS6;SH3PXD2B;ADAM19;ITGA8;LAMA4;LAMA3;COL6A2;ATP7A
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.4031827230959052,1.1303479775499485,0.2912400455062571,0.6870034001453672,1.0,14/58,13.40%,NSMCE2;ERCC6;UVRAG;BABAM2;BRCA1;PIAS4;XRCC4;XRCC5;KDM2A;POLL;NBN;PSMD14;DCLRE1B;POLA1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.441867008824919,1.1301572159437014,0.31008717310087175,0.6865111173053962,1.0,11/31,20.30%,POLR2A;GTF2H5;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;MNAT1;RAMAC;CMTR2
prerank,7-methylguanosine RNA capping (GO:0009452),0.441867008824919,1.1301572159437014,0.31008717310087175,0.6865111173053962,1.0,11/31,20.30%,POLR2A;GTF2H5;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;MNAT1;RAMAC;CMTR2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3913132026858587,1.129891218550285,0.29418472063854045,0.6867148353950807,1.0,11/69,9.38%,HTR2B;PIK3R5;GAB2;PTEN;IGF1;IRS2;PIK3CA;PTAFR;PIK3C2G;PLCB4;PLEKHA1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3846751564913587,1.129612653589823,0.2825361512791991,0.6869699352921064,1.0,30/78,23.43%,NFE2L2;RNF19A;SIRT6;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;PRKN;HSPA1A;HECTD1;UBQLN2;KEAP1;SGTA;BBS7;BCAP31;DDA1;RNF19B;PIAS1;CEBPA;TAF1;HSPBP1;VCP;HERPUD1;ARIH1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5380977498538253,1.1289368109295996,0.3181126331811263,0.6883385409872964,1.0,2/10,3.44%,NR1H3;ABCD1
prerank,actin filament bundle assembly (GO:0051017),0.4338847012325535,1.1288545631856501,0.3083645443196005,0.688071340743298,1.0,4/33,3.01%,LIMA1;NEDD9;BAIAP2;LCP1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.5490553157362085,1.1288085116301063,0.328335832083958,0.6877013975986703,1.0,2/10,8.66%,PRKCH;NCOA3
prerank,regulation of chromatin organization (GO:1902275),0.5031195821064639,1.1287851384354919,0.3525073746312684,0.6872535532065267,1.0,7/14,26.88%,TLK1;HNRNPU;MLLT3;TLK2;SETD5;IGF2;METTL4
prerank,dorsal/ventral pattern formation (GO:0009953),-0.3834313273432266,-1.1287619586114885,0.2775800711743772,0.6854156977162347,1.0,3/20,1.69%,ACVR1;PTCH1;BMPR1A
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5225497397786253,1.1281706684685602,0.3406754772393539,0.68846570234938,1.0,1/12,0.55%,XDH
prerank,regulation of TOR signaling (GO:0032006),0.3875112011515747,1.128079904254483,0.2943820224719101,0.6882260814103948,1.0,23/67,21.98%,FNIP1;HTR6;GNA12;PIK3CA;FLCN;EPM2A;LAMTOR1;FBXO9;SIRT1;TREM2;MIOS;SLC38A9;GAS6;LAMTOR3;DGKQ;NPRL3;GOLPH3;GPAT3;NPRL2;RHEB;AKT1S1;RICTOR;TTI1
prerank,mitochondrial translational termination (GO:0070126),0.38527009077758106,1.1279751644739229,0.28431372549019607,0.6879998624281305,1.0,27/88,19.56%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL1;MRPL14;MRPL32;MRPL36;MRPS35;MRPS28;MRPL30;MRPL28;MRPS21;MRPL19;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31
prerank,cellular response to purine-containing compound (GO:0071415),-0.46421910040486586,-1.1279103160236434,0.3010471204188482,0.6856359493769453,1.0,3/10,8.15%,RYR3;RYR2;TRPM2
prerank,positive regulation of signal transduction (GO:0009967),0.3601119520427025,1.127738812033627,0.22233400402414488,0.6881742761314175,1.0,46/238,15.95%,CCBE1;F7;SASH1;VWF;ZMIZ1;ERN1;LANCL2;MGAT5;IL6;ITGA5;FAS;CD63;SNX5;ASXL2;LY96;PTEN;CITED2;SORL1;IGF1;RWDD3;MAML1;MAML2;CREBBP;SULF2;SLC39A14;PTK2B;SIRT1;MT3;PRKCB;WLS;NOTCH1;TREM2;SULF1;IL7R;MACF1;GAS6;ATP6V0C;TNFAIP3;PHIP;BAX;ATP6AP2;NLGN2;DEPDC1B;ASXL1;CDC73;NRP1
prerank,response to peptide (GO:1901652),0.4359253295599841,1.127458238099045,0.3018633540372671,0.6884342550744245,1.0,3/33,5.39%,MMP12;ANXA1;STAT5B
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4046342647747642,1.1272629702042016,0.3028169014084507,0.6885108426183788,1.0,11/47,18.09%,NEDD9;CORO1C;DOCK5;TRIOBP;RREB1;OLFM4;FBLN1;DOCK1;NRP1;MELTF;C1QBP
prerank,GPI anchor biosynthetic process (GO:0006506),0.43278447151753824,1.127047081084133,0.31056701030927836,0.6885873167832895,1.0,7/30,15.19%,PGAP3;DPM2;PGAP1;PIGH;PIGX;PIGC;PIGQ
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3652273592142378,1.1270457640809906,0.23243801652892562,0.6880833587242684,1.0,43/175,19.68%,NFE2L2;ST18;FOXO3;PSMD1;TANK;RIPK1;TNFRSF1B;PID1;ZFP36L2;BRCA1;ADAM17;PTK2B;BIRC3;SIRT1;ARHGEF2;PSMF1;BAG4;PSMD14;TRAF1;PSMD12;ZFAND6;RELA;TRAF3;ERBIN;CX3CL1;ACOD1;PSME2;TRAF5;CCL7;TRAF2;LTB;LTBR;TNFRSF14;PSMB10;PSMD5;BIRC2;PSMD8;PSMA3;ASAH1;PSMA2;TNFRSF21;CCL25;PSMD11
prerank,positive regulation of B cell proliferation (GO:0030890),0.443727498556059,1.1266280996393243,0.3159235668789809,0.6887170054209422,1.0,4/29,5.76%,CD38;VAV3;TFRC;IRS2
prerank,microtubule anchoring at centrosome (GO:0034454),0.5523986825686279,1.1261302106350863,0.3364485981308411,0.6895955484780293,1.0,2/10,7.43%,HOOK3;KIF3A
prerank,fatty acid beta-oxidation (GO:0006635),0.4006298929305269,1.1259947436609896,0.30154946364719903,0.6894756962760179,1.0,22/51,25.87%,AMACR;ABCD1;HADHA;MTLN;ACADL;ACADVL;CRAT;PPARD;ECHDC1;EHHADH;ACAA2;GCDH;ACAD10;DECR2;ETFA;SLC25A17;IVD;SCP2;ABCD2;ACOT8;HSD17B4;CPT2
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.5439094184714685,1.1255805786035185,0.34036144578313254,0.690077945823409,1.0,3/10,14.64%,RENBP;NAGK;GNPDA1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4455355982378928,1.1255451666209084,0.31926121372031663,0.689660064033396,1.0,5/24,14.49%,LILRB1;EIF2AK4;MAVS;PQBP1;TRAF3IP2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.36407512104776524,-1.125538745310824,0.28346456692913385,0.6898447820486754,1.0,8/22,20.29%,SPRED1;ATM;ATR;RPL37;SPRED2;SPRED3;CDK5RAP3;CHD5
prerank,cell cycle checkpoint signaling (GO:0000075),0.5214107118675622,1.125462051502178,0.3238805970149254,0.6893653517914509,1.0,2/12,2.83%,WEE2;PLK2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4621805688734527,1.1252476595432057,0.3252361673414305,0.6894164063422521,1.0,7/22,19.13%,LILRB1;TNFRSF1B;SPHK2;BTK;TRIL;TNFRSF14;SCIMP
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3435914388461224,-1.1249801000880242,0.29493087557603687,0.6889846210552323,1.0,6/29,7.50%,P2RY12;IRS1;FGF2;FLT3;PRKD1;ATG14
prerank,leukotriene biosynthetic process (GO:0019370),0.5073910707120574,1.1247988102422743,0.32992700729927005,0.6901628647207015,1.0,3/14,11.47%,MGST2;LTA4H;GGTA1
prerank,embryonic digit morphogenesis (GO:0042733),0.4791419449045695,1.1243802108128507,0.3328804347826087,0.6908307543410999,1.0,3/18,6.49%,MAP3K20;CREBBP;WDPCP
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.39500353779489433,1.1240812636053414,0.29076396807297605,0.6911599215161647,1.0,22/62,25.44%,NFE2L2;HTRA2;MAPK7;PPIF;SNAI2;SIRT1;ARHGEF2;PRKN;HSPA1A;CXCL12;MCL1;CREB3;NDUFS3;NOC2L;DNAJA1;CREB3L1;PLAUR;HERPUD1;NDUFA13;BCL2L1;PPIA;TXNDC12
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.516103504822223,1.1240383847156206,0.3264094955489614,0.6907582537105418,1.0,3/13,15.36%,CBLB;CHMP6;CBL
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.41396003966680245,1.1231265151056369,0.3076923076923077,0.6927861073347447,1.0,12/43,18.25%,PRKCD;SNX5;ENPP1;PID1;SLC27A4;PTPRE;SORL1;SIRT1;PRKCB;PTPN1;PIP4K2A;ZBTB7B
prerank,JNK cascade (GO:0007254),0.41956541089416693,1.1227401569799573,0.3159806295399516,0.6933592417352491,1.0,8/40,11.59%,GPS1;IRAK2;RPS27A;UBC;MAP4K3;MAP2K4;PTGER4;TAB2
prerank,cell junction organization (GO:0034330),-0.2709145381385762,-1.1225296340190376,0.19101123595505617,0.6936097912218199,1.0,15/71,10.41%,GRM5;OPHN1;SDK1;SMAD3;CTNND2;VASP;MAPT;PPFIA4;SEMA3E;SH3BP1;AGRN;TGFB2;SLC6A1;FERMT2;NLGN3
prerank,cellular response to BMP stimulus (GO:0071773),-0.28110172343139866,-1.1220625237175077,0.205607476635514,0.6925620578917849,1.0,19/66,15.55%,ACVR1;SMAD3;BMPR1A;ACVR2B;HIVEP1;SMURF1;MEGF8;RGMB;ENG;SMAD1;SMAD7;PDCD4;VSTM2A;TGFB2;RGMA;SMAD2;TMEM100;ADAMTS12;HFE
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5251731160211368,1.121832975989376,0.33636363636363636,0.6953073042127667,1.0,1/11,0.68%,SYK
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4253667210591595,1.1216458536953824,0.32320777642770354,0.695294730133746,1.0,5/40,5.56%,SDCBP;GCNT2;CTNNB1;IL6;COL1A1
prerank,cardiac ventricle development (GO:0003231),0.4735430823603084,1.1211408680365769,0.3143631436314363,0.696151917561922,1.0,2/20,1.11%,TMEM65;STRA6
prerank,mRNA transport (GO:0051028),-0.2542636493960146,-1.121025921884869,0.18032786885245902,0.6931818236844892,1.0,40/101,21.60%,NUP133;SLU7;SRSF6;SRSF5;FYTTD1;FMR1;RBM8A;SMG6;NUP214;ZC3H11A;AAAS;NUP85;THOC5;POM121;SEH1L;NUP35;MCM3AP;SLBP;NUP37;SRSF11;NUP155;RAE1;NUP153;DDX39B;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;SYMPK;SRSF4;HNRNPA2B1
prerank,ureteric bud morphogenesis (GO:0060675),-0.40473572211140596,-1.1204655677155266,0.3062730627306273,0.6924793956267097,1.0,5/16,12.55%,SALL1;FGF2;PAX2;PKD2;NPNT
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.36447845384533123,1.1202606527717212,0.2625,0.698101977137221,1.0,38/149,18.56%,CD36;RAB7B;PRKCH;FLOT1;IRAK2;TFRC;IL6;RIPK1;TRIM25;ADAM8;NFKBIB;IRAK3;HSPA1B;RPS27A;UBC;NLRC4;RIPK4;MTPN;ARHGEF2;APP;TAB2;PRKCB;TRAF1;ROR1;BTK;RELA;HSPA1A;CX3CL1;TRAF5;MYD88;TRAF2;SLCO3A1;ERC1;ZBTB7A;TRIM14;UBE2V1;CARD11;CLOCK
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5423920832301707,1.120154266514906,0.34627329192546585,0.6978897016866307,1.0,1/10,0.15%,HTR2B
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5078263786821244,1.119887188193844,0.3431516936671576,0.6981414384026748,1.0,2/13,11.08%,APOE;ERLIN1
prerank,defense response to virus (GO:0051607),0.3724499433116323,1.1197547671846253,0.2902208201892745,0.6980183493435769,1.0,22/100,16.53%,LYST;TLR8;LILRB1;ATG7;IFITM1;IL6;IFNAR2;RNASEL;RNF135;AKAP1;IRF2;IFITM2;MAVS;CNOT7;BST2;PQBP1;RELA;ATAD3A;ACOD1;BNIP3;MYD88;IFIT2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.4983718192635266,1.1195128581121405,0.324822695035461,0.6981875607100023,1.0,5/15,16.40%,LRP1;IL6;FGFR4;CLASP1;MELTF
prerank,positive regulation of embryonic development (GO:0040019),0.4808531141913425,1.119357415809571,0.3433048433048433,0.6980992249630348,1.0,3/19,10.21%,B4GALT5;NIBAN2;CFL1
prerank,early endosome to Golgi transport (GO:0034498),0.520578765372008,1.1192938093772438,0.3561430793157076,0.6977824722104016,1.0,3/11,13.92%,SNX8;STX5;TRAPPC10
prerank,axoneme assembly (GO:0035082),0.4389047462441195,1.1188847679117113,0.3193166885676741,0.698364672493353,1.0,6/30,12.58%,DNAJB13;SPEF1;CCDC40;DNAAF3;TOGARAM1;SPAG17
prerank,embryonic axis specification (GO:0000578),-0.3995510406835815,-1.1187829227624553,0.3377049180327869,0.6948074561612795,1.0,4/15,14.28%,PTCH1;CXXC4;SMAD2;TASOR
prerank,actin cytoskeleton reorganization (GO:0031532),0.3919805397038322,1.118287142965117,0.3052749719416386,0.699486532938825,1.0,6/63,1.74%,DTNBP1;GRB2;NEDD9;ANXA1;RAP2A;MICALL2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.44779423163211124,1.1179031159571347,0.334610472541507,0.7000538989292369,1.0,10/25,22.26%,FBXL17;LONP1;CUL3;ZER1;STUB1;OMA1;UGGT1;ATXN3;TOR1A;VCP
prerank,regulation of viral transcription (GO:0046782),0.4104803455973342,1.1172585775314177,0.32558139534883723,0.7012905966961261,1.0,10/39,17.81%,MDFIC;POLR2A;POLR2L;POLR2G;POLR2I;LARP7;GTF2F2;CTDP1;NELFE;TRIM14
prerank,protein ADP-ribosylation (GO:0006471),0.4460844269719639,1.1172439066387008,0.3265856950067476,0.700825861193058,1.0,11/28,17.90%,TIPARP;PARP4;PARP2;SIRT6;PARP3;ZC3HAV1;SIRT1;TNKS;SIRT3;ARF4;TNKS2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3752993694557028,1.1168949471870324,0.2752688172043011,0.7012712603538985,1.0,38/101,24.68%,SAMD4A;ATG7;VIM;NR1H3;IL6;CD28;YTHDF3;FGFR4;ATG10;THBS1;TBC1D10A;EIF6;LARP4B;MSN;NAT10;CYFIP2;STUB1;HNRNPD;VPS11;EIF4A3;RPL26;AURKAIP1;EIF3C;BCL3;LARP4;OGT;PCIF1;NR1H2;PRKDC;VPS35;UPF3A;FAF1;ASPSCR1;EZR;ZCCHC4;PLXNB2;CASP8;SOX4
prerank,regulation of cell division (GO:0051302),0.3882356042526771,1.1168756922511318,0.30245535714285715,0.7008221711265358,1.0,9/72,8.66%,HTR2B;PLK2;BIRC6;UVRAG;SH3GLB1;SMYD5;MYO19;FLCN;NCOA3
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4776787821321718,1.1162067796572201,0.33090379008746357,0.702145177445904,1.0,7/17,17.60%,BAIAP2;STAP1;FES;BCAS3;HCLS1;NRP1;TEK
prerank,positive regulation of developmental process (GO:0051094),0.36083309645179534,1.1160861060540976,0.2642857142857143,0.7019605103138,1.0,36/164,19.43%,DDHD1;B4GALT5;APOE;SLC6A6;VEGFA;CEBPB;CORO1C;TFRC;NIBAN2;LMNA;SORL1;DAG1;AGO2;RREB1;SOX9;DVL1;NCOA3;BMPR2;CFL1;SIRT1;ACVR1B;KMT5B;CLASP1;PRKN;LLPH;GDNF;RTN4;BNIP3;SHLD1;CAMK1;C1QBP;CCN2;SOX8;FBXO5;CORO1B;PPP1R13L
prerank,response to tumor necrosis factor (GO:0034612),0.3788083242385989,1.1153192212838068,0.2959738846572361,0.7035211141880899,1.0,24/91,19.25%,NFE2L2;ADAM9;TANK;RIPK1;PID1;NUB1;ZFP36L2;BRCA1;MAP4K3;SIRT1;ARHGEF2;BAG4;ZFAND6;RELA;ERBIN;CX3CL1;ACOD1;YTHDC2;CCL7;CASP3;GCH1;ASAH1;TNFRSF21;CCL25
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4628889101721833,1.1149861626786883,0.32920110192837465,0.7039331288322261,1.0,6/21,13.11%,ENPP1;SOX9;ROCK1;PTK2B;NOTCH1;GAS6
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.42309677689131264,1.1141408247525428,0.3337423312883436,0.7057762515318392,1.0,11/37,14.95%,RNASE3;ENTPD1;DFFB;ADPRM;DNASE1L1;SND1;SIDT2;RNASEH2A;HNRNPD;RNASEH1;MTREX
prerank,skeletal muscle organ development (GO:0060538),0.4449405918198559,1.1141347133984982,0.32486631016042783,0.7052796832501459,1.0,3/26,7.08%,STRA6;IGSF8;SVIL
prerank,RNA export from nucleus (GO:0006405),-0.25386271896333584,-1.1140260297877889,0.1774193548387097,0.7053659203311183,1.0,39/100,21.60%,NUP133;SLU7;SRSF6;SRSF5;FYTTD1;RBM8A;SMG6;NUP214;ZC3H11A;AAAS;NUP85;THOC5;POM121;SEH1L;NUP35;MCM3AP;SLBP;NUP37;SRSF11;NUP155;RAE1;NUP153;DDX39B;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;SYMPK;SRSF4;HNRNPA2B1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.39019330036171923,1.1137926221536532,0.32805429864253394,0.7056969841144719,1.0,17/57,22.63%,DDHD1;BCL2L11;HTRA2;PPIF;MLLT11;GSK3B;TREM2;PRKN;BAX;BNIP3;BID;BBC3;HTT;FBXO7;PDCD5;VPS35;PLAUR
prerank,peroxisome organization (GO:0007031),0.44352121331028765,1.1137354340774748,0.3544973544973545,0.7053521546907625,1.0,6/25,12.51%,ABCD1;PEX11A;PEX7;PEX14;PLAAT3;LONP2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.537558530103707,1.1136929212112507,0.3577981651376147,0.7049587733749718,1.0,3/10,11.72%,ITGA5;MT3;PRKCB
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.457107576331247,-1.1131106486326094,0.3434065934065934,0.7056759052703074,1.0,2/10,3.29%,BIN1;ATP1A2
prerank,regulation of mitochondrial fission (GO:0090140),0.45034139681565977,1.1125761514898762,0.3333333333333333,0.7075527467130535,1.0,5/24,15.61%,DDHD1;MYO19;INF2;PRKN;BNIP3
prerank,regulation of synapse organization (GO:0050807),-0.35044803898766536,-1.1121564197113043,0.27555555555555555,0.7060921928466581,1.0,3/26,0.69%,MEF2C;IL1RAPL1;CTNNA2
prerank,mitochondrion organization (GO:0007005),0.35451463557108626,1.1119813313727933,0.28865979381443296,0.7086120849447356,1.0,49/165,20.62%,MTM1;MPV17;CHCHD4;TIMM22;PID1;LONP1;MTFR1L;IMMP2L;PITRM1;AIFM2;POLG2;TIMM17A;TOMM20;VPS13D;AFG1L;MTFP1;GABPB1;CYCS;VPS13C;ATP5F1D;TIMM17B;TMEM70;POLRMT;GDAP1;OMA1;PPRC1;SSBP1;ATAD3A;PRKN;BAX;ATP7A;NDUFS1;BNIP3;TWNK;HSPD1;BID;SIRT3;TOMM34;IFIT2;RAB29;TFB2M;GABPA;TOMM7;TOMM22;USP30;FBXO7;AFG3L2;BCAP31;FMC1
prerank,artery morphogenesis (GO:0048844),0.43357194275413447,1.111739075614786,0.30875,0.7087971018568124,1.0,7/30,11.96%,STRA6;VEGFA;LRP1;TFAP2B;FOLR1;BMPR2;NOTCH1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.4566923330231396,1.110943755786801,0.3426183844011142,0.7105053823543571,1.0,5/21,13.77%,ABCB7;ABCD1;BRCA1;MT3;PRKN
prerank,histone H2A monoubiquitination (GO:0035518),-0.3831434981127958,-1.1105162121682794,0.31654676258992803,0.7082905084077695,1.0,6/17,14.66%,PCGF3;DDB2;TRIM37;RYBP;BCOR;PCGF2
prerank,transcription by RNA polymerase II (GO:0006366),0.3502249550589529,1.109803696890352,0.21385542168674698,0.713023527679527,1.0,90/305,22.11%,PPARG;TSC22D1;POLR2A;ERCC6;NR1H3;E2F3;AFF4;RXRA;CPSF1;NCOR1;NOTCH2;RARA;GTF2B;GTF2H5;TAF7;PCID2;MAML1;NR3C1;MAML2;NR1H4;INTS9;DDX5;CREBBP;CSTF3;ATF4;RREB1;TAF5;POLR2L;RPAP2;WDR33;CBFB;INTS6;TBL1XR1;SNAPC1;NR5A1;ESR1;NR2C1;INTS1;POLR2G;INTS13;INTS8;MED16;CDK7;MED26;POLR2I;PPARD;TRIP11;NCBP2;NOTCH1;GTF2F2;RORA;MAZ;NRBF2;INTS2;INTS5;INTS7;CTDP1;ICE2;POU2F1;SNRPF;GTF2A1;MLLT1;MNAT1;SSU72;CDC73;ELP4;TAF5L;TAF15;NELFE;MLLT3;ZBTB7B;CCN2;E2F2;TAF1A;NFX1;CDK13;NFIC;NR2F1;WWTR1;DTX1;NFE2L3;SNRPB;ABT1;HNF4G;TAF1;NR1H2;RARB;LSM11;SNAPC4;CCNT1
prerank,actin filament organization (GO:0007015),0.36234861369508753,1.1094394170356867,0.2897489539748954,0.7135431489618534,1.0,24/151,11.39%,MYO5A;GAS2L3;VILL;NEDD9;RUFY3;CORO1C;BAIAP2;MYO1E;LCP1;BIN3;ABI1;ACTN1;CAPG;TRIOBP;MYO19;SVIL;PPP1R9B;TPM3;MYO1F;ARHGAP17;RHOD;ARHGEF2;TPM4;PLS3
prerank,regulation of defense response to virus by host (GO:0050691),0.4210015729216006,1.108710084449347,0.33076923076923076,0.7150447237689609,1.0,6/30,14.49%,LILRB1;EIF2AK4;MAVS;PQBP1;TNFAIP3;TRAF3IP2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.45837055038117974,1.1086573330077019,0.3557692307692308,0.7146791752208159,1.0,4/21,9.12%,XDH;AMPD3;NT5C2;NT5E
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5360448862691704,1.108644783941519,0.3801526717557252,0.7142041318311038,1.0,2/10,13.54%,LILRB1;FGR
prerank,detection of visible light (GO:0009584),0.48273310103047823,1.108514222046,0.362339514978602,0.7140344955256176,1.0,1/16,2.40%,GNAQ
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.4737687346849618,1.1084391412392374,0.36415362731152207,0.7137272230864189,1.0,8/17,22.77%,NPLOC4;FAF2;HM13;RHBDD1;DERL2;TMEM129;VCP;HERPUD1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.436436000024916,1.107914594803152,0.3384223918575064,0.7146640912886895,1.0,8/27,16.67%,PRKCD;ENPP1;PID1;SLC27A4;PTPRE;PRKCB;PTPN1;PIP4K2A
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4125313984634122,1.1075875850426646,0.31971153846153844,0.7150525793782182,1.0,15/40,25.34%,BCL2L11;HGF;IGF1;PPIF;MLLT11;PRKN;BAX;BNIP3;BID;BBC3;PDCD5;PLAUR;BCL2L1;GPX1;FXN
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2574206957991961,-1.1075363250733117,0.15151515151515152,0.7143228837513496,1.0,39/96,21.60%,NUP133;SLU7;SRSF6;SRSF5;FYTTD1;RBM8A;SMG6;NUP214;ZC3H11A;AAAS;NUP85;THOC5;POM121;SEH1L;NUP35;MCM3AP;SLBP;NUP37;SRSF11;NUP155;RAE1;NUP153;DDX39B;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;SYMPK;SRSF4;HNRNPA2B1
prerank,stress-activated MAPK cascade (GO:0051403),0.389879364865446,1.1072519148161322,0.3248554913294798,0.7154743585843856,1.0,22/61,26.49%,MAP3K20;GPS1;IRAK2;RPS27A;UBC;MAP3K8;MAP4K3;MAP2K4;PTGER4;TAB2;CUL1;SH2D3C;UBE2V1;CCM2;IRAK1;TRAF6;TAB1;ZFP36;MAP3K7;TAB3;MAPK14;MAP3K12
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.534587864708364,1.107160777675796,0.3826219512195122,0.7152059028185446,1.0,4/10,15.61%,NR1H3;NINJ1;TICAM2;LBP
prerank,organophosphate catabolic process (GO:0046434),0.5205559540567022,1.1069046273366585,0.3604135893648449,0.7154381566346646,1.0,2/11,10.95%,LIPG;PLBD2
prerank,microtubule depolymerization (GO:0007019),-0.3953662287045956,-1.1066991807298288,0.32014388489208634,0.7144142228885841,1.0,13/17,36.20%,STMN3;STMN4;STMN2;KIF18A;STMN1;NCKAP5;KATNB1;KIF14;CCSAP;KIF2C;KIF18B;KIF19;KIF2A
prerank,glycerophospholipid catabolic process (GO:0046475),0.44414976631230824,1.1065401587251855,0.35347043701799485,0.7158631683613063,1.0,6/27,14.95%,PLA2G7;GPCPD1;PLA2G4F;INPP5F;GDE1;PRDX6
prerank,mitotic metaphase plate congression (GO:0007080),0.39223026262661304,1.1063919524472268,0.3448275862068966,0.7157681503786478,1.0,12/51,17.57%,SPDL1;PIBF1;CUL3;CHMP2A;EML3;PDCD6IP;BOD1;VPS4A;CHMP6;CHMP5;CDT1;CHMP7
prerank,positive regulation of defense response (GO:0031349),0.3709987234142743,1.106145198600516,0.3268608414239482,0.7159100690758773,1.0,12/89,12.24%,PLA2G7;OPTN;TLR8;MGST2;TNIP1;RIPK1;NINJ1;ADAM8;CYBA;PTGER4;APP;IL15
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.41873374265559454,-1.1060684930101516,0.3081761006289308,0.7139403155587158,1.0,6/13,17.41%,HACD2;ELOVL7;ELOVL4;ELOVL6;HACD3;TECR
prerank,response to reactive oxygen species (GO:0000302),0.3944782324530532,1.105823968222083,0.3233601841196778,0.7162649770659486,1.0,10/54,13.18%,APOE;MPV17;ADAM9;JUN;STK24;HMOX1;CAT;HP;SIRT1;ERCC6L2
prerank,ameboidal-type cell migration (GO:0001667),0.3916008072545803,1.10581081696784,0.3247663551401869,0.7157862589335148,1.0,6/51,5.42%,HTR2B;SGPL1;CORO1C;ITGA4;SEMA4B;PKN3
prerank,positive regulation of cartilage development (GO:0061036),0.4761567969851148,1.1054696058262132,0.3555858310626703,0.7162022046065326,1.0,4/17,9.45%,SOX9;PKDCC;ACVRL1;BMPR2
prerank,actin filament polymerization (GO:0030041),0.4257351409108581,1.1048871461934018,0.3320754716981132,0.7172455415493264,1.0,8/29,19.12%,DIAPH1;MICALL2;MSRB1;PSTPIP1;PSTPIP2;WASL;WASHC3;WASHC5
prerank,negative regulation of protein secretion (GO:0050709),0.41310020843232964,1.1048729685862868,0.3236009732360097,0.7167839478603144,1.0,4/38,3.76%,APOE;SERGEF;NR1H3;RHBDF2
prerank,peptidyl-lysine modification (GO:0018205),0.3656120551694652,1.1048088189745646,0.304162219850587,0.716434700168339,1.0,34/99,24.34%,EYA1;NSMCE2;SENP3;SUMO2;ETFBKMT;PIAS4;P3H3;TOPORS;NDUFAB1;TPR;SENP5;NUP50;SIRT1;SIRT7;USPL1;ATP7A;NUP98;SIRT3;SENP7;PLOD1;SENP1;NUP88;PIAS2;BCL11A;PIAS1;NUP188;NDC1;NUP43;NUP54;P3H4;RANBP2;GCSH;EGR2;METTL21A
prerank,endoderm development (GO:0007492),0.4992640786337828,1.1047217651079062,0.36694677871148457,0.7161720277303338,1.0,1/13,3.69%,KIF16B
prerank,regulation of osteoblast proliferation (GO:0033688),0.478119739779009,1.104660803017772,0.35294117647058826,0.7158237041677759,1.0,5/17,18.68%,HPSE;TNN;CCN1;NELL1;SOX8
prerank,response to cadmium ion (GO:0046686),0.43845135689401366,1.1045184740789218,0.3563968668407311,0.7157017012571644,1.0,11/26,20.51%,JUN;MT3;NCF1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,negative regulation of kinase activity (GO:0033673),0.387984623140875,1.104474430187228,0.32134831460674157,0.7153228968005175,1.0,12/62,10.64%,DTNBP1;GNAQ;PRKAG2;PDPK1;TAF7;IRS2;GSKIP;HNRNPU;RB1;DVL1;CEP85;PAK2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.39736794585924284,-1.1043837400919487,0.3111888111888112,0.7164507191197781,1.0,10/15,30.30%,LIMK1;RPL5;SMAD7;BAG5;PARK7;BAG2;MAD2L2;ABL1;MAD2L1;DTX3L
prerank,Golgi ribbon formation (GO:0090161),0.5026730412182691,1.1042723619098422,0.35942028985507246,0.7154087434599831,1.0,5/13,14.55%,OPTN;VTI1A;TRIP11;STX6;GOLPH3
prerank,BMP signaling pathway (GO:0030509),-0.27958390730463817,-1.104196675014544,0.26605504587155965,0.7147175593864709,1.0,16/62,13.58%,ACVR1;SMAD3;BMPR1A;ACVR2B;HIVEP1;SMURF1;MEGF8;RGMB;ENG;SMAD1;SMAD7;PDCD4;TGFB2;RGMA;SMAD2;TMEM100
prerank,protein homotrimerization (GO:0070207),0.5045779772212604,1.104080415632733,0.3598265895953757,0.7148979521622792,1.0,2/14,7.23%,SLC1A5;P2RX3
prerank,protein trimerization (GO:0070206),0.5045779772212604,1.104080415632733,0.3598265895953757,0.7148979521622792,1.0,2/14,7.23%,SLC1A5;P2RX3
prerank,regulation of activated T cell proliferation (GO:0046006),0.43029197349745807,1.104062384619988,0.35058214747736094,0.7144452799875167,1.0,3/30,5.10%,FOXP3;CD274;IGF1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3629534685874715,1.1040389018311059,0.3081761006289308,0.7140048497923265,1.0,23/119,14.03%,PIK3R5;MTM1;PIKFYVE;MTMR3;PGAP3;DPM2;ITPKB;INPP4A;PTEN;TMEM150A;SOCS6;FIG4;PIK3CA;PIGH;PIK3C2G;SLC27A1;PLEKHA1;TTC7B;PI4K2A;PIGC;OCRL;INPP5F;EFR3A
prerank,regulation of protein phosphorylation (GO:0001932),0.3520810010574861,1.1039261047552178,0.2537917087967644,0.7138144052956129,1.0,40/256,15.25%,GPNMB;FNIP2;PLPP3;XDH;RAP2A;VEGFA;FLOT1;FNIP1;CEBPB;CORO1C;ATF3;TFRC;HGF;FAS;PDGFA;RIPK1;SESN2;PID1;PTEN;FLCN;ATF4;SOX9;ACVR2A;SIRPA;TNIK;MAVS;ADAM17;SIRT1;CCN1;MT3;FBLN1;APP;TREM2;GAS6;FGR;PRKN;PHIP;LRP6;ARRB1;CDK2AP1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.35692131779381486,1.103845436160597,0.28794178794178793,0.7135409218369884,1.0,13/152,6.50%,PSAP;ADGRE5;ABCA1;ADGRG3;ADRA1D;GNAQ;GNA13;LPAR2;ADCY7;CNR2;GNA12;ADGRE1;PTGER2
prerank,positive regulation of histone modification (GO:0031058),0.4171934262109959,1.1034694786607615,0.3476658476658477,0.7140626544459837,1.0,6/33,8.96%,APLNR;FOXP3;CHTOP;NIPBL;BRCA1;BRD7
prerank,positive regulation of viral life cycle (GO:1903902),0.4550539033755455,1.1033457811220555,0.34573002754820936,0.7139181425718856,1.0,5/22,10.04%,TMPRSS4;KPNA2;CHMP2A;VPS4A;DDB1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4356450526790317,1.1029544296707396,0.3546734955185659,0.7144627367084427,1.0,15/28,26.87%,IRAK2;RPS27A;UBC;TAB2;RELA;TNFAIP3;UBE2V1;AAMP;IRAK1;TRAF6;CASP8;TAB1;MAP3K7;TAB3;CYLD
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.39972896009866266,1.1028509508202402,0.345707656612529,0.7142574678040472,1.0,7/52,5.51%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;STAC2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4989559089968996,1.1027114357886227,0.3466666666666667,0.7141030164608783,1.0,7/13,25.71%,IRAK2;UNC93B1;EPG5;MYD88;IRAK1;TRAF6;TLR9
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4839226169250603,1.102430245494472,0.3541666666666667,0.7144126189322162,1.0,1/16,0.07%,ARHGAP24
prerank,acyl-CoA biosynthetic process (GO:0071616),0.4676582956456938,1.101538103304117,0.3495702005730659,0.7163768906355821,1.0,6/16,17.89%,FASN;SLC25A1;PPT1;SCD;GCDH;CBR4
prerank,regulation of axonogenesis (GO:0050770),0.39396204928648026,1.1014050719793842,0.345707656612529,0.7162248870398815,1.0,6/51,4.72%,PLXNA1;KIF13B;PLXNC1;PLXND1;RUFY3;PTEN
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4924571839481206,1.1008134928602018,0.36749633967789164,0.7173177310701778,1.0,4/15,13.77%,HGF;IGF1;PPIF;PRKN
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.40136872275865254,1.1007085286236329,0.3349339735894358,0.7170847162225413,1.0,11/42,19.25%,CD36;VEGFA;ROCK1;GSK3B;PTK2B;RRAS;CX3CL1;UTRN;NRP1;TEK;CCL25
prerank,pulmonary valve development (GO:0003177),0.4644300679848945,1.0999886268576595,0.3651452282157676,0.7185736895004021,1.0,5/18,11.96%,STRA6;TNFRSF1B;NOTCH2;BMPR2;NOTCH1
prerank,arachidonate transport (GO:1903963),0.5200895873896447,1.0990965070088194,0.37351190476190477,0.7199374273370658,1.0,3/10,22.10%,ANXA1;ACE;DRD2
prerank,arachidonic acid secretion (GO:0050482),0.5200895873896447,1.0990965070088194,0.37351190476190477,0.7199374273370658,1.0,3/10,22.10%,ANXA1;ACE;DRD2
prerank,microvillus organization (GO:0032528),0.5092201260085252,1.0990880292688607,0.3680351906158358,0.7194622080173664,1.0,3/13,10.22%,RAP2A;TNIK;RAP2B
prerank,embryonic digestive tract development (GO:0048566),0.47227045090592024,1.09905458975403,0.3585164835164835,0.719055749849264,1.0,5/18,10.82%,STRA6;ID2;NIPBL;PKDCC;RBPMS2
prerank,cell part morphogenesis (GO:0032990),0.4991788321105023,1.0986145001375622,0.37349397590361444,0.719746612594452,1.0,2/13,4.72%,MTM1;PID1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.342521714642653,1.0985738250341983,0.102,0.7193569854577122,1.0,209/1082,16.67%,EPAS1;PPARG;MDFIC;MMP12;CD38;NAMPT;TFEC;APOE;MRTFA;LITAF;MRTFB;ELF2;ZMIZ1;ATP1B4;IRX3;TFEB;LPIN3;LILRB1;NFE2L2;CTNNB1;MITF;NCK2;VEGFA;CEBPB;ZEB2;ERCC6;GRHL1;FOXP3;IER5;ST18;ATF3;CXXC1;SPP1;ALYREF;VEZF1;RUNX2;NR1H3;E2F3;LMO1;ID2;IL6;HGF;FOXO3;TNIP1;NIBAN2;WAC;TFAP2B;RUNX3;RXRA;JUN;MED12;SNX5;RIPK1;ASXL2;HNRNPAB;MAP2K5;RARA;MZF1;PID1;CITED2;FOXO4;E2F1;TAF7;IGF1;HAS3;MAPK7;PCID2;MAML1;STAT5B;COL1A1;AGO2;RNF10;NUFIP1;GLMP;NR3C1;TCERG1;RNASEL;CRTC1;MAML2;MLLT11;NSD3;NR1H4;CREBBP;THOC1;MLLT10;DOT1L;FLCN;DYRK1A;TET3;HNRNPU;KLF5;ATF4;REL;KDM3A;RPS27A;UBC;BRCA1;RREB1;POU3F1;TCF20;SOX9;ACVR2A;ACTR3;EPC1;GABPB1;GABPB2;IRF2;DVL1;NCOA3;ACVRL1;BRD7;COPS5;TBL1XR1;HIPK2;PICALM;NCOA1;PPP3CA;TET2;NR5A1;BMPR2;PAXBP1;DDIT3;FZD7;MAVS;PAX8;ESR1;PPP3R1;FOXK1;POU3F3;FOXO1;MED16;KMT2E;SIRT1;MAFB;CDK7;PRPF6;SALL2;ARHGEF2;CCN1;NFATC3;PPARD;MT3;CAND2;BCAS3;APP;MYRFL;FZD5;SP3;NOTCH1;RORA;CAMTA2;SIRT7;MAZ;AFAP1L2;HCLS1;FZD2;RFX5;SMARCC1;PPRC1;RELA;KDM1B;BCLAF1;USP21;USP16;SOX2;BCL11B;ICE2;POU2F1;MSANTD1;SLC11A1;PRKN;ZKSCAN3;FOXJ3;SMARCD1;JUNB;GDNF;ATF1;CX3CL1;NAT14;SQSTM1;PRDM2;HNRNPD;PHIP;ZNF513;LRP6;MCRS1;SHC1;MAP3K2;INO80;ZFP64;TNKS;WASL;ARRB1;CDK8;QRICH1;ASXL1;PCBP1;PPARGC1B;NHLH2;KLF6;WWOX;BRPF1;MTF1;THRAP3;TCF12;NFATC2IP;CAMK1;CREB3L4;CREB3
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.26538340253603543,-1.0981977609458407,0.2647058823529412,0.7290652727720077,1.0,29/94,18.68%,CEP83;CNTRL;CSNK1E;RAB3IP;RPGRIP1L;NINL;HSP90AA1;DYNC1I2;TUBB4A;CSNK1D;AKAP9;DCTN2;CEP57;SCLT1;TCTN3;TMEM67;RAB11A;MARK4;PRKACA;NPHP1;CEP164;YWHAG;MKS1;MAPRE1;CEP97;PRKAR2B;TCTN2;TMEM216;CEP290
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.372718844133763,1.0981466573242542,0.33370786516853934,0.7200302298924317,1.0,19/72,19.66%,PIK3R5;HGF;PDGFA;IGF1;IRS2;PIK3CA;SOX9;SIRT1;ROR1;TREM2;MAZ;HCLS1;FGR;CBL;NCF1;TEK;PIK3CB;GAB1;OSM
prerank,muscle organ development (GO:0007517),-0.2868436064474462,-1.0979755677397038,0.24060150375939848,0.7274449339785325,1.0,7/54,6.59%,MEF2C;SGCE;MEF2A;CAPN3;SGCD;VAMP5;POU6F1
prerank,regulation of neuron apoptotic process (GO:0043523),0.365005048606819,1.097793300479896,0.31487513572204123,0.7205059509924887,1.0,21/96,15.91%,APOE;CTNNB1;CPEB4;FOXO3;TFAP2B;SRPK2;PPT1;CLN3;ADAM8;ATF4;BACE1;DDIT3;EGLN3;PTK2B;MT3;TREM2;PRKN;GDNF;BAX;PRKCG;GRN
prerank,respiratory system development (GO:0060541),0.42594123763441744,1.0977133919962974,0.34711779448621555,0.720229479953784,1.0,7/32,17.46%,STRA6;VEGFA;CCDC40;ABCA3;ITGA3;CHD7;NKX2-1
prerank,regulation of interferon-gamma production (GO:0032649),0.3739311303179808,1.097385096325848,0.341545352743561,0.7206273059164687,1.0,11/71,13.74%,TLR8;LILRB1;FOXP3;CD274;RARA;NR1H4;SIRPA;DDIT3;FZD5;GAS6;SLC11A1
prerank,negative regulation of double-strand break repair (GO:2000780),0.4239848655416814,1.0970781133277712,0.3266832917705736,0.7209610901329931,1.0,8/30,20.10%,TRIP12;ERCC6;TFIP11;HELB;RNF169;SHLD1;RADX;SHLD2
prerank,negative regulation of MAPK cascade (GO:0043409),0.3723469227615287,1.096383288637027,0.3381057268722467,0.7223445281361703,1.0,16/87,12.25%,APOE;CD300A;PRKCD;TNIP1;PTEN;SORL1;DUSP3;DAG1;PPEF2;IRAK3;FLCN;CNKSR3;SIRPA;FOXO1;FBLN1;STK38
prerank,regulation of platelet aggregation (GO:0090330),0.4676101561763788,1.0959212492539372,0.36768802228412256,0.7230870210810426,1.0,2/17,3.10%,SYK;PRKCD
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.476429253410363,1.095683094332769,0.3701657458563536,0.7232418638690522,1.0,4/16,8.63%,TBC1D25;CLN3;IRAK3;ETF1
prerank,cellular response to organonitrogen compound (GO:0071417),0.3692644348479698,1.0956448649973958,0.32055378061767836,0.7228415730252914,1.0,23/99,15.58%,HRH1;DIAPH1;CTNNB1;AQP1;IPO5;CPEB4;P2RX4;SESN2;SLC5A5;NR1H4;CAPN2;P2RX3;BRCA1;FOLR1;SOX9;LAMTOR1;RAPGEF1;RELA;SLC38A9;LAMTOR3;HTR1B;GOLPH3;CTNNA1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5064054737841956,1.0956249551828705,0.3788098693759071,0.7224020197425987,1.0,3/13,8.76%,SYK;PRKCD;TYROBP
prerank,DNA double-strand break processing (GO:0000729),-0.37300505341454193,-1.0949294343578302,0.32971014492753625,0.7334899263294438,1.0,7/18,20.44%,EXD2;ATM;RAD50;UBE2V2;UBE2N;SMARCAD1;SETMAR
prerank,artery development (GO:0060840),0.4525433895061397,1.094817427776343,0.35514018691588783,0.7241910688713508,1.0,5/23,9.45%,APLNR;STRA6;VEGFA;ACVRL1;BMPR2
prerank,regulation of neuron migration (GO:2001222),-0.3529093615865543,-1.0943273432050131,0.334841628959276,0.7330231955730918,1.0,12/26,14.94%,CTNNA2;NTNG1;PHACTR1;SRGAP2;ADGRG1;ULK4;SEMA3A;DAB2IP;CAMK2A;SEMA6A;NEXMIF;RAPGEF2
prerank,cAMP metabolic process (GO:0046058),0.5002771820364708,1.0942055785483937,0.3689604685212299,0.7253628259217696,1.0,7/13,22.88%,ADCY7;ADCY8;ADCY3;EPHA2;PDE4D;ADCY5;ADCY9
prerank,DNA metabolic process (GO:0006259),0.3464135544107478,1.093888274991115,0.2686868686868687,0.7256964936161591,1.0,63/270,17.62%,ACD;MUS81;RFC3;SRPK2;MUTYH;UVRAG;PARP4;ZRANB3;KPNA2;BACH1;LONP1;UHRF2;PARP2;GADD45A;HELB;PARP3;DOT1L;RPS27A;UBC;NEIL1;BRCA1;TOP1;ENDOV;DFFB;SMC1A;RTEL1;NT5E;TERF1;POLH;XRCC5;DDB1;XRCC2;POLL;DNASE1L1;DDX23;DBF4;MBD4;INIP;NBN;DCLRE1B;SIRT7;KMT5B;WRN;NSMCE3;FBXO6;POLA1;RNASEH2A;NOC3L;RNASEH1;INO80;STN1;MNAT1;NSMCE4A;ORC1;DNMT1;DNASE2;FANCA;ORC4;CDC34;ALKBH1;CDT1;POLI;SMARCB1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.42717756658654016,1.0937078795029365,0.3697585768742058,0.7256837131830471,1.0,5/29,13.04%,APOE;SHISA9;CLN3;APP;MCTP1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.39622539421939473,-1.0936391258796672,0.3311036789297659,0.7326639314005144,1.0,8/15,22.46%,UST;B3GAT3;CSGALNACT1;DSEL;BCAN;CSPG4;NCAN;CHST12
prerank,sensory organ development (GO:0007423),0.390873093374262,1.0934153232458141,0.3395784543325527,0.72594939502095,1.0,10/51,13.44%,STRA6;ZDHHC16;HIPK1;HIPK2;PAX8;MAFB;SALL2;RAB18;SOX2;SH3PXD2B
prerank,cytoplasmic microtubule organization (GO:0031122),-0.2832068994761962,-1.093239788832455,0.25547445255474455,0.7315284369905652,1.0,19/54,22.92%,TUBGCP5;DST;MAPT;STMN3;TPPP;SPAST;RAB11A;DLG1;NUMA1;LIMK2;RHOA;WDR73;FIGNL2;KATNAL2;TUBGCP6;FSD1;CAMSAP1;CIB1;PLK3
prerank,positive regulation of cell division (GO:0051781),0.40074331861880674,1.0931786907323817,0.3341614906832298,0.7260731078037562,1.0,5/38,10.63%,HTR2B;KIF20B;CUL3;SVIL;PKN2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.34441160545162214,1.0931727233210444,0.205,0.7255938263693221,1.0,86/476,14.73%,PPARG;MDFIC;CD38;APOE;ELF2;ZMIZ1;TFEB;CTNNB1;MITF;CEBPB;FOXP3;CXXC1;SPP1;RUNX2;NR1H3;ID2;IL6;FOXO3;NIBAN2;WAC;TFAP2B;RUNX3;RXRA;JUN;MED12;SNX5;HNRNPAB;RARA;CITED2;E2F1;IGF1;HAS3;PCID2;COL1A1;RNF10;MLLT11;NSD3;NR1H4;CREBBP;DYRK1A;ATF4;KDM3A;BRCA1;RREB1;POU3F1;SOX9;EPC1;ACVRL1;BRD7;TBL1XR1;HIPK2;PICALM;NCOA1;DDIT3;FZD7;PAX8;ESR1;FOXK1;POU3F3;FOXO1;MED16;KMT2E;MAFB;PPARD;MT3;CAND2;MYRFL;SP3;NOTCH1;RORA;MAZ;AFAP1L2;FZD2;SMARCC1;RELA;USP21;USP16;SOX2;MSANTD1;ZKSCAN3;NAT14;HNRNPD;PHIP;LRP6;SHC1;MAP3K2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4474582498671265,1.092945335653608,0.37962962962962965,0.7256893308427799,1.0,1/22,0.14%,MDFIC
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.42351411244519327,1.0928193056025954,0.35107731305449935,0.7255253922184167,1.0,11/31,16.82%,DDX6;EXOSC3;EXOSC9;PATL1;POLR2G;CNOT7;EXOSC8;NT5C3B;CNOT6;EDC3;EXOSC1
prerank,negative regulation of cellular protein localization (GO:1903828),0.4159365876769717,1.092699031100294,0.3682896379525593,0.725366620191209,1.0,13/34,20.59%,FLCN;MFHAS1;NEDD4L;PICALM;SNX33;GSK3B;LATS1;CTNNA1;CDT1;LEPROTL1;GOPC;DNAJA1;SIN3A
prerank,mRNA export from nucleus (GO:0006406),-0.2534103416645682,-1.0926486437219236,0.2033898305084746,0.7309011527024091,1.0,40/102,21.60%,IWS1;NUP133;SLU7;SRSF6;SRSF5;FYTTD1;RBM8A;SMG6;NUP214;ZC3H11A;AAAS;NUP85;THOC5;POM121;SEH1L;NUP35;MCM3AP;SLBP;NUP37;SRSF11;NUP155;RAE1;NUP153;DDX39B;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;SYMPK;SRSF4;HNRNPA2B1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3756580971346829,1.0925165421128127,0.3325867861142217,0.7253682381759354,1.0,23/70,21.40%,SYK;GRB2;VAV3;ARPC2;BAIAP2;PRKCD;PLD2;ABI1;PIK3CA;ACTR3;VAV1;CYFIP2;DOCK1;FGR;WASL;CD247;ARPC1A;PIK3CB;FCGR2B;ARPC4;ACTG1;WIPF1;MYH2
prerank,DNA-dependent DNA replication (GO:0006261),0.35400104164584106,1.0920670641878796,0.32708333333333334,0.7261313919250313,1.0,44/128,25.76%,BAZ1A;PSMD1;RFC3;SRPK2;MCMBP;HELB;POLG2;RPS27A;UBC;DDX23;PSMF1;DBF4;PSMD14;PSMD12;SIRT7;WRN;SSBP1;POLA1;NOC3L;PSME2;ORC1;CDK2AP1;TWNK;ORC4;CDC34;CDT1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;RPAIN;PSMB3;PSME3;POLD1;CDK2;POLE3;PRIMPOL;PSMC5;PRIM2;ORC6;MCM3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4247595087255888,1.09173074534183,0.3484646194926569,0.7265348398766035,1.0,10/29,21.16%,FBXW7;ARRDC4;UBE2L3;TOPORS;DCUN1D5;DCUN1D3;DCUN1D4;DCUN1D1;FBXO5;ARRDC3
prerank,ERAD pathway (GO:0036503),0.3700582407660383,1.09161822192953,0.3333333333333333,0.7263201836361998,1.0,34/83,24.39%,TRIM25;UBXN8;NPLOC4;FAM8A1;TMUB2;UBXN4;FAF2;ERLIN1;STUB1;RHBDD1;DNAJB14;FBXO6;PRKN;DERL2;UGGT1;UBQLN2;TMUB1;DNAJC18;TMEM129;SGTA;AMFR;MAN1B1;ATXN3;WFS1;BRSK2;TOR1A;FOXRED2;JKAMP;ECPAS;VCP;HERPUD1;UBE4A;UBE4B;UBE2J2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4105556823461983,1.0915461279960617,0.3580097087378641,0.7260164513014695,1.0,6/38,7.28%,SASH1;TLR8;ANKRD17;LY96;ADAM8;CYBA
prerank,homotypic cell-cell adhesion (GO:0034109),0.4064580436196993,1.0913739986194624,0.35547355473554737,0.725991602986512,1.0,16/39,25.57%,PLPP3;ACTN1;TLN1;RAP2B;STXBP3;MYH9;CLIC1;FIBP;PIK3CB;ACTG1;ILK;FLNA;PPIA;MYL12A;ACTB;ITGB3
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.41141118497304674,1.09134727572215,0.350920245398773,0.725579583681235,1.0,13/37,21.63%,SDCBP;WAC;RPL23;HIPK2;CSNK2A2;N4BP1;CSNK2A1;EIF3H;SGTA;TLK2;OGT;TAF1;GIPC1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.33466290730536336,-1.091222603457718,0.33189655172413796,0.7324844830608103,1.0,12/27,25.50%,CACNB2;ANK2;CACNB4;JPH1;PRKACA;SELENON;CACNB1;FKBP1B;JPH4;ADRA2A;NOS1;JPH3
prerank,ncRNA 3'-end processing (GO:0043628),0.4841720187446565,1.0907762209701346,0.3649851632047478,0.7266035305218523,1.0,7/14,13.35%,TOE1;INTS6;INTS8;ERI1;INTS2;INTS5;INTS7
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3826546117942792,1.0906082602948806,0.3416856492027335,0.7265369294207294,1.0,10/57,10.68%,CTSD;SYK;DAPK1;HTRA2;TBC1D10A;NLRC4;MEFV;CYFIP2;CYCS;SIRT1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3955505668347179,-1.090520893789216,0.33876221498371334,0.7321629450614633,1.0,7/16,16.74%,MEF2C;RIMS1;SNCAIP;FMR1;CAMK2A;CPLX1;CPLX2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.42952504186180385,1.0903908501370578,0.3723958333333333,0.7266773024043635,1.0,9/29,16.53%,RIPK1;HTRA2;THBS1;PAK2;DEDD2;WWOX;TRAF2;BID;LTBR
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4959028366152802,1.0894536416018157,0.36779911373707536,0.7287062091737271,1.0,3/13,8.04%,CTNNB1;VEGFA;COL4A1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3671512391041602,1.0884276790391547,0.35185185185185186,0.7310146079836355,1.0,35/87,24.57%,CHCHD4;LYRM7;UQCRFS1;IMMP2L;SDHAF3;NDUFS8;NDUFA10;SDHAF4;NDUFC1;ECSIT;NDUFAB1;TMEM126A;NDUFAF8;COA5;OMA1;NDUFB6;DMAC1;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFAF7;UQCC1;COA3;NDUFB8;NDUFAF4;SDHAF2;NDUFB9;NDUFAF2;AIFM1;NDUFA13;TMEM126B;COA8;PET100;DMAC2
prerank,positive regulation of gene expression (GO:0010628),0.3428860011543823,1.0883769819985958,0.22322322322322322,0.7306512526968219,1.0,73/442,13.96%,CD36;HTR2B;DTNBP1;HNRNPLL;SAMD4A;LILRB1;NFE2L2;MITF;ERN1;VEGFA;POLR2A;FLOT1;ERCC6;TFRC;VIM;IL36G;NAT8;ID2;IL6;CD28;CD46;SRPK2;RIPK1;CELF1;PID1;CITED2;TENT4B;YTHDF3;E2F1;IGF1;FGFR4;THBS1;AGO2;EIF6;SPHK2;DDX5;HSPA1B;DYRK1A;NWD1;ATF4;BRCA1;LARP4B;RPL23;POLR2L;MSN;POU3F1;STAP1;SOX9;TAF1B;CTSH;TYROBP;NAT10;TNRC6B;NR5A1;POLR1A;PTGER4;ROCK1;GSK3B;POU3F3;AGO3;MED26;MT3;APP;NOTCH1;IL15;TREM2;MAZ;GAS6;DGKQ;FGR;SLC11A1;PRKN;HSPA1A
prerank,response to UV-A (GO:0070141),0.4963597077574011,1.0883069571919717,0.3654970760233918,0.7303359484829945,1.0,1/14,0.97%,TIMP1
prerank,regulation of macrophage cytokine production (GO:0010935),0.49185313634048383,1.0882665398309284,0.38258164852255055,0.7299672530437263,1.0,3/13,10.68%,LILRB1;IRAK3;SIRT1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.40577938296630484,1.0881603963942261,0.3482466747279323,0.7297631933832273,1.0,11/35,18.26%,ACSS3;FASN;SLC25A1;PPT1;AACS;GGTA1;HMGCL;SCD;GCDH;CBR4;PAM
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3659370404385107,-1.0881285602747959,0.32094594594594594,0.7367222645833876,1.0,5/20,11.45%,KCNB2;CHRM3;CHRM2;DAPK3;NMU
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.267919271515975,-1.0879196488414744,0.24719101123595505,0.7350961879331158,1.0,12/80,5.43%,P2RY12;TENM2;GPM6A;TWF2;NLGN1;AUTS2;ABI2;PLPPR5;RIPOR2;ANLN;NCKAP1;FMR1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.4910304682042757,1.0878695445631195,0.39593114241001565,0.7300403216551244,1.0,5/12,18.68%,VEGFA;SOX9;PAX8;GDNF;SOX8
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.44040637500716107,1.0878084009723317,0.3900134952766532,0.7297220956087697,1.0,5/23,12.99%,WEE2;PLK2;ZFYVE19;VPS4A;CHFR
prerank,histone H3-K4 trimethylation (GO:0080182),0.5144207085314708,1.0874895350617373,0.3987915407854985,0.7301187695408483,1.0,6/11,26.50%,TET3;TET2;KMT2A;OGT;KMT2D;SETD1B
prerank,pharyngeal system development (GO:0060037),-0.40106590398028347,-1.0871983469628166,0.3287671232876712,0.7348512085049491,1.0,4/15,8.98%,PTCH1;BMPR1A;TGFBR1;TGFB2
prerank,cell cycle G1/S phase transition (GO:0044843),0.38706433308086213,1.0870980784586064,0.34942528735632183,0.7306813902943362,1.0,19/61,16.20%,PLK2;E2F3;CDKN1A;E2F1;CUL3;CACUL1;RB1;NASP;CDK7;USP26;CCNA2;DBF4;ACVR1B;CUL4A;PPP6C;CUL1;MNAT1;LATS1;CDC34
prerank,gluconeogenesis (GO:0006094),0.4054015304534685,1.08614372163718,0.371007371007371,0.7327252628025472,1.0,12/39,24.09%,TPI1;SLC25A1;ATF4;ENO3;SLC39A14;PGM1;CRY1;GAPDHS;MDH1;SLC37A4;SLC25A13;GOT1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.42532412017471644,1.0858371355991494,0.3774069319640565,0.7330711159529475,1.0,14/27,29.29%,NAT8;PHF20;CREBBP;PHF20L1;SGF29;KAT2A;RUVBL2;KAT6B;KAT6A;KAT2B;MRGBP;BRD8;EP300;MORF4L1
prerank,negative regulation of protein kinase activity (GO:0006469),0.3668817508980768,1.0857213539295079,0.3372717508055854,0.7328895653323707,1.0,16/88,10.64%,DTNBP1;CORO1C;GNAQ;PRKAG2;PDPK1;CDKN1A;SORL1;SLC8A1;TAF7;DUSP3;GADD45A;GSKIP;RB1;DVL1;CEP85;PAK2
prerank,cellular response to interleukin-12 (GO:0071349),0.3904307457729749,1.0855857598998224,0.36811254396248533,0.7327631402270249,1.0,17/48,24.60%,TALDO1;LCP1;ANXA2;MSN;SIRPA;CFL1;PITPNA;PAK2;PSME2;CAPZA1;HNRNPDL;GSTO1;CD47;HSPA9;JAK2;AIP;PPIA
prerank,histone H4-K16 acetylation (GO:0043984),0.4648309478663386,1.0855007491540238,0.3756906077348066,0.732528584130365,1.0,7/19,22.46%,KANSL1;PHF20;ING4;MCRS1;KMT2A;OGT;KANSL3
prerank,organic substance transport (GO:0071702),0.3555037312358907,1.085301226296707,0.3217665615141956,0.7325940515094148,1.0,31/121,21.68%,ABCA1;FLVCR1;SLC18A1;ABCG1;RAB7A;ABCD1;ARRDC4;PPT1;PLTP;MFSD12;CHMP2A;KIF3A;ABCA3;ABCA2;ABCA6;GM2A;MYH9;SLC23A1;TOM1;ABCG4;SLC6A4;LRP2;SLC19A1;SLC50A1;SLC19A2;VAMP2;CALCRL;ARRDC3;CHMP2B;NDC1;SLC22A5
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3712673129278166,1.0851235993892299,0.35333333333333333,0.7325658349393867,1.0,23/71,21.40%,SYK;GRB2;VAV3;ARPC2;BAIAP2;PRKCD;PLD2;ABI1;PIK3CA;ACTR3;VAV1;CYFIP2;DOCK1;FGR;WASL;CD247;ARPC1A;PIK3CB;FCGR2B;ARPC4;ACTG1;WIPF1;MYH2
prerank,rRNA processing (GO:0006364),0.3486546118246513,1.0849441647652454,0.3123092573753815,0.732574376713315,1.0,66/172,26.43%,C1D;EBNA1BP2;MPHOSPH10;BYSL;SENP3;RPL18A;EIF6;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;SART1;NOP14;EXOSC3;TEX10;NAT10;WDR18;POP4;EXOSC9;WDR74;RPL22;NOB1;DKC1;MRPL1;ERI1;EXOSC8;NOL8;RPL10A;KRR1;MRM2;TSR3;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;PWP2;UTP15;RCL1;DHX37;EXOSC7;RPS27;WDR43;PRKDC;FBL;BOP1;NOLC1;RPL7A;LYAR;XRN2;NOL6;RPL32;SNU13;RRP36;LSM6;RPS9;MPHOSPH6;DDX49;EXOSC4;WDR36
prerank,cellular response to interferon-beta (GO:0035458),0.4966820789440494,1.084886191364805,0.37626628075253254,0.7322249486819605,1.0,5/14,16.20%,HTRA2;UBE2K;IFITM2;ACOD1;CDC34
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.4708889049652486,1.0847377000342364,0.38653001464128844,0.7321098548527458,1.0,5/15,18.68%,VEGFA;SOX9;PAX8;GDNF;SOX8
prerank,mitotic recombination (GO:0006312),0.48690970508907994,1.0841527557515431,0.3982808022922636,0.7331524017732218,1.0,2/15,4.73%,NSMCE2;TEP1
prerank,plasma membrane tubulation (GO:0097320),0.49777972443823193,1.0840149343489163,0.3787425149700599,0.7330326959325527,1.0,5/13,14.30%,BIN3;SNX9;MICALL1;SNX33;WHAMM
prerank,renal water homeostasis (GO:0003091),0.4423389078405704,1.0839927825467708,0.37101063829787234,0.7326120807237686,1.0,9/23,24.68%,AQP1;TFAP2B;ADCY7;ADCY8;ADCY3;WFS1;ADCY5;ADCY9;RAB11FIP2
prerank,negative chemotaxis (GO:0050919),-0.3234864019253474,-1.0836725003561163,0.3225806451612903,0.7424321845577095,1.0,9/33,14.21%,UNC5C;ROBO1;SLIT1;SEMA4G;SEMA3E;SEMA3A;EPHA7;SEMA6A;RHOA
prerank,DNA alkylation (GO:0006305),0.46422063243378453,1.083410465873503,0.3894039735099338,0.7331538118877627,1.0,7/19,21.49%,DNMT3A;GATAD2A;KMT2E;DNMT1;MTRR;EHMT2;DMAP1
prerank,DNA methylation or demethylation (GO:0044728),0.46422063243378453,1.083410465873503,0.3894039735099338,0.7331538118877627,1.0,7/19,21.49%,DNMT3A;GATAD2A;KMT2E;DNMT1;MTRR;EHMT2;DMAP1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5248015901079676,1.083405462765757,0.3901689708141321,0.7326788255769552,1.0,5/10,23.03%,MMGT1;EMC2;EMC4;EMC3;EMC10
prerank,regulation of calcium ion transport (GO:0051924),0.38689762389052,1.0831069399566078,0.338785046728972,0.7330102344658154,1.0,8/54,5.19%,LILRB1;CTNNB1;CD84;ATP2B1;P2RX4;SLC8B1;HOMER3;GRIN3B
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.36796507584461474,1.0829610374550418,0.360529217199559,0.7329145011883964,1.0,23/73,21.40%,SYK;GRB2;VAV3;ARPC2;BAIAP2;PRKCD;PLD2;ABI1;PIK3CA;ACTR3;VAV1;CYFIP2;DOCK1;FGR;WASL;CD247;ARPC1A;PIK3CB;FCGR2B;ARPC4;ACTG1;WIPF1;MYH2
prerank,positive regulation of signaling (GO:0023056),-0.3114024490700743,-1.0829537106274625,0.3238095238095238,0.7421252216448526,1.0,8/37,11.45%,SYT1;RIMS1;RIMS2;GRIK2;CD80;HOMER1;ECE1;NMU
prerank,inorganic ion transmembrane transport (GO:0098660),0.5068912108657507,1.0823040193622162,0.38763197586727,0.7341971850123395,1.0,2/12,7.23%,ATP1B4;P2RX3
prerank,protein sumoylation (GO:0016925),0.38752969431436496,1.082257444286363,0.36941176470588233,0.733832050842654,1.0,18/49,23.72%,EYA1;NSMCE2;SUMO2;PIAS4;TOPORS;TPR;NUP50;NUP98;NUP88;PIAS2;BCL11A;PIAS1;NUP188;NDC1;NUP43;NUP54;RANBP2;EGR2
prerank,regulation of BMP signaling pathway (GO:0030510),0.37717353376998425,1.0817986707964227,0.36853685368536854,0.7345519464799486,1.0,15/73,12.77%,PPARG;TFAP2B;SORL1;XIAP;ACVR2A;ACVRL1;HIPK2;BMPR2;FSTL1;RBPMS2;CCN1;NOTCH1;SULF1;LEMD3;ITGA3
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5125965124708567,1.0816012567223494,0.38837920489296635,0.7346030196016787,1.0,3/11,8.81%,RUNX3;CD274;CBFB
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4446645587064822,1.081521930252029,0.37889039242219213,0.7343220281503386,1.0,10/22,21.38%,NOP14;EXOSC3;EXOSC9;RPS21;ERI1;EXOSC8;EXOSC10;WDR12;EXOSC7;ABT1
prerank,cellular response to organic cyclic compound (GO:0071407),0.35137949489423925,1.0813253612286342,0.3515463917525773,0.7343478229117137,1.0,30/141,15.58%,HRH1;DIAPH1;CTNNB1;AQP1;TIPARP;TGM2;SPP1;P2RX4;UBE2L3;NR3C1;SLC5A5;NR1H4;P2RX3;BRCA1;NCOA4;MSN;FOLR1;LCOR;NCOA3;ESR1;EPG5;FES;RORA;RAPGEF1;FAM210B;ADCY8;ADCY3;GOLPH3;CASP6;CTNNA1
prerank,negative regulation of chemotaxis (GO:0050922),-0.3225570918142291,-1.0810978770632909,0.319047619047619,0.7450804112995436,1.0,8/31,12.08%,SEMA5A;ROBO2;ROBO1;AIF1;SEMA4G;SEMA3E;SEMA3A;SEMA6A
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.4326559355900493,-1.081036556196539,0.36253776435045315,0.7430797744283322,1.0,2/11,2.63%,PTPRT;SH2B3
prerank,positive regulation of axonogenesis (GO:0050772),0.39929006363530184,1.080274691928697,0.3633004926108374,0.7366752999024735,1.0,5/43,5.09%,PLXNA1;PLXNC1;PLXND1;RUFY3;ZFYVE27
prerank,negative regulation of protein modification process (GO:0031400),0.3687663489897317,1.0801720714689342,0.3653631284916201,0.7364503145627966,1.0,14/79,14.56%,PLPP3;XDH;CORO1C;PID1;PTEN;ENSA;MFHAS1;SIRPA;CDYL;GSK3B;SIRT1;FBLN1;PRKN;LRP6
prerank,glucan catabolic process (GO:0009251),0.4711201667374407,1.0801700736226925,0.3921015514809591,0.735971131434301,1.0,5/15,21.80%,PYGL;AGL;PHKG2;MGAM;PYGB
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.36902251594281654,-1.0800822079274786,0.3592592592592593,0.7434363644848778,1.0,5/18,15.09%,IWS1;NUP133;ZC3H11A;MCM3AP;HHEX
prerank,long-term synaptic potentiation (GO:0060291),-0.3618681975544534,-1.079882288298359,0.324,0.741870362457448,1.0,4/21,4.69%,GRIN2A;GRIN2B;SLC24A2;TSHZ3
prerank,regulation of superoxide anion generation (GO:0032928),0.490906161487892,1.079810997402522,0.4005805515239477,0.7364606665863335,1.0,3/14,8.76%,SYK;PRKCD;TYROBP
prerank,diol metabolic process (GO:0034311),0.4645440557908837,1.079553653194656,0.3857729138166895,0.7366742155283943,1.0,5/19,19.72%,PLPP3;SPHK2;PTS;GCH1;SGPP2
prerank,lung epithelium development (GO:0060428),0.5362122033413477,1.0790879063459093,0.4232558139534884,0.7374541833923135,1.0,1/10,1.11%,STRA6
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5072280686908962,1.078643036664858,0.3931888544891641,0.7376179685805444,1.0,4/11,18.52%,AGO2;EIF6;AGO3;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5072280686908962,1.078643036664858,0.3931888544891641,0.7376179685805444,1.0,4/11,18.52%,AGO2;EIF6;AGO3;AGO4
prerank,positive regulation of vacuole organization (GO:0044090),0.520423093561685,1.0784932807470589,0.37936267071320184,0.7375467199696486,1.0,7/10,24.98%,SH3GLB1;ANXA2;RAB3GAP2;GRN;PIP4K2A;RAB3GAP1;PIP4K2C
prerank,ribosomal small subunit assembly (GO:0000028),0.47604294088229254,1.0783381283286375,0.4028985507246377,0.7374742032840849,1.0,8/16,21.95%,RPS14;MRPS7;XRCC5;RPSA;PWP2;RPS27;ABT1;PRKDC
prerank,cellular response to interleukin-6 (GO:0071354),-0.3370873672428223,-1.0782983958710992,0.30288461538461536,0.7441896539544958,1.0,5/26,4.94%,SELPLG;ST3GAL6;PTPRT;FER;IL6ST
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5292427796814145,1.077931772414931,0.4074074074074074,0.7381006811237769,1.0,5/10,19.29%,SPHK2;BRCA1;CAMK1;SMARCB1;KMT2A
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5247659644850893,1.0779187447974943,0.410958904109589,0.7376484123512662,1.0,5/10,22.34%,RIC1;ANXA2;NELL1;EPHA4;FURIN
prerank,synaptic vesicle membrane organization (GO:0048499),0.47236389793208144,1.0777741514344727,0.4072992700729927,0.7375698551674256,1.0,7/17,20.79%,STX3;SNAP29;STX11;AP3D1;SNAP47;SNAP23;TOR1A
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3406304726734422,1.0775998590991502,0.279,0.7375566028282727,1.0,87/366,19.02%,ATP1B4;TFEB;MITF;POLR2A;CEBPB;ATXN1;FOXP3;CXXC1;WWC2;FOXO3;ANKRD17;RUNX3;PDGFA;MYCBP;ATXN2;MZF1;FOXO4;BACH1;E2F1;UBE2L3;SAP30;APBB2;NR3C1;ASCC2;NSD3;CREBBP;BHLHE40;TESMIN;ATF4;RREB1;TAF5;JMJD1C;SNAI2;RBAK;RB1;PRDM8;IRF2;DVL1;CHD3;PUM3;ZFAT;ACVRL1;DDIT3;FZD7;ESR1;HCFC2;PSPC1;ASCC1;ZFPL1;MTPN;MAFB;CCNA2;GPBP1L1;APP;SP3;ACVR1B;NOTCH1;RORA;PQBP1;APBB3;HCLS1;RELA;SOX2;PPIE;LIMD1;ZKSCAN5;PRDM2;HNRNPD;RPL10;SMC3;PPARGC1B;MYT1;CCAR1;ZBTB11;CHD7;TAF5L;ERC1;NFYC;HMGN5;UBE2V1;NAB1;CLOCK;NFX1;ZNF431;PPP2CA;FBXO5;NCOA2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5137298637715221,1.0774987644896004,0.38263665594855306,0.7373268506146203,1.0,5/10,22.17%,ACADL;ACADVL;GCDH;ETFA;IVD
prerank,ion homeostasis (GO:0050801),-0.3298225018529323,-1.0772372343346994,0.3333333333333333,0.7449941737124463,1.0,8/30,12.12%,SLC4A7;UNC80;WNK3;SLC4A10;SLC4A8;WNK2;SLC4A2;WNK1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.40780866329072,1.0770228802216462,0.40148698884758366,0.7380259819088348,1.0,8/34,11.99%,IL6;ENPP1;E2F1;FLCN;ZFP36L2;FOXO1;SIRT1;RORA
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.44849429502409677,1.0768679620878632,0.38675496688741723,0.7379473831900287,1.0,6/21,16.78%,SAMD4A;CNOT4;CNOT6L;CNOT7;CNOT6;PAN3
prerank,protein monoubiquitination (GO:0006513),0.4054259080875173,1.076589052920146,0.38170731707317074,0.7382028472617634,1.0,13/36,24.76%,WAC;TRIM25;CUL3;TOPORS;HUWE1;PRKN;CDC73;UBE2O;UBE2R2;KLHL12;OBI1;UBE2D3;UBE2E1
prerank,regulation of MAPK cascade (GO:0043408),0.3488551153260858,1.0761208147030026,0.3494347379239466,0.7389792356166707,1.0,27/157,15.21%,IQGAP1;GDF15;SYK;ADRA1D;ADRA1A;TAOK3;IL6;TMEM106A;FAS;PDGFA;IGF1;DUSP3;DAG1;PPEF2;STK3;LAMTOR1;TNIK;ROCK1;PAK2;CCN1;STYX;ROR1;SOX2;RRAS;CX3CL1;SHC1;ATP6AP2
prerank,protein homotetramerization (GO:0051289),-0.2882330928326485,-1.0756090826578957,0.2802547770700637,0.7474138602857257,1.0,14/49,16.79%,HCN1;RYR3;ACACA;KCNJ2;TRPM4;TRPM2;SOD2;MCOLN1;APIP;PKD2;PKD2L1;ALDOA;GBP5;OSBPL2
prerank,cellular response to heat (GO:0034605),0.40929977666353484,1.0755907397614886,0.35315985130111527,0.7399359141910519,1.0,9/35,13.96%,IER5;HTRA2;THBS1;HSPA1B;HMOX1;TPR;STUB1;RBBP7;HSPA1A
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.49427250818284135,1.075514554101797,0.3918918918918919,0.7391754211586792,1.0,5/12,25.49%,CORO1C;FBLN1;MELTF;RCC2;EFNA5
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.49427250818284135,1.075514554101797,0.3918918918918919,0.7391754211586792,1.0,5/12,25.49%,CORO1C;FBLN1;MELTF;RCC2;EFNA5
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.446838757134574,1.0749763555134064,0.395128552097429,0.7400963374303454,1.0,5/23,13.73%,MTM1;MTMR3;PTEN;OCRL;INPP5F
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5120038031420323,1.0748405822350249,0.3850837138508371,0.7399924554303985,1.0,1/10,0.78%,GALNT3
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.34185338473930454,1.0746921430032246,0.3049147442326981,0.7399177042896847,1.0,77/327,19.02%,ZMIZ1;ATP1B4;TFEB;MITF;POLR2A;CEBPB;ATXN1;FOXP3;CXXC1;WWC2;RUNX3;MYCBP;MZF1;FOXO4;BACH1;E2F1;UBE2L3;SAP30;APBB2;NR3C1;ASCC2;NSD3;CREBBP;BHLHE40;TESMIN;ATF4;RREB1;TAF5;JMJD1C;SNAI2;RBAK;RB1;PRDM8;IRF2;DVL1;CHD3;ZFAT;ACVRL1;DDIT3;FZD7;ESR1;HCFC2;PSPC1;ASCC1;ZFPL1;MAFB;GPBP1L1;SP3;ACVR1B;NOTCH1;RORA;PQBP1;APBB3;HCLS1;RELA;SOX2;PPIE;LIMD1;ZKSCAN5;PRDM2;HNRNPD;PPARGC1B;MYT1;CCAR1;ZBTB11;CHD7;TAF5L;ERC1;NFYC;HMGN5;UBE2V1;NAB1;CLOCK;NFX1;ZNF431;PPP2CA;NCOA2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.46540989492339835,1.0746068122512284,0.39136490250696376,0.7396570623614515,1.0,3/17,9.26%,PLA2G2D;SERAC1;PLA2G4F
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.46701430592174176,1.0745979804116716,0.39106145251396646,0.7391960774581532,1.0,5/18,20.76%,CXCR4;TNFRSF1B;NOTCH1;TNFRSF21;HES5
prerank,polyamine metabolic process (GO:0006595),0.47914143463602865,1.0744315241237283,0.375186846038864,0.7391159338537937,1.0,4/13,12.82%,PAOX;SAT1;OAZ2;DHPS
prerank,cellular response to oxygen-containing compound (GO:1901701),0.33821878956373064,1.0743719626616535,0.2995991983967936,0.7387843589046434,1.0,54/291,13.19%,LILRB1;AQP1;IPO5;PDK4;TGM2;MPV17;CPEB4;VIM;IL36G;NR1H3;ADAM9;IL6;ABL2;PRKCD;P2RX4;JUN;DAPK1;CD274;TNFRSF1B;LY96;SESN2;SHPK;PID1;HTRA2;NFKBIB;SLC5A5;NR1H4;CAPN2;P2RX3;STAP1;FOLR1;SOX9;LCOR;SIRPA;NFKBIL1;TICAM2;NCOA3;LAMTOR1;FZD7;ESR1;PTK2B;FOXO1;FES;MT3;TRIM41;RORA;RAPGEF1;KCNK4;FAM210B;RELA;GPLD1;SLC38A9;ERCC6L2;LAMTOR3
prerank,regulation of heart contraction (GO:0008016),-0.2595291632669617,-1.0742359144187246,0.2987012987012987,0.7489290996604443,1.0,17/90,12.35%,ATP1B1;RYR3;ANK2;ITPR2;TRPC1;ATP1A2;ASPH;RYR2;ATP1B2;SMAD7;ATP2B3;TGFB2;CELF2;PRKACA;ATP2B2;ATP2B4;AGT
prerank,copper ion transport (GO:0006825),0.5018693953772626,1.0740138067326697,0.39908256880733944,0.7392348882149153,1.0,4/11,16.65%,STEAP3;SLC11A2;ATP7A;SLC31A2
prerank,neuron development (GO:0048666),0.3506202930480531,1.0739914918125706,0.3429454170957775,0.7388163483201118,1.0,32/141,14.47%,LRP12;B4GALT5;APOE;DTNBP1;STX3;MICALL2;ERCC6;IL6;RUNX3;FRY;PPT1;UGDH;CLN5;ZFYVE27;B4GALT6;TBC1D23;MICALL1;RB1;PPP1R9B;VAPA;ROCK1;GSK3B;TBC1D24;APP;THOC2;PQBP1;TDP2;TENM1;ARL3;GDNF;UHMK1;UNC5A
prerank,positive regulation of cation channel activity (GO:2001259),-0.30262525187263806,-1.0739051518677465,0.2722222222222222,0.7476598580215099,1.0,11/40,17.42%,ANK2;ANK3;RELN;TMSB4X;NLGN3;ACTN2;PKD2;ATPSCKMT;CCR2;STAC;ANTKMT
prerank,anion transmembrane transport (GO:0098656),0.3741349389133732,1.0736488440054401,0.36971046770601335,0.7392058597059806,1.0,17/67,19.77%,LRRC8D;SLC7A2;SLC36A4;SLC25A1;MFSD12;SLC27A1;LRRC8C;SLC6A8;SLC23A2;SLC23A1;SLC25A42;SLC7A1;ABCC1;SLC35A2;SLC19A1;SLC35C2;SLC7A8
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.4678105095295368,1.0735135475035797,0.39633286318758815,0.7391185908878974,1.0,1/15,0.68%,SYK
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.4046445923064289,-1.0734639620642978,0.3710691823899371,0.7467327681948883,1.0,3/14,4.41%,MEF2C;BMPR1A;AIF1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.4195052750658281,1.072793836523302,0.3743455497382199,0.7405451405941471,1.0,6/29,10.25%,YTHDF3;IFNAR2;UBE2K;RNASEL;MAVS;CNOT7
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4338324041568198,1.072566102943398,0.3891891891891892,0.7406520694340952,1.0,5/25,8.84%,B3GNT8;NDST1;EXT1;HAS3;HS2ST1
prerank,megakaryocyte differentiation (GO:0030219),-0.4341134613809192,-1.0724346288615927,0.384180790960452,0.7475488852660562,1.0,2/11,5.36%,SH2B3;TAL1
prerank,regulation of lamellipodium organization (GO:1902743),-0.3898320735811156,-1.0724031222558426,0.37735849056603776,0.7454973138817145,1.0,4/14,7.81%,TWF2;FER;WAS;CARMIL1
prerank,homocysteine metabolic process (GO:0050667),0.5116415788282269,1.0721804616205843,0.3945371775417299,0.7411799790472611,1.0,3/11,17.75%,TST;BLMH;MTRR
prerank,aminoglycan metabolic process (GO:0006022),0.513742667236594,1.072056692500862,0.3941267387944359,0.7410327800252647,1.0,2/10,4.54%,XYLT1;B4GALT7
prerank,steroid catabolic process (GO:0006706),0.5308997131785274,1.071837933299663,0.41068702290076337,0.7411284877122423,1.0,2/10,16.99%,SPP1;HSD17B11
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3350144879606866,1.071628074520435,0.224,0.7412153849660824,1.0,138/807,14.90%,PPARG;MDFIC;FNIP2;CD38;SDCBP;TFEC;IRX3;FRK;RCOR1;TRPS1;ZNF3;CTNNB1;MITF;VEGFA;WWP1;FNIP1;CEBPB;ZEB2;ATXN1;FOXP3;DNMT3A;ATF3;WWC2;LANCL2;RUNX2;ARID4A;NR1H3;GATAD2A;ID2;FOXO3;NIBAN2;LIN37;CBX8;ZNF692;TFAP2B;RUNX3;RXRA;JUN;NCOR1;MAP2K5;RARA;MZF1;CITED2;BACH1;E2F1;TAF7;SAP30;GADD45A;NR3C1;SIRT6;TCERG1;EED;NR1H4;DDX5;CREBBP;BHLHE40;RPS14;FLCN;HNRNPU;PEX14;TGIF1;ATF4;NIPBL;RPS27A;UBC;RITA1;BRCA1;ZNF177;RPL23;ETV6;RREB1;UXT;PIAS4;SOX9;SNAI2;RBAK;RB1;NEDD4L;LCOR;EPC1;WWP2;ZNF148;FOXP1;IRF2;CHD3;CBFB;BRD7;ARID5B;TBL1XR1;DACH1;TPR;DDIT3;RLIM;XRCC5;ESR1;NR2C1;HCFC2;PSPC1;VPS72;CNOT7;FOXK1;KDM2A;POU3F3;FOXO1;SIRT1;LARP7;PPARD;CUX1;ING4;MT3;CIPC;CBX3;SP3;NOTCH1;TBX6;SARS1;DEDD2;SIRT7;DDX20;MAZ;RELA;KDM1B;GAS6;BCLAF1;SOX2;ATP8B1;POU2F1;LIMD1;PRKN;ZKSCAN3;DCAF1;SUV39H2;PRDM2;SHC1;ID4;EID1;PER3;RPL10
prerank,neuron cell-cell adhesion (GO:0007158),-0.3879466908732962,-1.071460143631525,0.3745704467353952,0.7459324882376716,1.0,8/14,11.69%,NRXN1;NRXN3;NLGN1;CNTN4;CDK5R1;ASTN2;NLGN3;NCAM2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5181163152588824,1.0711393549777366,0.40923076923076923,0.7415396628324601,1.0,3/10,11.02%,PPP3CA;PPP3R1;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),0.5181163152588824,1.0711393549777366,0.40923076923076923,0.7415396628324601,1.0,3/10,11.02%,PPP3CA;PPP3R1;NFATC3
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.48403419758151184,1.071096814975271,0.391304347826087,0.7411586196457546,1.0,4/14,16.15%,TIMP1;CD63;PHACTR4;BST1
prerank,regulation of mononuclear cell migration (GO:0071675),0.43962799221504767,1.0709645368437595,0.38235294117647056,0.7410206681274483,1.0,3/23,7.65%,LGALS3;THBS1;MSN
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.4393978626489455,1.0707382327842974,0.3691899070385126,0.7411786227799256,1.0,10/24,24.43%,DNMT3A;SMYD5;EED;EPC1;RBBP7;MPHOSPH8;DNMT1;PHF1;MTF2;AEBP2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.45680505690572065,1.0700475741192754,0.3772290809327846,0.7425597947269121,1.0,7/18,18.48%,RPS27A;UBC;EDEM2;DERL2;UGGT1;AMFR;MAN1B1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3597110383255549,1.0699528492387653,0.381057268722467,0.7423194326133986,1.0,32/84,26.55%,PSMD1;ANAPC1;CUL3;RPS27A;UBC;RB1;PSMF1;PSMD14;PSMD12;PSME2;ANAPC10;PSMB10;PSMD5;PSMD8;PSMA3;FBXO5;FBXO31;PSMA2;UBE2S;ANAPC15;PSMD11;PSMA6;PSMB3;PSME3;CDK2;PTTG1;UBE2E1;PSMC5;ANAPC7;FZR1;PSMC1;ANAPC2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.4728157058922707,1.0697302425006134,0.3903448275862069,0.7424350315745315,1.0,6/17,16.35%,TFAP2B;XIAP;FSTL1;SULF1;ITGA3;ZDHHC17
prerank,hyaluronan metabolic process (GO:0030212),0.44215402319174707,1.0696111731612699,0.3847184986595174,0.7422694649771929,1.0,5/23,6.15%,CD44;STAB2;CEMIP2;HAS3;HEXA
prerank,endoplasmic reticulum organization (GO:0007029),0.36808092914848395,1.0694836026315953,0.3827433628318584,0.7421432821004327,1.0,22/72,20.18%,REEP4;GAK;STX5;HMOX1;RTN3;VAPA;VCPIP1;CYB5A;RAB10;RAB18;APP;ALDH3A2;LPCAT3;ATL2;ATL1;MOSPD3;RTN4;SGTA;TMEM170A;SEC31A;SHTN1;VAMP2
prerank,positive regulation of neuron death (GO:1901216),0.387440567778927,1.0693439825182947,0.3829787234042553,0.7420371659016369,1.0,10/46,10.31%,CTNNB1;FOXO3;TFAP2B;SRPK2;ATF4;TYROBP;PICALM;BACE1;DDIT3;GSK3B
prerank,response to interferon-gamma (GO:0034341),0.3742827205142885,1.068544118260618,0.36954087346024633,0.7437048829078694,1.0,18/67,20.69%,KYNU;IFITM1;DAPK1;GBP6;NUB1;SIRPA;MEFV;IFITM2;BST2;EPRS1;SLC11A1;CX3CL1;ACOD1;CCL7;SYNCRIP;GCH1;CCL25;CD47
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4592664118459181,1.0684570432272626,0.391304347826087,0.7434521210867323,1.0,7/17,22.80%,MVD;ALG13;ALG12;MPDU1;ALG6;DPAGT1;SRD5A3
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3554413734041879,-1.0678883918876847,0.37593984962406013,0.753558739976471,1.0,6/21,10.24%,CYRIB;RASAL3;SH3BP1;TGFB2;DAB2IP;CD2AP
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.39170437574966555,-1.0677585553494828,0.3611111111111111,0.7518002092498737,1.0,4/15,7.46%,ACVR1;ACVR2B;MAGI2;SMAD7
prerank,regulation of DNA repair (GO:0006282),0.3922189039695366,1.067658239336109,0.3673469387755102,0.7449969340458344,1.0,11/44,17.94%,EYA1;TRIP12;ERCC6;BABAM2;BRCA1;POLH;SIRT1;SIRT7;BRCC3;RADX;UBE2V1
prerank,negative regulation of translation (GO:0017148),0.3599889716401958,1.0676540872851743,0.3751363140676118,0.7445338809913622,1.0,21/87,19.65%,SAMD4A;CPEB4;DAPK1;DDX6;CELF1;IGF2BP3;YTHDF3;AGO2;EIF2AK4;EIF4EBP2;TPR;ROCK1;CNOT7;FTO;EPRS1;EIF4A3;SYNCRIP;CAPRIN1;MALSU1;CPEB2;NCL
prerank,cellular protein localization (GO:0034613),0.33667793099252163,1.067644553030036,0.32831325301204817,0.7440820023339794,1.0,100/285,25.13%,TLK1;CTNNB1;STX3;SNX8;RAP2A;ACD;TBC1D22A;SNX27;RIC1;TBC1D25;RAB20;TBC1D1;TBC1D2;CTSA;CD63;SNX9;TBC1D12;GRIN3B;RAB21;STX8;TBC1D10A;COG7;RAB3GAP2;STX5;NIPBL;TBC1D2B;RAB31;RAB1B;HPS6;TICAM2;RAB28;VPS33A;UNC93B1;STX11;LAMTOR1;EPB41L3;SIL1;TBC1D22B;RAB18;ARHGEF2;TBC1D15;WLS;RAB24;STXBP3;CPLANE2;AP3D1;PACS2;RAB43;ATG13;LAMTOR3;SH3PXD2B;ARL4C;CELSR1;STX6;AP3B1;SNX17;TBC1D9;RABGAP1;RAB29;GGA2;RAB22A;ARF4;PTPRU;ITSN1;VPS29;AP4M1;ARF5;STXBP2;CORO1B;TM9SF1;ARL5B;PIGU;SEC31A;RAB1A;SGSM2;CROCC;GGA3;RPGR;TBC1D4;DNAJC27;VPS35;TM9SF3;SNX13;VPS45;TRAPPC8;MFN2;TMED3;FLNA;TMED10;ARMCX3;TM9SF4;RRAGC;CEP250;STX17;ARL11;PRPF19;STX16;ARFGAP3;CLTC;ARL6
prerank,regulation of cell cycle phase transition (GO:1901987),0.3554752306316437,1.0674752927283537,0.35867237687366166,0.7440484184852244,1.0,33/91,26.55%,FBXW7;CDKN1A;PSMD1;ANAPC1;GTSE1;DDB1;PSMF1;DBF4;PSMD14;PSMD12;PSME2;CUL1;ANAPC10;PSMB10;PSMD5;PSMD8;PSMA3;FBXO5;PSMA2;UBE2S;ANAPC15;PSMD11;PSMA6;XPC;TAF1;PSMB3;PSME3;UBE2E1;PSMC5;ANAPC7;FZR1;PSMC1;ANAPC2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.38666452850893596,1.0674122396130588,0.3748558246828143,0.7437361371757167,1.0,17/54,22.25%,RPL3L;MRPL20;EBNA1BP2;EIF6;WDR74;MRPL1;RPL10A;PAK1IP1;RPL10;WDR12;RPL7;RPL26;MALSU1;NOC2L;PPAN;GTF3A;BOP1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.41877076991392326,1.0671986984857853,0.39690721649484534,0.74381371395055,1.0,7/27,19.65%,MAP3K20;RPS27A;UBC;MAP3K8;CUL1;CCDC88C;CCM2
prerank,regulation of lamellipodium assembly (GO:0010591),-0.310755103474499,-1.06635899046891,0.33678756476683935,0.7536430581858369,1.0,6/34,4.57%,TWF2;AUTS2;FER;ABI2;WAS;NCKAP1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5091060983235094,1.066179482410892,0.4050235478806907,0.7460245941984863,1.0,5/12,20.56%,STX3;SNAP29;STX11;SNAP47;SNAP23
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.4662050531483965,1.0658302034379363,0.4111888111888112,0.7464335380764835,1.0,7/16,19.94%,SNRNP200;SART1;DDX23;NCBP2;WBP11;RBM22;PRPF39
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.43545892244899387,1.0656837331582936,0.37876802096985585,0.7463590322050846,1.0,6/22,22.17%,NFE2L2;PSMB10;PSMA3;PSMA2;PSMA6;PSMB3
prerank,calcium ion homeostasis (GO:0055074),0.3595667483309482,1.0656637684988763,0.38276990185387133,0.7459264414988703,1.0,8/95,5.00%,HTR2B;TPCN2;ATP2B1;TFAP2B;ATP13A3;SLC8B1;TMEM165;SLC8A1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3948470464713096,1.0655650373272787,0.3898916967509025,0.7457312813487292,1.0,9/39,15.36%,GRB2;DUSP3;STAM;PTPN12;SH3KBP1;RNF115;EPS15;STAM2;CBL
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4472369561875855,1.0650847455784644,0.3906040268456376,0.7464740799562474,1.0,5/21,15.93%,ERN1;JUN;IGF1;HTR1B;DNMT1
prerank,regulation of chemotaxis (GO:0050920),0.41768254005182653,1.0650712140129452,0.39555006180469715,0.746043555466775,1.0,5/30,5.50%,CXCR4;STX3;P2RX4;DUSP3;THBS1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5110430554955228,1.0650549656980874,0.3993759750390016,0.7456037268411667,1.0,3/11,6.69%,TIPARP;PARP4;PARP3
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3886122579448975,1.064966031177113,0.3773809523809524,0.7453600426014833,1.0,8/47,11.57%,APOE;NR1H3;FOXO3;ATXN2;WDR91;PUM3;MTPN;APP
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4984373421588518,1.064286276421185,0.39906103286384975,0.7466823295070909,1.0,6/11,25.00%,NR1H3;SLC27A1;GPLD1;SREBF1;NR1H2;CTDNEP1
prerank,DNA duplex unwinding (GO:0032508),0.38125069418608787,1.0642202865183499,0.3771626297577855,0.7463753427351096,1.0,11/50,13.17%,ANXA1;MCM9;GTF2H5;RPS27A;UBC;RTEL1;DDB1;NBN;CUL4A;WRN;SSBP1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.46981619117271417,1.0640407492424095,0.4,0.7463707372314357,1.0,3/15,10.47%,TEC;DYRK1A;PTK2B
prerank,lung development (GO:0030324),0.4109507075414808,1.0637359775629749,0.39627329192546584,0.7467019811119361,1.0,4/33,7.85%,STRA6;VEGFA;CCDC40;ABCA3
prerank,positive regulation of interleukin-13 production (GO:0032736),0.5193258966490606,1.0637000631153697,0.4057315233785822,0.7463092035977051,1.0,2/10,6.29%,RARA;SPHK2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.47704594867948474,1.0636067840235213,0.4051355206847361,0.746062074908293,1.0,5/14,20.60%,TFRC;KMT5B;SHLD1;SHLD2;PAXIP1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.35393077194879596,1.063462277185286,0.384204909284952,0.7459616256935689,1.0,34/114,23.08%,ST18;FOXO3;PSMD1;RIPK1;TNFRSF1B;ADAM17;PTK2B;BIRC3;PSMF1;BAG4;PSMD14;TRAF1;PSMD12;RELA;TRAF3;PSME2;TRAF5;TRAF2;LTB;LTBR;TNFRSF14;PSMB10;PSMD5;BIRC2;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;TXNDC17;PSMB3;ILK;PSME3;JAK2
prerank,neural crest cell differentiation (GO:0014033),0.4517458739907629,1.0633074417469426,0.38687150837988826,0.7458893828854362,1.0,8/18,23.08%,HTR2B;FBXL17;SNAI2;LRP6;SOX8;PEF1;KLHL12;NOLC1
prerank,regulation of establishment of protein localization (GO:0070201),0.48140684930511507,1.0631966315693306,0.39446870451237265,0.7457310881859843,1.0,5/13,22.95%,CTSD;TREM2;GAPVD1;DNAJA1;SPIDR
prerank,mitochondrial transport (GO:0006839),0.37745510906613394,1.0631610607923376,0.39348079161816063,0.7453571191448617,1.0,20/53,24.36%,FLVCR1;TIMM22;PPIF;PITRM1;TIMM17A;TOMM20;TIMM17B;GDAP1;BNIP3;TOMM34;TOMM7;TOMM22;FBXO7;BCAP31;SLC25A24;SLC25A13;MFN2;AIP;MTX2;BCL2L1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3199227157778011,-1.062816396227442,0.35648148148148145,0.7615315749690903,1.0,10/29,14.57%,SMAD3;DGCR8;METTL3;TUT4;PUM1;SMAD1;SNIP1;SMAD2;ADAR;DICER1
prerank,regulation of JUN kinase activity (GO:0043506),0.4062543801863011,1.0627839304610398,0.39086294416243655,0.7458615644287072,1.0,4/33,6.33%,SASH1;TAOK3;AIDA;PPEF2
prerank,negative regulation of cell junction assembly (GO:1901889),0.42876674400726256,1.0627319006988678,0.38961038961038963,0.7455303232296063,1.0,9/25,17.48%,CORO1C;PTEN;THBS1;DLC1;ACVRL1;ROCK1;BCAS3;ACE;APOD
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.49187346845586516,1.0617062675739708,0.4259818731117825,0.7477017720314095,1.0,5/12,9.79%,HNRNPU;BRCA1;CDYL;LRIF1;RLIM
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3464524574583339,1.0615460568600572,0.37048503611971106,0.7476430188965021,1.0,43/153,19.98%,SGK1;TLK1;PIKFYVE;PRKCH;RPS6KA2;ERN1;MAPKAPK3;IKBKE;PLK2;PDPK1;PRKCD;SRPK2;RIPK1;PKN3;DYRK1A;TOP1;HIPK1;HIPK2;CSNK2A2;ROCK1;GSK3B;PKN2;PAK2;DCLK3;PRKCB;STK38;DYRK2;GAS6;DGKQ;MAST4;UHMK1;TNKS;LATS1;PRKCG;CAMK1;CSNK2A1;CSNK1G1;STK4;STK32C;TLK2;TBK1;MKNK2;CAB39
prerank,regulation of response to cytokine stimulus (GO:0060759),0.447580362407051,1.0614892004610967,0.3946629213483146,0.747332736778845,1.0,5/19,9.88%,IRAK2;MAP2K5;MAPK7;CBFB;MAVS
prerank,mitochondrial translation (GO:0032543),0.3569323699477835,1.0614585111817132,0.39186295503211993,0.7469312330566723,1.0,40/104,26.80%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL1;MRPL14;MRPL32;MRPL36;MRPS35;MRPS28;MRPL30;MRPL28;MRPS21;IARS2;MRPL19;MRPL44;QRSL1;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31;MTIF2;MTIF3;MRPS2;MRPL16;MRPS18B;MRPL42;GATB;MRPL54;MRPS18C;MTRF1L;MRPS22
prerank,activation of protein kinase activity (GO:0032147),0.3517879557586581,1.0614460933772922,0.3665254237288136,0.7464964691012618,1.0,21/106,16.07%,OSBPL8;VEGFA;TXN;PIBF1;TAOK3;PDPK1;PRKCD;IGF1;ADCY7;STK3;TNIK;PRRC1;PTK2B;PAK2;MT3;GAS6;SLC11A1;ADCY8;ADCY3;MAPKAP1;TRAF2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.34746374203122327,1.0612513861340744,0.38509316770186336,0.7464911820149795,1.0,25/124,14.47%,LRP12;APOE;DTNBP1;LIMA1;STX3;MICALL2;ERCC6;IL6;FRY;ZFYVE27;TBC1D23;WDPCP;MICALL1;RB1;PPP1R9B;VAPA;PLEKHA1;ROCK1;GSK3B;TBC1D24;APP;PQBP1;GDNF;UHMK1;UNC5A
prerank,Golgi to plasma membrane transport (GO:0006893),0.378221605086085,1.0609301995993412,0.3745541022592152,0.7468750046805603,1.0,18/47,21.42%,OPTN;RABEP1;RAB31;RAB10;VPS35L;ARFGEF2;MACF1;ARL3;GOLPH3;EXOC4;GOLPH3L;GOLGA4;GGA2;EXOC1;GOPC;BBS1;VAMP2;GGA3
prerank,regulation of stem cell proliferation (GO:0072091),0.4547030545013784,1.0607821189208806,0.40680272108843535,0.7467677354156149,1.0,5/17,21.13%,HNRNPU;AGO3;FBLN1;ACE;PTPRC
prerank,pre-replicative complex assembly (GO:0036388),0.3672434674775042,1.0607344108581378,0.3922902494331066,0.7464203066432945,1.0,23/64,26.36%,PSMD1;RPS27A;UBC;PSMF1;PSMD14;PSMD12;PSME2;ORC1;ORC4;CDT1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;PSMC5;ORC6;MCM3;PSMC1
prerank,negative regulation of nuclear division (GO:0051784),0.5067160880264321,1.0606278627591292,0.41515151515151516,0.7462493750273584,1.0,3/11,18.99%,TOM1L2;AURKAIP1;FBXO5
prerank,iron-sulfur cluster assembly (GO:0016226),0.43093858211981456,1.0606048069699048,0.3955026455026455,0.7458444860938293,1.0,11/24,25.50%,ABCB7;NUBP2;NUBP1;GLRX3;CIAO2B;CIAO2A;NFS1;GLRX5;HSPA9;FXN;CIAO1
prerank,DNA repair (GO:0006281),0.3342828314109422,1.0601487210770995,0.3697394789579158,0.7465701459970726,1.0,86/284,23.45%,EYA1;ERCC6;MUS81;RFC3;MUTYH;UVRAG;PARP4;ZRANB3;KPNA2;GTF2H5;BRIP1;BACH1;PARP2;FAM111A;GADD45A;BABAM2;ASCC2;PARP3;DOT1L;PMS1;RPS27A;UBC;NEIL1;BRCA1;PIAS4;EME1;ENDOV;WDR33;RAD23A;SMC1A;VCPIP1;HUWE1;POLH;XRCC4;XRCC5;DDB1;ASCC1;XRCC2;FTO;POLL;SIRT1;MBD4;INIP;NBN;DCLRE1B;TDP2;KMT5B;WRN;NSMCE3;FBXO6;ERCC6L2;POLA1;RNASEH2A;INO80;MNAT1;NSMCE4A;BRCC3;CENPX;FANCA;TEX264;BAZ1B;ALKBH1;POLI;UBE2V1;ALKBH5;RAD21;ATXN3;PDS5A;MRE11;USP3;TNKS1BP1;CUL4B;RAD51B;XPC;APEX2;FANCM;MGMT;RPAIN;PRKDC;XRCC1;VCP;RNF168;SMUG1;POLD1;ERCC4;SPRTN
prerank,protein polymerization (GO:0051258),0.3712152622604004,1.05927117962925,0.39838337182448036,0.7483376611354992,1.0,8/55,6.62%,DIAPH1;MICALL2;MSRB1;PSTPIP1;UBE2K;GPX4;RNF135;CHMP2A
prerank,defense response to symbiont (GO:0140546),0.35683400777565794,1.0591594719008537,0.40552016985138006,0.7481601479558013,1.0,19/92,16.53%,LYST;TLR8;LILRB1;ATG7;IFITM1;IL6;IFNAR2;RNASEL;IRF2;IFITM2;MAVS;CNOT7;BST2;PQBP1;RELA;ACOD1;BNIP3;MYD88;IFIT2
prerank,regulation of protein transport (GO:0051223),0.42385896928301064,1.058364677677893,0.4018324607329843,0.7496992658630844,1.0,12/27,25.24%,LCP1;RHBDF2;STXBP5;WWP2;GAPVD1;PTPN1;SNX3;DNAJA1;NDFIP1;DNAJC1;ATP13A2;DISP1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.4690270999387336,1.0578120178525068,0.38945827232796487,0.7507147683502603,1.0,3/14,11.96%,MAP2K5;THBS1;NOTCH1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.34210193488367296,1.057753272063523,0.3604887983706721,0.7503898122833399,1.0,59/173,24.33%,F7;DYNC1H1;RANGRF;MCFD2;F10;CUL3;VTI1B;YIF1A;PROC;COG7;PGAP1;STX5;YIF1B;TRAPPC5;RAB1B;FOLR1;CTSZ;TICAM2;VAPA;CAPZB;VTI1A;BET1;TRIP11;KDELR2;ATL2;GAS6;WHAMM;COG5;RAB2A;TRAPPC6A;RAB29;CAPZA1;COG2;ARF4;BCAP29;ARFGAP2;GOPC;SEC31A;RAB1A;BCAP31;ERGIC2;SEC24C;SEC24B;PEF1;PREB;COG6;TRAPPC2L;TRAPPC8;DYNC1LI2;KLHL12;TRAPPC1;TMED3;TMED10;TFG;GOLT1A;DCTN4;STX17;SPTBN5;COPB1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3498448820934172,1.0577523928565988,0.3820704375667022,0.7499235678112429,1.0,23/101,16.59%,LILRB1;VIM;IL36G;NR1H3;ADAM9;IL6;CD274;TNFRSF1B;LY96;SHPK;NFKBIB;STAP1;SIRPA;NFKBIL1;TICAM2;TRIM41;RELA;TNFAIP3;ACOD1;LBP;CDC73;MYD88;CHMP5
prerank,regulation of mitotic nuclear division (GO:0007088),0.37782152907683464,1.0574481194475733,0.39976415094339623,0.7502431686537258,1.0,5/55,5.10%,CCDC8;KIF20B;CD28;TOM1L2;IGF1
prerank,regulation of intracellular signal transduction (GO:1902531),0.3308577894036049,1.0570690331492416,0.3353353353353353,0.7507508466352731,1.0,97/420,18.44%,ARHGAP24;ARHGAP10;ARHGAP21;ABR;SGK1;ARHGAP19;VWF;OPTN;ARHGAP15;VAV3;VEGFA;PRKAG2;WWC2;TAOK3;SOS1;PDPK1;RHOJ;ARAP2;ARHGAP9;RFC3;ARHGAP31;MYO9B;PHF20;GNA13;PTEN;BRIP1;TAF7;GNA12;SPHK2;STK3;FLCN;ARAP1;BRCA1;TAF5;NF2;XIAP;AKAP13;VAV1;HIPK1;TRIP10;CHD3;DLC1;BRD7;ARHGAP18;HIPK2;STYXL1;CSNK2A2;TNIK;ARHGAP17;RHOD;FBXO9;FAM13B;BIRC3;PAK2;ARHGEF2;NBN;TRAF1;ZFAND6;TREM2;WRN;RNF34;RELA;DYRK2;TRAF3;CASTOR1;RBBP7;OCRL;MCF2;SOS2;RRAS;SQSTM1;FGD3;PAK1IP1;TRAF5;ATP6AP2;MAPKAP1;SMYD2;DEPDC1B;TMBIM4;TRAF2;BST1;GPAT3;BRPF1;ARHGAP25;MYO9A;PIP4K2A;TAF15;SGMS1;CSNK2A1;TEK;AKAP7;ITSN1;BIRC2;TTC5;STK4;NOC2L;PPP2R5C
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5007285350810905,1.0567234035937254,0.43377001455604075,0.7511858929677211,1.0,4/11,18.01%,RIPK1;BIRC3;ARHGEF2;BIRC2
prerank,canonical glycolysis (GO:0061621),0.42589528945732186,1.0565601255947779,0.39342105263157895,0.7506803550329971,1.0,10/24,24.02%,HK3;TPI1;ENO3;FOXK1;PFKP;GAPDHS;PFKM;GCK;PKM;HK1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.42589528945732186,1.0565601255947779,0.39342105263157895,0.7506803550329971,1.0,10/24,24.02%,HK3;TPI1;ENO3;FOXK1;PFKP;GAPDHS;PFKM;GCK;PKM;HK1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.36450914470822215,1.0564062469643882,0.3951165371809101,0.7505878305787176,1.0,14/72,15.84%,GALNT3;GRB2;POLR2A;KIF16B;FGFR4;POLR2L;POLR2G;POLR2I;NCBP2;HNRNPM;GTF2F2;CBL;FRS2;FLRT1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3138377827115939,-1.0563851118162884,0.350253807106599,0.7773767192468397,1.0,15/33,20.34%,CCND3;RPTOR;PLCB1;AIF1;EGFR;PHB2;EZH2;PAF1;HYAL1;UBE2E2;FGF10;RGCC;PLCG2;STXBP4;EIF4G1
prerank,substantia nigra development (GO:0021762),-0.30567541309402346,-1.0562781316228609,0.35353535353535354,0.775511949968073,1.0,15/37,22.00%,MBP;PADI2;BASP1;GLUD1;INA;SIRT2;YWHAH;RHOA;ATP5PF;SUDS3;RAD1;TTBK1;CKB;COX6B1;GNB4
prerank,positive regulation of protein import (GO:1904591),0.4097806746650514,1.0559068060490615,0.3979460847240051,0.7513418891663499,1.0,13/30,26.13%,IPO5;PRKCD;TPR;MAVS;HCLS1;RBM22;EFCAB7;DMAP1;PDCD5;FLNA;BAG3;UBR5;ZIC1
prerank,phospholipid catabolic process (GO:0009395),0.4303079534609843,1.0558591537710722,0.4189723320158103,0.7510023357973157,1.0,6/24,14.95%,LIPG;GPCPD1;PLA2G4F;PLBD2;GDE1;PRDX6
prerank,endocardial cushion development (GO:0003197),-0.3576659269450822,-1.0557228958380307,0.3745173745173745,0.7749745676580052,1.0,6/21,12.48%,ACVR1;BMPR1A;ENG;MDM4;TGFB2;CRELD1
prerank,positive regulation of cellular protein localization (GO:1903829),0.36717703158461046,1.055579789675724,0.3970917225950783,0.751256918133887,1.0,14/69,15.35%,GPR137B;STX3;TFRC;RANGRF;SESN2;GPD1L;APC;GTSE1;TYROBP;SNX33;GSK3B;PRKN;PARD6A;RTN4
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.45872957940226833,1.055198307675612,0.411522633744856,0.7517825759897587,1.0,7/16,22.63%,PIBF1;NF2;INPP5F;PPP2CA;BCL3;PPP2R1A;ADIPOR1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4136370419128513,1.054596219178669,0.40076335877862596,0.7528647415427242,1.0,12/26,26.50%,SMYD5;TET3;ETFBKMT;TET2;KMT5B;SUV39H2;KMT2A;OGT;SETD3;SETD5;KMT2D;SETD1B
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.34814285411273604,-1.0545702162087314,0.36101083032490977,0.7761666963618641,1.0,7/23,16.35%,ANK2;UBASH3B;ATP1A2;NOS1AP;PRNP;CACNA2D1;CACNB1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3662085739501284,1.053979338798933,0.39325842696629215,0.7540376250658597,1.0,13/65,15.36%,GRB2;RHBDF2;DUSP3;STAM;MVB12B;PTPN12;ARAP1;SH3KBP1;RNF115;AFAP1L2;EPS15;STAM2;CBL
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.36086908076403446,1.053375970681991,0.3900789177001127,0.7550959760016751,1.0,7/76,4.93%,HTR2B;HRH1;ADRA1D;ADRA1A;TGM2;GPR157;C3AR1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.4115870102668931,1.0531978304900533,0.4069767441860465,0.7550790772937157,1.0,12/28,26.13%,IPO5;PRKCD;TPR;MAVS;HCLS1;RBM22;EFCAB7;DMAP1;FLNA;BAG3;UBR5;ZIC1
prerank,regulation of insulin secretion (GO:0050796),-0.24699622159712484,-1.0531899682869246,0.2923076923076923,0.7777838825215436,1.0,24/101,14.77%,EPHA5;CACNA1E;KCNC2;ITPR2;CACNA1C;IRS1;SNAP25;SYT7;LRP5;RAPGEF4;ACSL4;REST;CACNA2D2;PICK1;RFX3;GLUD1;LRRC8A;MYRIP;TM7SF3;PRKCA;DPP4;BAD;STX1A;RAPGEF3
prerank,motile cilium assembly (GO:0044458),0.49115969586777575,1.0522990981043643,0.42503639010189226,0.7569822335885072,1.0,2/12,5.75%,CCDC40;DNAAF3
prerank,synaptic vesicle localization (GO:0097479),-0.40572043735843777,-1.05208659565343,0.3782051282051282,0.778832034287548,1.0,4/13,8.36%,NLGN1;RAB27A;KIF5A;SYNDIG1
prerank,glycerol metabolic process (GO:0006071),0.5030314877907422,1.0519227967602884,0.42476489028213166,0.7575030515027961,1.0,6/10,24.09%,TPI1;TKFC;PGP;GK5;GK;GOT1
prerank,canonical Wnt signaling pathway (GO:0060070),0.36269102251155266,1.051916417669454,0.38764044943820225,0.7570506917284588,1.0,11/68,14.56%,PLPP3;CTNNB1;PTEN;APC;DVL1;FZD7;GSK3B;FZD5;FZD2;PPP1CA;LRP6
prerank,cellular response to interleukin-4 (GO:0071353),0.5108693953083545,1.0518599420266979,0.41437308868501527,0.7567371005124333,1.0,3/10,19.30%,SHPK;JAK3;STAT6
prerank,positive regulation of protein modification process (GO:0031401),0.33833996605212985,1.051824056726382,0.381243628950051,0.756353877696168,1.0,26/203,11.57%,GPNMB;RAP2A;ATG7;VEGFA;FLOT1;TXN;FNIP1;TFRC;HGF;PRKCD;FAS;RIPK1;ATG10;RAB3GAP2;FLCN;DYRK1A;SOX9;ACVR2A;DLC1;TNIK;MAVS;ADAM17;SIRT1;CCN1;MT3;APP
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4345409468435824,1.051784411298131,0.42650918635170604,0.7559914828175738,1.0,5/21,13.12%,MITF;JUN;MED12;MED16;BCLAF1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.443150694721748,1.051556395604623,0.41621621621621624,0.756140034906182,1.0,8/20,20.30%,FAS;GSK3B;APPL1;BAX;MCL1;CASP2;CASP3;ITGAV
prerank,osteoclast differentiation (GO:0030316),0.43289744472852454,1.0512747143261714,0.4156378600823045,0.7563741768713359,1.0,6/22,12.31%,GAB2;SNX10;ANXA2;FOXP1;TYROBP;TREM2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3005771657076718,-1.0512363502447566,0.32,0.7791719468048386,1.0,9/34,12.29%,P2RY12;IRS1;FGF2;FLT3;PRKD1;ATG14;DAB2IP;PIK3R2;PIK3R3
prerank,negative regulation of cell differentiation (GO:0045596),0.33630576944919977,1.0510962750612254,0.38922764227642276,0.7563807149841918,1.0,25/181,11.99%,PPARG;ABCA1;XDH;HOPX;ABCG1;NR1H3;ID2;IL6;ENPP1;PTEN;E2F1;TNN;HNRNPU;EIF2AK4;ZFP36L2;ANP32B;SOX9;SNAI2;RB1;COL5A2;PTK2B;FOXO1;SIRT1;NOTCH1;RORA
prerank,lymphocyte chemotaxis (GO:0048247),-0.3045512630731785,-1.050874389595187,0.3544973544973545,0.7780262207642635,1.0,5/34,7.30%,SLC12A2;GPR183;CYP7B1;CCL4;CXCL16
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.43849610518115495,1.0507360136679829,0.42105263157894735,0.7568276378231076,1.0,9/21,25.44%,BCL2L11;DDIT3;PRKN;HSPA1A;CREB3;CREB3L1;HERPUD1;BCL2L1;TXNDC12
prerank,positive regulation of JUN kinase activity (GO:0043507),0.4327103051440244,1.0503757057673038,0.4262295081967213,0.7572664021018494,1.0,2/23,2.86%,SASH1;TAOK3
prerank,positive regulation of synaptic transmission (GO:0050806),-0.25794195573437445,-1.0501690706088955,0.35789473684210527,0.7778619230416807,1.0,23/72,17.28%,GRIN2A;NRXN1;SYT1;NLGN1;RIMS1;GRIN2B;SLC24A2;RIMS2;GRIK2;RELN;TSHZ3;FMR1;CACNG4;NLGN3;NMU;ADCY1;GRIN2D;CACNG3;AKAP5;CCR2;CACNG2;SHISA7;TNF
prerank,glycerolipid catabolic process (GO:0046503),0.4476760442388799,1.049291264249337,0.42954856361149113,0.7595451648255211,1.0,6/19,17.97%,MGLL;GPCPD1;PLA2G4F;GDE1;PRDX6;LYPLA2
prerank,regulation of defense response to virus (GO:0050688),0.4681252217513356,1.04910062903952,0.3946980854197349,0.7595814141661871,1.0,4/14,18.09%,RNF26;TRAF3;TNFAIP3;C1QBP
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4914340205066045,1.0490831329032484,0.40672782874617736,0.7591542504324843,1.0,5/12,22.22%,IDH1;IDH3G;IDH3B;IDH2;ACO1
prerank,protein modification by small protein removal (GO:0070646),0.33275797331292706,1.049045763537686,0.3834510595358224,0.7587927704244253,1.0,78/252,22.26%,GPS1;TNIP1;PSMD1;RIPK1;ASXL2;PTEN;FOXO4;STAM;BABAM2;SENP3;APC;RNF128;TOMM20;RPS27A;UBC;BRCA1;USP42;RAD23A;USP12;VCPIP1;COPS5;SENP5;ESR1;FOXK1;BIRC3;USP40;USP26;CCNA2;PSMF1;USP48;PSMD14;PSMD12;COPS7A;KDM1B;TRAF3;USP21;USP16;TNFAIP3;PRKN;RNF123;USPL1;MCRS1;PSME2;INO80;STAM2;USP36;CCP110;BRCC3;ASXL1;USP8;TRAF2;NFRKB;OTUD5;SENP7;KEAP1;PSMB10;PSMD5;USP32;SNX3;SENP1;BIRC2;CDC25A;PSMD8;PSMA3;USP30;PSMA2;ATXN3;STAMBP;PSMD11;PSMA6;USP3;OGT;TOR1A;USP9X;KAT2A;USP2;PSMB3;VCP
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.3486701230543169,1.048680490670322,0.40086206896551724,0.7592410036171718,1.0,34/94,26.36%,ST18;IRAK2;PSMD1;IRAK3;RPS27A;UBC;MAP3K8;PSMF1;PSMD14;TAB2;PSMD12;RELA;SQSTM1;PSME2;CUL1;MYD88;PSMB10;PSMD5;UBE2V1;PSMD8;PSMA3;PSMA2;PSMD11;PELI2;PSMA6;PSMB3;PSME3;IRAK1;TRAF6;PSMC5;TAB1;MAP3K7;TAB3;PSMC1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.38105212273969336,1.0478856880163063,0.4117647058823529,0.7607925422062893,1.0,17/48,25.84%,ZMIZ1;ERCC6;SPHK2;POLR2L;TAF1B;POLR1A;SMARCD1;BAZ1B;TAF1A;ATAD2B;PHF2;KAT2A;MYO1C;ELOF1;ACTB;KAT2B;POLR2F
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3847255797751966,1.0474950393157558,0.4127557160048135,0.7613312008634656,1.0,16/42,24.11%,FARS2;DARS1;TARS3;NARS2;EPRS1;SARS2;SARS1;TARS2;IARS2;PARS2;CARS2;AIMP1;IARS1;FARSA;WARS2;LARS1
prerank,protein localization to organelle (GO:0033365),0.34439538184113816,1.0474458389346213,0.40209424083769635,0.760991362537052,1.0,20/133,9.01%,OPTN;PIKFYVE;LAMP1;SNX10;RAB33B;LMNA;SORL1;TSPAN17;COL1A1;GAK;COG7;STX5;LMBRD1;HMOX1;MICALL1;LAMP2;DVL1;VAPA;TOPORS;CYB5A
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.35508393609034716,1.0474069399819288,0.4069264069264069,0.7606229267009353,1.0,16/87,15.84%,GALNT3;GRB2;POLR2A;CD44;KIF16B;FGFR4;ZFP36L2;POLR2L;POLR2G;POLR2I;NCBP2;HNRNPM;GTF2F2;CBL;FRS2;FLRT1
prerank,regulation of phosphorylation (GO:0042325),0.3445057998141503,1.0473839271131113,0.4161425576519916,0.7602108180976264,1.0,37/120,23.63%,FNIP2;SDCBP;FNIP1;CORO1C;PRKAG2;CDKN1A;SESN2;THBS1;EIF6;FLCN;STAP1;DSCAM;TPR;FZD7;ROCK1;NUP50;SIRT1;APP;PHIP;NUP98;NRP1;CCDC88C;ZBTB7A;KCTD20;PPP2CA;NUP88;GCK;OGT;NUP188;NDC1;NUP43;NUP54;ILK;RANBP2;CDH5;BCL10;SLAMF8
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.380804327162336,1.0473498535636547,0.41317365269461076,0.7598269287372759,1.0,17/46,24.02%,CHCHD4;TIMM22;PITRM1;TIMM17A;TOMM20;TIMM17B;GDAP1;HSPD1;TOMM34;TOMM7;TOMM22;FBXO7;BCAP31;MFN2;AIFM1;AIP;HK1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.36337505374063306,1.0468263235605704,0.4165733482642777,0.7606793090522458,1.0,12/61,12.63%,EYA1;ERCC6;HGF;FGFR4;BABAM2;SIRT6;PARP3;BRCA1;RTEL1;SIRT1;NBN;WRN
prerank,positive regulation of type 2 immune response (GO:0002830),0.4773189533162879,1.046696896745089,0.43453237410071943,0.7605523009697822,1.0,3/14,8.09%,IL6;RARA;DENND1B
prerank,negative regulation of response to stimulus (GO:0048585),0.3673423698188402,1.0466939347782334,0.40940366972477066,0.7600984808609037,1.0,21/60,22.86%,FOXP3;NR1H3;FCRLB;APPL2;MAP2K5;BRAP;MAPK7;PIM3;SIRT1;VPS13C;LPCAT3;COL3A1;MCTP1;ZKSCAN3;PTPN1;FBXO5;WFS1;FCGR2B;NR1H2;IGFBP3;CDK6
prerank,regulation of centrosome duplication (GO:0010824),0.4050490641425317,1.0463439130623013,0.41419354838709677,0.7604985791177744,1.0,8/29,16.59%,PLK2;CHMP2A;PDCD6IP;NAT10;SIRT1;CEP76;ALMS1;CHMP5
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.39397057182260203,1.046225579098022,0.418227215980025,0.76032543900322,1.0,8/36,12.71%,CTNNB1;AGO2;TNRC6B;PPP3CA;PPP3R1;AGO3;FZD5;FZD2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.39407866422247056,1.0456613591679091,0.4201474201474201,0.761311126081244,1.0,8/34,18.09%,NEDD9;DOCK5;TRIOBP;RREB1;OLFM4;DOCK1;NRP1;C1QBP
prerank,regulation of cell-matrix adhesion (GO:0001952),0.362705368223304,1.0452407294169554,0.4244851258581236,0.7618734738958138,1.0,18/64,20.27%,CD36;CORO1C;DUSP3;THBS1;NF2;PLAU;ROCK1;GSK3B;PTK2B;MACF1;CLASP1;CX3CL1;UTRN;BST1;ACER2;CCL25;PIK3CB;ACTG1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.488030722499861,1.0448601111268825,0.43032159264931086,0.7619711782745103,1.0,3/12,13.07%,HOMER3;GSK3B;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.488030722499861,1.0448601111268825,0.43032159264931086,0.7619711782745103,1.0,3/12,13.07%,HOMER3;GSK3B;DYRK2
prerank,gene silencing by miRNA (GO:0035195),0.4064286389442179,1.0448112591499812,0.4180645161290323,0.761636132673698,1.0,9/32,14.92%,AGO2;EIF6;TNRC6B;CNOT7;AGO3;PUM2;SPOUT1;LIMD1;CNOT6
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.4198491596692461,1.044769232634474,0.4251968503937008,0.7612808433808973,1.0,8/25,16.30%,FOXO3;STAT5B;HSPA1B;ACVR2A;ACVR1B;FAM210B;HSPA1A;BRD1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.43900730067904714,1.0447001634539685,0.4243243243243243,0.7610066551819863,1.0,9/20,25.11%,AGO2;AGO3;DROSHA;PUM2;SPOUT1;MRPL44;AGO4;TSNAX;ZC3H7A
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.39781463408175244,1.0444925301700323,0.4218551461245235,0.761083412432063,1.0,11/30,21.42%,OPTN;RAB31;RAB10;MACF1;GOLPH3;GOLPH3L;GOLGA4;GGA2;BBS1;VAMP2;GGA3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.36911078173691525,1.0444654411264818,0.41676234213547647,0.7606872527647026,1.0,10/59,17.89%,BAAT;LIPG;AMACR;OSBPL1A;ACSM3;NDUFAB1;CYP46A1;ALDH1A2;CYP27A1;CBR4
prerank,negative regulation of cell migration (GO:0030336),0.3420309104457535,1.0439625615906603,0.4192546583850932,0.7615044415283891,1.0,32/137,15.42%,TIMP1;MITF;RAP2A;CORO1C;LRP1;IFITM1;FOXO3;PTEN;CITED2;DUSP3;ZMYND8;DAG1;TNN;STK24;FLCN;HMOX1;NF2;MCC;DLC1;ACVRL1;DACH1;RAP2B;BST2;SULF1;ARID2;COL3A1;MCTP1;PODN;CLASP1;CX3CL1;PFN2;ADARB1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4175730710546616,1.0436589655007182,0.3912466843501326,0.7618359135105052,1.0,9/23,22.77%,RANGRF;NPLOC4;TECPR2;FAF2;DERL2;TMEM129;PREB;VCP;HERPUD1
prerank,RNA biosynthetic process (GO:0032774),0.4052279831888156,1.0435162589610913,0.42278481012658226,0.7617249436963615,1.0,10/31,18.57%,POLR2A;GTF2B;TAF7;HELB;TAF5;POLA1;NAT14;SMN1;TTF1;NCOA6
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.33184429892907186,1.0434114341920953,0.39375629405840884,0.7615380898743825,1.0,63/264,16.61%,DHX8;POLR2A;ALYREF;PLRG1;TFIP11;HNRNPH2;CPSF1;SRPK2;SCAF11;CLNS1A;RNPC3;RBM41;HNRNPUL1;DDX5;CSTF3;CTNNBL1;HNRNPU;PRPF8;SNRNP200;POLR2L;WDR33;ISY1;SNRNP25;SART1;HNRNPA0;SF1;PPIH;WDR77;PSPC1;POLR2G;PRPF6;DDX23;POLR2I;NCBP2;HNRNPM;SRSF3;SYF2;ZMAT5;CWC27;GTF2F2;SF3A3;PQBP1;SNRNP35;DDX20;CWF19L2;RSRC1;BUD31;SUGP1;RBM10;PPIE;WBP11;SNRPF;HNRNPD;MTREX;EIF4A3;ZRSR2;PCBP1;DDX39A;SMN1;PUF60;SYNCRIP;DHX38;CCAR1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3509908980240236,-1.0431547769096192,0.3678571428571429,0.7956895145245243,1.0,2/19,3.73%,CAMK1D;RIPOR2
prerank,microvillus assembly (GO:0030033),0.4766083302327784,1.042894477649738,0.4375,0.7623696104299359,1.0,3/14,10.22%,RAP2A;TNIK;RAP2B
prerank,ncRNA processing (GO:0034470),0.332409631089375,1.0426627326150737,0.4002016129032258,0.762503101847019,1.0,54/200,19.06%,C1D;FARS2;EBNA1BP2;MPHOSPH10;BYSL;AGO2;SENP3;RPL18A;INTS9;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;NOP14;INTS6;EXOSC3;TEX10;WDR18;POP4;EXOSC9;WDR74;INTS1;RPL22;NOB1;DKC1;INTS8;AGO3;DROSHA;EXOSC8;NOL8;SARS1;RPL10A;KRR1;INTS2;INTS5;INTS7;MRPL44;MRM2;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;PWP2;AGO4;UTP15;RCL1;DHX37
prerank,inorganic anion transport (GO:0015698),0.3692543979205312,1.042262752291327,0.42905788876276957,0.7630948259087155,1.0,9/53,17.12%,SLC26A11;ANO6;ENPP1;SLC26A1;SLC5A5;XPR1;SLC11A1;CLIC1;CLCN4
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3240337369506789,1.0421812612406736,0.247,0.7628386004178072,1.0,395/1668,22.16%,EPAS1;PPARG;FNIP2;MMP12;ANXA4;SDCBP;NAMPT;TFEC;APOE;MRTFA;LITAF;MRTFB;ELF2;ZMIZ1;ATP1B4;IRX3;FRK;RCOR1;TFEB;HOPX;LPIN3;LILRB1;TRPS1;NFE2L2;ZNF3;CTNNB1;MITF;NCK2;VEGFA;FNIP1;CEBPB;ZEB2;ATXN1;GRHL1;FOXP3;EN2;DNMT3A;IER5;ST18;KDM4C;ATF3;VEZF1;WWC2;RUNX2;ARID4A;NR1H3;GATAD2A;E2F3;LMO1;ID2;IL6;HGF;TOX4;CDKN1A;FOXO3;TNIP1;LIN37;CBX8;BAZ1A;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;MED12;RIPK1;ASXL2;NCOR1;PHF20;MAP2K5;RARA;ZFP28;MZF1;PID1;PTEN;CITED2;GTF2H5;FOXO4;BRIP1;BACH1;E2F1;TAF7;IGF1;ZBTB42;MAPK7;MAML1;STAT5B;SAP30;AGO2;GADD45A;RNF10;NUFIP1;GLMP;NR3C1;SIRT6;TCERG1;RNASEL;EED;CRTC1;MAML2;NR1H4;DDX5;CREBBP;BHLHE40;RPS14;MLLT10;DOT1L;FLCN;TET3;HNRNPU;KLF5;TGIF1;ATF4;NIPBL;REL;IFRD1;MED15;KDM3A;RPS27A;UBC;RITA1;ZBTB20;BRCA1;ZNF177;RPL23;ETV6;BAZ2B;RREB1;POU3F1;UXT;PIAS4;JMJD1C;BRD2;TCF20;SOX9;ACVR2A;ACTR3;RPAP2;SNAI2;RBAK;RB1;NEDD4L;HOXA3;LCOR;EPC1;WWP2;ABCA2;ZNF148;GABPB1;GABPB2;FOXP1;IRF2;DVL1;CHD3;NCOA3;CBFB;ACVRL1;CARF;BRD7;ARID5B;COPS5;TBL1XR1;CHD2;DACH1;HIPK2;NCOA1;TNRC6B;PPP3CA;TET2;NR5A1;BMPR2;TPR;PAXBP1;DDIT3;BRD3;MAVS;PAX8;ESR1;NR2C1;WDR77;HCFC2;PPP3R1;VPS72;FOXK1;KDM2A;MAFG;POU3F3;FOXO1;MED16;AGO3;SIRT1;MAFB;CDK7;PRPF6;SALL2;ARHGEF2;MED26;CCN1;NFATC3;LARP7;PPARD;CUX1;ZNF691;LCORL;BCAS3;APP;PRKCB;FZD5;ZKSCAN7;SP3;NOTCH1;RORA;TBX6;CAMTA2;SARS1;RELB;SIRT7;DDX20;RFX1;MAZ;HCLS1;RFX5;SMARCC1;PPRC1;RELA;BUD31;KDM1B;BBX;BCLAF1;DGKQ;USP16;SOX2;BCL11B;CTDP1;HBP1;POU2F1;SLC11A1;PRKN;ZKSCAN3;FOXJ3;SMARCD1;DCAF1;PGBD1;SUV39H2;JUNB;GDNF;ATF1;ZKSCAN5;CX3CL1;SQSTM1;KDM7A;PRDM2;PHIP;ZNF513;BAX;LRP6;MCRS1;CREG1;ID4;EID1;PER3;INO80;RPL10;SNF8;MNAT1;ZFP64;TNKS;SSU72;WASL;ETV3;ARRB1;CDK8;SMYD2;ASXL1;PCBP1;PPARGC1B;PHF20L1;CDC73;HSPD1;NHLH2;KLF6;WWOX;ZNF32;MYT1;MTF1;THRAP3;TCF12;NFATC2IP;CAMK1;CREB3L4;CREB3;BAZ1B;BRWD1;ELP4;PLAGL2;ZNF18;CRY1;ZBTB7A;NKX2-1;ARF4;SMARCB1;ZBTB41;GABPA;NFYC;CREB1;ZNF23;CIR1;SENP1;C1QBP;ZBTB7B;ZNF319;NOC2L;E2F2;HOXD8;BBS7;AGO4;CLOCK;NCOA6;FLI1;SOX8;KLF8;RAD21;CRTC3;NFX1;ZNF431;NCOA2;ATAD2B;CDK13;MCPH1;ZBTB40;KMT2A;STAT6;NFIC;HDAC8;METTL23;WFS1;PPP1R13L;CREB3L1;TBK1;NR2F1;AKIRIN1;OSM;PURB;PRDM16;WWTR1;ZNF367;PIAS2;EFCAB7;TCF7L2;TCF4;SP8;PHF2;SPEN;PFKM;HSF2;BCL11A;NFE2L3;SREBF1;SSBP4;SIN3A;OGT;HES5;JMJD6;ZFP62;ZBTB16;FUBP3;HSBP1;MLXIP;PIAS1;MGA;NPAS2;SAFB;EHMT2;MYPOP;HNF4G;DMAP1;CEBPA;MBD2;TAF1;NR1H2;ZBTB24;TARBP1;USP9X;KAT2A;MAMLD1;IER2;RARB;PRKDC;MED31;USP2;CBX5;CCNT1;POU6F2;RUVBL2
prerank,positive regulation of vascular permeability (GO:0043117),0.48511408745015466,1.0418432047324266,0.4329446064139942,0.763241801903536,1.0,1/12,1.73%,VEGFA
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4693155284635178,1.0414751281775623,0.41424418604651164,0.7637078458877505,1.0,8/14,25.41%,AMACR;ABCD1;CRAT;EHHADH;DECR2;SCP2;ACOT8;HSD17B4
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.34404381881909146,1.0413770709815862,0.41966173361522197,0.7634901834989377,1.0,13/113,10.68%,HTR2B;MMP12;VEGFA;NOTCH2;IGF1;NRP2;NRAS;RREB1;SOX9;VASH2;BMPR2;FZD7;SIRT1
prerank,negative regulation of cell adhesion (GO:0007162),0.3618358122260422,1.0413537936788326,0.423728813559322,0.7631010127940823,1.0,12/72,11.96%,PLXNA1;PLXNC1;PLXND1;GCNT2;LPXN;NF2;SNAI2;ACVRL1;DSCAM;FZD7;FBLN1;NOTCH1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.4048933751639944,1.0412151179206977,0.4122137404580153,0.7629806537950466,1.0,10/29,16.82%,DDX6;EXOSC3;EXOSC9;PATL1;CNOT7;EXOSC8;NT5C3B;CNOT6;EDC3;EXOSC1
prerank,regulation of nervous system process (GO:0031644),-0.3609853902964243,-1.040732469487359,0.39568345323741005,0.8007348814791195,1.0,4/18,6.64%,HTR2C;DLGAP1;DLGAP2;AKAP9
prerank,necroptotic process (GO:0070266),0.4646608318691945,1.0403086168034694,0.43922651933701656,0.7647488776099068,1.0,4/16,13.49%,RIPK1;LY96;TICAM2;TRPM7
prerank,T cell differentiation (GO:0030217),0.3905670433554877,1.0402959960445342,0.4369747899159664,0.7643194177999943,1.0,8/40,16.91%,ANXA1;CD28;ZFP36L2;LFNG;ADAM17;GPR89A;GPR89B;CHD7
prerank,regulation of sodium ion transport (GO:0002028),-0.31045603522738735,-1.039979138329441,0.400990099009901,0.8007508120298755,1.0,13/34,13.77%,SNTA1;ANK3;FGF12;SCN1B;WNK3;SPTBN4;WNK2;DLG1;NKAIN3;WNK1;ATP2B4;YWHAH;NKAIN2
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.2795939812675049,-1.0398257670678943,0.4,0.7989646679198145,1.0,12/50,15.23%,PTCH1;SMO;FGFR2;MEGF8;INTU;RACK1;GLI3;ARMC9;TTC23;BTRC;ULK3;PDCL
prerank,hyaluronan catabolic process (GO:0030214),0.44698080080446256,1.0395108227371497,0.41793103448275865,0.7658508849751644,1.0,4/18,6.15%,CD44;STAB2;CEMIP2;HEXA
prerank,positive regulation of acute inflammatory response (GO:0002675),0.45914418778272453,1.039442130172327,0.44298245614035087,0.7655721332570634,1.0,2/14,5.77%,IL6;ADAM8
prerank,smoothened signaling pathway (GO:0007224),-0.30887983441894884,-1.0393618189826508,0.3755656108597285,0.7980472537291796,1.0,16/32,26.36%,PTCH1;SMO;GLI3;MAP3K10;TCTN3;PKD2L1;ULK3;IFT27;TCTN2;TTBK2;GPC2;DISP2;CC2D2A;EVC2;STIL;GLI2
prerank,regulation of peptide hormone secretion (GO:0090276),-0.2592875461472964,-1.0393521911992756,0.3217391304347826,0.7959152750985642,1.0,18/67,17.28%,CACNA1E;KCNC2;HTR2C;ITPR2;CACNA1C;SNAP25;SYT7;RAPGEF4;CACNA2D2;PICK1;RFX3;PRKCA;DPP4;STX1A;RAPGEF3;HFE;KCNG2;TNF
prerank,aorta morphogenesis (GO:0035909),0.45025863440249914,1.0393152185033094,0.4303448275862069,0.7654172912581508,1.0,4/17,12.21%,LRP1;TFAP2B;ACVRL1;MYLK
prerank,ncRNA export from nucleus (GO:0097064),-0.29814478867098565,-1.0390056050451466,0.3853658536585366,0.7947777405974707,1.0,12/36,14.68%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,regulation of cellular protein catabolic process (GO:1903362),0.44471278716461604,1.0389727986900672,0.44583333333333336,0.7658375391488691,1.0,8/18,22.90%,RIC1;WDR91;MSN;VPS11;NELL1;VPS35;FAF1;EZR
prerank,morphogenesis of an epithelium (GO:0002009),0.4150959542605995,1.038841033949741,0.43455497382198954,0.7657024722133524,1.0,11/25,26.46%,DAG1;SOX9;RIPK4;LRP6;LAMA3;SOX8;ACTG1;ARHGAP12;ACTB;LIN7C;KDM2B
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3739643043854541,1.0385999349223298,0.4257075471698113,0.7658488165041467,1.0,17/50,22.96%,PSMD1;OAZ2;PSMF1;PSMD14;PSMD12;PSME2;AZIN1;OAZ1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3
prerank,manganese ion transport (GO:0006828),0.46406790033932627,1.038040931074987,0.4353448275862069,0.7667581001561801,1.0,5/14,13.74%,SLC11A2;TMEM165;TRPC3;SLC39A14;SLC11A1
prerank,DNA replication (GO:0006260),0.34064586672098374,1.037542964197227,0.4095744680851064,0.767527074706039,1.0,21/105,16.14%,RBMS1;BAZ1A;MCM9;RFC3;BRIP1;FAM111A;MCMBP;HELB;POLG2;BRCA1;TOP1;POLL;DBF4;ING4;NBN;WRN;POLA1;RNASEH2A;ORC1;CDK2AP1;ORC4
prerank,positive regulation of behavior (GO:0048520),-0.42213971857661514,-1.0370902470693772,0.4084084084084084,0.7982157173098269,1.0,3/10,1.88%,MEF2C;NLGN1;SGIP1
prerank,DNA methylation (GO:0006306),0.43124670041993374,1.0368893061882911,0.4355909694555113,0.7687211799356534,1.0,12/23,28.37%,DNMT3A;GATAD2A;N6AMT1;KMT2E;DNMT1;MTRR;EHMT2;DMAP1;METTL4;BAZ2A;EHMT1;FOS
prerank,ERBB2 signaling pathway (GO:0038128),0.4003668298892898,1.0361554581538686,0.4419475655430712,0.770097840675628,1.0,8/31,14.61%,GRB2;SOS1;PIK3CA;PTPN12;NRG4;STUB1;ERBIN;SHC1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3590420846950234,1.0361485196381024,0.425764192139738,0.7696637045265463,1.0,29/80,22.52%,SAMD4A;ABCG1;VIM;IL6;CD28;PRKCD;YTHDF3;THBS1;EIF6;SPHK2;LARP4B;ABCA2;PICALM;NAT10;RELA;HNRNPD;EIF4A3;SIRT3;RPL26;CASP3;NSMAF;EIF3C;BCL3;LARP4;PCIF1;GSAP;EPHA4;PRKDC;UPF3A
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.41600887867689224,1.0360482236130588,0.40261437908496733,0.7694427279806173,1.0,10/25,24.02%,HK3;TPI1;ENO3;FOXK1;PFKP;GAPDHS;PFKM;GCK;PKM;HK1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.37595711440506013,1.035762493854646,0.42441860465116277,0.7696912713146273,1.0,14/52,16.82%,SAMD4A;DDX6;CNOT4;EXOSC3;CNOT6L;EXOSC9;PATL1;CNOT7;EXOSC8;NT5C3B;CNOT6;EDC3;PAN3;EXOSC1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.31769375145759765,-1.03544452680798,0.3794642857142857,0.8006126037306017,1.0,6/26,10.51%,VSIR;GRIN2B;MBP;GRIN1;PRELID1;PYCARD
prerank,protein destabilization (GO:0031648),0.3946638369342686,1.0353060299226333,0.42659974905897113,0.770388855007957,1.0,11/32,18.77%,CUL3;FBXL3;CREBBP;RAD23A;CTSH;SIRT1;PRKN;CDC73;CCDC88C;HTT;SERF2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.3185323282777799,-1.0350587626718193,0.3619047619047619,0.7996085848100684,1.0,7/29,13.66%,LDLRAD4;SPRED1;SMAD7;DAB2IP;HPN;SPRED2;SPRED3
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3970374950675376,-1.0349767416979683,0.40524781341107874,0.7977056704449592,1.0,3/13,9.74%,MAPT;NEFL;SPAST
prerank,gas transport (GO:0015669),0.49938131640480626,1.0348734580191992,0.4616519174041298,0.7710144467889359,1.0,3/10,16.84%,AQP1;MB;CA2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.3671401935777785,-1.0348517067178455,0.40441176470588236,0.7959514146853948,1.0,6/17,13.66%,SPRED1;PARD3;SMAD7;SPRED2;SIRT2;SPRED3
prerank,regulation of cartilage development (GO:0061035),0.4426709106483873,1.0344776301962866,0.4438356164383562,0.7715062498189347,1.0,7/18,25.38%,TRPS1;SOX9;BMPR2;ZBTB16;KAT2A;BMPR1B;SOX5
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5036363800563358,1.0343338516033105,0.4434108527131783,0.7714055486982289,1.0,2/10,6.20%,ABCD1;MLLT11
prerank,regulation of DNA replication (GO:0006275),0.37120184460102523,1.0343288147849408,0.41509433962264153,0.7709650894671657,1.0,20/49,22.92%,ANKRD17;ACVRL1;TERF1;CCNA2;NPM2;STN1;SMC3;ATAD5;CDT1;PPP2CA;FBXO5;BCAR3;PDS5A;PPP2R1A;EHMT2;GTPBP4;CDAN1;FAF1;WAPL;OBI1
prerank,embryonic organ morphogenesis (GO:0048562),-0.28777858952073043,-1.0341565432499458,0.36470588235294116,0.7957547155537058,1.0,14/42,21.65%,ACVR1;FGFR2;RYR2;MEGF8;RARG;FBN2;HOXD4;HOXD3;HOXC9;HOXA9;FOXE1;SOX11;HOXB9;DSCAML1
prerank,regulation of phagocytosis (GO:0050764),0.37014408014760525,1.0339857596103448,0.4235705950991832,0.771383216707618,1.0,17/53,21.13%,SYK;TGM2;MERTK;CYBA;SIRPA;OLFM4;IL15;TREM2;DOCK2;GAS6;FGR;SLC11A1;SNX3;FCGR2B;ITGAV;CD47;PTPRC
prerank,positive regulation of macrophage migration (GO:1905523),-0.35708584680117705,-1.0337224266287774,0.39792387543252594,0.7948488673216749,1.0,3/19,2.94%,P2RY12;CSF1R;CSF1
prerank,protein-containing complex assembly (GO:0065003),0.32804945253827367,1.033379920734193,0.41566265060240964,0.7724382061701228,1.0,86/259,24.87%,REPS2;CTNNB1;MITF;ANO6;SKAP2;PDZD11;FAS;MCFD2;SNX9;RIPK1;CUL3;CAPG;WDCP;LPXN;CREBBP;APC;STX5;DET1;PEX14;DARS1;TRAPPC5;RAB1B;FOLR1;SOX9;CTSZ;MEFV;PICALM;PPIH;GSK3B;PTK2B;BET1;CAND2;TUBGCP4;TRAF1;CDC123;EPRS1;SLC2A1;DNAJB14;VAMP3;SH3PXD2B;PPP6C;TRAPPC10;ADCY8;CX3CL1;CXCL12;CUL1;MNAT1;WASL;CD247;CDC73;FANCA;TRAF2;TRAPPC6A;CAPZA1;KPNA3;RANBP9;TAPBP;KMT2A;SEC31A;RAB1A;TCF7L2;VAMP2;AFG3L2;PPP2R1A;HES5;WIPF1;SEC24C;SEC24B;PEF1;ADAM10;PPP6R1;PREB;HGSNAT;TRAPPC2L;TLE3;KLHL12;TRAPPC1;TMED10;GSDMD;TFG;MEN1;ST13;CASP8;TRAPPC9;AFDN;TSPAN33
prerank,maturation of 5.8S rRNA (GO:0000460),0.44972590386636263,1.0332952807178386,0.44490358126721763,0.7721904788519082,1.0,8/17,26.40%,C1D;EIF6;MTREX;EXOSC10;WDR12;PRKDC;MPHOSPH6;EXOSC4
prerank,ribosome biogenesis (GO:0042254),0.3312626114850265,1.0330198020148276,0.4117647058823529,0.772438519956756,1.0,68/187,26.43%,C1D;EBNA1BP2;MPHOSPH10;BYSL;SENP3;RPL18A;EIF6;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;NOP14;EXOSC3;TEX10;WDR18;POP4;EXOSC9;WDR74;RPL22;NOB1;DKC1;MRPL36;EXOSC8;NOL8;CUL4A;RPL10A;KRR1;MRM2;PAK1IP1;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;MALSU1;PWP2;NOC2L;UTP15;RCL1;DHX37;XPO1;EXOSC7;CUL4B;RPS27;WDR43;GTF3A;FBL;BOP1;NOLC1;RPL7A;LYAR;XRN2;NOL6;RPL32;SNU13;RRP36;RPS9;MPHOSPH6;LSG1;DDX49;EXOSC4;WDR36
prerank,translational elongation (GO:0006414),0.348947437855816,1.0328260785101107,0.43567567567567567,0.7724743956867085,1.0,30/101,20.41%,MRPS26;MRPL20;EEF1A1;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL1;MRPL14;MRPL32;MRPL36;GTPBP2;MRPS35;MRPS28;MRPL30;MRPL28;MRPS21;MRPL19;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31;EEF1D
prerank,mRNA processing (GO:0006397),0.32712330771635956,1.0323904029561348,0.41624874623871616,0.773105806432928,1.0,67/287,16.61%,DHX8;ERN1;POLR2A;ALYREF;PLRG1;TFIP11;HNRNPH2;CPSF1;SCAF11;CELF1;GTF2H5;CHTOP;RNPC3;TCERG1;RBM41;HNRNPUL1;DDX5;CSTF3;CTNNBL1;THOC1;HNRNPU;PRPF8;SNRNP200;POLR2L;WDR33;ISY1;SNRNP25;SART1;HNRNPA0;SF1;PPIH;PSPC1;POLR2G;CDK7;PRPF6;DDX23;POLR2I;NCBP2;HNRNPM;SRSF3;SYF2;THOC2;ZMAT5;CWC27;GTF2F2;SF3A3;PQBP1;SNRNP35;CWF19L2;RSRC1;BUD31;SUGP1;RBM10;PPIE;WBP11;SNRPF;HNRNPD;MNAT1;MTREX;EIF4A3;ZRSR2;PCBP1;DDX39A;PUF60;SYNCRIP;DHX38;CCAR1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.4712961120791389,1.0321484705492918,0.43870014771048743,0.7732449228120335,1.0,5/13,23.75%,SORL1;EDEM2;BCAP31;TMEM30A;TM9SF4
prerank,covalent chromatin modification (GO:0016569),0.4537274392659187,1.0319131845003138,0.45255474452554745,0.7733661995484566,1.0,7/14,25.67%,PARP2;SIRT1;MT3;SIRT7;MBD2;SETD5;HDAC1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3283629601644952,1.0317226480807906,0.4222222222222222,0.773397789193427,1.0,57/241,16.61%,DHX8;POLR2A;ALYREF;PLRG1;TFIP11;HNRNPH2;CPSF1;RNPC3;RBM41;HNRNPUL1;DDX5;CSTF3;CTNNBL1;HNRNPU;PRPF8;SNRNP200;POLR2L;WDR33;ISY1;SNRNP25;SART1;HNRNPA0;SF1;PPIH;PSPC1;POLR2G;PRPF6;DDX23;POLR2I;NCBP2;HNRNPM;SRSF3;SYF2;ZMAT5;CWC27;GTF2F2;SF3A3;PQBP1;SNRNP35;CWF19L2;RSRC1;BUD31;SUGP1;RBM10;PPIE;WBP11;SNRPF;HNRNPD;MTREX;EIF4A3;ZRSR2;PCBP1;DDX39A;PUF60;SYNCRIP;DHX38;CCAR1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4934665243871883,1.031568121335321,0.44728915662650603,0.773304540662617,1.0,3/10,2.56%,CTNNB1;VEGFA;DCT
prerank,production of siRNA involved in RNA interference (GO:0030422),0.5009520424568288,1.0313880598588074,0.4376899696048632,0.7733136176178251,1.0,4/10,22.47%,AGO2;DROSHA;MRPL44;TSNAX
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.34152102314360805,1.031348196599529,0.4293193717277487,0.7729627070518938,1.0,42/122,24.68%,NAMPT;SAMD4A;VIM;IL6;HGF;CD28;TMEM106A;YTHDF3;IGF1;FGFR4;THBS1;IRS2;EIF6;LARP4B;NAT10;MTPN;SIRT1;DYRK2;NPM2;HNRNPD;STN1;EIF4A3;ATAD5;CDT1;RPL26;EPM2AIP1;BCAR3;EIF3C;BCL3;GCK;LARP4;PCIF1;PRKDC;UPF3A;FAF1;NMD3;JAK2;ZCCHC4;PDGFRB;PLXNB2;IGF2;SOX4
prerank,regulation of gene expression (GO:0010468),0.3212008480130265,1.0312183679090472,0.358,0.7728103230325,1.0,158/903,15.94%,CD36;APLNR;XDH;APOE;DTNBP1;AFF1;HNRNPLL;ATP1B4;TFEB;LILRB1;NFE2L2;GCNT2;MITF;AHNAK;VEGFA;POLR2A;CEBPB;TIPARP;ATXN1;FOXP3;TMPRSS4;TFRC;FBXW7;C1D;CXXC1;WWC2;IL36G;NAT8;ID2;IL6;CD28;CD46;AFF4;COQ7;HNRNPH2;RUNX3;MBNL1;SRPK2;NOTCH2;HNRNPAB;CELF1;TRIM17;MYCBP;MZF1;IGF2BP3;PID1;CITED2;FOXO4;AHNAK2;BACH1;E2F1;SLC8A1;IGF1;UBE2L3;FGFR4;SAP30;AGO2;APBB2;NR3C1;ASCC2;NSD3;CREBBP;BHLHE40;TESMIN;FLCN;HSPA1B;NWD1;ATF4;REL;BRCA1;RPL23;RREB1;TAF5;MSN;POU3F1;STAP1;JMJD1C;SOX9;SNAI2;RBAK;RB1;PRDM8;WWP2;SIRPA;ZNF148;FOXP1;IRF2;DVL1;CTSH;CHD3;MEFV;TYROBP;ZFAT;ACVRL1;PICALM;TNRC6B;NR5A1;DDIT3;RLIM;FZD7;ESR1;HCFC2;CNPY2;PSPC1;ASCC1;ROCK1;GRSF1;CNOT7;GSK3B;ZFPL1;POU3F3;AGO3;SIRT1;MAFB;PTBP3;MED26;MT3;GPBP1L1;APP;PUM2;SP3;ACVR1B;NOTCH1;RORA;PTBP2;PQBP1;TREM2;APBB3;SPOUT1;MAZ;HCLS1;RELA;GAS6;TRAF3;DGKQ;SOX2;PPIE;LIMD1;SLC11A1;PRKN;HSPA1A;GDNF;ZKSCAN5;PRDM2;HNRNPD;ZNF513;ADAM19;SNF8;PRX;ZFP64;USP36;TOB2;PCBP1;PPARGC1B;MBNL2;MYD88;DNMT1;NELL1
prerank,positive regulation of neurogenesis (GO:0050769),0.35937530537147166,1.0305202457250637,0.43896976483762595,0.7740787201499534,1.0,7/68,2.56%,PLXNA1;PLXNC1;PLXND1;CTNNB1;VEGFA;TGM2;DCT
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3869934841852286,1.0302906676654513,0.45692883895131087,0.7742105417448029,1.0,7/38,10.68%,XDH;PTEN;DAG1;FLCN;PLEKHA1;DDIT3;SIRT1
prerank,axonal transport (GO:0098930),0.3885072551337482,1.0301952301478958,0.4419753086419753,0.77400066939952,1.0,5/36,7.43%,DTNBP1;AP3S1;DYNC1H1;RAB21;KIF3A
prerank,cellular response to amyloid-beta (GO:1904646),0.4009746578383004,1.0299214129452032,0.43451652386780903,0.7742451513007347,1.0,7/35,12.31%,CD36;LRP1;ITGA4;IGF1;GSK3B;APP;TREM2
prerank,signal release from synapse (GO:0099643),-0.28501336933681687,-1.0298948769236425,0.4068965517241379,0.803682501658851,1.0,7/43,5.18%,NRXN1;SYT1;RIMS1;SYN2;PTPRN2;LIN7A;SNAP25
prerank,chromatin remodeling (GO:0006338),0.34293674579514605,1.0298601715064641,0.4205405405405405,0.7739452210772833,1.0,34/100,25.98%,ERCC6;FOXP3;KDM4C;BAZ1A;BAZ2B;TOP1;SOX9;RB1;CHD3;ESR1;HCFC2;SIRT1;CBX3;SMARCC1;NPM2;SMARCD1;SUV39H2;INO80;BAZ1B;PBRM1;ZBTB7A;SMARCB1;MBD2;KAT2A;KDM5C;RUVBL2;POLE3;SMARCE1;SMARCD2;ACTB;HDAC1;KAT2B;SMARCA1;CECR2
prerank,positive regulation of inflammatory response (GO:0050729),0.34430715104371984,1.0298162168563483,0.44,0.7736159690691449,1.0,13/86,15.91%,PLA2G7;MGST2;IL6;TNIP1;RIPK1;NINJ1;ADAM8;PTGER4;APP;IL15;CX3CL1;LBP;GRN
prerank,endothelial cell migration (GO:0043542),0.38508619198701943,1.0297504741686656,0.4297820823244552,0.7733276524017749,1.0,12/37,24.10%,PLXND1;VEGFA;LPXN;PIK3CA;FSTL1;MYH9;NRP1;CORO1B;RAB13;GIPC1;CDH5;CCN3
prerank,regulation of cell-cell adhesion (GO:0022407),-0.28884580825432726,-1.029579156092606,0.38764044943820225,0.8024910307881888,1.0,8/39,12.85%,PTPRG;TENM3;FLOT2;FUT9;SMAD7;EPHA7;DPP4;CELSR2
prerank,protein stabilization (GO:0050821),0.33065944748848053,1.0284491684554355,0.46494845360824744,0.776039207380889,1.0,46/168,22.59%,PLPP3;LAMP1;FLOT1;GNAQ;FBXW7;PRKCD;CDKN1A;PTEN;IGF1;RAB21;GLMP;STK3;COG7;HSPA1B;GTSE1;RPL23;LAMP2;DVL1;TYROBP;CDK7;BAG4;IFT46;MT3;SUGT1;PFN1;PRKN;HSPA1A;PER3;PFN2;USP36;RTN4;GRN;HSPD1;CREB1;TBRG1;STK4;CCT2;BAG1;WFS1;TAF1;GTPBP4;EPHA4;USP9X;USP2;NAA15;AAK1
prerank,regulation of hormone secretion (GO:0046883),0.4546078162206672,1.0281324789463318,0.4542728635682159,0.7764099390579425,1.0,4/15,20.18%,ANXA1;VAMP3;OSM;VAMP2
prerank,Golgi to endosome transport (GO:0006895),0.45238250347584064,1.0280615573308107,0.4446064139941691,0.7761301615235676,1.0,6/16,19.07%,KIF16B;KLHL20;VPS13C;EPS15;AP4M1;VPS13A
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3691222272797067,1.0280342777898237,0.4342258440046566,0.7757438370241411,1.0,10/49,12.31%,TFIP11;RAF1;AIDA;SORL1;MEFV;NLRP2B;PTGER4;NLRC3;GSK3B;TREM2
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.41013103668187734,1.0279460497044208,0.42578125,0.775508223705492,1.0,5/25,11.57%,SDCBP;THBS1;DSCAM;FZD7;APP
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.37656853704120175,1.0279253574817975,0.4297719087635054,0.7751058259872028,1.0,4/38,8.26%,CD36;GLA;P2RX4;SIRPA
prerank,sulfur amino acid catabolic process (GO:0000098),0.5004001140251301,1.0276067366905774,0.4546875,0.7753916359752021,1.0,4/10,20.81%,TST;BLMH;MTRR;TXN2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.41038662806287146,1.0273826241567474,0.4344262295081967,0.7754957906471128,1.0,11/24,25.44%,NR1H3;LPCAT3;PRKN;HSPA1A;CREB3;WFS1;CREB3L1;NR1H2;HERPUD1;BCL2L1;TXNDC12
prerank,tRNA transport (GO:0051031),-0.29827810949103606,-1.0272614533772626,0.39303482587064675,0.8069009553130762,1.0,12/35,14.68%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,establishment of spindle localization (GO:0051293),0.45959047229066086,1.0263474235942074,0.4495677233429395,0.7775594918825173,1.0,3/14,13.70%,DYNC1H1;CFL1;CLASP1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.43685437844002045,1.0262663085440125,0.449868073878628,0.7773217023472694,1.0,4/19,10.10%,PRKCH;SNAI2;CBFB;ROCK1
prerank,negative regulation of coagulation (GO:0050819),0.4697883342243867,1.0262549882809926,0.43923865300146414,0.7768983729274186,1.0,2/14,6.48%,APOE;PROC
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.45451327604094227,1.0258935852259041,0.45,0.7773626094202253,1.0,1/14,0.68%,SYK
prerank,phosphate ion transport (GO:0006817),0.44384359546841634,1.0258111401321275,0.43546099290780144,0.777132556583684,1.0,6/16,28.64%,XPR1;SLC37A3;SLC20A2;SLC37A4;SLC25A30;SLC25A10
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4843581112319167,1.025546583927722,0.4493865030674847,0.7768574372850384,1.0,5/11,19.46%,PTEN;OCRL;INPP5A;IMPA2;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4843581112319167,1.025546583927722,0.4493865030674847,0.7768574372850384,1.0,5/11,19.46%,PTEN;OCRL;INPP5A;IMPA2;SYNJ2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.34850189399193243,1.025542721945239,0.4466230936819172,0.7759687181378537,1.0,30/78,27.54%,CTSD;PIKFYVE;CTSL;OSBPL1A;RAB7A;DYNC1H1;KIF3A;CTSS;CAPZB;AP1G1;AP2B1;CAPZA1;ACTR1B;AP1M1;SEC31A;FCGR2B;LGMN;SEC24C;SEC24B;DYNC1LI2;AP2S1;DCTN4;CLTC;AP2A2;AP2A1;KIF22;DYNC1LI1;AP1B1;SEC24A;DCTN5
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.34850189399193243,1.025542721945239,0.4466230936819172,0.7759687181378537,1.0,30/78,27.54%,CTSD;PIKFYVE;CTSL;OSBPL1A;RAB7A;DYNC1H1;KIF3A;CTSS;CAPZB;AP1G1;AP2B1;CAPZA1;ACTR1B;AP1M1;SEC31A;FCGR2B;LGMN;SEC24C;SEC24B;DYNC1LI2;AP2S1;DCTN4;CLTC;AP2A2;AP2A1;KIF22;DYNC1LI1;AP1B1;SEC24A;DCTN5
prerank,regulation of cell morphogenesis (GO:0022604),0.40468039601337813,1.0253236695951726,0.4552332912988651,0.7760593579245721,1.0,10/30,21.07%,ZMYM6;CD44;CAPZB;CFL1;MACF1;PHIP;SH3D19;MYO9A;LARP4;FMNL2
prerank,regulation of neurogenesis (GO:0050767),0.37016898421709715,1.0251291269637957,0.4376443418013857,0.7760595098193207,1.0,9/55,11.96%,CTNNB1;HOOK3;TGM2;IL6;APPL2;SORL1;BHLHE40;NUMBL;NOTCH1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4258015437577424,1.0250283940403777,0.45466491458607095,0.7758496877149873,1.0,4/22,10.68%,CDKN1A;STAP1;ROCK1;SIRT1
prerank,magnesium ion transport (GO:0015693),0.4814773824829315,1.024788738175027,0.434654919236417,0.7759701325770405,1.0,4/12,15.22%,NIPAL3;MMGT1;MAGT1;NIPA1
prerank,positive regulation of cell aging (GO:0090343),0.48202007882953063,1.0244799308375772,0.4394409937888199,0.7762935965065952,1.0,3/11,10.68%,LMNA;ARG2;SIRT1
prerank,indolalkylamine catabolic process (GO:0046218),0.49167663641805004,1.0239395467209726,0.44780635400907715,0.7771941590413511,1.0,1/10,2.55%,KYNU
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4048607238646008,1.0238853372408163,0.4520725388601036,0.7768707678580732,1.0,3/25,6.68%,ERCC6;ALYREF;THOC1
prerank,engulfment of apoptotic cell (GO:0043652),-0.3782390641800702,-1.0235531336366799,0.4340836012861736,0.8152085683141352,1.0,10/15,31.14%,RHOBTB1;ADGRB1;RHOBTB2;RHOG;RHOH;RAC1;XKR8;RAC2;XKR4;XKR6
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3331053270164314,-1.0230121555702674,0.390625,0.8147388328919991,1.0,8/24,15.61%,AGBL4;TTLL7;TTLL3;AGBL5;PARP1;TTLL11;AGTPBP1;TTLL1
prerank,B cell activation (GO:0042113),0.3540340472568849,1.0228582868027416,0.443701226309922,0.778972482007242,1.0,16/68,17.42%,ADGRG3;TPD52;ITGA4;MS4A1;BLNK;CD22;ITGB1;ADAM17;CTPS1;PRKCB;BTK;DCAF1;JAK3;HSPD1;KLF6;ZBTB7A
prerank,neural crest cell migration (GO:0001755),0.3862537482127611,1.0227863600568783,0.44611528822055135,0.7787080528699754,1.0,8/36,16.02%,HTR2B;CORO1C;SEMA4B;FOLR1;PHACTR4;GDNF;NRP1;SEMA3B
prerank,sprouting angiogenesis (GO:0002040),0.3661109848493421,1.022564128230815,0.4510250569476082,0.7788186883032002,1.0,5/51,10.47%,CCBE1;VEGFA;THBS1;ACVRL1;PTK2B
prerank,positive regulation of macrophage differentiation (GO:0045651),0.4808171110857855,1.0223292249443214,0.46401225114854516,0.7789625419950819,1.0,2/11,4.15%,ID2;RIPK1
prerank,macrophage activation (GO:0042116),0.38934203629026254,1.0215561628887067,0.46296296296296297,0.7803863255488699,1.0,11/34,18.80%,SYK;TMEM106A;CD93;FOXP1;APP;TREM2;SLC11A1;CX3CL1;LBP;TLR1;CRTC3
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.35692179190287926,1.0211955218577127,0.44932432432432434,0.780781890691268,1.0,23/66,26.13%,IPO5;TFRC;PRKCD;SESN2;GTSE1;TPR;MAVS;DKC1;LARP7;MEPCE;HCLS1;MCRS1;RBM22;CCT2;WWTR1;EFCAB7;DMAP1;NMD3;FLNA;BAG3;UBR5;CCT7;ZIC1
prerank,negative regulation of binding (GO:0051100),0.3490252351210073,1.0209847158269045,0.46909492273730685,0.7808488744242594,1.0,18/81,16.59%,PRKCD;CDKN1A;TFIP11;JUN;E2F1;SORL1;PSME3IP1;PEX14;CTSZ;DVL1;ROCK1;GSK3B;STYX;PPP1CA;SLPI;BAX;IFIT2;CAMK1
prerank,vitamin D metabolic process (GO:0042359),0.46925929677589107,1.0209610424455393,0.43859649122807015,0.7804684310985215,1.0,3/13,20.84%,PIAS4;LRP2;LGMN
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4760171760111981,1.0207565697034684,0.4362017804154303,0.7805301741862357,1.0,2/12,7.43%,HOOK3;KIF3A
prerank,cellular response to metal ion (GO:0071248),-0.2300571885771061,-1.0206558452736763,0.44642857142857145,0.8194068444377515,1.0,27/123,12.63%,DLG2;SLC12A2;MEF2C;SYT1;NLGN1;MEF2A;RYR3;CAPN3;ADD1;ANK3;PRKAA2;KCNH1;SYT7;EGFR;SYT2;TRPM2;SYT4;GLRA1;SYT6;CPNE8;MCOLN1;ADGRV1;ADCY1;PKD2;CPNE4;PRNP;HVCN1
prerank,cellular response to misfolded protein (GO:0071218),0.4301943673659262,1.020615354383576,0.45285524568393093,0.7804262854666228,1.0,12/20,28.94%,CUL3;STUB1;DNAJB14;UGGT1;DNAJC18;ATXN3;TOR1A;VCP;DNAJB12;KLHL15;RNF185;RNF5
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3880183399966514,1.020463609891771,0.4440344403444034,0.7803503901433262,1.0,5/36,8.88%,PPARG;APOE;THBS1;GADD45A;ACVRL1
prerank,mammary gland epithelium development (GO:0061180),-0.3694939087110134,-1.0203369679195724,0.42628205128205127,0.818151076288103,1.0,2/14,1.05%,ERBB4;CSF1R
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3645123701380933,-1.0202556276109869,0.4105263157894737,0.8162268823206212,1.0,9/15,23.54%,COQ3;COQ10B;NDUFA9;COQ2;COQ9;COQ10A;COQ5;COQ8A;UBIAD1
prerank,glycine transport (GO:0015816),0.5071972741262656,1.0199217884110146,0.48073959938366717,0.781254953637747,1.0,4/10,23.11%,SLC36A2;SLC36A1;SLC7A8;SLC25A38
prerank,nuclear body organization (GO:0030575),0.4764869688131678,1.0198851488153924,0.45864661654135336,0.7809008403868627,1.0,4/12,14.02%,SRPK2;HIPK2;SERBP1;USPL1
prerank,regulation of supramolecular fiber organization (GO:1902903),0.41984140603106646,1.0197774682246072,0.4340878828229028,0.7807265235641013,1.0,3/22,7.96%,APOE;PIK3CA;AKAP13
prerank,regulation of cytokinesis (GO:0032465),0.347297641593083,1.0190830159942457,0.4649610678531702,0.7820080127813305,1.0,12/78,10.63%,KIF20B;PLK2;BIRC6;UVRAG;SH3GLB1;CUL3;MYO19;FLCN;SVIL;ZFYVE19;VPS4A;PKN2
prerank,rRNA metabolic process (GO:0016072),0.3295418378771077,1.019034490724712,0.44753086419753085,0.7816777313221867,1.0,59/160,26.43%,C1D;EBNA1BP2;MPHOSPH10;BYSL;SENP3;RPL18A;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;NOP14;EXOSC3;TEX10;WDR18;POP4;EXOSC9;WDR74;RPL22;NOB1;DKC1;EXOSC8;NOL8;DEDD2;RPL10A;KRR1;MRM2;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;PWP2;UTP15;RCL1;DHX37;EXOSC7;RPS27;WDR43;FBL;BOP1;NOLC1;RPL7A;LYAR;XRN2;NOL6;RPL32;SNU13;RRP36;RPS9;MPHOSPH6;DDX49;EXOSC4;WDR36
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.3630625734922192,1.0188560953900314,0.4557109557109557,0.781645708338725,1.0,17/53,22.96%,PSMD1;OAZ2;PSMF1;PSMD14;PSMD12;PSME2;AZIN1;OAZ1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3
prerank,peptidyl-lysine methylation (GO:0018022),0.40855552564158115,1.018564332079329,0.45454545454545453,0.7819256092248797,1.0,10/26,25.59%,SMYD3;ETFBKMT;N6AMT1;SETD7;SUV39H2;SMYD2;EHMT2;SETD3;METTL21A;SETD6
prerank,response to growth factor (GO:0070848),0.3791359433684977,1.0182590682219919,0.4479041916167665,0.7822122747059136,1.0,11/41,14.61%,CTNNB1;MAP2K5;HTRA2;MAPK7;STAT5B;ACVR2A;ACVRL1;BMPR2;ACVR1B;SOX2;SHC1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.35099555938934024,-1.0179670709697866,0.4201954397394137,0.8205925412322962,1.0,2/17,3.73%,CAMK1D;RIPOR2
prerank,cAMP biosynthetic process (GO:0006171),0.4903401823024528,1.0176465939350432,0.47305389221556887,0.7833016319063132,1.0,5/10,22.88%,ADCY7;ADCY8;ADCY3;ADCY5;ADCY9
prerank,regulation of Notch signaling pathway (GO:0008593),0.3520227303901221,1.0175741697994458,0.4569832402234637,0.7830558794601519,1.0,11/76,8.18%,ZMIZ1;FBXW7;CD46;NIBAN2;MMP14;MAML1;MAML2;CREBBP;RITA1;LFNG;WWP2
prerank,neuron projection development (GO:0031175),0.3265200562013629,1.017543811132465,0.47657841140529533,0.7826783931675337,1.0,32/168,15.22%,LRP12;APOE;SGK1;DTNBP1;STX3;MICALL2;ERCC6;KIF20B;TAOK3;IL6;FRY;PTEN;ZFYVE27;TBC1D23;DOCK10;MICALL1;RB1;PPP1R9B;VASH2;VAPA;EPB41L3;TNIK;ROCK1;GSK3B;TBC1D24;APP;PQBP1;GDNF;UHMK1;UNC5A;WASL;ATP7A
prerank,lymphocyte mediated immunity (GO:0002449),0.4698662053407218,1.0175260208448635,0.45606060606060606,0.7822701193857661,1.0,2/12,15.23%,CD46;KLRD1
prerank,T-helper cell differentiation (GO:0042093),0.452863584940427,1.0174097194414493,0.4398216939078752,0.7821136758020383,1.0,4/14,15.22%,IL6;FOXP1;PTGER4;ATP7A
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.37310521983663764,1.0172020051590858,0.4733178654292343,0.7821792153163019,1.0,15/51,20.54%,CTNNB1;ACD;TENT4B;HNRNPU;NAT10;TERF1;XRCC5;TEN1;STN1;TNKS;EXOSC10;TNKS2;GNL3L;CCT2;PKIB
prerank,cognition (GO:0050890),0.37839741178310476,1.0167715120775669,0.45907473309608543,0.7827856472208351,1.0,7/42,11.57%,CBR3;STRA6;NIPBL;ST3GAL4;JAKMIP1;MAGT1;APP
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.4522961494477673,1.0162651685356403,0.4425287356321839,0.7835800327264484,1.0,2/15,8.66%,PRKCH;NCOA3
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.3969033634680478,1.0158122058439605,0.4505208333333333,0.7842536982906344,1.0,7/30,14.71%,CD44;THOC1;DYRK1A;SNAI2;RTEL1;SIRT1;CXCL12
prerank,histone lysine methylation (GO:0034968),0.39184329533792167,1.015253518776507,0.453416149068323,0.7851520090029531,1.0,14/33,26.50%,SMYD3;CXXC1;DOT1L;N6AMT1;SUV39H2;SMYD2;KMT2A;PAXIP1;EHMT2;SETD3;MEN1;SETD6;KMT2D;SETD1B
prerank,ceramide catabolic process (GO:0046514),0.45843617929469493,1.015144048629962,0.4585714285714286,0.7849657156036622,1.0,6/14,19.08%,GLA;HEXA;GM2A;NEU1;ACER2;ASAH1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4849013479799874,1.0151210329027032,0.46407185628742514,0.7845791052875982,1.0,2/10,3.12%,XYLT1;DSE
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3517312124419931,1.0147983116718629,0.4610244988864143,0.7849277867484918,1.0,27/73,25.84%,ERCC6;DNMT3A;SMYD5;EED;SPHK2;POLR2L;EPC1;TAF1B;POLR1A;KDM1B;RBBP7;MPHOSPH8;DNMT1;BAZ1B;TAF1A;PHF1;PHF2;KAT2A;MTF2;MYO1C;AEBP2;IGF2;TDG;GPX1;ACTB;KAT2B;POLR2F
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3403906197284559,1.0145583806247833,0.4577922077922078,0.7850552734337906,1.0,19/95,15.05%,SDCBP;ZEB2;PDPK1;CITED2;THBS1;CREBBP;FLCN;RPS27A;UBC;FOLR1;HIPK2;SNX25;ADAM17;SIRT1;STUB1;LEMD3;ITGA3;HSPA1A;LATS1
prerank,tRNA metabolic process (GO:0006399),-0.3510573303215338,-1.014463617419882,0.4163934426229508,0.8284682411355512,1.0,11/17,27.96%,ADAT1;AARS1;SSB;DTD2;KARS1;RPP30;YARS2;POP5;DTD1;POP7;THG1L
prerank,positive regulation of neuron migration (GO:2001224),0.488186207121047,1.014451577275414,0.46646341463414637,0.784857164545375,1.0,5/11,20.23%,KIF20B;NIPBL;ARHGEF2;SHTN1;PLAA
prerank,regulation of ERBB signaling pathway (GO:1901184),0.45344521166096613,1.0143668722231456,0.46,0.7846113088547538,1.0,3/15,6.71%,RHBDF2;MVB12B;PTPN12
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.46040489798061,1.0143479388546437,0.4624113475177305,0.7842166374424161,1.0,2/15,3.67%,ERN1;CPSF1
prerank,peptidyl-lysine acetylation (GO:0018394),0.48791813059870814,1.0143085812525463,0.48412698412698413,0.783863316823008,1.0,5/10,28.87%,CREBBP;SIRT1;KAT2A;KAT2B;EP300
prerank,regulation of osteoblast differentiation (GO:0045667),0.3423834594908874,1.0141989766471644,0.4647887323943662,0.7836797615445883,1.0,18/82,14.33%,PPARG;IFITM1;RUNX2;IL6;HGF;IGF1;TNN;DDX5;ATF4;SOX9;ACVR2A;SNAI2;BMPR2;IL6R;CCN1;NOTCH1;LIMD1;GDF10
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.336947237394221,1.014083795442862,0.44694533762057875,0.7835331861077484,1.0,34/100,23.43%,SDCBP;WAC;RNF19A;GNA12;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;N4BP1;PRKN;HSPA1A;HECTD1;KEAP1;EIF3H;BBS7;TLK2;XPO1;DDA1;RNF19B;OGT;PIAS1;CEBPA;TAF1;GIPC1;HSPBP1;VCP;HERPUD1;ARIH1
prerank,negative regulation of cell cycle (GO:0045786),0.3497730000164153,1.0140064702058869,0.4557235421166307,0.7832671869167825,1.0,10/73,9.53%,LILRB1;RPS6KA2;IPO5;RUNX3;PTEN;HTRA2;APC;NUDT6;RB1;NLRP2B
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3193022916559155,1.0139150377464665,0.4563691073219659,0.7830562928713677,1.0,62/348,15.93%,CD36;DTNBP1;LILRB1;NFE2L2;MITF;VEGFA;TFRC;IL36G;NAT8;ID2;IL6;CD28;CD46;CD63;SRPK2;CELF1;MAP2K5;PID1;CITED2;E2F1;IGF1;MAPK7;FGFR4;AGO2;ANXA2;HSPA1B;NWD1;ATF4;BRCA1;RPL23;MSN;POU3F1;STAP1;SOX9;CTSH;TYROBP;TNRC6B;NR5A1;ROCK1;GSK3B;MTPN;POU3F3;AGO3;MED26;MT3;APP;NOTCH1;TREM2;MAZ;GAS6;DGKQ;VAMP3;INPP5F;SLC11A1;PRKN;HSPA1A;ADAM19;SNF8;ARRB1;MPHOSPH8;MYD88;DNMT1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.48473075980765784,1.0137413720519117,0.4774774774774775,0.7830192824441443,1.0,2/10,14.56%,CTNNB1;LRP6
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4343919113428061,1.013666837436162,0.46195652173913043,0.7827575166080739,1.0,3/17,4.35%,CXCR4;ID2;TNFRSF1B
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.3883250387943332,-1.0135983830150739,0.44329896907216493,0.8287822127037643,1.0,5/12,15.67%,MAP2;TUBB4A;STMN2;MAPRE1;STMN1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.38072111971836486,1.0134559395732883,0.4605911330049261,0.7828237385887084,1.0,13/39,22.48%,ITPKB;TMEM150A;SOCS6;PIK3CA;PIK3C2G;TTC7B;PI4K2A;EFR3A;PIP4K2A;PIK3CB;SOCS4;SOCS7;PI4K2B
prerank,selective autophagy (GO:0061912),0.35918389618671603,1.0130195980929695,0.46039035591274396,0.7834372850038511,1.0,22/56,23.49%,RAB7A;VIM;DYNC1H1;AMBRA1;RPS27A;UBC;ATG5;UBA5;ATG13;WDFY3;PRKN;SQSTM1;TEX264;UBE2V1;USP30;ARL13B;ACBD5;IFT88;RETREG1;ATG2B;DYNC1LI2;KLHL3
prerank,striated muscle cell differentiation (GO:0051146),0.4415963710999415,1.0129059285886381,0.4643356643356643,0.78325595802049,1.0,4/16,7.96%,PLD3;MTLN;SIK1;AKAP13
prerank,response to amino acid (GO:0043200),0.39843595915157975,1.0128695315237808,0.469910371318822,0.7829243386692002,1.0,7/31,13.19%,IPO5;CPEB4;SESN2;CAPN2;LAMTOR1;SLC38A9;LAMTOR3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.45454958433728176,1.0126006346396856,0.45592705167173253,0.783132018687627,1.0,8/14,28.75%,PRKN;HSPA1A;CREB3;CREB3L1;HERPUD1;BCL2L1;TXNDC12;LRRK2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3543429787278578,1.0125850102078358,0.4632768361581921,0.7827364153720084,1.0,17/62,17.27%,POLR2A;AFF4;GTF2H5;PCID2;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;CTDP1;MLLT1;MNAT1;CDC73;ELP4;NELFE;MLLT3
prerank,response to interleukin-4 (GO:0070670),0.4912657049930421,1.0123293244199663,0.46444780635400906,0.7829091624646387,1.0,2/10,14.72%,SHPK;JAK3
prerank,CENP-A containing chromatin organization (GO:0061641),-0.30682370278865606,-1.0122311028422677,0.4155251141552511,0.8284025017134247,1.0,13/29,24.83%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;RBBP4;CENPK;CENPO;NPM1;CENPT;CENPQ;CENPN;CENPH
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.30682370278865606,-1.0122311028422677,0.4155251141552511,0.8284025017134247,1.0,13/29,24.83%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;RBBP4;CENPK;CENPO;NPM1;CENPT;CENPQ;CENPN;CENPH
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.3020860215853639,-1.0121325220159345,0.4588744588744589,0.8266032574032788,1.0,8/28,10.68%,SMURF1;PSMC2;OSBPL7;FMR1;CLU;ECSCR;DAB2IP;RNF139
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.34341387372874776,-1.0119583712902178,0.4244604316546763,0.8249929225000591,1.0,5/20,12.08%,SEMA5A;SEMA4G;SEMA3E;SEMA3A;SEMA6A
prerank,regulation of transferase activity (GO:0051338),-0.3612669732842669,-1.0117709927292673,0.445993031358885,0.8233391863872576,1.0,10/17,29.05%,ATM;SMG6;FEM1B;LDB1;LDB2;BAG5;PPP1R3F;SPTSSB;FEM1A;EMP2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3939183366114139,1.0117528550165988,0.47036082474226804,0.7838701933552622,1.0,6/30,10.68%,KLK3;KDM4C;NCOR1;DDX5;FOXP1;SIRT1
prerank,protein localization to cell periphery (GO:1990778),0.3313702515550787,1.0117379217618117,0.4932781799379524,0.7834615144442129,1.0,26/133,14.60%,MYO5A;DENND4C;RAP2A;FLOT1;RAB8B;PRAM1;PDZD11;ZFYVE27;TMEM150A;TSPAN17;GAK;RABEP1;TTC7B;EPB41L3;TNIK;RAB12;ROCK1;RAB10;RAB40C;PACS2;GAS6;TSPAN15;ARL3;EFR3A;LRP6;CACNB3
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3155542831326428,-1.0115058542987472,0.437984496124031,0.822044831371625,1.0,9/24,25.50%,JPH1;PRKACA;PKD2;SELENON;FKBP1B;JPH4;CALM3;NOS1;JPH3
prerank,protein modification process (GO:0036211),0.34427951292484876,1.0114405706076652,0.46763392857142855,0.7837760268653987,1.0,23/76,22.41%,MSRA;ABL2;PARP4;B4GALT7;GNMT;UBE2L3;MANBA;PIGH;PPP4R2;WWP2;FBXO11;STK38;UBA3;FBXW2;MCRS1;CDC34;UBE2M;ICMT;UBE2S;NAGPA;PRKDC;NTAQ1;DUSP12
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.3356204934893777,-1.0109695838261428,0.4395973154362416,0.8215175023837364,1.0,3/19,2.94%,CAMK1D;CSF1R;CSF1
prerank,regulation of microglial cell activation (GO:1903978),0.4396320438678819,1.0105957853506193,0.44477172312223856,0.7853762564085471,1.0,5/15,15.91%,IL6;STAP1;TREM2;CX3CL1;GRN
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3641689397733417,1.0104505037060758,0.4630952380952381,0.7853040875326784,1.0,8/49,10.66%,RAB7B;THBS1;EIF6;CNOT4;CBFB;TNRC6B;AGO3;KMT2E
prerank,triglyceride biosynthetic process (GO:0019432),0.43218973332734245,1.0102191870206383,0.4732394366197183,0.7854077544465389,1.0,2/18,1.55%,LPIN3;GPAT2
prerank,presynapse organization (GO:0099172),-0.4140019991999051,-1.0097452120673422,0.43989071038251365,0.8229193419503001,1.0,3/10,10.41%,NLGN1;LRRTM3;NLGN3
prerank,barbed-end actin filament capping (GO:0051016),0.4258373943492064,1.0096036078903756,0.45694444444444443,0.7860368901362685,1.0,5/18,9.37%,VILL;CAPG;TRIOBP;SVIL;CAPZB
prerank,actin filament capping (GO:0051693),0.4258373943492064,1.0096036078903756,0.45694444444444443,0.7860368901362685,1.0,5/18,9.37%,VILL;CAPG;TRIOBP;SVIL;CAPZB
prerank,cell-cell junction assembly (GO:0007043),-0.25901465821158226,-1.0094735132169999,0.47706422018348627,0.8215514475764526,1.0,13/63,8.96%,CTNND1;CTNND2;TLN2;CDH11;CDH9;JUP;CDH8;PATJ;CDH2;CDH6;SMAD7;CDH12;CLDN11
prerank,regulation of phospholipid metabolic process (GO:1903725),0.4849293092354968,1.0092742806351638,0.47303543913713403,0.7864147087105182,1.0,2/10,7.85%,MTMR3;ABCA3
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.32580723397574546,1.0092697719803985,0.4714867617107943,0.7859856676865866,1.0,46/166,22.87%,CD36;SAMD4A;ZEB2;VIM;NR1H3;IL6;HGF;CD28;PAOX;P2RX4;YTHDF3;IGF1;FGFR4;THBS1;IRS2;EIF6;LARP4B;SLC27A1;NAT10;DDB1;SIRT1;APPL1;GPLD1;DYRK2;NPM2;HNRNPD;STN1;ATP7A;EIF4A3;ATAD5;CDT1;RPL26;EPM2AIP1;BCAR3;EIF3C;BCL3;GCK;SREBF1;LARP4;PCIF1;NR1H2;GIPC1;PRKDC;UPF3A;FAF1;NMD3
prerank,camera-type eye development (GO:0043010),0.4038644813822465,1.0091975271362408,0.473753280839895,0.7857196865377735,1.0,2/25,1.73%,STRA6;VEGFA
prerank,phosphatidylinositol metabolic process (GO:0046488),0.33625321505829153,1.0091047349208118,0.475635593220339,0.7854954888932713,1.0,19/109,13.73%,PIK3R5;MTM1;PIKFYVE;MTMR3;PGAP3;PLA2G2D;INPP4A;PTEN;FIG4;PIK3CA;PGAP1;PIK3C2G;SLC27A1;PLA2G4F;PLEKHA1;PLAAT3;PI4K2A;OCRL;INPP5F
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.3430153406436822,-1.0091017989247675,0.4365079365079365,0.8205467652573208,1.0,3/19,6.02%,CX3CR1;CD33;NLRP3
prerank,positive regulation of histone methylation (GO:0031062),0.4052313863449101,1.0090933613356194,0.45161290322580644,0.7850884089641066,1.0,10/24,22.43%,CTNNB1;CHTOP;BRCA1;SIRT1;DNMT1;KMT2A;PHF1;PAXIP1;OGT;MTF2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.32351778508669127,1.0090922319131845,0.4774590163934426,0.7846570329974442,1.0,34/199,15.91%,GPNMB;GDF15;TIMP1;FOXP3;CORO1C;WWC2;NR1H3;ATP2B1;PTEN;NR1H4;PROC;PARP3;FLCN;ATF4;MCC;SOX9;RB1;BMPR2;DDIT3;PTGER4;WDR77;ROCK1;ADAM17;GSK3B;NOTCH1;IL15;GAS6;PLCL2;N4BP1;SLC11A1;PFN2;LAMA4;LNPEP;GRN
prerank,positive regulation of translation (GO:0045727),0.33952118510986534,1.009067340300791,0.4690831556503198,0.7842894142111682,1.0,29/94,22.52%,SAMD4A;VIM;IL6;CD28;YTHDF3;THBS1;AGO2;EIF6;LARP4B;NAT10;POLR2G;CDC123;RMND1;USP16;UHMK1;HNRNPD;EIF4A3;RPL26;C1QBP;TRMT10C;EIF3C;BCL3;JMJD4;COA3;LARP4;PCIF1;PRKDC;PKM;UPF3A
prerank,NIK/NF-kappaB signaling (GO:0038061),0.34836101143698456,1.00903968733768,0.4594894561598224,0.7839239291231256,1.0,28/72,26.36%,PSMD1;REL;BIRC3;PSMF1;PSMD14;PSMD12;RELB;RELA;PSME2;CUL1;TRAF2;PSMB10;PSMD5;BIRC2;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;TIRAP;MALT1;PSME3;IRAK1;TRAF6;PSMC5;MAP3K7;PSMC1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.40824355757674646,1.008969862879915,0.4653333333333333,0.7836588319047678,1.0,6/27,11.60%,LPIN3;PLA2G2D;SLC27A1;ABHD4;PLAAT1;PLAAT3
prerank,protein deacylation (GO:0035601),0.4095805233782188,1.0087104434556224,0.45152722443559096,0.7838362305214013,1.0,9/23,21.13%,PPT1;SIRT6;ABHD10;SIRT1;SIRT7;SIRT3;LYPLA2;SIN3A;ABHD17C
prerank,T cell proliferation (GO:0042098),-0.38831925151798513,-1.0084530122856905,0.45794392523364486,0.8203817081334802,1.0,2/13,0.26%,CADM1;DOCK8
prerank,substrate-dependent cell migration (GO:0006929),-0.3767482938272021,-1.0081787643957008,0.4370629370629371,0.8191867106630027,1.0,5/14,10.24%,P2RY12;OPHN1;ITGB1BP1;ANKS1A;CD2AP
prerank,regulation of secretion (GO:0051046),0.46147650349840286,1.0081095763118628,0.46726190476190477,0.7848887341133849,1.0,3/13,13.34%,SGK1;GPLD1;POFUT2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4002913282448184,1.0080181863837172,0.47334200260078024,0.7846614037248814,1.0,3/26,8.04%,NSMCE2;CUL3;RB1
prerank,regulation of T cell cytokine production (GO:0002724),0.4397017773055862,1.0077549015541962,0.48484848484848486,0.7848637510437347,1.0,7/15,26.02%,FOXP3;TNFRSF1B;FZD5;TRAF2;MALT1;TRAF6;MAP3K7
prerank,metanephros development (GO:0001656),-0.31036251322981245,-1.00772140365959,0.40963855421686746,0.8185073515704312,1.0,7/26,16.18%,ROBO2;PTCH1;PAX2;BASP1;PKD2;PKD1;FGF10
prerank,telomere organization (GO:0032200),0.3710702806611336,1.00757791206751,0.49404761904761907,0.7848504207609488,1.0,10/43,14.85%,ACD;PARP3;DOT1L;RTEL1;TERF1;XRCC5;NBN;DCLRE1B;WRN;STN1
prerank,external encapsulating structure organization (GO:0045229),0.3248945195444404,1.0072374045470716,0.4898580121703854,0.7852328385688505,1.0,33/205,15.22%,MMP12;VWF;ICAM2;ADAMTS8;MMP27;SPP1;CD44;ITGA5;ITGA4;PDGFA;COL4A6;MMP14;THBS1;COL1A1;DAG1;LUM;COL4A1;HRNR;COL5A2;ITGB1;ITGA10;COL11A1;APP;VIT;COL5A3;ITGA3;COL3A1;ADAM19;ITGA8;LAMA4;LAMA3;COL6A2;ATP7A
prerank,protein localization to membrane (GO:0072657),0.32451943861510996,1.0072212262581794,0.4796747967479675,0.7848352520709989,1.0,38/187,14.60%,MYO5A;DENND4C;RFTN1;RAP2A;FLOT1;NPC1;RAB8B;PRAM1;ITGA4;PDZD11;SH3GLB1;SYNE3;ZFYVE27;TMEM150A;TSPAN17;GAK;RABEP1;HPS6;DVL1;TTC7B;EPB41L3;TNIK;RAB12;ROCK1;RAB10;RAB40C;CYP46A1;AP3D1;PACS2;RAB11B;GAS6;TSPAN15;SH3PXD2B;NRXN2;ARL3;EFR3A;LRP6;CACNB3
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4931524294613499,1.0071548357546583,0.4683734939759036,0.7845691079810014,1.0,5/10,20.42%,PIBF1;NF2;INPP5F;PPP2CA;PPP2R1A
prerank,negative regulation of viral process (GO:0048525),0.3575349189000833,1.0070482381069186,0.4599774520856821,0.7844027421518261,1.0,14/57,17.81%,IFITM1;TNIP1;SRPK2;FAM111A;RNASEL;ZC3HAV1;IFITM2;MAVS;LARP7;BST2;N4BP1;SLPI;SRPK1;TRIM14
prerank,import into nucleus (GO:0051170),0.3439794595887704,1.006767585597732,0.48478015783540024,0.7846434185767934,1.0,19/73,22.78%,MMP12;SYK;IPO5;E2F3;APPL2;TPR;NUP50;TNPO1;APPL1;DDX20;SNRPF;SMN1;NUP88;CSE1L;NUP188;SNRPB;PPP1R10;RPAIN;STAT3
prerank,UV-damage excision repair (GO:0070914),0.45980149232192236,1.0067072566706363,0.48049921996879874,0.7843401280365372,1.0,6/12,21.54%,DDB1;SIRT1;POLA1;INO80;CUL4B;XPC
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.342330865693123,1.0067045981599698,0.4888641425389755,0.7839184462130363,1.0,25/76,22.26%,FBXW7;RNF19A;PTEN;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;PRKN;HSPA1A;HECTD1;KEAP1;BBS7;DDA1;RNF19B;PIAS1;CEBPA;TAF1;HSPBP1;VCP
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.40649249802412013,1.0066326983901477,0.47459893048128343,0.7836581063529388,1.0,2/23,1.58%,LILRB1;LAMP1
prerank,protein phosphorylation (GO:0006468),0.3164870761559561,1.0062874752029323,0.489,0.7840161174114241,1.0,79/478,13.84%,FNIP2;SGK1;MAP3K20;MAK;SYK;TLK1;FRK;PRKCH;RPS6KA2;MAP3K1;ERN1;TEC;PDK4;MAPKAPK3;PRKAG2;IKBKE;PLK2;TAOK3;PDPK1;ABL2;PRKCD;PPP4R1;RUNX3;BIRC6;SIK3;FAM20C;DAPK1;SRPK2;RIPK1;ABI1;RARA;MAPK6;GTF2H5;PIM1;FGFR4;MAML1;PKN3;MERTK;MELK;RNASEL;SIK1;STK24;STK3;IRAK3;INCENP;DYRK1A;EIF2AK4;TOP1;BRD2;ACVR2A;PKDCC;HIPK1;MAP4K3;ACVRL1;HIPK2;CSNK2A2;BMPR2;TNIK;ROCK1;PIM3;GSK3B;PTK2B;PKN2;PAK2;CDK7;FES;CCNA2;APP;DCLK3;PRKCB;ACVR1B;STK38;BTK;DYRK2;GAS6;DGKQ;FGR;STK16;MAST4
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3412060872740425,1.0059620959405662,0.4788273615635179,0.7843623366464287,1.0,30/79,27.54%,CTSD;PIKFYVE;CTSL;OSBPL1A;RAB7A;DYNC1H1;KIF3A;CTSS;CAPZB;AP1G1;AP2B1;CAPZA1;ACTR1B;AP1M1;SEC31A;FCGR2B;LGMN;SEC24C;SEC24B;DYNC1LI2;AP2S1;DCTN4;CLTC;AP2A2;AP2A1;KIF22;DYNC1LI1;AP1B1;SEC24A;DCTN5
prerank,protein deubiquitination (GO:0016579),0.31949006246577233,1.0057836097073105,0.48787878787878786,0.7843670191919109,1.0,85/242,26.02%,MINDY1;TNIP1;PSMD1;RIPK1;ASXL2;PTEN;FOXO4;STAM;BABAM2;APC;RNF128;TOMM20;RPS27A;UBC;BRCA1;USP42;RAD23A;USP12;VCPIP1;COPS5;ESR1;FOXK1;BIRC3;USP40;USP26;CCNA2;PSMF1;USP48;PSMD14;PSMD12;KDM1B;TRAF3;USP21;USP16;TNFAIP3;PRKN;RNF123;MCRS1;PSME2;INO80;STAM2;USP36;CCP110;BRCC3;ASXL1;USP8;TRAF2;NFRKB;OTUD5;KEAP1;PSMB10;PSMD5;USP32;SNX3;BIRC2;CDC25A;PSMD8;PSMA3;USP30;PSMA2;ATXN3;STAMBP;PSMD11;PSMA6;USP3;OGT;USP9X;KAT2A;USP2;PSMB3;VCP;SIAH2;PSME3;TRAF6;USP47;ATXN7;SHMT2;USP46;PSMC5;TAB1;ACTB;RCE1;KAT2B;WDR20;MAP3K7
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.36366017610636525,1.0054222623089824,0.48014018691588783,0.784800894175122,1.0,15/46,24.60%,TALDO1;LCP1;ANXA2;MSN;CFL1;PITPNA;PAK2;PSME2;CAPZA1;HNRNPDL;GSTO1;HSPA9;JAK2;AIP;PPIA
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.33304297749150585,1.0053835007687826,0.49042553191489363,0.7844617059654847,1.0,23/112,16.01%,GDF15;ZMIZ1;GCNT2;ADAM9;JUN;APPL2;MAPK7;NR3C1;LPXN;RPS27A;UBC;ZFP36L2;SOX9;ACVRL1;ITGB1;SIRT1;APPL1;COL3A1;GDF10;PARD6A;NRROS;CBL;WWOX
prerank,regulation of cellular localization (GO:0060341),-0.26238110257428093,-1.0052793045922799,0.41333333333333333,0.8234659040120107,1.0,8/46,6.40%,EPHA5;CSNK1E;FER;REEP5;MAP2;HSP90AA1;LRP5;PPM1F
prerank,I-kappaB phosphorylation (GO:0007252),-0.4216602507001684,-1.005210209050101,0.4281609195402299,0.8216425269187723,1.0,4/10,18.24%,TLR3;DAB2IP;TLR2;CHUK
prerank,protein hydroxylation (GO:0018126),-0.3672803442416079,-1.0049117861202383,0.41118421052631576,0.8204845475307437,1.0,3/15,8.03%,P3H2;ASPH;PLOD2
prerank,circulatory system development (GO:0072359),0.33005677776282455,1.004780425128382,0.4857142857142857,0.7854591041108622,1.0,21/118,13.66%,APLNR;ALPK3;STRA6;FBXW7;ID2;CDKN1A;ZDHHC16;MYL2;PTEN;CITED2;PIK3CA;PDLIM5;SOX9;AKAP13;ACVRL1;TAB2;NOTCH1;MICAL2;COL3A1;SH3PXD2B;SMYD4
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4848440435981839,1.0046603314115323,0.4850863422291994,0.785323942658442,1.0,2/10,9.57%,FOXP3;DDIT3
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.35381867608475737,1.0046298609903865,0.47435897435897434,0.7849702587712034,1.0,7/56,10.22%,GDF15;SDCBP;RBPMS;ACVR2A;ACVRL1;BMPR2;SNX25
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3710109221570583,1.0045725720185172,0.47664670658682634,0.7846822447661258,1.0,7/40,9.03%,ALYREF;MCM9;ZRANB3;FAM111A;THOC1;EME1;RTEL1
prerank,regulation of neuron death (GO:1901214),0.3388230921960062,1.004512054839141,0.48344370860927155,0.7844047592676997,1.0,12/82,10.86%,GPNMB;CD200R1;TNFRSF1B;SORL1;HTRA2;CTSZ;TYROBP;PICALM;EGLN3;GSK3B;SNCG;NENF
prerank,cell-matrix adhesion (GO:0007160),0.3420290571971926,1.0044579620769098,0.4887940234791889,0.784107731732007,1.0,17/95,15.01%,HPSE;CD44;ADAM9;ITGA4;CD63;ACTN1;TNN;DLC1;OTOA;ITGB1;RHOD;ITGA10;SIGLEC1;ITGA3;COL3A1;WHAMM;ITGA8
prerank,peptidyl-lysine dimethylation (GO:0018027),0.42836804276349383,1.0038064327271614,0.45228215767634855,0.785230124225798,1.0,10/18,28.32%,SETD7;SUV39H2;SMYD2;KMT2A;ASH1L;EHMT2;SETD3;KMT2D;SETD1B;EHMT1
prerank,regulation of telomerase activity (GO:0051972),0.3695656829996229,1.0034321315665666,0.46689895470383275,0.7857117980355176,1.0,13/45,23.97%,CTNNB1;ACD;PARP4;TERF1;XRCC5;DKC1;TNKS;CCT2;CERS1;PKIB;ERCC4;NEK7;MEN1
prerank,response to nutrient levels (GO:0031667),-0.354723724953781,-1.0031042310296088,0.4276094276094276,0.8234938452919395,1.0,2/17,3.12%,RPTOR;PRKAA2
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.4660591426016852,1.002998188340877,0.47969924812030074,0.7862789930278892,1.0,4/12,14.73%,UMPS;CTPS1;CRMP1;CTPS2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.4050605580623074,-1.0027786243779138,0.42950819672131146,0.8224476794435978,1.0,3/12,8.84%,NFIB;SPTBN4;SZT2
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.24739611483635265,-1.0025008109362437,0.46218487394957986,0.8212161280994542,1.0,12/70,6.34%,MEF2C;OPHN1;TMEFF2;NTNG1;FER;ABI2;SRGAP2;RELN;METTL3;SIPA1L3;RILPL1;SRCIN1
prerank,RNA splicing (GO:0008380),0.33595497021816517,1.0023789548095101,0.47071352502662406,0.7873214052319277,1.0,32/95,24.75%,DHX8;MBNL1;SRPK2;MPHOSPH10;SCAF11;RNPC3;TCERG1;PRPF8;PPP1R9B;SNRNP25;PRPF6;DDX23;NCBP2;ZMAT5;SF3A3;SNRNP35;RSRC1;SNRPF;ZRSR2;SYNCRIP;SRPK1;PPP2CA;PPP2R1A;SNRNP40;YJU2;SNRPB;SNRNP48;WDR83;RRAGC;PPIG;SF3B2;PRPF3
prerank,regulation of mitochondrial translation (GO:0070129),0.4131669273926794,1.0020783884411313,0.468,0.787586257996631,1.0,8/21,20.24%,NSUN3;RMND1;ALKBH1;MTG1;MALSU1;C1QBP;TRMT10C;COA3
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3484561691724241,1.0018181764284173,0.4780652418447694,0.7877626528051794,1.0,17/64,17.27%,POLR2A;AFF4;GTF2H5;PCID2;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;CTDP1;MLLT1;MNAT1;CDC73;ELP4;NELFE;MLLT3
prerank,positive regulation of peptidase activity (GO:0010952),0.41122372792302003,1.00170864375911,0.4738292011019284,0.7875875039305813,1.0,9/20,23.59%,TANK;CTSH;PSME2;NCSTN;GRN;VCP;APH1B;PSME3;NDUFA13
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.45287136779302,1.0013967838944122,0.47285714285714286,0.7879189605728283,1.0,7/15,24.66%,ADRA1A;CLN3;ZDHHC12;NLGN2;BAIAP3;DRD2;USP46
prerank,regulation of myoblast differentiation (GO:0045661),-0.2974676022037236,-1.0013272896371772,0.4343891402714932,0.8224848144891085,1.0,4/32,3.73%,MEF2C;PLCB1;FLOT2;RIPOR2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.41636994853523224,-1.0010630072105242,0.4657534246575342,0.8211126765819248,1.0,2/10,2.63%,SERPINE2;SH2B3
prerank,supramolecular fiber organization (GO:0097435),0.3147826934616793,1.001046362096405,0.5045135406218656,0.7883431576291297,1.0,66/333,19.23%,CD36;MFGE8;MYO5A;MTM1;TLL2;HOOK3;RUFY3;CORO1C;MYO1E;VIM;DNAJB6;NAT8;DYNC1H1;BIN3;CD151;COL4A6;RIPK1;B4GALT7;SORL1;ACTN1;COL1A1;TRIOBP;KLHL41;MYO19;RPS27A;UBC;NCKAP5L;LUM;COL4A1;PPP1R9B;CALB1;TPM3;BACE1;COL5A2;MYO1F;ARHGAP17;RHOD;ARHGEF2;TPM4;COL11A1;KLHL24;APP;TUBGCP4;COL5A3;MFAP4;COL3A1;TSPAN15;PRKN;WHAMM;LAMA3;COL6A2;NCSTN;ATP7A;RND2;CCDC88C;ARHGAP25;GGA2;COL11A2;COL4A5;PLOD1;COL12A1;PLEC;FLII;KATNA1;CALCA;CORO1B
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.439629642446387,1.0009931613838559,0.48735955056179775,0.7880489856202773,1.0,5/17,11.96%,PLXND1;MAML1;MAML2;CREBBP;NOTCH1
prerank,negative regulation of developmental process (GO:0051093),0.34671483647765977,1.0005968799924818,0.47554038680318544,0.7885476134179029,1.0,13/69,13.77%,VAT1;HOPX;TFRC;PARP3;ANP32B;SOX9;HUWE1;WDR77;ROCK1;NOTCH1;OMA1;GAS6;PRKN
prerank,piRNA metabolic process (GO:0034587),0.42171701223116226,0.9999913150888649,0.4777327935222672,0.7895667813964258,1.0,1/19,1.55%,GPAT2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3457882304784061,0.9999596645921944,0.48645598194130923,0.7892138688073669,1.0,17/68,18.63%,POLR2A;CPSF1;GTF2H5;CSTF3;POLR2L;WDR33;TAF1B;POLR1A;CDK7;NCBP2;MAZ;SNRPF;MNAT1;SSU72;SMN1;TTF1;TAF1A
prerank,response to UV (GO:0009411),0.3382037855997405,0.9999563746417395,0.4891540130151844,0.7887938140033484,1.0,34/95,25.27%,AQP1;ERCC6;PRKCD;ZRANB3;COPS9;CREBBP;EIF2AK4;ATF4;CAT;MAP4K3;POLH;DCUN1D3;RHBDD1;WRN;MFAP4;NSMCE3;RELA;N4BP1;INO80;RPL26;CDC25A;NOC2L;BCL3;EIF2S1;TAF1;RUVBL2;POLD1;ERCC4;SPRTN;UBE4B;MEN1;USP47;PRIMPOL;GPX1
prerank,mucosal immune response (GO:0002385),0.44546891781954945,0.999699202421802,0.48405797101449277,0.7889653135926442,1.0,2/15,18.02%,RNASE3;DEFA6
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3479576126492183,0.9995862154066021,0.48761261261261263,0.788789243698207,1.0,11/64,12.88%,MGLL;ABCD1;SLC27A4;SLC27A3;ACADL;GPX4;CPT1A;AIG1;LTA4H;ELOVL1;ACSL5
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.42362043080795875,0.9994821212495789,0.47802197802197804,0.7886246012415229,1.0,6/19,10.10%,APOE;SORL1;IGF1;RTN3;PICALM;ROCK1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.37277960803512245,0.9993184228746497,0.48894348894348894,0.7885662607139844,1.0,4/44,2.43%,BAAT;AMACR;OSBPL1A;PRKAG2
prerank,vasculogenesis (GO:0001570),0.3844005356208794,0.9990327896604112,0.4699386503067485,0.7888244963151835,1.0,2/32,1.73%,APLNR;VEGFA
prerank,regulation of myelination (GO:0031641),-0.31752880785077997,-0.9990003455899031,0.450199203187251,0.8249392405451677,1.0,15/25,26.62%,PARD3;JAM2;TPPP;MYRF;CST7;TENM4;SIRT2;DICER1;TMEM98;EIF2AK3;NSUN5;LGI4;KLK8;NKX6-2;KIF14
prerank,regulation of sequestering of calcium ion (GO:0051282),0.46139773610206414,0.998769937410971,0.4806201550387597,0.7890723556915799,1.0,3/12,10.47%,DIAPH1;MTLN;PTK2B
prerank,positive regulation of biomineral tissue development (GO:0070169),0.37237284318341335,0.9985124128384488,0.4833729216152019,0.7892622060663561,1.0,8/40,10.93%,CEBPB;ANO6;ATP2B1;SLC8A1;ACVR2A;PKDCC;BMPR2;CCN1
prerank,chordate embryonic development (GO:0043009),0.35856591563240436,0.9981550247831157,0.4805936073059361,0.7896860478361952,1.0,15/55,21.26%,VEGFA;XYLT1;MBNL1;COL1A1;FLCN;SULF2;BRCA1;DVL1;SULF1;ALDH1A2;CHD7;FUT8;SOX8;HES5;ADAM10
prerank,cellular response to retinoic acid (GO:0071300),-0.27944922619302304,-0.9980435670389376,0.49142857142857144,0.8255401189900611,1.0,6/42,2.97%,BRINP3;TWF2;SETX;RORB;EPHA3;ATM
prerank,regulation of macrophage differentiation (GO:0045649),0.4384480016735314,0.998015164128364,0.46418338108882523,0.7895662528515092,1.0,2/15,4.15%,ID2;RIPK1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.33904038867350134,0.9980050198480521,0.4923913043478261,0.7891572362935856,1.0,18/87,15.36%,GDF15;ZMIZ1;GCNT2;ADAM9;JUN;APPL2;LPXN;RPS27A;UBC;ACVRL1;ITGB1;SIRT1;APPL1;COL3A1;GDF10;PARD6A;NRROS;CBL
prerank,response to endoplasmic reticulum stress (GO:0034976),0.33036578295538294,0.9974759068772497,0.503735325506937,0.7899636158252678,1.0,28/107,23.17%,BCL2L11;ERN1;FLOT1;CEBPB;ATF3;JUN;ATG10;THBS1;ATF4;DDIT3;GSK3B;RHBDD1;UBA5;PRKN;BAX;QRICH1;TRAF2;BBC3;WFS1;CREB3L1;BRSK2;BCAP31;EIF2S1;VCP;PPP1R15B;HERPUD1;TMCO1;AIFM1
prerank,negative regulation of translational initiation (GO:0045947),0.4516063099910505,0.9973528688509756,0.4736070381231672,0.7898315655873209,1.0,4/13,9.50%,AGO2;EIF2AK4;EIF4EBP2;TPR
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.39712920772425253,-0.9973182916256593,0.42857142857142855,0.825584186404226,1.0,4/11,22.29%,REST;PARK7;UBQLN1;STK26
prerank,heterocycle biosynthetic process (GO:0018130),0.44239277325921555,0.996926153001194,0.48409405255878285,0.7904092910525838,1.0,4/14,18.98%,MOCOS;LIAS;NFS1;GCH1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3333705478998313,0.9966386264306489,0.5010660980810234,0.7906613661071938,1.0,19/95,14.75%,B4GALT5;GCNT2;XYLT1;DSE;NDST1;EXT1;UGDH;B4GALT7;HAS3;B4GALT6;HEXA;ST3GAL4;LUM;HS2ST1;B4GALT3;SDC4;B4GALT2;SLC10A7;HS3ST2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3457002306624242,0.9965766727848521,0.5011494252873563,0.7903689603292757,1.0,14/67,14.72%,SYK;TEC;PIBF1;ABL2;ABI1;FGFR4;DYRK1A;PKDCC;PTK2B;FES;IL15;BTK;FGR;JAK3
prerank,regulation of stress fiber assembly (GO:0051492),-0.24057077543492014,-0.996308993052568,0.43564356435643564,0.8264494345121131,1.0,24/74,19.54%,TMEFF2;F11R;EVL;ASAP3;PPM1E;LIMCH1;WAS;LIMK1;TGFBR1;PAK1;PPM1F;ITGB1BP1;CARMIL1;TESK1;FERMT2;ARHGAP6;ARHGEF18;RHOA;RAPGEF3;STMN1;SLC9A1;TPM1;RGCC;PHLDB2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.42393043299168476,0.996111194759151,0.4878048780487805,0.7909956679771653,1.0,4/18,15.61%,SYK;TYROBP;DOCK2;LBP
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4264846540196693,0.9959236168359138,0.4865229110512129,0.791011728309087,1.0,2/19,2.99%,VIM;IL6
prerank,negative regulation of signaling (GO:0023057),0.3975458674144854,0.9958295696971616,0.4967741935483871,0.7907875922690442,1.0,3/25,5.84%,OPTN;BRAP;TRAT1
prerank,DNA catabolic process (GO:0006308),0.4683128960477895,0.995416830591709,0.4899536321483771,0.79131336556958,1.0,3/11,10.79%,MUS81;DFFB;DNASE1L1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3827773896953469,0.9943496397477398,0.4806007509386733,0.7934417528877923,1.0,2/32,3.03%,APLNR;PDPK1
prerank,Wnt signaling pathway (GO:0016055),0.3346260053520768,0.9939308206811005,0.49783549783549785,0.793977771652819,1.0,20/92,18.05%,PLPP3;CTNNB1;PTEN;APC;RPS27A;UBC;DVL1;STRN;FZD7;GSK3B;WLS;FZD5;FZD2;LRP6;CUL1;CCDC88C;DIXDC1;CSNK1G1;SNX3;VPS29
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.28850437062887435,-0.9938297757490474,0.47596153846153844,0.8315417022686641,1.0,5/34,6.49%,PTPRT;UBASH3B;PTPRO;DUSP6;DUSP7
prerank,eye development (GO:0001654),0.3565838830777835,0.9937522326296018,0.4755244755244755,0.7939621573539379,1.0,10/54,13.44%,STRA6;ZDHHC16;NIPBL;HIPK1;HIPK2;COL5A2;SALL2;RAB18;SOX2;SH3PXD2B
prerank,regulation of cilium assembly (GO:1902017),0.34272922127944727,0.9932375936864041,0.5,0.7947151786637306,1.0,17/62,21.52%,TBC1D22A;TBC1D1;TBC1D2;ODF2L;TBC1D10A;TBC1D2B;TBC1D22B;ATG5;TBC1D24;TBC1D15;IFT140;CCP110;RABGAP1;HTT;IFT88;CROCC;CDKL5
prerank,positive regulation of telomerase activity (GO:0051973),0.3824121516079816,0.9927789443502896,0.4783683559950556,0.7953601862828202,1.0,7/33,20.54%,CTNNB1;ACD;XRCC5;DKC1;TNKS;CCT2;PKIB
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.41154754712903496,0.9924905825175687,0.5026737967914439,0.7956364266761222,1.0,4/23,6.23%,PDK4;TFAP2B;SLC12A3;SLC12A8
prerank,COPII-coated vesicle budding (GO:0090114),0.34584220756864764,0.9924010925930093,0.4955555555555556,0.7954251972594465,1.0,27/68,25.33%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;VAPA;SEC23B;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;SEC24B;PEF1;PPP6R1;PREB;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,defense response to fungus (GO:0050832),-0.34332362154120577,-0.9917217238843805,0.45054945054945056,0.8354927140613123,1.0,1/17,0.09%,CX3CR1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4413230239652617,0.9913295150433452,0.46551724137931033,0.7975367309562407,1.0,1/13,0.65%,B3GNT8
prerank,ncRNA catabolic process (GO:0034661),0.38729649387707354,0.991310895853912,0.49746192893401014,0.7971623074325362,1.0,9/28,17.07%,TENT4B;EXOSC3;EXOSC9;SND1;EXOSC8;DEDD2;MTREX;EXOSC10;RBM7
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3738991908771145,0.9906754668154909,0.48581997533908755,0.7982197565285859,1.0,18/35,28.63%,FOXO3;STAT5B;HSPA1B;ACVR2A;MAFB;ACVR1B;FAM210B;HSPA1A;BRD1;PRKDC;STAT3;CDK6;HSPA9;ZFP36;MAPK14;NCKAP1L;INHBA;ZFP36L1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.38367902336896764,0.9906105249359021,0.5012406947890818,0.7979345104575711,1.0,6/33,8.88%,APOE;CORO1C;PTEN;THBS1;MCC;ACVRL1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.37623305160846443,-0.9905514823806812,0.47368421052631576,0.8368491190291832,1.0,1/13,0.13%,BIN1
prerank,lipid phosphorylation (GO:0046834),0.47449719038057236,0.9903159472691891,0.48091603053435117,0.798170855485865,1.0,4/10,17.23%,DGKZ;DGKA;DGKQ;DGKG
prerank,regulation of amyloid-beta formation (GO:1902003),0.3769387078212719,0.990058335493012,0.484394506866417,0.7983532982848447,1.0,16/34,23.37%,APOE;ABCG1;SORL1;IGF1;RTN3;ABCA2;PICALM;ROCK1;RELA;RTN4;CASP3;GSAP;GGA3;EPHA4;ABCA7;TMED10
prerank,metallo-sulfur cluster assembly (GO:0031163),0.40723147491722833,0.9898391153729323,0.4940079893475366,0.7984200128496438,1.0,10/22,25.50%,ABCB7;NUBP2;NUBP1;CIAO2B;CIAO2A;NFS1;GLRX5;HSPA9;FXN;CIAO1
prerank,keratinocyte differentiation (GO:0030216),0.38563529744835795,0.9897901070688795,0.5,0.7981032248895329,1.0,2/29,2.89%,ANXA1;ADAM9
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.4730205201098737,0.9891358884185936,0.4764795144157815,0.7991783178755588,1.0,3/10,12.99%,RPS27A;UBC;CHFR
prerank,aortic valve development (GO:0003176),0.3771902179768707,0.9885318333615137,0.5085158150851582,0.8001302919583824,1.0,7/34,11.96%,TNFRSF1B;SOX9;SNAI2;RB1;BMPR2;ROCK1;NOTCH1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.413255860742337,-0.9882697216602235,0.47790055248618785,0.8410348579639444,1.0,2/10,3.29%,PRKCE;ATP1A2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.38641368248837527,0.9880565674123779,0.4864516129032258,0.8008032385816459,1.0,4/29,8.01%,APOE;NR1H3;ZBTB20;SLC27A1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.35696604105693924,0.9876224828585112,0.49361207897793263,0.8013894621171634,1.0,9/51,12.77%,PPARG;SORL1;ACVR2A;HIPK2;BMPR2;FSTL1;RBPMS2;NOTCH1;LEMD3
prerank,regulation of regulated secretory pathway (GO:1903305),-0.29176390541461256,-0.9873966351220945,0.445,0.8414756701093973,1.0,8/34,8.84%,SYT1;RIMS1;RAB27A;RIMS2;SYT7;SYT2;SYT4;SYT6
prerank,negative regulation of protein binding (GO:0032091),0.33987196951948795,0.9870168356902179,0.5094130675526024,0.8023508576891952,1.0,17/71,16.59%,PRKCD;CDKN1A;ITGA4;TFIP11;SORL1;PSME3IP1;PEX14;CTSZ;DVL1;ROCK1;GSK3B;STYX;PPP1CA;SLPI;BAX;IFIT2;CAMK1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.32420754958500875,0.9866429345573917,0.5260960334029228,0.8027874861178781,1.0,24/128,15.36%,GDF15;ZMIZ1;GCNT2;RUNX2;ADAM9;JUN;APPL2;LPXN;DDX5;RPS27A;UBC;ACVR2A;ACVRL1;BMPR2;ITGB1;SIRT1;STUB1;ACVR1B;APPL1;COL3A1;GDF10;PARD6A;NRROS;CBL
prerank,regulation of cell growth (GO:0001558),0.31686124758438666,0.9859813786854459,0.5376016260162602,0.8038786674277638,1.0,36/204,13.96%,SDCBP;SGK1;TFRC;CDKN1A;RAB33B;PPT1;ENPP1;MYL2;SESN2;MMP14;OSGIN1;APBB2;NUBP1;SPHK2;FLCN;HSPA1B;N6AMT1;RB1;PPP1R9B;ACVRL1;BMPR2;EXOSC9;LAMTOR1;ADAM17;NAIF1;DCUN1D5;MTPN;SIRT1;MT3;DCUN1D3;BST2;ACVR1B;ATAD3A;RBBP7;DERL2;HSPA1A
prerank,vascular transport (GO:0010232),0.33766775945037514,0.9856251618720335,0.5233441910966341,0.8042821097632814,1.0,13/81,8.23%,SLC7A2;SLC6A6;TFRC;LRP1;SLC1A5;SLC16A1;SLC27A4;SLC38A1;SLC5A5;ABCC4;ABCC3;SLC27A1;ABCA2
prerank,establishment of epithelial cell polarity (GO:0090162),0.4169860147134702,0.9855981005869234,0.49794238683127573,0.8039202820847157,1.0,7/19,16.55%,RAP2A;CYTH1;FBF1;MSN;CLASP1;GOLPH3;MYO9A
prerank,regulation of viral entry into host cell (GO:0046596),0.38063477239270305,0.9850850558023319,0.4849246231155779,0.8046420165655241,1.0,4/30,8.91%,TMPRSS4;IFITM1;TRIM25;IFITM2
prerank,regulation of intracellular pH (GO:0051453),0.37573015269361576,0.9844864866944538,0.5061124694376528,0.8056172938908871,1.0,8/34,16.84%,SLC9B1;SLC9A3;TMEM165;CLN3;VPS33A;GPR89A;GPR89B;CA2
prerank,endodermal cell differentiation (GO:0035987),0.38016362283503724,0.9844454607367323,0.48370927318295737,0.8052838802312628,1.0,8/31,20.30%,ITGA5;ITGA4;MMP14;COL11A1;LAMA3;CDC73;COL12A1;ITGAV
prerank,negative regulation of developmental growth (GO:0048640),0.3860649120272708,0.9843378426657651,0.4839537869062901,0.805107194943831,1.0,4/30,4.72%,GDF15;WWC2;CDKN1A;PTEN
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.30962024909671154,0.9843138854742012,0.552,0.8047371150512976,1.0,66/417,14.74%,PPARG;MDFIC;CD38;RCOR1;CTNNB1;WWP1;ATXN1;FOXP3;LANCL2;RUNX2;ARID4A;GATAD2A;ID2;NIBAN2;TFAP2B;JUN;NCOR1;RARA;CITED2;E2F1;TAF7;NR3C1;EED;BHLHE40;PEX14;NIPBL;BRCA1;PIAS4;SOX9;RBAK;RB1;EPC1;WWP2;ZNF148;FOXP1;BRD7;ARID5B;DACH1;DDIT3;RLIM;XRCC5;PSPC1;CNOT7;FOXK1;POU3F3;FOXO1;SIRT1;PPARD;ING4;MT3;CIPC;CBX3;SP3;NOTCH1;DEDD2;RELA;GAS6;BCLAF1;ATP8B1;POU2F1;LIMD1;ZKSCAN3;SUV39H2;SHC1;ID4;EID1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.4620173513933187,0.9839490747480893,0.48714069591527986,0.8051703946394608,1.0,5/12,17.90%,TIPARP;PARP2;PARP3;TNKS;TNKS2
prerank,regulation of histone acetylation (GO:0035065),0.3724489127940927,0.9836333847703919,0.5086633663366337,0.8054695493858486,1.0,13/33,23.56%,FOXP3;TAF7;FLCN;BRCA1;BRD7;ARRB1;CAMK1;NOC2L;KMT2A;PAXIP1;RUVBL2;CTBP1;SETD5
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.39589274924208984,0.9836246017332249,0.5045395590142672,0.8050681094735975,1.0,3/27,5.34%,SLC7A2;SLC36A4;SLC38A1
prerank,myofibril assembly (GO:0030239),0.3631702074004018,0.9834396160503966,0.5215311004784688,0.8050687613380298,1.0,4/42,10.91%,SYNPO2L;MYL2;KLHL41;WDR1
prerank,meiosis I (GO:0007127),0.40156448284903146,0.9833038007555236,0.5019762845849802,0.8049720571282559,1.0,6/23,26.71%,BCL2L11;FOXJ3;SGO1;PTTG1;MYBL1;FOXJ2
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.29799284912049706,-0.9828588042275198,0.4975609756097561,0.8523835326886512,1.0,14/30,22.46%,ARSB;HEXB;CHST11;CSGALNACT1;CHST7;HYAL1;CHST9;DSEL;CHSY1;IDS;BCAN;CSPG4;NCAN;CHST12
prerank,cellular response to gamma radiation (GO:0071480),0.42116901051592937,0.9822970707370182,0.4712328767123288,0.8068357461433516,1.0,5/17,19.45%,MAP3K20;XRCC5;WRN;RPL26;TLK2
prerank,"phototransduction, visible light (GO:0007603)",0.4533946581555084,0.9820099393040927,0.5,0.8070589248454283,1.0,1/14,2.40%,GNAQ
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.30615173058892525,-0.9818606891153611,0.4567901234567901,0.8532842201186086,1.0,12/26,20.78%,CCND3;RPTOR;PLCB1;AIF1;EGFR;HYAL1;CDK10;UBE2E2;FGF10;RGCC;EIF4G1;MTBP
prerank,skin development (GO:0043588),0.34006889394251283,0.9816696735168511,0.5107587768969423,0.807412379339069,1.0,12/65,19.08%,ANXA1;ADAM9;PDGFA;COL1A1;HRNR;COL5A2;COL5A3;ITGA3;COL3A1;ATP7A;CASP3;ASAH1
prerank,calcium ion transmembrane transport (GO:0070588),0.3336255804575442,0.9812548250639545,0.5219298245614035,0.807890445421416,1.0,14/86,9.35%,MCOLN3;MCOLN2;ANO6;ATP2B1;P2RX4;SLC8B1;TMEM165;MICU2;MICU1;SLC8A1;PMPCA;LETM1;TRPC3;TRPV2
prerank,cranial nerve development (GO:0021545),-0.39274535383638937,-0.9812333611690371,0.49575070821529743,0.8530691922651116,1.0,3/11,12.17%,SALL1;PAX2;ERBB3
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3158537116986791,0.9810203591902785,0.5315682281059063,0.8079899773560807,1.0,41/190,19.31%,APLNR;XDH;ADGRG3;FNIP1;WWC2;TNIP1;TANK;RIPK1;PTEN;DUSP3;PPIF;THBS1;DAG1;GPD1L;NR1H4;PPEF2;FLCN;EPM2A;CD22;PLEKHA1;DDIT3;ESR1;NLRC3;SIRT1;RORA;TREM2;RNF34;RELA;NPRL3;LIMD1;TNFAIP3;MCL1;CDC34;ARHGAP25;NPRL2;DGKG;NDUFS3;NOC2L;PPP2R5C;PIK3CB;STAMBP
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.34392306410475104,0.9809650428569262,0.5349611542730299,0.8076854040316807,1.0,18/70,18.61%,PDPK1;FAS;RIPK1;TNFRSF1B;MLLT11;HIPK1;IL6R;GSK3B;ACVR1B;DEDD2;APPL1;BAX;MCL1;TRAF2;BID;CASP2;CASP3;CRADD
prerank,protein localization to synapse (GO:0035418),-0.37874952970792386,-0.9807604219234873,0.4817073170731707,0.8523832450028411,1.0,2/12,1.03%,NRXN1;NLGN1
prerank,cellular response to interleukin-7 (GO:0098761),0.42763662420723053,0.980729676685878,0.5,0.8073745909323629,1.0,5/17,16.87%,STAT5B;IRS2;IL7R;JAK3;BRWD1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.42763662420723053,0.980729676685878,0.5,0.8073745909323629,1.0,5/17,16.87%,STAT5B;IRS2;IL7R;JAK3;BRWD1
prerank,positive regulation of T cell migration (GO:2000406),-0.3381372869709522,-0.9806301787696606,0.45454545454545453,0.8507547126324012,1.0,6/20,15.74%,DOCK8;AIF1;PYCARD;WNK1;RHOA;CCR2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3803390122138703,0.9802580458702553,0.48284625158831,0.8080288757048218,1.0,6/31,11.79%,CHCHD4;PEX7;TIMM17A;PEX14;TOMM20;TIMM17B
prerank,RNA methylation (GO:0001510),0.3478856227577488,0.9802241736188129,0.5074285714285715,0.8076852066084375,1.0,30/60,27.14%,TRMT12;WTAP;LCMT2;TRDMT1;NSUN3;TRMT44;MEPCE;MRM2;GTPBP3;ALKBH8;TFB2M;CBLL1;TRMT10C;RBM15;PCIF1;TARBP1;FBL;TRMT13;DIMT1;MTERF4;TRMT6;METTL8;ZCCHC4;TGS1;NSUN4;TRMO;TRMT10A;FTSJ1;THUMPD3;MTO1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.38376233493546014,0.9801409986537047,0.5132408575031526,0.8074479353071815,1.0,15/29,27.73%,ACD;RTEL1;TERF1;DKC1;PPP6C;SHQ1;MRE11;TNKS1BP1;CDK2;TERF2IP;PPIA;PPP6R3;TINF2;WRAP53;RFC1
prerank,protein acetylation (GO:0006473),0.3779916094207881,0.9800693566903104,0.510939510939511,0.8071783041245232,1.0,13/30,25.74%,GTF2B;CREBBP;NAT10;FOXO1;SIRT1;ING4;NAA10;NAT9;CLOCK;NAA80;NAA15;KAT6A;KAT2B
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.40332276553967933,-0.9800123899210831,0.43380281690140843,0.8505221960896797,1.0,3/10,6.64%,DLGAP1;DLGAP2;AKAP9
prerank,regulation of focal adhesion assembly (GO:0051893),0.34989117940757264,0.9798779483272875,0.5118483412322274,0.8071968544567333,1.0,14/54,17.60%,VEGFA;CORO1C;PTEN;DUSP3;THBS1;DLC1;ACVRL1;ROCK1;BCAS3;MACF1;CLASP1;NRP1;APOD;TEK
prerank,negative regulation of protein catabolic process (GO:0042177),0.36788160660999825,0.979388664042101,0.5049382716049383,0.80786743071185,1.0,12/40,19.61%,TIMP1;RIC1;CTSA;IRAK3;TIMP2;ROCK1;AZIN1;PRKCG;NELL1;SNX3;HMGCR;AZIN2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.46193698517531523,0.9793720678919179,0.49696969696969695,0.8074840508512596,1.0,6/10,30.71%,SETD7;SMYD2;SETD3;SETD6;EHMT1;SETD4
prerank,inner dynein arm assembly (GO:0036159),0.4776653998185761,0.9792566978122641,0.5266362252663622,0.8073348257173488,1.0,1/10,3.80%,CCDC40
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4026668011475844,0.9792044206587756,0.463448275862069,0.807016632915747,1.0,6/20,17.89%,FASN;SLC25A1;PPT1;SCD;GCDH;CBR4
prerank,mesenchymal to epithelial transition (GO:0060231),-0.40999223626686054,-0.9791440394675504,0.47368421052631576,0.8510372397642288,1.0,3/10,8.51%,SALL1;PAX2;BASP1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.42504696056191354,0.9789916346251302,0.5062761506276151,0.807080187154721,1.0,5/17,10.10%,APOE;SORL1;IGF1;RTN3;ROCK1
prerank,regulation of secretion by cell (GO:1903530),0.3552131992795884,0.9789539582199043,0.5181711606096131,0.8067375522520767,1.0,12/54,13.30%,ANXA1;RAB8B;RIC1;RHBDF2;RAB21;STXBP5;RAB12;RAB10;CPLANE2;SYN1;MCTP1;VAMP3
prerank,aromatic amino acid family metabolic process (GO:0009072),0.47555596745815465,0.9788428251126976,0.5086071987480438,0.8065625110198557,1.0,2/10,15.22%,KYNU;ATP7A
prerank,regulation of leukocyte activation (GO:0002694),0.4349469212300225,0.9785012481696717,0.5065693430656935,0.8069231737088561,1.0,3/14,7.29%,GPR137B;SHPK;MFHAS1
prerank,positive regulation of cell differentiation (GO:0045597),0.31112484199270196,0.9781849041175831,0.5504032258064516,0.8072175001876032,1.0,30/237,11.54%,CD36;PPARG;SDCBP;SLC6A6;PRKCH;GCNT2;CTNNB1;CEBPB;IFITM1;RUNX2;ID2;IL6;HGF;ASXL2;ZC4H2;IGF1;COL1A1;SOX9;ACVR2A;PKDCC;ACVRL1;BMPR2;IL6R;PAX8;FES;ARHGEF2;CCN1;ASB4;PPARD;KCTD11
prerank,chondrocyte differentiation (GO:0002062),0.37450139046024394,0.9780962164646274,0.5120405576679341,0.8069949304947359,1.0,8/32,13.06%,RUNX2;RUNX3;SULF2;SOX9;BMPR2;SLC39A14;SULF1;GPLD1
prerank,histone methylation (GO:0016571),0.3977219685959457,0.9773268893340654,0.4979973297730307,0.808309127161262,1.0,7/26,15.44%,SMYD3;NSD3;CREBBP;N6AMT1;SIRT7;SUV39H2;SMYD2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3415118050806575,0.9772700680049786,0.5303867403314917,0.8080106478562152,1.0,21/72,20.72%,PLK2;CDKN1A;SESN2;E2F1;GADD45A;CNOT4;GTSE1;HIPK2;CNOT6L;CNOT7;ING4;NBN;BAX;CNOT6;RPL26;ACER2;CASP2;CRADD;BCL3;PAXIP1;TNKS1BP1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.2998402694193655,-0.9772147454447297,0.458128078817734,0.8544398314046382,1.0,14/28,32.83%,MAPT;MAP2;STMN3;STMN4;STMN2;MAPRE1;STMN1;CAMSAP1;ABL1;GBA2;MAP1S;CLASP2;CAMSAP3;SKA3
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.33079616597190753,0.9772079701267714,0.5403050108932462,0.8077292051870812,1.0,28/88,24.80%,FBXW7;PSMD1;FBXL17;FBXL3;FBXO9;PSMF1;PSMD14;PSMD12;CUL4A;FBXO6;PSME2;CUL1;AMN1;PSMB10;PSMD5;PSMD8;PSMA3;FBXO31;PSMA2;PSMD11;PSMA6;CUL4B;FBXL4;PSMB3;PSME3;FBXO4;DMAC2;PSMC5
prerank,regulation of neutrophil migration (GO:1902622),0.47535928212512035,0.9771725584502734,0.5101088646967341,0.8073844261829689,1.0,3/10,16.15%,MPP1;OLFM4;BST1
prerank,extracellular structure organization (GO:0043062),0.3154476326355051,0.976930389677405,0.5618661257606491,0.8075175215644042,1.0,32/204,15.22%,MMP12;VWF;ICAM2;ADAMTS8;MMP27;SPP1;CD44;ITGA5;ITGA4;PDGFA;COL4A6;MMP14;THBS1;COL1A1;DAG1;LUM;COL4A1;COL5A2;ITGB1;ITGA10;COL11A1;APP;VIT;COL5A3;ITGA3;COL3A1;ADAM19;ITGA8;LAMA4;LAMA3;COL6A2;ATP7A
prerank,tRNA methylation (GO:0030488),0.37954887075715127,0.9768327598870946,0.5254452926208651,0.8073046488963446,1.0,19/34,28.47%,TRMT12;LCMT2;TRDMT1;TRMT44;GTPBP3;ALKBH8;PRORP;TRMT1L;TRMT10C;TARBP1;TRMT13;DALRD3;TRMO;TRMT10A;FTSJ1;THUMPD3;MTO1;METTL1;METTL6
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.40905037354573426,-0.9767140338813087,0.484593837535014,0.8538144082347886,1.0,2/10,4.65%,THRA;PSMC2
prerank,positive regulation of tissue remodeling (GO:0034105),0.4676473836653967,0.9765597416129971,0.5222052067381318,0.8075071000674349,1.0,2/10,12.24%,ROCK1;IL15
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3848602484163048,0.9759467260460198,0.5044359949302915,0.8084336421087444,1.0,9/30,21.63%,SDCBP;WAC;STYX;N4BP1;EIF3H;SGTA;TLK2;OGT;GIPC1
prerank,actin filament depolymerization (GO:0030042),0.45875126617072914,0.9758635866346268,0.4872944693572496,0.8082012630282195,1.0,6/11,19.69%,CFL1;WDR1;MICAL2;DSTN;CFL2;MICAL1
prerank,positive regulation of histone acetylation (GO:0035066),0.38953361977983647,0.9756233702322474,0.5073041168658698,0.8083126229505693,1.0,8/23,22.16%,FOXP3;SPHK2;BRCA1;BRD7;ARRB1;SMARCB1;PAXIP1;RUVBL2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4147150340899414,0.9755619794992832,0.5191780821917809,0.8080327308446071,1.0,3/18,8.05%,SLC43A2;PPIF;NEDD4L
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.24681056693032302,-0.9754279979030065,0.5317460317460317,0.8553003760254284,1.0,21/59,19.05%,ACVR1;TGFBR2;CIT;CDC42BPA;WNK3;TGFBR1;CDK5R1;PRKD1;MAP2K1;MARK2;MAP3K10;PRKCA;CAMK2A;PRKD2;WNK1;CDK10;DYRK4;CSNK2B;TTBK1;SBK1;LMTK2
prerank,translation (GO:0006412),0.3142644760700983,0.9749461285737376,0.5635808748728383,0.8089882203163165,1.0,47/208,17.41%,RPL3L;FARS2;TNIP1;IGF2BP3;EEF1A1;AGO2;RPL18A;MRPL11;RPS14;RPS11;RPS27A;MRPL23;RPL17;RPL23;N6AMT1;DARS1;ETF1;RPL36A;EIF4EBP2;COPS5;MRPS7;RPL22;RPS21;RRBP1;MRPL32;MRPL36;GTPBP2;MRPS28;EPRS1;SARS2;SARS1;RPL10A;MRPL28;DHPS;RPS26;MRPS21;IARS2;SRBD1;QRSL1;MRPL35;RPL15;RPL10;RPSA;AIMP1;MRPL43;RPL7;RPL26
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.45857977349459333,0.9748596717498081,0.5105421686746988,0.8087329570690783,1.0,1/11,0.92%,ZMIZ1
prerank,mismatch repair (GO:0006298),0.3911983252965227,0.9748525042700503,0.507323568575233,0.8083261466164278,1.0,4/27,6.89%,MCM9;MSH4;MUTYH;PMS1
prerank,positive regulation of GTPase activity (GO:0043547),0.3127146127115704,0.9747492006241706,0.5582573454913881,0.8081192098414174,1.0,25/188,11.43%,ARHGAP24;ABR;TBC1D22A;TGM2;RIC1;CORO1C;TBC1D25;TBC1D1;TBC1D2;SNX9;TBC1D12;RALGAPA2;SLC27A4;TBC1D10A;FLCN;DOCK10;ARAP1;TBC1D2B;PICALM;ITGB1;GSK3B;TBC1D22B;CCDC125;TBC1D15;BCAS3
prerank,transition metal ion transport (GO:0000041),0.3691823920814465,0.9747397670127825,0.5182849936948297,0.8077163546359604,1.0,11/35,19.32%,TFRC;SLC11A2;HEPH;TRPC3;MT3;SLC11A1;ATP7A;MELTF;SLC31A2;FTH1;SLC30A1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4214346463993222,0.9744618794526884,0.5235378031383737,0.8079100450508724,1.0,8/18,19.90%,KIF20B;RUFY3;ROCK1;PTK2B;BCAS3;TEK;ARFGEF1;SHTN1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.30987177482135847,0.974007187491801,0.5721493440968718,0.8085173429642669,1.0,50/259,15.95%,MTSS1;SDCBP;MAK;RILPL2;FGD6;RAP2A;RAB8B;PIBF1;SPEF1;SNX10;ANO6;EMP1;CFAP70;SNAP29;ATP6V0D1;KIF27;ASAP1;ABCC4;PARVB;WDPCP;CFAP20;FBF1;KIF3A;ACTR3;DYNC2I2;PPP1R9B;TNIK;ITGB1;RAP2B;RHOD;CCDC66;IFT46;CFAP410;NOTCH1;PMP22;MYLK;CPLANE2;FGD5;IFT52;OCRL;IFT140;SSX2IP;ARL3;WHAMM;FGD3;GOLPH3;EXOC4;OFD1;VSTM5;NRP1
prerank,cellular response to light stimulus (GO:0071482),0.3414933300708505,0.9738439184264682,0.5401129943502825,0.8084953280389837,1.0,19/66,24.24%,AQP1;PRKCD;COPS9;CREBBP;EIF2AK4;ATF4;RHBDD1;NSMCE3;N4BP1;INO80;RPL26;CDC25A;NOC2L;EIF2S1;TAF1;RUVBL2;POLD1;ERCC4;USP47
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.3593733454986658,-0.9731284670767868,0.47586206896551725,0.8598732046809967,1.0,3/15,4.33%,TGFBR2;FGFR2;TGFBR1
prerank,regulation of protein polymerization (GO:0032271),-0.2789619667105599,-0.9724654139919369,0.48663101604278075,0.8597724257328747,1.0,18/35,31.38%,FCHSD2;MAPT;MAP2;HSP90AA1;TPPP;DBNL;TPPP3;TTBK1;ABITRAM;DBN1;CAMSAP1;PAK3;ABL1;GBA2;FCHSD1;ARHGAP28;ESAM;CAMSAP3
prerank,histone H3-K9 demethylation (GO:0033169),0.4706433561744969,0.9723043913935733,0.512743628185907,0.8116637949270334,1.0,4/11,14.36%,KDM4C;KDM3A;JMJD1C;KDM7A
prerank,dendritic cell chemotaxis (GO:0002407),-0.35912546384762073,-0.9722176225587001,0.48231511254019294,0.8585597419290422,1.0,7/14,15.93%,GPR183;CCR5;TRPM4;TRPM2;CCR2;PIK3CG;CCR1
prerank,positive regulation of phospholipase activity (GO:0010518),0.39748637055558045,0.9719587038859255,0.527027027027027,0.8120105823055668,1.0,4/22,9.91%,PDPK1;ABL2;GNA13;ESR1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4613288877362819,0.9719040307506532,0.5112540192926045,0.8117138093820396,1.0,3/10,13.96%,JUN;CITED2;HSPA1A
prerank,regulation of establishment of planar polarity (GO:0090175),0.32273865686721404,0.9718150828715606,0.5355603448275862,0.8115033081674708,1.0,33/88,27.06%,SPEF1;PSMD1;DVL1;FZD7;PSMF1;PSMD14;FZD5;PSMD12;PFN1;FZD2;AP2B1;PARD6A;CELSR1;PSME2;DAAM1;VANGL2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;NPHP3;AP2S1;PSMC5;CLTC;AP2A2;PSMC1;AP2A1;ROR2
prerank,chromatin remodeling at centromere (GO:0031055),-0.2953060403656312,-0.9717049747909108,0.46,0.8580646368633703,1.0,18/31,34.98%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;RBBP4;CENPK;CENPO;NPM1;CENPT;CENPQ;CENPN;CENPH;CENPI;CENPW;HELLS;SMARCA5;CENPL
prerank,positive regulation of telomere capping (GO:1904355),0.4282711508388065,0.9715904439616824,0.5334261838440112,0.8115902780574563,1.0,6/17,23.72%,RTEL1;HNRNPD;TNKS;TNKS2;PKIB;NEK7
prerank,regulation of inclusion body assembly (GO:0090083),0.4567585633844717,0.9714631446836468,0.5110062893081762,0.8114611336854551,1.0,3/11,13.96%,DNAJB6;HSPA1B;HSPA1A
prerank,vesicle coating (GO:0006901),0.3435453229899508,0.9714228813099651,0.5398633257403189,0.8102958824671878,1.0,25/61,25.33%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;SEC24B;PEF1;PPP6R1;PREB;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3435453229899508,0.9714228813099651,0.5398633257403189,0.8102958824671878,1.0,25/61,25.33%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;SEC24B;PEF1;PPP6R1;PREB;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,COPII vesicle coating (GO:0048208),0.3435453229899508,0.9714228813099651,0.5398633257403189,0.8102958824671878,1.0,25/61,25.33%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;SEC24B;PEF1;PPP6R1;PREB;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,peptide hormone secretion (GO:0030072),0.3895580171949658,0.9711397333440347,0.5082382762991128,0.8105152593925182,1.0,2/26,2.99%,ANXA1;IL6
prerank,peptidyl-serine modification (GO:0018209),0.3149622954462221,0.9704244021166024,0.5601233299075026,0.8116941768356957,1.0,43/166,19.98%,SGK1;GALNT3;TLK1;PRKCH;RPS6KA2;MAPKAPK3;IKBKE;PLK2;PDPK1;PRKCD;SRPK2;PARP2;PKN3;DYRK1A;TOP1;HIPK1;HIPK2;CSNK2A2;ROCK1;GSK3B;PKN2;PAK2;DCLK3;PRKCB;STK38;NAA10;DYRK2;GAS6;DGKQ;MAST4;UHMK1;TNKS;LATS1;PRKCG;CAMK1;CSNK2A1;CSNK1G1;STK4;STK32C;TLK2;TBK1;MKNK2;CAB39
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.4467443386601792,0.970403426307028,0.5169366715758469,0.8113271546984158,1.0,1/13,0.92%,ZMIZ1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.27111057071757516,-0.9703599454294758,0.5030674846625767,0.859849417453632,1.0,11/44,10.34%,EVL;PPM1E;LIMCH1;LIMK1;TGFBR1;PAK1;PPM1F;ITGB1BP1;CARMIL1;TESK1;FERMT2
prerank,sarcomere organization (GO:0045214),0.3833031514866379,0.9703198156101469,0.49428208386277,0.8111071968360004,1.0,2/27,10.91%,SYNPO2L;WDR1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.42382847532013546,0.9702574200341968,0.5378031383737518,0.8108359385312384,1.0,2/17,2.89%,SYK;ADAM9
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3041125653952413,0.9701219883200292,0.597,0.8107380414751345,1.0,77/497,14.74%,PPARG;MDFIC;CD38;RCOR1;SAMD4A;CTNNB1;WWP1;ATXN1;FOXP3;LANCL2;RUNX2;ARID4A;GATAD2A;ID2;CDKN1A;NIBAN2;TFAP2B;JUN;DAPK1;ENPP1;DDX6;NCOR1;RARA;IGF2BP3;CITED2;E2F1;TAF7;NR3C1;EED;BHLHE40;PEX14;NIPBL;BRCA1;PIAS4;SOX9;RBAK;RB1;EPC1;WWP2;ZNF148;FOXP1;ACVRL1;BRD7;ARID5B;DACH1;TERF1;BMPR2;DDIT3;RLIM;XRCC5;PSPC1;CNOT7;GSK3B;FOXK1;POU3F3;FOXO1;SIRT1;PPARD;ING4;MT3;CIPC;CBX3;SP3;NOTCH1;EPRS1;DEDD2;RELA;GAS6;BCLAF1;ATP8B1;POU2F1;LIMD1;ZKSCAN3;SUV39H2;SHC1;ID4;EID1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.24163131009285307,-0.9697546334234947,0.5299145299145299,0.859668388492128,1.0,14/65,13.66%,LDLRAD4;SMAD3;TGFBR2;SPRED1;SNX6;SMURF1;TGFBR1;SMAD7;HTRA3;LTBP1;SPRED2;FBN2;SMAD2;SPRED3
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.27420133239364053,-0.9695398729294673,0.49740932642487046,0.858288747647052,1.0,24/38,37.45%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;RBBP4;CENPK;CENPO;NPM1;CENPT;ATRX;ASF1B;CENPQ;CENPN;CENPH;ASF1A;CENPI;HIRA;HAT1;CENPW;SMARCA5;CENPL;H3-3A;CENPS
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.45197208758898616,0.9694227169423707,0.5250737463126843,0.811908512028098,1.0,1/11,1.59%,CTNNB1
prerank,detection of mechanical stimulus (GO:0050982),0.41300031442878715,0.9693019080531984,0.518970189701897,0.8117703863544099,1.0,4/19,11.82%,CTNNB1;PKD1L2;PIEZO1;PIEZO2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.4321004387046084,0.969168256053712,0.5181564245810056,0.8116520164709009,1.0,3/15,6.29%,SAMD8;PRKCD;SPHK2
prerank,response to interleukin-1 (GO:0070555),0.3301584980456122,0.9690703682900005,0.5400890868596881,0.8114489935757846,1.0,13/73,15.89%,ANXA1;IRAK2;TANK;IRAK3;SOX9;SIRPA;APP;RELA;CX3CL1;ACOD1;YTHDC2;MYD88;CCL7
prerank,regulation of sister chromatid cohesion (GO:0007063),0.44749307770178104,0.9690391728932258,0.5080291970802919,0.8110989587139091,1.0,5/12,22.74%,CTNNB1;RB1;RAD21;HDAC8;WAPL
prerank,regulation of gene silencing by miRNA (GO:0060964),0.34068794108606537,0.9689995502030868,0.5337209302325582,0.8107614561445333,1.0,18/62,23.05%,PPARG;POLR2A;AGO2;POLR2L;TPR;POLR2G;NUP50;POLR2I;PUM2;LIMD1;NUP98;NUP88;NUP188;NDC1;NUP43;NUP54;STAT3;RANBP2
prerank,positive regulation of immune response (GO:0050778),0.34210285587557254,0.9688313158614219,0.5292096219931272,0.810735895481664,1.0,9/64,12.24%,TLR8;LILRB1;CD46;ADAM8;SPHK2;EIF2AK4;CYBA;SIRT1;IL15
prerank,metal ion homeostasis (GO:0055065),0.3645650828906042,0.9687704943321692,0.5201465201465202,0.8104438681232836,1.0,9/40,14.19%,TFAP2B;SLC8A1;LETM2;SLC12A3;SLC12A8;TESMIN;LETM1;MT3;SLC12A7
prerank,hemidesmosome assembly (GO:0031581),-0.37782481199589957,-0.9687592658320574,0.4942528735632184,0.8585487429676095,1.0,2/11,2.19%,DST;ITGA6
prerank,ATP transport (GO:0015867),0.47276764905200835,0.968669400748325,0.5287878787878788,0.8102488521747487,1.0,5/10,22.74%,SLC25A42;SLC17A9;SLC25A17;CD47;SLC25A24
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.3700539622820147,-0.9684601493643921,0.5119760479041916,0.8574582802785323,1.0,3/13,9.15%,IL6ST;OAS2;STAT1
prerank,myelination (GO:0042552),0.35154072266191866,0.9682642174605893,0.5164433617539586,0.8107370178715321,1.0,8/46,13.47%,B4GALT5;CXCR4;ABCD1;B4GALT6;EPB41L3;PLLP;PMP22;DEGS1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3472381135909925,0.9682522287372596,0.5375,0.8103451277326398,1.0,18/57,22.25%,EBNA1BP2;BYSL;NOP14;WDR74;MRPL36;CUL4A;PAK1IP1;WDR12;RPL7;RPL26;SHQ1;MALSU1;NOC2L;DHX37;XPO1;CUL4B;GTF3A;BOP1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3157893879170115,-0.9678731195406249,0.504,0.8532850270797108,1.0,11/20,31.45%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3157893879170115,-0.9678731195406249,0.504,0.8532850270797108,1.0,11/20,31.45%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3157893879170115,-0.9678731195406249,0.504,0.8532850270797108,1.0,11/20,31.45%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.46558685838209124,0.967548849621574,0.5370650529500757,0.8115271675175123,1.0,1/10,2.08%,FOXP3
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3929337220612308,0.9673933740850791,0.5,0.8114490811615334,1.0,6/22,11.96%,P2RX4;IGF1;GLRX3;ROCK1;MTPN;NOTCH1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.37848728835190326,-0.9669740346265079,0.5161290322580645,0.8539051437161229,1.0,4/11,24.63%,SEMA5A;STMN2;NES;KATNB1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.44132342987823936,0.9669493976856481,0.4910979228486647,0.8120147097348084,1.0,1/12,0.65%,B3GNT8
prerank,folic acid-containing compound metabolic process (GO:0006760),0.41380181142467365,0.9668741339603133,0.5151915455746368,0.8117699638318391,1.0,6/19,18.81%,MTHFS;FOLR2;SLC25A32;MTHFD1L;MTRR;SLC19A1
prerank,cellular response to interleukin-1 (GO:0071347),0.3117115232207552,0.9668129796745689,0.5472481827622014,0.811473860413837,1.0,45/143,26.44%,ST18;IRAK2;PSMD1;TANK;IRAK3;RPS27A;UBC;SOX9;MAP3K8;SIRPA;PSMF1;PSMD14;TAB2;PSMD12;RELA;CX3CL1;SQSTM1;ACOD1;PSME2;CUL1;MYD88;CCL7;PSMB10;PSMD5;UBE2V1;PSMD8;PSMA3;PSMA2;CCL25;PSMD11;PELI2;PSMA6;CD47;PSMB3;PSME3;IRAK1;TRAF6;PSMC5;TAB1;MAP3K7;GBP3;TAB3;RC3H1;PSMC1;CCL2
prerank,metal ion export (GO:0070839),-0.2941428842665655,-0.9667959827213118,0.5,0.8524864511030318,1.0,3/31,5.29%,ATP1B1;ATP1A2;ATP1B2
prerank,linoleic acid metabolic process (GO:0043651),0.4222699201736475,0.9664529994436952,0.5115606936416185,0.8118580802837895,1.0,2/17,11.45%,ABCD1;ELOVL1
prerank,clathrin-dependent endocytosis (GO:0072583),0.3866407059606438,0.9662152798295914,0.5141752577319587,0.8119415261034589,1.0,16/26,28.55%,GAK;LMBRD1;PICALM;FCHO1;SIGLEC1;AP2B1;INPP5F;ITSN1;FCHO2;AP2S1;GPR107;CLTC;AP2A2;AP2A1;DNAJC6;CANX
prerank,response to UV-B (GO:0010224),0.448030111995009,0.9661623482238375,0.5123076923076924,0.81166734494213,1.0,3/12,12.98%,CDKN1A;MFAP4;RELA
prerank,regulation of mitotic cell cycle (GO:0007346),0.3082244173473144,0.9659625654195091,0.5682281059063137,0.8116908924767694,1.0,48/171,24.85%,IQGAP1;SDCBP;CCDC8;KIF20B;PSMD1;ANAPC1;DUSP3;SIK1;HNRNPU;RB1;DDB1;PIM3;INTS13;PKN2;SIRT1;PSMF1;PSMD14;APP;PSMD12;AFAP1L2;PSME2;CUL1;ANAPC10;GAS1;PSMB10;PSMD5;PSMD8;PSMA3;FBXO5;CDK13;PSMA2;UBE2S;ANAPC15;PSMD11;PSMA6;LGMN;TTL;CCDC57;XPC;USP2;PSMB3;PSME3;BTG1;NEK7;DLGAP5;UBE2E1;PSMC5;ANAPC7
prerank,apical junction assembly (GO:0043297),0.34615328958931346,0.9657602820618354,0.5552995391705069,0.8117159918695299,1.0,10/53,15.58%,MICALL2;APC;FBF1;PDCD6IP;STRN;PKN2;PAK2;WDR1;PARD6A;CTNNA1
prerank,response to glucagon (GO:0033762),0.4077294412913777,0.965712937255858,0.5256756756756756,0.8114134682130801,1.0,7/19,22.88%,ADCY7;ADCY8;ADCY3;CRY1;CREB1;ADCY5;ADCY9
prerank,inositol lipid-mediated signaling (GO:0048017),-0.25728275353394703,-0.9656197425425159,0.5253164556962026,0.8537064519069811,1.0,7/50,4.92%,PLCL1;CSF1R;PLCB1;ADAP2;KCNH1;IRS1;PLCH1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.44731576296842834,0.9654679781876867,0.5183016105417276,0.8115520245392341,1.0,3/13,17.79%,MTM1;TMEM39A;PHF23
prerank,response to ATP (GO:0033198),-0.33222801092322085,-0.9653864832816123,0.5053003533568905,0.8524355156061137,1.0,3/18,6.67%,P2RY12;RYR3;HSP90B1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.3969229355295517,-0.964875631225761,0.4702842377260982,0.851851645723029,1.0,1/10,1.84%,TGFBR2
prerank,C4-dicarboxylate transport (GO:0015740),0.44061873290811737,0.9648585793385158,0.512372634643377,0.8124928692122199,1.0,1/14,0.63%,LRRC8D
prerank,tryptophan catabolic process (GO:0006569),0.4541240898370407,0.9647989823110175,0.5142857142857142,0.8122145249110861,1.0,1/11,2.55%,KYNU
prerank,positive regulation of reproductive process (GO:2000243),0.37151276043598436,0.96470562269684,0.5224646983311938,0.8119993345697403,1.0,4/31,11.94%,VEGFA;LHFPL2;AGO2;ACVR1B
prerank,positive regulation of lamellipodium organization (GO:1902745),0.37213815385881793,0.9644924888343646,0.5417185554171855,0.8120671420571431,1.0,5/32,7.94%,ARPC2;CORO1C;PIK3CA;RREB1;ACTR3
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.31513697904280025,0.9643710883511097,0.582135523613963,0.8119160991953739,1.0,39/168,17.41%,DHX34;SAMD4A;TENT4B;RPL18A;DDX5;RPS14;RPS11;CNOT4;RPS27A;RPL17;RPL23;ETF1;RPL36A;TENT2;CNOT6L;EXOSC9;RPL22;RPS21;PATL1;POLR2G;CNOT7;PPP2R2A;NBDY;ERI1;NCBP2;EXOSC8;RPL10A;RPS26;UPF2;RPL15;RPL10;CNOT6;EIF4A3;RPSA;EXOSC10;THRAP3;PAN3;RPL7;RPL26
prerank,modulation by symbiont of host process (GO:0044003),0.4670974662724428,0.9641815919495471,0.5458860759493671,0.8119279045932172,1.0,2/10,7.19%,RPS27A;UBC
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.36314316603410196,0.9640619955651127,0.5190651906519065,0.8117786535751702,1.0,16/36,24.59%,APAF1;FOXO4;E2F1;EED;BRCA1;UXT;EPC1;CBX3;RBBP7;MGA;EHMT2;CBX5;TFDP1;PHC3;RNF2;PCGF6
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3746628680611022,0.9638934785441242,0.5451127819548872,0.8117236227862058,1.0,4/33,4.71%,CEL;ABR;FABP5;BTBD9
prerank,modulation by host of viral genome replication (GO:0044827),0.43219597776186874,0.9638823082512291,0.5140845070422535,0.8113369596507768,1.0,4/13,14.78%,EIF2AK4;VAPA;PRKN;YTHDC2
prerank,regulation of protein localization to membrane (GO:1905475),0.3826512823002243,0.9630633528849493,0.5287206266318538,0.8126568426819251,1.0,7/28,13.77%,MMP14;CLN3;STX8;VTI1B;VPS4A;APPL1;PRKN
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.43638061651455795,0.9630344305810977,0.5399129172714079,0.8123040168659429,1.0,5/13,24.93%,EDEM2;DERL2;BRSK2;BCAP31;SVIP
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3625506025614667,-0.9629815187026465,0.5273311897106109,0.8551617844406597,1.0,2/13,3.65%,TGFBR2;RYR2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.42528727641252284,0.96296706340668,0.5221745350500715,0.8120323877354428,1.0,5/15,14.21%,ZFAND2A;RAB3GAP2;RAB10;SPCS2;ZFAND2B
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.33055426185248166,0.9628416754348708,0.5487804878048781,0.8118913549636002,1.0,18/76,15.95%,SYNPO2L;NCK2;BAIAP2;SORBS3;DYNC1H1;SNX9;STAP1;PTK2B;FES;WDR1;BCAS3;PFN1;HCLS1;SYNPO;TENM1;CX3CL1;PFN2;NRP1
prerank,regulation of microtubule nucleation (GO:0010968),0.46332486576896487,0.9627608607163428,0.5310136157337367,0.8116592846619561,1.0,6/10,26.80%,RANGRF;HSPA1B;HSPA1A;EML2;CKAP5;MECP2
prerank,histone H4 deacetylation (GO:0070933),0.4613274091263705,0.9625600593867628,0.5077639751552795,0.8116633544460439,1.0,1/10,1.17%,RCOR1
prerank,aerobic respiration (GO:0009060),0.40078863013489496,0.962536912096046,0.53125,0.8113145196692032,1.0,5/20,16.44%,MTFR1L;NDUFS8;SDHB;ATP5F1D;SIRT3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.341448409643224,0.9624927165989696,0.5429864253393665,0.8110066147452523,1.0,8/60,10.53%,CTNNB1;ACD;HGF;RFC3;FGFR4;POLG2;XRCC5;DKC1
prerank,cellular component maintenance (GO:0043954),-0.37494669097788613,-0.9621040352751291,0.49101796407185627,0.8555880167841001,1.0,4/12,12.45%,PICK1;IGF1R;MTMR2;PRNP
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.39105378342885727,0.962071136826478,0.538562091503268,0.8114899069030678,1.0,6/24,17.60%,NFE2L2;PDPK1;MAPK7;GAS6;TNFAIP3;TEK
prerank,purine nucleotide biosynthetic process (GO:0006164),0.45180947301190577,0.9618690652443617,0.5513196480938416,0.8115273155533133,1.0,2/12,5.02%,ADSL;PPAT
prerank,ncRNA transcription (GO:0098781),0.4471331025680896,0.9615744349228768,0.5422222222222223,0.8117787024465922,1.0,4/13,21.79%,RPAP2;SIRT7;USPL1;GTF3A
prerank,proteoglycan biosynthetic process (GO:0030166),0.3678199474131735,0.9615174207845888,0.5336721728081322,0.8114841628511267,1.0,6/31,9.45%,XYLT1;EXT1;UGDH;B4GALT7;IGF1;BMPR2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3183550960316345,0.9614224602554187,0.564185544768069,0.8112848839695825,1.0,24/100,19.66%,PIK3R5;HGF;PDGFA;PTEN;IGF1;IRS2;PIK3CA;SOX9;NLRC3;SIRT1;ROR1;TREM2;MAZ;HCLS1;FGR;CBL;PIP4K2A;NCF1;TEK;PPP2R5C;PIK3CB;STAMBP;GAB1;OSM
prerank,prostanoid metabolic process (GO:0006692),-0.3642181070714664,-0.9611581415256284,0.5369127516778524,0.8562740389769933,1.0,3/13,3.72%,HPGD;PTGS1;ACOX1
prerank,apoptotic nuclear changes (GO:0030262),0.3914791167917897,0.9611551257159399,0.5351925630810093,0.8114468021714846,1.0,7/24,21.15%,DFFB;BLCAP;DEDD2;DNASE2;ACIN1;CASP3;DFFA
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3857125798013836,0.9606635320720311,0.5333333333333333,0.8120917197074509,1.0,11/25,21.70%,PSME3IP1;RPL23;HIPK2;CSNK2A2;PSMF1;PRKCG;CSNK2A1;SGTA;ALAD;TAF1;EPHA4
prerank,actin filament network formation (GO:0051639),0.4597661342338656,0.9606351192446946,0.5425531914893617,0.8117587522146589,1.0,3/11,11.39%,LCP1;ACTN1;PLS3
prerank,negative regulation of cell motility (GO:2000146),0.31826017399448314,0.960443007508953,0.5788359788359788,0.8117611960533413,1.0,23/108,13.12%,MITF;RAP2A;IFITM1;FOXO3;PTEN;CITED2;DUSP3;ZMYND8;DAG1;STK24;FLCN;NF2;DLC1;ACVRL1;DACH1;RAP2B;CCDC125;FBLN1;BST2;SULF1;ARID2;MCTP1;PODN
prerank,regulation of translation (GO:0006417),0.3116692432470853,0.9603041508076706,0.5760980592441267,0.8116632162361698,1.0,44/173,20.82%,SAMD4A;EIF1;VIM;IL6;CD28;FOXO3;DAPK1;DDX6;ATXN2;IGF2BP3;YTHDF3;NSUN3;THBS1;EIF6;EIF2AK4;LARP4B;ETF1;PUM3;NAT10;EIF3B;EIF5;CNOT7;MTPN;NCBP2;APP;EPRS1;HNRNPD;RPL10;EIF4A3;SYNCRIP;ALKBH1;MTG1;CAPRIN1;RPL26;EIF3H;MALSU1;EIF2B2;EIF4G3;EIF4G2;NCL;EIF3C;BCL3;LARP4;PCIF1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.38641715995039905,0.9602150569381045,0.5270805812417437,0.8114246082200158,1.0,8/25,18.65%,P2RX4;TRAT1;P2RX3;CD22;TREM2;TMBIM4;BST1;HTT
prerank,regulation of neuroblast proliferation (GO:1902692),0.42952919762388186,0.9601406571794854,0.5403458213256485,0.8111903758688458,1.0,3/15,2.56%,CTNNB1;VEGFA;DCT
prerank,protein insertion into ER membrane (GO:0045048),0.36161301367643506,0.9601296621799827,0.5116279069767442,0.81081682591671,1.0,13/37,20.18%,STX5;HMOX1;GET3;MMGT1;VAPA;CYB5A;APP;ALDH3A2;EMC2;EMC4;SGTA;EMC3;VAMP2
prerank,negative regulation of signal transduction (GO:0009968),0.3026541876136405,0.9598973670897915,0.5816532258064516,0.810924604246008,1.0,47/249,17.48%,GDF15;XDH;SIGIRR;FBXW7;LRP1;PRKCD;NIBAN2;ENPP1;MMP14;BRAP;PID1;PTEN;SLC27A4;PTPRE;PALM;THBS1;IRAK3;PTPN12;RITA1;SULF2;KCTD21;GPR108;SNAI2;RB1;WWP2;NFKBIL1;CSNK2A2;NLRP2B;PRKCB;APPL1;APCDD1;MAZ;SULF1;TSPAN15;PHACTR4;TNFAIP3;CX3CL1;ARRB1;ASXL1;WWOX;PTPN1;PIP4K2A;EGFL7;CRY1;ZBTB7A;CSNK2A1;APOD
prerank,kidney development (GO:0001822),0.33569692353889036,0.9596659583641037,0.5502762430939226,0.8110131702395615,1.0,17/65,20.97%,STRA6;VEGFA;TFAP2B;NIPBL;SULF2;CTSH;PAX8;SULF1;ARL3;GDNF;ITGA8;VANGL2;ACE;WFS1;IFT88;C1GALT1;ZBTB16
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3639032795829123,0.959490120699014,0.5230961298377028,0.8110015274038341,1.0,6/31,14.33%,PPARG;TNN;SOX9;NOTCH1;LIMD1;GDF10
prerank,positive regulation of T cell differentiation (GO:0045582),0.36896962883433393,0.9594046949490903,0.5489467162329615,0.8107825337385519,1.0,4/36,8.72%,ZMIZ1;CD46;ADAM8;SART1
prerank,nucleotide biosynthetic process (GO:0009165),0.40984964569175986,0.959167719915191,0.5236111111111111,0.8108627889570359,1.0,3/18,6.99%,ADSL;PPAT;NMNAT1
prerank,regulation of vasculogenesis (GO:2001212),0.43397970905771166,0.9590116562140167,0.5312046444121916,0.810812074733581,1.0,3/14,14.16%,XDH;ASB4;RRAS
prerank,cilium movement (GO:0003341),0.3505053979465748,0.958208025931382,0.5332541567695962,0.8121283695284262,1.0,6/47,12.58%,SPEF1;CFAP70;CCDC40;CFAP53;ODAD1;SPAG17
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.38339903543220044,0.9581947731136297,0.5301369863013699,0.8117522370986862,1.0,5/23,14.13%,VEGFA;SIRT6;SOX9;PAX8;GDNF
prerank,negative regulation of cellular component movement (GO:0051271),-0.3447436317104987,-0.9581882121068451,0.4935483870967742,0.862742533543405,1.0,3/15,5.18%,FRMD5;WAS;SPOCK3
prerank,macrophage activation involved in immune response (GO:0002281),0.42784245762435247,0.957694173834898,0.5361890694239291,0.8124096818569937,1.0,5/13,15.91%,SYK;TYROBP;TREM2;LBP;GRN
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.2744194859490696,-0.9564467976593206,0.5,0.8656564863231406,1.0,13/32,22.86%,NAV3;HDGFL3;MAP2;FGF13;TUBB4A;STMN2;MAPRE1;STMN1;MID1IP1;TPX2;TTBK2;CAMSAP1;CIB1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4611869239889228,0.956440119986035,0.5278219395866455,0.8147348201373033,1.0,5/10,24.02%,HK3;GFPT1;PFKP;PFKM;HK1
prerank,cation transmembrane transport (GO:0098655),0.35357013869127996,0.9560514712987112,0.5495818399044206,0.815177318884641,1.0,6/44,9.83%,SLC7A2;ATP1B4;SLC36A4;MFSD12;P2RX3;SLC25A20
prerank,regulation of establishment of cell polarity (GO:2000114),0.42195951073782323,0.9557056772485227,0.5501432664756447,0.8155315220787831,1.0,5/16,11.43%,KIF20B;RUFY3;ROCK1;PTK2B;BCAS3
prerank,negative regulation of defense response to virus (GO:0050687),0.4597773488874735,0.9555984381157319,0.5312,0.8153631227473207,1.0,1/10,2.85%,RNF26
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.2847601835477473,-0.955287214587665,0.5353535353535354,0.8667887330468307,1.0,9/32,15.22%,PTPRD;IL1RAPL1;ADGRB3;KNDC1;CUX2;CDKL3;YWHAH;RAPGEF2;SS18L2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.39176262448243304,0.9548927759425394,0.5271739130434783,0.8164816479586694,1.0,5/23,11.96%,PIBF1;IL6;IL10RB;PTK2B;NOTCH1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3227245733967389,0.9548346195445891,0.5652173913043478,0.8161964907360677,1.0,9/85,10.14%,MTSS1;VEGFA;RUNX3;RAB33B;IGF1;MCC;SOX9;ACVRL1;NLRC3
prerank,negative regulation of transmembrane transport (GO:0034763),0.45990758018962463,0.9546780871234026,0.5353383458646617,0.8161213338525188,1.0,3/10,11.72%,THBS1;IRS2;PRKCB
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.2454669282296001,-0.9545320434992278,0.5315315315315315,0.866981838797001,1.0,14/57,16.04%,P2RY12;GRM8;OPRM1;CHRM3;CHRM2;AKAP12;GPR37;GABBR1;GNAL;HTR1F;ADCY1;HTR4;AKAP5;GRM7
prerank,regulation of B cell activation (GO:0050864),0.38605286342072015,0.9544694698069391,0.5352480417754569,0.8162087147442506,1.0,5/25,13.66%,IL6;SH3KBP1;ZFP36L2;CD22;TNFAIP3
prerank,phosphate ion transmembrane transport (GO:0035435),0.44391547530752473,0.9540773448535793,0.5335365853658537,0.8166392154666968,1.0,6/12,28.64%,XPR1;SLC37A3;SLC20A2;SLC37A4;SLC25A30;SLC25A10
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.2658379369585316,-0.9536997016275274,0.5254237288135594,0.8673394997006109,1.0,11/41,14.45%,GRM5;CSF1R;TGFA;RELN;NTRK2;SRCIN1;LRP8;ERBB3;AGT;PRNP;DLG3
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.3083359471469064,-0.953168217095315,0.5462184873949579,0.8668684440447785,1.0,8/26,24.58%,THADA;ATP1A2;FMR1;PKD2;FKBP1B;UBQLN1;ADRA2A;CALM3
prerank,base-excision repair (GO:0006284),0.3452437980857584,0.9531561725320723,0.5465116279069767,0.8182340776647574,1.0,8/48,12.63%,ERCC6;RFC3;MUTYH;NEIL1;HUWE1;POLL;MBD4;WRN
prerank,telomere maintenance via telomerase (GO:0007004),0.3761140303856835,0.9527209268208352,0.5586734693877551,0.8187419576433147,1.0,14/28,27.73%,ACD;RTEL1;TERF1;DKC1;PPP6C;SHQ1;MRE11;TNKS1BP1;CDK2;TERF2IP;PPP6R3;TINF2;WRAP53;RFC1
prerank,nucleoside salvage (GO:0043174),-0.396737696097727,-0.9520230730470816,0.5371428571428571,0.8681121229556689,1.0,4/10,18.13%,UPP2;DCK;UCK1;UCKL1
prerank,folic acid metabolic process (GO:0046655),0.4130076890019673,0.9518655384882159,0.5391891891891892,0.8202083750524617,1.0,6/18,18.81%,MTHFS;FOLR2;SLC25A32;MTHFD1L;MTRR;SLC19A1
prerank,response to sterol (GO:0036314),-0.3818109546198022,-0.9518058275855931,0.5365168539325843,0.8668295005860508,1.0,3/11,4.33%,CCR5;TGFBR2;TGFBR1
prerank,regulation of GTPase activity (GO:0043087),0.30825110953632323,0.9516692730336995,0.5957230142566191,0.820249552367503,1.0,29/177,14.42%,PLXNA1;GPR137B;PLXNC1;PLXND1;ARHGAP15;FGD6;VAV3;TGM2;RIC1;TBC1D2;ARHGAP9;SNX9;ADAP1;RASA4;RAB3GAP2;FLCN;DOCK10;ARAP1;VAV1;PICALM;ITGB1;GSK3B;TBC1D15;BCAS3;FGD5;RAPGEF1;OCRL;CX3CL1;FGD3
prerank,replication fork processing (GO:0031297),0.3547328151772509,0.9515005978744173,0.5569155446756426,0.8202119976922628,1.0,7/38,12.63%,ALYREF;ZRANB3;FAM111A;THOC1;EME1;RTEL1;WRN
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.4679267445958073,0.9513606902154542,0.5504587155963303,0.8200994028335383,1.0,5/10,26.38%,NOTCH1;PHACTR4;LRP6;ARHGAP12;LIN7C
prerank,gland development (GO:0048732),0.3405639062850236,0.9513501616973946,0.5675368898978433,0.8197214707906789,1.0,7/59,9.89%,STRA6;ANXA1;CITED2;MSN;SOX9;ARID5B;PAX8
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3653030364514493,0.951316371907718,0.5347985347985348,0.8193959548519832,1.0,6/35,9.91%,ZMIZ1;NR3C1;DDX5;KDM3A;NCOA4;ESR1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3230747453764353,0.9513011486072124,0.5572354211663066,0.8190177227980233,1.0,24/83,18.99%,PLK2;E2F3;CDKN1A;BACH1;E2F1;CUL3;CACUL1;RB1;NASP;CDK7;USP26;DBF4;ACVR1B;CUL4A;POLA1;PPP6C;CUL1;MNAT1;LATS1;ORC1;CDC34;CDT1;CDC25A;FBXO5
prerank,phosphate-containing compound metabolic process (GO:0006796),0.30460252514620656,0.95123270127538,0.6204453441295547,0.8187774888361451,1.0,46/198,20.25%,HTR2B;PLPP3;CERK;HK3;ITPKB;NUDT14;PLA2G2D;ENPP1;SHPK;INPP4A;PTEN;DUSP3;SPHK2;PIK3CA;GPX4;IPPK;TOP1;GFPT1;LHPP;PLCB4;PLA2G4F;PPP3CA;HDHD2;ACYP1;PAK2;PLAAT3;PGP;LIMD1;OCRL;PPP1CA;GDE1;PANK2;PRKCG;INPP5A;PIP4K2A;IMPA2;PFKP;GK5;CERKL;PIK3CB;XYLB;DUSP10;PFKM;PLAA;GCK;GK
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3563809751100033,0.9507406449711144,0.5394088669950738,0.8194428221888491,1.0,7/39,8.18%,RANGRF;RIPK1;PPIF;GPD1L;SPHK2;NEDD4L;WWP2
prerank,protein localization to plasma membrane (GO:0072659),0.3120122365042644,0.9502388773547853,0.6097308488612836,0.8200983340746496,1.0,23/129,14.60%,MYO5A;DENND4C;RAP2A;FLOT1;RAB8B;PRAM1;ZFYVE27;TMEM150A;TSPAN17;GAK;TTC7B;EPB41L3;TNIK;RAB12;ROCK1;RAB10;RAB40C;PACS2;GAS6;TSPAN15;EFR3A;LRP6;CACNB3
prerank,cellular metal ion homeostasis (GO:0006875),0.3180815177348526,0.9502217896532545,0.5804721030042919,0.8197255908054417,1.0,11/102,8.59%,HTR2B;TPCN2;ATP2B1;ATP13A3;SLC8B1;TMEM165;SLC8A1;LETM2;TESMIN;NEDD4L;LETM1
prerank,ganglion development (GO:0061548),-0.3787038823488582,-0.9501838620786225,0.5047318611987381,0.8692001512792376,1.0,4/11,9.00%,UNC5C;FZD3;TUBB3;SEMA3A
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.42804675895877053,0.9495760769514037,0.5384615384615384,0.8207196340081345,1.0,2/13,5.19%,SHISA9;CLN3
prerank,ceramide biosynthetic process (GO:0046513),0.35532114306889273,0.9494887674620021,0.551219512195122,0.8205020348403397,1.0,6/40,7.38%,SPTLC2;SAMD8;SGMS2;B4GALT6;CERS6;SPTSSA
prerank,apical protein localization (GO:0045176),0.44841169712820755,0.9493096809864922,0.5289747399702823,0.8204630344753766,1.0,5/10,25.32%,ATP8B1;CELSR1;VANGL2;GOPC;ACTB
prerank,epithelial cell morphogenesis (GO:0003382),0.4077677691972927,0.9491073709977363,0.5343618513323983,0.8204926482794782,1.0,1/17,0.95%,RILPL2
prerank,cellular response to osmotic stress (GO:0071470),0.39584391147424386,0.9486681835441937,0.5481283422459893,0.8209989817799976,1.0,4/21,12.21%,LRRC8D;AQP1;ARHGEF2;MYLK
prerank,N-glycan processing (GO:0006491),-0.31894850274964254,-0.9486608254391217,0.5376344086021505,0.8714084373607428,1.0,6/18,10.90%,MGAT4A;ST8SIA6;MAN1A2;ST8SIA1;ST8SIA5;ST8SIA3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.31635592661629264,0.9485637815287549,0.5757575757575758,0.8208161807585944,1.0,23/107,20.51%,HTR2B;TPCN2;ATP2B1;ATP13A3;SLC8B1;TMEM165;SLC8A1;SLC39A14;MT3;SLC11A1;SLC39A12;SLC10A7;CXCL12;CCL7;SLC30A1;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,RNA destabilization (GO:0050779),0.4001171965084272,0.9485065597591807,0.5496503496503496,0.8205356653928653,1.0,4/18,10.44%,CELF1;YTHDF3;ROCK1;FTO
prerank,response to metal ion (GO:0010038),0.3275207521850533,0.9484095722366664,0.5679287305122495,0.8203314710782916,1.0,20/67,21.25%,SLC11A2;ADAM9;D2HGDH;THBS1;TESMIN;NEDD4L;PPP3CA;TRPC3;MT3;ATP5F1D;PPP1CA;MTF1;ANXA11;PAM;PPP2CA;CALM2;SEC31A;MT1X;MT1A;PEF1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.39411682704901596,0.9483007380946881,0.5439056356487549,0.820143692127302,1.0,5/23,12.18%,PLA2G2D;ABHD4;PLA2G4F;PLAAT3;LPCAT3
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4190607760338263,0.9479857383648275,0.5619596541786743,0.8203952117764993,1.0,4/14,13.06%,IRS2;DDB1;SIRT1;GPLD1
prerank,pyroptosis (GO:0070269),-0.3383670601033514,-0.9472775298059554,0.5352564102564102,0.8734074003724339,1.0,4/15,11.18%,CASP4;GSDME;APIP;ZBP1
prerank,T cell mediated immunity (GO:0002456),-0.3618852185794632,-0.9472410669143521,0.5028735632183908,0.8716280619903264,1.0,1/13,0.11%,CADM1
prerank,response to glucose (GO:0009749),0.34134403323954976,0.9469472121797795,0.5687645687645687,0.8221575752322247,1.0,12/46,20.25%,ERN1;THBS1;IRS2;ZBTB20;SLC39A14;GPLD1;GAS6;ADCY8;EIF2B2;TCF7L2;VAMP2;GCK
prerank,error-prone translesion synthesis (GO:0042276),0.39646271787927956,0.9467964514139036,0.5444887118193891,0.8220774579216845,1.0,4/21,9.37%,RFC3;RPS27A;UBC;POLH
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.31775366398303384,-0.9467642722414766,0.5254237288135594,0.8710955840838224,1.0,7/23,20.70%,SMAD3;TRIM33;ENG;SMAD7;SMAD2;SMAD4;SOX11
prerank,regulation of endothelial cell migration (GO:0010594),0.3219899098378233,0.9467288688149291,0.5838779956427015,0.8218300215375994,1.0,19/85,19.26%,SASH1;APOE;VEGFA;RHOJ;NRP2;THBS1;FOXP1;ACVRL1;BMPR2;PTK2B;BCAS3;GPLD1;RRAS;GRN;NRP1;TEK;AAMP;PRCP;PIK3CB
prerank,mesoderm formation (GO:0001707),0.41428618106335946,0.9466826521087554,0.5337837837837838,0.8215322786226514,1.0,4/17,15.01%,BMPR2;ITGB1;ITGA3;ITGA8
prerank,pre-miRNA processing (GO:0031054),0.42785490344040167,0.9462776675521429,0.5602322206095791,0.8219547911403943,1.0,5/14,18.52%,AGO2;AGO3;DROSHA;MRPL44;AGO4
prerank,positive regulation of response to wounding (GO:1903036),0.38537345609971435,0.9460442799684746,0.5384615384615384,0.822074906022199,1.0,9/24,26.90%,ANXA1;ITGB1;MYLK;GRN;ARFGEF1;ACTG1;HRAS;HBEGF;VTN
prerank,positive regulation of ruffle assembly (GO:1900029),-0.36131693890030525,-0.9457720260279524,0.5234899328859061,0.8719202125091657,1.0,2/13,1.03%,P2RY12;NLGN1
prerank,protein autophosphorylation (GO:0046777),0.30548436264880335,0.945626202903772,0.6186094069529653,0.8225704337113307,1.0,22/157,10.87%,MAK;PIKFYVE;ERN1;TEC;MAPKAPK3;TAOK3;PDPK1;DAPK1;RIPK1;PIM1;FGFR4;MELK;SIK1;STK24;DYRK1A;EIF2AK4;TNIK;PIM3;GSK3B;PTK2B;PAK2;FES
prerank,mitotic cytokinesis (GO:0000281),-0.25848268258361184,-0.9454583558602028,0.5548387096774193,0.8708714864845643,1.0,21/47,22.65%,ANK3;CIT;ANLN;TRIM36;KLHDC8B;SPAST;SNX18;CENPA;RACGAP1;MYH10;KIF23;STMN1;ECT2;CUL7;CNTROB;EFHC2;EFHC1;NUSAP1;RTKN;KIF4A;CEP55
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3878801670982596,0.9453552694636911,0.5527704485488126,0.8227355357494119,1.0,5/24,16.37%,ITGA5;NIBAN2;MT3;PRKCB;PTPN1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.30430060971568057,0.9453092359798677,0.6123076923076923,0.8224259752664398,1.0,45/161,23.28%,APOE;PSMD1;ZNRF3;CUL3;TNN;STK3;APC;MCC;SOX9;SNAI2;DVL1;DDIT3;GSK3B;PSMF1;PSMD14;PSMD12;SOX2;LIMD1;PRKN;LRP6;PSME2;KREMEN1;LATS1;CCDC88C;MLLT3;PSMB10;PSMD5;PTPRU;PSMD8;AMFR;STK4;PSMA3;PSMA2;PSMD11;WWTR1;TCF7L2;PSMA6;TLE3;RUVBL2;PSMB3;SDHAF2;KLHL12;SIAH2;PSME3;BICC1
prerank,cellular response to pH (GO:0071467),-0.33296744142209256,-0.9449235911610624,0.5179856115107914,0.870437159860403,1.0,7/17,18.43%,MCOLN1;RAB11FIP5;HVCN1;HYAL1;PKD2L1;GPR68;SLC9A1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4227485523268049,0.9445768878751903,0.5481049562682215,0.8235687593059818,1.0,1/14,0.55%,XDH
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.33825205244857975,0.9444990501415458,0.5662790697674419,0.8233386887003268,1.0,10/53,15.49%,EYA1;ERCC6;PRKCD;BABAM2;DDX5;BRCA1;SIRT1;BCLAF1;NSMCE4A;BRCC3
prerank,axon extension (GO:0048675),-0.3096944960978675,-0.9444757983832298,0.5103734439834025,0.8697771821156537,1.0,8/23,14.30%,SEMA5A;AUTS2;HSP90AA1;SLIT1;SEMA3A;NLGN3;ULK2;CYFIP1
prerank,carbohydrate catabolic process (GO:0016052),0.3530797505698503,0.9443983153006994,0.5433734939759036,0.823151137526261,1.0,14/38,26.60%,HK3;TPI1;MANBA;ENO3;DERA;PGM1;NEU1;GAPDHS;PFKM;GCK;PKM;HK1;PGK1;MAN2C1
prerank,positive regulation of chromosome organization (GO:2001252),0.4225140821435125,0.9443867835770405,0.5433186490455213,0.8227785654865183,1.0,7/15,21.62%,SIRT6;RTEL1;SHCBP1L;NBN;RAD21;MRE11;PPP1R10
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2934606987042087,0.9439733039768103,0.795,0.8232534508920537,1.0,330/1646,20.43%,EPAS1;PPARG;MDFIC;ANXA4;CD38;TFEC;APOE;LITAF;ELF2;ZMIZ1;ATP1B4;IRX3;RCOR1;TFEB;HOPX;TRPS1;NFE2L2;ZNF3;CTNNB1;MITF;VEGFA;POLR2A;WWP1;CEBPB;ZEB2;ERCC6;ATXN1;GRHL1;FOXP3;EN2;ST18;KDM4C;ATF3;CXXC1;SPP1;VEZF1;WWC2;LANCL2;RUNX2;ARID4A;NR1H3;GATAD2A;E2F3;ID2;IL6;TOX4;CDKN1A;FOXO3;NIBAN2;WAC;BAZ1A;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;MED12;SNX5;NCOR1;PHF20;HNRNPAB;MYCBP;RARA;ZFP28;MZF1;CITED2;FOXO4;BRIP1;BACH1;E2F1;TAF7;IGF1;HAS3;ZBTB42;UBE2L3;PCID2;STAT5B;COL1A1;SAP30;RNF10;APBB2;NR3C1;ASCC2;EED;MLLT11;NSD3;NR1H4;DDX5;CREBBP;BHLHE40;TESMIN;THOC1;DYRK1A;PEX14;KLF5;TGIF1;ATF4;NIPBL;REL;IFRD1;KDM3A;ZBTB20;BRCA1;ZNF177;ETV6;BAZ2B;RREB1;TAF5;POLR2L;POU3F1;UXT;PIAS4;JMJD1C;BRD2;TCF20;SOX9;SNAI2;RBAK;RB1;HOXA3;PRDM8;LCOR;EPC1;WWP2;ABCA2;ZNF148;FOXP1;IRF2;DVL1;CHD3;ZFAT;CBFB;ACVRL1;CARF;BRD7;ARID5B;TBL1XR1;CHD2;DACH1;HIPK2;PICALM;NCOA1;NR5A1;DDIT3;BRD3;RLIM;FZD7;XRCC5;PAX8;ESR1;NR2C1;WDR77;HCFC2;PSPC1;ASCC1;CNOT7;FOXK1;ZFPL1;KDM2A;MAFG;POU3F3;FOXO1;MED16;KMT2E;SIRT1;MAFB;SALL2;MED26;NFATC3;PPARD;CUX1;ZNF691;ING4;MT3;GPBP1L1;CAND2;LCORL;CIPC;CBX3;MYRFL;PRKCB;ZKSCAN7;SP3;ACVR1B;NOTCH1;RORA;TBX6;PQBP1;CAMTA2;DEDD2;RELB;APBB3;RFX1;MAZ;AFAP1L2;HCLS1;FZD2;RFX5;SMARCC1;RELA;BBX;GAS6;BCLAF1;DGKQ;USP21;USP16;SOX2;BCL11B;POLA1;ATP8B1;HBP1;POU2F1;PPIE;LIMD1;MSANTD1;TENM1;ZKSCAN3;FOXJ3;SMARCD1;PGBD1;SUV39H2;JUNB;ATF1;ZKSCAN5;NAT14;KDM7A;PRDM2;HNRNPD;PHIP;LRP6;CREG1;SHC1;ID4;MAP3K2;EID1;SNF8;MNAT1;ORC1;ETV3;ARRB1;QRICH1;MPHOSPH8;PPARGC1B;PHF20L1;HSPD1;NHLH2;KLF6;ZNF32;BRPF1;MYT1;MTF1;THRAP3;TCF12;RRP8;CCAR1;ZBTB11;CREB3L4;CREB3;BAZ1B;BRWD1;NCF1;CHD7;ELP4;PLAGL2;TAF5L;TAF15;ZNF18;CRY1;MLLT3;ERC1;CDT1;ZBTB7A;NKX2-1;SMARCB1;ZBTB41;GABPA;NFYC;HMGN5;CREB1;ZNF23;UBE2V1;CIR1;NAB1;ZBTB7B;ZNF319;E2F2;HOXD8;BBS7;CLOCK;NCOA6;FLI1;SOX8;KLF8;RAD21;NFX1;ZNF431;PPP2CA;FBXO5;NCOA2;CALCA;ZBTB40;KMT2A;STAT6;NFIC;PPP1R13L;CREB3L1;NR2F1;PURB;PRDM16;WWTR1;ZNF367;PIAS2;TCF7L2;TCF4;BCL3;SAP30L;SCMH1;SP8;PHF1;PHF2;RBM15;SPEN;HSF2;BCL11A;SFMBT2;POLR3C;NFE2L3;PPP2R1A;SREBF1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.30949401208449623,-0.9438051093174846,0.5211864406779662,0.869717857438081,1.0,3/23,6.02%,CX3CR1;CD33;NLRP3
prerank,negative regulation of neuron differentiation (GO:0045665),0.39104366441249594,0.943780614737058,0.540650406504065,0.8232718521792799,1.0,7/22,22.34%,EIF2AK4;SOX9;GSK3B;SOX2;DTX1;HES5;DISP3
prerank,positive regulation of cell adhesion (GO:0045785),0.32600563508600394,0.9436853020723727,0.5887005649717514,0.8230630891423132,1.0,10/74,10.29%,SYK;STX3;VEGFA;TGM2;ADAM9;CITED2;ADAM8;FLCN;PPP3CA;RHOD
prerank,sodium ion homeostasis (GO:0055078),0.3886831711429934,0.9434389894625399,0.5609103078982597,0.8231739868043693,1.0,4/21,8.05%,TFAP2B;SLC8A1;SLC12A3;NEDD4L
prerank,regulation of endocytic recycling (GO:2001135),0.44596577536060106,0.9434351113779044,0.5416666666666666,0.8227842346717188,1.0,4/11,13.73%,SORL1;EIPR1;RAB11B;INPP5F
prerank,establishment of vesicle localization (GO:0051650),-0.3401843431593158,-0.943199121880952,0.5703703703703704,0.8694907678397286,1.0,6/18,12.70%,RAB27A;KIF5A;CCDC186;TESK1;RAB11A;LIMK2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.3602954998093999,-0.9425996222006828,0.5344262295081967,0.8691403121341146,1.0,4/13,6.53%,TGFBR2;NKAP;PNP;GLI3
prerank,nerve growth factor signaling pathway (GO:0038180),0.4544885802048144,0.9425183249565803,0.5687789799072643,0.8243147649818805,1.0,2/10,12.57%,KIDINS220;RAPGEF1
prerank,"transcription, DNA-templated (GO:0006351)",0.30008076894171243,0.9417133590897675,0.6275303643724697,0.8255880139357237,1.0,59/207,22.76%,TSC22D1;POLR2A;ERCC6;AFF4;FOXO3;GTF2B;GTF2H5;E2F1;TAF7;NFKBIB;DDX5;ATF4;RREB1;TAF5;POLR2L;EPC1;TAF1B;CBFB;TOPORS;PAX8;POLR2G;MED16;CDK7;GTF3C4;POLR2I;TRIP11;NCBP2;GTF2F2;POLRMT;CTDP1;GTF2A1;MLLT1;NAT14;MNAT1;PWP1;CDC73;TWNK;SMN1;TFB2M;TAF5L;TAF15;NELFE;MLLT3;TTF1;ZBTB7B;NCOA6;TAF1A;NFX1;NFIC;BCL3;DTX1;NFE2L3;FUBP3;ABT1;TAF1;GTF3A;CCNT1;POLR3K;SUPT4H1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.31369246425633435,-0.9416218785722298,0.5353159851301115,0.8699944327620047,1.0,8/21,24.55%,COX16;COX10;COX19;COX17;SCO1;COX14;COX18;COA6
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.32519833957424926,0.9413884663703468,0.5875706214689266,0.825856389708125,1.0,13/67,13.86%,TBC1D22A;TBC1D1;TBC1D2;P2RX4;TBC1D10A;TBC1D2B;CAPZB;TBC1D22B;ATG5;TBC1D24;TBC1D15;ATP8B1;IFT140
prerank,carnitine shuttle (GO:0006853),0.44135496867791224,0.9412754252669211,0.54,0.8257061078539916,1.0,3/11,9.83%,PRKAG2;CPT1A;SLC25A20
prerank,regulation of TORC1 signaling (GO:1903432),0.35867929123040193,0.9406814436788777,0.5592592592592592,0.8265401065359197,1.0,6/33,13.43%,GPR137B;SIK3;SESN2;FLCN;DGKQ;CASTOR1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.38489736794601737,0.9404418471190988,0.5485122897800776,0.8266449397721654,1.0,11/24,27.01%,FLVCR1;PGRMC1;FECH;COX15;RSAD1;ALAD;SLC25A38;NFE2L1;FXN;UROS;TSPO
prerank,response to axon injury (GO:0048678),-0.3306989162361659,-0.9404271406917055,0.506993006993007,0.871280129724851,1.0,2/18,0.30%,P2RY12;RTN4RL1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.44946212011868664,0.9402999916750723,0.5508982035928144,0.8265460302199353,1.0,1/10,0.48%,APLNR
prerank,positive regulation of protein transport (GO:0051222),0.3283854002940989,0.9401746421307757,0.5817361894024803,0.8264122090127639,1.0,18/67,18.07%,ABCG1;KIF20B;RUFY3;ADAM9;IGF1;CLN3;ADAM8;TPR;OAZ2;BCAS3;TREM2;APBB3;TENM1;GOLPH3;GOLPH3L;RAB29;OAZ1;EXOC1
prerank,peptidyl-tyrosine modification (GO:0018212),0.33192957350501323,0.9401173791340409,0.6068476977567887,0.8261315574192141,1.0,12/56,14.72%,SYK;TEC;ABL2;ABI1;FGFR4;DYRK1A;PKDCC;PTK2B;FES;BTK;FGR;JAK3
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.39917783799174833,0.9400442960805159,0.5504587155963303,0.8258816540409857,1.0,5/21,10.31%,ENSA;MFHAS1;STYXL1;BOD1;GSK3B
prerank,postreplication repair (GO:0006301),0.34396793530538816,0.9397897624277987,0.5704225352112676,0.8260130193073553,1.0,7/45,9.37%,RFC3;TRIM25;RPS27A;UBC;BRCA1;WDR33;POLH
prerank,microtubule nucleation (GO:0007020),-0.32532107274536604,-0.9395651514143589,0.4982078853046595,0.8717386364263826,1.0,4/19,6.64%,TUBGCP5;TPPP;CSNK1D;AKAP9
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.390029021036475,0.9395256199650993,0.543448275862069,0.8261712112288644,1.0,5/22,12.76%,MGAT5;IL6;IL10RB;NOTCH1;IL7R
prerank,fatty acid biosynthetic process (GO:0006633),0.32470252144119327,0.9389952481548228,0.5778275475923852,0.8268720518091391,1.0,13/63,17.89%,LIPG;ABCD1;HACD4;ACSM3;GPX4;NDUFAB1;LTA4H;LIAS;ELOVL1;DEGS1;SCD;DECR2;CBR4
prerank,ribonucleoprotein complex assembly (GO:0022618),0.3073817756402447,0.9387194315791151,0.6174004192872118,0.8270177089351073,1.0,39/132,22.25%,RPL3L;MRPL20;SRPK2;SCAF11;CELF1;CLNS1A;EIF3A;EIF6;RPS14;SNRNP200;ISY1;SART1;MRPS7;SF1;EIF5;XRCC5;WDR77;PRPF6;DDX23;DDX20;SNRPF;RPL10;ZRSR2;RPSA;CDC73;SMN1;PUF60;LUC7L;SRPK1;SHQ1;PWP2;EIF2S2;RAMAC;PPAN;RPS27;SNRPB;ABT1;PRKDC;BOP1
prerank,cellular response to estradiol stimulus (GO:0071392),0.3996856511389522,0.9378978514764974,0.5617021276595745,0.8283110804248197,1.0,4/18,12.74%,LCOR;NCOA3;ESR1;FAM210B
prerank,regulation of stem cell differentiation (GO:2000736),0.31431791184358837,0.9378361243003948,0.6019629225736096,0.8280429149140832,1.0,26/89,22.96%,LMO1;PSMD1;SMYD5;HNRNPU;ZFP36L2;CBFB;PSMF1;PSMD14;NOTCH1;PSMD12;GDNF;PSME2;TCF12;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;KMT2A;OSM;PSMD11;PSMA6;HES5;PRKDC;PSMB3;PSME3
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3482942564612022,0.9377792763383397,0.5662650602409639,0.8277670407590695,1.0,14/42,24.71%,RFC3;TRIM25;RPS27A;UBC;POLH;SIRT1;WRN;POLA1;POLI;VCP;POLD1;SPRTN;ISG15;PRIMPOL
prerank,rRNA modification (GO:0000154),0.39341977234228076,0.9377005112596293,0.5419440745672437,0.8275347319155644,1.0,11/21,25.79%,NSUN3;NAT10;DKC1;MRM2;TSR3;TFB2M;FBL;DIMT1;MTERF4;ZCCHC4;NSUN4
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3629806013274518,0.9375242769617099,0.5580182529335072,0.8275071018118766,1.0,8/28,21.95%,ERCC6;TFIP11;PARP3;SIRT7;KMT5B;SHLD1;SHLD2;PRKDC
prerank,regulation of amyloid fibril formation (GO:1905906),0.41930757942301805,0.9372692709347804,0.5660112359550562,0.8276400998673443,1.0,3/15,12.31%,APOE;APP;TREM2
prerank,arachidonic acid metabolic process (GO:0019369),0.35337841654956625,0.9368733454661158,0.5656441717791411,0.8280239446690727,1.0,4/35,8.70%,MGLL;GPX4;PTGES2;HPGDS
prerank,RNA transport (GO:0050658),0.32269223441675715,0.9367107430980048,0.5778508771929824,0.8279524061351016,1.0,15/71,16.52%,RFTN1;FLOT1;ALYREF;TST;ATXN2;CHTOP;THOC1;TPR;NCBP2;SRSF3;THOC2;SIDT2;EIF4A3;DDX39A;DHX38
prerank,protein K11-linked ubiquitination (GO:0070979),0.3715550259462383,0.936576273693998,0.5815789473684211,0.8278223490793133,1.0,11/27,26.55%,RNF26;UBE2L3;ANAPC1;PRKN;ANAPC10;UBE2S;UBE2H;UBE2D3;ANAPC7;FZR1;ANAPC2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.3734556303674905,0.9365076309441442,0.5693527080581242,0.827568350973671,1.0,9/26,22.04%,DUSP3;CUL3;PKN2;APP;LGMN;TTL;CCDC57;PPP1R10;USP2
prerank,heart looping (GO:0001947),0.35060601913128453,0.9361415380514482,0.5623501199040767,0.8278959385939686,1.0,6/39,12.29%,APLNR;CCDC40;FOLR1;NOTCH1;TBX6;MICAL2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4250717615460966,0.9357643111462866,0.5555555555555556,0.8282584129058301,1.0,3/12,12.31%,IL6;STAP1;TREM2
prerank,striated muscle tissue development (GO:0014706),-0.2791752257343424,-0.9357231773909486,0.5580357142857143,0.8801339011497902,1.0,5/29,13.02%,MEF2C;SGCD;SGCZ;ZBTB18;MYH14
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.45091393596929386,0.9353779282332064,0.5439137134052389,0.828673563536362,1.0,3/10,15.93%,BRCA1;SIRT1;DNMT1
prerank,mitochondrial gene expression (GO:0140053),0.3452016540539564,0.9351987411378131,0.5803782505910166,0.8286460022187769,1.0,15/42,25.03%,FOXO3;MRPL23;MRPS7;MRPS28;POLRMT;MRPS21;IARS2;QRSL1;TWNK;TFB2M;MRPS18A;MRPS2;MRPL16;MRPS18B;GATB
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.4234361676405783,0.9347899319570031,0.5568345323741007,0.829117998306373,1.0,6/14,20.60%,CTNNB1;BRCA1;KMT2E;DNMT1;KMT2A;PAXIP1
prerank,positive regulation of phosphorylation (GO:0042327),0.2975040210971305,0.9342758502021372,0.6572864321608041,0.8297775810745243,1.0,30/240,12.31%,GPNMB;SDCBP;RAP2A;VEGFA;FLOT1;FNIP1;TFRC;HGF;FAS;RIPK1;IGF1;FGFR4;THBS1;MERTK;FLCN;ZBTB20;SOX9;ACVR2A;DSCAM;TNIK;FZD7;MAVS;ADAM17;SIRT1;CCN1;NBN;MT3;APP;ROR1;TREM2
prerank,glutamate metabolic process (GO:0006536),0.3941459183470106,0.9341192417008573,0.5493506493506494,0.8297134251658842,1.0,4/19,18.03%,MTHFS;PRODH;ALDH18A1;OAT
prerank,activation of protein kinase A activity (GO:0034199),0.40728270173927716,0.9340616006584679,0.5568022440392707,0.8294332931017127,1.0,6/16,22.88%,ADCY7;PRRC1;ADCY8;ADCY3;ADCY5;ADCY9
prerank,autophagy of peroxisome (GO:0030242),-0.3556485183336514,-0.9331530746535928,0.5233644859813084,0.8849168105958648,1.0,3/12,8.45%,ATM;NBR1;RB1CC1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.4412802971054428,0.9330136005860636,0.590288315629742,0.8312114749721853,1.0,1/12,7.89%,SOX9
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3933235567440759,0.9326533852225343,0.5631868131868132,0.8315606079587562,1.0,7/20,26.02%,IL6;DENND1B;FZD5;TRAF2;MALT1;TRAF6;MAP3K7
prerank,mitochondrial genome maintenance (GO:0000002),-0.38108424738016117,-0.9326509469202338,0.5420054200542005,0.8844118793575305,1.0,5/11,9.52%,MEF2A;AKT3;SLC25A36;SLC25A4;PARP1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3675902206691272,0.9323896525068619,0.5517693315858454,0.8317025652968565,1.0,6/26,14.18%,B4GALT5;B4GALT6;ST3GAL4;LUM;B4GALT3;B4GALT2
prerank,maturation of SSU-rRNA (GO:0030490),0.35565609010687094,0.9316754087998405,0.5723192019950125,0.8327828741190455,1.0,10/34,19.06%,DCAF13;RPS14;HELB;NOP14;NAT10;NOB1;TSR3;PWP2;NGDN;DHX37
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.30422877230919265,-0.9312082625859917,0.5041666666666667,0.8864260449171802,1.0,5/22,8.01%,CACNB2;CACNB4;FMR1;NOS1AP;PDE4B
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4473169722561195,0.9311898251534808,0.5539906103286385,0.8333403616130214,1.0,3/10,16.90%,FBXW7;ADAM17;NCF1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.4060869656889246,0.9311843327364293,0.5407725321888412,0.8329543030226138,1.0,6/16,25.00%,NR1H3;SLC27A1;GPLD1;SREBF1;NR1H2;CTDNEP1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.38975408858863103,0.9305750152766934,0.5620736698499318,0.8338521365397155,1.0,3/21,2.56%,CTNNB1;VEGFA;DCT
prerank,T cell receptor signaling pathway (GO:0050852),0.30294864987590314,0.930516963558735,0.6426332288401254,0.8335676530339778,1.0,43/138,26.41%,RFTN1;TEC;PRAM1;CD28;PDPK1;PSMD1;CD3D;TRAT1;PIK3CA;DENND1B;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELA;PSME2;CUL1;CD247;PSMB10;PSMD5;EIF2B2;PSMD8;CARD11;PSMA3;PSMA2;TNFRSF21;PIK3CB;PSMD11;PSMA6;PTPRC;PSMB3;PDE4D;MALT1;PSME3;BCL10;TRAF6;PSMC5;SPPL3;MAP3K7;RC3H1;PSMC1;RNF31
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.37370648801166184,0.9305143257826543,0.5551181102362205,0.833175638519599,1.0,3/26,8.59%,HTR2B;SLC8B1;LETM1
prerank,cellular response to inorganic substance (GO:0071241),0.3884813667905469,0.9303815441612757,0.5632823365785814,0.8330585398897538,1.0,8/21,23.55%,AQP1;FOXO1;MT3;NSMCE3;DDI2;RTF2;SPIDR;CDK2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3335404802659383,0.9303554680178285,0.5880281690140845,0.8327128759222678,1.0,3/48,3.03%,APLNR;DIAPH1;PDPK1
prerank,regulation of RNA export from nucleus (GO:0046831),-0.37894919651894265,-0.9302743545497258,0.5384615384615384,0.8868999338101303,1.0,4/11,14.68%,IWS1;KHDRBS1;NSUN2;NUP153
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.37433487818197453,0.9301818506255571,0.5445026178010471,0.8326796712049799,1.0,2/25,3.03%,APLNR;PDPK1
prerank,cellular response to alkaloid (GO:0071312),0.39716657332242067,0.9301021023558762,0.5798319327731093,0.8324539043366337,1.0,5/17,18.39%,TGM2;SLC8A1;HTR1B;CASP6;CASP3
prerank,spinal cord development (GO:0021510),-0.3549020301402443,-0.929282100581741,0.5657894736842105,0.8877045613503841,1.0,5/12,26.36%,RELN;PKD2;PKD1;SOX11;GLI2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.4234392998134715,0.9292085591908616,0.5901639344262295,0.8338945765551129,1.0,6/13,22.84%,TCERG1;HNRNPU;LARP7;NELFE;SUPT4H1;RNF168
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.37675357306488,0.9291815970635695,0.5503978779840849,0.8335526080483067,1.0,6/23,22.44%,CBLB;CHMP6;CBL;SH3BP5;PTPRC;SOCS4
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3495900310412371,0.9290628228247204,0.5877300613496933,0.8334243799095494,1.0,11/39,19.70%,MYO5A;MYO1E;CLN3;MYO19;MYO1F;NDE1;WASL;KIF5B;PAFAH1B1;HTT;RAB1A
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3700175528374488,-0.928497875799835,0.5511363636363636,0.8878565446135576,1.0,6/12,28.85%,CHEK2;STK33;NAE1;SETMAR;TOPBP1;TICRR
prerank,sulfur compound catabolic process (GO:0044273),0.3447181450385755,0.9277118348990724,0.5841463414634146,0.8357584624626239,1.0,6/38,9.48%,GALNS;GNS;TST;HEXA;LUM;IDUA
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4421708742273792,0.9272196408596827,0.5727136431784108,0.8363758019033517,1.0,2/10,11.96%,VEGFA;NOTCH1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.37334234757357604,0.9267891097517513,0.5647668393782384,0.8368720374906656,1.0,6/25,12.04%,MPHOSPH10;SCAF11;PRPF8;PRPF6;DDX23;SF3A3
prerank,miRNA metabolic process (GO:0010586),0.38452309178123856,0.9266140037776069,0.5752330226364847,0.836828174111635,1.0,4/20,12.02%,TENT4B;AGO2;DROSHA;SND1
prerank,negative regulation of innate immune response (GO:0045824),0.3523723809233896,0.9262825359160973,0.5862944162436549,0.8371005366284902,1.0,12/34,24.55%,YTHDF3;IRAK3;NLRC3;CNOT7;TRAFD1;TNFAIP3;ACOD1;GRN;SLAMF8;ISG15;LYAR;DHX58
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.40036000673708444,0.9260811036999074,0.5683760683760684,0.8371177588566997,1.0,6/15,22.77%,NPLOC4;FAF2;DERL2;TMEM129;VCP;HERPUD1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.3858565152881967,-0.9260328002034911,0.5529411764705883,0.8923318028890888,1.0,3/10,13.86%,PDE3B;WNK1;NEXMIF
prerank,fibrinolysis (GO:0042730),0.4168028744223028,0.9259309702553247,0.5733333333333334,0.837034233589675,1.0,2/13,22.63%,PLAU;PLAUR
prerank,positive regulation of protein sumoylation (GO:0033235),0.4469806029444017,0.9259165314987582,0.5723172628304821,0.8366702418118307,1.0,2/10,7.75%,RWDD3;PIAS4
prerank,regulation of interleukin-13 production (GO:0032656),0.42576166230296597,0.9258475541369066,0.5789473684210527,0.8364028333461179,1.0,2/13,6.29%,RARA;SPHK2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.421998658529603,0.9258439239899097,0.5684830633284241,0.8360160456089798,1.0,2/13,11.45%,CPSF1;NCBP2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.2330593182048076,-0.92552427700213,0.5974025974025974,0.8917681763326221,1.0,18/75,17.08%,GIT2;PLCB1;RGS6;RPGRIP1L;KCTD8;RGS20;FRMPD1;METAP2;ADCYAP1;CAMK2A;NMT1;RGS12;USP20;GIT1;RASGRP4;RGS2;SYP;SAG
prerank,endothelial tube morphogenesis (GO:0061154),0.455328099650085,0.9251910784113433,0.5829457364341085,0.8369478810819907,1.0,2/10,8.88%,CTNNB1;ACVRL1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3389974433060635,0.9250965282507284,0.5923718712753278,0.8367373087611816,1.0,5/45,7.20%,WEE2;CTNNB1;PLK2;TOM1L2;ZFP36L2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.39084777857193426,0.9250455407733517,0.5664335664335665,0.8364440426698019,1.0,4/18,15.24%,CCDC40;CFAP53;SPAG17;OFD1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.3342751611632183,-0.9247901279791162,0.534965034965035,0.8919034698325301,1.0,3/16,4.62%,ANK2;RYR2;GABARAPL2
prerank,endothelial cell proliferation (GO:0001935),0.39699025644208713,0.9244907170837114,0.5837912087912088,0.8371764850637398,1.0,4/17,9.45%,ERN1;HMOX1;ACVRL1;BMPR2
prerank,ether lipid biosynthetic process (GO:0008611),-0.3857482614109281,-0.9243752837386485,0.5761772853185596,0.8910924385205745,1.0,4/10,7.24%,AGPS;LPCAT2;CHPT1;PLA2G4A
prerank,centromere complex assembly (GO:0034508),-0.2795260051981388,-0.9243400266859064,0.5865921787709497,0.8893391103899805,1.0,14/36,24.83%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;RBBP4;CENPK;CENPO;NPM1;CENPF;CENPT;CENPQ;CENPN;CENPH
prerank,mRNA 3'-end processing (GO:0031124),0.3169276430184389,0.9236373846296098,0.6178414096916299,0.8385015772064597,1.0,18/78,16.52%,ALYREF;CPSF1;TENT4B;CHTOP;CSTF3;THOC1;WDR33;TENT2;GRSF1;NCBP2;SRSF3;APP;THOC2;SSU72;EIF4A3;DDX39A;CDC73;DHX38
prerank,peptidyl-amino acid modification (GO:0018193),0.44463308480873004,0.9234410261324293,0.5968503937007874,0.8384946865319448,1.0,4/10,22.05%,METAP1D;ATP7A;FKBP7;TTLL4
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.3979308154138291,0.9233663596554864,0.5694822888283378,0.8382405667619328,1.0,7/18,23.08%,ST18;IL6;IL6R;CBL;CEBPA;STAT3;JAK2
prerank,rRNA catabolic process (GO:0016075),0.39617482537823145,0.9229260922741763,0.5716272600834492,0.8387372865253268,1.0,6/16,20.78%,EXOSC3;EXOSC9;EXOSC8;DEDD2;EXOSC10;EXOSC7
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3986941656278947,0.9227802386136481,0.5600578871201157,0.838650067351693,1.0,3/15,13.77%,CD44;SIRT1;PRKN
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.42541895349116526,0.9220192365715667,0.5805515239477503,0.8397526527615852,1.0,1/12,0.58%,APOE
prerank,tryptophan metabolic process (GO:0006568),0.4332046114218808,0.9216688255618114,0.5658093797276853,0.8400755135583208,1.0,2/11,15.22%,KYNU;ATP7A
prerank,positive regulation of chemokine production (GO:0032722),0.3385159874755074,0.9214007413907066,0.5950413223140496,0.8401907449507404,1.0,7/44,11.57%,SYK;IL6;HMOX1;IL6R;MAVS;ADAM17;APP
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.34986435349291317,0.9212569467683349,0.5694618272841051,0.8400695205778976,1.0,11/33,26.57%,FBXW7;ARAP1;ADAM17;AFAP1L2;CBL;NCF1;BCAR3;PLAUR;HIP1;DOK1;HBEGF
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3978429619467545,0.9205286671490933,0.5845070422535211,0.8411281380084418,1.0,8/17,22.61%,AFG1L;COX6A1;CYCS;COX8A;COX7B;COX15;COX4I1;COX5A
prerank,spermatid development (GO:0007286),-0.276413074597622,-0.9204174541875063,0.568075117370892,0.8979189940719781,1.0,11/32,26.79%,JAM2;RNF8;CEP57;IQCG;TDRD5;ZMYND15;NME5;CIB1;RFX2;MKKS;SYCP3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.321518419889834,0.9198650271119461,0.634850166481687,0.8420795784596143,1.0,7/74,5.57%,SDCBP;GCNT2;CTNNB1;IL6;PTEN;COL1A1;DAG1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.3732047964596975,-0.9198319842579605,0.5613079019073569,0.8975987564876375,1.0,4/10,13.79%,GABRA2;GABRA3;GABRG3;GABRA4
prerank,negative regulation of dephosphorylation (GO:0035305),0.3906324574723986,0.919761893283238,0.589041095890411,0.8419004526334746,1.0,3/18,12.23%,ENSA;MFHAS1;GPATCH2
prerank,nuclear export (GO:0051168),-0.22116919321046968,-0.9196222196252589,0.65,0.8963127883493724,1.0,35/80,25.83%,SLU7;SRSF6;SMURF1;WASHC4;SRSF5;RBM8A;NUP214;ZC3H11A;THOC5;STRADB;POM121;SRSF11;NUP155;RAE1;PKD1;NUP153;DDX39B;SRRM1;U2AF1;RANBP17;MAGOH;SRSF1;MAGOHB;STRADA;SRSF9;CCHCR1;THOC6;SRSF4;XPO6;EIF4E;UPF3B;TGFB1;PHAX;POLDIP3;XPO4
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.26484377340854043,-0.9187371152923507,0.5821596244131455,0.8967702839100447,1.0,7/35,9.00%,PLXNA4;SEMA5A;ARHGDIA;SEMA4G;SEMA3E;SH3BP1;SEMA3A
prerank,nucleotide-sugar metabolic process (GO:0009225),0.42544143152351377,0.9185622783692964,0.5778443113772455,0.8438644962146968,1.0,6/12,25.64%,GFPT1;UGP2;FUT8;EXTL2;GALT;SLC35A3
prerank,mesoderm development (GO:0007498),0.39709167621308605,0.918374316953251,0.5691056910569106,0.8438561007175374,1.0,3/18,12.65%,VEGFA;TBX6;BTK
prerank,positive regulation of cell development (GO:0010720),-0.26788517165779363,-0.9179339502760397,0.6066350710900474,0.8970343771246245,1.0,6/31,12.87%,CX3CR1;NUMB;OPRM1;RFX3;NAP1L1;BAD
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.35165166915025386,0.9178867868554956,0.605296343001261,0.8444236136280326,1.0,8/33,19.95%,NFE2L2;PDPK1;MAPK7;GAS6;TNFAIP3;TEK;WFS1;TCF7L2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4235895425823184,0.9173272561438588,0.5603053435114503,0.8451565125949303,1.0,2/11,10.68%,CD44;SIRT1
prerank,negative regulation of protein depolymerization (GO:1901880),0.370371268458143,0.9170279500617523,0.5708762886597938,0.8453979761824922,1.0,6/24,13.70%,LIMA1;SPEF1;PIK3CA;APC;ARHGEF2;CLASP1
prerank,protein complex oligomerization (GO:0051259),0.30611302716129685,0.9169113240511518,0.631578947368421,0.8452318163023391,1.0,17/85,15.79%,LRRC8D;UGDH;MICU1;NINJ1;MS4A1;WDCP;RNF135;CHMP2A;NLRC4;PDCD6IP;LETM1;LRRC8C;ATL2;ADCY8;ATL1;VSTM5;TWNK
prerank,steroid biosynthetic process (GO:0006694),0.33093768247912514,0.9169026699265845,0.6175438596491228,0.8448503734367526,1.0,4/56,2.43%,BAAT;AMACR;OSBPL1A;PRKAG2
prerank,regulation of G0 to G1 transition (GO:0070316),0.3446059418026173,0.91689695936385,0.587378640776699,0.8444688040734768,1.0,16/38,24.59%,APAF1;FOXO4;E2F1;EED;BRCA1;UXT;EPC1;CBX3;RBBP7;MGA;EHMT2;CBX5;TFDP1;PHC3;RNF2;PCGF6
prerank,glucose transmembrane transport (GO:1904659),-0.32397840748036383,-0.9166513944668606,0.5719298245614035,0.8984352478865523,1.0,5/18,16.78%,SLC2A3;SLC2A5;SLC2A9;SLC2A8;SLC2A6
prerank,sister chromatid segregation (GO:0000819),0.3554113156796651,0.91635156883715,0.5798212005108557,0.8451825977614308,1.0,5/31,15.05%,NCAPG2;RB1;SMC1A;INO80;LATS1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.3838831793026445,0.9152629359686861,0.5759577278731837,0.8469786442327814,1.0,5/18,17.72%,RAB21;MSN;VPS11;DNAJC13;SNX3
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.35343209568399186,0.9151640990467643,0.6071428571428571,0.8467730809157628,1.0,7/32,17.43%,LPIN3;SLC27A1;CSNK2A2;PCYT1A;LPCAT3;SLC44A2;CSNK2A1
prerank,translesion synthesis (GO:0019985),0.3400361879762974,0.9150290052492023,0.5912938331318017,0.8466404791075982,1.0,6/42,9.37%,RFC3;TRIM25;NPLOC4;RPS27A;UBC;POLH
prerank,muscle cell migration (GO:0014812),0.44696726388158736,0.9149750824603647,0.5825688073394495,0.8463360357958407,1.0,5/10,27.81%,ROCK1;AAMP;CCN3;ITGB3;DDR1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.20164313516952387,-0.9148344363549719,0.8214285714285714,0.901331281164921,1.0,34/152,16.32%,GPC5;SEMA5A;SALL1;DISC1;CSNK1E;LGR4;CSNK1G3;FGFR2;JUP;PSMC2;TRPM4;LGR5;CSNK1D;EGFR;PSMD6;CSNK1G2;AMER1;PRDM15;DAPK3;WNK2;WNK1;PSMD7;RSPO3;RSPO2;UBE2B;SCEL;RNF220;PSMB5;DAAM2;HHEX;WNT5B;TLR2;FGF10;PSMB4
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3186896495657561,0.9147843107149646,0.5900692840646651,0.8463188325342859,1.0,7/57,7.79%,TAOK3;CDKN1A;WAC;MUS81;BABAM2;BRCA1;EME1
prerank,endoderm formation (GO:0001706),0.34973525693234697,0.9143620526816673,0.5948275862068966,0.8467501669426807,1.0,7/35,20.30%,ITGA5;ITGA4;MMP14;COL11A1;LAMA3;COL12A1;ITGAV
prerank,filopodium assembly (GO:0046847),0.4048660164013085,0.9143402152307493,0.6064880112834978,0.8464004004574176,1.0,6/16,15.56%,FGD6;SPEF1;PPP1R9B;FGD5;FGD3;VSTM5
prerank,nuclear pore complex assembly (GO:0051292),0.44764171623056803,0.9139171696259647,0.592375366568915,0.8468168717238334,1.0,5/10,21.66%,TPR;RTN4;NUP98;TMEM170A;NDC1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.34007915050790705,-0.9139005447709412,0.56875,0.9018036203127808,1.0,2/14,2.94%,CSF1R;CSF1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.3885211644385411,0.9132770410137074,0.5696022727272727,0.8476534590668727,1.0,2/18,3.06%,LILRB1;CD46
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.24380288044360143,-0.9130504198507968,0.6527777777777778,0.9021826396993352,1.0,14/51,14.77%,EVL;PPM1E;LIMCH1;LIMK1;TGFBR1;PAK1;PPM1F;ITGB1BP1;CARMIL1;TESK1;FERMT2;SYNPO2;RHOA;RAPGEF3
prerank,negative regulation of cell projection organization (GO:0031345),-0.24392415116651614,-0.9127402099273321,0.6,0.9012060952195435,1.0,12/48,15.69%,RTN4RL1;SPOCK1;DCC;GRIN2B;PTPRO;MAG;SEMA3A;PRNP;STMN2;YWHAH;RAPGEF2;BAG5
prerank,Ras protein signal transduction (GO:0007265),0.2960241475125141,0.9121108611815135,0.6603970741901777,0.8495806284239329,1.0,29/137,16.03%,GRB2;RAP2A;PLK2;SOS1;CDKN1A;JUN;RGL2;MYO9B;GNA13;BRAP;IGF1;NRAS;GNA12;RREB1;RB1;KSR2;ROCK1;CFL1;RAP2B;RHOD;CCNA2;RAPGEF1;RIT1;PHACTR4;RRAS;CELSR1;SHC1;DNMT1;USP8
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.36686747249731144,-0.9118333525154538,0.5606060606060606,0.9017026060091818,1.0,6/11,21.94%,FBH1;MSH3;DONSON;LIG3;TIMELESS;TIPIN
prerank,mitotic cytokinetic process (GO:1902410),0.37804319016044624,0.9116285723886797,0.5982905982905983,0.8501030712403234,1.0,7/20,21.48%,CHMP2A;PDCD6IP;VPS4A;CHMP6;CHMP5;CHMP7;CHMP2B
prerank,mitochondrial transcription (GO:0006390),0.43318213887948404,0.9114152218696313,0.5930047694753577,0.8501340852419554,1.0,4/10,16.97%,FOXO3;POLRMT;TWNK;TFB2M
prerank,pulmonary valve morphogenesis (GO:0003184),0.39653490353118737,0.9113373495039934,0.5785007072135785,0.8498926104058996,1.0,3/17,11.96%,STRA6;NOTCH2;NOTCH1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.29552690814397065,0.9112795882565918,0.6486486486486487,0.8496173178622927,1.0,31/124,20.63%,CTNNB1;PSMD1;AGO2;DVL1;TNRC6B;PPP3CA;FZD7;PPP3R1;AGO3;PSMF1;PSMD14;FZD5;PSMD12;PFN1;FZD2;AP2B1;PARD6A;CELSR1;PSME2;DAAM1;VANGL2;CCDC88C;PSMB10;PSMD5;PSMD8;AGO4;PSMA3;PSMA2;PSMD11;TCF7L2;PSMA6
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4072935633465653,0.9109539289798606,0.5937052932761088,0.8498387715825402,1.0,8/16,31.01%,ABCD1;PPIF;ATP7A;VCP;SHMT2;NUPR1;UQCC2;SLC25A33
prerank,epithelial tube morphogenesis (GO:0060562),0.35502639717223217,0.910810284920286,0.5838587641866331,0.8497357259938939,1.0,4/32,8.88%,MTSS1;CTNNB1;COL4A1;ACVRL1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3564857941838149,0.910069487123926,0.5928297055057619,0.8508015131894086,1.0,7/29,15.05%,BRCA1;CBFB;ESR1;STRN3;UBA5;VPS11;LATS1
prerank,regulation of telomere capping (GO:1904353),-0.29603060554608507,-0.9098162674331493,0.5853658536585366,0.9050884678655912,1.0,5/23,8.94%,ATM;USP7;MAP2K7;SMG6;RAD50
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3260556766899486,-0.9097732880365691,0.6047297297297297,0.9034008083591526,1.0,6/15,23.20%,SNAP91;DGKD;TNK2;HIP1R;DAB2;SCYL2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4277908232907381,0.9094777145074322,0.6071964017991005,0.8515370554471152,1.0,3/12,12.13%,FLOT1;MAVS;PQBP1
prerank,cellular calcium ion homeostasis (GO:0006874),0.30114789956667065,0.9093007189366519,0.6547368421052632,0.8514945960061928,1.0,20/133,15.89%,HTR2B;TPCN2;ATP2B1;ATP13A3;SLC8B1;TMEM165;MICU2;MICU1;SLC8A1;CLN3;CALB1;LETM1;TRPC3;PACS2;ADCY8;SLC10A7;BAX;CXCL12;SMDT1;CCL7
prerank,negative regulation of organelle assembly (GO:1902116),0.34906607565227266,0.909140378549233,0.6035131744040151,0.8514014940522253,1.0,8/35,17.79%,MTM1;ODF2L;BRCA1;STYXL1;NBDY;CCP110;TMEM39A;PHF23
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.3385015842929994,0.9088540675678874,0.6236297198538368,0.8515536455289152,1.0,5/40,5.73%,VEGFA;CD63;PPT1;RAB21;ANXA2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.3774532703286958,-0.9087999235976879,0.5636856368563685,0.9040975341545834,1.0,4/10,9.15%,TGFBR2;FGFR2;LRP5;STAT1
prerank,prostaglandin metabolic process (GO:0006693),-0.2822854492810893,-0.9086500353841364,0.591304347826087,0.9027001636289844,1.0,4/26,7.24%,HPGD;PTGS1;ACOX1;PLA2G4A
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.3251077345241124,0.9085329790707228,0.6145124716553289,0.85178351956305,1.0,15/55,18.61%,BCL2L11;FAS;RIPK1;STYXL1;DDIT3;PAK2;DEDD2;BCLAF1;BAX;WWOX;TRAF2;BID;LTBR;BBC3;CRADD
prerank,inositol phosphate catabolic process (GO:0071545),0.41992790839861327,0.9083322017300772,0.5916542473919523,0.851779699601868,1.0,5/12,19.46%,PTEN;OCRL;INPP5A;IMPA2;SYNJ2
prerank,presynapse assembly (GO:0099054),0.3949011351823695,0.9083168427810427,0.6198581560283688,0.8514189023145634,1.0,3/16,8.51%,CEL;PTEN;DVL1
prerank,neural tube closure (GO:0001843),0.33874987722966626,0.9078473167348381,0.6078914919852034,0.8518994364374872,1.0,15/34,29.07%,FOLR1;DVL1;DLC1;MTHFD1L;PHACTR4;CELSR1;LRP6;VANGL2;LRP2;BCL10;PLXNB2;SKI;KDM2B;DEAF1;MTHFR
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3366471386681341,0.9077700214846778,0.6041162227602905,0.8516714690683761,1.0,5/39,11.96%,VEGFA;MAP2K5;MAPK7;NF2;NOTCH1
prerank,positive regulation of innate immune response (GO:0045089),0.35047253798880895,0.9074622885784361,0.5933250927070457,0.851879789043406,1.0,4/30,9.88%,TLR8;ADAM8;UBE2K;MAVS
prerank,cartilage development (GO:0051216),0.32852295925668323,0.9071301322666849,0.6239813736903376,0.8521250736765873,1.0,11/49,16.98%,CD44;RUNX2;RUNX3;SULF2;SOX9;SLC39A14;TRIP11;SULF1;GPLD1;ATP7A;COL11A2
prerank,cellular response to organic substance (GO:0071310),0.2995194262134121,0.9070101709400693,0.6617647058823529,0.8519601689266993,1.0,16/116,9.45%,CXCR4;CTNNB1;SIGIRR;TIPARP;MAP2K5;PID1;HTRA2;MAPK7;STAT5B;NR1H4;PTPN12;ACVR2A;NCOA3;ACVRL1;NCOA1;BMPR2
prerank,positive regulation of locomotion (GO:0040017),-0.2735707927042789,-0.9069999221787407,0.6468253968253969,0.9051680692800271,1.0,4/27,6.40%,P2RY12;CSF1R;AIF1;PPM1F
prerank,calcium ion import into cytosol (GO:1902656),0.405638125496057,0.9068159169192018,0.5921625544267054,0.8519267723627398,1.0,3/15,9.35%,SLC8A1;MS4A1;TRPV2
prerank,cardiac muscle contraction (GO:0060048),-0.26592754420187126,-0.9064500733049816,0.6484848484848484,0.9046948059585611,1.0,4/34,3.93%,ATP1B1;ATP1A2;RYR2;SCN1B
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3237653289926663,0.9062212526463873,0.6138728323699422,0.8527159086919548,1.0,11/53,15.51%,APOE;FBXW7;PSME3IP1;GNA12;RAD23A;PSMF1;PSMD14;TREM2;PRKN;PSME2;PRKCG
prerank,quinone biosynthetic process (GO:1901663),-0.3304694143635842,-0.9062155261563565,0.563573883161512,0.9034964477419103,1.0,8/14,23.54%,COQ3;COQ10B;COQ2;COQ9;COQ10A;COQ5;COQ8A;UBIAD1
prerank,neuron apoptotic process (GO:0051402),-0.2993131599393739,-0.9055087687273513,0.583941605839416,0.9033972948761314,1.0,6/19,12.17%,SIAH1;SCN2A;CIT;BCL2;ATN1;ERBB3
prerank,heme biosynthetic process (GO:0006783),0.3756198346914224,0.9054128696727185,0.5966057441253264,0.8538485744787747,1.0,10/22,27.01%,FLVCR1;PGRMC1;FECH;COX15;ALAD;SLC25A38;NFE2L1;FXN;UROS;TSPO
prerank,defense response to tumor cell (GO:0002357),0.43775415994813965,0.9051238434295539,0.5823170731707317,0.8539911570475621,1.0,2/10,8.29%,DAPK1;DLEC1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.31861035590220144,0.9051222588045856,0.6234498308906427,0.8535991729300235,1.0,21/63,24.99%,PLK2;CDKN1A;WAC;E2F1;GADD45A;CNOT4;GTSE1;CNOT6L;CNOT7;BAX;CNOT6;RPL26;CASP2;CRADD;FBXO31;TNKS1BP1;PRKDC;CDK2;TFDP1;SOX4;CARM1
prerank,response to iron ion (GO:0010039),0.41566049473346844,0.9050324197459734,0.593939393939394,0.8534022315569062,1.0,1/12,2.50%,SLC11A2
prerank,glycolytic process (GO:0006096),0.3561702275899756,0.904803641017653,0.61489898989899,0.8534631884243147,1.0,9/28,24.02%,HK3;TPI1;ENO3;PGM1;GAPDHS;PFKM;GCK;PKM;HK1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.38225440687365153,0.9047427863405224,0.6095505617977528,0.8532000742414295,1.0,5/19,8.84%,XYLT1;NDST1;EXT1;UGDH;HS2ST1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.41433972584886314,0.9046688422591482,0.5913978494623656,0.8529438399990671,1.0,4/12,15.22%,MAOA;TRH;OAZ2;ATP7A
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3398322526233334,0.904505043053407,0.6112469437652812,0.8528949633548328,1.0,9/37,13.91%,KIF3A;DYNC2I2;DYNLRB1;IFT46;TRIP11;TNPO1;IFT52;IFT140;SSX2IP
prerank,regulation of protein binding (GO:0043393),0.3014685823219313,0.9044547800908039,0.6578947368421053,0.8525907815489601,1.0,27/114,18.98%,FLOT1;LRP1;PRKCD;CDKN1A;TFIP11;SORL1;PSME3IP1;STK3;PEX14;BTBD1;CTSZ;DVL1;HIPK2;ROCK1;GSK3B;STYX;APP;PRKN;PPP1CA;SLPI;BAX;IFIT2;CAMK1;AMFR;STK4;GNL3L;PPP2CA
prerank,positive regulation of receptor internalization (GO:0002092),0.3718423513348571,0.9044172495612867,0.6061827956989247,0.8522793019359736,1.0,2/22,3.65%,VEGFA;CD63
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.41424415366905015,0.904370985458182,0.6119186046511628,0.8519690541882773,1.0,5/14,23.54%,TRAT1;RELA;RAB29;CARD11;BCL10
prerank,regulation of sensory perception of pain (GO:0051930),0.4312346535589691,0.90423115104809,0.5905044510385756,0.8518573181281871,1.0,1/11,1.78%,MGLL
prerank,photoreceptor cell development (GO:0042461),0.40943214255064597,0.9041924742882171,0.5996978851963746,0.8515456557465326,1.0,3/14,13.99%,VEGFA;TOPORS;ARL3
prerank,positive regulation of cell cycle process (GO:0090068),0.2999842643104619,0.9040691831162659,0.6485310119695321,0.8514138908923673,1.0,15/91,16.16%,MAP3K20;KIF20B;CD28;DYNC1H1;IGF1;PCID2;CUL3;SVIL;TPR;PKN2;DBF4;NPM2;PHIP;INO80;RANBP1
prerank,erythrocyte development (GO:0048821),-0.3781051332591051,-0.9040425478681043,0.5761194029850746,0.9052306303166262,1.0,5/10,26.33%,SH2B3;ABCB10;ALAS2;MED1;ALAS1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3031344268920743,0.9040028347078847,0.6427807486631016,0.8511334252088152,1.0,19/98,17.78%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;E2F1;STAC2;ITGB1;MTCL1;PPP3R1;TREM2;ITGA3;PRKN;SQSTM1;STAC3;BID;BBC3;KIF5B
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3365683150833192,0.9036630986751514,0.6230110159118727,0.8514066724480657,1.0,18/42,25.98%,ERCC6;ZNHIT1;NASP;CHD3;VPS72;SMARCC1;INO80;PBRM1;SMARCB1;DMAP1;MBD2;SMARCE1;ANP32E;SMARCD2;ACTB;HDAC1;SMARCA1;CECR2
prerank,cardiac atrium morphogenesis (GO:0003209),0.39880707889846356,0.9032442545537461,0.6028571428571429,0.851844876105061,1.0,3/16,11.96%,NOTCH2;BMPR2;NOTCH1
prerank,relaxation of cardiac muscle (GO:0055119),0.4246469233763432,0.9031699693112405,0.6255639097744361,0.8515938494372256,1.0,3/13,6.43%,P2RX4;SLC8A1;PIK3CA
prerank,mitotic nuclear division (GO:0140014),0.31191483541535725,0.9030360940697135,0.6491428571428571,0.8514651926735177,1.0,21/71,23.82%,NCAPG2;PIBF1;CHMP2A;SMC1A;TOGARAM1;STAG2;CTDP1;CLASP1;CEP192;INO80;NDE1;SMC3;OFD1;CHMP7;ARHGEF10;UBE2S;SGO1;MZT1;FLNA;EPS8;BCCIP
prerank,homologous chromosome segregation (GO:0045143),-0.3044142672830473,-0.9028414917610761,0.5779467680608364,0.9064127937564476,1.0,5/20,19.60%,FMN2;FANCD2;ZCWPW1;IHO1;TERB1
prerank,heart contraction (GO:0060047),-0.25322264721186444,-0.9024345638909843,0.6923076923076923,0.9056588345006046,1.0,5/41,3.93%,ATP1B1;ATP1A2;SGCD;RYR2;SCN1B
prerank,membrane lipid metabolic process (GO:0006643),0.3685632805724004,0.9020859126043612,0.6103723404255319,0.8529086765642087,1.0,3/22,6.29%,MGST2;CERK;SPHK2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.20264755970042264,-0.9014598462148579,0.717948717948718,0.9063143710708398,1.0,38/125,20.54%,EML1;NUP133;BUB3;DYNC1I2;DYNLL2;ZW10;NUDC;DCTN2;AHCTF1;GPSM2;NUP85;SEH1L;ITGB3BP;ZWILCH;CENPP;EML4;KNL1;CENPA;NUP37;KIF18A;NDEL1;MAPRE1;STMN1;KIF11;PMF1;RMDN1;CENPK;CENPO;BUB1;DCTN6;CENPF;DYNC1I1;CENPT;EFHC2;EFHC1;SEC13;NDC80;NUSAP1
prerank,positive regulation of chromatin organization (GO:1905269),0.4139783463223512,0.9012599584631925,0.5955882352941176,0.8541402376683666,1.0,2/12,9.24%,ACD;TERF1
prerank,polarized epithelial cell differentiation (GO:0030859),0.40802540086094957,0.9010623864453421,0.5963172804532578,0.8541080816152795,1.0,4/13,16.55%,RAP2A;MSN;RAB10;MYO9A
prerank,N-terminal protein amino acid modification (GO:0031365),-0.3297662906089457,-0.9010564906504301,0.5741935483870968,0.9054922488181828,1.0,5/14,15.82%,NAA35;METAP2;NTMT1;NAA60;NAA16
prerank,histone H4 acetylation (GO:0043967),0.3276847338049323,0.9010277547387336,0.6179640718562874,0.8537982257054743,1.0,12/47,22.46%,KANSL1;ZZZ3;PHF20;ING3;EPC1;ING4;MCRS1;KMT2A;OGT;DMAP1;RUVBL2;KANSL3
prerank,ribosome assembly (GO:0042255),0.32956855783526795,0.9009269767301167,0.629013079667063,0.8536189839965977,1.0,15/47,23.32%,RPL3L;MRPL20;EIF6;RPS14;MRPS7;RPL10;RPSA;C1QBP;PWP2;DHX37;PPAN;RPS27;BOP1;MTERF3;MRPS2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2918557203338531,0.900916879303771,0.6863966770508827,0.8532466124786968,1.0,40/148,22.25%,SGK1;PRKAG2;PDPK1;RFC3;PHF20;BRIP1;TAF7;BRCA1;RPL23;TAF5;HIPK1;CHD3;BRD7;HIPK2;CSNK2A2;NBN;WRN;RNF34;DYRK2;RBBP7;PAK1IP1;MAPKAP1;SMYD2;BRPF1;PIP4K2A;TAF15;CSNK2A1;TTC5;NOC2L;PPP2R5C;CCNG1;RMI1;PPP1R13L;MRE11;TOP3A;RICTOR;EHMT2;TAF1;USP2;BOP1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.32478859944175537,-0.9007671026154768,0.5972696245733788,0.9044737020685631,1.0,10/17,28.94%,VPS9D1;ATP5PO;DMAC2L;ATP5F1E;ATP5PF;ATP5MC3;ATP5ME;ATP5F1B;ATP5MG;STOML2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3191171605986247,-0.9005770608172219,0.6101083032490975,0.9031368639634183,1.0,6/18,22.02%,COX16;COX19;COX17;SCO1;COX14;COX18
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.39287872234609234,0.9002156717328448,0.6056737588652482,0.8541724847823905,1.0,2/15,9.50%,ANAPC1;TPR
prerank,neuron projection morphogenesis (GO:0048812),0.2920893479650891,0.900030785280822,0.6690721649484536,0.8541408570249558,1.0,18/137,10.48%,IQGAP1;SGK1;DTNBP1;CTNNB1;KIF20B;BAIAP2;ALCAM;TAOK3;SLITRK6;PTEN;TNN;DOCK10;EIF2AK4;DVL1;EPB41L3;TNIK;ROCK1;RAB10
prerank,regulation of cellular response to heat (GO:1900034),-0.2157057528986376,-0.8996787124977823,0.7,0.9036158170506022,1.0,27/77,22.22%,RPTOR;MAPT;NUP133;ATM;CD34;HSP90AA1;HIKESHI;ATR;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;CAMK2A;NUP37;NUP155;RAE1;NUP153;BAG5;CRYAB;RPA3;MLST8;SEC13;DNAJB1;HSF1;RPA1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3082791853090173,0.8995027665825404,0.6618942731277533,0.8547710061454991,1.0,12/79,12.77%,PPARG;NIBAN2;SORL1;THBS1;SULF2;ACVR2A;HIPK2;BMPR2;RBPMS2;NOTCH1;SULF1;LEMD3
prerank,embryonic organ development (GO:0048568),-0.2335692555469702,-0.8994716795058658,0.6752136752136753,0.9023669813901593,1.0,9/61,6.53%,SALL1;BMPR1A;TGFBR2;KITLG;SH2B3;FGFR2;PBX3;TAL1;GLI3
prerank,positive regulation of protein acetylation (GO:1901985),-0.35599653994364333,-0.8994424868515305,0.6116504854368932,0.900675138460782,1.0,5/12,25.95%,PRKAA2;DIP2B;RAPGEF3;DIP2A;DDX3X
prerank,striated muscle contraction (GO:0006941),-0.23873913045110556,-0.8993812999353532,0.688,0.8990397231426244,1.0,13/53,20.12%,ATP1B1;DTNA;ATP1A2;RYR2;SCN1B;RCSD1;MYH14;GRK2;ALDOA;STAC;TPM1;SCN4B;TNNI1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.4022143431519534,0.8991642428566567,0.6014388489208633,0.8550269049226412,1.0,6/13,20.32%,IGF1;IRS2;DYRK2;EPM2AIP1;GCK;PHKG2
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.3322853094900927,-0.8991395801234978,0.5918367346938775,0.8979271286476552,1.0,4/14,6.47%,PPP5C;NCK1;PPM1F;PPP2CB
prerank,relaxation of muscle (GO:0090075),0.4185748286608214,0.898865908604714,0.6106194690265486,0.8552347097549337,1.0,3/13,6.43%,P2RX4;SLC8A1;PIK3CA
prerank,cellular response to estrogen stimulus (GO:0071391),0.4053047246050969,0.8984102457309965,0.6103896103896104,0.855717170993151,1.0,3/14,11.43%,RARA;NCOA4;BCAS3
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3646413823361033,0.8979865008934766,0.5809906291834003,0.8561602837247769,1.0,5/22,12.24%,GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,histone H2A acetylation (GO:0043968),0.39069157538644317,0.8978278238054265,0.6111111111111112,0.8560875418609019,1.0,3/16,8.17%,SPHK2;ING3;EPC1
prerank,activation of adenylate cyclase activity (GO:0007190),0.3392828519561049,0.8977845706360921,0.6059113300492611,0.8557816120841956,1.0,6/35,14.12%,EDNRA;RAF1;ADCY7;CAP1;ADCY8;ADCY3
prerank,double-strand break repair (GO:0006302),0.2899783812076716,0.8974532442700486,0.7204081632653061,0.8560185673579925,1.0,42/158,23.38%,EYA1;NSMCE2;SEM1;MCM9;KPNA2;BRIP1;PARP2;BABAM2;PARP3;BRCA1;PIAS4;EME1;XRCC4;XRCC5;XRCC2;KDM2A;POLL;AP5S1;NBN;PSMD14;DCLRE1B;TDP2;WRN;POLA1;INO80;AP5Z1;BRCC3;BAZ1B;RAD21;RMI1;MRE11;PAXIP1;TNKS1BP1;RAD51B;PRKDC;XRCC1;VCP;RNF168;SPIDR;RNF138;PALB2;ERCC4
prerank,regulation of ion transmembrane transport (GO:0034765),-0.2699306087743549,-0.897191609135353,0.6666666666666666,0.9009204388560569,1.0,7/33,12.12%,CHRM3;WNK3;KCNJ2;KCNJ3;AKAP9;KCNJ9;WNK1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3309395969353878,0.8970066947418699,0.640661938534279,0.8564701004148266,1.0,9/43,10.93%,IFITM1;RUNX2;IL6;HGF;IGF1;ACVR2A;BMPR2;IL6R;CCN1
prerank,negative regulation of locomotion (GO:0040013),-0.35411761331562275,-0.896643924642362,0.5796178343949044,0.9005298179357781,1.0,3/12,5.18%,FRMD5;WAS;SPOCK3
prerank,regulation of bone mineralization (GO:0030500),0.32209752741803593,0.8962263203808343,0.6465909090909091,0.8575741973911681,1.0,10/55,10.93%,ANO6;ATP2B1;ENPP1;SLC8A1;SGMS2;ACVR2A;PKDCC;BMPR2;PTK2B;CCN1
prerank,regulation of axon guidance (GO:1902667),0.42638959079375316,0.8961068669185732,0.6040061633281972,0.8573957854263397,1.0,3/10,18.25%,VEGFA;NRP1;MYCBP2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.41579728416667905,0.8959726571850866,0.6144578313253012,0.8572441721545978,1.0,5/12,25.54%,PTEN;UBE2S;RAB1A;CDC14B;FZR1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3469989513588717,0.8959088756462721,0.628498727735369,0.8565907143552314,1.0,8/29,23.92%,BAAT;ACSM3;GLYAT;ACOT9;ACOT2;ACOT6;ACOT13;ACOT8
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3469989513588717,0.8959088756462721,0.628498727735369,0.8565907143552314,1.0,8/29,23.92%,BAAT;ACSM3;GLYAT;ACOT9;ACOT2;ACOT6;ACOT13;ACOT8
prerank,hexose transmembrane transport (GO:0008645),-0.29389544996077377,-0.89472750083866,0.625,0.9035082843831325,1.0,6/21,19.87%,SLC2A3;SLC2A5;SLC2A9;SLC2A8;SLC2A6;SLC45A3
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3328652761964491,0.8944936418793773,0.6419902912621359,0.8589042572400519,1.0,10/39,17.45%,GCNT2;CORO1C;THBS1;NF2;FZD7;FBLN1;NOTCH1;CX3CL1;MELTF;ACER2
prerank,determination of heart left/right asymmetry (GO:0061371),0.33219580669803234,0.89437926606708,0.6233611442193087,0.8587452397363676,1.0,6/42,12.29%,APLNR;CCDC40;FOLR1;NOTCH1;TBX6;MICAL2
prerank,hepaticobiliary system development (GO:0061008),0.3727467893292197,0.8938457863879411,0.6162790697674418,0.8593720281227417,1.0,3/20,9.02%,CITED2;NIPBL;ARID5B
prerank,lipid translocation (GO:0034204),0.38065627714338107,0.8937232201660719,0.636604774535809,0.8592157394593767,1.0,9/21,23.00%,ABCA1;ATP8B4;ATP8B1;RFT1;ABCC1;ATP11C;TMEM30A;ATP9B;ABCA7
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.30658596099612245,0.8934138696485447,0.659316427783903,0.8594406555348573,1.0,6/75,5.50%,PPARG;CTNNB1;KLK3;NIBAN2;FOXO4;THBS1
prerank,mitochondrial fission (GO:0000266),0.3924787177186374,0.8933233579692286,0.6167400881057269,0.8592146309964203,1.0,4/16,13.77%,MTFR1L;MTFP1;GDAP1;PRKN
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3338603495922976,-0.8931663454065027,0.5947712418300654,0.9057261125030016,1.0,8/13,31.20%,TOX;CLPTM1;TESPA1;GLI2;FOXJ1;CAMK4;BMP4;ZC3H8
prerank,tRNA wobble uridine modification (GO:0002098),0.4014832615643858,0.893085191948599,0.6161616161616161,0.859276444967881,1.0,5/14,16.99%,CTU2;ELP1;GTPBP3;ALKBH8;ELP4
prerank,negative regulation of vascular permeability (GO:0043116),0.41734557440860004,0.8927171922118272,0.5994108983799705,0.8596057043985041,1.0,1/12,1.73%,VEGFA
prerank,regulation of tau-protein kinase activity (GO:1902947),0.433161438102036,0.8923503437632548,0.6120058565153733,0.8599049069577704,1.0,2/10,8.04%,SORL1;RB1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.35056841028813235,-0.8922736443255637,0.6153846153846154,0.9062479030152923,1.0,6/11,31.68%,MEF2C;SOX6;TGFB1;GREM1;BMP2;EFNB2
prerank,kinetochore organization (GO:0051383),-0.3511049631006619,-0.8919388193269319,0.5950155763239875,0.9053564857015395,1.0,7/13,33.17%,CENPA;CENPF;CENPT;NDC80;CENPH;CENPW;NUF2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.24477338336064922,-0.8918093451676796,0.6938775510204082,0.9039318212691577,1.0,15/50,20.64%,CD86;NR3C2;PTP4A3;TLR3;EGFR;IFI35;PDCD4;PHB2;LIMS1;RHOA;TLR2;TNF;CD14;TCIM;NOD1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.3264922339807367,0.8909738815311475,0.6375291375291375,0.8620411985538425,1.0,6/45,8.47%,CD44;PRKCD;IFNGR2;TRIM25;PTAFR;IRF2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.3438220594664645,-0.8906303513931608,0.5870967741935483,0.9051265453936573,1.0,9/13,36.88%,BMPR1A;TGFBR1;DAB2;SMAD4;TGFB1;BMP4;TGFB3;SH2B1;NUP93
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.34018893078253243,0.8906154916829504,0.6035131744040151,0.862314878776914,1.0,8/32,18.99%,ID2;BACH1;E2F1;RB1;POLA1;ORC1;CDT1;FBXO5
prerank,positive regulation of response to stimulus (GO:0048584),0.3281052085458148,0.8905349112820461,0.6365883807169345,0.8620760982971514,1.0,8/40,15.06%,IER5;PRKCD;ARG2;MAVS;SIRT1;IL15;BCLAF1;NSMCE4A
prerank,cellular response to leucine starvation (GO:1990253),0.43329545241137196,0.8901189738051071,0.6333333333333333,0.8624767009609863,1.0,2/10,7.01%,SESN2;EIF2AK4
prerank,endothelial cell differentiation (GO:0045446),0.41998217500046403,0.8898878226677592,0.6166180758017493,0.862530825034577,1.0,3/12,9.51%,ACVRL1;BMPR2;FSTL1
prerank,anion transport (GO:0006820),0.34363259057387,0.8898623845874329,0.6240601503759399,0.8621934885268763,1.0,4/33,8.84%,LRRC8D;VDAC2;SLC17A5;LRRC8C
prerank,cation transport (GO:0006812),0.2882826410620962,0.8897819986511152,0.721881390593047,0.8619612169425659,1.0,15/167,8.05%,SGK1;SLC6A6;SLC36A2;SLC36A4;AQP1;ANO6;SLC11A2;SLC8B1;SLC8A1;TAF7;CLN3;SLC5A5;SLC12A3;SLC38A7;NEDD4L
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.32632447608681203,-0.8896084363291673,0.6060606060606061,0.9059996614803201,1.0,5/15,11.97%,SEMA5A;FGF2;PRKD1;TMSB4X;PRKD2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3494703719427476,0.8892636768635311,0.6260978670012547,0.8625534400203354,1.0,11/29,23.08%,STAT5B;SOCS6;IFNAR2;IL15;JAK3;IFNAR1;STAT6;STAMBP;PIAS1;STAT3;JAK2
prerank,calcium ion import (GO:0070509),0.3466810189401068,0.8890918996214594,0.6104725415070242,0.8624819231354712,1.0,4/28,5.18%,MICU2;MICU1;SLC8A1;MS4A1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3362039978216014,-0.8889791641377834,0.6270627062706271,0.9058409824340492,1.0,5/13,15.74%,GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3234162205621045,0.8889663177935616,0.6156583629893239,0.8623396423855574,1.0,12/41,25.41%,MGLL;ABCD1;GPX4;ELOVL1;DEGS1;SCD;DECR2;SCP2;ACOT8;EPHX1;GPX1;HSD17B4
prerank,positive regulation of isotype switching (GO:0045830),0.3976424259107215,0.8887363529630872,0.6073446327683616,0.8623946078864988,1.0,5/15,20.60%,TFRC;KMT5B;SHLD1;SHLD2;PAXIP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.2897451630370832,0.8879680773914461,0.7159329140461216,0.8633976765198101,1.0,19/121,13.29%,NEDD9;VEGFA;TEC;PIBF1;CD44;IL6;HGF;ITGA5;IGF1;IL5;IL6R;PTK2B;PAK2;ARHGEF2;IL15;TREM2;HCLS1;GAS6;DGKQ
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3441599954002697,0.8878845929906158,0.6145038167938931,0.8631710373366264,1.0,8/30,18.63%,GTF2H5;POLR2L;TAF1B;POLR1A;CDK7;MNAT1;TTF1;TAF1A
prerank,camera-type eye morphogenesis (GO:0048593),0.42822579398299737,0.8876013936544981,0.6257668711656442,0.8632856304439352,1.0,1/10,1.73%,VEGFA
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.31962922749069145,0.8875615540263099,0.6591981132075472,0.86297933631631,1.0,4/51,2.86%,SGK1;DTNBP1;KIF20B;TAOK3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.33376097314188435,0.8871687819370905,0.6421686746987951,0.8633136757129927,1.0,11/36,21.63%,SDCBP;WAC;PSME3IP1;PSMF1;N4BP1;PRKCG;EIF3H;ALAD;TLK2;OGT;GIPC1
prerank,sterol biosynthetic process (GO:0016126),0.34226995966534207,0.8869036468593385,0.6225,0.8634118998369835,1.0,10/33,20.66%,PRKAG2;MVD;PLPP6;IDI1;INSIG2;PMVK;ACAA2;SC5D;HMGCR;ARV1
prerank,regulation of centrosome cycle (GO:0046605),0.3633478992692307,0.886825990747556,0.6218130311614731,0.8631691540720867,1.0,5/21,16.59%,CHMP2A;PDCD6IP;NAT10;SIRT1;CHMP5
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.39877202716247107,0.8867082860552916,0.6213872832369942,0.8630013180714672,1.0,2/14,4.64%,ANXA1;RARA
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.40080640233472814,0.8866564239575653,0.6047904191616766,0.862716572343656,1.0,3/12,17.41%,CD44;SIRT1;RPL26
prerank,microtubule bundle formation (GO:0001578),0.327927395743494,0.8866174531709157,0.642594859241126,0.862403980242022,1.0,8/42,13.70%,SPEF1;CCDC40;NCKAP5L;MTCL1;CCDC66;TOGARAM1;GAS2L1;CLASP1
prerank,negative regulation of cyclase activity (GO:0031280),-0.32711439792653607,-0.8865640714464987,0.6381578947368421,0.9101703767688792,1.0,5/14,15.74%,GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.35301608634073445,-0.8862234207354168,0.5746478873239437,0.9092682451527745,1.0,7/11,23.22%,TGFBR2;FGFR2;LRP5;STAT1;MYC;CTNNBIP1;WNT5A
prerank,embryonic appendage morphogenesis (GO:0035113),-0.348502003508798,-0.885739811365914,0.6116207951070336,0.9087645220914384,1.0,3/12,8.98%,PTCH1;MEGF8;TGFB2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.34186037532418023,0.8853125833755328,0.6224747474747475,0.8644335312538652,1.0,10/35,24.04%,CTNNB1;ACD;RTEL1;XRCC5;TNKS;TNKS2;CCT2;PKIB;NEK7;FBXO4
prerank,response to retinoic acid (GO:0032526),0.3143761662560107,0.8850416655615958,0.6502347417840375,0.8645673539821027,1.0,9/59,10.47%,AQP1;ABL2;RXRA;RARA;HTRA2;SOX9;CTSH;FZD7;PTK2B
prerank,protein localization to cell junction (GO:1902414),-0.2824537037715809,-0.8848853171485067,0.6544117647058824,0.9091364036610329,1.0,12/22,32.98%,NLGN1;HEG1;FERMT2;ARHGEF18;NECTIN1;BSN;MPP4;JAM3;SHANK1;PCLO;TJP3;JAK1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.30736299121452515,0.8845836985316177,0.6527621195039459,0.8649881246140573,1.0,22/65,26.36%,PSMD1;ZFYVE19;VPS4A;PSMF1;PSMD14;PSMD12;CHFR;PSME2;CUL1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;USP47;PSMC5;AVEN;PSMC1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.305016535500959,-0.8841022908850569,0.6538461538461539,0.9093484800579938,1.0,5/19,11.93%,GMPR2;PNP;AMPD2;DCK;GMPR
prerank,regulation of feeding behavior (GO:0060259),0.42066796327078004,0.8839106959080666,0.6035242290748899,0.8658573234167203,1.0,2/11,7.01%,CFAP20;EIF2AK4
prerank,ribosomal large subunit assembly (GO:0000027),0.35748430321949076,0.8836130777427095,0.6351706036745407,0.8660169933402064,1.0,2/24,3.31%,RPL3L;MRPL20
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.32153215177168754,0.8834944974576675,0.6369047619047619,0.865854920402125,1.0,9/45,14.90%,GCNT2;FOXO3;ATXN2;PUM3;MTPN;APP;PUM2;SPOUT1;RPL10
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.29184372193328534,-0.883095557553366,0.6282527881040892,0.9099641795630302,1.0,9/21,22.46%,CHST11;CSGALNACT1;CHST7;CHST9;CHSY1;BCAN;CSPG4;NCAN;CHST12
prerank,positive regulation of axon extension (GO:0045773),0.3608206737687044,0.8829635136508363,0.6241426611796982,0.8664373964924589,1.0,10/22,21.80%,VEGFA;RUFY3;ZFYVE27;DSCAM;MACF1;GOLGA4;NRP1;SHTN1;CDKL5;NTN1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.40736772247879316,0.882696867392835,0.6313432835820896,0.866544726657544,1.0,4/12,17.20%,TCERG1;HNRNPU;LARP7;NELFE
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3904103701613946,0.8822173816773874,0.6511627906976745,0.8670401216969251,1.0,7/17,23.03%,GET3;MMGT1;EMC2;EMC4;SGTA;EMC3;EMC10
prerank,negative regulation of cell growth (GO:0030308),0.2910234671043508,0.8821525711208167,0.7019730010384216,0.8667746941778917,1.0,22/121,13.96%,CDKN1A;PPT1;ENPP1;MYL2;SESN2;OSGIN1;APBB2;SPHK2;FLCN;HSPA1B;RB1;PPP1R9B;ACVRL1;BMPR2;NAIF1;SIRT1;MT3;DCUN1D3;BST2;ACVR1B;RBBP7;HSPA1A
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.29660316437200296,-0.8821084196526586,0.6313725490196078,0.9106174365658202,1.0,7/22,23.82%,PDE3B;APOC1;TNF;PPP2R5A;CCDC3;IL1B;ADRA2A
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.32330797807505895,-0.881467598463418,0.6196721311475409,0.9103712428546391,1.0,7/15,15.95%,CSNK1E;TIAM1;CSNK1D;RNF213;RSPO3;DAAM2;WNT5B
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2835535529395287,0.8814665915705185,0.7459349593495935,0.867650029167596,1.0,48/184,21.54%,ID2;DYNC1H1;PSMD1;APPL2;HAUS6;E2F1;ANAPC1;CUL3;RPS27A;UBC;ZFP36L2;PPP1R9B;DDB1;PSMF1;PSMD14;CEP76;PSMD12;APPL1;NPM2;TUBA1A;CLASP1;CEP192;PSME2;CUL1;INO80;ALMS1;NDE1;ANAPC10;OFD1;CCP110;SSNA1;HAUS7;PSMB10;PSMD5;PSMD8;PAFAH1B1;PSMA3;FBXO5;PSMA2;UBE2S;ANAPC15;PSMD11;CDC14B;PPP2R1A;PSMA6;HAUS5;CEP41;XPC
prerank,regulation of cell-substrate adhesion (GO:0010810),0.32589390043642874,0.881415768853132,0.6292270531400966,0.8673616562067966,1.0,10/42,19.26%,GCNT2;CORO1C;FZD7;NOTCH1;VIT;CX3CL1;BST1;RSU1;ATXN3;PIK3CB
prerank,proteasome assembly (GO:0043248),-0.34907961792961173,-0.8812607943448195,0.6301369863013698,0.909174373811947,1.0,5/11,22.93%,PSMG1;PSMG2;POMP;PSMD10;ADRM1
prerank,cellular copper ion homeostasis (GO:0006878),-0.329979406363415,-0.8811518629733606,0.595166163141994,0.9077441026539744,1.0,4/14,12.45%,SLC31A1;COX19;ATOX1;PRNP
prerank,ribosomal subunit export from nucleus (GO:0000054),0.40681337365311016,0.880453324001592,0.6273006134969326,0.8687141126906563,1.0,6/13,26.28%,EIF6;NUP88;XPO1;NMD3;NOP9;LSG1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.32290991292437615,0.8802564737003165,0.6574712643678161,0.868671821466393,1.0,17/49,24.36%,BCL2L11;PPIF;STYXL1;DDIT3;BCLAF1;BAX;MCL1;BID;NDUFS3;SGMS1;BBC3;NOC2L;BCAP31;PLAUR;HERPUD1;NDUFA13;BCL2L1
prerank,leukotriene metabolic process (GO:0006691),0.37213037410430294,0.8800193995973795,0.6215846994535519,0.8687252059812923,1.0,4/19,21.56%,MGST2;LTA4H;ABCC1;DPEP2
prerank,limb morphogenesis (GO:0035108),0.37273873781271605,0.8797784653935906,0.6292875989445911,0.8687661935334956,1.0,3/20,7.02%,TFAP2B;MBNL1;NIPBL
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.29901617405193026,0.8795939281094873,0.6897689768976898,0.8687239353887678,1.0,7/88,5.19%,APOE;SAMD4A;RIC1;DAPK1;DDX6;IGF2BP3;CLN3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.29706307641217544,0.8792960349176405,0.686059275521405,0.868901071060365,1.0,26/85,22.26%,FBXW7;RNF19A;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;TREM2;PRKN;HSPA1A;HECTD1;KEAP1;BBS7;ATXN3;DDA1;RNF19B;PIAS1;CEBPA;TAF1;HSPBP1;VCP
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3160871955084342,-0.8787566904683931,0.6232876712328768,0.9114848028243653,1.0,4/15,11.42%,WHRN;ADGRV1;TMEM120A;HPN
prerank,androgen metabolic process (GO:0008209),0.3788625278773136,0.8787339703420967,0.6610878661087866,0.8695585939662727,1.0,5/18,25.41%,SPP1;HSD17B11;SRD5A1;SRD5A3;HSD17B4
prerank,serine family amino acid biosynthetic process (GO:0009070),0.41133076487837206,0.8786929943548184,0.6286149162861492,0.8692713101633598,1.0,2/12,6.93%,PHGDH;SEPHS2
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.3591364202168474,-0.8786119420638994,0.6028571428571429,0.910114800126007,1.0,6/11,17.04%,IP6K2;PPIP5K1;FGF2;ITPKC;PPIP5K2;IP6K1
prerank,histone H3-K4 methylation (GO:0051568),0.347433732905453,0.8781556481345312,0.6248399487836107,0.8698281401906479,1.0,10/26,26.65%,CXXC1;TET3;TET2;KMT2A;PAXIP1;OGT;MEN1;KMT2D;SETD1B;KMT2C
prerank,acylglycerol biosynthetic process (GO:0046463),0.3611765346919579,0.8779850305308448,0.6530054644808743,0.8697307643363028,1.0,2/23,1.55%,LPIN3;GPAT2
prerank,ncRNA metabolic process (GO:0034660),-0.2385935076153803,-0.8776218239098476,0.6888888888888889,0.9107243671242521,1.0,11/37,25.12%,MAPT;DGCR8;TDRKH;TUT4;DTD2;DICER1;BCDIN3D;PARN;DTD1;EXD1;DDX4
prerank,lymphocyte migration (GO:0072676),0.33960724740052084,0.8775143723656952,0.6535141800246609,0.8701656085181009,1.0,6/32,19.25%,ADAM8;CKLF;MSN;CX3CL1;CCL7;CCL25
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3373092492759482,-0.877259843347159,0.6172506738544474,0.9097789512037514,1.0,3/12,13.68%,TMEFF2;SELENOS;AR
prerank,calcium-mediated signaling (GO:0019722),0.2969506058571738,0.8772478453247102,0.7114754098360656,0.8702787417768553,1.0,10/93,9.31%,HTR2B;TPCN2;CXCR4;PDPK1;P2RX4;XCR1;SLC8A1;PPP1R9B;KSR2;PPP3CA
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.35631891163299584,0.8769518573758653,0.6498637602179836,0.8704181991149154,1.0,1/24,0.15%,HTR2B
prerank,regulation of actomyosin structure organization (GO:0110020),0.3947598801419472,0.8767606492126414,0.6289855072463768,0.870385399163124,1.0,5/13,20.27%,AKAP13;PTGER4;ROCK1;ALMS1;ACTG1
prerank,protein-DNA complex assembly (GO:0065004),0.286753650341544,0.8763367351095787,0.7070600632244468,0.8707672984827862,1.0,31/116,23.32%,PSMD1;GTF2H5;RPS27A;UBC;ANP32B;BRD2;SOX9;DDB1;CDK7;PSMF1;PSMD14;PSMD12;CUL4A;PSME2;MNAT1;ORC1;ORC4;CDT1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;TCF4;PSMA6;CUL4B;XPC;PSMB3;PSME3;KAT6B
prerank,stem cell differentiation (GO:0048863),0.32417114519683055,0.8757681880680541,0.6707616707616708,0.8714295850231715,1.0,3/39,4.86%,HTR2B;FBXL17;FOXO4
prerank,negative regulation of cell division (GO:0051782),0.4172826640562082,0.8756628611395474,0.6309523809523809,0.8712440317602776,1.0,2/11,9.57%,ZFYVE19;VPS4A
prerank,myeloid dendritic cell activation (GO:0001773),-0.3511667171833247,-0.8753317667493049,0.6135693215339233,0.912673208279008,1.0,6/12,30.69%,TGFBR2;PYCARD;BATF3;BATF;CAMK4;BATF2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.38913518339329006,0.8748800903316385,0.6258992805755396,0.87222418747815,1.0,3/15,15.81%,IL6;APPL1;MYD88
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2795927273952902,-0.8744666596672701,0.6530612244897959,0.9129397980779429,1.0,11/21,31.45%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3365704772520254,0.8744140692187394,0.6593406593406593,0.872666402914299,1.0,16/33,27.73%,ACD;RTEL1;TERF1;DKC1;DCLRE1B;PPP6C;STN1;SHQ1;MRE11;TNKS1BP1;CDK2;TERF2IP;PPP6R3;TINF2;WRAP53;RFC1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.28216737935570696,-0.874263512243578,0.6771653543307087,0.9100179627754552,1.0,7/23,13.64%,TFDP2;BCL2;PPP1R13B;NMT1;BAD;YWHAG;YWHAH
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.28216737935570696,-0.874263512243578,0.6771653543307087,0.9100179627754552,1.0,7/23,13.64%,TFDP2;BCL2;PPP1R13B;NMT1;BAD;YWHAG;YWHAH
prerank,mitotic spindle organization (GO:0007052),-0.19623971964163875,-0.8740758484978394,1.0,0.9088209586913081,1.0,49/153,20.27%,EML1;NUP133;BUB3;DYNC1I2;DYNLL2;ZW10;NUDC;DCTN2;AHCTF1;GPSM2;AAAS;LSM14A;NUP85;SPAST;RAB11A;CHEK2;SEH1L;ITGB3BP;ZWILCH;CENPP;EML4;KNL1;CENPA;NUP37;KIF18A;MAP9;RHOA;NDEL1;MAPRE1;KIF23;STMN1;KIF11;PMF1;RMDN1;CENPK;TPX2;CENPO;BUB1;DCTN6;PRC1;CENPF;DYNC1I1;CENPT;CCDC61;KIFC2;EFHC2;EFHC1;SEC13;NDC80
prerank,renal system development (GO:0072001),0.31507860013834543,0.8736889000973072,0.67152466367713,0.873582395333508,1.0,12/52,20.89%,STRA6;VEGFA;TFAP2B;SULF2;PAX8;SULF1;ARL3;ITGA8;ACE;WFS1;IFT88;C1GALT1
prerank,pancreas development (GO:0031016),0.40827472881386073,0.8727681817436523,0.6471449487554904,0.874845787476853,1.0,3/12,23.84%,CCDC40;TCF7L2;NPHP3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2786342256107839,0.8723011292634762,0.7666325486182191,0.8753116815440761,1.0,50/186,23.84%,APOE;LRP1;PSMD1;ZNRF3;CUL3;STK3;APC;MCC;SOX9;SNAI2;DVL1;DDIT3;GSK3B;PSMF1;PSMD14;PSMD12;APCDD1;SOX2;LIMD1;PRKN;LRP6;PSME2;KREMEN1;LATS1;WWOX;CCDC88C;MLLT3;PSMB10;PSMD5;PTPRU;PSMD8;AMFR;STK4;PSMA3;RNF43;PSMA2;PSMD11;WWTR1;TCF7L2;PSMA6;TLE3;RUVBL2;PSMB3;SDHAF2;KLHL12;SIAH2;PSME3;BICC1;HMGXB4;NPHP3
prerank,cell junction maintenance (GO:0034331),-0.3186252462719029,-0.8722463900267379,0.6387096774193548,0.9113904687495039,1.0,10/14,41.56%,CSF1R;CHCHD10;CBLN2;F2R;DCTN1;MYADM;CLDN1;CBLN1;PRTN3;CD177
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.29087588107674134,-0.8719282366980671,0.6666666666666666,0.9104672641523448,1.0,6/23,14.13%,PTCH1;MEGF8;RACK1;GLI3;BTRC;ULK3
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3999842127622944,0.8717354970586083,0.6302765647743813,0.8759313852156728,1.0,5/13,19.78%,GLRX3;CIAO2B;CIAO2A;GLRX5;YAE1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.3353321895449789,-0.8713742568753557,0.6096096096096096,0.9101306927424202,1.0,3/11,12.67%,DCK;DCTD;ERH
prerank,negative regulation of protein processing (GO:0010955),0.40387106136725787,0.8712347853077694,0.6525679758308157,0.8764390126332497,1.0,3/12,16.42%,THBS1;CTSZ;GAS1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3172766906801407,-0.8711572589219759,0.620253164556962,0.9089921997980394,1.0,8/15,27.26%,ZC3H12B;DICER1;RPP30;NUDT16;ZC3H12C;NYNRIN;KHNYN;POP7
prerank,divalent inorganic cation homeostasis (GO:0072507),0.35094390607347903,0.870556892126933,0.6525641025641026,0.8772738484424852,1.0,5/25,13.77%,TFAP2B;SLC8A1;MT3;TRPM7;PRKN
prerank,fatty acid oxidation (GO:0019395),0.308330363102472,0.8703586142563239,0.6905882352941176,0.8772445585660957,1.0,18/57,25.87%,ABCD1;HADHA;MTLN;ACADL;ACADVL;PPARD;ALDH3A2;ECHDC1;EHHADH;ACAA2;ACAD10;SLC25A17;ADIPOR1;SCP2;ADIPOR2;ABCD2;HSD17B4;CPT2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3475945944545832,0.8702101581284997,0.638676844783715,0.8771197558701114,1.0,5/27,10.68%,CD44;DDX5;DYRK1A;SNAI2;SIRT1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.3239272739733551,0.8701933860563545,0.6539408866995073,0.8767764611239092,1.0,15/41,23.05%,PRKAG2;EIF6;SCARB2;TPR;NUP50;NUP98;ZBTB7A;NUP88;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,positive regulation of macrophage activation (GO:0043032),0.36961279004580483,0.8701885308750015,0.6409155937052933,0.8764017993666019,1.0,5/17,15.96%,THBS1;STAP1;TREM2;LBP;HSPD1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3434281099956077,0.8695118460975099,0.649810366624526,0.8772180942723896,1.0,5/29,12.18%,NR1H3;PLA2G2D;PLA2G4F;PLAAT3;LPCAT3
prerank,response to gamma radiation (GO:0010332),0.346752336742387,0.8686391667273345,0.646095717884131,0.8783704131338578,1.0,8/24,24.00%,MAP3K20;XRCC5;DCUN1D3;WRN;RPL26;TLK2;MEN1;HRAS
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.38791527484679095,0.8685872063857204,0.6289120715350224,0.8780872612724766,1.0,1/14,1.72%,CD84
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.3507797366368956,-0.868385005156135,0.5934718100890207,0.913604882946636,1.0,4/11,22.99%,HSP90AA1;QDPR;DHFR;SPR
prerank,histone H3-K36 demethylation (GO:0070544),0.41899392564137333,0.8683479908153957,0.6469719350073855,0.8781367359836689,1.0,4/10,17.02%,KDM4C;KDM2A;KDM7A;RIOX2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.31159515589495035,0.867354719837302,0.6770114942528735,0.8795227774756449,1.0,13/54,18.61%,PLK2;CDKN1A;E2F1;GADD45A;CNOT4;GTSE1;CNOT6L;CNOT7;BAX;CNOT6;RPL26;CASP2;CRADD
prerank,B cell activation involved in immune response (GO:0002312),-0.32948179250741505,-0.8673244516405989,0.6391752577319587,0.9143249986356803,1.0,2/13,5.02%,GPR183;RNF8
prerank,DNA strand elongation (GO:0022616),0.36813683939335884,0.8673058574879878,0.6432584269662921,0.8792273107843113,1.0,4/18,13.40%,RFC3;NBN;DCLRE1B;POLA1
prerank,global genome nucleotide-excision repair (GO:0070911),0.34300830928038384,0.8672720556353611,0.6370860927152318,0.8789054922664666,1.0,5/26,12.24%,GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4024501107422741,0.8670766005410898,0.6398809523809523,0.8788724756233216,1.0,3/12,11.96%,HNRNPU;ZFP36L2;NOTCH1
prerank,skeletal system morphogenesis (GO:0048705),-0.23956848274704076,-0.8666973536723772,0.7409638554216867,0.913996709350624,1.0,13/42,21.65%,FGFR2;TGFBR1;MEGF8;LRP5;FBN2;HOXD4;HOXD3;HOXC9;FGFR3;HOXA9;SOX11;HOXB9;DSCAML1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.38078437031494833,0.8662496718730975,0.6358381502890174,0.8799601742888812,1.0,4/16,12.31%,PID1;SPHK2;FLCN;TREM2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.34666072130098957,0.8658722032933451,0.6486129458388376,0.8802294100927935,1.0,7/24,20.25%,ENPP1;IGF1;IRS2;GSK3B;DYRK2;EPM2AIP1;GCK
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2946742787632612,0.8655620520998774,0.7086527929901424,0.8803939591016466,1.0,16/84,17.82%,APOE;SAMD4A;DAPK1;DDX6;IGF2BP3;SORL1;IGF1;RTN3;ROCK1;CNOT7;EPRS1;RTN4;EIF4A3;SYNCRIP;CAPRIN1;MALSU1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3366356320775455,0.8654785697773587,0.6649214659685864,0.8801762899685805,1.0,12/29,26.21%,DCAF13;RPS14;HELB;NOP14;RPS21;PWP2;NGDN;DHX37;ABT1;RRP36;NOP9;RPP40
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.37727566301975,0.8654394185465352,0.656934306569343,0.8798661445856439,1.0,3/16,14.48%,IGF1;ZFAND2B;PHIP
prerank,apoptotic DNA fragmentation (GO:0006309),0.37986290182014093,0.864991671141741,0.6460431654676259,0.8802734412899074,1.0,5/16,25.98%,DFFB;DNASE2;CASP3;DFFA;CECR2
prerank,histone modification (GO:0016570),0.2865555616743358,0.8649211193393354,0.734475374732334,0.8800161081076892,1.0,33/109,25.90%,EYA1;RCOR1;PRKCD;PHF20;PARP2;NSD3;CREBBP;INCENP;TBL1XR1;HUWE1;SIRT1;CCNA2;MT3;SIRT7;USP21;USP16;USP36;PHF20L1;BAZ1B;SGF29;SIN3A;USP3;EHMT2;KAT2A;RUVBL2;KAT6B;CDK2;ATXN7;MIDEAS;CARM1;KAT6A;HDAC1;RCOR3
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3035676415017816,-0.8649181463177358,0.6605839416058394,0.9163722318779054,1.0,6/17,20.34%,BCL2;CLU;SOD2;BAD;FIS1;TIMM50
prerank,nuclear envelope organization (GO:0006998),0.3632786398623366,0.8638915374715321,0.6426666666666667,0.881448167212981,1.0,6/20,20.79%,REEP4;VPS4A;LEMD3;NEMP1;TMEM170A;TOR1A
prerank,eye morphogenesis (GO:0048592),0.37190489500364554,0.8636169145653487,0.6531468531468532,0.8815533811661993,1.0,3/19,9.63%,VEGFA;NIPBL;COL5A2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3361711255770251,0.8635494792248728,0.655860349127182,0.8812810151525892,1.0,7/29,14.94%,GTF2H5;RPS27A;UBC;DDB1;CDK7;CUL4A;MNAT1
prerank,histone ubiquitination (GO:0016574),-0.28798320356240303,-0.8631501566893934,0.6341463414634146,0.9186305015349578,1.0,7/21,15.42%,RNF8;PHC1;RNF20;PAF1;UBE2B;ATXN7L3;UBE2N
prerank,acyl-CoA metabolic process (GO:0006637),0.324804846645586,0.8627137768117399,0.6738853503184713,0.8823284005555447,1.0,10/35,23.92%,BAAT;ACSM3;GLYAT;MCEE;ACOT9;OGDH;ACOT2;ACOT6;ACOT13;ACOT8
prerank,positive regulation of bone mineralization (GO:0030501),0.3283634834836534,0.8626397825732596,0.675577156743621,0.8820949512952234,1.0,7/35,10.93%,ANO6;ATP2B1;SLC8A1;ACVR2A;PKDCC;BMPR2;CCN1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.19856406081699976,-0.8623110463205506,0.8205128205128205,0.9188721364703811,1.0,28/129,16.32%,GPC5;SEMA5A;CSNK1E;LGR4;CSNK1G3;FGFR2;JUP;PSMC2;TRPM4;LGR5;CSNK1D;EGFR;PSMD6;CSNK1G2;AMER1;PRDM15;DAPK3;WNK2;WNK1;PSMD7;UBE2B;SCEL;RNF220;PSMB5;DAAM2;HHEX;FGF10;PSMB4
prerank,cardiolipin metabolic process (GO:0032048),0.3933910907021878,0.8622799869072048,0.6515373352855052,0.882327011765663,1.0,3/13,9.53%,HADHA;SLC27A1;TAMM41
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3264085104329913,0.8622361190959857,0.6682808716707022,0.8820350671967717,1.0,5/35,11.12%,RFC3;MUTYH;NEIL1;POLL;MBD4
prerank,regulation of T cell differentiation (GO:0045580),0.3305851039689301,0.8614250104663271,0.6720098643649816,0.8831206202608574,1.0,3/33,8.81%,ZMIZ1;FOXP3;CBFB
prerank,regulation of cell development (GO:0060284),0.32403747983537035,0.8613734243987677,0.6842105263157895,0.8828285848650466,1.0,9/36,20.76%,CTNNB1;NOTCH2;BHLHE40;FOXO1;CX3CL1;GRN;RHEB;CLOCK;HES5
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.283265474230553,-0.8612059942995562,0.6613545816733067,0.9196766266638798,1.0,10/21,24.63%,NAV3;HDGFL3;FGF13;STMN2;MID1IP1;TPX2;TTBK2;CAMSAP1;CIB1;KATNB1
prerank,cellular response to virus (GO:0098586),-0.2584562315790327,-0.8608931592472333,0.663594470046083,0.918710611926432,1.0,12/30,25.95%,POU2F2;HSP90AA1;IRGM;FMR1;GSDME;IFIH1;RRP1B;CHUK;GBF1;CCL5;LGALS9;DDX3X
prerank,ion transport (GO:0006811),0.2869536752292597,0.8601513333049915,0.7497348886532343,0.8845751495985132,1.0,11/111,6.03%,SLC26A11;SLC36A2;ANO6;SLC9A3;VDAC2;SLC8B1;SLC8A1;SLC26A1;SLC17A5;SLC5A5;SLC12A3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.2949238118578525,0.8596686569478678,0.7205387205387206,0.8850529933477508,1.0,20/70,22.96%,LMO1;PSMD1;CBFB;PSMF1;PSMD14;PSMD12;PSME2;TCF12;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;KMT2A;OSM;PSMD11;PSMA6;PRKDC;PSMB3;PSME3
prerank,platelet aggregation (GO:0070527),0.3325001399232552,0.8594073235230395,0.6875800256081946,0.8851463566323224,1.0,15/33,25.57%,ACTN1;TLN1;RAP2B;STXBP3;MYH9;CLIC1;FIBP;PIK3CB;ACTG1;ILK;FLNA;PPIA;MYL12A;ACTB;ITGB3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3290394164363891,0.8591314798828783,0.6687116564417178,0.8852423206852182,1.0,7/33,15.05%,KLK3;KDM4C;DDX5;CBFB;ESR1;UBA5;LATS1
prerank,positive regulation of protein binding (GO:0032092),0.3055180613033083,0.8590596942491756,0.6802259887005649,0.8849687617814019,1.0,16/56,23.97%,APOE;FLOT1;LRP1;STK3;HIPK2;GSK3B;APP;PRKN;AMFR;STK4;PPP2CA;TCF7L2;TAF1;FKBP1A;NMD3;MEN1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.33567530284251423,0.8588294106662064,0.6763959390862944,0.8849678226015351,1.0,11/32,27.18%,CTNNB1;ACD;XRCC5;TNKS;TNKS2;CCT2;PKIB;NEK7;FBXO4;CCT7;HMBOX1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.39061904597197084,0.8586682801577412,0.651872399445215,0.8848642266440687,1.0,3/13,10.88%,RENBP;NAGK;OGA
prerank,negative regulation of viral life cycle (GO:1903901),0.38692329054920405,0.8586164695986339,0.6425531914893617,0.8845755700560998,1.0,4/15,17.72%,IFITM1;IFITM2;BST2;SNX3
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.30494536353400564,0.8584383375924508,0.7041420118343196,0.8844865031743637,1.0,10/57,13.73%,VEGFA;PIBF1;IL6;IGF1;NF2;IL6R;CNOT7;IL15;HCLS1;INPP5F
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.2604529902949532,-0.8583374240363129,0.6772908366533864,0.922665349102898,1.0,12/27,25.52%,SNTA1;FGF12;SCN1B;PTPN3;DLG1;ATP2B4;YWHAH;FXYD7;SCN4B;FXYD1;NOS1;SCN2B
prerank,embryonic skeletal system development (GO:0048706),0.3270564238618639,0.8582421638193094,0.6938271604938272,0.8844496670196527,1.0,5/35,12.73%,XYLT1;COL1A1;SULF2;HOXA3;SULF1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.36187239186911413,0.8579059854780047,0.6527027027027027,0.884686886814021,1.0,9/19,24.68%,LY96;NR1H4;TICAM2;LBP;TRIL;SCIMP;TIRAP;IRAK1;RAB11FIP2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.4009196502035589,0.8578848572520711,0.6585365853658537,0.8843413506209542,1.0,5/12,25.41%,ABCD1;ELOVL1;SCP2;ACOT8;HSD17B4
prerank,negative regulation of myotube differentiation (GO:0010832),-0.32371859654476987,-0.857750965649574,0.6491228070175439,0.9224086132275712,1.0,1/12,1.91%,TMEM119
prerank,lipid biosynthetic process (GO:0008610),0.29220850703915713,0.8576591756936314,0.6935840707964602,0.8843616081240158,1.0,15/77,21.42%,LIPG;GPAT2;AGPAT4;MVD;ACSM3;NDUFAB1;ACSL5;DHRS11;SCD;CBR4;PAM;HMGCR;PDSS1;SREBF1;SRD5A1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3231415960850454,-0.8575727204240904,0.6515151515151515,0.9211519786274781,1.0,5/14,17.04%,PKIG;PKIA;ATP2B4;RAPGEF2;PRKAR2B
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.39724495469661947,0.8575494882853868,0.6646706586826348,0.8841669168698256,1.0,1/12,1.98%,DHRS3
prerank,glycolipid biosynthetic process (GO:0009247),0.31640191774373644,0.8573318158658697,0.6830143540669856,0.8841721087666456,1.0,8/38,15.19%,PGAP3;DPM2;B4GALT6;PIGH;ST3GAL4;A4GALT;PIGC;PIGQ
prerank,anterograde axonal transport (GO:0008089),0.3228471979809267,0.8571433225341528,0.6901579586877278,0.884130167581367,1.0,8/37,18.11%,DTNBP1;AP3S1;RAB21;KIF3A;AP3D1;AP3B1;KIF5B;KIF5C
prerank,synaptic vesicle exocytosis (GO:0016079),-0.23850092145185256,-0.8569457332751216,0.7883597883597884,0.9209225293975104,1.0,14/40,21.32%,SYT1;RIMS1;UNC13C;RIMS2;SNAP25;SYT7;SYT2;STX1A;CPLX1;CPLX2;BLOC1S6;UNC13A;STX4;OTOF
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2889668952616947,-0.8569160029650805,0.6666666666666666,0.9193311404335305,1.0,7/19,21.15%,RPTOR;MAF1;AR;POLR3F;CHD8;BRF2;POLR3G
prerank,regulation of pH (GO:0006885),0.4079840482853033,0.8567854040298833,0.6756352765321375,0.8843535802657425,1.0,1/11,1.98%,PDK4
prerank,positive regulation of lymphocyte activation (GO:0051251),0.3368102100008842,0.8565749551730806,0.6786188579017264,0.8843311431506659,1.0,4/28,8.76%,IL6;SH3KBP1;SIRPA;TYROBP
prerank,chromatin organization (GO:0006325),0.2783552077505137,0.8563963281242863,0.7654450261780105,0.8842621014648968,1.0,40/132,25.86%,FOXP3;KDM4C;BAZ1A;BAZ2B;TOP1;SOX9;RB1;SETD7;ESR1;HCFC2;SIRT1;CBX3;SMARCC1;NPM2;SOX2;SMARCD1;SUV39H2;INO80;BAZ1B;BRWD1;PBRM1;ZBTB7A;SMARCB1;HDAC8;PRDM16;PHF1;SAFB;CDAN1;KAT2A;KDM5C;RUVBL2;HMG20A;MTF2;SUPT4H1;SETD5;SMARCE1;SMARCD2;HDAC1;KAT2B;SMARCA1
prerank,regulation of microtubule-based movement (GO:0060632),0.4095076154982397,0.8563909946704743,0.6294027565084227,0.8838895284185577,1.0,1/11,1.58%,LAMP1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.42440909100266255,0.8555706883279904,0.6490683229813664,0.8849383037010581,1.0,2/10,11.18%,HIPK2;ING4
prerank,protein localization to kinetochore (GO:0034501),-0.32131470761133124,-0.8554342937568283,0.6349206349206349,0.9210180737361124,1.0,11/14,31.45%,BUB3;ZW10;ZWILCH;KNL1;CENPT;MTBP;IK;CDK1;CHAMP1;AURKB;TTK
prerank,histone mRNA catabolic process (GO:0071044),-0.32252534295548474,-0.8552719098611619,0.6387096774193548,0.919744559559614,1.0,6/15,13.39%,ATM;TUT4;SSB;MTPAP;LSM1;XRN1
prerank,cellular response to leucine (GO:0071233),-0.36118015257570685,-0.8551446758173952,0.6309523809523809,0.9167886684862857,1.0,2/10,2.75%,RPTOR;SESN3
prerank,response to leucine (GO:0043201),-0.36118015257570685,-0.8551446758173952,0.6309523809523809,0.9167886684862857,1.0,2/10,2.75%,RPTOR;SESN3
prerank,positive regulation of type I interferon production (GO:0032481),0.2937455951746739,0.8549014245078503,0.7111111111111111,0.8857382821100169,1.0,25/73,25.99%,TLR8;CTNNB1;FLOT1;CREBBP;RNF135;POLR2L;XRCC5;MAVS;PQBP1;RELA;MYD88;HSPD1;STAT6;TBK1;MRE11;POLR3C;PRKDC;POLR3K;IRAK1;ISG15;LRRFIP1;DHX58;TLR9;POLR2F;IRF7
prerank,protein-DNA complex disassembly (GO:0032986),0.37453635476022334,0.8548785747167209,0.6652421652421653,0.885402790448899,1.0,8/16,28.03%,RPL23;ARID2;SMARCC1;SMARCD1;SMARCB1;SMARCE1;SMARCD2;SMARCA4
prerank,in utero embryonic development (GO:0001701),0.3490603383459568,0.8546165551734175,0.6631439894319683,0.8854610458650902,1.0,7/25,21.26%,VEGFA;MBNL1;FLCN;CHD7;FUT8;SOX8;ADAM10
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3121993148191794,0.8543766579747766,0.6833130328867235,0.8855254518944524,1.0,10/43,20.19%,TAOK3;CDKN1A;BABAM2;BRCA1;NBN;CHFR;ORC1;BRCC3;CDC14B;MRE11
prerank,regulation of viral release from host cell (GO:1902186),0.3464213899543445,0.8541298839391267,0.6516393442622951,0.8855508446762617,1.0,4/21,10.04%,TRIM25;CHMP2A;VPS4A;DDB1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.3856977124340428,0.8531214768783281,0.6627393225331369,0.886919251657924,1.0,3/13,14.72%,CD46;FSTL1;NRROS
prerank,regulation of actin nucleation (GO:0051125),-0.3340525584927042,-0.8530955096733321,0.6484149855907781,0.9196377845614145,1.0,3/12,8.22%,CORO1A;PICK1;ARFIP2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.29020909412935625,0.8528722528867348,0.7296703296703296,0.8869723352060311,1.0,11/85,12.00%,EYA1;LOXHD1;P2RX4;COL1A1;NIPBL;SNAI2;WDR1;COL11A1;LHFPL3;PIEZO2;ROR1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2924353175699425,0.8519743959139262,0.7526881720430108,0.888152381623849,1.0,22/91,16.42%,SYK;RAB8B;ABL2;RAB33B;RAB21;STXBP5;CD22;PICALM;RAB12;RAB10;FES;OLFM4;CPLANE2;RAB11B;FGR;INPP5F;STON1;DNAJC13;SNX17;NRP1;PTPN1;GAS1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.39346793774465083,0.8519243546446116,0.6374622356495468,0.8878513338662165,1.0,2/12,4.22%,FYCO1;UVRAG
prerank,regulation of T cell migration (GO:2000404),-0.2962410898782987,-0.8512275690818518,0.6529209621993127,0.9221043156232427,1.0,6/18,14.21%,DOCK8;RIPOR2;AIF1;CD200;PYCARD;RHOA
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.30223267246844754,0.8511140376634191,0.7142857142857143,0.888896142921429,1.0,19/55,26.36%,PSMD1;PSMF1;PSMD14;PSMD12;PSME2;CUL1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;USP47;PSMC5;AVEN;PSMC1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.3997710622370405,0.8507374749095332,0.6745283018867925,0.8891734924196842,1.0,2/11,5.50%,CD46;THBS1
prerank,zinc ion transport (GO:0006829),0.35250557166808333,0.8506656553992195,0.6920980926430518,0.8889200635771375,1.0,10/21,30.68%,SLC39A14;MT3;SLC39A3;SLC39A11;SLC30A1;SLC30A9;SLC39A1;SLC39A13;SLC30A5;SLC30A6
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3703806822992512,0.8505307471331913,0.663013698630137,0.88877185520887,1.0,3/17,11.60%,PLA2G2D;PLA2G4F;PLAAT3
prerank,apoptotic process (GO:0006915),0.27501752527497425,0.8500508245938532,0.8054989816700611,0.8892230999999283,1.0,52/203,20.97%,CXCR4;ADRA1A;BCL2L11;PRKCD;FAS;APAF1;DAPK1;RIPK1;NOTCH2;RAF1;GADD45A;AIFM2;MELK;STK3;PIK3CA;THOC1;BNIPL;AKAP1;DLC1;CYFIP2;EGLN3;PTK2B;FOXO1;PPARD;ING4;APP;BCLAF1;VDAC1;CASP12;BAX;KREMEN1;RTN4;CASP6;NDUFS1;BNIP3;MYD88;HSPD1;BID;IFIT2;BBC3;CASP2;STK4;CASP3;TNFAIP1;PPP2CA;TNFRSF21;NUDT2;PPP2R1A;OGT;PAWR;RELT;ZBTB16
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3334149545432224,0.8498468006748553,0.6940874035989717,0.8891991993733892,1.0,8/28,15.05%,ARHGAP18;COTL1;WDR1;PFN1;HCLS1;CXCL12;PFN2;LATS1
prerank,regulation of cellular component organization (GO:0051128),0.2795044231563939,0.8496901500990047,0.7596656217345873,0.8890757368095559,1.0,22/135,16.40%,CD36;APOE;SGK1;TFRC;ABL2;RAB33B;NUBP1;IRAK3;HNRNPU;CD22;PICALM;LAMTOR1;ROCK1;DCUN1D5;RAPGEF1;ATAD3A;STON1;LATS1;SNX17;TRAF2;PTPN1;MELTF
prerank,monoacylglycerol metabolic process (GO:0046462),0.3901090883607049,0.8487656891013319,0.6497005988023952,0.8902644560581017,1.0,1/13,1.78%,MGLL
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.34829868818678356,0.8484540549580722,0.6692913385826772,0.8904100806519116,1.0,6/21,19.82%,PTEN;RPL23;FBXO5;UBE2S;RAB1A;CDC14B
prerank,positive regulation of growth (GO:0045927),0.295889194211224,0.8479541617118705,0.7155655095184771,0.8908957530155011,1.0,7/64,10.49%,RFTN1;SDCBP;MMP14;N6AMT1;EXOSC9;ADAM17;MTPN
prerank,histone lysine demethylation (GO:0070076),0.3458065530583472,0.8479461881779049,0.6792698826597132,0.8905333638681691,1.0,9/25,22.16%,KDM4C;KDM3A;JMJD1C;KDM2A;KDM1B;KDM7A;RIOX2;PHF2;KDM5C
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.369056953302232,0.8478381058419535,0.6686046511627907,0.8903528760464501,1.0,2/15,7.79%,MUS81;EME1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2889919547271968,-0.847386029687657,0.6736842105263158,0.9287090749193347,1.0,9/18,28.22%,RAB11A;CDK4;CDC7;CDC25B;BRD4;DTL;CDK1;CCND1;STOX1
prerank,cardiocyte differentiation (GO:0035051),0.40763407195630164,0.8470606235982705,0.6701807228915663,0.8912967971480632,1.0,2/10,7.96%,SIK1;AKAP13
prerank,positive regulation of leukocyte activation (GO:0002696),0.3625382714431965,0.8470219823615405,0.6745810055865922,0.8909812673952895,1.0,4/18,15.96%,CLEC4D;THBS1;LBP;HSPD1
prerank,negative regulation of proteolysis (GO:0045861),0.32515160468717297,0.8468892741515182,0.6831168831168831,0.890831119442951,1.0,4/34,10.10%,TIMP1;CLN3;TIMP2;ROCK1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3467228779165076,0.8468823800958253,0.6770691994572592,0.8904642597953658,1.0,6/23,21.15%,MUS81;DFFB;DNASE1L1;DNASE2;CASP3;DFFA
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.33239876866892965,-0.8465771277370705,0.6451612903225806,0.9287464831300328,1.0,2/11,17.91%,NFKBID;CARD9
prerank,protein kinase A signaling (GO:0010737),0.39206966421813255,0.8463596018861524,0.6676783004552352,0.8909642615038317,1.0,1/12,3.01%,LCP1
prerank,glycogen catabolic process (GO:0005980),0.3708944174948025,0.8463453959137087,0.6714905933429812,0.8906068667014713,1.0,4/15,21.80%,PYGL;AGL;PHKG2;PYGB
prerank,organic anion transport (GO:0015711),0.2907452202947989,0.8461858474471919,0.7268770402611534,0.8905097387095071,1.0,18/76,19.89%,LRRC8D;AQP1;ABCC4;LRRC8C;CYB5R4;SLC23A1;MGST1;SLC52A1;SLC25A42;SLC17A9;CA2;SLCO3A1;CYB5R2;CYB5R1;SLC35A2;SLC19A1;SLC35C2;SLC25A17
prerank,aerobic electron transport chain (GO:0019646),0.29253868401734145,0.8459742860610612,0.7187153931339978,0.8904920075315986,1.0,23/68,23.59%,UQCRFS1;NDUFS8;NDUFA10;AFG1L;NDUFC1;COX6A1;NDUFAB1;CYCS;SDHA;COX8A;NDUFB6;NDUFS6;NDUFS1;COX7B;COX15;NDUFS3;NDUFB4;NDUFB8;COX4I1;SDHAF2;COX5A;NDUFB9;NDUFA13
prerank,regulation of protein secretion (GO:0050708),0.27836189086397645,0.8459062698402376,0.7555555555555555,0.8902395149122594,1.0,13/119,8.25%,APOE;ABCG1;SERGEF;ADAM9;IL6;TFAP2B;RHBDF2;SLC8B1;IGF1;ADAM8;ENSA;STXBP5;EIPR1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.32557366494113005,0.8458207627914417,0.6877323420074349,0.8900025602387791,1.0,3/32,8.74%,CD300A;PRKCD;DLC1
prerank,autonomic nervous system development (GO:0048483),0.3689959051928812,0.8453661964321129,0.669971671388102,0.8903592527059503,1.0,5/17,18.68%,TFAP2B;PHACTR4;GDNF;NRP1;SOX8
prerank,cellular response to drug (GO:0035690),0.3389929476494072,0.8451512004195548,0.6964520367936925,0.8903551764778995,1.0,8/25,20.53%,RAP2A;TFRC;GPLD1;GAS6;HTR1B;ACER2;RBM22;CERS1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.32155124691456266,0.84453377654423,0.6796973518284993,0.8910092020538327,1.0,8/32,20.19%,TAOK3;CDKN1A;BABAM2;BRCA1;NBN;BRCC3;CDC14B;MRE11
prerank,regulation of interferon-alpha production (GO:0032647),0.3476248063886036,0.8444329839299126,0.6813922356091031,0.8907998593551658,1.0,5/23,19.57%,TLR8;MAVS;NLRC3;HSPD1;TBK1
prerank,striated muscle cell development (GO:0055002),-0.31326224782620454,-0.8442033852897366,0.7105263157894737,0.9320741525461615,1.0,2/14,5.48%,CAPN3;TMOD2
prerank,negative regulation of TOR signaling (GO:0032007),0.31836183798065376,0.8437763053121,0.7028714107365793,0.8914872227223541,1.0,7/36,13.50%,FNIP1;SESN2;FLCN;EPM2A;SIRT1;CASTOR1;NPRL3
prerank,organelle fusion (GO:0048284),0.34560290187564024,0.8437532716427079,0.6740027510316369,0.8911507693076478,1.0,7/22,22.86%,EEA1;GDAP1;BAX;VPS11;USP30;AFG3L2;MFN2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.3505520750004815,0.8436734477693889,0.7035040431266847,0.8909071456948844,1.0,5/23,20.25%,NCOR1;SIK1;PGP;CRY1;GCK
prerank,cell chemotaxis (GO:0060326),0.29860511634116554,0.8436100809045864,0.7274774774774775,0.8906401647642227,1.0,5/60,3.95%,CXCR4;VEGFA;HGF;PRKCD;XCR1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.3745201472476434,0.8435283894998008,0.6767537826685007,0.890415717394064,1.0,4/15,14.64%,RENBP;NAGK;OGA;GNPDA1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3790062638187779,0.8435023320011106,0.6725925925925926,0.8900767956456237,1.0,4/14,19.55%,THBS1;SULF2;SULF1;CREB3L1
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3145292825645716,-0.8430953847426121,0.6782334384858044,0.9327664994508662,1.0,5/15,12.35%,MEF2A;IL6ST;PARP1;PRKCA;AGT
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3288852634978779,0.8429246201706805,0.6830188679245283,0.8906581331845606,1.0,8/31,21.13%,TFRC;IL6;KMT5B;VAMP3;SHLD1;SHLD2;PAXIP1;PTPRC
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3002507798091602,0.8428426779324606,0.7069767441860465,0.8900471278199674,1.0,21/56,24.57%,NDUFS8;NDUFA10;NDUFC1;ECSIT;NDUFAB1;TMEM126A;NDUFAF8;NDUFB6;DMAC1;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFAF7;NDUFB8;NDUFAF4;NDUFB9;NDUFAF2;NDUFA13;TMEM126B;DMAC2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3002507798091602,0.8428426779324606,0.7069767441860465,0.8900471278199674,1.0,21/56,24.57%,NDUFS8;NDUFA10;NDUFC1;ECSIT;NDUFAB1;TMEM126A;NDUFAF8;NDUFB6;DMAC1;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFAF7;NDUFB8;NDUFAF4;NDUFB9;NDUFAF2;NDUFA13;TMEM126B;DMAC2
prerank,protein K48-linked deubiquitination (GO:0071108),0.341997973814351,0.8425650238125828,0.6942934782608695,0.8901537569517967,1.0,6/23,19.24%,MINDY1;VCPIP1;TNFAIP3;USP8;OTUD5;ATXN3
prerank,spliceosomal complex assembly (GO:0000245),0.308658278219672,0.8423834247057681,0.7051282051282052,0.8900893153130838,1.0,13/46,17.66%,SRPK2;SCAF11;CELF1;SNRNP200;SF1;PRPF6;DDX23;SF3A3;ZRSR2;SMN1;PUF60;LUC7L;SRPK1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.3890546314079325,0.8420139554063867,0.6722560975609756,0.8903023833547916,1.0,3/12,10.68%,SNX5;SORL1;SIRT1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3019126693425718,0.8418265522042429,0.7111111111111111,0.8902179372004431,1.0,18/54,21.62%,CTNNB1;COPS9;HSPA1B;DCUN1D3;SIRT7;N4BP1;TNFAIP3;HSPA1A;SQSTM1;ARRB1;PRKCG;CRY1;PRR7;GNL3L;HDAC8;DNAJA1;OGT;GTPBP4
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.3825526529401627,0.8418249756326001,0.6652110625909753,0.8898463459295319,1.0,3/13,12.43%,PRPF8;PRPF6;DDX20
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.33423634866752816,0.8413711700532983,0.6823529411764706,0.8902486175430916,1.0,8/26,25.35%,HOMER3;IGF1;GSK3B;DYRK2;STIMATE;HOMER2;EFHB;SPPL3
prerank,macrophage differentiation (GO:0030225),0.3790352518246405,0.8411030672224634,0.6746626686656672,0.8903210294499514,1.0,3/13,12.24%,VEGFA;SIRT1;IL15
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.28805128894385257,-0.8406017682080265,0.730909090909091,0.9364262978854856,1.0,3/18,7.02%,NAV3;CD34;HDAC7
prerank,negative regulation of lymphocyte migration (GO:2000402),0.4098736004344216,0.8400167579916787,0.6682464454976303,0.891698763256871,1.0,4/10,21.33%,CD200R1;WASL;APOD;LRCH1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.34565074122289413,0.8399976130778273,0.6775510204081633,0.8913592746372526,1.0,5/21,13.70%,CORO1C;DUSP3;ROCK1;MACF1;CLASP1
prerank,positive regulation of protein kinase activity (GO:0045860),0.2753394941188058,0.8398258418165205,0.7836438923395446,0.8912767657195075,1.0,19/148,11.59%,IQGAP1;NEDD9;VEGFA;PRKAG2;TAOK3;PRKCD;CDKN1A;SNX9;STK3;INCENP;CACUL1;SLC27A1;IL6R;TNIK;XRCC5;PTK2B;PAK2;CCN1;TAB2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.27413273608233235,-0.8397757506959228,0.7698412698412699,0.936485478381519,1.0,3/22,3.65%,ATP1B1;ANK2;RYR2
prerank,homeostasis of number of cells (GO:0048872),-0.332096899221999,-0.8394545451842979,0.6666666666666666,0.9355266306083178,1.0,1/12,0.09%,CX3CR1
prerank,protein targeting to ER (GO:0045047),0.28331785411063465,0.8393919480707229,0.769394261424017,0.8916281838537321,1.0,22/99,17.83%,ZFAND2A;RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;GET3;RPL36A;RPL22;RPS21;RPL10A;RPS26;SPCS2;ZFAND2B;RPL15;RPL10;RPSA;RPL7;RPL26;SGTA;SEC63
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.39867536250320945,0.8393646940050545,0.6788990825688074,0.8909265851721632,1.0,4/11,18.91%,DKC1;LARP7;MEPCE;CCT2
prerank,regulation of protein localization to Cajal body (GO:1904869),0.39867536250320945,0.8393646940050545,0.6788990825688074,0.8909265851721632,1.0,4/11,18.91%,DKC1;LARP7;MEPCE;CCT2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.2631107362335901,-0.8391291693342003,0.7657657657657657,0.934512700512434,1.0,12/27,22.46%,B3GAT3;CHST11;CSGALNACT1;B3GAT1;B3GAT2;CHST7;CHST9;CHSY1;BCAN;CSPG4;NCAN;CHST12
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3957117272776758,0.8382985517724213,0.6866566716641679,0.8922941105545346,1.0,2/11,9.92%,UQCRFS1;CYCS
prerank,regulation of lipase activity (GO:0060191),-0.32600365443844953,-0.838281045674854,0.6536144578313253,0.9346332001926899,1.0,4/13,27.89%,RHOA;ANGPTL3;PCSK5;LPL
prerank,positive regulation of cell cycle (GO:0045787),0.29215188691205807,0.8378215748782157,0.7327188940092166,0.8927241310172869,1.0,9/62,11.57%,ANKRD17;SRPK2;RARA;CITED2;DUSP3;RAD23A;ADAM17;PKN2;APP
prerank,regulation of lipid kinase activity (GO:0043550),0.3957722405172772,0.8375945488435921,0.6762481089258698,0.8927221389736849,1.0,2/11,8.04%,WDR91;RB1
prerank,receptor signaling pathway via STAT (GO:0097696),0.33680322063631984,0.8371538274751046,0.6900510204081632,0.8930495892363838,1.0,9/25,23.08%,STAT5B;SOCS6;IFNAR2;IFNAR1;STAT6;STAMBP;PIAS1;STAT3;JAK2
prerank,axon guidance (GO:0007411),0.2672280701899468,0.8370377907415785,0.8133198789101918,0.8928590427572128,1.0,20/201,7.14%,PLXNA1;CXCR4;PLXNC1;GRB2;PLXND1;PALLD;GAB2;VEGFA;ALCAM;SOS1;NIBAN2;SEMA4B;NTN3;NOTCH2;MAPK7;NRP2;DAG1;IRS2;PIK3CA;SH3KBP1
prerank,epithelial cell development (GO:0002064),0.3521369560826262,0.836544793826562,0.6759388038942976,0.8932820606892392,1.0,1/20,0.95%,RILPL2
prerank,positive regulation of myelination (GO:0031643),-0.34242171503255026,-0.8364601458690325,0.6898550724637681,0.9369055040237207,1.0,6/11,14.57%,PARD3;TPPP;MYRF;CST7;TENM4;DICER1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.32000180420041396,0.8351332770633507,0.6893081761006289,0.8952082354911183,1.0,12/35,23.08%,IL6;IL10RB;DOT1L;NF2;NOTCH1;JAK3;PIGU;BCL3;HES5;PTPRC;ADIPOR1;JAK2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2875160961322382,0.834851999058995,0.7411894273127754,0.8952993024135367,1.0,23/69,23.59%,UQCRFS1;NDUFS8;NDUFA10;AFG1L;NDUFC1;COX6A1;NDUFAB1;CYCS;SDHA;COX8A;NDUFB6;NDUFS6;NDUFS1;COX7B;COX15;NDUFS3;NDUFB4;NDUFB8;COX4I1;SDHAF2;COX5A;NDUFB9;NDUFA13
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3526086717065714,-0.8347192343263007,0.6486486486486487,0.9388182463978008,1.0,2/10,6.09%,CX3CR1;ARRB2
prerank,neuron projection regeneration (GO:0031102),-0.34612277576159217,-0.8346266724471404,0.7077363896848138,0.9373659879585425,1.0,1/10,0.30%,RTN4RL1
prerank,brain morphogenesis (GO:0048854),-0.3228701858328137,-0.8344644950569295,0.6876790830945558,0.9361046469700318,1.0,3/12,7.93%,CTNNA2;BBS2;PAX2
prerank,myotube cell development (GO:0014904),0.4030899311513444,0.8339143847374789,0.6718266253869969,0.8964386793801369,1.0,1/10,5.10%,IGF1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.28716940308368705,-0.833840980592321,0.6901408450704225,0.9357771559638696,1.0,2/18,3.73%,CAMK1D;RIPOR2
prerank,TOR signaling (GO:0031929),0.3337440784172481,0.833810291340058,0.6842800528401585,0.8962440976991576,1.0,8/26,22.71%,FNIP1;FLCN;EIF4EBP2;NPRL3;MAPKAP1;CARD11;RICTOR;SYAP1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.31598913911148935,0.8337266232605487,0.705,0.8959945007350388,1.0,9/32,21.58%,GTF2H5;POLR2L;TAF1B;POLR1A;CDK7;MNAT1;TAF1A;RRN3;TAF1
prerank,catecholamine metabolic process (GO:0006584),0.3774907888757055,0.8335101756357587,0.6914119359534207,0.8959898602574325,1.0,5/14,24.49%,PRKN;ATP7A;DRD2;COMT;RNF180
prerank,muscle tissue development (GO:0060537),0.3841138789774526,0.8334243508799449,0.6780923994038748,0.8957582365599835,1.0,1/13,1.11%,STRA6
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4027321004047737,0.833422862410013,0.6728682170542636,0.8953886036993881,1.0,4/10,17.36%,DBF4;SSBP1;INO80;CDT1
prerank,protein localization to condensed chromosome (GO:1903083),-0.33510978619178255,-0.833128534434822,0.6770186335403726,0.9356117698298794,1.0,10/12,31.45%,BUB3;ZW10;ZWILCH;KNL1;MTBP;IK;CDK1;CHAMP1;AURKB;TTK
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.40267655233201755,0.8329730994474523,0.6696562032884903,0.8957504549898944,1.0,6/10,23.08%,STAT5B;JAK3;PTPN1;STAT6;STAT3;JAK2
prerank,regulation of axon extension (GO:0030516),0.31616936972627363,0.8328981114331314,0.7091584158415841,0.895496420664196,1.0,12/37,21.80%,APOE;RUFY3;ZFYVE27;GSK3B;MT3;MACF1;GOLGA4;RTN4;SHTN1;SIN3A;CDKL5;NTN1
prerank,negative regulation of secretion (GO:0051048),0.40106254113103307,0.832878492473614,0.6833333333333333,0.8951548779120211,1.0,2/10,13.30%,NR1H3;VAMP3
prerank,positive regulation of DNA repair (GO:0045739),0.29966614184195495,0.8328657552705805,0.7029940119760479,0.8948093209863187,1.0,14/46,23.98%,EYA1;ERCC6;BABAM2;BRCA1;SIRT1;BRCC3;PRKCG;NPAS2;MGMT;XRCC1;RNF168;SPIDR;SLF1;FOXM1
prerank,regulation of phosphatase activity (GO:0010921),-0.2671662096974765,-0.8325655883262267,0.7306122448979592,0.9351194742172154,1.0,15/24,42.13%,PPP6R2;TIPRL;HSP90B1;MTMR9;CDK5RAP3;PPP1R35;BMP2;PPP1R2;PTPA;CHP2;SH2D4A;ZCCHC9;PPP1R26;PPP1R17;RIPK3
prerank,termination of RNA polymerase II transcription (GO:0006369),0.31820184476925084,0.8321748670401394,0.724907063197026,0.8955918600639002,1.0,7/33,15.00%,CPSF1;CSTF3;WDR33;NCBP2;MAZ;SNRPF;SSU72
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3796534017288082,0.831697113225875,0.6651785714285714,0.8959713421522411,1.0,5/12,20.25%,IGF1;IRS2;DYRK2;EPM2AIP1;GCK
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2468286493628018,-0.8312504543538805,0.7745098039215687,0.9362528475724878,1.0,8/32,14.60%,ERBB4;HK2;BCL2;CLU;SOD2;CAMK2A;BAD;FIS1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.34686398485770786,0.8312009918500779,0.6929460580912863,0.896385281107614,1.0,6/20,18.91%,HOPX;LONP1;HSPA1A;HSPD1;HSPA4;CCT2
prerank,determination of bilateral symmetry (GO:0009855),0.3349361378625215,0.8308249426310604,0.7125668449197861,0.8966289502737353,1.0,7/24,25.35%,CITED2;CFAP53;NOTCH1;BBS7;NPHP3;ARL6;DNAH5
prerank,zinc ion transmembrane transport (GO:0071577),0.3452514246736496,0.8305582074427107,0.6991758241758241,0.8966935541096955,1.0,10/22,30.68%,SLC39A14;SLC39A12;SLC39A3;SLC39A11;SLC30A1;SLC39A10;SLC39A1;SLC39A13;SLC30A5;SLC30A6
prerank,positive regulation of interferon-beta production (GO:0032728),0.3212435089268681,0.8299146986035354,0.7072243346007605,0.8973407761874853,1.0,4/33,9.88%,TLR8;FLOT1;RNF135;MAVS
prerank,neural crest cell development (GO:0014032),0.30407995614120453,0.829555036296534,0.708029197080292,0.8975584603526431,1.0,3/44,3.86%,HTR2B;CORO1C;SEMA4B
prerank,regulation of cytoplasmic translation (GO:2000765),0.37216091773917676,0.829539724045915,0.6926406926406926,0.8972134813756554,1.0,4/14,23.46%,CPEB4;CPEB2;PKM;CPEB1
prerank,maintenance of protein location in nucleus (GO:0051457),0.34496541335498876,0.8293849524901531,0.691156462585034,0.8970927460181358,1.0,5/20,23.52%,HNRNPU;TOPORS;SUPT7L;BCL3;TAF8
prerank,regulation of ATP metabolic process (GO:1903578),0.2960001584738667,0.8291190561569027,0.7204176334106729,0.897154883849399,1.0,17/54,23.05%,PRKAG2;ABCD1;EIF6;SPHK2;TPR;NUP50;ATP7A;NUP98;ZBTB7A;NUP88;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,RNA 3'-end processing (GO:0031123),0.28756882489348584,0.8285461146245964,0.7677777777777778,0.8977085849602384,1.0,14/69,16.52%,ALYREF;CPSF1;TENT4B;CHTOP;CSTF3;THOC1;WDR33;TENT2;NCBP2;SRSF3;THOC2;EIF4A3;DDX39A;DHX38
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2754533279844062,0.8284134851187539,0.7935349322210636,0.8975544351030703,1.0,33/128,21.51%,OPTN;CDKN1A;DYNC1H1;HAUS6;FBXL17;BACH1;MELK;FBXL3;ENSA;PPP2R2A;CDK7;CCNA2;CEP76;TUBA1A;CLASP1;CEP192;CUL1;ALMS1;NDE1;MNAT1;LATS1;OFD1;CCP110;SSNA1;HAUS7;CDC25A;PAFAH1B1;BRSK2;PPP2R1A;PHLDA1;HAUS5;CEP41;CCDC57
prerank,regulation of microtubule depolymerization (GO:0031114),-0.2573206811021909,-0.8283347014814679,0.71875,0.9403059783409301,1.0,3/25,5.27%,NAV3;HDGFL3;FGF13
prerank,Golgi inheritance (GO:0048313),0.3892805185677346,0.8280678010116915,0.6602086438152012,0.8977261747702991,1.0,2/11,8.93%,STX5;VCPIP1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.347112089874234,0.8279188716684559,0.6933514246947082,0.8976041950273069,1.0,4/18,12.93%,DTNBP1;RIMS4;GSK3B;SYN1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.3811995661712098,0.827817170347447,0.6901615271659325,0.8973977392253429,1.0,3/13,18.68%,SOX9;NOTCH1;SOX8
prerank,secretion (GO:0046903),0.368951897881805,0.8277995881307674,0.7058823529411765,0.8970543935693907,1.0,1/14,2.57%,TPD52
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.40414581878265315,0.8276654849197133,0.6940993788819876,0.8968893083588011,1.0,5/10,26.80%,DNMT3A;KDM1B;IGF2;PCGF5;MECP2
prerank,negative regulation of cartilage development (GO:0061037),0.3739294116763173,0.8275794244937098,0.696969696969697,0.8966616452405345,1.0,2/13,7.99%,SOX9;SNAI2
prerank,cell projection organization (GO:0030030),0.3213886893987904,0.8275181616385977,0.7101827676240209,0.8963902455075824,1.0,5/30,9.80%,RHOJ;PDGFA;CAPG;PARVB;ITGB1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3392142343159641,-0.8274450468162181,0.6876790830945558,0.9404567895400396,1.0,4/10,14.83%,WDR76;THOC5;FEM1B;DDX39B
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.3743193475170531,0.8272153174406306,0.6953242835595776,0.8965048486370347,1.0,3/13,10.68%,SNX5;SORL1;SIRT1
prerank,organelle assembly (GO:0070925),0.26040253150642484,0.8269759921633141,0.9099099099099099,0.8965166673181515,1.0,89/384,21.51%,MAK;RILPL2;ATG7;RAB8B;PIBF1;SNX10;RAB7A;CFAP70;DYNC1H1;SNAP29;UBAP2L;ATP6V0D1;KIF27;DDX6;NCOR1;HAUS6;ATXN2;YTHDF3;ASAP1;STAM;ABCC4;WDPCP;KLHL41;CHMP2A;CFAP20;FBF1;AMBRA1;VMP1;KIF3A;RAB1B;ABCA3;ACTR3;DYNC2I2;PDCD6IP;VPS4A;PATL1;ATG5;CCDC66;IFT46;CHMP6;TUBGCP4;CFAP410;NOTCH1;CPLANE2;PACS2;RAB43;ATG13;SYNPO;IFT52;SH3PXD2B;CDS2;LIMD1;OCRL;IFT140;SSX2IP;ARL3;INO80;SNF8;TNKS;STAM2;UBQLN2;EXOC4;OFD1;PRRC2C;EDC3;HAUS7;TRAPPC6A;CHMP5;ARF4;CHMP7;EXOC7;EXOC1;BBS7;FLII;DHX37;ARL13B;TMEM231;RAB1A;CDC14B;BBS1;IFT88;TCTN1;VPS36;EIF2S1;HAUS5;RPGR;CHMP2B;CEP41;CCDC57
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3704296301022024,0.8267466602529788,0.6924198250728864,0.8965152726193093,1.0,4/14,16.97%,FOXO3;POLRMT;TWNK;TFB2M
prerank,tRNA wobble base modification (GO:0002097),0.3758839813313136,0.8265670432717862,0.6814814814814815,0.8964274521300142,1.0,5/14,16.99%,CTU2;GTPBP3;ALKBH8;ALKBH1;ELP4
prerank,mitotic cell cycle phase transition (GO:0044772),0.26754972722853015,0.8262126539126974,0.8540816326530613,0.8966635651499708,1.0,52/203,21.51%,OPTN;PLK2;E2F3;CDKN1A;DYNC1H1;HAUS6;FBXL17;E2F1;ANAPC1;CUL3;MELK;FBXL3;CHMP2A;ENSA;CACUL1;RB1;NASP;PPP2R2A;CDK7;USP26;CCNA2;DBF4;CEP76;ACVR1B;CUL4A;CTDP1;PPP6C;TUBA1A;CLASP1;CEP192;CUL1;ALMS1;NDE1;MNAT1;LATS1;OFD1;CCP110;SSNA1;CDC34;HAUS7;CHMP7;CDC25A;PAFAH1B1;CCNG1;UBE2S;BRSK2;PPP2R1A;CUL4B;PHLDA1;HAUS5;CEP41;CCDC57
prerank,purine-containing compound biosynthetic process (GO:0072522),0.33291118981660184,0.8259671634939844,0.7029831387808041,0.8967089055077071,1.0,3/25,5.55%,ADSL;PPAT;AMPD3
prerank,mRNA metabolic process (GO:0016071),0.27922568651010027,0.8255423032691928,0.7652173913043478,0.8970344305669354,1.0,31/90,25.95%,ERN1;SCAF11;CELF1;TCERG1;DDX5;CSTF3;HSPA1B;PRPF8;ZFP36L2;HNRNPA0;AGO3;NCBP2;SF3A3;HSPA1A;SNRPF;RNH1;ALKBH5;AGO4;AURKAIP1;SNRPB;LSM11;HNRNPR;SUPT4H1;LSM5;ZC3H12D;SF3B2;PRPF3;CPSF6;LSM6;ZFP36;RIDA
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3348998202585836,0.8247237786811795,0.7101449275362319,0.8979751577548093,1.0,9/25,22.84%,TCERG1;HNRNPU;LARP7;CDC73;NELFE;CDK13;WDR43;SUPT4H1;RNF168
prerank,dendritic spine morphogenesis (GO:0060997),0.36591575397254494,0.8244044832544744,0.6987951807228916,0.8980985047232445,1.0,3/15,15.04%,PTEN;DOCK10;WASL
prerank,cellular response to glucose stimulus (GO:0071333),0.3155832638690812,0.8242778946563261,0.7130214917825537,0.897942723117558,1.0,6/30,14.11%,ERN1;ZBTB20;SLC39A14;RAB11B;GAS6;ADCY8
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.31619267656357103,-0.8239620142083702,0.6736526946107785,0.945729746020888,1.0,5/12,18.13%,UPP2;DCK;DHODH;UCK1;UCKL1
prerank,dopamine metabolic process (GO:0042417),0.3520751224126405,0.8237804275815391,0.6998616874135546,0.8983572059370841,1.0,6/18,22.32%,MAOA;PRKN;ATP7A;GCH1;DRD2;COMT
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.35965838811780104,0.8235726331062926,0.7175989085948158,0.8983177180086416,1.0,6/16,24.03%,KLK3;BMPR2;ACE;PRCP;DRD2;KLK1
prerank,methylguanosine-cap decapping (GO:0110156),-0.3409049055983793,-0.8235073004953779,0.6848137535816619,0.9449869421941286,1.0,7/10,29.79%,DCPS;PNRC2;LSM1;DCP1B;DCP1A;PATL2;DCP2
prerank,maturation of LSU-rRNA (GO:0000470),0.3346259188704649,0.8231490599730157,0.718508997429306,0.89863584298382,1.0,9/26,25.04%,EIF6;MRPL1;RPL10A;RPL7L1;WDR12;RPL7;BOP1;RPL7A;SNU13
prerank,tRNA aminoacylation (GO:0043039),0.3104674741173548,0.8230771268052817,0.724179829890644,0.8983634959700568,1.0,13/37,25.03%,FARS2;DARS1;EPRS1;SARS2;SARS1;IARS2;QRSL1;AIMP1;IARS1;FARSA;WARS2;LARS1;GATB
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.35731912390102016,0.8227842602209638,0.7013513513513514,0.8984431497925403,1.0,1/17,0.63%,CD300A
prerank,cortical cytoskeleton organization (GO:0030865),-0.22384047405388652,-0.8221694252652352,0.8012048192771084,0.9459199079723997,1.0,16/41,27.06%,NLGN1;RHOBTB1;NCKAP1;RND3;DLG1;RHOA;TNF;LLGL2;RHOBTB3;RHOBTB2;STRIP1;RHOG;RHOH;RAC1;RAC3;FMNL1
prerank,histone deubiquitination (GO:0016578),0.3524006204458825,0.8219358453809269,0.6927453769559033,0.8994013980162595,1.0,7/18,24.31%,USP21;USP16;USP36;BRCC3;USP3;KAT2A;ATXN7
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.32718835276324765,0.821924600184864,0.7118421052631579,0.8990481872109344,1.0,8/25,26.02%,SPHK2;FZD5;TRAF2;TNFRSF14;SCIMP;MALT1;TRAF6;MAP3K7
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2758961197960064,0.8217942264841116,0.7857911733046287,0.8988904105126756,1.0,24/95,23.38%,NSMCE2;SEM1;MUS81;MCM9;NIPBL;BRCA1;XRCC2;POLL;AP5S1;NBN;PSMD14;WRN;INO80;AP5Z1;RAD21;RMI1;MRE11;RAD51B;FANCM;XRCC1;SPIDR;RNF138;PALB2;ERCC4
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.31539018189477147,0.8216735119594253,0.7182741116751269,0.8987031435743548,1.0,8/29,17.89%,FASN;SLC25A1;PPT1;ELOVL1;ACSL5;SCD;GCDH;CBR4
prerank,spindle assembly (GO:0051225),0.2878159079139605,0.8216056704473619,0.7600896860986547,0.8984407427806147,1.0,20/67,23.82%,PIBF1;NCOR1;HAUS6;SMC1A;TOGARAM1;TUBGCP4;STAG2;CLASP1;CEP192;INO80;SMC3;TNKS;OFD1;HAUS7;ARHGEF10;MZT1;HAUS5;FLNA;NEK7;BCCIP
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.37464371599435203,0.8213991307354434,0.6995581737849779,0.898399252098836,1.0,4/13,23.75%,SORL1;BRSK2;TMEM30A;TM9SF4
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.3469797715482449,0.8213887302790235,0.7280334728033473,0.8980530896344422,1.0,3/22,8.81%,FOXP3;CD46;CBFB
prerank,cellular response to hexose stimulus (GO:0071331),0.333621814951951,0.8213754361540111,0.7083333333333334,0.8977097447542868,1.0,5/23,14.11%,ERN1;ZBTB20;SLC39A14;GAS6;ADCY8
prerank,transcription by RNA polymerase I (GO:0006360),0.31029364880881916,0.8212443060466887,0.7229813664596273,0.8975465674610071,1.0,10/34,21.58%,GTF2H5;POLR2L;TAF1B;POLR1A;CDK7;MNAT1;TTF1;TAF1A;RRN3;TAF1
prerank,regulation of protein localization to centrosome (GO:1904779),0.40545461535988103,0.8211228179482553,0.696969696969697,0.8973670616175099,1.0,3/10,14.36%,APC;GSK3B;PARD6A
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3212152463365463,-0.8209372653395108,0.7177914110429447,0.9467148843657657,1.0,4/12,14.70%,CCT3;CCT5;CCT4;GNL3
prerank,intracellular protein transmembrane transport (GO:0065002),0.3069257486498638,0.8208110118690929,0.7226277372262774,0.89749064476237,1.0,9/42,17.83%,CHCHD4;PEX7;TIMM17A;PEX14;TOMM20;TIMM17B;ZFAND2B;HSPD1;SEC63
prerank,tube closure (GO:0060606),0.3116610099296828,0.8207056217777889,0.7175,0.8972885335337478,1.0,13/31,29.07%,FOLR1;DLC1;MTHFD1L;PHACTR4;CELSR1;LRP6;VANGL2;LRP2;BCL10;PLXNB2;SKI;DEAF1;MTHFR
prerank,pyruvate metabolic process (GO:0006090),0.2945130797189924,0.8206184759145823,0.7359357060849598,0.8970537038199373,1.0,11/52,20.25%,HK3;TPI1;SLC16A1;ENO3;PGM1;HAGH;VDAC1;ME2;GAPDHS;PFKM;GCK
prerank,lipoxygenase pathway (GO:0019372),0.3701358807226925,0.8205556101291618,0.7,0.8967950452330122,1.0,2/14,6.55%,PON3;GPX4
prerank,protein kinase B signaling (GO:0043491),-0.2625208739288408,-0.8201739148819907,0.732824427480916,0.9466830970813359,1.0,13/23,24.79%,SETX;PAX2;PIK3R3;SIRT2;TSC2;TNF;TYRO3;PLK3;CCL3;IL1B;THEM4;TGFB1;CCL5
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.32549436611839333,0.8200956180134973,0.7163029525032092,0.8971305425904116,1.0,8/25,26.53%,ARAP1;AFAP1L2;RTN4;CBL;BCAR3;PLAUR;HIP1;DOK1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3617866636852811,0.8195893438422436,0.6920863309352518,0.8975874547340885,1.0,2/15,3.87%,VEGFA;P2RX4
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.24740668146666983,-0.8190980095716224,0.7711864406779662,0.9472874700057892,1.0,10/26,25.46%,EPHA5;TRPM4;LRP5;PLA2G6;KLF7;C2CD2L;STXBP4;STX4;ADRA2A;CDK16
prerank,anterior/posterior pattern specification (GO:0009952),-0.21859200240636478,-0.8188603466504064,0.7985611510791367,0.946099635170646,1.0,30/53,37.59%,ACVR2B;TGFBR1;LRP5;BASP1;SMAD2;CELSR2;HHEX;HOXD4;HOXA7;HOXD3;HOXC9;HOXC5;HOXA9;HOXB9;HOXC6;PCSK5;HOXA5;HOXB5;HOXB7;BHLHE41;BMP2;LHX1;HEY1;HEY2;HES1;HOXB6;CYP26C1;HEYL;HOXD9;HES7
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.38753099890626674,0.8186313276808949,0.7027863777089783,0.8983529100665373,1.0,7/10,30.60%,AP2B1;MYLIP;AP2S1;CLTC;AP2A2;AP2A1;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.38753099890626674,0.8186313276808949,0.7027863777089783,0.8983529100665373,1.0,7/10,30.60%,AP2B1;MYLIP;AP2S1;CLTC;AP2A2;AP2A1;AP2M1
prerank,protein localization to mitochondrion (GO:0070585),-0.32164045968741334,-0.8185167760420117,0.6982248520710059,0.9451925728495245,1.0,1/11,1.24%,HK2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.31101494514483574,0.8183004547016824,0.7167487684729064,0.898475269358309,1.0,13/35,27.61%,FLOT1;PPT1;RAB21;PICALM;CBL;PIK3CB;MKLN1;LDLRAP1;AAK1;HIP1;C3;VTN;SMAP1
prerank,heme catabolic process (GO:0042167),0.3645009111975779,0.8181922498634872,0.6976090014064698,0.8979124655605574,1.0,5/14,18.34%,BLVRB;HMOX1;HMOX2;BLVRA;ABCC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.3645009111975779,0.8181922498634872,0.6976090014064698,0.8979124655605574,1.0,5/14,18.34%,BLVRB;HMOX1;HMOX2;BLVRA;ABCC1
prerank,negative regulation of viral transcription (GO:0032897),-0.3139038805375651,-0.8178035674343729,0.7103658536585366,0.9450328232516292,1.0,6/13,27.37%,TRIM11;TRIM13;TRIM62;IFITM3;TRIM32;TRIM27
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.24013752354920165,-0.8173994440708023,0.7846153846153846,0.9442091897676824,1.0,13/32,22.85%,FHIT;STK11;PML;PPP1R13B;PYCARD;AEN;JMY;MYBBP1A;CDIP1;HINT1;SNW1;RPS27L;PHLDA3
prerank,ganglioside biosynthetic process (GO:0001574),0.36572849035654653,0.8173862578360123,0.6994301994301995,0.8988073073600867,1.0,2/15,5.71%,B4GALT5;B4GALT6
prerank,regulation of protein acetylation (GO:1901983),0.38810919775735947,0.8168692764871958,0.6980854197349042,0.899245864457523,1.0,5/12,26.18%,GSK3B;SIRT1;CAMK1;TERF2IP;CEP295
prerank,neuron remodeling (GO:0016322),-0.3346354479106612,-0.8167129132251035,0.6853932584269663,0.9439346516451889,1.0,2/10,9.48%,ADGRB3;ANKS1A
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.3753921438427016,0.8162344887655418,0.6914893617021277,0.8998687327570257,1.0,4/12,23.55%,WAC;FBXO31;PRKDC;CDK2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.3592886627610808,0.8159387154915684,0.717201166180758,0.8999662658054454,1.0,1/16,1.46%,LILRB1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.29378039320703614,0.8158197294314187,0.751207729468599,0.8997882015631664,1.0,7/49,12.69%,VEGFA;PIBF1;IL6;IGF1;IL6R;IL15;HCLS1
prerank,regulation of intracellular transport (GO:0032386),0.31115811236421353,0.8158106329339493,0.7394957983193278,0.8994338036436742,1.0,8/38,16.42%,LAMP1;LCP1;DYNC1H1;MYBPC3;RAB11B;INPP5F;PTPN1;GAS1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2801980449774683,0.8157942540074753,0.7577142857142857,0.8991014819684455,1.0,12/69,15.91%,APOE;CPEB4;PPT1;CLN3;ADAM8;PTK2B;MT3;PRKN;GDNF;CX3CL1;PRKCG;GRN
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3686422545998097,0.8154400783468425,0.7023809523809523,0.8992908955694396,1.0,2/14,8.01%,LPIN3;SLC27A1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.402410351901733,0.8149229710687673,0.6957831325301205,0.8997497847085395,1.0,2/10,12.66%,MTHFS;MTHFD1L
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3311793692244224,0.8145485733464978,0.716321243523316,0.8999643115177811,1.0,2/23,3.04%,BCL2L11;TIMM22
prerank,regulation of actin filament-based movement (GO:1903115),-0.330257945308948,-0.8143767770079694,0.6929577464788732,0.9467976144258123,1.0,2/10,8.01%,ANK2;PDE4B
prerank,neuron fate commitment (GO:0048663),0.3635101572449193,0.814138318674743,0.7072463768115942,0.900227610430863,1.0,1/14,2.97%,ID2
prerank,synaptic vesicle recycling (GO:0036465),0.3168876623431721,0.8141123907470278,0.7335058214747736,0.8998960579784793,1.0,9/31,20.18%,CEL;PLD2;SNCG;TBC1D24;STON1;NLGN2;FCHO2;SYNJ2;VAMP2
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3013576298350835,-0.8125004708315009,0.7120253164556962,0.9487582579614643,1.0,3/14,17.28%,CSF1;CCR1;TNF
prerank,dephosphorylation (GO:0016311),0.26585038839221986,0.8116921996340083,0.8310880829015544,0.9032900014979461,1.0,24/147,14.07%,PLPP3;MTM1;MTMR3;PPM1H;PPP4R1;PPEF1;PTEN;PTPRE;DUSP3;PPEF2;PTPN12;PLPP6;PDP1;PPP4R2;PLPP5;LHPP;PPP3CA;HDHD2;PPP2R2A;ILKAP;PGP;CTDP1;PPP6C;PPP1CA
prerank,eye photoreceptor cell development (GO:0042462),0.35804001211792924,0.8114788410748205,0.7191176470588235,0.9032633325401463,1.0,2/15,9.00%,VEGFA;TOPORS
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3404910347055132,0.811153330065105,0.7443105756358769,0.9033866263471183,1.0,6/21,18.01%,PCID2;MEFV;BIRC3;MT3;SOX2;BIRC2
prerank,positive regulation of vasculogenesis (GO:2001214),-0.34022657394844114,-0.8110044119478539,0.7238372093023255,0.9498726486048609,1.0,4/10,15.42%,CD34;TMEM100;RAPGEF2;RIN2
prerank,regulation of centriole replication (GO:0046599),0.3568625773718471,0.810495981796188,0.7321428571428571,0.9040663412169859,1.0,4/17,14.88%,PLK2;BRCA1;CEP76;ALMS1
prerank,endocrine system development (GO:0035270),0.3395513427849904,0.8102319544856045,0.7483085250338295,0.9041291162976106,1.0,4/21,17.46%,STRA6;PAX8;SOX2;NKX2-1
prerank,myelin assembly (GO:0032288),0.38717613636538095,0.8100950719404949,0.7018927444794952,0.9039715813394853,1.0,3/10,12.01%,ABCA2;EPB41L3;PMP22
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.27716682595868525,-0.8100902980560926,0.75,0.9499199772319307,1.0,3/21,4.34%,CSF1R;CSF1;MTUS1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.28907881525690543,-0.8100564335319436,0.7359154929577465,0.9484033867371087,1.0,2/18,1.71%,FCHSD2;DTNA
prerank,regulation of lymphocyte migration (GO:2000401),0.3928253792316919,0.8100460954071732,0.7130434782608696,0.9036815707757361,1.0,3/10,15.04%,SLC8B1;MSN;WASL
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2699573711623185,0.8100159733137609,0.787257019438445,0.9033667848023489,1.0,31/85,27.06%,PSMD1;DVL1;FZD7;PSMF1;PSMD14;FZD5;PSMD12;PFN1;FZD2;AP2B1;PARD6A;CELSR1;PSME2;DAAM1;VANGL2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;AP2S1;PSMC5;CLTC;AP2A2;PSMC1;AP2A1;ROR2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.2748833752698659,-0.8097578124356767,0.7383512544802867,0.9473872889754138,1.0,8/18,27.71%,PTGS1;PLA2G4A;CD74;CBR1;PNPLA8;PTGDS;PTGIS;PRXL2B
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.38478914304818945,0.8096851938498902,0.7088791848617176,0.903500155077274,1.0,3/11,9.88%,STAP1;TYROBP;MAVS
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2730626643266091,-0.8096841773018754,0.7634408602150538,0.9459691697702598,1.0,6/18,20.69%,PTP4A3;CCT3;CCT5;CCT4;TNF;CEP135
prerank,regulation of cellular pH (GO:0030641),0.3162372102048465,0.8092113906636076,0.7567221510883483,0.9038633179388726,1.0,3/29,5.19%,SLC9B1;SLC9A3;CLN3
prerank,regulation of exocytosis (GO:0017157),0.2968885713702144,0.8090565263131655,0.755868544600939,0.9037132846589487,1.0,9/46,13.70%,ANXA1;RAB8B;RAB21;STXBP5;RAB12;RAB10;CHMP6;CPLANE2;CLASP1
prerank,response to hexose (GO:0009746),0.3219511794563189,0.8086801487995599,0.727741935483871,0.9039453981314864,1.0,6/25,20.18%,THBS1;IRS2;GPLD1;EIF2B2;TCF7L2;VAMP2
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3501168765856003,0.8079775425157619,0.7111111111111111,0.9046286661416535,1.0,2/15,7.35%,CELF1;BRCA1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.2941552267935372,0.8078055329216038,0.757396449704142,0.9045479472374484,1.0,16/46,22.70%,NR1H3;FLCN;ATF4;RB1;DDIT3;ADAM17;NOTCH1;IL15;PLCL2;LAMA4;LNPEP;RHEB;ARRDC3;NR1H2;TLE3;ACOT13
prerank,positive regulation of interferon-gamma production (GO:0032729),0.28955395392127437,0.8075919398160397,0.7511848341232228,0.9045022077018197,1.0,2/48,1.46%,TLR8;LILRB1
prerank,negative regulation of cation channel activity (GO:2001258),-0.25034542017453615,-0.8069706742592292,0.7730769230769231,0.9495554519527262,1.0,7/26,24.74%,KCNAB1;FMR1;PKD2;FKBP1B;UBQLN1;CALM3;SLC6A9
prerank,cell differentiation in spinal cord (GO:0021515),-0.3241389565957773,-0.8069408513440237,0.7095808383233533,0.94805237329102,1.0,2/10,10.51%,MDGA2;SOX6
prerank,atrioventricular valve development (GO:0003171),0.3624274770372246,0.8066128792888904,0.7028231797919762,0.905640210939784,1.0,3/14,11.96%,APLNR;BMPR2;NOTCH1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.29471065652599604,-0.8060520519542582,0.7665505226480837,0.9481415473819517,1.0,5/15,21.80%,GGT5;GGT7;SARDH;ABHD12;ALDH4A1
prerank,response to cholesterol (GO:0070723),0.3530456174800353,0.8058978234423333,0.7353361945636624,0.906377767398512,1.0,6/17,15.80%,GRAMD1B;ABCA2;GRAMD1C;GPLD1;LRP6;PMVK
prerank,skeletal muscle tissue development (GO:0007519),0.3087037431189448,0.8058120920106745,0.7383059418457648,0.9061308318590102,1.0,3/32,7.08%,IGSF8;KLHL41;SVIL
prerank,cellular protein-containing complex assembly (GO:0034622),0.2595566402315191,0.8053879031929165,0.8558187435633368,0.9064393389517215,1.0,36/159,20.18%,HOPX;NCK2;CHCHD4;CCDC40;SNX9;UVRAG;GTF2B;LONP1;IMMP2L;DNAAF3;GPX4;CHMP2A;CYBA;PICALM;TPR;FCHO1;DNAJB14;OMA1;VAMP3;EPS15;TBCA;HSPA1A;RTN4;NUP98;HSPD1;TRAF2;TBCEL;HSPA4;SHQ1;TMEM170A;FCHO2;CCT2;VBP1;PSMD11;TCF4;VAMP2
prerank,Notch signaling pathway (GO:0007219),0.28662097338774245,0.8052448315597804,0.7793952967525196,0.9062796878942143,1.0,17/59,24.61%,PLXND1;NOTCH2;MAML1;MAML2;CREBBP;SNAI2;ADAM17;NOTCH1;NCSTN;DTX1;HES5;DTX2;ADAM10;APH1B;PSEN2;MIB1;DLGAP5
prerank,plasma membrane invagination (GO:0099024),0.3208626911643235,0.805038505980228,0.7357992073976222,0.9062362663359397,1.0,5/29,12.50%,CD36;SNX9;SNX33;MYH9;DOCK1
prerank,regulation of monooxygenase activity (GO:0032768),0.3220040947613459,0.8045359722305403,0.7431693989071039,0.9066479804716349,1.0,4/23,15.04%,POR;NOSIP;GDNF;WASL
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.304059960776756,-0.8045150963473923,0.7138157894736842,0.9492423117288494,1.0,2/14,4.81%,ZFP91;TLR3
prerank,cardiac muscle tissue development (GO:0048738),0.29286781106035537,0.80416298595552,0.7565118912797282,0.9068497209103805,1.0,6/50,11.96%,NOTCH2;MAML1;SIK1;AKAP13;BMPR2;NOTCH1
prerank,negative regulation of wound healing (GO:0061045),0.32400252961369597,0.8038916401152373,0.7410256410256411,0.9069146303457045,1.0,3/28,6.48%,APOE;PTEN;PROC
prerank,positive regulation of sodium ion transport (GO:0010765),-0.32089372957442813,-0.8035409843328885,0.7134328358208956,0.9495208369879773,1.0,3/12,4.32%,ANK3;SCN1B;WNK3
prerank,alpha-amino acid metabolic process (GO:1901605),-0.21535270917994495,-0.803228763570889,0.8758620689655172,0.948587006198703,1.0,21/45,36.27%,NAALAD2;ASPA;NAT8L;GLUD1;FOLH1;ASNS;KMO;PYCR2;PYCR3;NOX4;MTHFD1;DDAH1;GLS;RIMKLB;DDAH2;KYAT1;SLC25A12;GPT;CBS;GADL1;GPT2
prerank,negative regulation of cilium assembly (GO:1902018),-0.3149787581366216,-0.8030530594326923,0.7270114942528736,0.9474016029627284,1.0,5/12,17.93%,TESK1;LIMK2;CDK10;CEP97;YAP1
prerank,histone acetylation (GO:0016573),0.2777068667748394,0.8022878331342532,0.7847533632286996,0.9089728192775302,1.0,26/69,27.76%,ZZZ3;PHF20;CREBBP;TAF5;ING3;EPC1;ING4;SUPT7L;PHF20L1;BRD1;BRPF1;TAF5L;SGF29;DMAP1;KAT2A;RUVBL2;KAT6B;POLE3;MBIP;BRCA2;KAT6A;KAT2B;MAP3K7;MRGBP;PER1;BRD8
prerank,cellular response to dsRNA (GO:0071359),0.3586158382121645,0.8020575022831026,0.7205056179775281,0.9089474421433805,1.0,3/15,12.13%,FLOT1;MAVS;PQBP1
prerank,negative regulation of complement activation (GO:0045916),0.38043469600576263,0.8019333010403592,0.712143928035982,0.9087570380216441,1.0,1/10,3.06%,CD46
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.24931847904925666,-0.8010679841995552,0.7890295358649789,0.9494294534679117,1.0,3/27,3.56%,GRM1;HTR2C;GNA15
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.26936659211801584,-0.8003403110577471,0.8,0.9492299942142971,1.0,3/22,8.10%,CYRIB;STX7;FBXO38
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.3505175301575948,0.8001337728210967,0.7255747126436781,0.9111548008149987,1.0,3/16,15.23%,LAMP1;AP1G1;KLRD1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3453188820224932,0.8000264588474956,0.7364771151178918,0.9109496134313358,1.0,3/17,10.10%,VEGFA;PROC;ROCK1
prerank,visual system development (GO:0150063),0.3008129473683799,0.8000182039682342,0.7815950920245399,0.9105950274537565,1.0,7/37,13.44%,ZDHHC16;HIPK1;HIPK2;SALL2;RAB18;SOX2;SH3PXD2B
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3801223773222201,0.799502842074396,0.707533234859675,0.9109655245784843,1.0,2/11,11.18%,HIPK2;ING4
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.3435094019761791,0.7993688937652542,0.7189265536723164,0.9108135003939898,1.0,3/17,15.23%,LAMP1;AP1G1;KLRD1
prerank,positive regulation of nuclear division (GO:0051785),0.3168127669892078,0.7988584832637461,0.7529880478087649,0.9111827891747025,1.0,4/25,14.48%,CD28;IGF1;NPM2;PHIP
prerank,protein insertion into membrane (GO:0051205),0.3094889148559477,0.7986621865191951,0.7639429312581063,0.9111153614893932,1.0,7/32,11.84%,GRIN3B;STX5;HMOX1;VAPA;CYB5A;APP;ALDH3A2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.2920426853540356,0.7981452662696756,0.7746144721233689,0.9114953682310181,1.0,7/47,14.45%,TIMP1;SORL1;PCID2;TIMP2;MT3;SERPINB8;SERPINC1
prerank,rRNA transcription (GO:0009303),0.345275589500871,0.7977147648898394,0.7373595505617978,0.9117543067199934,1.0,3/17,12.34%,TAF1B;GTF3C4;SIRT7
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2727278543923355,-0.7967377788670472,0.7241379310344828,0.9541780077612725,1.0,5/18,12.49%,PHF8;HEATR1;MAF1;POLR2K;UBTF
prerank,positive regulation of ossification (GO:0045778),0.2966749664725703,0.7961063585320316,0.7643540669856459,0.9137434543421304,1.0,7/39,10.93%,ANO6;ATP2B1;SLC8A1;ACVR2A;PKDCC;BMPR2;CCN1
prerank,transcription by RNA polymerase III (GO:0006383),-0.24241475074538968,-0.7960525847170871,0.8015873015873016,0.9538464393558003,1.0,7/27,16.87%,IVNS1ABP;CRCP;TBP;RO60;POLR2K;GTF3C6;POLR3H
prerank,response to calcium ion (GO:0051592),0.2621575337877142,0.7959721417350182,0.8132337246531484,0.9135787434700312,1.0,12/102,10.01%,IQGAP1;CPNE2;ADAM9;ITPKB;D2HGDH;PPIF;THBS1;RASA4;CARF;PPP3CA;TRPC3;SYT17
prerank,histone H3 acetylation (GO:0043966),-0.21934462900382773,-0.7955717012328806,0.8406593406593407,0.9530854444031701,1.0,17/40,26.60%,YEATS2;PHF14;BRPF3;TADA1;TAF12;LDB1;NAA60;TAF10;WDR5;MEAF6;DR1;ING5;KAT14;TAF6L;TAF9;JADE1;LEF1
prerank,B cell homeostasis (GO:0001782),-0.33241472206870853,-0.7950226633680494,0.7076023391812866,0.9524730458218729,1.0,1/10,0.41%,MEF2C
prerank,reticulophagy (GO:0061709),-0.3074711312244971,-0.7947757871520758,0.7269938650306749,0.9513805919337338,1.0,5/12,17.16%,RB1CC1;UFM1;ULK2;UFL1;ATG2A
prerank,aspartate family amino acid metabolic process (GO:0009066),0.33804302195623326,0.7945855270588666,0.7541899441340782,0.915274525559846,1.0,1/18,0.75%,MSRA
prerank,aortic valve morphogenesis (GO:0003180),0.3124285318956912,0.7943134993819567,0.758576874205845,0.915309742501342,1.0,5/30,11.96%,SOX9;SNAI2;RB1;ROCK1;NOTCH1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.34736352559903183,0.794169157780571,0.7349570200573066,0.9151524205957569,1.0,6/16,25.07%,IL6;ST3GAL4;RELA;IRAK1;TRAF6;NFAT5
prerank,positive regulation of DNA recombination (GO:0045911),0.31706299303113433,0.7941669703167935,0.756687898089172,0.9147904540746046,1.0,7/27,20.60%,ERCC6;TFRC;KMT5B;ARID2;SHLD1;SHLD2;PAXIP1
prerank,regulation of viral life cycle (GO:1903900),0.327794831628067,0.794138045689372,0.7448559670781894,0.9144682333953171,1.0,3/21,9.57%,KPNA2;TRIM25;VPS4A
prerank,inorganic cation transmembrane transport (GO:0098662),0.2522457467601593,0.7934971765572519,0.9107321965897693,0.9150493334756538,1.0,31/268,13.86%,MCOLN3;SLC6A6;ATP1B4;SLC36A2;MCOLN2;ATP6V1A;ABCB7;ANO6;SLC9A3;SLC11A2;KCNK13;RHD;P2RX4;ATP6V0D1;TMEM165;SLC8A1;SLC12A3;P2RX3;KCNAB2;TRPC3;TRPV2;SLC39A14;SLC6A8;KCNK4;NNT;ATP6V0E1;GAS6;ATP6V0C;TRPM7;SLC11A1;ATP6V1H
prerank,nucleus organization (GO:0006997),0.28680384431379613,0.7934844674309215,0.7785714285714286,0.914705909881467,1.0,18/47,25.00%,REEP4;CHMP2A;PDCD6IP;TPR;VPS4A;CHMP6;LEMD3;USP36;NUP98;CHMP5;CHMP7;TMEM170A;TOR1A;CHMP2B;NDC1;NUP54;ATXN7;CTDNEP1
prerank,histone monoubiquitination (GO:0010390),-0.25045713751227816,-0.7934731418096531,0.7777777777777778,0.9521095835408613,1.0,7/24,13.75%,DDB2;TRIM37;RYBP;BCOR;RNF20;PAF1;ATXN7L3
prerank,positive regulation of secretion by cell (GO:1903532),0.27481759852950427,0.7931638839286095,0.7948430493273543,0.9148094168877544,1.0,12/70,15.27%,DTNBP1;ABCG1;ADAM9;P2RX4;IGF1;ADAM8;STXBP5;TREM2;APBB3;CLASP1;GOLPH3;GOLPH3L
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.32034352686707024,-0.7930624159505453,0.7210682492581603,0.95125363238805,1.0,7/10,28.03%,CST3;TNFRSF1A;DPP4;FAP;TGFB1;EMILIN1;CHADL
prerank,response to cAMP (GO:0051591),-0.22836421097586024,-0.7928905276359826,0.8295454545454546,0.9500616478664646,1.0,11/37,19.64%,HCN1;AKAP9;STAT1;HCN2;NDUFS4;RAP1B;PKD2;RAPGEF3;RAPGEF2;AHR;SLC26A6
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.22840854222746276,-0.7928158786387394,0.8043478260869565,0.9486688394237999,1.0,9/37,13.66%,RPTOR;SPRED1;PARD3;WNK3;IRGM;SMAD7;SPRED2;SIRT2;SPRED3
prerank,negative regulation of angiogenesis (GO:0016525),0.2690662194645678,0.7927815726727632,0.8098360655737705,0.9150215892637131,1.0,6/84,5.50%,PPARG;CTNNB1;KLK3;NIBAN2;FOXO4;THBS1
prerank,lymphocyte proliferation (GO:0046651),-0.2599795364051121,-0.7927537456571011,0.832,0.947236509006012,1.0,6/22,17.32%,MEF2C;FLT3;BCL2;PIK3CG;CD40;LMBR1L
prerank,MAPK cascade (GO:0000165),0.2494988876669238,0.7925811273597795,0.9108216432865731,0.9149628577697994,1.0,45/295,14.75%,HTR2B;MAP3K20;GRB2;TAOK3;SOS1;HGF;RASA3;PSMD1;PDGFA;RGL1;RGL2;BRAP;RAF1;IGF1;FGFR4;CUL3;IRS2;NRAS;RASA4;PIK3CA;CSF2RB;RPS27A;UBC;ZFP36L2;SOX9;MAP3K8;CTSH;IL5;TNIK;PTGER4;IL3RA;PSMF1;ARTN;MT3;PSMD14;NRG4;PSMD12;CSF2RA;RASGEF1A;LAMTOR3;GDNF;PSME2;SHC1;JAK3;CUL1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.2518298651574093,0.7922707149147294,0.9022177419354839,0.9150640894665564,1.0,62/248,22.96%,APOE;CTNNB1;ZEB2;GNAQ;PSMD1;ZNRF3;COL1A1;CUL3;GSKIP;STK3;APC;FOLR1;MCC;SOX9;XIAP;SNAI2;RNF146;DVL1;TBL1XR1;DDIT3;FZD7;GSK3B;PSMF1;PSMD14;WLS;PSMD12;SOX2;LIMD1;PRKN;PPP1CA;LRP6;PSME2;KREMEN1;TNKS;LATS1;ATP6AP2;USP8;CCDC88C;MLLT3;PSMB10;CSNK1G1;PSMD5;PTPRU;TNKS2;PSMD8;AMFR;STK4;PSMA3;PSMA2;PSMD11;WWTR1;TCF7L2;PSMA6;TLE3;RUVBL2;PSMB3;VCP;SDHAF2;KLHL12;ILK;SIAH2;PSME3
prerank,regulation of double-strand break repair (GO:2000779),0.29489845009565163,0.7920791205503049,0.7653429602888087,0.9149771059782733,1.0,13/39,25.19%,TRIP12;SIRT6;PPP4R2;RTEL1;SIRT7;RNF169;SHLD2;MGMT;SPIDR;SLF1;FOXM1;TERF2IP;UBR5
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2656818706114946,0.7910511696273556,0.8336886993603412,0.9161676906461353,1.0,9/101,10.68%,HTR2B;PIK3R5;VEGFA;PDGFA;ADAM8;INCENP;SLC27A1;ADAM17;SIRT1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.24871469300737348,-0.7909239625624901,0.8102766798418972,0.948836113934429,1.0,6/24,15.67%,TMEFF2;F11R;WAS;ARHGAP6;ARHGEF18;STMN1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.3669666070758312,0.790186151275691,0.7285921625544267,0.917012076883093,1.0,2/12,8.41%,MAP2K5;FOXP1
prerank,collagen fibril organization (GO:0030199),0.26677188012602643,0.7901416826676021,0.8362637362637363,0.9167209569484677,1.0,18/88,18.32%,TLL2;CD151;COL4A6;COL1A1;LUM;COL4A1;COL5A2;COL11A1;COL5A3;COL3A1;LAMA3;COL6A2;ATP7A;COL11A2;COL4A5;PLOD1;COL12A1;PLEC
prerank,oxoacid metabolic process (GO:0043436),0.31656391786791394,0.7900122949468756,0.7677419354838709,0.916546698322536,1.0,4/27,10.85%,ENPP1;GNMT;GRHPR;LIAS
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.32708414796082563,-0.7899563241061355,0.7254901960784313,0.9489370300391863,1.0,3/10,16.55%,HNMT;SARDH;CHDH
prerank,sodium ion transport (GO:0006814),0.26767638197626664,0.7896301368550344,0.8295081967213115,0.9167391034099253,1.0,8/85,8.05%,SGK1;SLC6A6;ANO6;SLC8A1;SLC5A5;SLC12A3;SLC38A7;NEDD4L
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.32745337457276247,-0.789583130310761,0.7210682492581603,0.9480802085246606,1.0,3/10,6.40%,MAPT;NDFIP2;PPM1F
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3430320830874114,0.7890961036345598,0.7420289855072464,0.9171754738486877,1.0,4/16,10.49%,IGF1;TRPC3;ROCK1;MTPN
prerank,dermatan sulfate metabolic process (GO:0030205),0.36119622019870606,0.7890855950404543,0.7559523809523809,0.9168324303357478,1.0,2/13,9.48%,DSE;IDUA
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.2516804195651152,-0.7888585355667833,0.7887931034482759,0.9478436383556506,1.0,9/24,21.21%,SAR1B;ERAP1;MFSD6;IDE;TAP2;HFE;PDIA3;SEC13;FCER1G
prerank,cellular response to glucagon stimulus (GO:0071377),0.34135818170561655,0.7883125683731282,0.7475728155339806,0.9175797598663972,1.0,5/17,22.88%,ADCY7;ADCY8;ADCY3;ADCY5;ADCY9
prerank,positive regulation of rRNA processing (GO:2000234),-0.3190308762587468,-0.7881997878720768,0.7259475218658892,0.9473825999909662,1.0,4/10,17.07%,HEATR1;BUD23;RIOK2;TRMT112
prerank,cell cycle G2/M phase transition (GO:0044839),0.2613468637869698,0.7881062045859505,0.8440748440748441,0.9175145549761408,1.0,32/129,21.51%,OPTN;CDKN1A;DYNC1H1;HAUS6;FBXL17;MELK;FBXL3;ENSA;PPP2R2A;CDK7;CCNA2;CEP76;TUBA1A;CLASP1;CEP192;CUL1;ALMS1;NDE1;MNAT1;LATS1;OFD1;CCP110;SSNA1;HAUS7;CDC25A;PAFAH1B1;BRSK2;PPP2R1A;PHLDA1;HAUS5;CEP41;CCDC57
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.34300802339032477,0.7880652946693197,0.749656121045392,0.91721342663396,1.0,3/17,14.46%,UBE2L3;NR3C1;ACOD1
prerank,positive regulation of telomere maintenance (GO:0032206),0.3083213132898893,0.7876221099341576,0.7687420584498094,0.917480203147085,1.0,10/31,23.72%,SIRT6;RTEL1;NBN;HNRNPD;TNKS;TNKS2;MRE11;PKIB;PPP1R10;NEK7
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.2644003843587194,0.7875379693186195,0.8382663847780126,0.9172462280184249,1.0,22/110,17.41%,DHX34;RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;ETF1;RPL36A;RPL22;RPS21;PPP2R2A;NCBP2;RPL10A;RPS26;UPF2;RPL15;RPL10;EIF4A3;RPSA;RPL7;RPL26
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3059764038272587,0.7873907434430443,0.7716129032258064,0.9171054108743684,1.0,5/30,15.19%,SYNPO2L;AKAP13;COL3A1;LPAR6;ARRB1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.259949605054384,-0.7872954103764194,0.7761194029850746,0.9473376162366469,1.0,12/20,33.36%,TGFBR1;ENG;PDCD4;TGFB2;RBPJ;SPRY1;BMP2;OLFM1;HAS2;BMP4;HEY1;HEY2
prerank,positive regulation of translational initiation (GO:0045948),0.3400898271572174,0.7872549537725037,0.7434842249657064,0.9169447315407931,1.0,4/18,14.38%,YTHDF3;POLR2G;CDC123;UHMK1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.3188348112479737,0.7872518795115955,0.7574123989218329,0.9165881922723127,1.0,3/23,10.37%,GSTM1;GPX4;LTA4H
prerank,response to organonitrogen compound (GO:0010243),0.29648360116910244,0.7872473282378033,0.7677496991576414,0.9162360069247839,1.0,6/38,13.77%,KYNU;IL6;NR1H4;IRAK3;RHBDD1;PRKN
prerank,regulation of muscle contraction (GO:0006937),-0.2512908860977138,-0.7872274250672044,0.8149606299212598,0.9459387199092658,1.0,3/26,3.62%,KCNB2;ATP1A2;CHRM2
prerank,autophagosome organization (GO:1905037),0.28379973406718584,0.7871023357595051,0.7889273356401384,0.9160742313221323,1.0,10/50,15.10%,ATG7;RAB7A;AMBRA1;VMP1;RAB1B;ATG5;PACS2;RAB43;ATG13;UBQLN2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.27477343169584356,0.7870979954101361,0.8046103183315039,0.9157188628549542,1.0,19/78,24.01%,IPO5;CDKN1A;PTEN;GADD45A;APC;ADAM17;CDK7;CCNA2;CNPPD1;MNAT1;LATS1;CDC25A;CCNG1;CEBPA;GTPBP4;CCNT1;BCCIP;MEN1;NR2F2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.36108542857454096,0.786921561564228,0.7253731343283583,0.9156180335610651,1.0,2/12,9.17%,VEGFA;DSCAM
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.31638933700179067,0.7861763231202403,0.7366310160427807,0.9163188008151752,1.0,4/24,14.71%,CD44;SNAI2;SIRT1;CXCL12
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.34210227073204713,0.7854685933673953,0.7569832402234636,0.9169755219490031,1.0,2/17,5.10%,DOCK5;IGF1
prerank,mRNA modification (GO:0016556),-0.25543825365562695,-0.7854398082017521,0.7786259541984732,0.9475030479175861,1.0,5/22,8.56%,METTL3;VIRMA;PUS7;CMTR1;NSUN2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.26011810054166634,-0.7853950203167245,0.7786885245901639,0.9460901266148435,1.0,11/21,30.45%,RAB11A;CDK4;CDC7;CDC25B;NPM1;BRD4;DTL;CDK1;CCND1;STOX1;DYRK3
prerank,mitochondrion disassembly (GO:0061726),0.3021050096720782,0.7850734906035733,0.7707317073170732,0.917194916226548,1.0,10/34,19.28%,ATG7;AMBRA1;ATG5;FUNDC1;PRKN;FUNDC2;SQSTM1;BNIP3;USP30;FBXO7
prerank,cellular response to cAMP (GO:0071320),-0.23931523674187027,-0.785073455088813,0.8403755868544601,0.9451494988125116,1.0,18/30,34.75%,HCN1;AKAP9;HCN2;RAP1B;PKD2;RAPGEF3;RAPGEF2;AHR;SLC26A6;PDE2A;HCN3;IGFBP5;HCN4;AANAT;CRHBP;DMTN;AKAP6;KCNQ1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.277747726489974,0.7845904749817447,0.801605504587156,0.9175022782298439,1.0,7/56,10.66%,NSMCE2;ANXA1;ANKRD17;CUL3;RB1;ADAM17;KMT2E
prerank,regulation of mRNA processing (GO:0050684),0.30033092869982553,0.7845579964021684,0.76125,0.917191036090454,1.0,8/32,21.17%,SRPK2;RBM39;SF1;LARP7;SRSF3;SRPK1;JMJD6;SAFB
prerank,mRNA methylation (GO:0080009),-0.2841511783305747,-0.7843802869845232,0.7444794952681388,0.9448183659147397,1.0,4/15,8.56%,METTL3;VIRMA;CMTR1;NSUN2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3151929150483299,0.7843537924241247,0.7665369649805448,0.9171231465766206,1.0,10/27,26.44%,CD44;IL6;SIRPA;RELA;HSPD1;CD47;IRAK1;TRAF6;NFAT5;CCL2
prerank,histone exchange (GO:0043486),-0.2262244422023766,-0.7842244927704931,0.8852459016393442,0.943569465359262,1.0,15/37,24.83%,RSF1;RNF8;ITGB3BP;CENPP;KNL1;CENPA;RBBP4;CENPK;CENPO;NPM1;CENPT;ACTR6;CENPQ;CENPN;CENPH
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.3174753544292951,-0.7834869949364921,0.7417417417417418,0.9433919670818283,1.0,2/10,3.71%,PRKCE;IRS1
prerank,development of primary male sexual characteristics (GO:0046546),0.29801759440249936,0.783434128768834,0.7747183979974969,0.9180971415855107,1.0,4/34,9.43%,LHFPL2;NCOA4;SOX9;NR5A1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3066333629714528,-0.7831426192582494,0.7597402597402597,0.9424337103082036,1.0,4/12,9.49%,KHDRBS1;NUP214;AAAS;IFI27
prerank,myeloid cell development (GO:0061515),0.33730175883705066,0.7831332955509751,0.7478753541076487,0.9181623719853343,1.0,4/18,14.72%,ANXA2;FOXP1;APP;NRROS
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2935767710714105,0.7830033803999286,0.7723270440251573,0.9179871612831544,1.0,12/36,26.57%,FBXW7;NCOA3;ITGB1;ADAM17;BUD31;NRP1;NCF1;TAF1;JAK2;HDAC1;CCL2;HBEGF
prerank,histone mRNA metabolic process (GO:0008334),-0.2439412456997027,-0.7823416960056541,0.7957446808510639,0.942228061798745,1.0,8/27,13.39%,ATM;TUT4;SSB;SNRPE;MTPAP;LSM1;SLBP;XRN1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.33640940823041743,0.782150966441025,0.7635327635327636,0.9188709288969479,1.0,3/17,9.40%,SPDL1;RB1;BOD1
prerank,regulation of coagulation (GO:0050818),0.3671189635690232,0.7821474867636059,0.7360890302066773,0.9185161355567412,1.0,1/11,6.48%,PROC
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2680516850376678,0.7820229499369814,0.8416945373467113,0.9183446363015213,1.0,20/73,22.96%,LMO1;PSMD1;CBFB;PSMF1;PSMD14;PSMD12;PSME2;TCF12;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;KMT2A;OSM;PSMD11;PSMA6;PRKDC;PSMB3;PSME3
prerank,cell proliferation in forebrain (GO:0021846),0.3756919647014486,0.7819595622591379,0.7296875,0.9180805848695253,1.0,2/10,11.14%,HOOK3;NUMBL
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.31071753975256206,0.7816081339557946,0.7708860759493671,0.9182407462814887,1.0,7/29,14.87%,LIMA1;PRKCD;PIK3CA;PFN1;CLASP1;PRKN;PFN2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3019299605778858,0.7812243941441973,0.7718631178707225,0.9184173639085589,1.0,6/29,17.02%,RAB33B;VTI1B;VTI1A;TRAPPC10;COG5;COG2
prerank,cell-cell junction maintenance (GO:0045217),-0.30930861566824,-0.781178215001892,0.7383720930232558,0.9426622024209839,1.0,2/11,10.34%,CSF1R;FERMT2
prerank,axonemal dynein complex assembly (GO:0070286),0.31598401937884885,0.7810523749837618,0.752258064516129,0.9183003436852913,1.0,3/27,10.02%,CCDC40;DNAAF3;ODAD1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.2920048962186915,0.7809542139332863,0.7762836185819071,0.9180763254011292,1.0,6/37,12.24%,RFC3;GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,neuron projection organization (GO:0106027),0.3478117161160945,0.7807688503516595,0.731638418079096,0.9179781117718477,1.0,3/15,11.57%,ABCD1;GSK3B;APP
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2580143202330288,0.7791865944507848,0.8388473852721452,0.9199352955652015,1.0,16/104,13.96%,PPARG;PDPK1;SORL1;RPS27A;UBC;ACVR2A;HIPK2;BMPR2;SNX25;ADAM17;SIRT1;RBPMS2;STUB1;NOTCH1;LEMD3;HSPA1A
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.3780664920207968,0.7787635740968761,0.7515243902439024,0.9201536923389592,1.0,2/10,7.65%,RAP2A;MSN
prerank,positive regulation of transferase activity (GO:0051347),0.25306711088273853,0.7786629026264659,0.8825363825363826,0.9199377735034481,1.0,21/142,15.00%,CTNNB1;ACD;FBXW7;ARRDC4;RFC3;SORL1;UBE2L3;FGFR4;MERTK;POLG2;TOPORS;XRCC5;DCUN1D5;DKC1;NBN;DCUN1D3;ROR1;TREM2;DCUN1D4;HNRNPD;TNKS
prerank,synaptic vesicle endocytosis (GO:0048488),0.29906948204081624,0.7784815669516808,0.7738246505717916,0.9198345503214128,1.0,10/33,20.18%,CEL;GAK;PICALM;SNCG;STON1;NLGN2;ITSN1;FCHO2;SYNJ2;VAMP2
prerank,dendritic cell migration (GO:0036336),0.3415638573146745,0.7784069400522563,0.7549857549857549,0.9195810267881671,1.0,1/16,0.59%,CXCR4
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3646987290474926,0.7781933304591708,0.773071104387292,0.9195324293474171,1.0,3/12,17.36%,WDR18;NBN;CDT1
prerank,nucleosome disassembly (GO:0006337),0.35015376961562356,0.7779677462669657,0.7592867756315007,0.9191256758345885,1.0,7/14,28.03%,ARID2;SMARCC1;SMARCD1;SMARCB1;SMARCE1;SMARCD2;SMARCA4
prerank,chromatin disassembly (GO:0031498),0.35015376961562356,0.7779677462669657,0.7592867756315007,0.9191256758345885,1.0,7/14,28.03%,ARID2;SMARCC1;SMARCD1;SMARCB1;SMARCE1;SMARCD2;SMARCA4
prerank,positive regulation of kinase activity (GO:0033674),0.2584605740588304,0.7779039985751532,0.8486140724946695,0.9188579293376037,1.0,15/107,13.11%,IQGAP1;PRKAG2;CDKN1A;SNX9;FGFR4;MERTK;CACUL1;XRCC5;PTK2B;CCN1;NBN;TAB2;ROR1;TREM2;GAS6
prerank,protein dephosphorylation (GO:0006470),0.25581129189578644,0.7778561045388821,0.8612836438923396,0.9185626269824679,1.0,22/135,14.07%,EYA1;MTM1;MTMR3;PPM1H;PPP4R1;PPEF1;PTEN;PTPRE;DUSP3;PPEF2;PTPN12;PDP1;PPP4R2;RPAP2;LHPP;PPP3CA;PPP2R2A;ILKAP;PGP;CTDP1;PPP6C;PPP1CA
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.32762540324614464,0.7773420811976741,0.7553191489361702,0.9189111138331049,1.0,3/20,9.21%,PID1;PKDCC;PICALM
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2891549745071106,0.7770682719811997,0.7825030376670717,0.9189264171424304,1.0,6/39,12.24%,RFC3;GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,protein export from nucleus (GO:0006611),-0.23607805370753257,-0.7769937314518623,0.852017937219731,0.9478327641087674,1.0,10/27,25.83%,SMURF1;NUP214;STRADB;PKD1;RANBP17;STRADA;CCHCR1;XPO6;TGFB1;XPO4
prerank,recombinational repair (GO:0000725),0.2683157660890908,0.7769313795693199,0.8372093023255814,0.9187656711605678,1.0,20/77,23.38%,NSMCE2;SEM1;MCM9;BRCA1;XRCC2;POLL;AP5S1;NBN;PSMD14;WRN;INO80;AP5Z1;RMI1;MRE11;RAD51B;XRCC1;SPIDR;RNF138;PALB2;ERCC4
prerank,polyol biosynthetic process (GO:0046173),-0.27786969182015636,-0.7767718584206816,0.782608695652174,0.9466859997649915,1.0,6/16,17.04%,IP6K2;PPIP5K1;FGF2;ITPKC;PPIP5K2;IP6K1
prerank,cAMP-mediated signaling (GO:0019933),0.3120491170782714,0.7762643859964221,0.7771952817824378,0.9193338348735476,1.0,5/24,13.29%,PDE7B;MAPK7;SOX9;CAP1;DGKQ
prerank,cellular response to interferon-gamma (GO:0071346),0.26262528969819177,0.77618460315047,0.8360128617363344,0.9190923339966516,1.0,14/88,16.19%,CD44;PRKCD;DAPK1;IFNGR2;TRIM25;PTAFR;GBP6;SIRPA;IRF2;EPRS1;CX3CL1;ACOD1;CCL7;SYNCRIP
prerank,regulation of glycolytic process (GO:0006110),0.2700102495577648,0.7761532385555041,0.8161434977578476,0.9187763521826531,1.0,19/68,23.05%,PRKAG2;NCOR1;IGF1;EIF6;ZBTB20;TPR;NUP50;APP;NUP98;ZBTB7A;NUP88;GAPDHS;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,histone H3 deacetylation (GO:0070932),0.3373658476913209,0.7745430395635261,0.7460087082728593,0.9206564623487549,1.0,4/15,19.37%,SIRT6;SIRT1;SIRT7;HDAC8
prerank,nucleocytoplasmic transport (GO:0006913),0.2914661615227086,0.7740892070179676,0.7901085645355851,0.92095425197318,1.0,11/40,22.64%,ATXN1;RITA1;NCBP2;DDX20;RSRC1;SNRPF;NUP98;SMN1;XPO1;SNRPB;MALT1
prerank,cyclooxygenase pathway (GO:0019371),0.36905700148185105,0.7736899437474848,0.7379518072289156,0.9211583830613829,1.0,2/10,8.70%,PTGES2;HPGDS
prerank,nuclear pore organization (GO:0006999),-0.2885654531662637,-0.7735316528076192,0.7619047619047619,0.9502383019196898,1.0,5/14,14.68%,NUP133;AHCTF1;SEH1L;NUP35;NUP153
prerank,negative regulation of viral entry into host cell (GO:0046597),0.3640295084300802,0.7733875708081114,0.7563150074294205,0.9211972176070833,1.0,2/12,8.91%,IFITM1;IFITM2
prerank,positive regulation of cytokinesis (GO:0032467),0.29189554167524534,0.7730669520828497,0.7946084724005135,0.9212536513354957,1.0,4/32,10.63%,KIF20B;CUL3;SVIL;PKN2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.32914218367148096,0.7729259900302557,0.7743732590529248,0.921097770833809,1.0,7/18,21.70%,ABCG1;ABCA2;PICALM;RELA;CASP3;GSAP;EPHA4
prerank,regulation of chromosome segregation (GO:0051983),-0.28573909079564364,-0.772776510370186,0.7732342007434945,0.9499877600995197,1.0,11/16,35.48%,SMC6;PUM1;NUMA1;MKI67;BUB1;IHO1;RMI2;AURKB;KIF2C;RAD18;HORMAD1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.3464931900373226,0.7718840222823015,0.7733333333333333,0.9222071337007907,1.0,2/14,7.99%,SOX9;SNAI2
prerank,regulation of cardiac muscle contraction (GO:0055117),0.2945718875466449,0.7715790088666529,0.7984886649874056,0.9222871229149759,1.0,3/34,5.00%,ADRA1A;P2RX4;SLC8A1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.2891023755917357,-0.7713717882456405,0.7565982404692082,0.950764781968057,1.0,5/14,18.37%,TMSB4X;PKD2;NFKBIE;PKD1;PSMD10
prerank,aromatic amino acid family catabolic process (GO:0009074),0.33982856944710965,0.7710990460707756,0.7604617604617605,0.9226094777234225,1.0,1/15,2.55%,KYNU
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.30812621400969653,0.771073538806604,0.7846952010376135,0.9222921580071268,1.0,5/27,14.62%,ERN1;TOE1;CSTF3;LACTB2;RNASEH1
prerank,establishment of spindle orientation (GO:0051294),0.30203747972440603,0.771047097058379,0.7776349614395887,0.9219710863444252,1.0,6/28,18.65%,SPDL1;ITGB1;CLASP1;NDE1;PAFAH1B1;HTT
prerank,dendrite self-avoidance (GO:0070593),0.34505874421055444,0.770721049277298,0.7747093023255814,0.9220646288938054,1.0,3/16,9.17%,PALLD;TNN;DSCAM
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.33859090030787564,0.7704865381490942,0.7461430575035063,0.9220406675921253,1.0,5/16,20.60%,CTNNB1;BRCA1;DNMT1;KMT2A;PAXIP1
prerank,autophagy of mitochondrion (GO:0000422),0.28985376430992604,0.7686301557199252,0.8057210965435042,0.9242522532177375,1.0,11/38,19.28%,ATG7;AMBRA1;ATG5;FUNDC1;ATG13;PRKN;FUNDC2;SQSTM1;BNIP3;USP30;FBXO7
prerank,dicarboxylic acid catabolic process (GO:0043649),0.359320905292946,0.7686141993142341,0.7593123209169055,0.9239137585234666,1.0,1/13,2.63%,MTHFS
prerank,microtubule-based transport (GO:0099111),0.35388615381366934,0.7684205668373082,0.7592319054652881,0.923822484202827,1.0,3/12,18.65%,CCDC40;SPAG17;HTT
prerank,gastrulation (GO:0007369),0.3426718131201545,0.7681145292740235,0.75,0.9239003760384313,1.0,2/15,6.72%,UGDH;LMBRD1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3497541094996733,0.7680602518068975,0.7576687116564417,0.9236257951156185,1.0,5/13,21.61%,NR1H3;LPCAT3;WFS1;FCGR2B;NR1H2
prerank,smooth muscle tissue development (GO:0048745),0.37212653829519815,0.7676371214482745,0.75,0.9238487578828843,1.0,1/10,1.11%,STRA6
prerank,mitochondrion distribution (GO:0048311),0.3568365733125108,0.7673421845884562,0.7766116941529235,0.9239002584699648,1.0,1/12,0.93%,MTM1
prerank,synaptic vesicle transport (GO:0048489),0.36142175134737464,0.767191019798167,0.7733333333333333,0.9237585942327652,1.0,5/11,21.81%,SPG11;KIF5B;KIF5C;TOR1A;TMEM230
prerank,negative regulation of protein metabolic process (GO:0051248),0.2756374785026311,0.7669159479579969,0.7976190476190477,0.9237778484057084,1.0,12/48,20.30%,APOE;CD84;IRAK3;ROCK1;TREM2;AZIN1;PRKCG;SNX3;HMGCR;VBP1;AZIN2;ITGAV
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.3385990913695032,0.7666018561211262,0.7391304347826086,0.9238404577270706,1.0,7/16,25.74%,CREBBP;NAA10;NAA30;NAA25;NAA80;NAA15;KAT2B
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.318761097015025,-0.766426989418502,0.7748538011695907,0.9569655430550464,1.0,3/10,14.55%,CCT3;CCT5;CCT4
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.35767667042126366,0.7659489043127531,0.7652439024390244,0.924350870220017,1.0,4/12,20.43%,ABCA2;LPCAT3;DGKQ;SREBF1
prerank,insulin secretion (GO:0030073),0.32334953833901975,0.7653718155421633,0.7579092159559835,0.9247436029346113,1.0,3/19,13.02%,ANXA1;CYB5R4;RAB11B
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.26783419486711996,-0.7652246995471156,0.8438538205980066,0.9573065220756822,1.0,8/17,23.04%,TGFB2;ARL6IP5;RNF13;CARD9;STK25;KLHDC10;TAOK2;LYN
prerank,V(D)J recombination (GO:0033151),0.3618023885598015,0.7646254170259617,0.7553516819571865,0.9254114531471929,1.0,3/11,21.95%,XRCC4;DCAF1;PRKDC
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.35452766784349526,0.7644083026047908,0.7628111273792094,0.9253533604463628,1.0,4/13,14.35%,EIF2AK4;APP;ADCY8;SQSTM1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.31576649875629736,-0.7638647011125952,0.7824858757062146,0.9579361158476865,1.0,2/11,5.95%,JUP;PLEKHA7
prerank,signal transduction by p53 class mediator (GO:0072331),-0.22516564866605523,-0.763810842603851,0.845,0.9565392236319562,1.0,9/30,16.87%,FHIT;STK11;MDM4;PPP1R13B;PYCARD;USP10;JMY;MYBBP1A;HINT1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.2812110191540065,-0.7637691897521509,0.7987987987987988,0.9551234729903311,1.0,3/15,9.97%,ACSS1;ACACA;HMGCS1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3137460305796685,0.7637257882163894,0.787598944591029,0.9258866320256032,1.0,2/23,7.60%,PPEF1;CAMKMT
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.2828690569382496,-0.7635539757025639,0.8013937282229965,0.9539691227644049,1.0,9/16,28.94%,ATP5PO;DMAC2L;ATP5F1E;ATP5PF;ATP5MC3;ATP5ME;ATP5F1B;ATP5MG;STOML2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.31144877178789443,0.7632181539963083,0.7828418230563002,0.9262622927801295,1.0,8/22,21.70%,ABCG1;ABCA2;PICALM;RELA;RANBP9;CASP3;GSAP;EPHA4
prerank,regulation of transposition (GO:0010528),0.3512396389356125,0.7629294693443063,0.7797356828193832,0.9262948122468491,1.0,2/13,12.34%,SMYD5;SIRT7
prerank,nucleotide metabolic process (GO:0009117),0.30982641749572526,0.7625726139605759,0.7883116883116883,0.9264173504336359,1.0,2/23,6.99%,AK8;NMNAT1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.311540735325327,0.7619424860783084,0.7773333333333333,0.9269014172305028,1.0,2/22,4.50%,ID2;APPL2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.30795694546389235,0.7616320641222011,0.8081471747700394,0.9269530760622748,1.0,3/24,7.94%,ARPC2;PIK3CA;ACTR3
prerank,negative regulation of blood pressure (GO:0045776),0.3478356655231122,0.7613348384605922,0.7915407854984894,0.9270106384745735,1.0,3/13,22.10%,BMPR2;PRCP;DRD2
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.36540514849082273,0.7612469225470092,0.7594339622641509,0.9267730918825515,1.0,1/10,4.26%,ENPP1
prerank,nuclear membrane disassembly (GO:0051081),-0.27755090909502994,-0.7600230938194252,0.8176100628930818,0.957811576406402,1.0,9/14,37.86%,PRKCA;VRK1;CNEP1R1;DCTN1;CDK1;CCNB2;LPIN1;PLK1;CCNB1
prerank,negative regulation of lyase activity (GO:0051350),-0.26760474710772875,-0.7598922319712587,0.7842465753424658,0.9565535973446605,1.0,5/16,15.74%,GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,T cell differentiation in thymus (GO:0033077),0.3433893946512788,0.7591914461197694,0.7638483965014577,0.9291542665499807,1.0,2/14,10.29%,ZFP36L2;ADAM17
prerank,embryonic heart tube morphogenesis (GO:0003143),0.2820349781178106,0.7590522511523473,0.8141486810551559,0.9289667380580502,1.0,6/43,12.29%,APLNR;CCDC40;FOLR1;NOTCH1;TBX6;MICAL2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.26504350655739484,0.7582293127691792,0.8463251670378619,0.9297319712486466,1.0,13/72,14.87%,APOE;LIMA1;SPEF1;PRKCD;PIK3CA;APC;DYRK1A;ARHGEF2;PFN1;TREM2;CLASP1;PRKN;PFN2
prerank,potassium ion export across plasma membrane (GO:0097623),0.34766777575491226,0.758084572074773,0.7787234042553192,0.9295740242978683,1.0,13/13,65.26%,KCNK5;KCND3;KCNH2;KCNE5;KCNK18;KCNE1;KCNE2;KCNA5;KCNE4;KCNE3;KCNIP2;KCNT2;KCNQ1
prerank,sensory perception of smell (GO:0007608),0.36069839407192267,0.7575569776756614,0.7797619047619048,0.9299028161120211,1.0,3/11,22.18%,ADCY3;DRD2;UBR3
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.26539304067658237,-0.7574683447409528,0.8135593220338984,0.9586961975505202,1.0,5/17,23.82%,PDE3B;APOC1;TNF;IL1B;ADRA2A
prerank,retina homeostasis (GO:0001895),0.3120883507915073,0.7570832898739469,0.7788079470198676,0.9301629952833105,1.0,6/23,25.32%,PRDX1;CCDC66;ACTG1;SLC28A2;ACTB;POTEF
prerank,regulation of histone modification (GO:0031056),-0.28753797199687464,-0.7566207427412073,0.8129032258064516,0.9584139706969577,1.0,4/13,16.22%,HPF1;UBE2N;PARK7;CDK9
prerank,regulation of cellular response to stress (GO:0080135),0.24776166485029175,0.7558880332994705,0.869198312236287,0.9314104777985928,1.0,28/115,21.74%,CEBPB;ATF3;DNAJB6;ABCD1;CLN3;AIFM2;CREBBP;HSPA1B;ATF4;TPR;GSK3B;NUP50;SIRT1;BAG4;PRKN;HSPA1A;ADCY8;MCL1;NUP98;AMFR;BAG1;NUP88;AKT1S1;HSBP1;NPAS2;NUP188;NDC1;NUP43
prerank,positive regulation of protein secretion (GO:0050714),0.2621148243179089,0.7558699854718186,0.8602029312288614,0.9310839249342706,1.0,13/69,15.48%,ABCG1;ADAM9;IGF1;IRS2;ADAM8;TRH;AACS;WLS;TREM2;APBB3;GOLPH3;GOLPH3L;NLGN2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3220738727637171,0.7558648886898376,0.7986206896551724,0.9307355182852346,1.0,4/19,19.57%,TLR8;MAVS;HSPD1;TBK1
prerank,bicellular tight junction assembly (GO:0070830),0.2769073975379399,0.7556523794870548,0.8170011806375442,0.930663956151184,1.0,6/46,14.36%,MICALL2;APC;PDCD6IP;STRN;PAK2;PARD6A
prerank,negative regulation of calcium ion transport (GO:0051926),0.33510897065229694,0.7553887450228168,0.7890295358649789,0.9306630458744678,1.0,1/15,1.46%,LILRB1
prerank,cholesterol biosynthetic process (GO:0006695),0.29160945287994366,0.7552745989378783,0.7949685534591195,0.9304535792962294,1.0,9/31,20.66%,MVD;PLPP6;IDI1;INSIG2;PMVK;ACAA2;SC5D;HMGCR;ARV1
prerank,peptidyl-threonine modification (GO:0018210),0.2619747712168601,0.7550475367868271,0.8536036036036037,0.9303940294168132,1.0,11/66,13.07%,GALNT3;PDPK1;PRKCD;DYRK1A;HIPK1;HIPK2;CSNK2A2;ROCK1;GSK3B;ACVR1B;DYRK2
prerank,digestive tract development (GO:0048565),0.2965670200770333,0.7548620195430278,0.8249370277078085,0.9302829178512603,1.0,4/32,8.29%,STRA6;CCDC40;NIPBL;PKDCC
prerank,positive regulation of ATP metabolic process (GO:1903580),0.2892794489813988,0.7537543375462057,0.8024844720496894,0.931361158064867,1.0,5/32,12.31%,PID1;IGF1;ZBTB20;APP;TREM2
prerank,negative regulation of telomere maintenance (GO:0032205),0.33562615763041365,0.7533908968905491,0.7931034482758621,0.931496185918263,1.0,7/15,24.33%,RTEL1;TERF1;NBN;TNKS;TNKS2;ERCC4;TERF2IP
prerank,spliceosomal snRNP assembly (GO:0000387),0.278129543733466,0.7527712174157025,0.8279181708784596,0.9319447282823193,1.0,8/38,16.08%,CLNS1A;PRPF8;SART1;WDR77;PRPF6;DDX20;SNRPF;SMN1
prerank,cilium organization (GO:0044782),0.24027481029368655,0.7523835893068491,0.9226856561546287,0.9320762845359457,1.0,45/209,21.51%,MAK;RILPL2;RAB8B;PIBF1;SNX10;CFAP70;SNAP29;ATP6V0D1;KIF27;ASAP1;ABCC4;WDPCP;CFAP20;FBF1;KIF3A;ACTR3;DYNC2I2;CCDC66;IFT46;CFAP410;NOTCH1;CPLANE2;IFT52;OCRL;IFT140;SSX2IP;ARL3;EXOC4;OFD1;CCP110;RTTN;ARF4;EXOC7;EXOC1;BBS7;ARL13B;TMEM231;RAB1A;CDC14B;BBS1;IFT88;TCTN1;RPGR;CEP41;CCDC57
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.30097251676061243,-0.7520186835019945,0.794392523364486,0.9635124752016891,1.0,2/11,3.87%,NOVA1;PCBP3
prerank,lysine metabolic process (GO:0006553),0.3473210100481158,0.7519641050084603,0.7807153965785381,0.9318965244199615,1.0,3/12,16.57%,GCDH;ALDH7A1;OGDH
prerank,lysine catabolic process (GO:0006554),0.3473210100481158,0.7519641050084603,0.7807153965785381,0.9318965244199615,1.0,3/12,16.57%,GCDH;ALDH7A1;OGDH
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3037303653021378,0.75189785028051,0.7866666666666666,0.9316342641843082,1.0,5/24,16.02%,VEGFA;SEMA4B;DSCAM;NRP1;SEMA3B
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3109881890033187,0.750573400623312,0.796,0.9330402113289328,1.0,3/23,12.98%,ADGRG3;NLRC3;RELA
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.2211137266968253,-0.7501780090240868,0.9037433155080213,0.9647088731045844,1.0,8/31,13.64%,TFDP2;BCL2;PPP1R13B;NMT1;HIP1R;BAD;YWHAG;YWHAH
prerank,protein O-linked mannosylation (GO:0035269),0.3179193068194485,0.7500185117350145,0.7947295423023578,0.9334070546403891,1.0,5/18,23.20%,DPM2;TMTC4;FKTN;CRPPA;FKRP
prerank,positive regulation of phosphatase activity (GO:0010922),0.3084899956631687,0.7499634307831516,0.783180026281209,0.9331225423480128,1.0,1/21,0.63%,CD300A
prerank,lipid droplet organization (GO:0034389),0.30635027168597445,0.7497485858826494,0.78125,0.9330391049223937,1.0,6/22,27.71%,FAF2;RAB18;CDS2;RAB3GAP1;PPIA;BSCL2
prerank,DNA packaging (GO:0006323),0.3269592560806707,0.7495174488279526,0.8017241379310345,0.9329878874103276,1.0,8/16,30.44%,NAA10;NOC2L;PRM1;CDAN1;AIFM1;KAT6A;TP53;CHAF1B
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.25657788718371044,0.7492998439795283,0.8656554712892741,0.9329178925017503,1.0,18/87,17.83%,RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;RPL36A;RPL22;RPS21;RPL10A;RPS26;ZFAND2B;RPL15;RPL10;RPSA;RPL7;RPL26;SEC63
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2571313359219613,0.7491463244135741,0.868675995694295,0.9327480272680937,1.0,22/84,20.87%,WTAP;MBNL1;SRPK2;CELF1;RBM39;DDX5;HNRNPU;SF1;LARP7;SRSF3;PRDX6;NUP98;MBNL2;PUF60;THRAP3;RBM7;ZBTB7A;SRPK1;C1QBP;NCL;RBM15;JMJD6
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.31730480043680176,0.7486168943887397,0.79890560875513,0.9330808520706703,1.0,7/20,24.60%,PPIF;PPIH;CWC27;PPIE;FKBP1A;PPIG;PPIA
prerank,protein import into mitochondrial matrix (GO:0030150),0.3210633400503153,0.7484218641760133,0.7773109243697479,0.9329740948876177,1.0,3/18,11.79%,TIMM17A;TOMM20;TIMM17B
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.28748785722455306,0.7483065469753915,0.8106060606060606,0.932763694552029,1.0,4/33,9.79%,SYK;ADAM9;SNAI2;PLAU
prerank,dendritic cell differentiation (GO:0097028),0.29910911620040115,0.7481673814885513,0.7958333333333333,0.932603535175184,1.0,3/22,13.11%,LILRB1;TREM2;GAS6
prerank,regulation of telomere maintenance (GO:0032204),0.30460415189944284,0.7481397103439945,0.8072289156626506,0.9322882242875835,1.0,10/26,24.33%,SIRT6;RTEL1;XRCC5;NBN;HNRNPD;HDAC8;MRE11;PPP1R10;ERCC4;TERF2IP
prerank,positive regulation of hydrolase activity (GO:0051345),0.24456070627162324,0.7467225687237152,0.9034267912772586,0.9337731649115273,1.0,16/137,12.63%,PSAP;TGM2;RIC1;TBC1D2;SNX9;FLCN;DOCK10;ARAP1;CTSH;PICALM;ITGB1;MTCL1;GSK3B;BCAS3;RAPGEF1;WRN
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3242782342317301,0.7467209292385858,0.7860199714693296,0.9334224764951913,1.0,6/16,19.09%,DDX5;HNRNPM;PQBP1;RSRC1;PUF60;CDK13
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.30372271412742113,0.7465123995701555,0.7901726427622842,0.9333267710893957,1.0,3/24,7.19%,RFC3;RPS27A;UBC
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3033278630571722,-0.7464035533033152,0.7988505747126436,0.9684959305986236,1.0,1/10,5.43%,FMR1
prerank,type I interferon signaling pathway (GO:0060337),0.2764942087454368,0.746251264269284,0.8066825775656324,0.9329540520056945,1.0,9/41,16.95%,IFITM1;IFNAR2;RNASEL;IRF2;IFITM2;BST2;MYD88;IFIT2;IFNAR1
prerank,cellular response to type I interferon (GO:0071357),0.2764942087454368,0.746251264269284,0.8066825775656324,0.9329540520056945,1.0,9/41,16.95%,IFITM1;IFNAR2;RNASEL;IRF2;IFITM2;BST2;MYD88;IFIT2;IFNAR1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.30285356499973437,0.7461045314488863,0.8107752956636005,0.9327782445916835,1.0,5/23,18.65%,SPDL1;ITGB1;NDE1;PAFAH1B1;HTT
prerank,negative regulation of ossification (GO:0030279),0.3027947755599633,0.7450189326453162,0.796221322537112,0.9338426405211137,1.0,4/23,11.96%,ENPP1;SOX9;PTK2B;NOTCH1
prerank,negative regulation of macrophage activation (GO:0043031),0.3184408548502637,0.7443168111117329,0.7893982808022922,0.934401267806856,1.0,5/16,21.13%,NR1H3;CX3CL1;GRN;FCGR2B;PTPRC
prerank,response to purine-containing compound (GO:0014074),0.3232710153626914,0.7437431358046911,0.8103448275862069,0.9348082361330594,1.0,3/17,13.29%,P2RX4;TRPC3;DGKQ
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.34308592974428037,0.7436351438690136,0.783359497645212,0.934613681765859,1.0,2/11,10.68%,ANXA1;SIRT1
prerank,cardiac conduction system development (GO:0003161),0.299688558674469,0.7434894655368732,0.821969696969697,0.9344449806200104,1.0,2/24,5.37%,NOTCH2;MAML1
prerank,basement membrane organization (GO:0071711),-0.2792298171135847,-0.7427089953202225,0.8397435897435898,0.9720941464929551,1.0,7/14,25.06%,NTNG1;HPN;NTN4;NID2;FLRT2;LAMB2;LAMB1
prerank,establishment of mitotic spindle localization (GO:0040001),0.2922924504089252,0.7424525420587877,0.8239074550128535,0.9354265387053186,1.0,6/28,18.65%,SPDL1;ITGB1;CLASP1;NDE1;PAFAH1B1;HTT
prerank,cytoplasmic translation (GO:0002181),0.25301642173593275,0.7424219142835494,0.8711063372717508,0.9351124866552846,1.0,18/91,17.41%,RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;ETF1;RPL36A;EIF4A1;RPL22;RPS21;RPL10A;RPS26;RPL15;RPL10;RPSA;RPL7;RPL26
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.3045825374308405,0.7423618484265478,0.8161953727506427,0.9348375764315521,1.0,10/25,23.81%,ACVR2A;ACVRL1;BMPR2;CCN1;NOTCH1;SULF1;UBE2O;HES5;CDH5;BMPR1B
prerank,contractile actin filament bundle assembly (GO:0030038),-0.2753102263942901,-0.7422383282819803,0.8225255972696246,0.9697984935560546,1.0,4/15,14.21%,SORBS1;PHACTR1;FHDC1;RHOA
prerank,stress fiber assembly (GO:0043149),-0.2753102263942901,-0.7422383282819803,0.8225255972696246,0.9697984935560546,1.0,4/15,14.21%,SORBS1;PHACTR1;FHDC1;RHOA
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.3350768962111626,0.7421890247100615,0.7928571428571428,0.9347094913532112,1.0,9/14,32.46%,SEC23B;SEC31A;RAB1A;SEC24C;SEC24B;SEC24A;SAR1A;SEC24D;SEC23A
prerank,mitochondrial membrane organization (GO:0007006),-0.21942174862013508,-0.74139331314406,0.8762886597938144,0.9694315948184096,1.0,9/32,20.34%,SLC25A4;BCL2;MFN1;BAD;SAMM50;CHCHD6;RCC1L;CHCHD3;TIMM50
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3087420748195825,0.7411909047314108,0.8152173913043478,0.9356358242680632,1.0,4/19,13.07%,HIPK1;HIPK2;SIRT1;DYRK2
prerank,muscle tissue morphogenesis (GO:0060415),0.3283241257814397,0.7411464558287325,0.7870879120879121,0.9353369331877374,1.0,2/16,12.21%,NOTCH1;MYLK
prerank,atrial septum morphogenesis (GO:0060413),0.3537405316638246,0.7408204926961802,0.7807407407407407,0.9354111974530092,1.0,2/10,9.45%,NOTCH2;BMPR2
prerank,alpha-amino acid catabolic process (GO:1901606),0.29142833527349565,0.7407147302327313,0.8257575757575758,0.9351918333204203,1.0,5/29,17.75%,KYNU;PRODH;FAH;BLMH;MTRR
prerank,cochlea morphogenesis (GO:0090103),-0.30097615453477355,-0.7406045218906275,0.803921568627451,0.969011049762363,1.0,3/10,19.43%,PAX2;HPN;MYO3B
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3381519947579771,0.7401326925913773,0.8005908419497785,0.9355762503010944,1.0,3/13,9.30%,TBC1D10A;NLRC4;CYFIP2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.2768904480700666,0.7396848748679341,0.816747572815534,0.9358012855549174,1.0,9/38,17.26%,NEDD9;NCK2;RAP2B;APP;GAS6;SHC1;PTPN1;ACE;SH3BP5
prerank,regulation of astrocyte differentiation (GO:0048710),0.3474923929124424,0.7393815180396077,0.7953846153846154,0.9358147538330578,1.0,2/12,2.99%,ID2;IL6
prerank,positive regulation of double-strand break repair (GO:2000781),-0.2087855335567266,-0.7392482861745968,0.9053254437869822,0.9693464929599318,1.0,12/39,20.44%,FMN2;SPIRE1;WAS;FUS;KMT5C;PARP1;SMCHD1;KDM4D;ZCWPW1;TIMELESS;RAD51AP1;SETMAR
prerank,autophagosome assembly (GO:0000045),0.26654960496731994,0.7391326431228648,0.851894374282434,0.9357541534923807,1.0,10/52,15.10%,ATG7;RAB7A;AMBRA1;VMP1;RAB1B;ATG5;PACS2;RAB43;ATG13;UBQLN2
prerank,purine ribonucleotide metabolic process (GO:0009150),0.25404961966781875,0.7385720523447603,0.8639910813823858,0.9360939847808284,1.0,17/68,23.92%,BAAT;ENPP1;AMPD3;ACSM3;GLYAT;NT5C2;ACOT9;BPNT2;ADSS1;ACOT2;ACOT6;PDE9A;EPHA2;HPRT1;ACOT13;GNAI3;ACOT8
prerank,regulation of gene silencing by RNA (GO:0060966),0.2668670423411161,0.7382322439662563,0.8452380952380952,0.9358019095464505,1.0,15/50,23.05%,POLR2A;AGO2;POLR2L;TPR;POLR2G;NUP50;POLR2I;PUM2;NUP98;NUP88;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2668670423411161,0.7382322439662563,0.8452380952380952,0.9358019095464505,1.0,15/50,23.05%,POLR2A;AGO2;POLR2L;TPR;POLR2G;NUP50;POLR2I;PUM2;NUP98;NUP88;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,interstrand cross-link repair (GO:0036297),0.2603206093816874,0.7379973040311744,0.8331402085747392,0.9357383075231436,1.0,9/53,16.03%,MUS81;MCM9;RPS27A;UBC;EME1;DCLRE1B;ERCC6L2;CENPX;FANCA
prerank,C-terminal protein amino acid modification (GO:0018410),0.3471903850157584,0.737809703609715,0.7608346709470305,0.9356089605600373,1.0,5/11,21.36%,ATG7;ATG5;GPLD1;ICMT;TTL
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3188957381557591,0.7374093188141697,0.810966810966811,0.9357512933226697,1.0,1/17,3.06%,CD46
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.220326412759031,-0.7372063581565063,0.8949771689497716,0.9706075992066289,1.0,13/29,36.31%,FANCD2;ZCWPW1;IHO1;TERB1;STAG3;TRIP13;PRDM9;SYCE2;TEX11;REC8;MAJIN;HORMAD1;BAG6
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.267743674497142,0.73664757929812,0.8435294117647059,0.9363262654325072,1.0,7/46,11.35%,TNIP1;PTEN;DUSP3;FLCN;CNKSR3;SIRPA;FBLN1
prerank,cellular response to nitrogen compound (GO:1901699),0.30815725253272414,0.7365106981072838,0.8029689608636977,0.9361500674191527,1.0,6/20,22.95%,NR1H4;EPG5;NSMCE3;DDI2;RTF2;SPIDR
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3145955326521412,0.736155598825758,0.8102710413694721,0.9362468252182882,1.0,1/17,2.82%,NR1H3
prerank,fatty acid elongation (GO:0030497),0.3373064605080517,0.7354326994357409,0.8209606986899564,0.9367977900466401,1.0,3/13,11.45%,ABCD1;HACD4;ELOVL1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.2771240130487714,-0.7352972155874744,0.8327974276527331,0.9717452700067559,1.0,5/13,19.18%,NR3C2;PLPP1;PGR;AR;ABHD2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.28021509252762683,0.7345851315336313,0.8423028785982478,0.937508594525023,1.0,8/33,24.56%,ID2;RIPK1;FES;HCLS1;ACIN1;TRAF6;HAX1;CASP8
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.24631052061981992,0.7345718412986811,0.8998935037273695,0.9371778168064517,1.0,26/104,22.71%,CDKN1A;UVRAG;SLC8A1;GADD45A;PPEF2;INCENP;SLC27A1;RB1;SIRT1;CDK7;CCNA2;CNPPD1;LRP6;SNF8;MNAT1;CAMK1;CDC25A;HTT;CCNG1;PPP2CA;CALM2;CAB39;KSR1;GTPBP4;CCNT1;SYAP1
prerank,regulation of interleukin-2 production (GO:0032663),0.2693324562051765,0.7345547245756419,0.8510131108462455,0.9368526880604117,1.0,4/43,4.61%,ANXA1;FOXP3;CD28;HOMER3
prerank,bicarbonate transport (GO:0015701),0.294014893043262,0.7337019375458913,0.8013245033112583,0.9375592049391663,1.0,5/25,18.39%,AQP1;CYB5R4;CA2;CYB5R2;CYB5R1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.34820890631827955,0.7336289588603541,0.7984126984126985,0.937300494784017,1.0,3/10,22.16%,NUFIP1;SHQ1;RUVBL2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.29189904496877594,0.7325264533372263,0.8333333333333334,0.9382899926770956,1.0,6/30,15.05%,TFAP2B;FOLR1;XIAP;FSTL1;ITGA3;LATS1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.22542846525799948,-0.7324979147222717,0.8893617021276595,0.9738432457605648,1.0,6/24,19.88%,NUMB;ITGB1BP1;GDI1;PPP2R5A;DAB2;ABI3
prerank,positive regulation of cellular senescence (GO:2000774),0.35053597921965496,0.7320363714954081,0.7968,0.9385536482578553,1.0,2/10,10.68%,ARG2;SIRT1
prerank,regulation of dopamine secretion (GO:0014059),0.2940310344416963,0.7314463011610336,0.8200782268578879,0.9389018382988538,1.0,4/25,14.13%,DTNBP1;SYT17;PRKN;GDNF
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.22193917990712253,-0.7298810222029308,0.8848167539267016,0.9755664662478388,1.0,4/30,12.60%,CSF1R;FLT3;PLD4;UFL1
prerank,amino acid import (GO:0043090),0.30202918012691155,0.7298506970291584,0.8106666666666666,0.9404628949250522,1.0,1/21,0.70%,SLC6A6
prerank,regulation of proteolysis (GO:0030162),0.2607125489288848,0.7297938177302762,0.8574793875147232,0.9401858820393494,1.0,14/48,24.56%,CLN3;FGFR4;TBC1D10A;CYFIP2;STUB1;TRAF3;PARL;AURKAIP1;OGT;SPOP;GSAP;PLAUR;DNAJC1;CASP8
prerank,ruffle organization (GO:0031529),0.327249206663602,0.7294818003874086,0.7982456140350878,0.9402160743707165,1.0,2/16,9.38%,LIMA1;PLEKHA1
prerank,peripheral nervous system development (GO:0007422),0.2997070011253168,0.7293864223758502,0.8269754768392371,0.9399839692421752,1.0,7/23,26.32%,ARTN;ALDH3A2;PMP22;GDNF;SOX8;EGR2;ADGRG6
prerank,catecholamine biosynthetic process (GO:0042423),-0.294866926086552,-0.7293765772044596,0.8093841642228738,0.9746984855564754,1.0,4/11,36.23%,TGFB2;MOXD1;GATA3;DAO
prerank,double-strand break repair via break-induced replication (GO:0000727),0.3344505082415288,0.7293562630744789,0.8199121522693997,0.9396716920414646,1.0,1/12,3.34%,MUS81
prerank,regulation of dephosphorylation (GO:0035303),0.326431548443321,0.7289375517684424,0.818705035971223,0.9398238590910388,1.0,1/15,1.34%,MTMR3
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2723614458887065,-0.7288725241136541,0.8202614379084967,0.9738674545697958,1.0,4/14,13.32%,FAM98B;DDX1;TSEN34;RTRAF
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.2623218470722421,0.7281522345392721,0.8722415795586528,0.9404107580734244,1.0,14/48,23.18%,NEDD9;DOCK5;TRIOBP;RREB1;CUX1;OLFM4;DOCK1;NRP1;CAPRIN1;C1QBP;CDKL5;PRKDC;ILK;FLNA
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.2851438925944706,-0.7278971021289538,0.8211920529801324,0.9736511577182629,1.0,5/13,17.28%,FUT9;ETS1;ITGB2;RHOA;TNF
prerank,regulation of spindle organization (GO:0090224),0.3104873957423834,0.7277910562423433,0.8038147138964578,0.940474218445654,1.0,2/18,6.69%,DYNC1H1;PARP3
prerank,hemopoiesis (GO:0030097),0.24582680453832242,0.7270736799849649,0.9004376367614879,0.9410067005780376,1.0,25/87,22.24%,RUNX2;ZNF160;RUNX3;NOTCH2;MELK;FLCN;ATF4;ZFP36L2;ETV6;HIPK1;TET2;ARIH2;RRAS;PRRC2C;TEK;NCOA6;GLRX5;CDK13;KMT2A;MKNK2;ZBTB16;PTPRC;CEBPA;SNRK;TIRAP
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.2953134506196458,0.7270106301859849,0.8315508021390374,0.9407283898864751,1.0,1/24,0.48%,APLNR
prerank,nucleosome assembly (GO:0006334),0.2760911122786508,0.7265388822253844,0.8520408163265306,0.9409558291026933,1.0,4/31,8.44%,ANP32B;BRD2;SOX9;NASP
prerank,regulation of transmembrane transport (GO:0034762),0.2828883592418728,0.7263523665491943,0.843236409608091,0.9408192280441393,1.0,5/31,12.38%,PIM1;NEDD4L;WWP2;PRKCB;SLC2A1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.2731825840440162,-0.7263337905724988,0.8144329896907216,0.9740165468620011,1.0,8/14,27.34%,ENTPD5;NUDT5;ENTPD6;ENTPD7;NUDT16;NUDT1;ENTPD3;NUDT18
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2709611361540425,0.726240491923,0.8492159227985525,0.9406168034146911,1.0,9/42,20.10%,ERCC6;SIRT6;HELB;PPP4R2;RTEL1;ARID2;SHLD1;RADX;SHLD2
prerank,retinoic acid metabolic process (GO:0042573),-0.2713114857200497,-0.7261868907458605,0.8235294117647058,0.9727639797236638,1.0,9/14,43.90%,BCO2;CYP26B1;CYP26C1;ALDH1A3;ALDH8A1;CYP2S1;UGT1A7;UGT1A8;UGT1A1
prerank,heterochromatin organization (GO:0070828),0.31936097120386,0.7251261377678333,0.8237082066869301,0.9415482462026291,1.0,5/14,27.63%,SETD7;SIRT1;PRDM16;POLE3;HP1BP3
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.26980907500104073,0.7243877973593525,0.8495684340320592,0.9420642096634231,1.0,14/41,23.05%,PRKAG2;EIF6;TPR;NUP50;NUP98;ZBTB7A;NUP88;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,tight junction assembly (GO:0120192),0.2626116886721625,0.7242927016714126,0.8591549295774648,0.9418297716109051,1.0,9/49,20.37%,MICALL2;APC;PDCD6IP;STRN;PAK2;PARD6A;RAB13;ACTG1;FRMPD2
prerank,regulation of microtubule-based process (GO:0032886),0.2753856062526627,0.7241468541864976,0.849009900990099,0.941653680060885,1.0,7/36,13.70%,DIAPH1;APC;ROCK1;GSK3B;CDK2AP2;MACF1;CLASP1
prerank,DNA recombination (GO:0006310),-0.2130703496884408,-0.7241018477998359,0.9470899470899471,0.9739637664234397,1.0,18/37,33.39%,RHNO1;FBH1;RAD50;MSH3;RECQL;GEN1;RAD54B;RAD54L;RPA1;TSN;SUPV3L1;RAD51;HMGB3;LIG4;EXO1;ENDOG;DMC1;XRCC3
prerank,positive regulation of heart contraction (GO:0045823),0.3020910923763722,0.7240713389458904,0.830110497237569,0.9414054122031138,1.0,1/19,1.52%,ADRA1A
prerank,cristae formation (GO:0042407),-0.22380280765994462,-0.7238127111284262,0.8968609865470852,0.9728776396290487,1.0,12/27,26.37%,ATP5PO;DMAC2L;ATP5F1E;SAMM50;ATP5PF;ATP5MC3;CHCHD6;CHCHD3;ATP5ME;UQCC3;ATP5F1B;ATP5MG
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.34498677246711856,0.7233120842351506,0.802130898021309,0.9419504947642756,1.0,1/11,3.04%,TIMM22
prerank,positive regulation of cilium assembly (GO:0045724),-0.2545080971193691,-0.7226485470265519,0.8631578947368421,0.972741682666212,1.0,5/18,21.25%,ENTR1;MARK4;TAPT1;CEP135;KCTD17
prerank,ephrin receptor signaling pathway (GO:0048013),0.2446527097503126,0.7221167620992052,0.9061488673139159,0.9430150911349364,1.0,21/82,24.14%,SDCBP;VAV3;NCK2;ARPC2;ANKS1B;ACTR3;ROCK1;AP2B1;WASL;NCSTN;ARPC1A;ITSN1;ARPC4;ACTG1;EPHA2;EPHA4;APH1B;ARPC5;PSEN2;HRAS;AP2S1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.32874011133451125,0.7218707826170323,0.7879656160458453,0.9429542312545623,1.0,1/13,3.23%,NIBAN2
prerank,regulation of axon regeneration (GO:0048679),-0.2883661492597076,-0.7217263933706599,0.8359133126934984,0.9724086457299641,1.0,1/12,0.30%,RTN4RL1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.25716862317843625,0.7216768266704117,0.8587962962962963,0.9428361149540797,1.0,8/56,10.10%,BIN3;SNX9;APC;INCENP;PDCD6IP;VPS4A;SNX33;ROCK1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.24273829441984193,-0.7215980067589013,0.8714859437751004,0.9711089220125154,1.0,11/21,38.31%,BMPR1A;TGFBR1;DAB2;SMAD4;TGFB1;FAM89B;BMP4;TGFB3;SH2B1;NUP93;VEPH1
prerank,dicarboxylic acid transport (GO:0006835),0.28791942101132484,0.7213555927998169,0.8453738910012675,0.9428651051873522,1.0,4/28,8.86%,SLC26A1;FOLR2;FOLR1;SLC25A32
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.33902039107694526,0.7204536391535298,0.7984496124031008,0.943563623535606,1.0,2/11,15.74%,NCBP2;CDC73
prerank,tRNA processing (GO:0008033),0.2543358564350063,0.7204350477260406,0.8804960541149943,0.9432427907636975,1.0,5/61,4.21%,DTWD1;FARS2;CPSF1;LCMT2;TRDMT1
prerank,presynaptic endocytosis (GO:0140238),0.2904995295679869,0.7200042669089932,0.8262032085561497,0.9434146408991568,1.0,7/24,20.18%,CEL;SNCG;STON1;NLGN2;FCHO2;SYNJ2;VAMP2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.30409851096064333,0.7199319612315307,0.8300561797752809,0.9431528207092807,1.0,4/19,17.60%,VEGFA;ROCK1;NRP1;TEK
prerank,antibacterial humoral response (GO:0019731),0.3141336633517286,0.7193549251374576,0.8415841584158416,0.9434850474104759,1.0,3/16,18.02%,RNASE3;SLPI;DEFA6
prerank,nucleosome organization (GO:0034728),0.25546497964666526,0.7189565350818106,0.8758782201405152,0.9436036559279827,1.0,17/55,25.16%,ANP32B;BRD2;SOX9;ZNHIT1;NASP;VPS72;ARID2;SMARCC1;SMARCD1;INO80;SMARCB1;DMAP1;KAT6B;POLE3;SMARCE1;ANP32E;SMARCD2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2597288484273879,0.7183066939477967,0.8788235294117647,0.9439948894853517,1.0,5/47,10.61%,RAP2A;TAOK3;FAS;COPS5;FOXO1
prerank,regulation of catabolic process (GO:0009894),-0.24836948353728455,-0.7182088853034398,0.8771331058020477,0.9735423896507658,1.0,5/18,17.71%,HPGD;CENATAC;CHEK2;ODC1;FAP
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.2914869798161666,-0.7182001574790048,0.8376811594202899,0.972123730220711,1.0,2/11,9.15%,IL6ST;STAT1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.27511238014699413,-0.7176892330317027,0.8429003021148036,0.971290401334426,1.0,8/12,37.86%,PRKCA;VRK1;CNEP1R1;CDK1;CCNB2;LPIN1;PLK1;CCNB1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3189100644615588,0.717522928903317,0.8344923504867872,0.9445689722310844,1.0,1/16,2.52%,VIM
prerank,body fluid secretion (GO:0007589),0.3195041163466418,0.7171836120286591,0.8081805359661495,0.9446246317850707,1.0,1/15,1.73%,VEGFA
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3228543688555992,0.716383719431828,0.8398268398268398,0.9451980601665078,1.0,6/14,23.08%,STAT5B;JAK3;PTPN1;STAT6;STAT3;JAK2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.30299681225853814,-0.7157668647666858,0.8259668508287292,0.9721537156800254,1.0,2/10,12.42%,UPP2;NT5C
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.25382572434762973,0.7155190515127581,0.8689095127610209,0.9455304403422548,1.0,14/51,21.74%,REEP4;LMNA;CHMP2A;VPS4A;PPP2R2A;CHMP6;NUP98;CHMP7;PPP2CA;PPP2R1A;NUP188;CHMP2B;NDC1;NUP43
prerank,mitotic nuclear membrane organization (GO:0101024),0.25382572434762973,0.7155190515127581,0.8689095127610209,0.9455304403422548,1.0,14/51,21.74%,REEP4;LMNA;CHMP2A;VPS4A;PPP2R2A;CHMP6;NUP98;CHMP7;PPP2CA;PPP2R1A;NUP188;CHMP2B;NDC1;NUP43
prerank,cilium assembly (GO:0060271),0.2265205792712181,0.7153488423796525,0.9649298597194389,0.9453842417099337,1.0,64/296,21.51%,MAK;RILPL2;RAB8B;PIBF1;SNX10;CFAP70;DYNC1H1;SNAP29;CCDC40;ATP6V0D1;KIF27;HAUS6;ASAP1;DNAAF3;ABCC4;WDPCP;CFAP20;FBF1;KIF3A;ACTR3;DYNC2I2;DYNLRB1;CCDC66;IFT46;TRIP11;TOGARAM1;CEP76;TNPO1;CFAP410;NOTCH1;CPLANE2;IFT52;TUBA1A;CLASP1;OCRL;CEP192;IFT140;SSX2IP;ARL3;ALMS1;NDE1;EXOC4;OFD1;CCP110;SSNA1;VANGL2;HAUS7;ARF4;EXOC7;EXOC1;PAFAH1B1;BBS7;ARL13B;TMEM231;RAB1A;CDC14B;BBS1;IFT88;TCTN1;PPP2R1A;HAUS5;RPGR;CEP41;CCDC57
prerank,mRNA destabilization (GO:0061157),0.2703786096082801,0.7152121137286742,0.8455790784557908,0.945188763088773,1.0,5/38,10.44%,CELF1;YTHDF3;ZFP36L2;ROCK1;FTO
prerank,negative regulation of DNA replication (GO:0008156),0.3294389558013944,0.7149684384796281,0.8325859491778774,0.9451149525381733,1.0,7/13,29.75%,TERF1;PDS5A;GTPBP4;CDAN1;WAPL;S100A11;RAD17
prerank,primary neural tube formation (GO:0014020),0.27229100072023715,0.7143705833192076,0.8600252206809584,0.945446255451748,1.0,12/30,29.07%,DLC1;MTHFD1L;PHACTR4;CELSR1;LRP6;VANGL2;LRP2;BCL10;PLXNB2;SKI;DEAF1;MTHFR
prerank,establishment of apical/basal cell polarity (GO:0035089),0.32241705249164465,0.7142168501210922,0.8402877697841726,0.9452756358781534,1.0,2/14,7.65%,RAP2A;MSN
prerank,negative regulation of metabolic process (GO:0009892),0.253461211997767,0.7142153305615065,0.8708189158016147,0.9449302631197157,1.0,16/54,22.70%,NR1H3;FLCN;ATF4;RB1;DDIT3;ADAM17;NOTCH1;IL15;PLCL2;LAMA4;LNPEP;RHEB;ARRDC3;NR1H2;TLE3;ACOT13
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.30619414959511915,0.7142049521348638,0.8312056737588652,0.9445942447120956,1.0,6/16,28.63%,ZFP36L2;ZC3H12D;PLEKHN1;ZFP36;RC3H1;ZFP36L1
prerank,protein K63-linked deubiquitination (GO:0070536),0.27622698762688663,0.714147813276737,0.8324742268041238,0.9443107840683125,1.0,9/31,19.31%,BABAM2;PSMD14;USP16;TNFAIP3;BRCC3;USP8;OTUD5;ATXN3;STAMBP
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.3157833203895594,0.7126910096456709,0.8441926345609065,0.94562282074352,1.0,4/16,15.65%,DDX5;NCOA4;ESR1;PPARGC1B
prerank,chromosome organization (GO:0051276),0.2398278646212441,0.7125867176739549,0.9163043478260869,0.9453986609274456,1.0,25/99,22.76%,GPS1;DOT1L;RPS27A;UBC;COPS5;SETD7;DDB1;SIRT1;CUL4A;COPS7A;SOX2;LATS1;BRWD1;CDT1;ZBTB7A;HDAC8;TCF7L2;PHF1;CUL4B;SAFB;XPC;CDAN1;HMG20A;MTF2;SUPT4H1
prerank,L-serine metabolic process (GO:0006563),0.34993483429945915,0.712210309573214,0.8115501519756839,0.9454912175835005,1.0,1/10,2.26%,PHGDH
prerank,toxin transport (GO:1901998),0.3457737847067829,0.7114580352550616,0.8123076923076923,0.945983794032926,1.0,3/10,21.26%,ANTXR2;RAB29;ADAM10
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.2951068066524117,0.7114572323847203,0.8265582655826558,0.9452926610522402,1.0,3/20,11.57%,IGF1;ZBTB20;APP
prerank,positive regulation of glycolytic process (GO:0045821),0.2951068066524117,0.7114572323847203,0.8265582655826558,0.9452926610522402,1.0,3/20,11.57%,IGF1;ZBTB20;APP
prerank,regulation of neuron projection arborization (GO:0150011),-0.2531229047118163,-0.7111558935950818,0.8422818791946308,0.9759908902592224,1.0,2/15,5.74%,NTNG1;MAP3K13
prerank,Rho protein signal transduction (GO:0007266),0.25362923296059015,0.7107196513390427,0.8823529411764706,0.9457862820138523,1.0,9/53,14.50%,RHOJ;MYO9B;GNA13;GNA12;ROCK1;CFL1;RHOD;PHACTR4;CELSR1
prerank,limb development (GO:0060173),0.2839979305715767,0.7105525183940861,0.8774193548387097,0.9456192480077233,1.0,2/28,5.24%,MAP3K20;ZNRF3
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.29286215634345636,-0.7105475757854892,0.8306709265175719,0.9724170874943726,1.0,2/11,5.56%,PANK3;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),-0.29286215634345636,-0.7105475757854892,0.8306709265175719,0.9724170874943726,1.0,2/11,5.56%,PANK3;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.29286215634345636,-0.7105475757854892,0.8306709265175719,0.9724170874943726,1.0,2/11,5.56%,PANK3;ACOT7
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2718482649293275,0.7099067000194584,0.8592411260709915,0.9459835519288878,1.0,7/31,23.05%,MOCOS;LIAS;DHRS11;NFS1;GCH1;SRD5A1;SCP2
prerank,RNA modification (GO:0009451),0.25490388086302185,0.7096040741308569,0.9031505250875146,0.9459710400883355,1.0,11/54,16.93%,DTWD1;LCMT2;TRDMT1;NSUN3;NAT10;CTU2;MEPCE;MRM2;TSR3;ADARB1;ALKBH1
prerank,mitochondrion localization (GO:0051646),0.299659057798129,0.7094649487514101,0.8367911479944675,0.9457841117534632,1.0,1/19,0.93%,MTM1
prerank,establishment of endothelial barrier (GO:0061028),0.2773947372520517,0.7093308571041783,0.8453865336658354,0.9455833558600543,1.0,9/29,24.89%,MSN;RAB1B;RAP2B;RAPGEF1;RAB1A;PDE4D;EZR;AFDN;RAP2C
prerank,protein localization to cilium (GO:0061512),0.27101572435714905,0.7086741911146105,0.849936948297604,0.9459535546243897,1.0,7/32,20.34%,SNX10;RABEP1;IFT140;ARL3;RAB29;BBS1;TCTN1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.25343458811792596,-0.70831728132467,0.88,0.9735508569344776,1.0,6/17,22.12%,VIRMA;RNF20;CDK9;CPEB3;NUDT21;HSF1
prerank,regulation of plasminogen activation (GO:0010755),0.331700355561126,0.7083067680384895,0.8803030303030303,0.9460082013833222,1.0,3/12,16.40%,THBS1;CTSZ;MELTF
prerank,chromatin assembly or disassembly (GO:0006333),0.33496387076656975,0.7078258003569569,0.8343558282208589,0.9461785454116266,1.0,4/11,21.71%,SUV39H2;NOC2L;HDAC8;CDAN1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3056780983101451,0.7076659714850135,0.8215767634854771,0.9460160009785101,1.0,2/17,7.89%,VEZF1;SOX9
prerank,regulation of cell killing (GO:0031341),0.3072189772599487,0.7071551792316311,0.8527245949926362,0.946218239132716,1.0,2/16,9.80%,CYBA;FZD7
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.2874991589522039,0.7064843218383283,0.842985842985843,0.9466266968115955,1.0,6/23,18.11%,HOOK3;TUBA1A;TUBA1C;CCDC88C;KIF5B;KIF5C
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.2341975379680849,-0.7051118679025667,0.9288537549407114,0.9741482412825608,1.0,9/21,24.57%,GTF2H2;DDB2;PARP1;ERCC5;XPA;RPA3;GTF2H4;RPA1;ERCC2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.2341975379680849,-0.7051118679025667,0.9288537549407114,0.9741482412825608,1.0,9/21,24.57%,GTF2H2;DDB2;PARP1;ERCC5;XPA;RPA3;GTF2H4;RPA1;ERCC2
prerank,SNARE complex assembly (GO:0035493),0.338380382359716,0.7050536995154403,0.832258064516129,0.9478788461273966,1.0,3/10,20.18%,UVRAG;VAMP3;VAMP2
prerank,regulation of cellular senescence (GO:2000772),-0.21474389102699035,-0.7048099083789909,0.9103139013452914,0.9730726267343192,1.0,8/28,20.94%,NUAK1;AKT3;YPEL3;CGAS;RBL1;VASH1;ABI3;NEK4
prerank,autophagy of nucleus (GO:0044804),0.3061753256948688,0.7040368662645298,0.841225626740947,0.9486706120787324,1.0,3/16,13.07%,ATG7;ATG5;ATG13
prerank,cytoplasmic translational initiation (GO:0002183),0.30033980895938706,0.7034987422313588,0.8288159771754636,0.9489148494774516,1.0,3/17,9.73%,EIF3A;EIF5;EIF4A1
prerank,regulation of endopeptidase activity (GO:0052548),0.24972257441770293,0.7034699318497097,0.8972286374133949,0.9486038830981686,1.0,13/59,22.96%,TIMP1;TIMP2;PICALM;BIRC3;SERPINB8;SERPINC1;PSME2;NCSTN;BIRC2;PSMA3;APH1B;FURIN;PSME3
prerank,GTP metabolic process (GO:0046039),-0.2502073212188819,-0.7033564158185915,0.8733333333333333,0.9732302003794211,1.0,7/15,32.44%,GTPBP1;RAB23;MFN1;ENTPD7;EFL1;IMPDH1;AK4
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.263818859867677,0.7029160004129789,0.8753026634382567,0.9488848050597964,1.0,4/39,6.44%,ZMIZ1;MAML1;MAML2;CREBBP
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3467783199894322,0.7026979059488978,0.8356164383561644,0.9484363591608497,1.0,4/10,19.05%,PRKCD;SPHK2;SIRT3;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3467783199894322,0.7026979059488978,0.8356164383561644,0.9484363591608497,1.0,4/10,19.05%,PRKCD;SPHK2;SIRT3;NSMAF
prerank,positive regulation of ion transport (GO:0043270),0.2550849209297496,0.702656038188961,0.8777648428405123,0.9481399114504134,1.0,9/48,14.13%,ANO6;ATP2B1;P2RX4;GPD1L;CNKSR3;MYLK;CRACR2A;PRSS8;GDNF
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.27724830157410923,0.7026387900214738,0.881979695431472,0.9478162783854752,1.0,11/29,30.16%,CTNNB1;CREBBP;CDC73;TCF7L2;TLE3;MEN1;HDAC1;KMT2D;SMARCA4;EP300;TLE4
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.21034861085656195,-0.7015697243757286,0.9402985074626866,0.9737110261577794,1.0,8/28,25.95%,TNFRSF1A;BCL2;DAB2IP;DEDD;TNF;DIABLO;DELE1;DDX3X
prerank,positive regulation of hormone secretion (GO:0046887),0.2979061487639721,0.7013955418513712,0.8482758620689655,0.9488260191047742,1.0,1/17,2.67%,SPP1
prerank,tRNA modification (GO:0006400),0.2468954399928317,0.7004945436045619,0.8990825688073395,0.9494456952297142,1.0,11/62,16.93%,TRMT12;DTWD1;LCMT2;TRDMT1;OSGEP;TRMT44;CTU2;DUS2;GTPBP3;ALKBH8;ALKBH1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3334907650362062,0.7003070928321865,0.8445440956651719,0.9492989136966523,1.0,1/11,3.00%,HGF
prerank,regulation of immunoglobulin production (GO:0002637),0.28826532509597874,0.6998120725657986,0.8554216867469879,0.9495041822334167,1.0,5/23,21.13%,IL6;CD22;VAMP3;FCGR2B;PTPRC
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3265624441345275,0.6997468275540593,0.810477657935285,0.9488805557871672,1.0,4/11,22.37%,SRI;CALM2;GSTO1;FKBP1A
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3265624441345275,0.6997468275540593,0.810477657935285,0.9488805557871672,1.0,4/11,22.37%,SRI;CALM2;GSTO1;FKBP1A
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.32502050826618056,0.6995445190171907,0.8228228228228228,0.9487375611867852,1.0,5/11,24.89%,RAB1B;RAP2B;RAB1A;AFDN;RAP2C
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.30569464832911436,0.6990055240458037,0.849507735583685,0.9489816591500091,1.0,4/18,16.40%,IL6;RB1;CLASP1;MELTF
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.2880218734435739,0.6988335078075377,0.8518024032042724,0.9488293782498594,1.0,6/23,20.72%,PRKAG2;UBE2K;APP;CALM2;CAB39;TNKS1BP1
prerank,protein import into peroxisome matrix (GO:0016558),0.32612173055918386,0.6984995905371597,0.8361669242658424,0.9488466264710463,1.0,2/12,6.89%,PEX7;PEX14
prerank,positive regulation of interleukin-12 production (GO:0032735),0.26852740784881124,0.6981554831267085,0.8825031928480205,0.9488578804886227,1.0,1/31,0.68%,SYK
prerank,atrial septum development (GO:0003283),0.31773151697313895,0.6974286410482892,0.8306569343065694,0.9493329163721413,1.0,2/13,9.45%,NOTCH2;BMPR2
prerank,positive regulation of cellular respiration (GO:1901857),0.3350636179079428,0.6970423230644868,0.8330733229329174,0.949408243600734,1.0,3/11,22.26%,IL10RB;IFNAR1;VCP
prerank,maintenance of protein localization in organelle (GO:0072595),0.2974465176177245,0.6963192200524524,0.8698060941828255,0.9498509939336729,1.0,6/19,24.02%,HNRNPU;TOPORS;SUPT7L;BCL3;TAF8;HK1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.250540023905461,0.6959243438821361,0.882903981264637,0.9499100269855869,1.0,15/48,23.05%,PRKAG2;EIF6;TPR;NUP50;NUP98;ZBTB7A;NUP88;PRDM16;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,sensory perception of sound (GO:0007605),0.23583379244278085,0.6954587005385491,0.9163916391639164,0.9500537299859937,1.0,9/88,12.00%,EYA1;LOXHD1;COL1A1;NIPBL;SNAI2;WDR1;COL11A1;LHFPL3;ROR1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.2651877545663839,-0.6950539290241429,0.8597014925373134,0.9791374483654914,1.0,7/12,38.26%,PLCB1;NBL1;BMP5;GREM1;DUSP1;SLIT2;ADTRP
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.34372035264127254,0.6949537703502361,0.8335809806835067,0.9499194322534998,1.0,1/10,4.33%,NCOR1
prerank,negative regulation of glycolytic process (GO:0045820),0.34372035264127254,0.6949537703502361,0.8335809806835067,0.9499194322534998,1.0,1/10,4.33%,NCOR1
prerank,negative regulation of transferase activity (GO:0051348),0.2716519133295237,0.6941835934647207,0.879746835443038,0.9503589632413177,1.0,13/28,29.85%,IRS2;HNRNPU;TERF1;GSK3B;NPRL2;FBXO5;CERS1;ERCC4;MEN1;ZFP36;SRC;TP53;GSK3A
prerank,sensory perception of pain (GO:0019233),0.2852222659819769,0.6934044987549866,0.8418156808803301,0.9508618996341678,1.0,7/21,29.86%,P2RX4;KCNK4;RETREG1;OPRK1;CCL2;PTGES;KCNA2
prerank,extracellular matrix assembly (GO:0085029),0.28530963757609673,0.6930920193775987,0.8461538461538461,0.9508545063569828,1.0,5/23,15.22%,HAS3;QSOX1;MFAP4;GAS6;ATP7A
prerank,secondary alcohol biosynthetic process (GO:1902653),0.269174917238192,0.6930183873771918,0.8699494949494949,0.9505797520483732,1.0,8/30,20.66%,MVD;PLPP6;IDI1;INSIG2;PMVK;ACAA2;HMGCR;ARV1
prerank,regulation of nervous system development (GO:0051960),0.2614519331706847,0.6926512764049629,0.8801498127340824,0.950635746913929,1.0,3/37,6.45%,CTNNB1;TNFRSF1B;BHLHE40
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.31469928922574486,0.6922682569897608,0.8382789317507419,0.9506742123690919,1.0,2/13,9.50%,PCID2;TPR
prerank,cellular response to catecholamine stimulus (GO:0071870),0.2801091221591311,0.69185105976881,0.8811748998664887,0.9507691902734207,1.0,4/23,17.71%,TGM2;ATF4;PRKN;GABPA
prerank,negative regulation of peptidase activity (GO:0010466),0.2540997659639356,0.6918421698228023,0.8814553990610329,0.9504387140308039,1.0,5/47,14.45%,TIMP1;LRP1;TIMP2;SERPINB8;SERPINC1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3216577063806172,0.6916853049687754,0.8264094955489614,0.9502519543736035,1.0,2/12,15.34%,KDELR2;INSIG2
prerank,regulation of cilium movement (GO:0003352),0.3316438307342461,0.6915296590157111,0.8442367601246106,0.9500630995386934,1.0,1/10,3.80%,CCDC40
prerank,regulation of lipid catabolic process (GO:0050994),-0.23548725673867932,-0.691296804615177,0.9144981412639405,0.9814633741255674,1.0,6/19,23.82%,PDE3B;APOC1;TNF;ANGPTL3;IL1B;ADRA2A
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3292220452519281,0.6907209555312454,0.8378378378378378,0.9505585727477942,1.0,5/11,27.60%,TERF1;DKC1;CCT2;CCT7;WRAP53
prerank,B cell proliferation (GO:0042100),-0.24371032376580942,-0.6902906079923387,0.9190140845070423,0.9810448803824506,1.0,2/17,7.54%,MEF2C;BCL2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.2845110075918716,0.6901536396401176,0.8641304347826086,0.950813454710826,1.0,8/22,24.25%,ATF4;IPPK;PWP1;SMARCB1;UTP15;NCL;WDR43;LYAR
prerank,negative regulation of bone mineralization (GO:0030502),0.31611993899326973,0.6898920233247475,0.86002886002886,0.9507418924166189,1.0,2/13,10.47%,ENPP1;PTK2B
prerank,UV protection (GO:0009650),0.33493706145903557,0.6895587086737368,0.8491446345256609,0.9507531234026995,1.0,2/10,12.85%,CAT;MFAP4
prerank,regulation of peptidase activity (GO:0052547),-0.23279731298253492,-0.6895462963188309,0.9222614840989399,0.9803222796484722,1.0,3/19,12.16%,CST3;CST7;SVBP
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.3214587650221629,0.6890668036421401,0.8491704374057315,0.95091901446965,1.0,1/12,3.12%,DSE
prerank,negative regulation of protein ubiquitination (GO:0031397),0.24965058208760435,0.6887564407255325,0.9066985645933014,0.9509138598228347,1.0,17/50,21.62%,HSPA1B;SIRT7;N4BP1;TNFAIP3;HSPA1A;SQSTM1;ARRB1;PRKCG;CRY1;PRR7;GNL3L;FBXO5;HDAC8;DNAJA1;OGT;TAF1;GTPBP4
prerank,negative regulation of histone methylation (GO:0031061),0.33355561457666694,0.6885228340440327,0.8367346938775511,0.9508327275016232,1.0,4/10,22.43%,BRCA1;DNMT1;PHF1;MTF2
prerank,regulation of T cell mediated immunity (GO:0002709),-0.28596537150285967,-0.6885149169889038,0.8729281767955801,0.9798888397272553,1.0,2/10,4.96%,WAS;TRPM4
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.2691037878274857,-0.6878090108162305,0.8827361563517915,0.9791471330951947,1.0,4/12,20.86%,TRPM4;PLA2G6;C2CD2L;STX4
prerank,nucleoside catabolic process (GO:0009164),0.32520552542710446,0.6878023663755072,0.8492307692307692,0.9512385008347463,1.0,2/11,9.85%,NT5E;DERA
prerank,positive regulation by host of viral transcription (GO:0043923),0.303739193793887,0.6876358361090783,0.83810888252149,0.9510524941431683,1.0,4/15,22.11%,JUN;CTDP1;SMARCB1;CCNT1
prerank,non-motile cilium assembly (GO:1905515),-0.20660551792106002,-0.6853162616457895,0.9482758620689655,0.9800478777684605,1.0,10/30,22.36%,DISC1;RPGRIP1L;CSNK1D;GORAB;IFT57;TMEM216;CEP290;TMEM80;BBS10;TTC8
prerank,dendritic spine organization (GO:0097061),0.2710532068011022,0.6846897365556728,0.8921438082556591,0.9536667653280154,1.0,5/26,15.04%,PTEN;DOCK10;TREM2;ITGA3;WASL
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.30952638874611077,0.6843799561164362,0.8692528735632183,0.9536358387386149,1.0,1/14,1.93%,ERCC6
prerank,cortical actin cytoskeleton organization (GO:0030866),0.2883116267578444,0.684176563046837,0.8489010989010989,0.9535046703701382,1.0,4/20,21.07%,LCP1;ROCK1;RAB13;FMNL2
prerank,regulation of cellular protein localization (GO:1903827),0.2521992306962669,0.6841720048602786,0.8931116389548693,0.9531701810108318,1.0,8/45,13.02%,CTNNB1;LCP1;KCNAB2;ABCA2;DVL1;VCPIP1;CCDC66;RAB11B
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.28650496800550584,0.6841672322487183,0.8584656084656085,0.9528359309143004,1.0,6/21,22.88%,ADCY7;ADCY8;ADCY3;NPR2;ADCY5;ADCY9
prerank,lipid droplet formation (GO:0140042),-0.28719984683265715,-0.6841559695735161,0.8468468468468469,0.9797925021399756,1.0,2/10,11.99%,CDS1;SQLE
prerank,response to light stimulus (GO:0009416),0.24552190943348817,0.683951000664091,0.9049255441008018,0.9526996455110265,1.0,14/55,24.71%,ERCC6;DCT;ZRANB3;MAP4K3;FECH;CRY1;CLOCK;DRD2;POLD1;ERCC4;SPRTN;UBE4B;MEN1;PRIMPOL
prerank,endodermal cell fate commitment (GO:0001711),0.3367237511018887,0.6839456306969881,0.8322981366459627,0.9523639552605543,1.0,2/10,15.74%,SOX2;CDC73
prerank,negative regulation of cell aging (GO:0090344),0.2964532375171775,0.6834708166282617,0.8633802816901408,0.9524960597445686,1.0,7/16,29.64%,SIRT1;ZKSCAN3;FBXO5;CDK6;FOXM1;YBX1;TERF2
prerank,regulation of neurotransmitter secretion (GO:0046928),0.26444195129637776,0.6834365039489322,0.8784810126582279,0.9521898475768429,1.0,5/32,13.04%,DTNBP1;RIMS4;GSK3B;SYN1;MCTP1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.26522773521224274,-0.6831640988693214,0.8901734104046243,0.9793572390323223,1.0,3/12,23.31%,IL18;CCR2;IL1B
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2612860481147792,0.682775323123194,0.8994011976047904,0.9525108749983925,1.0,12/35,25.33%,CD300A;STYXL1;BOD1;GSK3B;HTT;CALM2;PPP6R1;FKBP1A;PPP1R12A;PPP1R15B;PDGFRB;PPP6R3
prerank,positive regulation of interleukin-2 production (GO:0032743),0.2774727294673224,0.6826403091387617,0.8771466314398944,0.9523144457151701,1.0,2/25,3.02%,ANXA1;CD28
prerank,negative regulation of synaptic transmission (GO:0050805),0.27819555934455986,0.6819779029591331,0.8641304347826086,0.9526529015265315,1.0,2/23,4.72%,PLK2;PTEN
prerank,ubiquinone metabolic process (GO:0006743),0.30363674612897185,0.6807926156973196,0.8491620111731844,0.9534751640005333,1.0,2/15,5.95%,COQ7;AIFM2
prerank,positive regulation of cellular component movement (GO:0051272),0.2684502597267231,0.6805523470464564,0.8842105263157894,0.9533817884921131,1.0,3/24,10.29%,VEGFA;CFAP20;ADAM17
prerank,positive regulation of dendritic spine development (GO:0060999),0.2876217962471625,0.6803427116194559,0.8726790450928382,0.9532427985174853,1.0,1/20,0.58%,APOE
prerank,"phagocytosis, engulfment (GO:0006911)",0.25817326858052303,0.6797973060220063,0.8959390862944162,0.9534511806050591,1.0,2/36,5.50%,CD36;THBS1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.2576926481917696,0.6788396910712828,0.9014778325123153,0.9540304922716657,1.0,10/36,18.61%,FAS;RB1;STYXL1;CSNK2A2;TRAF1;MAZ;CX3CL1;SGMS1;CSNK2A1;CRADD
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.2545007513180223,0.6787368251342998,0.9051094890510949,0.953784699254615,1.0,8/39,17.46%,CTNNB1;VEGFA;COL4A1;PAX8;GDNF;LRP6;NRP1;NKX2-1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.26938636799806914,-0.6786148892127004,0.8355795148247979,0.9821419267952123,1.0,6/11,35.96%,NOS1AP;ALG10B;LRRC55;RNF207;AKAP6;KCNIP2
prerank,regulation of chromosome organization (GO:0033044),0.2835406893653528,0.6781510465672174,0.8740053050397878,0.9540132667944645,1.0,8/22,24.33%,RB1;XRCC5;SHCBP1L;HNRNPD;CDT1;HDAC8;WAPL;TERF2IP
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2523954644427322,0.6777523460333447,0.8939213349225268,0.9540383114623691,1.0,12/40,21.14%,PRKCD;POLH;SIRT7;BCLAF1;MCL1;NSMCE4A;SMYD2;CRY1;RADX;UBE2V1;FBXO5;NPAS2
prerank,protein homooligomerization (GO:0051260),0.22195476785907028,0.6776358273403063,0.9447983014861996,0.9538148344470574,1.0,23/114,19.22%,SLC1A5;MICU1;APPL2;GNMT;NINJ1;RNF135;CHMP2A;P2RX3;NLRC4;PDCD6IP;LETM1;ATL2;SSBP1;USP16;ADCY8;ATL1;ALDH1A2;VSTM5;TK1;ALDH9A1;CBR4;CARD11;ALAD
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.2534169937912515,-0.6770340524557141,0.8741935483870967,0.9821504074925673,1.0,11/14,49.02%,ECE1;ENPEP;RASL10B;AVPR2;OXTR;EDN3;EDN2;AVPR1A;ACE2;AGTR1;EDN1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.32234059512046714,0.6764313787976781,0.8716323296354992,0.9546561018061794,1.0,1/10,3.48%,FAS
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.28011206442299186,-0.6760448756226879,0.8885793871866295,0.9816809505542535,1.0,4/10,26.72%,DPP4;WNK1;CCL5;PODXL
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.19899987902130456,-0.6757430226740765,0.9624413145539906,0.9805434396136598,1.0,10/32,31.88%,RPL30;RNASE7;ANG;ROMO1;HMGN2;CAMP;RNASE6;GAPDH;CXCL14;PGLYRP1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3197398710840005,0.6757189239539437,0.8489984591679507,0.9550096677960498,1.0,2/11,10.09%,STAP1;RIN3
prerank,pseudouridine synthesis (GO:0001522),-0.2545276667445644,-0.6756375100548877,0.8872832369942196,0.9792448634044872,1.0,3/13,15.81%,PUS7;GAR1;TRUB2
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2630816720189156,-0.6752993676944332,0.8835820895522388,0.978162856877138,1.0,4/13,13.62%,GET4;PKD2;NFKBIE;PKD1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.23167783434126835,0.6752244162752751,0.9200887902330743,0.9551404487749147,1.0,9/72,12.24%,MUS81;RFC3;ENPP1;GTF2H5;RPS27A;UBC;DDB1;DNASE1L1;CUL4A
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.2564004766114605,-0.6750768541525173,0.8844884488448845,0.9769651034988366,1.0,6/13,23.67%,TPST1;TPST2;SULT1A1;ABHD14B;SULT4A1;BPNT1
prerank,ear morphogenesis (GO:0042471),0.28305118841223814,0.6740692551296885,0.8884239888423989,0.9558904128133894,1.0,3/20,16.91%,NIPBL;PAX8;CHD7
prerank,outer dynein arm assembly (GO:0036158),-0.24589990966401806,-0.6735422558685495,0.8980263157894737,0.9769470964678919,1.0,9/14,39.36%,DNAH8;LRRC49;DNAAF5;ODAD2;ODAD4;DNAL1;ODAD3;DNAH17;DNAAF1
prerank,blood vessel endothelial cell migration (GO:0043534),0.2789577573824261,0.6732224422865836,0.8909825033647375,0.9563367380856165,1.0,4/22,15.95%,VEGFA;MYH9;GPLD1;NRP1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.27913231167635694,0.6732117304079075,0.8715846994535519,0.9560058079079878,1.0,3/20,8.96%,FOXP3;BRCA1;BRD7
prerank,regulation of striated muscle contraction (GO:0006942),0.26517986829118095,0.6730447568411094,0.8835078534031413,0.9558217910946326,1.0,3/27,8.19%,P2RX4;MYL2;MYBPC3
prerank,regulation of adaptive immune response (GO:0002819),0.28701665025752515,0.6729301589108482,0.8756830601092896,0.9555898845895913,1.0,3/18,10.68%,ADCY7;EIF2AK4;SIRT1
prerank,regulation of monocyte differentiation (GO:0045655),-0.24744929440957067,-0.6728028476480055,0.9037800687285223,0.976210845671538,1.0,6/14,20.63%,CSF1;CD74;HOXA7;MYC;CTNNBIP1;IL34
prerank,cotranslational protein targeting to membrane (GO:0006613),0.228882548921202,0.672470557664001,0.9401709401709402,0.9556850038308048,1.0,18/91,17.83%,RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;RPL36A;RPL22;RPS21;SIL1;RPL10A;RPS26;RPL15;RPL10;RPSA;RPL7;RPL26;SEC63
prerank,DNA replication initiation (GO:0006270),0.2516423843282313,0.6723580693775832,0.917189460476788,0.9554525775404007,1.0,15/37,29.15%,DBF4;POLA1;NOC3L;ORC1;ORC4;CDC34;CDT1;CDK2;POLE3;PRIM2;ORC6;MCM3;ORC2;POLE;POLA2
prerank,icosanoid metabolic process (GO:0006690),0.2513440568597946,0.6722319172524565,0.8976857490864799,0.9552371600518517,1.0,4/40,10.37%,MGLL;PON3;GPX4;LTA4H
prerank,stabilization of membrane potential (GO:0030322),0.29399312432928393,0.6722287080717059,0.8595744680851064,0.9549021976919022,1.0,3/16,19.19%,KCNK13;KCNK4;KCNK5
prerank,regulation of membrane repolarization (GO:0060306),-0.25838931040308366,-0.6720803469023149,0.875,0.9754741753339046,1.0,3/13,14.72%,KCNJ2;AKAP9;CACNA2D1
prerank,copper ion homeostasis (GO:0055070),0.2848462768452284,0.6717454076770605,0.8579626972740315,0.955006939538182,1.0,4/17,16.65%,XIAP;APP;ATP7A;SLC31A2
prerank,negative regulation of DNA binding (GO:0043392),0.2672604791008894,0.671693105103699,0.8950777202072538,0.9547136297607896,1.0,2/28,4.97%,JUN;E2F1
prerank,protein methylation (GO:0006479),0.2507193547869842,0.6706167403565553,0.9136868064118372,0.955396470690894,1.0,12/40,24.99%,NSD3;ETFBKMT;N6AMT1;CAMKMT;ETF1;ICMT;METTL22;EHMT2;SNRPB;SETD3;METTL21A;CARM1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.30229941645491176,0.670249868007683,0.8635703918722787,0.9553898056938848,1.0,6/14,28.77%,HNRNPA0;MYD88;TIRAP;ZFP36;MAPK14;HNRNPC
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.29246607358898274,0.6693569668428377,0.8826086956521739,0.9558950711474369,1.0,3/16,11.99%,NT5E;TET2;CRMP1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.32961869368652263,0.6692998231966073,0.8629283489096573,0.9556062453682446,1.0,3/10,14.81%,ATP5F1A;ATP5F1D;ATP5F1C
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.3119993439224542,0.669178868245628,0.865625,0.9553807932173322,1.0,3/11,18.89%,NASP;UBN1;CABIN1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3158095722988159,0.669086039063779,0.8548895899053628,0.9551325044546333,1.0,3/10,19.92%,AIDA;DNAJA1;DUSP10
prerank,regulation of ossification (GO:0030278),0.2532630230542202,0.6677503999844304,0.912883435582822,0.9560122484140805,1.0,6/36,14.56%,ENPP1;SGMS2;SOX9;BMPR2;NOTCH1;LRP6
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3016272047820408,0.6676410461571773,0.8614008941877794,0.9557938220153911,1.0,6/13,26.21%,NOP14;RPS21;RCL1;ABT1;NOP9;RPP40
prerank,positive regulation of cell growth (GO:0030307),0.22465982146418148,0.6675306143119993,0.9547900968783638,0.9555507550796636,1.0,15/96,15.29%,SDCBP;RUFY3;MMP14;ZFYVE27;IGF1;N6AMT1;NEDD4L;EXOSC9;SYT17;ADAM17;MTPN;MACF1;DERL2;INO80;GOLGA4
prerank,nuclear membrane reassembly (GO:0031468),0.23553887911393545,0.6672372844993434,0.9341801385681293,0.9554777157843224,1.0,14/54,21.74%,REEP4;LMNA;CHMP2A;VPS4A;PPP2R2A;CHMP6;NUP98;CHMP7;PPP2CA;PPP2R1A;NUP188;CHMP2B;NDC1;NUP43
prerank,negative regulation by host of viral transcription (GO:0043922),0.3110293805003459,0.6671643399627363,0.8535825545171339,0.9552127050649462,1.0,1/12,3.94%,JUN
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.28025198183262523,0.6663356375528979,0.8885869565217391,0.9556228205430237,1.0,3/20,12.73%,THBS1;SULF2;SULF1
prerank,regulation of chromatin binding (GO:0035561),-0.27212373710443083,-0.6649456313975189,0.8756906077348067,0.9801290598629026,1.0,2/10,12.05%,MED25;KDM4D
prerank,regulation of wound healing (GO:0061041),0.24557737064557708,0.6641417884372836,0.9186893203883495,0.9573044944013257,1.0,5/42,13.66%,ANXA1;PLAU;ITGB1;MYLK;TNFAIP3
prerank,negative regulation of neuron projection development (GO:0010977),0.23552618208214632,0.663522208567188,0.9259259259259259,0.9575261322662114,1.0,11/56,17.92%,APOE;RUFY3;PTEN;GAK;MT3;CRMP1;ITM2C;MCF2;RTN4;RAB29;MYLIP
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.2859825606735617,0.6630412882993256,0.8658367911479945,0.9576006159394759,1.0,3/17,11.96%,NOTCH2;SNAI2;NOTCH1
prerank,intraciliary retrograde transport (GO:0035721),-0.26102060761449125,-0.6621951562825359,0.9023668639053254,0.9808704184285849,1.0,6/12,29.56%,DYNC2H1;IFT43;TTC21B;DYNLT2B;DYNC2LI1;DYNC2I1
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.188492629966782,-0.6614244970056815,0.9666666666666667,0.980169999022799,1.0,11/42,26.30%,SH2B3;CCL4;WNK1;CCR2;CCR1;CIB1;CCL3;CCL14;FOXC1;CCL5;GPR75
prerank,mitotic spindle assembly (GO:0090307),0.24400126730118438,0.6609011485109524,0.9302045728038508,0.9591608793935613,1.0,9/42,17.80%,PIBF1;SMC1A;TOGARAM1;STAG2;CLASP1;CEP192;SMC3;OFD1;ARHGEF10
prerank,regulation of phospholipase C activity (GO:1900274),0.2849794647554579,0.6606223887972545,0.873546511627907,0.9590791144871731,1.0,2/15,9.91%,ABL2;ESR1
prerank,peptidyl-methionine modification (GO:0018206),0.3085969113985613,0.6603848284844758,0.87701317715959,0.9589726909150016,1.0,4/12,22.19%,METAP1D;NAA30;NAA25;NAA15
prerank,positive regulation of mRNA processing (GO:0050685),0.2720405010245208,0.6597983594864417,0.8741450068399452,0.959146118012669,1.0,6/21,19.65%,NCBP2;PRDX6;NUP98;CDC73;THRAP3;NCL
prerank,diacylglycerol metabolic process (GO:0046339),0.2678342564933994,0.659588988923738,0.9041278295605859,0.9589841733931302,1.0,4/23,17.23%,DGKZ;DGKA;DGKQ;DGKG
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.29737287630858245,0.6594977030966083,0.8755622188905547,0.9587326593040212,1.0,2/13,12.31%,PID1;TREM2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.2627817949903291,0.6590564819585684,0.897503285151117,0.9587967362780533,1.0,6/27,13.77%,ARAP1;DLC1;PAK2;PFN1;CLASP1;PRKN
prerank,positive regulation of insulin secretion (GO:0032024),0.2509558165670466,0.6589675555137776,0.9195678271308524,0.9585396591804332,1.0,9/36,20.25%,IRS2;TRH;AACS;GPLD1;ADCY8;NLGN2;BAIAP3;TCF7L2;GCK
prerank,modulation by host of symbiont process (GO:0051851),0.255400241528171,0.6586346988935861,0.921875,0.9584971228087563,1.0,3/31,5.58%,AQP1;JUN;SAP30
prerank,regulation of cellular respiration (GO:0043457),0.2834737311948785,0.6582653453091435,0.8909348441926346,0.9584705698229902,1.0,5/17,24.43%,IL10RB;IFNAR1;PRDM16;VCP;SHMT2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.27024209860901877,0.6578777997171118,0.898236092265943,0.9584483848994182,1.0,7/22,25.25%,MED12;ESR1;MED16;PAXIP1;MED30;PSMC5;MED13
prerank,negative regulation of ATPase activity (GO:0032780),0.288022257826992,0.6578445119397252,0.8838896952104499,0.9581399776539473,1.0,2/16,10.68%,PPIF;SIRT1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.27299590472128316,0.6570034514262523,0.8840970350404312,0.9584884541681373,1.0,7/20,22.81%,TGM2;PACS2;BAX;WFS1;BCAP31;HERPUD1;TMCO1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.24964671447409853,-0.6567657492513493,0.8840125391849529,0.9824942742696664,1.0,4/13,22.99%,HSP90AA1;QDPR;FPGS;SPR
prerank,gonad development (GO:0008406),-0.18342240175737942,-0.6564446263809703,0.9883720930232558,0.9813768128958257,1.0,11/41,25.99%,SALL1;KITLG;BASP1;TGFB2;AR;WNT4;BIK;COL9A3;WNT5A;MKKS;WNT2B
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.23927493629294805,-0.6561085606774556,0.8797250859106529,0.9802550593831001,1.0,10/15,34.39%,PHB2;EZH2;PAF1;NPM1;PLCG2;STXBP4;DDRGK1;DYRK3;CRNN;FAM83D
prerank,neural tube development (GO:0021915),-0.23647319284862375,-0.6535391428643338,0.9047619047619048,0.9808196727181175,1.0,7/15,26.35%,PTCH1;PKD2;PKD1;SOX11;TGFB1;DACT1;STIL
prerank,cGMP biosynthetic process (GO:0006182),-0.2689100033096834,-0.653454366738815,0.8957055214723927,0.9795158685673921,1.0,6/10,40.58%,GUCY1A1;GUCY1B1;NPR1;GUCY2F;GUCY2D;GUCY2C
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.24597134005622717,0.6525488968264072,0.9213349225268176,0.9619878044364895,1.0,7/37,17.51%,BCL2L11;STYXL1;DDIT3;BCLAF1;BAX;BID;BBC3
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.2998457562164351,0.6524812088409927,0.8791848617176128,0.9617114189259723,1.0,2/13,10.25%,ZC3HAV1;CNOT7
prerank,regulation of exit from mitosis (GO:0007096),0.24207002930632615,0.6515899121787545,0.9144981412639405,0.9621357087506015,1.0,9/38,19.82%,ANAPC1;RPS27A;UBC;PPP1R9B;NPM2;ANAPC10;UBE2S;ANAPC15;CDC14B
prerank,regulation of rRNA processing (GO:2000232),-0.23468605980591917,-0.6466941007984001,0.9420289855072463,0.9830558603049548,1.0,6/16,19.77%,HEATR1;BUD23;RIOK2;YTHDF2;TRMT112;NUDT16
prerank,modulation by symbiont of entry into host (GO:0052372),0.2824382274818101,0.6458993018368673,0.9005763688760807,0.9665603828638172,1.0,3/16,18.06%,TRIM25;TRIM14;EXOC7
prerank,cellular amino acid catabolic process (GO:0009063),0.2182783938403287,0.6452583390137191,0.9677765843179377,0.9667530854135886,1.0,19/87,24.43%,ARG1;KYNU;PRODH;MCCC1;HMGCL;HIBADH;FAH;GCDH;SLC25A44;ALDH7A1;OGDH;BLMH;MTRR;BCAT2;CARNMT1;IVD;GCSH;GOT1;SHMT2
prerank,DNA replication checkpoint signaling (GO:0000076),-0.2313759407078288,-0.6443546144176782,0.9137380191693291,0.9833870572469372,1.0,6/16,28.85%,RAD9B;TIMELESS;NAE1;TIPIN;TOPBP1;TICRR
prerank,bone morphogenesis (GO:0060349),-0.24217489108007684,-0.6443105935199102,0.9238410596026491,0.9820520041896281,1.0,2/14,6.05%,FGFR2;LRP5
prerank,calcium ion import across plasma membrane (GO:0098703),0.2930158745945358,0.6442748462061598,0.8897058823529411,0.9672098655610452,1.0,2/14,9.35%,SLC8A1;TRPV2
prerank,regulation of ion transport (GO:0043269),0.22299817258029322,0.6437408389797011,0.9572072072072072,0.9673057357436097,1.0,10/76,14.13%,DTNBP1;P2RX4;SIK1;NEDD4L;WWP2;SYT17;RAB11B;VAMP3;PRKN;GDNF
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.25977370198964,0.6431390968508683,0.9101876675603218,0.9674683585317451,1.0,3/23,11.57%,IGF1;ZBTB20;APP
prerank,tRNA 5'-leader removal (GO:0001682),0.2942938211212176,0.6429893072079745,0.9043348281016442,0.9672492263724184,1.0,3/13,16.13%,RPP25L;POP4;PRORP
prerank,ribosomal small subunit biogenesis (GO:0042274),0.24001583115060474,0.6420888259589952,0.9364508393285371,0.9676355349076795,1.0,15/39,29.34%,RPS14;NOP14;MRPS7;NOB1;TSR3;RPSA;PWP2;RPS27;SNU13;RRP36;LSM6;RIOK3;EMG1;NOL11;RPS7
prerank,negative regulation of hormone secretion (GO:0046888),-0.26828271167110784,-0.6419097085690473,0.9183673469387755,0.9823640795530348,1.0,2/10,23.31%,RAB11FIP5;IL1B
prerank,myelination in peripheral nervous system (GO:0022011),-0.2466872509436489,-0.6413237338902061,0.9003115264797508,0.9813655401232073,1.0,6/13,29.63%,PARD3;SIRT2;DICER1;LGI4;CNTNAP1;MYOC
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.2730680756160936,0.6407550030672748,0.9029126213592233,0.9683495489905601,1.0,5/18,25.67%,FZD7;NOTCH1;FRS2;CCN3;HDAC1
prerank,determination of left/right symmetry (GO:0007368),0.24079011644918819,0.639259510515254,0.9461444308445532,0.9691727124196089,1.0,6/36,18.47%,CCDC40;CITED2;CFAP53;NOTCH1;OFD1;BBS7
prerank,histone H2B ubiquitination (GO:0033523),0.3074365203463404,0.639054676851532,0.888208269525268,0.9690034089582948,1.0,1/10,3.29%,WAC
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.3018200314722019,0.6388563755053324,0.8819776714513556,0.9688198063043619,1.0,4/11,19.55%,THBS1;E2F2;PIK3CB;CREB3L1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.2291340284443515,-0.6387671919666608,0.9335664335664335,0.981698462486066,1.0,7/16,27.39%,RBMX;CIRBP;CELF4;TRA2B;SNW1;SF3B4;TRA2A
prerank,negative regulation of phosphatase activity (GO:0010923),0.2575437347444277,0.6386470828723276,0.9227799227799228,0.9686514644839,1.0,4/25,12.23%,STYXL1;BOD1;GSK3B;GPATCH2
prerank,rRNA pseudouridine synthesis (GO:0031118),0.3039736894697659,0.6380289204837911,0.874251497005988,0.9688019994856785,1.0,2/10,14.79%,DKC1;TSR3
prerank,regulation of histone methylation (GO:0031060),0.29083935418773715,0.6366214909547282,0.9057437407952872,0.9695479602336947,1.0,1/13,5.01%,CHTOP
prerank,negative regulation of GTPase activity (GO:0034260),0.2620342606012494,0.6361370193447156,0.926729986431479,0.9695807412660159,1.0,10/22,29.05%,RASA4;BCAS3;ARFGEF1;CPEB2;LRCH1;RCC2;HRAS;SH3BP4;LRRK2;GPSM1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.2961876802942818,0.6359661874825783,0.8910256410256411,0.9693828650268441,1.0,3/11,19.28%,ATF4;PRKN;FBXO7
prerank,negative regulation of cellular senescence (GO:2000773),0.28701112694167863,0.6347979602564199,0.9034175334323923,0.9699372151596153,1.0,6/13,29.64%,SIRT1;ZKSCAN3;FBXO5;CDK6;YBX1;TERF2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.30209302490606665,0.6341944955085163,0.9077598828696926,0.9700575577290602,1.0,4/10,31.06%,APP;DRD2;RAB5A;DLG4
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.2788615137083564,0.6336908480107877,0.8876080691642652,0.970081849116335,1.0,3/16,16.37%,PDGFA;NRP1;PTPN1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.24480733122185977,0.6318099266320163,0.9414012738853503,0.9711560095757592,1.0,3/30,5.22%,ABCD1;SLC27A4;HACD4
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.2662922905465912,-0.6311417356700562,0.9010989010989011,0.9852135091023945,1.0,1/10,2.11%,PRKCE
prerank,regulation of tube diameter (GO:0035296),0.2881981774082095,0.6311020484410537,0.8795355587808418,0.9710001948678678,1.0,2/13,16.72%,ROCK1;ACE
prerank,vascular process in circulatory system (GO:0003018),0.2881981774082095,0.6311020484410537,0.8795355587808418,0.9710001948678678,1.0,2/13,16.72%,ROCK1;ACE
prerank,rRNA methylation (GO:0031167),0.2597078529252312,0.6297346354209665,0.9009628610729024,0.9716235376653184,1.0,9/22,26.30%,NSUN3;MRM2;TFB2M;FBL;DIMT1;MTERF4;ZCCHC4;NSUN4;FDXACB1
prerank,nuclear membrane organization (GO:0071763),0.26662353988076326,0.6293983226988068,0.9258241758241759,0.971549289567915,1.0,5/19,20.79%,CHMP2A;VPS4A;NEMP1;CHMP7;TOR1A
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.2722327124822286,0.629036417960069,0.9184861717612809,0.9714826252870126,1.0,5/16,21.95%,PARP3;KMT5B;SHLD1;SHLD2;PRKDC
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.27424352375924166,0.6276060365791379,0.9124293785310734,0.9721729192144778,1.0,3/17,15.95%,VEGFA;GPLD1;NRP1
prerank,regulation of protein dephosphorylation (GO:0035304),0.2359725289880957,0.6255796738496449,0.9454545454545454,0.973275647858696,1.0,12/37,25.35%,PRKCD;ENSA;MFHAS1;DLC1;HTT;CALM2;PPP6R1;CDH5;PPIA;YWHAB;PPP6R3;SPPL3
prerank,focal adhesion assembly (GO:0048041),0.26045793429906433,0.6243053631226037,0.9195250659630607,0.9738204438049447,1.0,4/21,14.30%,ACTN1;DLC1;RHOD;WHAMM
prerank,regulation of stem cell population maintenance (GO:2000036),-0.22064933031740153,-0.6220405124510634,0.9475524475524476,0.989598194042778,1.0,6/18,22.88%,REST;CNOT2;CNOT1;MYC;ELAVL1;TAF6L
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.2557192624488155,-0.6219588104592604,0.9,0.9882862878849349,1.0,3/11,17.71%,FZD3;SIRT2;FAP
prerank,cell-substrate junction assembly (GO:0007044),0.2386811705679801,0.6217880389715658,0.9433962264150944,0.9752205623427298,1.0,6/33,15.07%,CD151;ACTN1;DLC1;RHOD;WHAMM;LAMA3
prerank,protein localization to phagophore assembly site (GO:0034497),0.3042112130958756,0.6214366853835244,0.9041095890410958,0.9751294680047372,1.0,5/11,24.26%,PACS2;ATG13;TRAPPC8;MFN2;STX17
prerank,histone deacetylation (GO:0016575),0.2261952978770509,0.6194851066833389,0.9573690621193667,0.9761312133676465,1.0,5/43,12.34%,RCOR1;SIRT6;TBL1XR1;SIRT1;SIRT7
prerank,tRNA 5'-end processing (GO:0099116),0.2739847516558028,0.6194659975928997,0.9179856115107914,0.9758087206815397,1.0,4/15,19.67%,RPP25L;POP4;PRORP;TRMT10C
prerank,regulation of cell aging (GO:0090342),0.29376614922107397,0.6184896737055164,0.9016393442622951,0.9761317196789617,1.0,1/11,4.42%,LMNA
prerank,protein deacetylation (GO:0006476),0.22702888363815005,0.617823159789674,0.9582309582309583,0.9762127820171439,1.0,5/41,12.34%,RCOR1;SIRT6;TBL1XR1;SIRT1;SIRT7
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.23347021768789572,0.6171216365508093,0.9485924112607099,0.9763559829039808,1.0,12/38,23.59%,NDUFS8;NDUFA10;NDUFC1;NDUFAB1;NDUFB6;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFB8;NDUFB9;NDUFA13
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.28937060746791654,0.6158714864865686,0.8953488372093024,0.9768785551539884,1.0,3/12,17.83%,GET3;SGTA;SEC63
prerank,regulation of cell projection organization (GO:0031344),-0.23509516827975419,-0.6154148241004782,0.9305135951661632,0.9907114687062012,1.0,1/13,0.90%,NTNG1
prerank,regulation of water loss via skin (GO:0033561),-0.22909098648003184,-0.615404299485599,0.9413793103448276,0.9880081710986988,1.0,6/15,33.43%,STMN1;FA2H;LSR;ALOXE3;SFN;CLDN1
prerank,establishment of skin barrier (GO:0061436),-0.22909098648003184,-0.615404299485599,0.9413793103448276,0.9880081710986988,1.0,6/15,33.43%,STMN1;FA2H;LSR;ALOXE3;SFN;CLDN1
prerank,regulation of catecholamine secretion (GO:0050433),0.23968014175694896,0.6148381546215552,0.9424552429667519,0.9772157401553699,1.0,1/29,0.64%,DTNBP1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.2736279264792121,0.6125138618564127,0.9212481426448736,0.9783857362286582,1.0,4/14,21.26%,ADAM17;PTK2B;CCL7;ADAM10
prerank,mammary gland development (GO:0030879),0.2608225749478819,0.6106555611815253,0.9482288828337875,0.9792433099328411,1.0,1/21,1.73%,VEGFA
prerank,protein alkylation (GO:0008213),0.2525501045722623,0.6093631486912958,0.9414965986394558,0.9797313362366487,1.0,3/22,8.63%,ETFBKMT;CAMKMT;ETF1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.19919324846143782,0.6092048974792742,0.9917355371900827,0.9794956376597758,1.0,45/145,26.80%,DYNC1H1;PSMD1;HAUS6;PSMF1;PSMD14;CEP76;PSMD12;TUBA1A;CLASP1;CEP192;PSME2;CUL1;ALMS1;NDE1;OFD1;CCP110;SSNA1;HAUS7;PSMB10;PSMD5;CDC25A;PSMD8;PAFAH1B1;PSMA3;FBXO5;PSMA2;PSMD11;PPP2R1A;PSMA6;RAD51B;HAUS5;CEP41;PSMB3;RCC2;PSME3;CDK2;CEP250;USP47;PSMC5;CEP152;CKAP5;AVEN;PSMC1;TUBA4A;MECP2
prerank,hippo signaling (GO:0035329),0.24293362769293103,0.6088228858560255,0.9423076923076923,0.9794062983390336,1.0,11/26,30.69%,STK3;LATS1;STK4;CASP3;WWTR1;MOB1A;YWHAB;MOB1B;TJP1;YWHAE;TEAD2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.2376791108714229,-0.607478285849829,0.926605504587156,0.9909475319577665,1.0,3/12,23.31%,CCR2;CARD9;IL1B
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.27534037357009183,0.6071634025380344,0.9033674963396779,0.9801065667639198,1.0,2/14,9.12%,UMPS;NT5E
prerank,positive regulation of ATPase activity (GO:0032781),0.22574141256486455,0.606845225555494,0.9533492822966507,0.979967192051865,1.0,7/41,14.87%,CHTOP;HNRNPU;VMP1;MYBPC3;PFN1;SSBP1;PFN2
prerank,regulation of complement activation (GO:0030449),0.22530273080580288,0.6064669527734587,0.9612121212121212,0.9798792074288161,1.0,2/40,4.93%,CD46;C3AR1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.22517006721279403,0.6048647581632831,0.9660606060606061,0.9805159181698173,1.0,3/40,4.99%,ABCD1;PID1;MTLN
prerank,organelle disassembly (GO:1903008),0.2297749753678726,0.6045072654612789,0.9553571428571429,0.9803968363840393,1.0,10/33,22.43%,KIF9;STX5;UBA5;TEX264;KIF5B;MTIF2;RETREG1;ATG2B;VCP;MTIF3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.24238295521659883,-0.6042195939919803,0.954954954954955,0.9912432140314018,1.0,2/11,6.64%,FMR1;PUM1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.2895579555336413,0.6041302484227071,0.9139280125195618,0.9802902910073855,1.0,2/10,10.68%,FLCN;SIRT1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.2883368665452199,0.6017295273574145,0.9158730158730158,0.9814117584161861,1.0,2/11,9.78%,ETV6;ARIH2
prerank,glial cell development (GO:0021782),0.24109910578734706,0.6013310267184224,0.9380764163372859,0.9812974696978607,1.0,8/25,24.68%,PRDM8;MT3;APP;NRROS;EIF2B2;HES5;CDK6;SOX4
prerank,regulation of gastrulation (GO:0010470),0.27421812756951025,0.6003933870739797,0.930780559646539,0.9814942989990632,1.0,2/14,13.70%,DAG1;CLASP1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.23989468483206156,0.5995345943652791,0.9556962025316456,0.9816650523221556,1.0,3/29,11.96%,MYL2;MYBPC3;NOTCH1
prerank,regulation of humoral immune response (GO:0002920),0.21983371403809182,0.5991089441078431,0.9784688995215312,0.9815767261240943,1.0,2/44,4.93%,CD46;C3AR1
prerank,isotype switching (GO:0045190),0.2865669302803181,0.5985330289822822,0.9129172714078374,0.981559126958626,1.0,3/10,22.84%,EXOSC3;HSPD1;RNF168
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2564516980449464,0.5981049214098016,0.9392265193370166,0.9814897120221728,1.0,6/18,25.75%,DKC1;EXOSC10;SHQ1;CCT2;RUVBL2;CCT7
prerank,negative regulation of hydrolase activity (GO:0051346),0.21491332816917713,0.5978531062726127,0.9673278879813302,0.9812872709437481,1.0,6/49,12.23%,MAPK7;RASA4;NEIL1;SLC39A14;BCAS3;GPATCH2
prerank,clathrin coat assembly (GO:0048268),0.2724829387398936,0.5967533408511633,0.9022222222222223,0.9815674175071092,1.0,7/15,25.02%,PICALM;FCHO1;EPS15;FCHO2;HIP1;AP2S1;CLTC
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.20676431713479043,-0.5966430889143769,0.953307392996109,0.9921345247577465,1.0,6/20,24.95%,BCAT1;DBT;ACADSB;AUH;ACAT1;HSD17B10
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.20676431713479043,-0.5966430889143769,0.953307392996109,0.9921345247577465,1.0,6/20,24.95%,BCAT1;DBT;ACADSB;AUH;ACAT1;HSD17B10
prerank,mitotic DNA replication (GO:1902969),-0.2503808348609523,-0.5964836379224967,0.931129476584022,0.9908731308870672,1.0,6/10,37.37%,LIG1;MCM6;MCMDC2;MCM4;GINS3;CDC45
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.20187075498992937,0.5955676739094886,0.985792349726776,0.9819083664991811,1.0,20/80,24.93%,PLPP3;UVRAG;COG7;KIF3A;RAB1B;KDELR2;GOLPH3;GOLPH3L;ARF4;ARF5;HTT;TAPBP;ARFGAP2;RAB1A;ERGIC2;ATP9B;TMED3;TMED10;COPB1;ARFGAP3
prerank,regulation of mRNA metabolic process (GO:1903311),0.2782462671211074,0.5938853147873212,0.9361370716510904,0.9824936855282412,1.0,3/11,21.17%,SRPK2;SRPK1;SAFB
prerank,coenzyme A metabolic process (GO:0015936),0.2632828108405204,0.5937168262471838,0.9295977011494253,0.9822564489397009,1.0,3/14,18.49%,COASY;PANK2;NUDT7
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.2647586345894947,0.5926712453056426,0.9180327868852459,0.9825178123139856,1.0,2/15,10.25%,YTHDF3;CNOT7
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.26167322468185267,0.5925979566698573,0.9346590909090909,0.9822208813525175,1.0,5/15,25.75%,DKC1;SHQ1;CCT2;RUVBL2;CCT7
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.21981612159074654,-0.5903103197061427,0.9584664536741214,0.9923878845450665,1.0,3/13,12.42%,UPP2;NEIL2;NT5C
prerank,negative regulation of ion transport (GO:0043271),0.24126173801188783,0.5898971749263818,0.943864229765013,0.9833628616593382,1.0,3/24,14.31%,LILRB1;PTK2B;HTR1B
prerank,female gamete generation (GO:0007292),-0.1853473412920114,-0.5895971804397359,0.9720930232558139,0.9913419172660328,1.0,14/29,38.79%,FMN2;METTL3;IHO1;PARN;TRIP13;PRDM9;MCM8;GDF9;PIWIL2;PTN;DMC1;HORMAD1;NANOS1;M1AP
prerank,cellular response to hydroxyurea (GO:0072711),0.28456617538143236,0.5867835381410397,0.9386503067484663,0.9846933920470333,1.0,4/10,22.95%,NSMCE3;DDI2;RTF2;SPIDR
prerank,heart process (GO:0003015),0.2649389961585136,0.5865039243460363,0.935064935064935,0.9844993223655206,1.0,7/14,32.37%,MYL2;ACE;GPX1;FYN;SGCG;SOD1;PPCS
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2576126204644112,0.5843178923661149,0.9360795454545454,0.9852987867208323,1.0,2/14,13.11%,NLRP2B;GAS6
prerank,positive regulation of collagen metabolic process (GO:0010714),0.2559376527197463,0.5832524393784543,0.9517906336088154,0.9855087257944855,1.0,1/17,2.52%,VIM
prerank,positive regulation of DNA replication (GO:0045740),0.25372076005709654,0.5810816032618236,0.9476584022038568,0.9862712508352366,1.0,6/16,22.53%,NPM2;STN1;ATAD5;CDT1;BCAR3;FAF1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.21082711177033311,0.5805564197170247,0.9769975786924939,0.9861956115800069,1.0,4/46,6.20%,MICALL2;ITGA4;LPXN;PARVB
prerank,protein depolymerization (GO:0051261),0.22925542183434433,0.5804662604153765,0.9534005037783375,0.9859049458309811,1.0,7/27,19.69%,NCKAP5L;CFL1;WDR1;MICAL2;DSTN;CFL2;MICAL1
prerank,mesenchymal cell development (GO:0014031),0.2467708977059618,0.5799975920553142,0.9396433470507545,0.9857987683857997,1.0,6/18,23.08%,SNAI2;NOTCH1;SOX8;PEF1;KLHL12;NOLC1
prerank,response to acidic pH (GO:0010447),0.2635016559695965,0.5793789526106792,0.943939393939394,0.9857607779637216,1.0,3/13,20.84%,CTSS;RAB11B;LGMN
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.24152648757218179,-0.5793339395911792,0.9585635359116023,0.9929579902189299,1.0,10/10,75.87%,CACNA2D4;REEP6;CNGB1;TULP1;GRM6;GNAT2;RPE65;GNAT1;CACNA1F;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.24152648757218179,-0.5793339395911792,0.9585635359116023,0.9929579902189299,1.0,10/10,75.87%,CACNA2D4;REEP6;CNGB1;TULP1;GRM6;GNAT2;RPE65;GNAT1;CACNA1F;CEP250
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.25388257512004775,0.578945974061873,0.9538461538461539,0.9856254394223629,1.0,4/16,17.90%,RTEL1;TERF1;TNKS;TNKS2
prerank,regulation of aerobic respiration (GO:1903715),0.2567639477711188,0.5780998188454147,0.9515669515669516,0.9857127369380422,1.0,4/15,24.43%,ABCD1;ATP7A;VCP;SHMT2
prerank,male meiosis I (GO:0007141),0.25128720331533344,0.5779218873161932,0.9486823855755895,0.9854650392236162,1.0,16/16,74.90%,FOXJ3;MYBL1;FOXJ2;BRDT;CCNA1;MEIOC;BTBD18;DNMT3L;ZSCAN21;MOV10L1;TDRD9;SLC25A31;ING2;HSF2BP;SYCP3;DDX4
prerank,embryonic eye morphogenesis (GO:0048048),-0.23022455162053673,-0.5772945069996311,0.945619335347432,0.9924077741644074,1.0,2/11,11.88%,RARG;FBN2
prerank,protein localization to cell-cell junction (GO:0150105),-0.21031013457403258,-0.5766343706811927,0.9654088050314465,0.9913447468082727,1.0,1/15,1.32%,F11R
prerank,protein localization to cell surface (GO:0034394),0.22994465580929085,0.5764345216344994,0.9540078843626807,0.9858416881525892,1.0,6/26,23.18%,CTNNB1;GGA2;PTPRU;PIGU;GGA3;FLNA
prerank,negative regulation of cholesterol transport (GO:0032375),0.2727558951470854,0.575589667379631,0.9390048154093098,0.9859034554072892,1.0,1/10,8.23%,ABCA2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2597780570650365,0.5745775941801519,0.9555555555555556,0.9860571056863744,1.0,2/14,11.85%,ANKRD17;PUM2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.24215220918923352,0.5745274854066047,0.9541160593792173,0.9857455489380424,1.0,2/20,12.17%,TSPOAP1;CYP46A1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.26590323521427384,0.5743366659380397,0.9457013574660633,0.9855038931552178,1.0,7/13,29.06%,BFAR;PTPN1;WFS1;PPP1R15B;ABCA7;ATF6B;DNAJB9
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.24066459735027274,-0.5734152186450276,0.9525065963060686,0.9911795118390184,1.0,4/10,24.79%,WNK1;CCR2;WNT5A;CCL5
prerank,regulation of immune effector process (GO:0002697),0.21369282934531672,0.5728016586090521,0.9721549636803875,0.9858753138938348,1.0,2/41,4.93%,CD46;C3AR1
prerank,DNA conformation change (GO:0071103),0.24222553984331197,0.5727129643251391,0.9615912208504801,0.9855753921965816,1.0,6/17,27.41%,TOP1;NAA10;PRM1;TOP3A;KAT6A;ERCC3
prerank,regulation of hippo signaling (GO:0035330),0.25008069056541576,0.5727096081640138,0.9393103448275862,0.9852429753074912,1.0,3/17,13.64%,WWC2;NF2;LIMD1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.19910698675603133,-0.5721923667465726,0.968421052631579,0.9903244916433539,1.0,2/18,7.21%,IRS1;REST
prerank,epithelial structure maintenance (GO:0010669),0.2738685581570523,0.5719919985080822,0.9401197604790419,0.9852236060948325,1.0,11/11,72.63%,TLR9;VSIG1;MUC2;MUC13;MUC4;RBP4;NOD2;MUC6;PIWIL4;CXADR;STRAP
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.2172133740458417,0.5705079704771426,0.9702602230483272,0.9855468314063608,1.0,6/34,21.13%,IL6;SPHK2;VAMP3;TNFRSF14;SCIMP;PTPRC
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.25055783867443016,0.5700978088297947,0.941908713692946,0.9854082996803172,1.0,3/16,15.79%,WRN;SSBP1;TWNK
prerank,monosaccharide transmembrane transport (GO:0015749),0.25203514607961075,0.5686037836812005,0.9424157303370787,0.9857273802790975,1.0,3/16,19.51%,SLC23A2;SLC23A1;SLC50A1
prerank,negative regulation of hippo signaling (GO:0035331),0.2631949943100476,0.5668342075928806,0.9447761194029851,0.9861694478406708,1.0,1/12,2.73%,WWC2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.23297743300714596,0.5660631942038489,0.951856946354883,0.9861803243093507,1.0,7/20,25.77%,PTK2B;MAFB;CDC73;ZBTB16;CDK6;HSPA9;ZFP36
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2116105543699713,0.5650878685624423,0.9855421686746988,0.9862697657317596,1.0,8/39,22.10%,IRS2;TRH;AACS;NLGN2;AIMP1;TCF7L2;GCK;DRD2
prerank,peptidyl-proline modification (GO:0018208),0.22980807614493004,0.5644145871057338,0.967828418230563,0.9862357175453653,1.0,5/25,15.24%,PPIF;PPIH;CWC27;PPIE;FKBP7
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.23599728305624482,0.5622141867340921,0.9595687331536388,0.9868372059923906,1.0,2/20,9.21%,PID1;PICALM
prerank,serine family amino acid catabolic process (GO:0009071),-0.23393170976650765,-0.5616749239514282,0.9467455621301775,0.9927673478526796,1.0,10/10,76.63%,SHMT1;CBS;THNSL2;DAO;GLDC;SDS;DLD;AMT;SHMT2;GCSH
prerank,negative regulation of insulin secretion (GO:0046676),0.24436940572631854,0.5599533062279607,0.9612625538020086,0.9874452949034097,1.0,3/17,13.77%,PIM3;MIDN;PRKN
prerank,protein prenylation (GO:0018342),-0.23740633474534065,-0.5594321823697911,0.9517045454545454,0.9921890299002512,1.0,2/10,18.00%,CHML;PTAR1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.25942699151319176,0.5593845016392996,0.93993993993994,0.9870242180901115,1.0,2/12,16.75%,IGF1;STIMATE
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.25942699151319176,0.5593845016392996,0.93993993993994,0.9870242180901115,1.0,2/12,16.75%,IGF1;STIMATE
prerank,xenobiotic transport (GO:0042908),0.24424884179380363,0.5579880280756429,0.9572413793103448,0.9872511143271204,1.0,2/17,7.85%,ABCC3;ABCA3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.1937628619866239,0.5578373798728113,0.9875141884222475,0.9869791950861572,1.0,2/76,1.42%,SASH1;ADGRG3
prerank,oligodendrocyte differentiation (GO:0048709),0.23012113713564925,0.5573250829061787,0.9656593406593407,0.986847737594533,1.0,5/19,20.76%,SOX9;PRDM8;EIF2B2;SOX8;HES5
prerank,visual perception (GO:0007601),0.18802598892373734,0.5569035096524805,0.9966960352422908,0.9866779018937621,1.0,16/84,24.31%,DHRS3;RDH12;COL1A1;PITPNA;COL11A1;MYO9A;DRAM2;OAT;WFS1;RPGR;POU6F2;EML2;KIFC3;RGS16;CEP250;ATXN7
prerank,negative regulation of RNA splicing (GO:0033119),0.23685323664733698,0.5565921238592403,0.9661246612466124,0.9864627352577541,1.0,4/19,18.09%,PTBP3;PTBP2;RPS26;C1QBP
prerank,cardiac myofibril assembly (GO:0055003),0.2453100322481662,0.5562811022426476,0.9474431818181818,0.9862592464458292,1.0,1/15,4.43%,MYL2
prerank,cGMP metabolic process (GO:0046068),-0.2130871293457651,-0.5550386206725132,0.9834437086092715,0.992342387493019,1.0,7/12,40.58%,GUCY1A1;GUCY1B1;PDE2A;NPR1;GUCY2F;GUCY2D;GUCY2C
prerank,regulation of transport (GO:0051049),0.20804876212504195,0.5547287088747416,0.9815270935960592,0.9865425353135251,1.0,10/36,22.34%,TRAT1;FES;POFUT2;PRKN;NRP1;GAPVD1;DNAJA1;VAMP2;ACTG1;DISP3
prerank,protein mannosylation (GO:0035268),0.2252757344766481,0.552456329255556,0.9588313413014609,0.9870627591332426,1.0,3/22,14.45%,DPM2;TMTC4;FKTN
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.1958433841830008,-0.5512289609750135,0.979933110367893,0.9922290055102637,1.0,4/16,24.31%,TGFB2;SOX6;NUDT21;FOXC1
prerank,negative regulation of transposition (GO:0010529),0.24148208723312264,0.5502393058969377,0.9558011049723757,0.9875690162451894,1.0,2/16,12.34%,SMYD5;SIRT7
prerank,response to hydroxyurea (GO:0072710),0.2636702606979147,0.5501778128726817,0.9578947368421052,0.9872593348674228,1.0,4/11,22.95%,NSMCE3;DDI2;RTF2;SPIDR
prerank,neurotransmitter biosynthetic process (GO:0042136),0.2484932194876944,0.5477355481918856,0.9608127721335269,0.987842983091194,1.0,14/14,75.17%,ALDH9A1;SLC6A4;DAGLB;PAH;DBH;SLC6A3;SLC44A4;SLC22A2;DAGLA;SLC5A7;ACHE;MOXD1;NOS1;CHAT
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.19744255714301293,0.5459904371322417,0.9827387802071347,0.9881186333592352,1.0,10/50,22.11%,CDKN1A;GADD45A;CDK7;CCNA2;CNPPD1;MNAT1;CDC25A;CCNG1;GTPBP4;CCNT1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.26082079029728844,0.5438882547597276,0.9609756097560975,0.9885018274182263,1.0,1/10,6.49%,APC
prerank,male gonad development (GO:0008584),0.20654567004295876,0.543569731776237,0.9825436408977556,0.9882779856784096,1.0,6/34,21.88%,NCOA4;SOX9;NR5A1;SOX8;LRP2;MAMLD1
prerank,stem cell development (GO:0048864),0.23806062485032092,0.5430606912580881,0.9699140401146131,0.9881156140853519,1.0,6/16,23.08%,SNAI2;SOX8;PTPRC;PEF1;KLHL12;NOLC1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.2155289760637173,0.5391746772233927,0.9782903663500678,0.9890605578522934,1.0,4/23,18.09%,MPP1;MOSPD2;BST1;C1QBP
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.24322276906168028,0.5374012600867817,0.96,0.9892918125371145,1.0,4/14,22.25%,RPL7L1;WDR12;RPL7;BOP1
prerank,motor neuron axon guidance (GO:0008045),0.2363113858069016,0.536297570865774,0.9686609686609686,0.9892966770724885,1.0,1/15,3.92%,NTN3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.2133534480886934,-0.5359063209751713,0.9745042492917847,0.9951409366555742,1.0,4/11,23.17%,UGGT2;DERL1;UFD1;POMT2
prerank,inner ear morphogenesis (GO:0042472),0.22143073009331912,0.532296288093911,0.973314606741573,0.9902322666180174,1.0,3/22,16.91%,SOX9;PAX8;CHD7
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.1835633284861659,0.5318493633053176,0.9978517722878625,0.990027772381274,1.0,18/82,21.48%,DYNC1H1;HAUS6;GTSE1;CEP76;TUBA1A;CLASP1;CEP192;ALMS1;NDE1;OFD1;CCP110;SSNA1;HAUS7;ATAD5;PAFAH1B1;PPP2R1A;HAUS5;CEP41
prerank,regulation of T cell chemotaxis (GO:0010819),-0.21631259890129495,-0.5303163048477002,0.972972972972973,0.9952307184275399,1.0,4/11,24.79%,WNK1;CCR2;WNT5A;CCL5
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.22865831997463976,0.5290532584408185,0.9790794979079498,0.9905146467784779,1.0,3/18,15.61%,PPIF;NAIF1;BNIP3
prerank,regulation of response to interferon-gamma (GO:0060330),0.23672820491452604,0.5265143214253852,0.963276836158192,0.9909045651724204,1.0,1/14,4.49%,IFNGR2
prerank,inner mitochondrial membrane organization (GO:0007007),0.19261438715917722,0.526368597104738,0.991812865497076,0.990614226570988,1.0,11/47,23.78%,TIMM22;LETM1;ATP5F1A;ATP5F1D;ATP5F1C;AFG3L2;IMMT;MICOS13;HSPA9;NDUFA13;MTX2
prerank,chromatin assembly (GO:0031497),0.1930352630527178,0.522457428225689,0.995085995085995,0.9914046927905212,1.0,4/38,10.68%,ANP32B;BRD2;SOX9;SIRT1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.2518221615591961,0.5216973154290491,0.9698890649762282,0.9912803593658623,1.0,3/10,23.46%,NCBP2;CDC73;CPEB1
prerank,skeletal muscle contraction (GO:0003009),0.2195628645913652,0.5207045330003549,0.9669876203576341,0.9912224089727887,1.0,2/19,16.15%,STAC2;STAC3
prerank,positive regulation of mitochondrial translation (GO:0070131),0.230318172229254,0.5201420145336171,0.9855699855699855,0.9910447819895388,1.0,4/14,20.24%,RMND1;C1QBP;TRMT10C;COA3
prerank,glutamine family amino acid metabolic process (GO:0009064),0.1999910437745121,0.5180938598648597,0.9939831528279182,0.9912696608127345,1.0,4/33,18.03%,MTHFS;PRODH;ALDH18A1;OAT
prerank,estrogen metabolic process (GO:0008210),-0.1849326050197129,-0.5167357938713318,0.9967637540453075,0.9969047811235555,1.0,9/15,43.90%,HSD17B7;SULT1A1;HSD17B10;HSD17B1;CYP1A1;CYP1B1;HSD17B14;UGT1A7;UGT1A1
prerank,mitochondrial fusion (GO:0008053),0.21841751384112668,0.5144975593090941,0.9730878186968839,0.9918550281356067,1.0,5/18,22.86%,GDAP1;BAX;USP30;AFG3L2;MFN2
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.21609378975667137,0.5121074652303382,0.9723756906077348,0.9921089498713888,1.0,1/18,5.10%,IGF1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.23591679917894187,0.5099504959378446,0.9610778443113772,0.9922899287734213,1.0,2/12,17.36%,BOD1;CDT1
prerank,protein polyglutamylation (GO:0018095),0.2409205322358395,0.5093661912834118,0.9696509863429439,0.9921001169745486,1.0,3/11,22.05%,CFAP20;CEP41;TTLL4
prerank,endothelial cell development (GO:0001885),-0.1565458842610875,-0.5074615987254439,1.0,0.9973404861900825,1.0,13/25,39.02%,RAP1B;RAPGEF3;RAPGEF2;MARVELD2;PDE2A;PPP1R16B;COL22A1;MYADM;COL18A1;PECAM1;COL15A1;STC1;RAP1A
prerank,amino sugar metabolic process (GO:0006040),0.24512067041618407,0.497287162436071,0.964451313755796,0.9943719608128794,1.0,5/10,31.38%,GFPT1;EXTL2;SLC35A3;GFPT2;ST3GAL1
prerank,positive regulation of dephosphorylation (GO:0035306),0.19564164869155704,0.4963916890048349,0.9937027707808564,0.9942234676285082,1.0,2/27,8.74%,PRKCD;DLC1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.2222343018375222,0.49582377187031634,0.9864864864864865,0.9939968615818081,1.0,2/13,13.11%,MAVS;GAS6
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.227051023463108,0.4920212645346712,0.9775112443778111,0.9944163075367819,1.0,3/13,21.58%,DDIT3;SIN3A;TAF1
prerank,odontogenesis (GO:0042476),0.1847169075346879,0.49150711081446363,0.9939098660170523,0.9941866760356258,1.0,1/35,1.90%,AQP1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.20567656731810718,0.4899634140014657,0.9817671809256662,0.9941352464288422,1.0,2/18,13.40%,RFC3;POLA1
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.1656688096139764,-0.4863451393570079,0.9894366197183099,0.9993094882237269,1.0,6/18,28.36%,METTL3;PRELID1;CCR2;IL4I1;ABL1;CD2
prerank,regulation of ERAD pathway (GO:1904292),-0.1925177327223652,-0.4805421345285448,0.9942363112391931,0.9986957502010736,1.0,11/11,80.77%,TMEM259;USP19;USP25;AQP11;BAG6;UBXN1;USP13;RNF185;RNFT1;HERPUD1;ATXN3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.20970923387351972,0.4768025233552494,0.9822646657571623,0.9960351610693706,1.0,8/16,30.26%,HELB;SHLD1;RADX;SHLD2;UBQLN4;KLHL15;FANCB;RIF1
prerank,synaptonemal complex assembly (GO:0007130),0.200853895900044,0.4529742400421497,0.9867256637168141,0.9984624473889655,1.0,15/15,79.93%,RAD21;P3H4;SYCP2;SYCE1;SYCE3;SYCP1;RAD21L1;TEX12;BAG6;HORMAD1;REC8;TEX11;SYCE2;TRIP13;STAG3
prerank,synaptonemal complex organization (GO:0070193),0.200853895900044,0.4529742400421497,0.9867256637168141,0.9984624473889655,1.0,15/15,79.93%,RAD21;P3H4;SYCP2;SYCE1;SYCE3;SYCP1;RAD21L1;TEX12;BAG6;HORMAD1;REC8;TEX11;SYCE2;TRIP13;STAG3
prerank,positive regulation of stem cell proliferation (GO:2000648),0.19151315301828872,0.4494088833035461,0.9958960328317373,0.9985201425242991,1.0,1/17,6.88%,HNRNPU
prerank,heterochromatin assembly (GO:0031507),-0.1544376406125026,-0.4492927301544427,1.0,1.0,1.0,11/20,37.30%,SMCHD1;SIRT2;BEND3;SUV39H1;ZNFX1;HELLS;EZH1;CDKN2A;HMGA1;HMGA2;H3-3A
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.2089945091320738,0.4351211164138835,0.9910044977511244,0.9994952016496648,1.0,3/10,30.36%,DERL2;SVIP;UBE2G2
prerank,hematopoietic stem cell differentiation (GO:0060218),0.21061972731151893,0.43044737259604837,0.992603550295858,0.9995307765134989,1.0,2/10,17.27%,ACE;MLLT3
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.1432462843884465,-0.4274621882282979,1.0,1.0,1.0,1/20,2.11%,PRKCE
prerank,aspartate family amino acid catabolic process (GO:0009068),0.18082595874082752,0.4244780198308082,0.9971631205673759,0.9996163406520837,1.0,3/19,16.57%,GCDH;ALDH7A1;OGDH
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.15812460358305444,-0.4220193645283094,1.0,0.9990444254447165,1.0,9/15,45.73%,EDA;FOXC1;GLI2;BMP2;ROGDI;WNT6;MSX1;TBX1;AMELX
prerank,mesonephros development (GO:0001823),0.19707558525634594,0.41644816756256825,0.9939849624060151,0.9997959787367017,1.0,2/11,20.97%,PAX8;ZBTB16
prerank,organic cation transport (GO:0015695),0.17342710915502102,0.4107713963988424,0.9958960328317373,0.9997617908819589,1.0,3/20,21.68%,SLC25A42;SLC44A2;SLC22A5
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.18312872078537729,0.4103703581935915,0.9985358711566618,0.9994512787319092,1.0,1/16,9.99%,SLC39A14
prerank,nuclear transport (GO:0051169),0.18057116475108714,0.41020521815179917,0.9972183588317107,0.999126161843804,1.0,3/16,19.83%,RSRC1;NUP98;XPO1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.17169081182259982,0.38946896584979585,1.0,0.9996648734638995,1.0,2/16,14.71%,SNAI2;CXCL12
prerank,steroid hormone biosynthetic process (GO:0120178),0.1465572504399648,0.3693093333989008,1.0,0.9998500481687607,1.0,7/29,29.10%,TSPOAP1;HSD17B11;SRD5A1;SRD5A3;HSD17B2;TSPO;FDXR
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.16403194589566097,0.349062275422672,1.0,0.9997907789252437,1.0,1/12,11.31%,TSPOAP1
